<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
<url><loc>https://www.posterkeep.com/</loc><lastmod>2026-07-18</lastmod><changefreq>weekly</changefreq><priority>1.0</priority></url>
<url><loc>https://www.posterkeep.com/collections</loc><lastmod>2026-07-18</lastmod><changefreq>weekly</changefreq><priority>0.9</priority></url>
<url><loc>https://www.posterkeep.com/pricing</loc><lastmod>2026-07-18</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/about</loc><lastmod>2026-07-18</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/contact</loc><lastmod>2026-07-18</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/</loc><lastmod>2026-07-09</lastmod><changefreq>weekly</changefreq><priority>0.9</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/1</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/2</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/3</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/4</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/5</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/6</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/7</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/8</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/9</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/10</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/11</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/12</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/13</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/14</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/15</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/16</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/17</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/18</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/19</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/20</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/21</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/22</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/23</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/24</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/25</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/26</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/27</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/28</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/29</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/30</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/31</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/32</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/33</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/34</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/35</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/36</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/37</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/38</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/39</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/40</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/41</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/42</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/43</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/44</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/45</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/46</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/47</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/48</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/49</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/50</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/51</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/52</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/53</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/54</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/55</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/56</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/57</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/58</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/59</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/60</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/61</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/62</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/63</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/64</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/65</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/66</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/67</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/68</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/69</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/70</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/71</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/72</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/73</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/74</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/75</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/76</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/77</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/78</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/79</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/80</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/81</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/82</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/83</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/84</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/85</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/86</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/87</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/88</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/89</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/90</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/91</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/92</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/93</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/94</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/95</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/96</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/97</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/98</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/99</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/100</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/101</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/102</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/103</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/104</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/105</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/106</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/107</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/108</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/109</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/110</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/111</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/112</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/113</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/114</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/115</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/116</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/117</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/118</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/119</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/120</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/121</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/122</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/123</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/124</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/125</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/126</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/127</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/128</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/129</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/130</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/131</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/132</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/133</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/134</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/135</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/136</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/137</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/138</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/139</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/140</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/141</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/142</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/143</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/144</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/145</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/146</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/147</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/148</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/149</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/150</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/151</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/152</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/153</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/154</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/155</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/156</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/157</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/158</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/159</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/160</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/161</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/162</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/163</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/164</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/165</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/166</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/167</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/168</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/169</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/170</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/171</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/172</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/173</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/174</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/175</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/176</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/177</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/178</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/179</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/180</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/181</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/182</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/183</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/184</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/185</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/186</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/187</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/188</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/189</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/190</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/191</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/192</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/193</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/194</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/195</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/196</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/197</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/198</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/199</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/200</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/201</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/202</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/203</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/204</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/205</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/206</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/207</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/208</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/209</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/210</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/211</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/212</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/213</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/214</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/215</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/216</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/217</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/218</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/219</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/220</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/221</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/222</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/223</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/224</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/225</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/226</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/227</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/228</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/229</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/230</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/231</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/232</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/233</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/234</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/235</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/236</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/237</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/238</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/239</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/240</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/241</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/242</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/243</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/244</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/245</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/246</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/247</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/248</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/249</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/250</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/251</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/252</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/253</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/254</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/255</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/256</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/257</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/258</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/259</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/260</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/261</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/262</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/263</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/264</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/265</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/266</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/267</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/268</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/269</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/270</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/271</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/272</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/273</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/274</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/275</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/276</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/277</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/278</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/279</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/280</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/281</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/282</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/283</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/284</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/285</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/286</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/287</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/288</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/289</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/290</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/291</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/292</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/293</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/294</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/295</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/296</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/297</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/298</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/299</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/300</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/301</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/302</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/303</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/304</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/305</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/306</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/307</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/308</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/s/309</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/0</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/0.jpg</image:loc><image:title>Enhanced therapeutic efficacy of ApoA1-Anti CD99 antibody fusion protein for treatment of Ewing sarcoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1.jpg</image:loc><image:title>Cutting-edge, drug-free targeted cancer therapeutic: Smart folate-conjugated copolymer intrinsically disables the YAP/TAZ-HIPPO oncoproteins and abrogates pancreatic cancer progression and metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2.jpg</image:loc><image:title>Design of a ligand targeted radiotherapy for treatment of bone metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3.jpg</image:loc><image:title>DNA damage chemical inducers of proximity (DD-CIP) for targeted cancer therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4.jpg</image:loc><image:title>AI guided engineering of pH responsive antibodies enables tumor selective targeting and improves the therapeutic index</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6.jpg</image:loc><image:title>An integrated high-throughput assay for proliferative phenotypic and omics profiling of single tumor cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/7.jpg</image:loc><image:title>Chemoproteomic discovery of allosteric covalent GSTO1 inhibitors reveals a previously unrecognized binding mode with anti-inflammatory activity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/8</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/8.jpg</image:loc><image:title>Transcriptomic evaluation of a potent trifluoromethyl phenyl acetamide derivative for its anticancer effect</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/9</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/9.jpg</image:loc><image:title>The natural compound KH617 reverses glioblastoma resistance to alkylating agents via MGMT modulation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/10</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/10.jpg</image:loc><image:title>KH617 API manufacturing: A synthetic biology approach</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/11</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/11.jpg</image:loc><image:title>Broad-spectrum antitumor activity of the biosynthetically derived molecule KHN705</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/12</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/12.jpg</image:loc><image:title>The natural compound KH617: A safe and selective therapeutic agent targeting GBM metabolic reprogramming</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/13</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/13.jpg</image:loc><image:title>Characterization of BLU-448: A potent and selective degrader of CDK4 for the treatment of HR+/HER2- breast cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/14</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/14.jpg</image:loc><image:title>A systematic mass spectrometry-based chemoproteomic platform (chomiXdegrade TM ) for molecular glue degrade discovery and mechanistic dissection</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/15</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/15.jpg</image:loc><image:title>Preclinical evaluation of a novel orally bioavailable MDM2 PROTAC, NW-8-461, in acute leukemia and myelofibrosis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/16</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/16.jpg</image:loc><image:title>Orally bioavailable BCL6 degrader HSK47977 featuring a novel CRBN ligand demonstrates potent antitumor activity and synergy with BCL2 inhibition in NHL</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/17</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/17.jpg</image:loc><image:title>Identification of a potent and selective PPIL4 degrader with therapeutic potential from a library of Cereblon modulators</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/18</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/18.jpg</image:loc><image:title>Decoding single-cell protein interactomes of CAR T cells with the Proximity Network Assay</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/19</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/19.jpg</image:loc><image:title>Elucidating plasma bacterial and host derived metabolites unique to epithelial ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/20</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/20.jpg</image:loc><image:title>A chemoproteomic photoaffinity platform(PAfBPP) enables target identification and mechanistic dissection of aristolochic acid-induced nephrotoxicity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/21</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/22</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/22.jpg</image:loc><image:title>Nutrigenomic stratification defines an HMGCS2-low, high-risk EO-CRC subset with a targetable stress-response vulnerability</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/23</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/23.jpg</image:loc><image:title>Integrated computational design and cDNA display selection enable cyclic peptide radiopharmaceutical ligand discovery</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/24</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/24.jpg</image:loc><image:title>DLL3 expression on circulating tumor cells predicts response to bispecific antibody tarlatamab</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/25</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/25.jpg</image:loc><image:title>Prostate cancer phenotypes determined from circulating tumor DNA associate with outcomes to 177 Lu-PSMA-617 therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/26</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/26.jpg</image:loc><image:title>Tumor CTR1 and serum copper dynamics reveal a coordinated copper axis linked to high-grade triple-negative breast cancer biology</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/27</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/27.jpg</image:loc><image:title>Mapping the spatiotemporal dynamics of CD44v9 reveals a senescent cell therapy-resistant niche in pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/28</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/28.jpg</image:loc><image:title>First-line (1L) trastuzumab deruxtecan (T-DXd) regimens in advanced HER2-positive (HER2+) gastric cancer (GC), gastroesophageal junction adenocarcinoma (GEJA), or esophageal adenocarcinoma (EA): Exploratory analysis of baseline HER2-related biomarkers in DESTINY-Gastric03 (DG-03) Part 2</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/29</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/29.jpg</image:loc><image:title>Exploratory biomarker analysis of the phase 3 RATIONALE 305 trial: First-line (1L) tislelizumab (TIS) + chemotherapy (CT) vs placebo (PBO) + CT for advanced gastric cancer/gastro-oesophageal junction adenocarcinoma (GC/GEJC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/30</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/30.jpg</image:loc><image:title>EphA2 expression across molecular and histological subtypes in muscle-invasive bladder cancer (MIBC) and its association with Nectin-4 and HER2</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/31</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/31.jpg</image:loc><image:title>Lorlatinib in advanced ALK-positive non-small cell lung cancer: Efficacy, safety and exploration of predictive biomarkers for therapeutic response</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/32</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/32.jpg</image:loc><image:title>HSPBP1 9 bp insertion mutation concurrent with pro-apoptosis and NF-&amp;#954;B genomic integrity predicts response to bortezomib-mediated proteasome inhibition in recurrent glioblastoma treated in NCT03643549 trial</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/33</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/33.jpg</image:loc><image:title>Precision biomarkers for cdk4/6 inhibitors plus endocrine treatment inHR+/HER2-breast cancer: External validation of mechanistic and hybrid predictive models across multiple neoadjuvant trials.</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/34</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/34.jpg</image:loc><image:title>Sensitive detection of MYCN amplified neuroblastoma in blood samples with structural variants using standard whole genome sequencing</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/35</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/35.jpg</image:loc><image:title>Cluster of differentiation 44 variant isoform 9 defines cancer stem cell reservoirs in pancreatic intraepithelial neoplastic spatial niches</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/36</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/37</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/37.jpg</image:loc><image:title>DAC-002, a novel IKZF1/3 MGD-CD38 degrader-antibody conjugate for MM treatment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/38</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/38.jpg</image:loc><image:title>Preclinical development of a potential first-in-class CDH17/CEACAM5 targeted bispecific antibody drug conjugate (ADC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/39</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/40</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/41</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/42</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/43</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/43.jpg</image:loc><image:title>Novel hydrophilic linker to improve stability and in vitro activity of antibody-drug conjugates</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/44</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/44.jpg</image:loc><image:title>Inhibiting WEE1 kinase enhances sensitivity of high grade serous ovarian cancer cells to the novel KIF18A inhibitor ATX020</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/45</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/46</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/47</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/47.jpg</image:loc><image:title>Pan-GATA molecular glues as novel tools for targeted degradation of GATA3in ER+breast cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/48</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/48.jpg</image:loc><image:title>Systematic discovery and validation of tumor-specific splice isoforms in endometrial cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/49</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/50</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/50.jpg</image:loc><image:title>A novel oral G-quadruplex stabilizer for the treatment of DNA repair-deficient cancers, including brain metastases</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/51</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/51.jpg</image:loc><image:title>Disruption of melanoma cell proliferation by inhibition of KIFC1</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/52</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/52.jpg</image:loc><image:title>Orthosteric and allosteric determinants of CRAF binding to RAS</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/53</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/54</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/54.jpg</image:loc><image:title>Oral fulvestrant nanoparticles deliver high, sustained exposure: An alternative to IM injection</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/55</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/55.jpg</image:loc><image:title>PLB-015 a novel anti-HER2 dual payload ADC for the treatment of HER2 positive solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/56</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/56.jpg</image:loc><image:title>Discovery of Helicon peptides that selectively degrade the agonist-bound androgen receptor (AR ON ) in prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/57</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/57.jpg</image:loc><image:title>Combination of isorhapontigenin and FSP1 inhibitor suppresses triple negative breast cancer cell progression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/58</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/58.jpg</image:loc><image:title>PAK4 inhibition enhances tumor immunity by inducing viral mimicry</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/59</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/59.jpg</image:loc><image:title>Targeting suv39h1 epigenetic silencing to induce viral mimicry and suppress glioblastoma growth</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/60</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/60.jpg</image:loc><image:title>Natural killer (NK) cell therapies for breast cancer brain metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/61</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/61.jpg</image:loc><image:title>Highly plastic macrophage niches orchestrate acquired quiescence and reactivation in breast-cancer bone metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/62</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/62.jpg</image:loc><image:title>Prostatic luminal epithelial cells in proliferative inflammatory atrophy display proinflammatory innate immune signaling activation that is absent in prostatic adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/63</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/63.jpg</image:loc><image:title>Obesity contributes to varied efficacy of non-covalent KRAS G12D inhibitor in murine models of pancreatic ductal adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/64</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/64.jpg</image:loc><image:title>Disrupting mismatch repair makes mismatch repair-proficient tumors immunogenic and induces CD8 T cell-dependent, but T cell receptor-independent, immune control of heterologous tumors in mice</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/65</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/65.jpg</image:loc><image:title>Gut microbiome signatures of survival and immunotherapy response in advanced thyroid cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/66</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/66.jpg</image:loc><image:title>Oncogenic KRAS suppresses DNA sensing via CD9 by remodeling membrane tension to clear extracellular tumor DNA</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/67</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/67.jpg</image:loc><image:title>Claudin-1 modulates the melanoma immune microenvironment to promote tumor growth and is a candidate therapeutic target for advanced melanoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/68</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/68.jpg</image:loc><image:title>Macrophage-dendritic cell-T-cell tetrads orchestrate antitumor immunity and response to checkpoint blockade</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/69</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/69.jpg</image:loc><image:title>Regulatory T cells control anti-tumor microglia function in breast cancer brain metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/70</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/70.jpg</image:loc><image:title>Identifying mechanisms of immune suppression in KRAS-inhibitor resistance in NSCLC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/71</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/71.jpg</image:loc><image:title>PHIP suppresses NuRD to enable the growth of SWI/SNF-mutant cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/72</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/73</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/74</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/74.jpg</image:loc><image:title>ACTL6A, subunit of SW/SNF chromatin remodeling complex, drives immune evasive phenotype in head and neck squamous cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/75</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/76</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/76.jpg</image:loc><image:title>Whole-genome analysis identifies novel molecular subtypes and driver structural variants in Japanese ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/77</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/77.jpg</image:loc><image:title>Cervical cancer in Guatemala: Molecular mechanisms of carcinogenesis by rare HPV types</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/78</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/78.jpg</image:loc><image:title>&amp;#8203;&amp;#8203;Whole-genome sequencing reveals distinct mutational mechanisms across endometrial cancer subtypes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/79</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/80</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/81</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/82</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/83</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/84</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/84.jpg</image:loc><image:title>Peptides targeting PIP4K2A : A novel therapeutic strategy for PTEN-deficient cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/85</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/85.jpg</image:loc><image:title>Single-cell dissection of ESCC identifies targetable cells-of-origin and therapeutic vulnerabilities in early tumorigenesis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/86</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/86.jpg</image:loc><image:title>Integrated transcriptomic and immune-clonal evolution defines stepwise molecular progression in lung adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/87</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/87.jpg</image:loc><image:title>Integrative analysis of genomic and transcriptomic data informs precancer progression in the pancreas</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/88</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/88.jpg</image:loc><image:title>Engineering antigen-dependent stability in nanobodies: A bioinformatics tool for tuning intracellular nanobody stability</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/89</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/89.jpg</image:loc><image:title>Epigenetic-neurotransmitter crosstalk between EZH2 and dopamine D1 receptor signaling in triple-negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/90</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/90.jpg</image:loc><image:title>scSubtype2.0: Predictor of breast cancer molecular subtypes at single cell resolution</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/91</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/91.jpg</image:loc><image:title>Identification of germline AEN polymorphisms as risk factors in cervical cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/92</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/92.jpg</image:loc><image:title>High-definition signatures of single-base substitutions in human cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/93</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/93.jpg</image:loc><image:title>Identifying noncanonical sources of cancer neoepitopes using PEPMatch and CEDAR</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/94</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/94.jpg</image:loc><image:title>Somatic NFKBIZ v ariant modulates inflammation at single-cell resolution</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/95</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/95.jpg</image:loc><image:title>The PER3-RORB axis defines a tumor-suppressive circadian state associated with improved survival in head and neck squamous cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/96</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/96.jpg</image:loc><image:title>Spatial transcriptomics uncovers patterns of transcriptional reprogramming and immune evasion in small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/97</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/97.jpg</image:loc><image:title>RAS(ON) multi-selective inhibition remodels cancer-associated fibroblast subtypes and extracellular matrix in pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/98</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/98.jpg</image:loc><image:title>Quantifying the selective advantage of copy number amplifications to reveal therapeutic targets in ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/99</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/99.jpg</image:loc><image:title>RNA fusions: An untapped source of neoantigens for immune based breast cancer prevention and treatment across all subtypes of breast cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/100</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/101</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/101.jpg</image:loc><image:title>Differentiation state and immune interaction contribute to drug response in AML</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/102</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/102.jpg</image:loc><image:title>COSMIC: Advancing the cancer genomics knowledgebase of somatic mutations</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/103</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/103.jpg</image:loc><image:title>Functional pathway analysis reveals discordance between clinical HER2 status and downstream effector activation in breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/104</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/104.jpg</image:loc><image:title>Characterizing tumor-stroma interfaces in chemotherapy-treated ovarian cancer via spatial transcriptomics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/105</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/105.jpg</image:loc><image:title>Mutational signatures in cancer genomes alter short linear protein motifs involved in cellular signaling networks</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/106</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/106.jpg</image:loc><image:title>CpGene: a DNA methylation-based biomarker discovery platform</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/107</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/107.jpg</image:loc><image:title>Defining spatial biomarkers of survival across solid tumors using a pan-cancer proteomics atlas</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/108</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/108.jpg</image:loc><image:title>Comprehensive characterization of m 6 A RNA methylation across human cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/109</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/109.jpg</image:loc><image:title>Intratumoral Candida albicans associates with hypoxia and poor outcomes in non small cell lung cancer (NSCLC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/110</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/110.jpg</image:loc><image:title>Mechanisms of resistance to CDK4/6 inhibitors: Insights from single-cell nucleus sequencing and spatial transcriptomics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/111</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/112</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/112.jpg</image:loc><image:title>Gene co-amplification and structural patterns reveal principles of extrachromosomal DNA in cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/113</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/113.jpg</image:loc><image:title>Validation of a gene pair-based machine learning model for treatment prioritization in breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/114</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/115</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/115.jpg</image:loc><image:title>SPOT-Met: Spatially decoding organotropism and immunotherapy response in colorectal cancer from 1,000 multi-omic tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/116</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/116.jpg</image:loc><image:title>Bridging histopathology and spatial transcriptomics for comprehensive tumor microenvironment profiling</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/117</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/117.jpg</image:loc><image:title>Unbiased AI detection of tertiary lymphoid structures from H&amp;#38;E whole-slide images using mRNA-derived labels predicts survival in NSCLC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/118</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/118.jpg</image:loc><image:title>Accurate prediction of microsatellite instability-high gastric cancer from H&amp;#38;E-stained whole slide images</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/119</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/119.jpg</image:loc><image:title>Improving histopathological diagnostic turnaround time through the GLORIA Telepathology Network in complex oncological cases</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/120</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/120.jpg</image:loc><image:title>From single H&amp;#38;E to virtual immunohistochemical biomarker staining in the lung tumor microenvironment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/121</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/121.jpg</image:loc><image:title>IHCExplore: An AI-driven computational pathology platform for accurate and scalable immunohistochemistry scoring</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/122</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/122.jpg</image:loc><image:title>AI-driven 3D spatial transcriptomics for 3D tumor microenvironment mapping in prostate adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/123</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/123.jpg</image:loc><image:title>OncoPredikt: A deep-learning framework for tumor detection and biomarker quantification in breast cancer IHC whole-slide images</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/124</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/124.jpg</image:loc><image:title>From pixels to spatial microenvironments: AI-powered CAF-Epi niche prediction on H&amp;#38;E slides</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/125</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/125.jpg</image:loc><image:title>Quantitative assessment of tumor-infiltrating lymphocytes using AI in non-small cell lung cancer and association with immunotherapy response</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/126</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/126.jpg</image:loc><image:title>Clinical-grade quality control and stain harmonization enhancement in whole-slide images of lung cancer using deep learning</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/127</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/127.jpg</image:loc><image:title>Artificial intelligence derived spatial transcriptomic signatures from H&amp;#38;E slides predict survival in primary melanoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/128</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/128.jpg</image:loc><image:title>AI-powered analysis of pancreatic ductal adenocarcinoma tissues to study the tumor immune ecosystem and identify novel classifiers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/129</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/129.jpg</image:loc><image:title>Deep-learning prediction of progression-free survival to EGFR inhibitors from H&amp;#38;E tissue slides in advanced EGFR -mutated non-small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/130</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/130.jpg</image:loc><image:title>Path2Marker: Cell-level prediction of multiplex protein expression from routine H&amp;#38;E slides</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/131</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/131.jpg</image:loc><image:title>Path2Prot offers a new way for breast tumor subtyping and treatment response prediction from AI-inferred proteomic biomarkers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/132</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/132.jpg</image:loc><image:title>Multiscale characterization of early morphologic radiation response in rectal cancer via digital pathology</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/133</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/133.jpg</image:loc><image:title>TissueTrek: An interactive multimodal web-based platform for exploring spatial morphology-molecular relationships in cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/134</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/134.jpg</image:loc><image:title>Histologic stratification of hepatocellular carcinoma using deep learning informed by spatial transcriptomics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/135</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/135.jpg</image:loc><image:title>Liquid biopsy profiling of the tumor microenvironment to determine response to immunotherapy regimens across solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/136</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/136.jpg</image:loc><image:title>PlasmaCHORD- A machine learning method for identifying clonal hematopoiesis variants in liquid biopsies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/137</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/137.jpg</image:loc><image:title>Real time multimodal ctDNA and imaging assessment enables adaptive treatment in HPV related oropharyngeal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/138</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/138.jpg</image:loc><image:title>Surveillance for recurrent bladder cancer using Oncuria-Monitor, a urine-based multiplex immunoassay</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/139</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/139.jpg</image:loc><image:title>Enhanced detection of EML4-ALK fusions through integration of complex genomic rearrangements in DNA-based assays</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/140</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/140.jpg</image:loc><image:title>Blood-based integration of epigenomic profiles, TMB, and MSI to predict immune checkpoint inhibitor response in advanced non-small cell lung cancer (aNSCLC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/141</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/141.jpg</image:loc><image:title>Fragmentomics-based cancer type and subtype classification in 60,000 cell-free DNA samples</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/142</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/142.jpg</image:loc><image:title>TAPS+ enables direct 5mC/5hmC-resolved genomic and methylation profiling of CNS tumors in CSF-derived ctDNA and FFPE</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/143</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/143.jpg</image:loc><image:title>A multiomic ensemble-based approach for high-specificity detection of clonal hematopoiesis in cfDNA liquid biopsy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/144</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/144.jpg</image:loc><image:title>A machine learning approach to predict and mitigate artifact variants for molecular residual disease detection</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/145</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/145.jpg</image:loc><image:title>Quantification of circulating tumor DNA (ctDNA) in patients using cancer-specific, methylation-based, tissue-free tests for the detection of molecular residual disease (MRD)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/146</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/146.jpg</image:loc><image:title>Integrated plasma multi-omics profiling identifies circulating predictive biomarkers and biological pathways associated with treatment response in NSCLC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/147</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/147.jpg</image:loc><image:title>An expanded negative prediction algorithm for actionable mutations utilizing genomic and epigenomic profiling in cfDNA</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/148</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/148.jpg</image:loc><image:title>Fragmentomics powers improved classification of somatic mutations in liquid biopsy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/149</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/149.jpg</image:loc><image:title>Integrative analyses of the cfDNA fragmentome and TCR repertoires capture chemo-immunotherapy response in diffuse pleural mesothelioma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/150</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/150.jpg</image:loc><image:title>Clinical utility of landmark ctDNA molecular response as an early indicator of immunotherapy outcomes in lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/151</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/151.jpg</image:loc><image:title>Integrated, base-resolution profiling of genetic and epigenetic signatures in cell-free DNA</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/152</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/152.jpg</image:loc><image:title>Analytical performance of an enhanced variant (EV) pipeline for improved circulating tumor DNA (ctDNA) detection in samples with low tumor burden</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/153</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/153.jpg</image:loc><image:title>Assessment of sequencing error rates in healthy plasma samples across two whole genome sequencing platforms</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/154</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/154.jpg</image:loc><image:title>Unraveling tumor- and tissue-specific gene expression patterns from plasma-derived cfRNA</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/155</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/155.jpg</image:loc><image:title>Comprehensive ctDNA profiling reveals molecular and prognostic landscapes in Korean pan-cancer patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/156</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/156.jpg</image:loc><image:title>Single-cell transcriptomic and CNV profiling reveal distinct circulating tumor cell signatures in pancreatic ductal adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/157</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/157.jpg</image:loc><image:title>Detecting early cancer using cfDNA methylation signatures with nanopore sequencing</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/158</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/158.jpg</image:loc><image:title>A lightweight self-supervised deep learning framework for automated detection of circulating tumor cells and cancer-associated fibroblasts</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/159</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/159.jpg</image:loc><image:title>Two integrative molecular subtypes of hepatocellular carcinoma with predictive therapeutic potential: Toward liquid biopsy-guided precision medicine</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/160</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/160.jpg</image:loc><image:title>Single stranded ligation enhances the performance of the duet evoC 6-base assay, enhancing value in low DNA input applications including liquid biopsy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/161</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/161.jpg</image:loc><image:title>Using the 6-base genome for full multiomic analysis of cfDNA through combined methylation and fragmentomic analysis to enhance classification of clinical cancer cfDNA samples</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/162</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/162.jpg</image:loc><image:title>The importance of high analytical sensitivity and specificity of 5 and 6-base assays to enhance the detection of ctDNA in liquid biopsy applications</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/163</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/163.jpg</image:loc><image:title>DrBioRight: an AI research assistant for cancer data analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/164</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/165</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/165.jpg</image:loc><image:title>GP CoPilot: An AI-enhanced agent for cancer research</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/166</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/166.jpg</image:loc><image:title>GenerAItive: An AI system for interpretation of gene expression analyses in cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/167</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/167.jpg</image:loc><image:title>An agentic AI workflow for automated, high-fidelity curation of cancer diagnosis and staging from unstructured patient records</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/168</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/168.jpg</image:loc><image:title>AI analysis agent to accelerate end-to-end spatial biology analysis for MERSCOPE</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/169</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/169.jpg</image:loc><image:title>Multi-agent AI system for autonomous CAR-T development: Integrated target discovery, toxicity prediction, and rational molecular design for cancer immunotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/170</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/170.jpg</image:loc><image:title>ImmunoVerse-Chat: A conversational agentic-AI engine for next-generation immunotherapeutic target discovery</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/171</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/171.jpg</image:loc><image:title>CertisAI Assistant: An agentic AI platform for dynamic preclinical oncology model selection</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/172</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/172.jpg</image:loc><image:title>Agentic AI for RNA-Seq: From workflow automation to actionable insights</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/173</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/173.jpg</image:loc><image:title>Multi-agent AI orchestration for temporal-aware extraction of social determinants of health from unstructured clinical records in cancer populations</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/174</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/175</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/175.jpg</image:loc><image:title>PortrAIgent: Co-scientist agent for end-to-end spatial transcriptomics discovery</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/176</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/176.jpg</image:loc><image:title>Reasoning&amp;#8209;guided retrieval improves oncology trial eligibility matching from clinical notes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/177</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/177.jpg</image:loc><image:title>Automated cohort extraction from real-world oncology data using adaptive LLM-based agentic systems for clinical trial feasibility and patient selection</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/178</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/178.jpg</image:loc><image:title>Charles: A self-critical agentic AI drug discovery analyst for cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/179</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/179.jpg</image:loc><image:title>Agentic AI-enabled exploration of real-world immune-related adverse events</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/180</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/180.jpg</image:loc><image:title>A healthcare system scale multimodal whole patient temporal foundation model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/181</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/181.jpg</image:loc><image:title>Attitudes and perception of artificial intelligence in healthcare: A cross-sectional survey among Arkansas-Louisiana-Texas (ArkLATX) veterans with cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/182</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/182.jpg</image:loc><image:title>Humans cannot live by artificial intelligence (AI) alone</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/183</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/183.jpg</image:loc><image:title>AI-driven- structure-based drug discovery and validation of novel compounds as CTLA-4/B7 inhibitors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/184</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/185</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/185.jpg</image:loc><image:title>FGFR3-TACC3 fusion: multi-omics and machine learning characterization across tumor types</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/186</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/186.jpg</image:loc><image:title>VINI: A multimodal in silico platform for discovering rational drug combinations in KRAS-mutant pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/187</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/187.jpg</image:loc><image:title>Deep learning frameworks for translating cancer drug response from cell-level to patient-level by modeling transcriptome</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/188</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/188.jpg</image:loc><image:title>DrugVLAB for oncogenic kinase inhibitor generation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/189</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/189.jpg</image:loc><image:title>Multimodal chemogenomic modeling-based drug repurposing for targeted therapy of PDAC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/190</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/190.jpg</image:loc><image:title>MTA-DTA: A multi-token attention framework for drug-target binding affinity prediction</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/191</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/191.jpg</image:loc><image:title>Pharmacophore profiling highlights diverging binding modes of nemtabrutinib and ibrutinib across tyrosine kinases</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/192</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/192.jpg</image:loc><image:title>Beyond the active site: Discovery of novel PYCR1 allosteric binding sites via structure-oriented fragment crystallographic screening</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/193</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/193.jpg</image:loc><image:title>MHC-associated peptide proteomics for immunogenicity risk assessment of immuno-oncology drug candidates</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/194</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/194.jpg</image:loc><image:title>Anticancer efficacy of tricarbonylperrhenato(bathophen)rhenium(I) organometallic compound in pancreatic ductal adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/195</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/196</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/196.jpg</image:loc><image:title>Optimization of bioinformatics parameters for DIA-based proteomics in targeted protein degradation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/197</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/198</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/198.jpg</image:loc><image:title>PTBP1-targeted siRNA reprograms cellular metabolism and induces apoptosis in human gastric cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/199</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/199.jpg</image:loc><image:title>SR-B1 gene variants, inhibitors and the effect of glucose on IC50s in breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/200</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/200.jpg</image:loc><image:title>Synergistic effects of antineoplastic drugs and gap junction enhancer in heterogenous colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/201</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/202</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/202.jpg</image:loc><image:title>From phenotypic screening to mechanistic insight: Rational discovery of chemosensitizers for glioblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/203</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/203.jpg</image:loc><image:title>Selective oncolysis via oncomiR-driven DNA self assembly</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/204</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/204.jpg</image:loc><image:title>Novel sulfonamide-aromatic amine hybrids: Synthesis, cytotoxic screening, and transcriptomic insights into anticancer activity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/205</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/205.jpg</image:loc><image:title>Development of polyHis-targeting chimeras (HisTACs) for targeted protein degradation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/206</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/206.jpg</image:loc><image:title>The NVL inhibitor benzothiazepinone targets colorectal cancer by blocking ribosome biogenesis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/207</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/207.jpg</image:loc><image:title>N/C-terminus modification: enhanced TROP2-targeting cyclic peptide for PET imaging</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/208</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/209</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/210</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/210.jpg</image:loc><image:title>Parallel drug development strategies for fibrolamellar hepatocellular carcinoma and proteasome-dependent multiple myeloma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/211</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/212</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/212.jpg</image:loc><image:title>Effect of the KRAS G12C inhibitor MK-1084 on circulating tumor DNA levels in participants with KRAS G12-mutated tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/213</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/213.jpg</image:loc><image:title>Landscape of homozygous copy number (CN) losses with established and emerging clinical actionability across 430,467 pan-tumor tissue samples</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/214</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/214.jpg</image:loc><image:title>DNA-level complex fusions show high discordance with RNA expression: A validation study of 115 Chinese cases</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/215</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/215.jpg</image:loc><image:title>Correlation of mitophagy related genes expression and clinical outcome in metastatic colorectal cancer patients enrolled in CALGB (Alliance)/SWOG 80405</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/216</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/216.jpg</image:loc><image:title>Multi-omic method to detect MTAP homozygous deletions enables high sensitivity detection from blood samples</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/217</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/218</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/218.jpg</image:loc><image:title>Multimodal AI predicts immune checkpoint inhibitor response from clinically available inputs and whole-slide images with explainable tumor biology and combination therapy insights</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/219</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/219.jpg</image:loc><image:title>Quantitative c-MET immunohistochemistry reveals prognostic subgroups in papillary renal cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/220</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/220.jpg</image:loc><image:title>PHIT score integrates tumor biology to predict PDAC prognosis and therapy response</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/221</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/221.jpg</image:loc><image:title>STAT5A promoter hypermethylation as a biomarker of immune checkpoint inhibitor response in squamous cell carcinoma in cfDNA liquid biopsies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/222</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/222.jpg</image:loc><image:title>Longitudinal peripheral blood TCR tracking predicts response to immune checkpoint inhibitors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/223</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/223.jpg</image:loc><image:title>Characterization of functional estrogen receptor (ER) dependence via comprehensive epigenomic liquid biopsy stratifies endocrine therapy (ET) responders with metastatic breast cancer (MBC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/224</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/224.jpg</image:loc><image:title>Detection of rare genomic fusions revealed through comprehensive genomic profiling of atypical tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/225</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/225.jpg</image:loc><image:title>NFKBIA amplification attenuates B2M expression in NKX2.1-amplified lung adenocarcinoma, indicating immune evasion potential</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/226</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/226.jpg</image:loc><image:title>Ki67-kinetics and tumor biology shifts during neoadjuvant letrozole and ribociclib in ER-pos./HER2-neg. breast cancer: Insights from the NEOLETRIB-trial</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/227</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/227.jpg</image:loc><image:title>CIN signatures as biomarkers of drug sensitivity: Real-world evidence from DNA targeted sequencing data</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/228</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/228.jpg</image:loc><image:title>Monitoring PD-L1 in tumor macrophage fusion cells in blood correlates to PD-L1 checkpoint inhibitor responses in metastatic breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/229</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/229.jpg</image:loc><image:title>The copy number amplification of MYCL indicated activation of angiogenesis in small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/230</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/230.jpg</image:loc><image:title>A robust predictive marker of clinical outcomes to immune-checkpoint inhibition in advanced squamous head-and-neck cancer calculated from histopathological slides</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/231</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/231.jpg</image:loc><image:title>A tumor-agnostic YAP/TAZ score predicts TEAD inhibitor sensitivity independent of Hippo alterations</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/232</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/232.jpg</image:loc><image:title>Leronlimab induces PD-L1 expression and is associated with long&amp;#8209;term survival with an ICI in PD-L1 low metastatic TNBC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/233</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/233.jpg</image:loc><image:title>Transcriptomic and genomic signatures associated with response or resistance to immunotherapy(IO) in locally advanced/metastatic (LA/M) head and neck squamous cell carcinoma (HNSCC) patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/234</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/234.jpg</image:loc><image:title>Ultrasensitive cfDNA fragmentomics assay for early treatment response assessment in solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/235</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/236</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/237</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/237.jpg</image:loc><image:title>Integrating genomics and real-world data to predict fam-trastuzumab deruxtecan response in metastatic breast cancer across HER2 subtypes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/238</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/238.jpg</image:loc><image:title>Blinded clinical validation of LiquidTME, a cell-free DNA assay for predicting response to immunotherapy by noninvasively profiling the tumor microenvironment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/239</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/239.jpg</image:loc><image:title>Extracellular vesicle-associated noncanonical ORFs as biomarkers of surgical outcome and chemoresistance in ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/240</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/240.jpg</image:loc><image:title>Clinical and immune correlates of response to neoadjuvant chemoimmunotherapy in dMMR/MSI-H gastric cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/241</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/241.jpg</image:loc><image:title>MUC5AC expression defines an immune-inflamed but functionally restrained tumor microenvironment in pancreatic ductal adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/242</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/242.jpg</image:loc><image:title>Class II HLA supertype diversity predicts poor outcomes with immune checkpoint inhibitors in a pan-cancer cohort</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/243</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/243.jpg</image:loc><image:title>A novel epithelial tumor signature predicts survival and response to PD-1 blockade in non-small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/244</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/244.jpg</image:loc><image:title>Leveraging transcriptomic profiles and deep learning to detect homologous recombination deficiency in breast cancer with softHRD</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/245</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/245.jpg</image:loc><image:title>MORPHEUS-lung: Biomarkers and clinical response to atezolizumab + bevacizumab + stereotactic body radiotherapy in patients with metastatic non-small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/246</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/246.jpg</image:loc><image:title>Smad deficiency impacts chemotherapeutic responses through alterations in immuno-stromal microenvironment of pancreatic adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/247</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/247.jpg</image:loc><image:title>DNA repair phenotypes inform carboplatin and PARP inhibitor response</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/248</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/248.jpg</image:loc><image:title>Assessment of spectral overlap and crosstalk in multiplex digital PCR for effective monitoring of next-generation CAR T-cells in cancer clinical trials</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/249</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/249.jpg</image:loc><image:title>CXCR4/LITAF as predictive biomarkers for nimotuzumab plus AG therapy in pancreatic cancer with liver metastasis: Integrative single-cell and spatial analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/250</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/250.jpg</image:loc><image:title>Real-world treatment patterns and outcomes reveal distinct clinical trajectories of patients with Cyclin E1-positive ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/251</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/251.jpg</image:loc><image:title>Single-cell immune profiling reveals biomarkers of pembrolizumab response in early triple-negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/252</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/252.jpg</image:loc><image:title>Plasma metabolomic profiling predicts response to neoadjuvant immunochemotherapy in locally advanced NSCLC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/253</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/253.jpg</image:loc><image:title>Assessing biomarker reproducibility for glioblastoma patient response stratification</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/254</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/254.jpg</image:loc><image:title>Integrative multi-omics characterization and AI-driven biomarker discovery for NSCLC stage III outcomes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/255</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/255.jpg</image:loc><image:title>Detection of postoperative minimal residual disease in colorectal cancer using a novel ultrasensitive whole-genome sequencing-based ctDNA test</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/256</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/256.jpg</image:loc><image:title>Methylation-based tumor fraction monitoring identifies patients with putative molecular progression who may benefit from comprehensive genomic profiling</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/257</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/257.jpg</image:loc><image:title>Machine learning classifier for cancer type identification via multi-feature genome-wide cfDNA profiling</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/258</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/258.jpg</image:loc><image:title>cfDNA fragmentomics enables sensitive early detection and tissue-of-origin prediction in gynecologic cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/259</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/259.jpg</image:loc><image:title>Characterizing the cfDNA fragmentome in patients with hepatocellular carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/260</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/260.jpg</image:loc><image:title>Pervasive early dissemination in pancreatic cancer uncovered by tissue-paired plasma whole-genomes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/261</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/261.jpg</image:loc><image:title>Interim analysis of tumor-informed ctDNA detection in head and neck squamous cell carcinoma: The PECAN trial</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/262</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/262.jpg</image:loc><image:title>Personalized cell-free DNA fragmentation dynamics in early-stage NSCLC in TRACERx</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/263</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/263.jpg</image:loc><image:title>Analytical and clinical sensitivity of tumor-informed and tumor-na&amp;#239;ve ctDNA residual disease detection during neoadjuvant immune checkpoint inhibition in resectable cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/264</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/264.jpg</image:loc><image:title>Tracing tumor-specific EV-miRNA signatures via patient-derived explant models to advance liquid biopsy in non-small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/265</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/265.jpg</image:loc><image:title>A novel detection strategy for an emerging biomarker: MTAP loss detection with circulating tumor DNA (ctDNA)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/266</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/266.jpg</image:loc><image:title>Malignant effusions for cfDNA/RNA genotyping and drug testing: Turning malignant fluids into personalized cancer models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/267</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/267.jpg</image:loc><image:title>Urine cell-free RNA captures tumor-reflective long intergenic noncoding and circular RNA programs in bladder cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/268</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/268.jpg</image:loc><image:title>Cell-free DNA fragmentomes capture response to immuno-radiotherapy in metastatic non-small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/269</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/269.jpg</image:loc><image:title>Lung cancer subtyping using cell-free DNA fragmentomes and protein biomarkers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/270</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/270.jpg</image:loc><image:title>Analytical evaluation of a whole genome tumor-informed molecular residual disease detection assay with high sensitivity and specificity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/271</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/271.jpg</image:loc><image:title>Validation of a sensitive, tissue-free blood test for biomarker discovery and tumor burden assessment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/272</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/272.jpg</image:loc><image:title>Clinical grade circulating tumor DNA methylation predicts outcome to brigatinib plus local consolidative therapy in patients with ALK rearranged NSCLC - Liquid biopsy correlates from the BRIGHTSTAR trial</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/273</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/274</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/274.jpg</image:loc><image:title>Longitudinal tumor-informed cell-free DNA whole genome sequencing coupled with transcriptomic analysis captures tumor burden dynamics in resectable gastroesophageal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/275</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/275.jpg</image:loc><image:title>A liquid biopsy-based predictive model identifies potential candidates for bladder preservation after neoadjuvant chemotherapy in muscle-invasive bladder cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/276</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/276.jpg</image:loc><image:title>Ultra-sensitive CRISPR-based NGS (MUTE-Seq) of pancreatic cyst fluid: KRAS variant allele fraction as an early marker of malignant potential</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/277</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/277.jpg</image:loc><image:title>Enspyre: A novel enrichment technology enables ultra-sensitive ctDNA detection with 98% reduction in sequencing requirements</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/278</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/278.jpg</image:loc><image:title>Tumor genomic features and postsurgical ctDNA status in patients with stage I-IV uterine cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/279</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/279.jpg</image:loc><image:title>Genome-wide cell-free DNA fragmentomes from blood and saliva enable early detection of head and neck cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/280</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/280.jpg</image:loc><image:title>Spatially resolved tumor-cell MHC class II shapes adaptive immunity and therapeutic response in triple-negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/281</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/281.jpg</image:loc><image:title>Spatial 3D and multi-omics mapping of diffuse gastric cancer evolution from preinvasive to invasive lesions in CDH1 mutation carriers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/282</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/282.jpg</image:loc><image:title>Spatially-resolved transcriptome analysis of renal tumors with sarcomatoid/rhabdoid dedifferentiation uncovers underlying biology and new biomarkers relevant to these tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/283</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/283.jpg</image:loc><image:title>Spatial archetypes of conserved and cancer-specific immune-stromal niches</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/284</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/284.jpg</image:loc><image:title>Spatial multiomic characterization of spontaneous lung tumors in aged mice</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/285</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/286</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/286.jpg</image:loc><image:title>Multimodal profiling of STIC lesions identifies precursor states with genomic features of high grade serous ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/287</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/287.jpg</image:loc><image:title>The MONSTAR-SCREEN-3 Spatial Atlas: Pan-cancer TME archetypes and clinically relevant tumor-immune ecosystems</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/288</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/288.jpg</image:loc><image:title>FGFR2 translocated sinonasal adenocarcinoma: A biphasic seromucinous adenocarcinoma with a distinctive and targetable molecular phenotype</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/289</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/289.jpg</image:loc><image:title>Integrated spatial and single-cell profiling uncovers a pre-existing, treatment-resistant subclone that drives early local relapse in luminal breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/290</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/290.jpg</image:loc><image:title>Spatial transcriptomics uncovers pharmacokinetic barriers and tumor-intrinsic determinants of resistance to trastuzumab deruxtecan in breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/291</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/291.jpg</image:loc><image:title>Spatial transcriptomics reveals distinct SPP1-CD44 signaling networks in neoadjuvant osimertinib treated EGFR mutant non-small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/292</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/293</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/293.jpg</image:loc><image:title>SPACE: Spatially resolved multiomic analysis for high-throughput CRISPR screening in 3D models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/294</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/294.jpg</image:loc><image:title>Spatial transcriptomic analysis of primary melanomas with extreme clinical outcomes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/295</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/295.jpg</image:loc><image:title>Profiling colon cancer architecture with spatial transcriptomics identifies clinically relevant stromal ecotypes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/296</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/296.jpg</image:loc><image:title>Multi-omics integration of bulk, single-cell, and spatial transcriptomics identifies robust prognostic biomarkers in head and neck salivary adenoid cystic carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/297</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/297.jpg</image:loc><image:title>Development of a proximity ligation-imaging mass cytometry platform for spatially resolved immune checkpoint analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/298</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/298.jpg</image:loc><image:title>Spatial multi-omic profiling to capture functional signatures in HER2-heterogeneous FFPE breast cancer tissue</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/299</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/299.jpg</image:loc><image:title>Spatial transcriptomics revealed potential resistance and response factors of sacituzumab govitecan in metastatic breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/300</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/300.jpg</image:loc><image:title>Imaging mass cytometry of pelareorep treated early breast cancer samples reveals developing tertiary lymphoid structures</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/301</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/301.jpg</image:loc><image:title>Spatial transcriptomics of trastuzumab deruxtecan-treated metastatic breast cancer identifies candidate response and resistance factors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/302</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/302.jpg</image:loc><image:title>Spatial transcriptomics identifies a suppressive T-cell excluded tumour microenvironment in extramedullary multiple myeloma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/303</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/303.jpg</image:loc><image:title>Antibody-drug conjugate immuno-oncology panel for comprehensive characterization of the tumor and associated microenvironment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/304</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/304.jpg</image:loc><image:title>3D spatial multiomics characterization of ovarian cancer tissue samples</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/305</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/305.jpg</image:loc><image:title>Prognostic implications of circulating Hepsin in prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/306</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/306.jpg</image:loc><image:title>STING-induced cytokine profiles in tumor fragments correlate with recurrence in head and neck cancer patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/307</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/307.jpg</image:loc><image:title>BRAF copy number alterations and ultralow BRAF mRNA expression are prognostic for poor overall survival in prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/308</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/308.jpg</image:loc><image:title>Integrating methylation-based circulating tumor DNA analysis with PSMA-PET/CT primary staging for enhanced risk stratification in de novo metastatic prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/309</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/309.jpg</image:loc><image:title>Transcriptomic analysis of NDRG1 amplification in aggressive breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/310</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/310.jpg</image:loc><image:title>A unified clinical and molecular framework to standardize chromosomal instability assessment in gastric, GEJ, and esophageal cancer (GEC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/311</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/311.jpg</image:loc><image:title>Early ctDNA quantification by ctFE outperforms Max VAF for survival stratification across locally advanced and oligometastatic NSCLC treated with radiotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/312</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/312.jpg</image:loc><image:title>IHC-based prognostic sub-stratification of ovarian endometrioid carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/313</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/313.jpg</image:loc><image:title>Radiographic thymic health as host-intrinsic determinant of immunotherapy outcomes across cancer types</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/314</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/314.jpg</image:loc><image:title>Plasma proteomic profiling of lung cancer blood samples reveals immune-related inflammatory signatures as prognostic biomarkers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/315</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/315.jpg</image:loc><image:title>Serological detection of Type XVII collagen shedding suggests prognostic relevance in esophageal adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/316</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/316.jpg</image:loc><image:title>Associations between Breast Cancer Index and MSK-IMPACT genomic and transcriptomic profiles in HR+ breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/317</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/317.jpg</image:loc><image:title>Decoding the multiomic signatures of oral cancer progression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/318</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/318.jpg</image:loc><image:title>Depth of immunoparesis predicts time to first therapy in newly diagnosed monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/319</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/319.jpg</image:loc><image:title>Survival trends in the management of carcinoid heart disease among patients with neuroendocrine tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/320</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/320.jpg</image:loc><image:title>Breast cancer recurrence risk stratification using rapid, cost-effective TempO-Seq profiling and an XGBoost classifier outperforms Oncotype DX</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/321</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/321.jpg</image:loc><image:title>A novel ferroptosis-related lncRNA-miRNA-mRNA genes signature for predicting prognosis and tumor immune microenvironment in endometrial cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/322</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/322.jpg</image:loc><image:title>Prognostic value of circulating CD11b + CD33 + myeloid cells in localized prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/323</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/323.jpg</image:loc><image:title>A pre-treatment cfDNA methylation signature linking prognosis and drug-resistance biology in pancreatic ductal adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/324</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/324.jpg</image:loc><image:title>Stage-dependent expression of Fanconi anemia pathway genes in HPV-negative head and neck squamous cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/325</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/325.jpg</image:loc><image:title>Noninvasive diagnosis of solid pulmonary nodules using peripheral blood ctDNA: Development of a multimodality platform</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/326</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/326.jpg</image:loc><image:title>Multi-analyte blood-based screening early detection of HPV-associated oropharyngeal and anal cancer within the PLCO cohort</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/327</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/327.jpg</image:loc><image:title>Validation of a blood test for multi-cancer risk stratification in a lung cancer screening cohort</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/328</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/328.jpg</image:loc><image:title>Circulating tumor DNA (ctDNA) for molecular residual disease (MRD) detection and recurrence monitoring in hepatocellular carcinoma (HCC); COSMOS-HCC01</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/329</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/329.jpg</image:loc><image:title>ARID1A protein expression enhances risk stratification in colorectal polyp surveillance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/330</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/330.jpg</image:loc><image:title>OncoSeek 2.0: An advanced multi-cancer blood test enhancing early detection and aiding cancer diagnosis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/331</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/331.jpg</image:loc><image:title>Performance of a blood-based screening test for the early detection of advanced precancerous lesions</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/332</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/332.jpg</image:loc><image:title>Discrete precancer subtypes and biomarkers of cancer progression identified with spatiotemporal analysis of CDH1-driven diffuse gastric cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/333</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/333.jpg</image:loc><image:title>The RNA editing enzyme ADAR1 is involved in carcinogenesis associated with intraductal papillary mucinous neoplasm</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/334</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/334.jpg</image:loc><image:title>Epigenetic profiling identifies markers of aggressive cancer subtype using a targeted methylation-based multi-cancer early detection (MCED) blood test</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/335</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/335.jpg</image:loc><image:title>A novel method for tumor fraction estimation using methylation sequencing data</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/336</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/336.jpg</image:loc><image:title>Uncovering early transcriptional alterations in lung cancer: Preliminary insights from the Boston Lung Trans-omics (BOLT) Initiative</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/337</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/337.jpg</image:loc><image:title>The genomic landscape of melanoma-prone skin</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/338</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/338.jpg</image:loc><image:title>Detection of bladder cancer via urinary DNA mutation and methylation using modified qPCR</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/339</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/339.jpg</image:loc><image:title>Nestin expression is prevalent but highly variable in human cancer: A tissue microarray study involving 5,917 cancers from 107 tumor entities</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/340</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/340.jpg</image:loc><image:title>Rapid identification of comprehensive multi-omic protein and RNA biomarkers on a single FFPE tissue section using a novel integrated nCounter&amp;#174; workflow</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/341</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/341.jpg</image:loc><image:title>Development and performance of a multiomics lung cancer screening blood test</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/342</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/342.jpg</image:loc><image:title>Performance of an optimized methylation-protein multi-cancer early detection (MCED) test classifier</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/343</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/343.jpg</image:loc><image:title>The complementary contributions of methylation and protein biomarker classes in a multi-cancer early detection (MCED) test</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/344</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/344.jpg</image:loc><image:title>Promote biomarker identification for early detection of head and neck cancers through AHEAD and EDRN programs under the leadership and collaboration between NIDCR and NCI</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/345</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/345.jpg</image:loc><image:title>Promoting awareness and enhancing access to low-dose computed tomography screening for early detection of lung cancer in underrepresented minority communities in Northern Illinois</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/346</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/346.jpg</image:loc><image:title>Circulating early myeloid-derived suppressor cells as indicators of tumor-driven myelopoiesis and disease progression in lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/347</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/348</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/348.jpg</image:loc><image:title>Informatics-Driven Integration of OpenMRS and iBreastCheck to Strengthen Community-Based Cancer Screening in Ethiopia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/349</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/349.jpg</image:loc><image:title>Expression of annexin A4 in cancer: A tissue microarray study involving 6,058 cancers from 105 tumor entities</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/350</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/350.jpg</image:loc><image:title>A scalable multimodal framework for unbiased risk biomarker discovery across multiple cancer types</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/351</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/351.jpg</image:loc><image:title>Prospective investigation of the blood metabolome to identify risk biomarkers for biliary tract cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/352</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/353</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/354</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/355</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/355.jpg</image:loc><image:title>Novel approach of single-cell RNAseq analysis to assess cancer cells in prostate core biopsy specimens</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/356</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/356.jpg</image:loc><image:title>Mitosis in circulating tumor cells correlates with highly aggressive disease in metastatic breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/357</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/357.jpg</image:loc><image:title>Early detection of prostate carcinoma using trajectories of circulating epithelial tumor cell (CETCs/CTCs) numbers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/358</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/359</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/360</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/361</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/361.jpg</image:loc><image:title>Molecular profiling of diffuse gliomas via liquid biopsy: Insights from circulating tumor cells and ctDNA analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/362</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/363</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/363.jpg</image:loc><image:title>Parallel microfluidic platform enables efficient label-free capture of p16+ circulating tumor cells in oropharyngeal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/364</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/364.jpg</image:loc><image:title>Monitoring androgen receptor and neuroendocrine marker expression dynamics in CTCs in patients with mCRPC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/365</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/366</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/366.jpg</image:loc><image:title>Comparison of tissue and liquid biopsy CGP in advanced solid tumors: Insights from a community cancer center</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/367</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/367.jpg</image:loc><image:title>Cancer-neuron interaction initiates neural mimicry and brain colonization in EGFR-mutant NSCLC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/368</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/368.jpg</image:loc><image:title>Discordance in molecular classification of primary and metastatic endometrial cancer: Implications for precision treatment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/369</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/369.jpg</image:loc><image:title>From protocol to practice: The gap in obtaining progression disease biopsies across 182 oncology trials</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/370</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/370.jpg</image:loc><image:title>Over expressing PD-L1 circulating tumor cells with clusters in prostate cancer patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/371</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/371.jpg</image:loc><image:title>Development of a murine leptomeningeal disease model for a point-of-care cerebrospinal fluid liquid biopsy assay</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/372</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/373</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/373.jpg</image:loc><image:title>Development of a novel CDH17 CTC assay to monitor colorectal patient blood and cerebrospinal fluid</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/374</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/374.jpg</image:loc><image:title>Kras activity-linked glycolysis and immunosuppression in metastatic pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/375</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/376</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/376.jpg</image:loc><image:title>PHF8 is a major upstream regulator of RIPK2 in prostate cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/377</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/378</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/379</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/379.jpg</image:loc><image:title>Multimodal liquid biopsy of Ewing sarcoma reveals high sensitivity prior to radiotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/380</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/380.jpg</image:loc><image:title>Combining CDK4/6 inhibitor with TMZ and radiation alters cell states for synergistic responses in orthotopic DIPG models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/381</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/381.jpg</image:loc><image:title>Targeting high risk osteosarcoma: MYC modulation alters metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/382</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/382.jpg</image:loc><image:title>Targeting Yap1 -B7-H3 signaling stimulates CD8&amp;#8314; anti-tumor response preferentially in male SHH medulloblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/383</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/383.jpg</image:loc><image:title>Genome-driven molecular stratification and clinical impact in pediatric solid tumors: Results from the STREAM program</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/384</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/385</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/385.jpg</image:loc><image:title>High-throughput screening identifies synergistic drug interactions between CDK8/19 and DHFR inhibitors in rhabdomyosarcoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/386</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/387</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/387.jpg</image:loc><image:title>Hypermutation patterns shape tumorigenesis and immunotherapy response in mismatch repair deficient glioma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/388</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/389</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/389.jpg</image:loc><image:title>Characterizing neddylation as a potential vulnerability in MYC-amplified medulloblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/390</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/390.jpg</image:loc><image:title>Comprehensive pediatric biobanking and model development in the Beat Childhood Cancer Research Consortium</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/391</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/391.jpg</image:loc><image:title>Revealing the transformative role of METTL13 in human hematopoietic stem cells and progression of pediatric leukemia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/392</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/392.jpg</image:loc><image:title>Combined AKT and XPO1 inhibition to target chimeric transcription factor-driven pediatric sarcoma pathogenesis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/393</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/394</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/394.jpg</image:loc><image:title>Vps34 inhibition enhances immunogenicity and immune-mediated killing in MYCN-amplified neuroblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/395</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/396</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/397</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/397.jpg</image:loc><image:title>Development of RT-dPCR-based functional release assays for the RPS19 gene therapy for Diamond-Blackfan anemia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/398</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/399</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/399.jpg</image:loc><image:title>Proton-induced exosomal signatures reveal radiation response pathways in pediatric diffuse midline glioma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/400</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/401</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/401.jpg</image:loc><image:title>Inhibition of GSK3B signaling in pediatric brain tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/402</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/403</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/403.jpg</image:loc><image:title>A novel therapeutic approach to overcome metabolic reprogramming in lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/404</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/404.jpg</image:loc><image:title>Synergistic inhibition of PARP and ATM leads to unresolved DNA damage and cohesin-mediated collapse in pediatric osteosarcoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/405</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/406</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/407</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/407.jpg</image:loc><image:title>Mutation-dependent sensitivity to the dual TTK/PLK1 inhibitor BAL0891 in patient-derived gastric cancer organoids</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/408</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/408.jpg</image:loc><image:title>Depletion of dominant-negative mutant p53 improves the efficacy of mutant p53 reactivators</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/409</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/409.jpg</image:loc><image:title>Development of a novel selective CDK4 inhibitor for HR+/HER2- breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/410</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/411</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/411.jpg</image:loc><image:title>PRKDC regulates CDK2 expression and pancreatic neuroendocrine cancer sensitivity to chemotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/412</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/412.jpg</image:loc><image:title>Targeting PRMT5 enhances ferroptosis in B-cell lymphomas</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/413</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/413.jpg</image:loc><image:title>Silencing of ACACA sensitizes acute myeloid leukemia cells to venetoclax</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/414</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/414.jpg</image:loc><image:title>Immunotoxin GB13 Targets GBM and H3.3K27M DIPG with the activation of Golgi-to-ER retrograde transport pathways</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/415</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/415.jpg</image:loc><image:title>Targeting autophagy sensitizes cancer cells to proteasome inhibitors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/416</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/416.jpg</image:loc><image:title>Antitumor activity of PARPi and POLQi combination therapy in a BRCA-mutated PDAC model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/417</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/417.jpg</image:loc><image:title>Integrated multiomics analysis identifies defective CoQ10 interactome in human kidney cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/418</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/418.jpg</image:loc><image:title>Phospholipase D1 overexpression drives metabolic survival and stress resistance in cervical cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/419</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/420</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/421</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/421.jpg</image:loc><image:title>Exploiting Wnt-induced DNA damage repair vulnerability with PARP inhibitors to overcome chemoresistance in multiple myeloma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/422</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/422.jpg</image:loc><image:title>Pathway-based radiosensitivity and therapeutic targeting in triple-negative breast cancer subtypes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/423</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/423.jpg</image:loc><image:title>Enhancing individualized interventions with machine learning: A better approach?</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/424</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/424.jpg</image:loc><image:title>Disparities in post-survivorship psychiatric diagnoses among adult cancer patients in a multi-center academic health system</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/425</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/425.jpg</image:loc><image:title>Suicidal ideation endorsed by long-term survivors of blood or marrow transplantation: A BMTSS report</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/426</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/426.jpg</image:loc><image:title>Surviving to thriving: Empowering breast cancer survivors through community-based health coaching</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/427</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/428</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/429</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/430</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/430.jpg</image:loc><image:title>Bioelectrical impedance analysis-derived body composition metrics as prognostic biomarkers in lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/431</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/431.jpg</image:loc><image:title>Exercise volume, skeletal muscle maintenance, and plasma IL-6/IL-6R in patients with PDAC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/432</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/433</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/433.jpg</image:loc><image:title>Effects of a home-based walking intervention on serum metabolomic profiles in men with prostate cancer on active surveillance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/434</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/434.jpg</image:loc><image:title>Ketamir-2, a novel oral ketamine analogue for chemotherapy-induced peripheral neuropathy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/435</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/435.jpg</image:loc><image:title>Clinical outcomes of Ayurveda Rasayana therapy (ART) in advanced pancreatic cancer patients: A retrospective study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/436</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/436.jpg</image:loc><image:title>Pain severity is related to molecular pathways underlying aggressive disease and poor survival in OSCC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/437</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/438</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/439</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/439.jpg</image:loc><image:title>Cancer survivors&#039; acceptance of technology-based tools for stress management and effective communication</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/440</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/440.jpg</image:loc><image:title>Health-related quality of life in EGFR-mutant lung cancer survivors: SEER-MHOS analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/441</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/441.jpg</image:loc><image:title>Suicide Risk in Oncology: Sex and Cancer Type Differences in a Case-Control Study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/442</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/443</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/444</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/444.jpg</image:loc><image:title>Perspectives on cancer survivorship: Voices of family caregivers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/445</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/445.jpg</image:loc><image:title>The inverse association between non-melanoma skin cancer and alopecia areata: A systematic review and meta-analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/446</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/447</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/447.jpg</image:loc><image:title>Real-world evaluation of multimodal AI: Foundation model-driven multimodal AI for GBM, NSCLC, and PDAC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/448</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/448.jpg</image:loc><image:title>LYW-105: A novel bispecific antibody-drug conjugate with enhanced antitumor efficacy and broader therapeutic index</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/449</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/449.jpg</image:loc><image:title>Role of BEN domain protein 4 (BEND4) in prostate cancer (PCa) and the effect of silencing BEND4 in PCa cell lines</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/450</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/450.jpg</image:loc><image:title>TIP60 mediates chemoresistance by reducing cisplatin-DNA adduct formation and enhancing their repair</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/451</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/451.jpg</image:loc><image:title>Therapeutic restoration of p53 via engineered synthetic mRNA analogs in p53 mutant cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/452</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/452.jpg</image:loc><image:title>TIP60 regulates PTEN expression, acetylation, and localization in cisplatin-resistant SCC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/453</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/453.jpg</image:loc><image:title>Dual dependency of large cell neuroendocrine carcinoma on Ras and ASCL1 oncogenic pathways</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/454</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/454.jpg</image:loc><image:title>GFH603: A molecular glue-like allosteric activator of the KEAP1-CUL3 E3 ligase complex for targeting NRF2-activated tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/455</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/455.jpg</image:loc><image:title>Next-generation sequencing and phospho-kinase analysis expose partner-specific profiles in CD74-ROS1 fusions</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/456</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/457</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/457.jpg</image:loc><image:title>Long non coding RNA plasmacytoma variant translocation 1 alternative splicing in prostate carcinogenesis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/458</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/459</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/459.jpg</image:loc><image:title>Distinct response profiles of TROP2-targeting ADCs Dato-DXd and sac-TMT across a large panel of cancer cell lines</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/460</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/460.jpg</image:loc><image:title>Co-expression of FIH1 and IL-12 in oncolytic HSV-1 blocks Notch signaling and enhances anti-tumor immunity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/461</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/461.jpg</image:loc><image:title>Rezatapopt and KRAS inhibitors for the treatment of TP53 Y220C and KRAS mutant cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/462</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/462.jpg</image:loc><image:title>DIRAS3 mimetic peptide achieves dual MAPK and PI3K pathway suppression across KRAS hotspot mutations</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/463</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/463.jpg</image:loc><image:title>EV-based delivery of chemically modified siRNA achieves MRTX1133-comparable efficacy in KRAS G12D-mutant pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/464</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/465</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/465.jpg</image:loc><image:title>TM4SF1 as a promising ADC target for KRAS-mutated cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/466</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/466.jpg</image:loc><image:title>Targeting RUNX transcriptional activity reduces tumor heterogeneity and aggressiveness in triple-negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/467</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/467.jpg</image:loc><image:title>Targeting scaffold/matrix associated regions in pancreatic ductal adenocarcinoma: A novel carbazole-derived therapeutic</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/468</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/469</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/469.jpg</image:loc><image:title>Subcellular localization of PARP1 by protein kinase D1 modulated cellular response to olaparib</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/470</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/471</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/471.jpg</image:loc><image:title>The combination of STX-478 and lorlatinib for the treatment of PIK3CA mutant colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/472</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/473</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/474</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/474.jpg</image:loc><image:title>PTPN1 activates neuroendocrine of treatment emergent prostate cancer by targeting the AR and REST complex</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/475</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/476</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/477</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/477.jpg</image:loc><image:title>ASCL1-mediated transcriptional regulation of RET in neuroendocrine prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/478</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/479</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/480</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/481</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/481.jpg</image:loc><image:title>Establishment of assay systems for drug development against the oncogenic phosphatase WIP1</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/482</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/483</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/483.jpg</image:loc><image:title>EGFR suppression and drug-induced potentiation are widespread features of oncogenic RTK fusions</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/484</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/485</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/486</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/487</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/488</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/489</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/490</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/490.jpg</image:loc><image:title>Discovery of novel pan-PI3K and mTOR dual inhibitors as first-in-class antibody-drug conjugate payloads</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/491</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/491.jpg</image:loc><image:title>Severe acidity in human tumors for pH-activatable cytokine therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/492</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/492.jpg</image:loc><image:title>From undruggable to actionable: Transcriptomic discovery of small-molecule modulators of oncogenic transcription factors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/493</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/493.jpg</image:loc><image:title>NEBNext UltraShear &amp;#174; Long Read: Enzymatic DNA fragmentation for long read sequencing of clinically relevant samples</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/494</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/494.jpg</image:loc><image:title>New approach methodologies for risk assessment and functional evaluation of immuno-oncology drug candidates</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/495</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/495.jpg</image:loc><image:title>Chemically ligated proteins enable quantitative ELISAs for p53 post-translational modifications</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/496</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/496.jpg</image:loc><image:title>Two-color bioluminescence analyses pairing NanoLuc&amp;#174; and red-shifted NanoPrism&amp;#8482; luciferases&amp;#8203;</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/497</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/497.jpg</image:loc><image:title>Tracking APOBEC3A to overcome drug resistance in lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/498</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/498.jpg</image:loc><image:title>Scientific justification for setting up an appropriate specification of residual solvent based on ICH guideline</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/499</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/499.jpg</image:loc><image:title>Dual PHD2-HDAC inhibitor 31c prevents cisplatin-bevacizumab nephrotoxicity and preserves antitumor efficacy in cervical cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/500</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/501</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/501.jpg</image:loc><image:title>Anti-cancer drug usage analysis among Korean patients with colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/502</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/502.jpg</image:loc><image:title>Comparative biochemical kinase activity analysis identifies lirafugratinib as a highly selective FGFR2 inhibitor</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/503</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/503.jpg</image:loc><image:title>Antitumor effect of a new pyruvate kinase M2 (PKM2) inhibitor Acyclovir in experimental esophageal adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/504</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/504.jpg</image:loc><image:title>Evaluation of ingenane diterpenoids for BL2 triple-negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/505</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/506</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/507</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/507.jpg</image:loc><image:title>From factory to patient: In vivo &amp;#8209;expressed biologics as a new paradigm for immunotherapy manufacturing</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/508</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/508.jpg</image:loc><image:title>Mapping cellular fate: From metabolic dynamics to DNA damage responses</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/509</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/509.jpg</image:loc><image:title>Population pharmacokinetics of nab-paclitaxel following administration of a nano-immunoconjugate with bevacizumab</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/510</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/511</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/511.jpg</image:loc><image:title>Turning tumors into therapeutic drug factories: Efficacy across oncology indications</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/512</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/513</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/514</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/515</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/516</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/517</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/517.jpg</image:loc><image:title>Oncogenic cooperation of MUC13 and NDRG1 signaling in liver cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/518</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/519</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/520</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/521</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/521.jpg</image:loc><image:title>CAR T cells engineered via mRNA exhibit enhanced targeting of colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/522</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/522.jpg</image:loc><image:title>A generic, high throughput unwinding assay for discovery of RNA helicase inhibitors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/523</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/523.jpg</image:loc><image:title>Next-generation ERbeta agonists with superior brain uptake suppress glioblastoma and enhance temozolomide response</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/524</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/525</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/526</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/527</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/528</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/528.jpg</image:loc><image:title>Combinatorial screening reveals novel gene-drug synergies in breast cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/529</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/530</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/530.jpg</image:loc><image:title>Leveraging single-cell multiomics for a generalizable approach to differentiation therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/531</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/532</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/533</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/533.jpg</image:loc><image:title>DELs in cells: Small-molecule hits for transcription factor identified by intracellular DNA-encoded library screening</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/534</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/535</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/535.jpg</image:loc><image:title>Accelerating integrated tumor profiling with QIAseq xHYB Pro: A fast, modular approach to CGP and HRD assessment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/536</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/536.jpg</image:loc><image:title>A comprehensive LinkLight platform for GPCR mechanistic profiling to support cancer drug discovery</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/537</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/537.jpg</image:loc><image:title>A bioluminescent assay for detection of fatty acid oxidation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/538</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/539</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/539.jpg</image:loc><image:title>Lumit&amp;#174; hKi-67 immunoassay for cell proliferation with optimized performance for screening applications</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/540</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/540.jpg</image:loc><image:title>Implementation of single B-cell screening to select antibodies in one day based on affinity and multiple binding properties</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/541</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/542</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/542.jpg</image:loc><image:title>An HTS assay for detection of XRN1 exoribonuclease activity with unmodified RNA</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/543</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/543.jpg</image:loc><image:title>Drug sensitivity profiling of oncology drugs reveals candidate therapeutic targets in uterine leiomyoma subtypes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/544</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/545</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/546</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/546.jpg</image:loc><image:title>Hit finding and assay enablement for VRK1, a paralog synthetic lethal kinase target in VRK2-deficient cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/547</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/547.jpg</image:loc><image:title>A new approach methodology (NAM) for specificity testing: ISTAND qualification of the membrane proteome array to evaluate off-target binding of MAb-based therapies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/548</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/548.jpg</image:loc><image:title>Targeting Brachyury with small molecules: A new therapeutic paradigm for chordoma and neuroendocrine carcinomas</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/549</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/549.jpg</image:loc><image:title>A robust automated workflow for precise oncoprotein quantification to accelerate targeted degradation and oncology research</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/550</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/550.jpg</image:loc><image:title>Target agnostic phage display for nanobodies that alter immune cell function</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/551</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/551.jpg</image:loc><image:title>Novel anti-CD3 heavy chain-only antibodies for use in T-cell engaging therapeutics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/552</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/552.jpg</image:loc><image:title>Redox-DNA repair co-targeting with IP-DNQ and rucaparib induces oxidative DNA damage and GSDME-mediated pyroptosis in NQO1-positive tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/553</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/553.jpg</image:loc><image:title>Targeting RNA demethylase ALKBH5 with mefloquine enhances antitumor immunity and reduces osteosarcoma progression and metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/554</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/554.jpg</image:loc><image:title>The multibody drug conjugate (MDC) BD200 mediates anti-tumor activity through a novel dual-targeting mode</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/555</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/555.jpg</image:loc><image:title>Inhibition of extracellular matrix remodeling and metastatic activity by dichloroacetate and chloroquine in the presence of arsenite in 4nqo-induced oral squamous cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/556</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/556.jpg</image:loc><image:title>Targeting oncogenic TBRI signaling inhibits androgen-independent prostate cancer growth and metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/557</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/557.jpg</image:loc><image:title>Breaking the KRAS inhibitor induced resistance-wall: Targeting KRAS-SOS1 to disarm hypoxic survival</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/558</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/558.jpg</image:loc><image:title>Crippling cancer&#039;s energy and escape: NAMPT and BCL2 as dual targets in T-ALL</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/559</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/559.jpg</image:loc><image:title>LMTK2: A novel driver of endocrine resistance in ERalpha+ breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/560</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/560.jpg</image:loc><image:title>Evaluation of HERV-K as an unusual cancer therapeutic target</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/561</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/561.jpg</image:loc><image:title>Pre-targeting with click chemistry facilitates selective MMAE activation in CEACAM5+ tumors: A first-in-class approach to enhance clinical benefit in targeted therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/562</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/562.jpg</image:loc><image:title>A M2-like tumor-associated macrophage-targeted nanoparticulate TLR7/8 agonist, UI-102, reprograms its phenotypes to induce potent anti-tumor immunity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/563</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/563.jpg</image:loc><image:title>Intranodal chemokine therapy targeting the sentinel lymph node in head and neck squamous cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/564</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/564.jpg</image:loc><image:title>Albumin-based DLL3-targeted nano-immunoconjugates of SN38 preserve potency and demonstrate high-affinity DLL3 binding in small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/565</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/565.jpg</image:loc><image:title>JZY-2233: An antigen-targeted CBP/p300 degrader-antibody conjugate for advanced prostate cancer therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/566</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/566.jpg</image:loc><image:title>Investigating SIX1 as a driver and target for a first in-class EMT degrader in head-and-neck squamous cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/567</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/567.jpg</image:loc><image:title>Therapeutic potential of AURKA inhibition in ER+ inflammatory breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/568</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/568.jpg</image:loc><image:title>Small molecule targeting of SERPINB3 as an anticancer strategy in cervical cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/569</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/569.jpg</image:loc><image:title>Overcoming PD-1 resistance with a first-in-class dual-mode agent that transforms &amp;#8216;cold&#039; tumors to &amp;#8216;hot&#039;</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/570</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/570.jpg</image:loc><image:title>MC001: A novel chemoimmunotherapy antibody drug conjugate for treating folate receptor alpha expressing pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/571</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/571.jpg</image:loc><image:title>Discovery of KAT6A degrader enabled by structural proteomics and AI</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/572</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/572.jpg</image:loc><image:title>Nebivolol triggers apoptosis, ferroptosis and necroptosis in triple-negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/573</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/573.jpg</image:loc><image:title>Interim results of clinical trial phase 1 of pan-mKARS or PTEN loss tumor targeting peptide drug conjugates (Maleimide-KGDEVD-Doxorubicin/Exatecan)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/574</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/574.jpg</image:loc><image:title>Fully human monoclonal antibodies for antibody drug conjugate development to a cell surface target expressed in cancers with unmet needs</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/575</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/575.jpg</image:loc><image:title>The therapeutic potential of CCL5 and endoglin in ER-positive breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/576</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/576.jpg</image:loc><image:title>CDC20 drives acquired resistance to CDK4/6 inhibitors in estrogen receptor positive breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/577</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/577.jpg</image:loc><image:title>Elucidation of intratumoral heterogeneity using patient-derived lung cancer cell line</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/578</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/578.jpg</image:loc><image:title>Low physiological pH drives P300 mediated acetylation of PARP1 and promotes PARP inhibitor resistance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/579</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/579.jpg</image:loc><image:title>Integrative analysis of capivasertib mediated AKT blockade with AR inhibition in mouse PTEN-deficient prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/580</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/580.jpg</image:loc><image:title>ARNT2 and AhR promote resistance to HIF2a inhibitor belzutifan</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/581</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/582</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/582.jpg</image:loc><image:title>On-target WRN mutations drive resistance to WRN inhibitors in TA-repeat-expanded MSI cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/583</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/583.jpg</image:loc><image:title>Effects of aneuploidy associated RAD21 gain on therapeutic response to PARP inhibition in Ewing sarcoma and prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/584</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/584.jpg</image:loc><image:title>PGRMC1 induced lipid metabolic reprogramming leads to sorafenib resistance in hepatocellular carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/585</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/585.jpg</image:loc><image:title>Cysteine-driven drug inactivation undermines covalent drug efficacy and drives resistance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/586</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/586.jpg</image:loc><image:title>Chromatin rewiring and transcriptional plasticity drive a distinct dual-resistant state in ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/587</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/587.jpg</image:loc><image:title>beta-Hydroxybutyrate-mediated lysine butyrylation determines therapy response in liver cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/588</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/588.jpg</image:loc><image:title>Exploring the role of LONP1 in lon-traditional mechanisms of glioblastoma resistance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/589</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/590</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/591</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/591.jpg</image:loc><image:title>Targeting the YBX1-SREBP2 axis to overcome drug resistance in hepatocellular carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/592</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/592.jpg</image:loc><image:title>Precision combination therapy opportunities in colorectal cancer revealed by PDX drug screening</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/593</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/593.jpg</image:loc><image:title>DYRK1A-mediated quiescence establishes a therapeutically-resistant reservoir for glioblastoma recurrence</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/594</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/594.jpg</image:loc><image:title>GSDMB drives cGAS-STING-mediated immune evasion in HER2-amplified colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/595</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/596</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/596.jpg</image:loc><image:title>TROP2 and PTEN are biomarkers of primary resistance to TUSC2 gene therapy in non-small cell lung cancer (NSCLC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/597</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/597.jpg</image:loc><image:title>EMT-like reprogramming drives drug-tolerant persister cell plasticity in mantle cell lymphoma via ribosome biogenesis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/598</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/598.jpg</image:loc><image:title>Uncovering mechanisms of PARP inhibitor resistance in IDH1-mutant cancers via serial tumor transplantation and genome wide CRISPR-Cas9 knockout screen</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/599</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/599.jpg</image:loc><image:title>Adaptive resistance mechanisms to mTOR inhibitor in lung squamous cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/600</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/600.jpg</image:loc><image:title>Identification of drug resistance factors in ALK-rearranged lung cancer using genome-wide CRISPR activation screening</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/601</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/601.jpg</image:loc><image:title>Nrf2 role in regulating kaempferol&#039;s inhibitory action on CDKs, PD-L-1, CCL2, and TGM2 in triple-negative breast cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/602</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/602.jpg</image:loc><image:title>Preclinical study of nucleic acid therapeutics targeting the Warburg effect</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/603</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/603.jpg</image:loc><image:title>Targeted STEAP2 knockdown with self-delivering antisense oligonucleotide reduces cancer malignant behavior</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/604</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/604.jpg</image:loc><image:title>EpCAM-CD3 bispecific antibody-encoding mRNA delivered by lung targeted lipid nanoparticles suppresses orthotopic lung tumor growth</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/605</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/605.jpg</image:loc><image:title>A mRNA-encoded trispecific CD19xBCMAxCD3 T cell engager to treat cancer and autoimmunity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/606</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/606.jpg</image:loc><image:title>Leveraging cancer-activated gene expression and cGAS-STING activation for efficient tumor killing via a DNA-LNP delivery platform</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/607</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/607.jpg</image:loc><image:title>Towards personalized cancer vaccines: LNP-mediated delivery of multi-epitope mRNA extends survival in aggressive melanoma cancer model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/608</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/608.jpg</image:loc><image:title>A novel gene therapy approach for treating breast cancer through the overexpression of mutant estrogen receptor</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/609</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/609.jpg</image:loc><image:title>Engineering robust AAV vectors: Addressing ITR instability for effective cancer gene therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/610</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/610.jpg</image:loc><image:title>Redtail: A dual-programmable virotherapy platform for systemic tumor targeting and localized gene delivery</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/611</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/611.jpg</image:loc><image:title>Engineering a novel epithelial-tropic pseudovirus platform for targeted gene therapy to carcinomas</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/612</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/612.jpg</image:loc><image:title>Functionalization of virus-like particles for improved in vivo immune cell engineering</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/613</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/613.jpg</image:loc><image:title>pIR-a new antibiotic free plasmid production platform for non-viral DNA delivery</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/614</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/614.jpg</image:loc><image:title>IL-7-secreting Salmonella synergizes with PD-L1 blockade to induce durable antitumor immune memory</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/615</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/615.jpg</image:loc><image:title>Attenuated Salmonella secreting IFN-beta via the flagellar secretion system enhances antitumor immunity and therapeutic efficacy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/616</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/616.jpg</image:loc><image:title>High-avidity reversible engager proteins efficiently redirect the entry of intravenously delivered lentiviral vectors, simplifying the direct in vivo delivery of CAR-T cell therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/617</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/618</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/618.jpg</image:loc><image:title>Bioluminescent tools for quantification of in vivo CAR&amp;#8209;T delivery systems</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/619</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/619.jpg</image:loc><image:title>Anti-tumor activity in humanized xenograft models and B-cell aplasia in non-human primates with a novel CD3-directed in vivo gene-modifying CAR (GCAR) lentivector encoding chimeric antigen receptors and a cellular fitness-enhancing co-stimulatory protein</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/620</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/620.jpg</image:loc><image:title>IMV102, an in vivo BCMA-targeting CAR-T therapy, achieves durable tumor control in multiple myeloma models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/621</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/621.jpg</image:loc><image:title>In vivo adenine base editing of STK11 Q37* reprograms tumor for radiosensitizing effect</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/622</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/622.jpg</image:loc><image:title>Completion of IND-enabling studies for NRT-YHD_001, a macrophage checkpoint inhibitor in liver cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/623</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/623.jpg</image:loc><image:title>AZD4956, a potent and selective inhibitor of DNA polymerase theta, enhances the activity of DNA-damaging agents in HRR defective cellular backgrounds and improves efficacy of the new generation PARP1-selective inhibitor, saruparib</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/624</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/625</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/625.jpg</image:loc><image:title>IDE034, A bispecific antibody-drug conjugate co-targeting PTK7 and B7-H3, exhibits avidity-driven selectivity and enhanced antitumor activity versus mono-specific ADCs</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/626</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/626.jpg</image:loc><image:title>Preclinical development of EIK1005, a potent and selective inhibitor of Werner helicase</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/627</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/627.jpg</image:loc><image:title>Proteomic profiling of FEN1 inhibition by BSM-1516 reveals chromatin-associated biomarkers for preclinical pharmacodynamic evaluation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/628</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/628.jpg</image:loc><image:title>Cellular comparison of a covalent and non-covalent WRN inhibitor reveals shared and unique response biomarkers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/629</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/629.jpg</image:loc><image:title>Targeting DNA damage sensors (DDS) to enhance Osimertinib response in EGFR-driven cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/630</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/630.jpg</image:loc><image:title>Selective Cytotoxicity of Base Excision Repair Inhibitor, TRC102, in DNA Damage Response Hyperactivated Glioblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/631</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/631.jpg</image:loc><image:title>Targeted degradation of DNA ligase IV through a double-stranded DNA-based PROTAC for precision radiosensitization</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/632</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/632.jpg</image:loc><image:title>Potent synergy between CHK1/2 inhibitor ACR-368 and the ADC payload topoisomerase I inhibitor: Rationale for ADC + ACR-368 combination therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/633</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/634</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/634.jpg</image:loc><image:title>Targeted drug screening identifies novel compounds enabling accelerated mismatch repair deficiency (MMRd) for immunotherapy sensitization</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/635</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/635.jpg</image:loc><image:title>Targeting the DNA damage response sensor replication protein A for first in class cancer therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/636</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/636.jpg</image:loc><image:title>DNA fiber-based replication phenotypes distinguish WEE1-inhibitor response in high-grade endometrial cancer patient-derived organoids (PDOs) treated with azenosertib</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/637</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/637.jpg</image:loc><image:title>DHX9 inhibition is synthetically lethal with homologous recombination deficient and dMMR/MSI-H cancers and synergizes with PARP1 inhibition and chemotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/638</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/638.jpg</image:loc><image:title>Expanding the therapeutic window of PARP inhibitors by co-administering PARG inhibitors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/639</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/639.jpg</image:loc><image:title>Discovery and mechanistic characterisation of the first oral bioavailable FEN1 inhibitor for treatment of HRD and EWS cancers and combination with various DDR inhibitors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/640</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/640.jpg</image:loc><image:title>Multiomic and preclinical assessment of ATR and Aurora kinase inhibitors in diverse TNBC models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/641</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/641.jpg</image:loc><image:title>Nesuparib (JPI-547), a dual tankyrase/PARP inhibitor, exhibits potent antitumor activity in small-cell lung cancer models by modulating Wnt and Hippo signaling pathways</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/642</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/642.jpg</image:loc><image:title>MOMA-313, an inhibitor of the DNA polymerase theta helicase domain, prevents BRCA reversions in preclinical models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/643</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/643.jpg</image:loc><image:title>Targeting DNA damage repair pathway and CCR2&amp;#8314; myeloid cell to overcome radioimmunotherapy resistance in small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/644</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/644.jpg</image:loc><image:title>Targeting cyclin K-CDK12 synergizes with ATR inhibition by limiting RPA chromatin loading in triple-negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/645</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/645.jpg</image:loc><image:title>Targeting replication stress promotes immunogenic cell death in chordoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/646</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/646.jpg</image:loc><image:title>Antitumor activity of PARP inhibitors in combination with Temozolomide in fumarate hydratase-deficient RCC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/647</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/647.jpg</image:loc><image:title>The PARP1-selective inhibitor and trapper saruparib achieves extended PARP1 target engagement in vitro , in vivo and in the clinic</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/648</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/648.jpg</image:loc><image:title>NOVO-111: A macrocycle drug conjugate engineered for improved tumor targeting and tolerability</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/649</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/649.jpg</image:loc><image:title>Cyclopamine tartrate enhances antitumor immunity and suppresses triple-negative breast cancer growth</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/650</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/650.jpg</image:loc><image:title>Combinatorial treatment of glioblastoma with temozolomide (TMZ) plus 5-ethynyl-2&#039;-deoxyuridine (EdU)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/651</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/651.jpg</image:loc><image:title>Targeting Hsp90beta potentiates nab-paclitaxel-based chemotherapy response in pancreatic cancer models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/652</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/652.jpg</image:loc><image:title>Discovery of JMKX005425, a potent WRN inhibitor highly efficacious in multiple MSI-H gastric cancer models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/653</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/653.jpg</image:loc><image:title>Synthesis and anti-cancer screening of benzopyran derivatives</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/654</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/654.jpg</image:loc><image:title>The non-pungent N-AVAM capsaicin analog DOHEVANIL displays robust growth-suppressive activity in human endrometriod ovarian cancers in vitro and in vivo</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/655</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/655.jpg</image:loc><image:title>(Z)-endoxifen modulates estrogen receptor and cell-cycle signaling to induce synergistic antiproliferative effects with CDK4/6 inhibition in endometrial cancer models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/656</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/656.jpg</image:loc><image:title>Discovery of potent and selective TRIB2 inhibitors with therapeutic efficacy in therapy-resistant neuroendocrine prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/657</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/658</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/658.jpg</image:loc><image:title>Discovery of a first-in-class dual microtubule- and RAF-targeting inhibitor</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/659</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/659.jpg</image:loc><image:title>Subcellular targeted therapy using HMCD-artemisinin conjugates for metastatic castration-resistant prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/660</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/660.jpg</image:loc><image:title>Characterization of CGT1263, a KRAS (ON/OFF) inhibitor clinical candidate with selectivity for mutant KRAS over HRAS and NRAS</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/661</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/662</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/662.jpg</image:loc><image:title>ADT-007: A mechanistically distinct Pan-RAS inhibitor with capacity to escape acquired resistance common to other RAS inhibitors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/663</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/663.jpg</image:loc><image:title>QED-203, a dual TRPV6 and AR small molecule preclinical candidate for advanced prostate cancer resistant to standard of care</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/664</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/664.jpg</image:loc><image:title>Combination of VLS-1488 and taxanes induces anti-tumor synergistic effect in cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/665</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/665.jpg</image:loc><image:title>HEC201625, a novel oral small molecule inhibitor of PD-L1, demonstrated potent anti-tumor activities both in vitro and in vivo</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/666</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/666.jpg</image:loc><image:title>Structure-guided design of JZY3032, a dual-engaging DALTAC that miswires AR-p300 in prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/667</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/667.jpg</image:loc><image:title>ETX-929, a potential best-In-class, oral, highly potent and selective dual ON / OFF state Pan-KRAS small molecule inhibitor for the treatment of KRAS mutant and wild-type amplified cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/668</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/668.jpg</image:loc><image:title>Targeting NAMPT using Novel Inhibitor RPT-E-037 in Pancreatic Neuroendocrine Tumor</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/669</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/669.jpg</image:loc><image:title>Targeting proliferating cell nuclear antigen via a miRNA-CSC axis as a new therapeutic approach in multiple myeloma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/670</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/670.jpg</image:loc><image:title>Kirsten rat sarcoma virus (KRAS) oncoprotein as a new therapeutic target in multiple myeloma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/671</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/671.jpg</image:loc><image:title>A novel potent tetrahydroisoquinoline analog: A cytostatic taxol-like agent</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/672</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/672.jpg</image:loc><image:title>ETX-880, a potential best-in-class, oral, highly potent and selective covalent inhibitor of Werner helicase for the treatment of microsatellite instability-high (MSI-H) cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/673</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/673.jpg</image:loc><image:title>Targeting tGLI1 in breast cancer brain metastases with a novel ketoconazole derivative</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/674</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/674.jpg</image:loc><image:title>ISM6166, a novel oral pan-KRAS (ON/OFF) inhibitor discovered with generative AI shows robust anti-tumor activity in solid tumors with KRAS alterations</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/675</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/675.jpg</image:loc><image:title>Development of heptamethine carbocyanine based small molecule targeting platform for tumor specific drug delivery</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/676</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/676.jpg</image:loc><image:title>PMR-116, a second-generation RNA polymerase I inhibitor displaying therapeutic efficacy in a broad spectrum of malignancies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/677</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/677.jpg</image:loc><image:title>PI3Kdelta in CD4&amp;#8314; T cells protects against lung metastases through IFNgamma-induced tumor senescence</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/678</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/678.jpg</image:loc><image:title>Itaconate promotes memory CD8 + T cell development by epigenetic modification and glucose flux redirection in viral infection and cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/679</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/679.jpg</image:loc><image:title>FGFR3 impairs DC1s/CD8 + T cell clustering in bladder cancer preventing the PD-1/PD-L1 blockade-induced CD8 + T cell phenotypes associated with immunotherapy efficacy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/680</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/680.jpg</image:loc><image:title>Adenosine signaling promotes double-negative t-cell anticancer responses in conditions of CD8 t-cell lymphopenia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/681</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/681.jpg</image:loc><image:title>Early CD8 + T and NK cell interactions orchestrate preemptive immunosurveillance to potentiate optimal cytotoxicity that blocks tumor antigen-escape variants</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/682</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/682.jpg</image:loc><image:title>Allogeneic double-negative T cells induce an innate-like cytotoxic function in CD8 + T cells against acute myeloid leukemia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/683</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/683.jpg</image:loc><image:title>Restoring TUSC2 function boosts NK cell cytotoxicity and antitumor immunity in vivo and in vitro</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/684</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/684.jpg</image:loc><image:title>Role of SRC-3 in regulatory T cells as a modulator of activation and immunological memory</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/685</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/685.jpg</image:loc><image:title>Rewiring the dendritic cell: Regulatory T cell axis sensitizes prostate cancer to immunotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/686</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/686.jpg</image:loc><image:title>Preclinic study of src3-ko regulatory T cells in mouse breast cancer model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/687</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/687.jpg</image:loc><image:title>Harnessing TLS-derived B cells through STING and LTbetaR activation reveals a novel opportunity to antibody-mediated immunotherapy in pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/688</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/688.jpg</image:loc><image:title>A TNF-producing neutrophil subset drives age-dependent hepatotoxicity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/689</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/690</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/691</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/691.jpg</image:loc><image:title>Investigating how host TLR5 signaling modulates FLT3 ligand therapeutic efficacy for ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/692</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/692.jpg</image:loc><image:title>Targeting tumoral GLI1 in triple-negative breast cancer: A novel strategy to reverse the immunosuppressive microenvironment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/693</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/693.jpg</image:loc><image:title>Tumor-reactive CD8 lymphocyte isolated from melanoma brain metastasis show that a subset of the total population is better at controlling tumor growth after adoptive transfer into a xenograft model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/694</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/694.jpg</image:loc><image:title>Intrinsic failure of immune activation in NRAS -mutant melanoma reveals a targetable mechanism of checkpoint resistance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/695</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/695.jpg</image:loc><image:title>In vivo CRISPR screening uncovers Folr1-mediated metabolic remodeling that sensitizes colorectal cancer to PD-1 blockade</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/696</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/696.jpg</image:loc><image:title>Exploring the role of catecholamine signaling in CD8+ T cell immunity to neuroblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/697</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/697.jpg</image:loc><image:title>Riboflavin biosynthesis byproducts increase the vulnerability of cancer to adoptive MAIT TCR-engineered T-cell transfer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/698</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/698.jpg</image:loc><image:title>Synthetic reprogramming of gammadelta CAR T cells with the LTBR gene optimizes function in the TME and overcomes effector limitations</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/699</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/699.jpg</image:loc><image:title>Expanding the ACT paradigm: B cell engineering via spherical nucleic acids for cancer immunotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/700</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/700.jpg</image:loc><image:title>Enhanced feeder-free expansion, survival, potency and post manufacture stability of NK cells for CAR-NK therapies using human platelet lysate</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/701</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/701.jpg</image:loc><image:title>Improving effector cells for CAR-NK immunotherapy against colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/702</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/702.jpg</image:loc><image:title>NEO-201-recognized truncated Core 1 O-glycans represent a new target for CAR-NK therapy in AML</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/703</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/703.jpg</image:loc><image:title>Anti-tumor activity of engineered iPSC-derived NK cells against metastatic uveal melanoma cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/704</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/704.jpg</image:loc><image:title>Memory-like NK cell targeting to CD123 and CD33 improves killing of acute myeloid leukemia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/705</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/705.jpg</image:loc><image:title>Surface engineered-NK/trastuzumab cells as a novel immunotherapy for HER2-low breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/706</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/707</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/707.jpg</image:loc><image:title>Generation of scalable off-the-shelf iNKT therapies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/708</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/708.jpg</image:loc><image:title>Functional profiling of an allogeneic NK cell therapy product in NSCLC patient-derived organotypic tumor spheroids</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/709</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/709.jpg</image:loc><image:title>Allogeneic CAR-iNKT cell therapy targeting CLDN18.2-positive gastric and pancreatic cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/710</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/710.jpg</image:loc><image:title>Selecting cord blood-derived NK cells enriched in mature subsets optimizes CAR-NK cell-based anti-tumor therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/711</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/711.jpg</image:loc><image:title>A universal multi-receptor NK cell platform engineered for synergistic combination with antibody and T-cell engager therapies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/712</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/712.jpg</image:loc><image:title>Enhancing gammadelta CAR T cell function through alternative CD3 cytoplasmic domains</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/713</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/713.jpg</image:loc><image:title>In vivo CAR mRNA engineering of both adaptive and myeloid cells enables potent anti-tumor control of solid cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/714</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/714.jpg</image:loc><image:title>CD8 nanobody-targeted lipid nanoparticles encapsulating CD13 nanoCAR circular RNAs for in situ CAR-T cell eradication of acute myeloid leukemia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/715</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/715.jpg</image:loc><image:title>In vivo lentiviral CAR-T gene delivery demonstrates high specificity and potent anti-tumor activity in a humanized B cell lymphoma model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/716</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/716.jpg</image:loc><image:title>A multipronged approach to improve gene delivery efficiency for in vivo CAR-T using CD3 and CD7 retargeted LVVs</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/717</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/717.jpg</image:loc><image:title>In vivo CAR-T T-LNP system (GT801) drives potent B cell depletion and clinical feasibility in hematologic and autoimmune conditions</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/718</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/718.jpg</image:loc><image:title>Erythrocyte-mediated mRNA delivery enables in vivo generation of CAR-myeloid cells for cancer immunotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/719</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/719.jpg</image:loc><image:title>T-cell specific transcriptional control eliminates CAR-mediated off-target transduction by CD3-retargeted lentiviral vectors, enabling safe in vivo generation of potent alphaBCMA-CAR T cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/720</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/720.jpg</image:loc><image:title>Combination of cytokines, PM21-particle stimulation, and TGF-beta conditioning results in Natural Killer cells with enhanced cytotoxicity and infiltration of solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/721</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/721.jpg</image:loc><image:title>Toward an in vivo anti-BCMA/CD19 CAR-T cell treatment of B cell-mediated autoimmune diseases</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/722</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/723</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/723.jpg</image:loc><image:title>Robust engraftment of human gammadelta T cells in humanized NSG TM -SGM3-IL-15 &amp;#215; MHC I/II double knockout mice for the evaluation of gammadelta T cell-based therapeutics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/724</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/724.jpg</image:loc><image:title>Systemic immune reprogramming by extracranial melanoma reshapes the melanoma brain metastasis microenvironment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/725</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/725.jpg</image:loc><image:title>NOX2-driven macrophage reprogramming enhances breast cancer metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/726</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/726.jpg</image:loc><image:title>TNF-alpha plays pleiotropic role in innate immune activation and blood-brain barrier disruption driving brain metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/727</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/727.jpg</image:loc><image:title>Thyroid hormones modulate the lung immune microenvironment to regulate breast cancer metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/728</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/728.jpg</image:loc><image:title>Thyroid hormones as systemic regulators of melanoma progression and dissemination</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/729</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/729.jpg</image:loc><image:title>Commensal dysbiosis mediates changes in mammary tissue mast cells and fibroblasts to promote HR + breast tumor dissemination</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/730</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/730.jpg</image:loc><image:title>Breast cancer liver metastasis: Primary tumor predictors and histopathologic characteristics of metastatic lesions</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/731</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/731.jpg</image:loc><image:title>Pulmonary tuberculosis as a modifier of molecular features and survival in lung cancer patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/732</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/732.jpg</image:loc><image:title>Chronological evolution of immune tumor microenvironment (TME) from esophageal dysplasia (ED) to esophageal squamous cell carcinoma (ESCC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/733</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/733.jpg</image:loc><image:title>Tumor-agnostic analysis identified pan-cancer immune archetypes and CD8&amp;#8314;FoxP3&amp;#8314; cells as novel in situ predictors of survival</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/734</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/734.jpg</image:loc><image:title>IL-33/JAK2/RAB21/PLD4-Sphingolipid network drives gastric carcinogenesis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/735</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/735.jpg</image:loc><image:title>Lung inflammation accelerates tumor progression in a mouse model of oncogenic KRAS driven lung adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/736</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/736.jpg</image:loc><image:title>LPS-induced superoxide anion-dependent macrophage extracellular traps by store-operated calcium entry</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/737</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/737.jpg</image:loc><image:title>The IL-33/ST2 signaling reshapes the immune landscape and promotes leukemia transformation in acute myeloid leukemia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/738</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/738.jpg</image:loc><image:title>Identification of oncohistone-dependent changes in chromatin accessibility and the tumor microenvironment in a new inducible and reversible H3.3K27M mouse model of diffuse midline glioma (DMG)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/739</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/740</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/740.jpg</image:loc><image:title>Development of an immunocompetent orthotopic mouse model recapitulating metastatic endometrial cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/741</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/741.jpg</image:loc><image:title>The early immune landscape of breast cancer and the role of tertiary lymphoid structures</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/742</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/742.jpg</image:loc><image:title>Dependencies of diffuse large B-cell lymphoma on EBV oncoproteins</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/743</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/743.jpg</image:loc><image:title>Decoding the circRNA-miRNA-mRNA regulatory network in hepatitis B Virus-driven hepatocellular carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/744</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/744.jpg</image:loc><image:title>HERV-K env gene promotes tumorigenicity and metastasis through multiple signal pathways, including the Ras/ERK signaling pathway and epithelial-mesenchymal transition (EMT), in breast cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/745</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/745.jpg</image:loc><image:title>Unexpected identification of tumor-infiltrating H. pylori or human papillomavirus (HPV) 16 in three exceptional responders in immunochemotherapy-treated esophageal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/746</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/747</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/747.jpg</image:loc><image:title>Association between prior smoking and the time between HPV16-E6 seroconversion and development of oropharyngeal squamous cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/748</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/748.jpg</image:loc><image:title>Targeting STAT3 promotes cell death and enhances T-cell activity in HPV-associated cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/749</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/749.jpg</image:loc><image:title>Targeting lytic cycle with ciclopirox derivative in Epstein-Barr Virus+ gastric cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/750</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/750.jpg</image:loc><image:title>Primary cardiac lymphoma and HIV: A nationwide analysis of hospitalizations</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/751</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/751.jpg</image:loc><image:title>Exploring viral influence on susceptibility to retinoblastoma in northern Tanzania, The ENVISION-Tanzania study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/752</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/752.jpg</image:loc><image:title>Advanced OnePCR HPV panel: Fast POCT platform covering complete high, medium &amp;#38; low-risk genotypes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/753</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/753.jpg</image:loc><image:title>Zika virus demonstrates oncolytic efficacy against high-risk rhabdomyosarcoma in both in vitro cultures and in vivo murine xenograft models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/754</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/754.jpg</image:loc><image:title>Spondweni virus is highly oncolytic in endometrial carcinoma-derived HEC-1-A cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/755</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/755.jpg</image:loc><image:title>Investigating nonsense-mediated decay (NMD) as a restriction factor for EBV-reactivation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/756</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/756.jpg</image:loc><image:title>Single-cell ATAC-sequencing profiling of HPV18 positive head and neck cancer cells reveals heterogeneity of HPV18 genome accessibility and its association with cancer progression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/757</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/757.jpg</image:loc><image:title>Aberrant T cell proliferation in HIV associated clonal hematopoiesis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/758</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/758.jpg</image:loc><image:title>HPV16 variant lineage in response to treatment in locally advanced cervical cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/759</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/759.jpg</image:loc><image:title>Analytical validation of viral detection in tumor-derived cell-free DNA</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/760</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/760.jpg</image:loc><image:title>Accelerating precision immunotherapy for HPV-driven cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/761</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/761.jpg</image:loc><image:title>Stochastic mutagenesis at lncBART-KDM5B-bound genomic loci in Epstein-Barr virus-associated nasopharyngeal carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/762</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/763</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/764</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/764.jpg</image:loc><image:title>Advancing cancer treatment through targeting dipeptidyl peptidase 8 an innovative strategy for overcoming resistance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/765</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/765.jpg</image:loc><image:title>Functional effects of miPEP133 on mitochondrial integrity and treatment response in ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/766</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/766.jpg</image:loc><image:title>Selective induction of cuproptosis in vivo by a soluble Elesclomol analog</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/767</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/768</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/769</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/769.jpg</image:loc><image:title>Inhibition of mitochondrial protein MAGMAS increases sensitivity to standard of care treatment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/770</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/770.jpg</image:loc><image:title>TRAP1 represents a mitochondrial target and biomarker of dedifferentiated liposarcoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/771</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/772</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/772.jpg</image:loc><image:title>Combination of PRMT5 and Mcl-1 inhibitors overcomes immune checkpoint inhibitor resistance in pleural mesothelioma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/773</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/774</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/774.jpg</image:loc><image:title>Clonal diversity drives cooperative growth in lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/775</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/775.jpg</image:loc><image:title>Establishing the mechanistic link between chemotherapy response and Hippo-YAP signaling in ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/776</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/776.jpg</image:loc><image:title>UVRAG-ITCH-ESCRT axis mediates a lysosomal off-switch dampening NOTCH1 signaling in cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/777</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/777.jpg</image:loc><image:title>SGK1 may represent a therapeutic target in BRAF-mutant melanoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/778</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/778.jpg</image:loc><image:title>The YAP1-IGFBP2 axis as a predictive biomarker and therapeutic target in gastric cancer metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/779</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/780</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/781</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/781.jpg</image:loc><image:title>WNT and Notch crosstalk in pregnancy-associated breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/782</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/782.jpg</image:loc><image:title>Defining a DLG5-NUAK2-LATS1 complex that regulates Hippo signaling output</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/783</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/784</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/784.jpg</image:loc><image:title>Exploring the therapeutic vulnerability of castration-resistant prostate cancer via Hippo-YAP/TAZ-TEAD signaling</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/785</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/785.jpg</image:loc><image:title>Cooperative regulation of YAP activity by STK40 and CDK7 in cancer progression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/786</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/787</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/787.jpg</image:loc><image:title>Defects in junctional localization of desmosomal proteins in cancer cells triggered by loss of Septin-9</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/788</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/788.jpg</image:loc><image:title>Emerging roles of Cyclin F in Non-small lung cell carcinoma during metabolic stress</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/789</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/789.jpg</image:loc><image:title>TPM4 overexpression modifies differentiated colon epithelial cell barrier integrity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/790</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/791</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/792</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/792.jpg</image:loc><image:title>Septin-9 binds to Desmoglein-2 and controls cell-cell junction strength in cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/793</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/793.jpg</image:loc><image:title>Context-dependent roles of sFRP1 in melanoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/794</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/795</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/795.jpg</image:loc><image:title>Pdcd4/mTORC2 axis regulates glycolysis via PFKFB3 in NSCLC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/796</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/796.jpg</image:loc><image:title>Choline Acetyltransferase: A novel drug target in lung adenocarcinoma patients who are exposed to tobacco smoke</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/797</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/798</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/799</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/799.jpg</image:loc><image:title>Role of cellular prion protein in breast cancer through Wnt signaling</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/800</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/800.jpg</image:loc><image:title>The ubiquitin ligase HUWE1 controls the balance between beta-catenin functions in WNT signaling and cell adhesion</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/801</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/801.jpg</image:loc><image:title>NSD2 regulates cell growth and oncogenic signaling pathways in laryngeal carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/802</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/802.jpg</image:loc><image:title>Early metabolic and differentiation remodeling in BRCA1/2 high-risk fallopian tube epithelium revealed by single-cell multi-omics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/803</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/804</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/804.jpg</image:loc><image:title>AZD5305, a PARP1 selective inhibitor, exhibits antitumor effects and stimulates immune response in homologous recombination (HR)-deficient gastric cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/805</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/805.jpg</image:loc><image:title>Potentiation ofPARP inhibitor activity in BRCA -wildtype breast cancer cell lines by 2-hydroxyflavanone</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/806</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/806.jpg</image:loc><image:title>Substrate selectivity and RPA-mediated regulation of Topoisomerase3-Rmi1 decatenation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/807</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/807.jpg</image:loc><image:title>Integrated genomic and transcriptional profiling of patient-derived ovarian cancers reveals HRD-associated features and in vivo response to PARP inhibition</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/808</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/808.jpg</image:loc><image:title>Comprehensive &amp;#38; precise structural variant detection with a single assay</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/809</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/809.jpg</image:loc><image:title>Caspase-4 deficiency impairs nuclear actin-mediated DNA double-strand break repair and increases radiosensitivity in cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/810</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/810.jpg</image:loc><image:title>Decoding oncogene amplification structures from retinoblastoma aqueous humor cfDNA as a model for chromothripsis and ecDNA biology</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/811</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/811.jpg</image:loc><image:title>Topoisomerase IIb binding delineates localized mutational processes and driver mutations in cancer genomes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/812</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/812.jpg</image:loc><image:title>Impression of AKT inhibitor in chromatin accessibility in mCRPC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/813</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/814</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/814.jpg</image:loc><image:title>Pan-cancer assessment of an RNA-based signature of HRD</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/815</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/815.jpg</image:loc><image:title>Characterizing PTEN:Ki67 interactions and contribution to radioresistance in glioblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/816</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/816.jpg</image:loc><image:title>The role of ssDNA in alternative DNA DSB repair and the opportunity for therapeutic intervention</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/817</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/817.jpg</image:loc><image:title>Development of novel Ku-targeted DNA-PK inhibitors for cancer therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/818</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/818.jpg</image:loc><image:title>Sun exposure shapes distinct mutational profiles in human skin cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/819</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/819.jpg</image:loc><image:title>Interplay of circadian cryptochrome 1 (CRY1) and DNA repair in prostate cancer (PCa)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/820</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/820.jpg</image:loc><image:title>Germline HRR alterations and ancestry-related outcomes in Brazilian triple-negative breast cancer patients: A comprehensive genomic and clinical study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/821</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/821.jpg</image:loc><image:title>In vitro and in vivo biology characterization of two novel inhibitors targeting the different domains of DNA polymerase theta (Pol&amp;#952;)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/822</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/823</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/824</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/824.jpg</image:loc><image:title>A 100 million cell single cell atlas enabling mechanistic and genotype-specific drug response discovery</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/825</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/825.jpg</image:loc><image:title>Uncovering therapeutically targetable mutations from The Cancer Genome Atlas (TCGA) whole-genome datasets</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/826</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/826.jpg</image:loc><image:title>Genomic landscape of targetable drivers in lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/827</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/827.jpg</image:loc><image:title>Multi-omics patient-derived organoid embeddings predict targeted therapy response and KRAS inhibitor sensitivity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/828</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/828.jpg</image:loc><image:title>Single-cell multiomic drug response profiling of PRISM-multiplexed cancer cell lines sequenced with SBX</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/829</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/829.jpg</image:loc><image:title>Oncolinkage: Discovery of tumor-selective surface targets for cancer therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/830</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/830.jpg</image:loc><image:title>Transcriptomic predictors of therapy response across age groups in an omani breast cancer cohort</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/831</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/831.jpg</image:loc><image:title>The perturbation data gap: Accelerating discovery with CRISPR screening</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/832</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/832.jpg</image:loc><image:title>Integrated genomic and spatial analyses elucidate the origins and vulnerabilities of urachal carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/833</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/833.jpg</image:loc><image:title>Co-occurrence of gene fusions and microsatellite instability (MSI) defines a clinically distinct subtype of colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/834</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/834.jpg</image:loc><image:title>Integrated multiomic profiling reveals SWI-SNF subunit-specific pathway alterations and targetable vulnerabilities</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/835</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/836</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/836.jpg</image:loc><image:title>Assessing paralog dependency in ovarian cancer to drive target discovery</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/837</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/837.jpg</image:loc><image:title>Interferon enriched gene expression signatures are associated with ADAR1 dependency in oral squamous cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/838</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/838.jpg</image:loc><image:title>Molecular Standard of Care</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/839</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/840</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/841</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/842</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/842.jpg</image:loc><image:title>Constitutive NRF2 activation drives excess cysteine stress</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/843</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/843.jpg</image:loc><image:title>Cholesterol triggers chromatin stress to drive senescence and inflammation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/844</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/844.jpg</image:loc><image:title>Cancer cells are sensitive to methionine cycle perturbation in low-lipid environments</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/845</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/846</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/846.jpg</image:loc><image:title>A novel one carbon pathway generates nuclear SAM for chromatin methylation in cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/847</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/847.jpg</image:loc><image:title>Prevalence and significance of PSAT1 expression in human cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/848</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/849</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/849.jpg</image:loc><image:title>PFAS-mediated DRP1 deamidation couples mitochondrial dynamics to purine biosynthesis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/850</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/850.jpg</image:loc><image:title>DDX3 modulates mitochondrial function to inhibit HCC progression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/851</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/851.jpg</image:loc><image:title>CREBBP mutation promotes tumor growth by impairing HDAC3 acetylation-dependent expression of PTEN</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/852</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/852.jpg</image:loc><image:title>CRISPR Cas9 Screens in Mice to Identify Tumor Suppressors of Aggressive Human Lymphoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/853</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/853.jpg</image:loc><image:title>AKT2 loss inhibits mixed lineage liver malignancy induced by PTEN loss involving TGFb-Notch-SOX9 signal</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/854</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/854.jpg</image:loc><image:title>ZNF865 as a novel molecular target for cancer treatment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/855</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/855.jpg</image:loc><image:title>Translational reprogramming disrupts mitosis to drive SMAD4-deficient esophageal adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/856</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/856.jpg</image:loc><image:title>Primary site specific distribution and prognostic significance of p53 immunohistochemistry patterns in 1,515 patients with head and neck squamous cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/857</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/857.jpg</image:loc><image:title>Variation at the R181 residue of p53 confers loss of p53 DNA binding cooperativity with the retention of mitochondrial-associated apoptosis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/858</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/858.jpg</image:loc><image:title>Second site rescue mutants as tools to uncover reactivation mechanisms of p53 cancer mutants</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/859</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/859.jpg</image:loc><image:title>Mapping loss of heterozygosity in Li-Fraumeni Syndrome to uncover early molecular drivers of tumorigenesis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/860</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/860.jpg</image:loc><image:title>DACH1 conveys isoform specific tumor suppressor functions</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/861</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/861.jpg</image:loc><image:title>Quantitative analysis of microtubule lattice damage in NF1-deficient HER2-positive breast cancer under mitotic and pharmacological stress</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/862</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/862.jpg</image:loc><image:title>Ccn6 loss cooperates with EZH2 overexpression to induce sarcomatoid differentiation in metaplastic breast carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/863</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/863.jpg</image:loc><image:title>Investigating tumor suppressor function and regulatory control of NISCH in breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/864</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/864.jpg</image:loc><image:title>Lack of circadian regulator PER2 enhances breast cancer susceptibility and progression via immunosuppression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/865</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/865.jpg</image:loc><image:title>NSD1-AURKA-SETD2 axis creates novel mitotic vulnerabilities in clear cell renal cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/866</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/866.jpg</image:loc><image:title>A novel regulatory pathway as a driver of malignant transformation in mesothelioma.</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/867</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/868</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/869</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/869.jpg</image:loc><image:title>Making sense of mis-sense and non-sense: Tumor cells hijack mutation-induced mis-localization of tumor suppressors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/870</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/870.jpg</image:loc><image:title>Evaluating the role of choline acetyltransferase (ChAT) in T cell malignancies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/871</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/871.jpg</image:loc><image:title>Synapse.org as a foundational platform supporting multicenter cancer data coordination, benchmarking, and broad community reuse</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/872</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/872.jpg</image:loc><image:title>Variant interpretation web services for precision oncology: Genome Nexus and reVUE</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/873</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/873.jpg</image:loc><image:title>Evaluation of an agentic LLM chatbot for clinico-genomic analysis of AACR GENIE BPC data</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/874</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/874.jpg</image:loc><image:title>A multi-agent conversational artificial intelligence ecosystem for real-time integration of clinical, genomic, and social determinants of health data in colorectal cancer precision oncology</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/875</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/875.jpg</image:loc><image:title>Artificial intelligence-driven precision medicine identifies prognostic WNT pathway alterations in African American colorectal cancer patients treated with FOLFOX</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/876</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/876.jpg</image:loc><image:title>Empowering populations at risk through conversational artificial intelligence: a framework for patient advocacy and precision oncology</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/877</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/877.jpg</image:loc><image:title>Molecularly-informed prediction of treatment efficacy in the GENIE BPC NSCLC cohort using computational reasoning</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/878</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/878.jpg</image:loc><image:title>Using in vitro models to predict imatinib responses in PDGFRA-mutant gastrointestinal stromal tumor</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/879</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/879.jpg</image:loc><image:title>ShinyEvents: Harmonizing real-world longitudinal data for clinical insights and survival analytics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/880</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/880.jpg</image:loc><image:title>A continuous modeling framework for age-dependent selection on melanoma driver mutations</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/881</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/881.jpg</image:loc><image:title>Artificial intelligence-based spatial analysis of the local tumor microenvironment in relation to c-MET expression in non-small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/882</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/882.jpg</image:loc><image:title>Integrative spatial multi-omics profiling enhanced by artificial intelligence reveals ancestry-associated molecular features in early-onset colorectal cancer among Southern California patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/883</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/883.jpg</image:loc><image:title>Integrating transcriptomic data to improve multi-omic tumor-of-origin classification</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/884</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/884.jpg</image:loc><image:title>Mutational profiling of chondrosarcoma across multicenter cohorts</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/885</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/886</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/886.jpg</image:loc><image:title>Chemoprevention of hepatocellular carcinoma by next-generation antipsychotic aripiprazole</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/887</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/888</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/889</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/890</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/891</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/891.jpg</image:loc><image:title>TRAIL inducing drug, ONC201 prevents adenocarcinoma in transgenic KRAS G12V mouse lung cancer model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/892</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/892.jpg</image:loc><image:title>Prevention of insulin receptor isoform A formation inhibits MASH-driven hepatocellular carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/893</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/893.jpg</image:loc><image:title>Efficacy of androgen receptor inhibitor, Apalutamide, in intercepting bladder cancer in a BBN-induced rat bladder tumor model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/894</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/894.jpg</image:loc><image:title>STAT3 inhibitor TTI-101 effectively intercepts bladder cancer in a carcinogen-induced rat bladder tumor model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/895</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/895.jpg</image:loc><image:title>Silibinin induced mast cell regulation: Potential immunomodulation via ODC1 in pancreatic cancer prevention and therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/896</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/897</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/898</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/898.jpg</image:loc><image:title>Development of HiBiT tagged high-throughput screening assay for the discovery of SKP2 targeting degraders in prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/899</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/900</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/901</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/901.jpg</image:loc><image:title>Harnessing Id1 as a Biomarker in a Plasmid Reporter System for Cervical Cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/902</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/902.jpg</image:loc><image:title>Dysregulation of the islet hormone cholecystokinin drives obesity-associated pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/903</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/903.jpg</image:loc><image:title>HSC-humanized mouse model: Invivo CAR-T mediated B-cell depletion and application in targeted drug screening</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/904</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/905</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/905.jpg</image:loc><image:title>Preclinical testing of A 2B adenosine receptor inhibitor PSB1115 for pancreatic cancer immunoprevention</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/906</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/907</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/907.jpg</image:loc><image:title>A novel agonist of CD137, SA-4-1BBL, as a single agent halts spontaneous breast cancer progression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/908</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/908.jpg</image:loc><image:title>Development of a humanized IL-17A/IL-17F mouse model for preclinical efficacy studies of IL-17-related diseases</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/909</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/909.jpg</image:loc><image:title>Prevention and interception of triple-negative breast cancer and its metastasis to the brain with brain-permeant L024</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/910</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/910.jpg</image:loc><image:title>Fully human anti-PD-L1 antibodies with tumor cytotoxicity: Screening in SmocMab mice</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/911</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/911.jpg</image:loc><image:title>Humanized TFR1 knock-in mice: A powerful platform for evaluating TFR1-targeting brain shuttles</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/912</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/912.jpg</image:loc><image:title>A Jak2-V617F knock-in mouse model for assessing therapeutic efficacy in myeloproliferative neoplasms</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/913</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/914</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/915</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/916</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/917</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/918</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/918.jpg</image:loc><image:title>Prolonged high fat dietary intake increases pancreatic intraepithelial neoplasia to cancer progression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/919</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/919.jpg</image:loc><image:title>Impact of loneliness on dietary habits of individuals with or without cancer history</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/920</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/920.jpg</image:loc><image:title>Variability in anthocyanin content among commercial blueberries and implications for dietary cancer prevention</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/921</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/921.jpg</image:loc><image:title>High red meat diet promotes colorectal tumorigenesis via gut microbiota mediated Th17/Treg imbalance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/922</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/923</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/923.jpg</image:loc><image:title>Air pollutants remodel mutant epithelia toward a convergent lung adenocarcinoma progenitor state</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/924</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/925</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/925.jpg</image:loc><image:title>PHGG supplementation modulates gut microbiome metabolites and breast cancer progression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/926</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/927</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/927.jpg</image:loc><image:title>Nutritional disruption of folate homeostasis triggers an endogenous genotoxic carcinogen</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/928</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/929</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/929.jpg</image:loc><image:title>Breast cancer risk prediction model for racially diverse women with benign breast disease</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/930</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/930.jpg</image:loc><image:title>Patient and oncologist factors associated with trastuzumab drug choice and administration route</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/931</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/932</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/932.jpg</image:loc><image:title>Assessment of disparities in breast reconstruction following breast cancer surgery at a Central Illinois Breast Cancer Program</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/933</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/933.jpg</image:loc><image:title>Addressing heterogeneity in breast cancer outcomes and patterns of care among Asian Americans in Los Angeles: the AMBER-LA Study.</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/934</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/934.jpg</image:loc><image:title>A comparison of black and white women with breast cancer in the Deep South and their experiences utilizing theAoUdataset</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/935</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/935.jpg</image:loc><image:title>Distance and deprivation: geographic and contextual influences on pediatric cancer outcomes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/936</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/937</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/937.jpg</image:loc><image:title>Prostate cancer outcomes in Hispanic/Latino ethnic enclaves: Results from the California Cancer Registry and American Community Survey</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/938</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/938.jpg</image:loc><image:title>Impact of immigration and acculturation on mortality in Asian American women with breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/939</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/939.jpg</image:loc><image:title>Age-based left-digit bias in the treatment of pancreatic adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/940</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/940.jpg</image:loc><image:title>Missed opportunity or standard of care</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/941</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/942</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/942.jpg</image:loc><image:title>Building a national network coordination center for clinical trials: Early implementation outcomes from the CP2CT DECC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/943</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/943.jpg</image:loc><image:title>Risk of second cancer in survivors of early-onset colorectal cancer: racial and ethnic differences in a population-based study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/944</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/944.jpg</image:loc><image:title>Disparities in gastric cancer treatment and related adverse events in older adults</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/945</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/945.jpg</image:loc><image:title>Characterizing barriers and facilitators to healthcare access among female breast cancer patients in The Gambia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/946</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/946.jpg</image:loc><image:title>Socioeconomic and system-level factors influencing receipt of advanced NSCLC surgery.</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/947</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/947.jpg</image:loc><image:title>Developing a polysocial risk score for prostate cancer patients treated with radical prostatectomy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/948</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/948.jpg</image:loc><image:title>Racial disparities in geographic access to uterine cancer clinical trials across U.S. counties</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/949</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/949.jpg</image:loc><image:title>Sex-based differences in lung cancer survival: A competing risks model using the PLCO trial</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/950</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/951</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/951.jpg</image:loc><image:title>An intersectional analysis of physical and mental health-related quality of life among LGBTQ+ patients with cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/952</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/952.jpg</image:loc><image:title>Disparate access and outcomes of immunotherapy treatment in patients with head and neck cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/953</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/954</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/955</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/955.jpg</image:loc><image:title>Non-Hodgkin&#039;s lymphoma survival by neighborhood disinvestment and socioeconomic composition</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/956</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/956.jpg</image:loc><image:title>Acuity circles policy and persistent socioeconomic disparities in liver transplantation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/957</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/957.jpg</image:loc><image:title>Racial disparities in immune&amp;#8209;related adverse events with immune checkpoint inhibitors: A systematic review and meta&amp;#8209;analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/958</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/958.jpg</image:loc><image:title>Disparities and underutilization of MyChart among patients with pancreatic ductal adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/959</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/959.jpg</image:loc><image:title>Prevalence of screen-detectable cancers among adults aged 18-49 years: Findings from HINTS-SEER</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/960</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/960.jpg</image:loc><image:title>The impact of age on the prevalence and management of high-grade cervical lesions: A retrospective cohort study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/961</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/962</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/962.jpg</image:loc><image:title>Lymphedema symptom burden patterns and cancer recurrence worry among Hispanic breast cancer survivors: Latent profile analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/963</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/963.jpg</image:loc><image:title>Impact of delayed screening/care and frequent mental distress during COVID-19 among SGM cancer survivors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/964</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/964.jpg</image:loc><image:title>Patient navigation as an equity intervention in head and neck cancer: Perspectives from a geocoded EMR cohort and qualitative insights from frontline navigators</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/965</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/965.jpg</image:loc><image:title>Development of and consensus building towards shared metrics, measures and benchmarks for the connecting patient populations to clinical trials (CP2CT)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/966</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/966.jpg</image:loc><image:title>Examining social determinants of health and clinical trial participation among cancer survivors: A multi-state cross-sectional study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/967</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/967.jpg</image:loc><image:title>Trends in disability among US adult cancer survivors, 2016-2024</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/968</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/968.jpg</image:loc><image:title>Internal, external and structural barriers in cancer care faced by survivors from the caribcares study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/969</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/969.jpg</image:loc><image:title>Association between emergency department (ED) involvement in cancer diagnosis and survival across cancer types in the Medicare population</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/970</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/970.jpg</image:loc><image:title>Chronic stressors, biological age and deficit accumulation frailty in black breast cancer survivors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/971</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/971.jpg</image:loc><image:title>Cancer treatment-related cardiotoxicity among survivors of childhood cancer: A comparative and integrated view of multiple measures of biological age acceleration</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/972</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/972.jpg</image:loc><image:title>Survival outcomes associated with hypothyroidism following cancer therapies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/973</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/973.jpg</image:loc><image:title>Sleep duration predicts quality of life during colorectal cancer survivorship across age groups: Results from the ColoCare Study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/974</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/974.jpg</image:loc><image:title>Neighborhood disparities and treatment outcomes in pediatric acute lymphoblastic leukemia (ALL): A report from the REDIAL Consortium</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/975</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/975.jpg</image:loc><image:title>Surgical approach and five year survival in early stage cervical cancer: A national cancer database analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/976</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/976.jpg</image:loc><image:title>Trajectories of body image distress among diverse young adult cancer survivors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/977</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/977.jpg</image:loc><image:title>Factors associated with functional status among older women with ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/978</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/979</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/979.jpg</image:loc><image:title>Identifying novel therapeutic targets for cancer-related fatigue in colorectal cancer patients using lipidomics: Results from the ColoCare Study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/980</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/980.jpg</image:loc><image:title>Medication adherence and contributing factors among cancer survivors with cardiovascular disease</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/981</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/981.jpg</image:loc><image:title>Optimal post-diagnostic dietary patterns for prevention of frailty among men with prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/982</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/982.jpg</image:loc><image:title>Long-term physical quality of life in survivors of adolescent and young adult Hodgkin lymphoma: Risk factors and associations with adverse health outcomes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/983</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/983.jpg</image:loc><image:title>Utilization of pelvic floor therapy after a colorectal cancer diagnosis in a universal-access health system</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/984</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/984.jpg</image:loc><image:title>Examining contextual distress and utility of a digital survivorship care toolkit</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/985</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/985.jpg</image:loc><image:title>Association of social support patterns on health-related quality of life among Hispanic breast cancer survivors&amp;#8239;</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/986</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/986.jpg</image:loc><image:title>Cardiovascular disease mortality among breast cancer survivors in Puerto Rico: A population-based competing risk analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/987</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/987.jpg</image:loc><image:title>Parental concerns about hereditary risk in adolescent and young adult cancer survivors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/988</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/988.jpg</image:loc><image:title>Waist-hip ratio (WHR) defined obesity phenotype and risk of diabetes in cancer survivor women from Sister Study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/989</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/989.jpg</image:loc><image:title>Association between health literacy and cancer history with medical trust among adults in the United States</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/990</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/990.jpg</image:loc><image:title>Single-cell and spatial profiling identifies tumor features and actionable surface targets in primary breast angiosarcoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/991</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/991.jpg</image:loc><image:title>Quantitative 3D histology: Million-cell-scale spatial multi-omics in intact FFPE specimens</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/992</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/992.jpg</image:loc><image:title>Enhanced in vivo and ex vivo analysis enables deeper characterization of humanized mouse models for immuno-oncology research</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/993</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/993.jpg</image:loc><image:title>Robust segmentation-free stain quality concordance metrics in the SpaceIQ&amp;#8482; multi-omic analysis platform</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/994</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/994.jpg</image:loc><image:title>AI-driven live 3D/4D spatial multimodal evaluation of a HER2-targeting ADC: delivery, lysosomal cleavage, payload action, and bystander effects resolved by holotomography and fluorescence</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/995</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/995.jpg</image:loc><image:title>Advancing spatial oncology research with open-panel multiplex IHC/IF using a novel heat-free antibody stripping reagent</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/996</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/997</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/997.jpg</image:loc><image:title>A multi-scale imaging pipeline identifies regions of NMII activation in colorectal cancer which promote tumor survival</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/998</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/998.jpg</image:loc><image:title>Nerve innervation in solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/999</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1000</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1001</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1001.jpg</image:loc><image:title>Geometry and orientation influences beam hardening in a new high-throughput bone imaging cassette system for microCT</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1002</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1002.jpg</image:loc><image:title>Engineered synthetic nano-composite hydrogels as tunable SERS substrates for biomolecule detection</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1003</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1004</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1004.jpg</image:loc><image:title>Engineered multiplexed optical sensors to detect inflammatory cytokines in the tumor microenvironment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1005</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1005.jpg</image:loc><image:title>Tumor specific induction of surface calreticulin by doxorubicin in pancreatic ductal adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1006</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1007</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1007.jpg</image:loc><image:title>A modular positioning platform for standardized ex vivo specimen analysis in preclinical optical imaging</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1008</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1008.jpg</image:loc><image:title>Clinical validation of pembro response predictions from TNBC patient biopsies using E slices</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1009</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1009.jpg</image:loc><image:title>A patient-derived ex vivo platform for personalized evaluation of both direct and immune-mediated drug responses</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1010</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1010.jpg</image:loc><image:title>The era of NAMS, incorporating tumor heterogeneity and immune context into human-relevant patient avatar cancer models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1011</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1011.jpg</image:loc><image:title>Establishment of a novel ex vivo bone metastasis culture platform for triple-negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1012</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1013</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1013.jpg</image:loc><image:title>Integrating passage-zero patient tumor tissues from distant institutions into a rapid, ex vivo drug screening platform</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1014</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1015</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1016</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1016.jpg</image:loc><image:title>TOP1i-ADC demonstrates immune-stimulating activity in colorectal cancer explants</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1017</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1017.jpg</image:loc><image:title>Bulk cancer spheroid preservation and post-thaw viability for high-throughput screening applications</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1018</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1019</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1019.jpg</image:loc><image:title>Developing an ascitic fluid-derived organoid model for transcriptomic and therapeutic investigations in ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1020</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1020.jpg</image:loc><image:title>Mapping and targeting spatial heterogeneity in CRC through patient-derived organoids</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1021</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1022</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1022.jpg</image:loc><image:title>Development and characterization of a patient-derived liver organoid biobank for toxicology and functional studies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1023</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1023.jpg</image:loc><image:title>Understanding the role of the tumor suppressor gene ARID1A in gastric cancer initiation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1024</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1025</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1026</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1026.jpg</image:loc><image:title>Expansion of multilineage prostate organoids derived from human tissue in ProstaCult&amp;#8482; organoid medium</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1027</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1027.jpg</image:loc><image:title>B7-H3 targeting ADC GSK5764227 demonstrates broad and varied anti-tumor activity across solid tumor translational models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1028</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1028.jpg</image:loc><image:title>Modeling patient-specific therapeutic outcomes in cervical cancer using organoid technology</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1029</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1029.jpg</image:loc><image:title>Development of an in vitro exhaustion assay for functional screening of CAR T cell enhancements</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1030</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1030.jpg</image:loc><image:title>BRAF-defined canine urothelial carcinoma organoids as a comparative oncology platform for drug response evaluation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1031</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1031.jpg</image:loc><image:title>Clinically predictive patient-derived cells and organoids platforms for precision therapeutic evaluation in NSCLC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1032</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1032.jpg</image:loc><image:title>C3PO: complex 3D patient organoids for preclinical drug testing in brain tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1033</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1033.jpg</image:loc><image:title>From hours to seconds: a new tool for accelerating in vivo rodent imaging data analysis using AI algorithms</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1034</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1035</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1035.jpg</image:loc><image:title>Targeting HCC tumor microenvironment interactions using an advanced HCC patient-derived on-chip model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1036</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1037</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1037.jpg</image:loc><image:title>Establishing diffuse gastric cancer patient-derived organoids for drug response analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1038</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1038.jpg</image:loc><image:title>Single cell stiffness analysis using a ferrohydrodynamic-microfluidic platform</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1039</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1039.jpg</image:loc><image:title>Organoids from primary human prostate cancer exhibit heterogeneity in the states of tumor-associated epithelial cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1040</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1040.jpg</image:loc><image:title>Tissue-engineered organ-specific cancer metastasis model for cancer research</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1041</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1041.jpg</image:loc><image:title>Illuminate your targets: Endogenous HiBiT knock-in monoclones-inventory + rapid custom</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1042</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1042.jpg</image:loc><image:title>Unlocking 3D: TumorMACS media as a dual-purpose solution for primary 2D and 3D tumor organoid cultures</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1043</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1043.jpg</image:loc><image:title>Characterizing organoid maturation and disease progression through recombinant monoclonal antibodies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1044</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1044.jpg</image:loc><image:title>In vitro and in vivo evaluation of the bystander-killing effect of ADCs</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1045</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1045.jpg</image:loc><image:title>Immunopeptidomic profiling of OncoPro tumoroid models enables MHC-I enrichment and neoantigen target discovery</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1046</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1046.jpg</image:loc><image:title>Modeling micro- and nanoplastics-induced colon aging in organoids to unravel pathways leading to early-onset colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1047</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1047.jpg</image:loc><image:title>Modulating cancer stemness in commercial OCSCC spheroid cultures through microenvironmental stress</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1048</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1048.jpg</image:loc><image:title>Optimization of cancer-associated fibroblast expansion and co-culture with patient-derived tumoroids</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1049</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1050</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1050.jpg</image:loc><image:title>Bioluminescent intestinal reporter organoids as in vitro tools to monitor inflammatory effects of compounds</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1051</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1051.jpg</image:loc><image:title>Infant KMT2A::AFF1 acute lymphoblastic leukemia stem cell model reveals early impact on the proteome</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1052</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1052.jpg</image:loc><image:title>Targeting PAX3::FOXO1 condensates in fusion-positive alveolar rhabdomyosarcoma via disordered-region mimetic peptides</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1053</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1053.jpg</image:loc><image:title>Early tumor priming in Li-Fraumeni Syndrome muscle using a rhabdomyosarcoma model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1054</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1055</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1055.jpg</image:loc><image:title>Investigating ATRT cell of origin and tumor heterogeneity via hiPSC-derived models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1056</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1056.jpg</image:loc><image:title>Investigating the role of BRCA2 in the development of pediatric rhabdomyosarcoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1057</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1058</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1058.jpg</image:loc><image:title>Elucidation of PAX3::FOXO1 tumor initiation mechanisms in human induced pluripotent stem cell models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1059</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1060</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1060.jpg</image:loc><image:title>Dynamic characterization of tumor-microenvironment factors that drive pediatric low-grade gliomas</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1061</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1062</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1063</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1063.jpg</image:loc><image:title>Defining the intertumoral and intratumoral transcriptional heterogeneity of EWS::FLI1 in Ewing sarcoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1064</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1064.jpg</image:loc><image:title>Dissecting the complex ecosystem of intracranial germ cell tumors by spatial RNA and protein analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1065</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1065.jpg</image:loc><image:title>CyTOF analysis of heterogeneity between Ewing sarcoma cell lines in vitro and in vivo</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1066</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1067</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1067.jpg</image:loc><image:title>Distinct microenvironments define subtypes of neuroblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1068</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1068.jpg</image:loc><image:title>Multiomic profiling reveals endothelial cell plasticity in metastatic osteosarcoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1069</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1070</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1070.jpg</image:loc><image:title>Extracellular viscosity modulates spheroid formation in SMARCB1-deficient brain tumor cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1071</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1071.jpg</image:loc><image:title>The Sean Karl Cohort: An international single-cell RNAseq study of paired patient Ewing sarcoma specimens</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1072</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1072.jpg</image:loc><image:title>Evaluating GD2-targeting antibody-drug conjugates for DIPG using human organoid-based preclinical platforms</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1073</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1073.jpg</image:loc><image:title>Enhancement of antigen presentation restores immune recognition in rhabdomyosarcoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1074</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1074.jpg</image:loc><image:title>Exploring actionable therapeutic targets associated with SMARCB1 deficiency in Epithelioid sarcoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1075</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1075.jpg</image:loc><image:title>EWSR1::FLI1 suppresses ribosome biogenesis and creates a targetable vulnerability in Ewing sarcoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1076</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1076.jpg</image:loc><image:title>PP2A reactivation upregulates FGA gene in neuroblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1077</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1077.jpg</image:loc><image:title>Site-specific phospho-regulatory collapse of PML governs RTK hyperactivation in high-risk pediatric malignancy.</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1078</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1078.jpg</image:loc><image:title>Netrin-1/UNC5B-TFF3 axis modulates cancer stem cells self-renewal and chemoresistance in metastatic colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1079</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1079.jpg</image:loc><image:title>PPARdelta overexpression drives transformation of multiple gastric progenitor and stem cells and tumorigenesis in mice</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1080</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1081</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1081.jpg</image:loc><image:title>Investigating TWEAK-mediated regulation of ovarian cancer cell survival</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1082</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1083</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1083.jpg</image:loc><image:title>Investigation of developmental LIN28/ let-7 /SOX2/SOX9 feedback loop during cell migration and metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1084</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1085</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1086</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1086.jpg</image:loc><image:title>Desmoglein-2 carrying cancer stem cell-derived extracellular vesicles promote lung cancer aggressiveness</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1087</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1087.jpg</image:loc><image:title>Unveiling the association of cancer stem cell markers with survival in follicular lymphoma patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1088</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1088.jpg</image:loc><image:title>Modeling endometrial cancer using iPSC-derived endometrial organoids integrating genetic determinants of ethnicity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1089</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1089.jpg</image:loc><image:title>IDH mutations disable the tumor suppressive activity of GSX2 to promote gliomagenesis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1090</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1090.jpg</image:loc><image:title>Single cell multiomic profiling of heterogenousPROCR+ cells in mouse mammary gland and its implication for breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1091</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1092</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1092.jpg</image:loc><image:title>Multi-tissue modeling of BRCA cancers using iPSC-derived organoids platform</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1093</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1093.jpg</image:loc><image:title>Maternal obesity reprograms intestinal stem cells to elevate colorectal cancer risk in offspring</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1094</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1094.jpg</image:loc><image:title>Protection of human bone marrow MSC from room air oxygen during isolation accelerates cell growth</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1095</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1095.jpg</image:loc><image:title>Investigating the ability of foxo1 to maintain stem cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1096</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1097</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1098</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1098.jpg</image:loc><image:title>The role of tissue renewal in early-onset colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1099</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1100</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1101</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1101.jpg</image:loc><image:title>BMP inhibition is an effective treatment for targeting stem-like glioblastoma cell states</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1102</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1102.jpg</image:loc><image:title>eTRACER illuminates the spatiotemporal landscape of immune escape in EGFR-mutant lung adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1103</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1103.jpg</image:loc><image:title>Dissecting colorectal cancer heterogeneity and microbiota interactions using murine and patient-derived organoids</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1104</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1104.jpg</image:loc><image:title>In situ KRAS -mapping and spatial -omics characterization in lung premalignancy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1105</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1105.jpg</image:loc><image:title>Pan-cancer mapping of genetic immune escape evolutionary trajectories</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1106</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1106.jpg</image:loc><image:title>Significance of prostaglandin E&amp;#8322; signaling in the carcinogenesis of ulcerative colitis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1107</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1108</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1109</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1110</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1110.jpg</image:loc><image:title>ET-resistant cell populations in ER positive breast cancer: From profiling to therapeutic targeting</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1111</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1111.jpg</image:loc><image:title>Spatially resolved genomics reveals evolutionary modes and imaging correlates in glioblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1112</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1112.jpg</image:loc><image:title>In vivo clonal lineage tracing using methylation barcodes in the protocadherin gene cluster</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1113</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1113.jpg</image:loc><image:title>Label-free spatial profiling of the melanoma tumor microenvironment using metasurface-enhanced Raman spectroscopy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1114</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1114.jpg</image:loc><image:title>Novel reporter tool for visualization of neuroblastoma cell state</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1115</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1116</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1116.jpg</image:loc><image:title>Feasibility to detect genomic loss of HLA alleles by One Lambda LABType products combined with novel data analysis algorithm</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1117</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1118</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1118.jpg</image:loc><image:title>Harnessing clonal dynamics to overcome resistance: An adaptive therapy framework in colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1119</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1119.jpg</image:loc><image:title>Tracking tumor evolution and heterogeneity in fusion-driven sarcomas through cell-free DNA analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1120</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1120.jpg</image:loc><image:title>Full-range genomic analysis at single-cell resolution reveals genetic, epigenetic, and parallel evolution of melanoma subclones</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1121</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1121.jpg</image:loc><image:title>Beyond a single core biopsy: Spatial genomic profiling improves therapeutic target detection in glioblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1122</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1122.jpg</image:loc><image:title>Phylogenetic and machine learning analyses of simulated ancestral sequences reveals heterogeneous ccRCC evolution</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1123</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1124</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1125</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1125.jpg</image:loc><image:title>Novel tools for spatial profiling of protein glycosylation in cancer biology</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1126</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1127</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1127.jpg</image:loc><image:title>Multiplexed spatial profiling of the tumor microenvironment in syngeneic mouse models using Cell DIVE imaging</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1128</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1129</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1130</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1131</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1132</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1133</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1133.jpg</image:loc><image:title>Integrated spatial multiomics pipeline for visualizing protein interactions in the tumor microenvironment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1134</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1135</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1135.jpg</image:loc><image:title>Multi-omic profiling maps the immune multicellular environment of renal cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1136</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1137</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1138</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1139</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1140</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1141</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1142</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1143</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1143.jpg</image:loc><image:title>Multi-omic spatial analysis reveals a distinct pattern of cellular neighborhood in gastric cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1144</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1144.jpg</image:loc><image:title>Spatial architecture of head and neck squamous cell carcinoma (SCCHN): An IMMUcan/EORTC analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1145</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1146</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1146.jpg</image:loc><image:title>Lymphatic exudate is a novel source of tumor-associated immune cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1147</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1147.jpg</image:loc><image:title>Simultaneous spatial transcriptome and epigenome profiling in fresh frozen and FFPE tissues with spatial CoPro</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1148</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1148.jpg</image:loc><image:title>Spatial metabolic gradients drive epigenetic reprogramming in human glioblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1149</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1150</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1150.jpg</image:loc><image:title>Simultaneous spatial transcriptome and methylation profiling in fresh frozen and FFPE tissues</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1151</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1152</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1152.jpg</image:loc><image:title>Matrix stiffness encoded mechanical memory maintains proliferative dominance in tumor metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1153</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1153.jpg</image:loc><image:title>ECM mimicking tunable 3D hydrogels to model Ewing sarcoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1154</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1155</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1156</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1157</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1157.jpg</image:loc><image:title>Bridging the translational gap: Critical TME differences between human PDAC and mouse models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1158</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1158.jpg</image:loc><image:title>Mig-6 deficiency accelerates fibrotic tumor microenvironment formation in P ten -deficient endometrial tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1159</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1159.jpg</image:loc><image:title>Tumor extracellular matrix drivesEMT and cellular reprogrammingin Wilms tumor</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1160</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1160.jpg</image:loc><image:title>Physically driven chromosome instabilities spur macrophages to attack cooperatively</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1161</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1162</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1162.jpg</image:loc><image:title>Modeling the triple-negative breast cancer extracellular matrix in a 3d tumor scaffold</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1163</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1163.jpg</image:loc><image:title>Matrix mechanics modulate cancer cell plasticity and drug responses</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1164</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1165</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1166</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1166.jpg</image:loc><image:title>Aligned ECM influences neuroblastoma cell plasticity via YAP-WT1 association</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1167</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1167.jpg</image:loc><image:title>Matrix stiffness remodels the immunosuppressive tumor microenvironment via the PIEZO1-DCLK1-STAT5B pathway</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1168</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1169</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1170</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1170.jpg</image:loc><image:title>Hypoxia shapes tumor immune microenvironment through cell-type dependent responses in diffuse astrocytomas</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1171</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1171.jpg</image:loc><image:title>Hypoxia-driven epithelial reprogramming elevates CD46 and promotes vasculogenic mimicry in immune-desert NSCLC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1172</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1172.jpg</image:loc><image:title>Tumor cell adaptation to nutrient stress via metabolic change due to fibronectin/integrin internalization</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1173</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1173.jpg</image:loc><image:title>Tolerance to extracellular acidic pH facilitates tumor plasticity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1174</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1174.jpg</image:loc><image:title>Exploring landscapes of T cell activation in acidic environment for tumor immunotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1175</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1175.jpg</image:loc><image:title>Elucidating the molecular regulation of superdark transmembrane protein 184C (TM184C)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1176</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1177</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1177.jpg</image:loc><image:title>SMURFS: A comprehensive Nextflow pipeline for consensus somatic variant detection</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1178</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1179</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1180</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1181</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1181.jpg</image:loc><image:title>Mutational signatures associated with Western dietary patterns in colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1182</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1182.jpg</image:loc><image:title>Predicting neoantigen immunogenicity through evolutionary selection pressure</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1183</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1184</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1185</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1186</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1186.jpg</image:loc><image:title>scVarID: Linking somatic variants to single-cell transcriptomes to reveal early cancer-associated cell states</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1187</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1188</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1189</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1189.jpg</image:loc><image:title>Mapping of somatic and RNA-level variants along the colorectal adenoma-carcinoma progression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1190</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1190.jpg</image:loc><image:title>H-optimus-1: A foundation model for computational histopathology</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1191</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1191.jpg</image:loc><image:title>Weakly supervised deep learning enables spatially resolved cell type inference from H&amp;#38;E histopathology</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1192</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1193</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1193.jpg</image:loc><image:title>Clinical feasibility study of an AI-driven liquid biopsy platform using Raman spectroscopy of plasma extracellular vesicles (EV)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1194</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1194.jpg</image:loc><image:title>ctDNA false negativity in colorectal cancer reflects CMS3 phenotype and DNASE1L3 positive macrophages, identifying recurrence prone subgroup</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1195</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1196</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1196.jpg</image:loc><image:title>Serum cell free DNA based duplex methyLight assay for liquid biopsy based detection of epithelial ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1197</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1197.jpg</image:loc><image:title>Precision profiling of TP53 alterations in advanced cancers: Real-world evidence linking mutation class to genomic instability and cooccurring actionable drivers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1198</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1199</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1199.jpg</image:loc><image:title>Driver-specific MRD strategy associated with pathological response and predicted recurrence in stage III driver-mutant NSCLC receiving neoadjuvant treatment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1200</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1200.jpg</image:loc><image:title>Multi-omic, HER2-directed monitoring in metastatic breast cancer through a clinic-ready wearable cytokine biosensor</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1201</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1201.jpg</image:loc><image:title>Dynamic interactions of spatially organized tumor, stromal and immune cellular niches predict outcome to immune checkpoint blockade (ICB) in recurrent or metastatic head and neck squamous cell carcinoma (RM-HNSCC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1202</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1202.jpg</image:loc><image:title>Spatial immune architecture at single-cell resolution predicts response to atezolizumab plus bevacizumab in advanced HCC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1203</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1203.jpg</image:loc><image:title>Patient-derived organoid-immune cell co-cultures and spatial biology support a CD44v9 cancer stem cell-directed therapeutic strategy for adamantinomatous craniopharyngioma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1204</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1204.jpg</image:loc><image:title>Automated immunohistochemical assay for detection of homozygous methylthioadenosine phosphorylase (MTAP) gene deletion based on absence of MTAP protein staining</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1205</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1205.jpg</image:loc><image:title>Carrier platin coupled with low dose focal SmART+ X-ray irradiation yields better tumor control than either alone</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1206</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1206.jpg</image:loc><image:title>Drivers and patterns of disease progression as a novel schema for risk stratification in metastatic non-small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1207</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1207.jpg</image:loc><image:title>Mapping genomically classified molecular clusters to therapeutic outcomes in a pan-Indian lung cohort: A strategy for smarter clinical trial randomization</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1208</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1208.jpg</image:loc><image:title>Clinical efficacy of computational reasoning for personalized treatment planning in a pan-cancer cohort discussed by a French multidisciplinary tumor board: A real-world experience-based analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1209</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1209.jpg</image:loc><image:title>High adherence to mammography screening before and after MCED testing</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1210</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1210.jpg</image:loc><image:title>The communal process through which prostate cancer survivors and their partners affect each other&#039;s diets: A qualitative descriptive study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1211</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1211.jpg</image:loc><image:title>Doxorubicin impairs the blood-brain barrier in a microfluidic model of the human neurovascular unit</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1212</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1212.jpg</image:loc><image:title>Flotillin-2 suppresses CD8&amp;#8314;T cell anti-tumor function by restricting T cell receptor nanoclustering and activation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1213</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1214</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1215</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1215.jpg</image:loc><image:title>Nanobody adaptor-directed CAR T cells enable precise and safe targeting of solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1216</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1216.jpg</image:loc><image:title>B7H3 CAR T cell therapy across immunocompetent ovarian cancer models with evidence of transferable anti-tumor immunity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1217</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1217.jpg</image:loc><image:title>High-throughput screening of chimeric RNA-binding proteins for improved CAR T cell function</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1218</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1218.jpg</image:loc><image:title>The inhibitory VISTA LRIG1 axis impairs the persistence and function of CAR T cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1219</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1219.jpg</image:loc><image:title>Modulation of G3BP1 influences the functional efficacy of CAR T cells against glioblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1220</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1220.jpg</image:loc><image:title>OBX-115 membrane-bound IL15 (mbIL15)-expressing engineered tumor-infiltrating lymphocytes (TIL) overcome target cell immune evasion related to major histocompatibility complex (MHC) silencing through both direct killing and transactivation of NK cells in patient-derived autologous non-small cell lung cancer (NSCLC) models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1221</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1221.jpg</image:loc><image:title>Lentiviral-based hematopoietic stem cell platform for macrophage-specific expression in glioma immunotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1222</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1222.jpg</image:loc><image:title>Integrating a fasting mimicking diet to augment antitumor immunity following adoptive cell transfer in breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1223</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1223.jpg</image:loc><image:title>Cryo-immune vaccination (CIV):A nontoxic locoregional multicomponent immunotherapeutic approach that can systemically eradicate disseminated metastatic cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1224</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1224.jpg</image:loc><image:title>Progenitor-to-intermediate differentiation of exhausted CD8+T cells is enhanced by HPK1 inhibition during anti-PD-1 therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1225</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1226</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1226.jpg</image:loc><image:title>Liposomal doxorubicin potentiates anti-tumor immune response in oral cavity squamous cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1227</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1227.jpg</image:loc><image:title>ACR-368 synergizes with PD-L1 blockade by coordinated activation of adaptive and innate immunity pathways to achieve robust anti-tumor efficacy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1228</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1228.jpg</image:loc><image:title>A quantitative MDSC infiltration assay in a tumor organoid-stromal microenvironment for immuno-oncology candidate evaluation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1229</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1229.jpg</image:loc><image:title>Anti-GARP reverts immune suppression and extends overall survival in a MASH-HCC murine model resistant to anti-PDL1+anti-VEGFA therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1230</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1230.jpg</image:loc><image:title>Durable anti-tumor immunity through in vivo CAR T cell engineering using the RetroT all-RNA genome integration platform</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1231</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1231.jpg</image:loc><image:title>Single-cell long-read transcriptomics reveals isoform centric molecular features of rare pseudomyxoma peritonei disease</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1232</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1232.jpg</image:loc><image:title>MicroNucML: A machine learning approach for micronuclei segmentation and the refinement of nuclei-micronuclei relationships</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1233</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1233.jpg</image:loc><image:title>Fusion epigenotyping using cell&amp;#8209;free DNA methylation improves detection of actionable ALK fusions in non-small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1234</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1234.jpg</image:loc><image:title>Transcriptional silencing of homologous recombination defines a functional HRD in invasive lobular carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1235</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1235.jpg</image:loc><image:title>&amp;#65279;Extrachromosomal DNA amplification defines a high-risk subgroup and unique molecular features in gastric cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1236</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1236.jpg</image:loc><image:title>Informatics-driven spatial-omics for cancer immunotherapy discovery in gynecologic cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1237</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1237.jpg</image:loc><image:title>Targetable gene dependencies in Ewing sarcoma subtypes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1238</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1238.jpg</image:loc><image:title>Shared gut virome profiles highlight potential early colorectal cancer markers in HIV-helminth co-infection</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1239</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1240</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1240.jpg</image:loc><image:title>Stress-responsive glucocorticoid receptor signaling shapes the immune tumor microenvironment in lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1241</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1241.jpg</image:loc><image:title>Bulk RNA-seq atlas guided annotation of tumor transcriptomes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1242</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1242.jpg</image:loc><image:title>Uncovering novel splice junctions in prostate cancer using DeepSAP</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1243</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1243.jpg</image:loc><image:title>Integrated spatial and genetic lineage tracing uncovers cell state plasticity underlying recurrence in group3 and group4 medulloblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1244</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1245</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1245.jpg</image:loc><image:title>Pediatric pan-cancer characterization of transposable elements and their modulation by germline TP53 variants</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1246</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1246.jpg</image:loc><image:title>Characterizing clinical toxicity in cancer combination therapies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1247</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1247.jpg</image:loc><image:title>Aneuploidy detection from FFPE archived tissues: A computational approach for FFPE-CUTAC data</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1248</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1248.jpg</image:loc><image:title>Unique tumor ecosystems in metaplastic breast cancer identified through single nucleus RNA sequencing</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1249</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1250</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1250.jpg</image:loc><image:title>A single-cell tumor atlas defines robust pathway and gene signatures enabling cancer cell-line fidelity assessment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1251</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1251.jpg</image:loc><image:title>Exploring high-resolution subtypes for pancreatic ductal adenocarcinoma via a meta-clustering approach</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1252</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1252.jpg</image:loc><image:title>Single cell RNA-seq analysis of osteosarcoma reveals conserved and distinct ecosystems across sites and species</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1253</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1254</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1254.jpg</image:loc><image:title>Conserved tumor imprinted T cell states across cancers revealed by pan cancer single cell atlases</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1255</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1255.jpg</image:loc><image:title>Functional heterogeneity of neutrophils in hepatocarcinogenesis in animal models and human patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1256</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1256.jpg</image:loc><image:title>Single-cell-derived gene-pair classifiers for prostate cancer prognostication</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1257</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1258</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1258.jpg</image:loc><image:title>Scalable, unsupervised deep learning frameworks for rare event detection and single cell phenotyping in enrichment free liquid biopsies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1259</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1259.jpg</image:loc><image:title>Generative AI improves breast cancer genomic subtype prediction from histology images</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1260</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1261</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1261.jpg</image:loc><image:title>FLEXMIL: A flexible multimodal multiple instance learning framework for clinical and translational research</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1262</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1262.jpg</image:loc><image:title>Whole-slide image and clinical feature integration for superior prostate cancer risk stratification</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1263</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1263.jpg</image:loc><image:title>Spatial transcriptomics informed tumor purity estimation from histology slides for triple negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1264</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1264.jpg</image:loc><image:title>AI-assisted quantitative tissue pathology identifies nuclear morphometric features distinguishing OSCC from normal oral epithelium</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1265</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1265.jpg</image:loc><image:title>Lauren subtype classification in gastric cancer using deep learning on real-world H&amp;#38;E images</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1266</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1266.jpg</image:loc><image:title>Predicting TCGA molecular subtypes of gastric cancer from H&amp;#38;E whole-slide images using a weakly supervised transMIL-attention framework</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1267</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1267.jpg</image:loc><image:title>Accurate focal plane is crucial for AI assessment of non-monolayer urine cytology specimens for bladder cancer screening and surveillance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1268</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1268.jpg</image:loc><image:title>DIANNE: Segmentation-free localization of histology differential attributes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1269</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1269.jpg</image:loc><image:title>Deep learning integration of molecular and histopathological data for prognostic stratification in non small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1270</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1270.jpg</image:loc><image:title>Label free virtual HE from 3D holotomography enables reliable nuclear and microanatomical readouts in thick cancer tissues</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1271</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1271.jpg</image:loc><image:title>3D holotomography-enabled virtual multiplexed staining of thick medical kidney tissue for comprehensive renal pathology</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1272</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1272.jpg</image:loc><image:title>Visualizing the genotype-phenotype link: Predicting drug-induced tissue dynamics with RNA-based diffusion models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1273</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1273.jpg</image:loc><image:title>A high-throughput slide scanning pipeline for digitizing and standardizing legacy genitourinary cancer slides</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1274</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1274.jpg</image:loc><image:title>Association of interpretable histomorphic features with molecular markers: A Computational Histology Artificial Intelligence (CHAI) biomarker development platform analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1275</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1275.jpg</image:loc><image:title>Development of an AI framework for identifying image based digital biomarkers predictive of immunotherapy response in malignant melanoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1276</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1276.jpg</image:loc><image:title>Comparison of digital and artificial intelligence (AI)-computational algorithms for quantifying low/ultralow human epidermal growth factor receptor 2 (HER2) protein expression in metastatic breast cancer (mBC) from clinical samples</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1277</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1277.jpg</image:loc><image:title>Paletrra TM AI: Automated phenotyping of multiplex immunofluorescence datasets via information maximizing self-training</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1278</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1278.jpg</image:loc><image:title>Prediction of gene expression and molecular pathway activity from H&amp;#38;E whole slide images in non-small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1279</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1279.jpg</image:loc><image:title>Deep learning of H&amp;#38;E slides adds prognostic value beyond IASLC grading in non-mucinous lung adenocarcinoma among never-smokers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1280</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1280.jpg</image:loc><image:title>Cell type-specific somatic variants captured from single-cell RNA sequencing underlie transcriptional programs in pre-malignant blood</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1281</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1282</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1282.jpg</image:loc><image:title>CELLama-Perturb: A virtual cell modeling approach for mapping drug sensitivity across spatial tumor heterogeneity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1283</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1283.jpg</image:loc><image:title>Expression-based immune-phenotyping ML model predict ICI response and long-term clinic benefit in lung adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1284</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1284.jpg</image:loc><image:title>CellNeighbor: A transcriptional atlas of patient tumors and cell line models to inform preclinical model selection</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1285</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1285.jpg</image:loc><image:title>Mechanism-aware cancer therapy planning with group-relative policy optimization on a multimodal oncology foundation model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1286</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1286.jpg</image:loc><image:title>Germline whole exome sequencing implicates homologous recombination repair pathway genes as risk factors in SMARCB1 deficient renal medullary phenotypes without sickle hemoglobinopathies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1287</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1287.jpg</image:loc><image:title>Multi-omics profiling of neuroblastoma identifies immunological biomarkers associated with higher risk of relapse: Results from the MICCHADO study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1288</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1288.jpg</image:loc><image:title>Selecting representative histologic sections for cost-efficient 3D spatial transcriptomics and tumor microenvironment reconstruction</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1289</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1289.jpg</image:loc><image:title>Unsupervised learning with MORPHAEUS enhances conventional tissue spatial phenotyping</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1290</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1290.jpg</image:loc><image:title>AI-derived nuclear morphometrics as a novel prognostic indicator in lung adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1291</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1291.jpg</image:loc><image:title>Local indicators of spatial association bioinformatics analysis identifies animmunosuppressive zone at the liver tumor margin</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1292</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1292.jpg</image:loc><image:title>An evidence-based tool to systematically identify potential adverse drug-drug interactions</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1293</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1293.jpg</image:loc><image:title>Improve spatial transcriptomic data with integrated hybrid transformer and graph convolutional networks</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1294</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1294.jpg</image:loc><image:title>Lysosomal routing geometry drives immunosuppressive secretion in triple negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1295</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1295.jpg</image:loc><image:title>Unifying molecular structure and cellular morphology to enhance drug-target interaction modeling in cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1296</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1297</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1297.jpg</image:loc><image:title>Transcriptional condensates at super-enhancers mediate pH-dependent transcriptional control in innate immunity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1298</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1298.jpg</image:loc><image:title>Integrative analysis identifies potential proteomic intermediates associated with renal cell carcinoma and its risk factors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1299</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1299.jpg</image:loc><image:title>A deep learning-based multimodal integration framework for clinical outcome prediction</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1300</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1300.jpg</image:loc><image:title>Cleaved ATP5A1 mediates a poly(ADP-ribose)-dependent regulatory axis for R-Loop homeostasis under oxidative stress</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1301</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1301.jpg</image:loc><image:title>p-EMT transitional hub and its DC2-macrophage niche define recurrence in oral squamous cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1302</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1302.jpg</image:loc><image:title>Multimodal AI for patient subtype discovery in LUSC using real-world data</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1303</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1303.jpg</image:loc><image:title>From animals to computational oncology: Digital twins as ethical enablers of next-generation bone metastasis research</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1304</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1305</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1305.jpg</image:loc><image:title>Structure-guided dual targeting of EZH2 and dopamine D1 receptor suppresses TNBC growth and metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1306</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1306.jpg</image:loc><image:title>STniche: An approach to identify functional niches in the tumor microenvironment from spatial transcriptomics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1307</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1307.jpg</image:loc><image:title>A single cell-based protein activity landscape for human small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1308</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1308.jpg</image:loc><image:title>Modeling GBM-vasculature interaction on chip</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1309</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1309.jpg</image:loc><image:title>Study on acquisition timing of KRAS mutations in the pancreatic ductal epithelium</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1310</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1310.jpg</image:loc><image:title>A novel, deep learning -based filtering tool for enhanced detection of technical artifacts in whole-genome sequencing data</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1311</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1311.jpg</image:loc><image:title>Long-read sequencing of 15 Ewing sarcoma cell lines uncovers extensive GGAA microsatellite variation shaping the landscape of EWSR1::FLI1 binding</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1312</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1312.jpg</image:loc><image:title>Long-read RNA-Seq reveals a novel isoform landscape of SRSF2 -mutant chronic myelomonocytic leukemia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1313</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1313.jpg</image:loc><image:title>A generalizable software framework for ultra-rapid sequence analysis and its application in enabling 1 day deep multi-omic data analysis turnaround for brain cancer precision oncology</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1314</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1314.jpg</image:loc><image:title>Pangenome-based somatic mutation landscape of early- and late-onset colorectal cancer in 99 Korean patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1315</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1315.jpg</image:loc><image:title>Modeling base-pair level mutation rate in metastatic breast cancer using a sequence-based deep learning model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1316</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1317</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1317.jpg</image:loc><image:title>Single-cell multiomics analysis reveals cell type-specific genetic regulatory programs underlying immunotherapy resistance in hepatocellular carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1318</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1318.jpg</image:loc><image:title>Fusobacterium-driven epithelial-stromal remodeling in CRC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1319</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1319.jpg</image:loc><image:title>Long-read sequencing of pancreatic adenocarcinoma transcriptome uncovered aberrant isoforms and tumor progression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1320</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1320.jpg</image:loc><image:title>Assessing allelic expression variation using somatic mutations vs. polymorphic germline variants</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1321</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1322</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1322.jpg</image:loc><image:title>A large-scale resource of standardized pediatric somatic cancer variant classifications</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1323</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1323.jpg</image:loc><image:title>Cost-effective, full-length transcriptome of chronic lymphocytic leukemia patient cd8 t cells reveals the impact of BTKi treatment on mRNA processing and gene expression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1324</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1324.jpg</image:loc><image:title>CASTLE: long-read sequencing panel of cancer cell lines to improve standards of somatic variant calling and benchmarking</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1325</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1325.jpg</image:loc><image:title>Longitudinal whole genome sequencing to investigate clonal hematopoiesis dynamics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1326</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1326.jpg</image:loc><image:title>Enhanced detection of immune and oncogenic signals in HER2-positive breast cancer by a novel data-scaling method</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1327</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1327.jpg</image:loc><image:title>Gene signatures and infiltration patterns of mast cells in breast cancer revealed by integrated bulk and single-cell RNA sequencing Analyses</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1328</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1328.jpg</image:loc><image:title>Mapping classifiability in the cancer DNA methylome: A data-learned disease hierarchy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1329</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1329.jpg</image:loc><image:title>Doublet removal enhances single-cell resolution and uncovers malignant transcriptional programs in NSCLC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1330</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1331</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1332</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1332.jpg</image:loc><image:title>DXC011, a novel dual-payload antibody-drug conjugate targeting folate receptor alpha</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1333</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1334</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1334.jpg</image:loc><image:title>Cell based payload release highlights design, site, and cell dependent ratio shifts in dual payload ADCs</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1335</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1335.jpg</image:loc><image:title>Dissecting ADC pulmonary toxicity: A murine ADC-associated ILD model to guide and inform ADC discovery</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1336</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1337</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1337.jpg</image:loc><image:title>Design and evaluation of mRNA translation inhibitors for use as antibody drug conjugate payloads</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1338</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1339</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1339.jpg</image:loc><image:title>Rapid lead generation with the Pioneer Antibody Discovery Platform</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1340</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1340.jpg</image:loc><image:title>Advancing precision oncology through innovative bioconjugation and linker architecture strategies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1341</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1341.jpg</image:loc><image:title>Selective tumor immune activation by novel nucleic acid drug</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1342</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1342.jpg</image:loc><image:title>A first-in-class IKZF1/3 degrader antibody conjugate (DAC) as a potential myeloma treatment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1343</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1344</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1344.jpg</image:loc><image:title>DAC-1522: A novel Trop2-targeting degrader-antibody conjugate for precision oncology</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1345</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1345.jpg</image:loc><image:title>ADCs in cancer treatment:&amp;#8239;SPR-driven insights into discovery and characterization&amp;#8239;&amp;#8203;</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1346</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1346.jpg</image:loc><image:title>Malic enzyme inhibition as a strategy to exploit metabolic reprogramming in cancer: A structure-based approach</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1347</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1347.jpg</image:loc><image:title>Insights in CYP2E1-mediated ferroptosis in hepatocellular carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1348</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1348.jpg</image:loc><image:title>Targeting the interferon-inducible isoform, p150 of ADAR1 for the treatment of oral squamous cell carcinoma (OSCC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1349</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1350</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1350.jpg</image:loc><image:title>Analyzing non-cancerous and cancerous protein structure using a novel Elliptical Dichroism Spectrometer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1351</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1351.jpg</image:loc><image:title>Proteome-wide target engagement and ternary complex mapping of molecular glues using LiP-MS</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1352</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1352.jpg</image:loc><image:title>Non-covalent small molecule probe discovery of large intrinsically disordered protein</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1353</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1354</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1354.jpg</image:loc><image:title>Combining deep mutational scanning and next-generation protein sequencing to harness dominant protein variants to develop DNA repair inhibitors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1355</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1355.jpg</image:loc><image:title>Next-generation chemical biology: Mapping the Purinome druggable space reveals genotype-specific vulnerabilities via phenotypic screening</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1356</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1356.jpg</image:loc><image:title>Evaluation of novel small molecule inhibitors targeting Polycomb repressive complex 1 as chemical probes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1357</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1357.jpg</image:loc><image:title>Evaluating the biochemical activity and endogenous engagement of covalent small molecule inhibitors of NSD1 and NSD3 in cancer cell lines</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1358</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1358.jpg</image:loc><image:title>The cryo-EM structure of ADGRL4 provides functional insights into its mechanism of activation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1359</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1360</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1360.jpg</image:loc><image:title>Structural proteomics and AI powers PROTAC rational design</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1361</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1361.jpg</image:loc><image:title>Nanoformulation enabling repurposing of niclosamide for the treatment of pancreatic cancer: Rapidly soluble oral formulation for enhanced bioavailability</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1362</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1362.jpg</image:loc><image:title>Clinical outcome of patients with early stage and metastatic non-small cell lung cancer (NSCLCa) harboring high genomic scarring score (GSS)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1363</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1363.jpg</image:loc><image:title>Precision genomics in leukemiareveals mutational and fusion landscapes in South Asian patients driving clinical decisions</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1364</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1364.jpg</image:loc><image:title>BAP1 loss confers ferroptosis resistance to cholangiocarcinoma via TLCD1-mediated membrane phospholipid remodeling</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1365</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1365.jpg</image:loc><image:title>Prognostic and predictive effects of TP53 co-mutations and RET fusion partners in RET -rearranged advanced NSCLC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1366</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1366.jpg</image:loc><image:title>Tertiary lymphoid structures induction predicts and enhances response to famitinib plus PD-L1 blockade in advanced thyroid cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1367</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1367.jpg</image:loc><image:title>Gastric cancer-derived tertiary lymphoid structure score from single-cell spatial transcriptomics with pan-cancer validation for immunotherapy response</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1368</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1368.jpg</image:loc><image:title>A comparative scoring framework for BCMA-, GPRC5D- and CD38-targeted therapies in multiple myeloma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1369</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1369.jpg</image:loc><image:title>Discovery of predictive circulating proteomic biomarkers for therapy response in HRR-driven solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1370</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1370.jpg</image:loc><image:title>Predictive modeling of venetoclax/azacitidine response in acute myeloid leukemia using inflammatory cytokine profiling and clinical data from the NCT04267081 trial cohort</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1371</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1371.jpg</image:loc><image:title>Single-cell MRD profiling identifies CXCR4-high AML as a responder population to CXCR4 inhibition with Motixafortide</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1372</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1372.jpg</image:loc><image:title>The myCAF and ECM landscape in KRAS-mutated cancer: Utilizing liquid biomarkers to track KRAS-induced fibrosis and KRAS inhibitor efficacy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1373</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1373.jpg</image:loc><image:title>Baseline single-cell mass distributions correlate with clinical response to acalabrutinib, venetoclax, and obinutuzumab in mantle cell lymphoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1374</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1374.jpg</image:loc><image:title>Urinary pesticide biomarkers and liver disease risk in Thailand: A machine-learning-based risk-prediction model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1375</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1375.jpg</image:loc><image:title>Multi-agent-augmented analysis of PD-1 checkpoint inhibitor response</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1376</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1376.jpg</image:loc><image:title>LAPNET-01: Translational results of a Phase 1b evaluating NP137, an inhibitor of the epithelial-to-mesenchymal transition in combination with mFOLFIRINOX for the first-line treatment of locally advanced pancreatic ductal adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1377</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1377.jpg</image:loc><image:title>High PRMT5 expression is associated with decreased immune infiltrate and worse outcomes to immune checkpoint inhibitors in non-small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1378</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1378.jpg</image:loc><image:title>Epigenomic liquid biopsy-based biomarkers of platinum and PARP inhibitor response in patients with germ line BRCA-associated PDAC: A pilot study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1379</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1379.jpg</image:loc><image:title>Somatic DDR mutations as potential predictive biomarkers of platinum benefit in metastatic pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1380</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1380.jpg</image:loc><image:title>Comparison of liquid versus solid tissue genomic profiling for the prediction of chemo-immunotherapy benefit in advanced NSCLC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1381</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1381.jpg</image:loc><image:title>Peritumoral adipose tissue as a prognostic imaging biomarker for immunotherapy response in HNSCC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1382</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1382.jpg</image:loc><image:title>Dual-function platform for chemotherapy prediction and mutation detection in pancreatic cancer by t CAM-seq</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1383</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1383.jpg</image:loc><image:title>Proteomic aging biomarkers predict survival in immunotherapy-treated tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1384</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1384.jpg</image:loc><image:title>Valproic acid enhances immune reprogramming in locally advanced rectal cancer: Insights from the VshoRTR3 trial</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1385</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1385.jpg</image:loc><image:title>A Drug Response Predictor (DRP&amp;#174;) is associated with enhanced overall survival in the phase 2 trial in advanced, recurrent ovarian cancer patients treated twice daily with 2X-121/ Stenoparib (NCT03878849)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1386</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1386.jpg</image:loc><image:title>Profiling the expression of antibody-drug conjugates in fibrolamellar hepatocellular carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1387</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1387.jpg</image:loc><image:title>Advancing liquid biopsies via integrated CRISPR-based extracellular vesicle RNA and protein analyses</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1388</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1388.jpg</image:loc><image:title>Tumor-informed circulating tumor DNA dynamics reflect aggressive histology and radiologic disease status in renal cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1389</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1389.jpg</image:loc><image:title>Methylation signatures from liquid biopsies predict anti-EGFR therapy response in patients with colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1390</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1390.jpg</image:loc><image:title>Plasma cell-free DNA nucleosome footprints in metastatic castration-resistant prostate cancer (mCRPC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1391</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1391.jpg</image:loc><image:title>Investigating a Wilms tumor DNA methylation signature in liquid biopsies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1392</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1393</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1393.jpg</image:loc><image:title>Monitoring ESR1 and other mutations linked to resistance with a tumor-informed MRD test: Analytical validation and real world data</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1394</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1394.jpg</image:loc><image:title>Prospective verification of OvaPrint and multi-omic profiling for precise adnexal mass classification</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1395</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1395.jpg</image:loc><image:title>Urine cfDNA 4-mer end-motif signatures outperform other fragmentomic features for tissue-of-origin classification in genitourinary cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1396</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1396.jpg</image:loc><image:title>Sequence and structural DNA alterations in the circulation of patients with cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1397</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1397.jpg</image:loc><image:title>Nocturnal rise in circulating tumor DNA in a subset of metastatic colorectal cancer patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1398</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1398.jpg</image:loc><image:title>Enspyre MRD: Validation of an ultra-sensitive kitted MRD solution at low sequencing depth</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1399</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1399.jpg</image:loc><image:title>A deep sampling and single molecule digital counting assay for rare molecule detection</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1400</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1401</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1401.jpg</image:loc><image:title>Ultrasensitive multiplex ddPCR for integrated genomic-epigenomic ctDNA detection in colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1402</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1403</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1403.jpg</image:loc><image:title>Analytical validation of an ultra-high sensitivity tumor-informed MRD assay</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1404</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1404.jpg</image:loc><image:title>Methylation-based circulating tumor DNA predicts recurrence in definitively treated non-small cell lung cancer (NSCLC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1405</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1405.jpg</image:loc><image:title>Investigating treatment response and resistance in non-small cell lung cancer patients through epigenetic profiling of plasma nucleosomes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1406</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1406.jpg</image:loc><image:title>Biomarker tail genes in blood plasma cell-free RNA enable accurate detection of prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1407</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1407.jpg</image:loc><image:title>Impact of targeted therapies in cancers classified as TMB-high by liquid biopsy: Insights from the Gustave Roussy molecular tumor board</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1408</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1408.jpg</image:loc><image:title>Comparing methylation signatures across 15 cancer types and 7 subtypes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1409</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1409.jpg</image:loc><image:title>Postoperative lymphatic exudate as a proximal liquid biopsy source in muscle-invasive bladder cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1410</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1410.jpg</image:loc><image:title>Concordance evaluation of plasma whole-exome sequencing (pWES) and tissue whole-exome sequencing (tWES): A pilot study in non-small cell lung cancer (NSCLC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1411</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1411.jpg</image:loc><image:title>A liquid biopsy assay of estrogen receptor activity predicts response to giredestrant in ER+/HER2&amp;#8722; advanced breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1412</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1412.jpg</image:loc><image:title>Non-invasive biomarker discovery and validation for the early detection of pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1413</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1413.jpg</image:loc><image:title>Effect of COPD diagnosis on TP53-mutated colony size distribution in airway epithelium of subjects with or without lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1414</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1414.jpg</image:loc><image:title>High throughput immunoproteomics for cancer biomarker discovery</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1415</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1415.jpg</image:loc><image:title>The ELF5 clock: A predictive marker for accelerated breast tissue aging and cancer susceptibility</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1416</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1416.jpg</image:loc><image:title>Plasma levels of Serphin-E1 (PAI-1) are significantly increased in patients with colorectal cancer compared to patients with benign colonic disease</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1417</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1417.jpg</image:loc><image:title>Innovative label-free and non-invasive urinary metabolite analysis integrating AI and SERS technology for early cancer detection: A retrospective clinical study involving five cancer types</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1418</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1418.jpg</image:loc><image:title>Blood-based mRNA signature detects pancreatic cancer and distinguishes IPMNs: Discovery and preliminary verification study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1419</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1419.jpg</image:loc><image:title>Genomic transposable elements, repetitive sequences, in early-onset melanoma and prostate cancer among West Africans in Nigeria</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1420</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1420.jpg</image:loc><image:title>High-resolution mapping of tumor-associated antigens for autoantibody-based lung cancer detection</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1421</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1421.jpg</image:loc><image:title>PD-L1 expression in oral premalignant and malignant lesions and its association with p53 expression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1422</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1422.jpg</image:loc><image:title>Machine learning-derived circulating ncRNA signature for early detection of breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1423</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1423.jpg</image:loc><image:title>miRNA profiling of prostate tissues reveals a molecular continuum from benign to tumor through peritumoral tissue</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1424</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1424.jpg</image:loc><image:title>A combined bioinformatics, deep learning analysis, and immunohistochemistry approach to define the biomarker potential of advanced glycosylated end products (AGER) complex proteins in colon cancer progression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1425</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1425.jpg</image:loc><image:title>Circulating sphingolipids and colorectal cancer risk in African American adults</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1426</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1426.jpg</image:loc><image:title>Assessing the TP53 mutation prevalence biomarker for lung cancer in subjects without COPD</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1427</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1427.jpg</image:loc><image:title>Serum calreticulin as a promising biomarker for cancer screening</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1428</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1429</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1429.jpg</image:loc><image:title>Genome-wide analysis of ctDNA-derived DNA palindromes for early detection of breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1430</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1430.jpg</image:loc><image:title>An alternative screening method for prostate cancer to serum prostate specific antigen</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1431</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1431.jpg</image:loc><image:title>Translating to targeted: Bridging discovery lipidomics to multi-omic clinical diagnostic application in ovarian cancer detection</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1432</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1432.jpg</image:loc><image:title>Circulating proteomic signatures for subtyping NF1 associated peripheral nerve sheath tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1433</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1434</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1435</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1435.jpg</image:loc><image:title>Dual recognition of beta-sheet proteinopathy and glycan moieties enables noninvasive detection of pancreatic ductal adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1436</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1436.jpg</image:loc><image:title>Cell-free RNA urogentital cancer biomarker detection from urine</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1437</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1437.jpg</image:loc><image:title>Multi&amp;#8209;omics liquid biopsy approach for sensitive detection of lung cancer via cfDNA and extracellular vesicles&amp;#8209;RNA</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1438</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1438.jpg</image:loc><image:title>Deficit accumulation as a predictor of lung cancer risk in older adults</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1439</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1440</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1440.jpg</image:loc><image:title>Longitudinal change in epigenetic aging and telomere length in breast cancer survivors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1441</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1441.jpg</image:loc><image:title>Microbiota-dependent complex dietary polysaccharide degradation suppresses inflammaging and colorectal cancer susceptibility</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1442</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1442.jpg</image:loc><image:title>Novel mechanism driving p53 loss that dictates bladder cancer aggressive phenotypes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1443</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1443.jpg</image:loc><image:title>Social support as a predictor of deficit accumulation in older breast cancer survivors and non-cancer controls</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1444</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1444.jpg</image:loc><image:title>The association between sleep and physical function in the longitudinal TLC cohort study of women</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1445</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1445.jpg</image:loc><image:title>Aging and cancer in the Caribbean: Incidence and mortality trends among older adults during Covid-19: Population-based analysis from Martinique, 2008-2022</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1446</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1447</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1448</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1449</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1449.jpg</image:loc><image:title>Non-completion of colorectal cancer screening among Alaska Native people in an intervention trial</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1450</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1451</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1452</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1452.jpg</image:loc><image:title>Graphic medicine: A patient-centered approach to oncology</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1453</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1453.jpg</image:loc><image:title>Advancing equitable preventative cancer screening on the Inova Saville mobile health bus</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1454</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1454.jpg</image:loc><image:title>Embedding community voices in clinical research: The value of community scientists in IIT protocol review</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1455</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1456</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1457</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1457.jpg</image:loc><image:title>The CAHR-model: A culturally adaptive hybrid recruitment strategy for Asian American breast cancer survivors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1458</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1458.jpg</image:loc><image:title>Survivorship and sexual health: What we learned from Black men in community town halls</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1459</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1459.jpg</image:loc><image:title>Exercise preferences and barriers in minority cancer patients undergoing chemotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1460</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1461</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1461.jpg</image:loc><image:title>Racial differences in clinical and cytogenetic features of pediatric acute myeloid leukemia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1462</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1463</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1463.jpg</image:loc><image:title>Transcriptomic landscape for African-specific low-grade prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1464</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1464.jpg</image:loc><image:title>Distinct HER2- breast cancer traits among subethnic Hispanics of South Florida</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1465</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1465.jpg</image:loc><image:title>Systemic molecular disparities in Black vs. White breast cancer survivors: Beyond socioeconomic determinants</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1466</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1466.jpg</image:loc><image:title>Glucocorticoids inhibit the GARP/TGF-betaaxis initiating immune-dependent melanoma control</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1467</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1467.jpg</image:loc><image:title>Multi-omic single-cell assessment of castration-resistant prostate cancer patients receiving 177 Lu-PSMA-617 and pembrolizumab shows timing of radioligand therapy alters immune response</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1468</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1468.jpg</image:loc><image:title>Identifying cancer cell intrinsic regulators of radiation-induced interferon signaling</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1469</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1469.jpg</image:loc><image:title>Radiotherapy shapes memory T cell dynamics and region-specific PD-1 expression in the glioblastoma microenvironment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1470</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1470.jpg</image:loc><image:title>Quantitative and functional immune reprogramming induced by a nanomedicine in breast cancer model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1471</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1471.jpg</image:loc><image:title>mTOR inhibition augments antitumor immune response by reprogramming the TP53 -mutant, immune-cold HNSCC tumor microenvironment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1472</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1472.jpg</image:loc><image:title>Investigating the combination of natural killer immunotherapy with radiation therapy for muscle invasive bladder cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1473</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1473.jpg</image:loc><image:title>mTOR as a mechanistic biomarker of FLASH radiotherapy: Implications for immune-modulated melanoma treatment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1474</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1474.jpg</image:loc><image:title>KRAS G12D inhibition enhances macrophage-mediated anti-tumor immunity via STING activation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1475</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1475.jpg</image:loc><image:title>Axl is a negative regulator of type I IFN in cDC1s hindering anti-tumor immunity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1476</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1477</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1477.jpg</image:loc><image:title>Reprogramming T-cell networks to overcome immune evasion in ovarian cancer relapse</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1478</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1478.jpg</image:loc><image:title>Pharmacological targeting of CTPS1 elicits macrophage-mediated anti-leukemia immunity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1479</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1479.jpg</image:loc><image:title>Identification and characterization of platinum agent-induced chemoimmunomodulation in triple-negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1480</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1480.jpg</image:loc><image:title>Identification and characterization of chemoimmunomodulatory induction trajectories in breast cancer via unsupervised transcriptomic analyses of pre- and post-treatment specimens</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1481</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1481.jpg</image:loc><image:title>Identification and characterization of anthracycline-induced chemoimmunomodulation in triple-negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1482</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1483</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1484</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1484.jpg</image:loc><image:title>Clinical feasibility study of Optim.AI 2.0, a co-culture high-content functional precision platform for predicting combinatorial immunotherapy response</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1485</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1485.jpg</image:loc><image:title>Development of a novel CAR T-cell therapy targeting thymic carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1486</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1487</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1488</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1489</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1490</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1490.jpg</image:loc><image:title>A novel ADAM9 ADC with robust anti-tumor efficacy and remarkable preclinical safety profile</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1491</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1492</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1492.jpg</image:loc><image:title>LPD002, a novel anti-PD-1/IL-2 fusion protein, demonstrates potent antitumor activity in preclinical studies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1493</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1494</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1494.jpg</image:loc><image:title>A T-cell engager antibody targeting the non-shed site of mesothelin in solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1495</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1495.jpg</image:loc><image:title>HEC-922:A CDH17-4-1BB bispecific antibody targeting CDH17 positive tumors shows potent anti-tumor activity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1496</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1497</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1498</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1498.jpg</image:loc><image:title>A DR5-targeting ADC exhibits superior anti-tumor activity and potentially better therapeutic window</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1499</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1499.jpg</image:loc><image:title>A rapid patient-derived organoids platform guides the evaluation of ERBB-targeting bispecific T-cell engagers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1500</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1500.jpg</image:loc><image:title>Mesothelin-targeted nanobody-drug conjugates to treat pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1501</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1502</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1503</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1504</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1504.jpg</image:loc><image:title>Enhancing safety to unlock efficacy: A novel class of conditionally-activated T cell engagers for solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1505</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1505.jpg</image:loc><image:title>Characterization of osemitamab in pancreatic cancer models and patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1506</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1506.jpg</image:loc><image:title>Prospective organoid drug profiling and clinical response correlation for patients with primary or recurrent ovarian carcinoma (OC) in the PROSPERITY study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1507</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1507.jpg</image:loc><image:title>Rapid clinical diagnostic classification and risk stratification in acute myelogenous leukemia (AML) using whole genome sequencing (WGS)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1508</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1508.jpg</image:loc><image:title>In silico screening of therapeutics candidates targeting minimal residual disease in glioblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1509</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1509.jpg</image:loc><image:title>OncoKB&amp;#8482;, MSK&#039;s precision oncology knowledge base: 2025 updates</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1510</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1510.jpg</image:loc><image:title>Single-cell transcriptomic comparison of tumor before and after chemotherapy reveals therapeutic vulnerabilities in chemo-tolerant osteosarcoma cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1511</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1511.jpg</image:loc><image:title>CMTR2 deficiency defines a novel RNA splicing-driven subtype of lung adenocarcinoma with therapeutic vulnerabilities</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1512</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1512.jpg</image:loc><image:title>Epigenetic screening in organoids identify KMT5A inhibition as a therapeutic strategy via PGK1in endometrial cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1513</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1513.jpg</image:loc><image:title>Lung cancer organoid-based diagnostic response prediction (CODRP) for predicting anticancer drug response and progression-free survival</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1514</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1514.jpg</image:loc><image:title>Activation of alternative receptor by CCL5 is associated with non-small cell lung cancer disparities</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1515</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1515.jpg</image:loc><image:title>Dual siRNAs for precision targeting of synthetic lethal vulnerabilities in Diffuse Pleural Mesothelioma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1516</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1516.jpg</image:loc><image:title>Genomic-driven targeted therapy evaluation using patient-derived organoids and xenografts in gastric cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1517</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1517.jpg</image:loc><image:title>Causal machine learning personalizes endocrine therapy selection for ductal carcinoma in situ</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1518</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1518.jpg</image:loc><image:title>New precision treatments for glioblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1519</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1519.jpg</image:loc><image:title>Building a Precision Therapeutics program at a tertiary care Children&#039;s Hospital</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1520</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1520.jpg</image:loc><image:title>Comprehensive genomic profiling drives precision oncology and expands accessibility to targeted therapies in Uzbek populations</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1521</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1521.jpg</image:loc><image:title>Ranking therapeutic recommendations of Molecular Tumor Board with an evidence-based algorithm to deliver optimal care and improve outcomes for cancer patients- continuous study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1522</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1522.jpg</image:loc><image:title>A real time imaging based functional precision medicine (FPM) assay for glioblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1523</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1524</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1524.jpg</image:loc><image:title>Patient-driven multi-omic longitudinal research study reveals novel insights into uveal melanoma progression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1525</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1526</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1527</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1527.jpg</image:loc><image:title>Real-world clinical performance of a combinatorial functional precision platform, Optim.AI&amp;#8482;, in hematological malignancies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1528</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1528.jpg</image:loc><image:title>Feasibility study of an ex vivo functional precision medicine platform, Optim.AI&amp;#8482;, in guiding treatment for gynecological cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1529</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1529.jpg</image:loc><image:title>Characterization of BRAF fusions and their therapeutic and resistance implications in NSCLC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1530</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1530.jpg</image:loc><image:title>Clinical impact of the personalized medicine for neuroblastoma patients: Six years of experience of the PREME program</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1531</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1531.jpg</image:loc><image:title>Illuminating the kinase starmap in NSCLC via tyrosine phosphoproteomics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1532</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1532.jpg</image:loc><image:title>Exploring the impact of RAS mutations in abdominopelvic Rosai Dorfman disease on responsiveness to targeted therapies: A case control study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1533</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1533.jpg</image:loc><image:title>Tumor endothelial cell and cancer cell targeting anti-PRND antibody-drug conjugate to treat hypervascular tumors such as glioblastoma and sarcomas</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1534</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1534.jpg</image:loc><image:title>Breaking immune silence: Tumor-targeted molecular therapy reprograms the tumor-immune interface in progressive neuroblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1535</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1535.jpg</image:loc><image:title>MGT-1142, an antibody-drug conjugate targeting a novel glycan for small-cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1536</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1536.jpg</image:loc><image:title>Sequencing immune checkpoint inhibitors and BRAF/MEK inhibitors in advanced melanoma: A meta-analysis of Kaplan-Meier-reconstructed individual level data</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1537</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1537.jpg</image:loc><image:title>DB-1421, an optimized EGFR/MUC1 bispecific ADC, exhibits improved tumor selectivity, promising efficacy and safety in preclinical studies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1538</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1538.jpg</image:loc><image:title>DB-1323, a next-generation mesothelin targeting antibody-drug conjugate, demonstrated anti-tumor activity and favorable safety profile in pre-clinical models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1539</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1539.jpg</image:loc><image:title>DB-1329: A novel antibody-drug conjugate targeting CDCP1 demonstrates potent preclinical anti-tumor activity across multiple solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1540</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1540.jpg</image:loc><image:title>DB-1326, a novel dual-payload TA-MUC1-directed antibody-drug conjugate, shows potent antitumor efficacy in pre-clinical tumor model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1541</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1542</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1542.jpg</image:loc><image:title>CD44v9-targeted antibody-drug conjugate as a novel therapy for advanced breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1543</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1543.jpg</image:loc><image:title>AV-P138-ADC (ARR-002), a novel MUC16/NaPi2b dual-target tetravalent ADC, for the treatment of ovarian and endometrial cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1544</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1544.jpg</image:loc><image:title>AZD5335, a folate receptor alpha-targeted ADC, exerts anti-tumor responses within lung adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1545</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1545.jpg</image:loc><image:title>MGT-1141, an antibody-drug-conjugate targeting DLL3 positive cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1546</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1546.jpg</image:loc><image:title>Targeting YAP/TEAD signaling disturbs RNA polymerase II activity and enhances immunotherapy response via activated cytosolic DNA sensing pathway in gastroesophageal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1547</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1547.jpg</image:loc><image:title>MGT-1143, a novel CDH17-targeting ADC for gastrointestinal cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1548</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1548.jpg</image:loc><image:title>The MET/HER3 antibody-drug conjugate with dual payload: A dual-target approach to eliminate tumor escape mechanism</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1549</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1549.jpg</image:loc><image:title>An open-label, multicenter Phase I clinical study of CVL006, a novel PD-L1/VEGF bispecific antibody, in advanced solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1550</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1550.jpg</image:loc><image:title>TM4SF1 as a novel tumor-associated antigen in biliary tract cancers targetable by immune effector cell therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1551</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1551.jpg</image:loc><image:title>TROP2 expression predicts sensitivity to datopotamab deruxtecan (Dato-DXd) in patient-derived breast cancer organoids</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1552</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1552.jpg</image:loc><image:title>Characterization of small molecule inhibitors against Lipocalin-2 in inflammatory breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1553</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1553.jpg</image:loc><image:title>Development and clinical evaluation of &amp;#8310;&amp;#8308;Cu-RAX301: A next-generation PSMA PET tracer for enhanced detection of metastatic prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1554</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1554.jpg</image:loc><image:title>Prospective evaluation of 68Ga-PSMA PET imaging in advanced hepatocellular carcinoma patients undergoing first line immunotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1555</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1555.jpg</image:loc><image:title>Development and preclinical validation of magnetomotive embolization for enhanced targeting of hepatocellular carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1556</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1556.jpg</image:loc><image:title>Multi-omic characterization of imaging invisible prostate tumors reveals microenvironmental drivers of PET visibility</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1557</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1557.jpg</image:loc><image:title>Advancing pancreatic cancer theragnostic through claudin-4-selective radiolabeled peptides: Design, optimization, and preclinical validation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1558</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1558.jpg</image:loc><image:title>Diffusion kurtosis imaging to predict tumor hypoxia and recurrence in HPV-associated oropharyngeal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1559</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1559.jpg</image:loc><image:title>ECM profiling of patient-matched endometrial PDX-tumors reveals translational drift and TME remodeling</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1560</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1560.jpg</image:loc><image:title>Rapid assessment of patient derived cancer organoids using label-free imaging and an automated analysis pipeline</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1561</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1561.jpg</image:loc><image:title>Thoracic ct-derived muscle indices improve prediction of respiratory function beyond standard L3 sarcopenia measures in lung cancer patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1562</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1562.jpg</image:loc><image:title>Quantitative modeling of autofluorescence and non-specific staining allows for improved cell phenotyping and marker assessment in highly multiplexed immunofluorescence studies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1563</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1563.jpg</image:loc><image:title>Comparison of 68 Ga-DOTANOC PET/CT with anatomical imaging in opsoclonus-myoclonus-ataxia syndrome in children: A retrospective analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1564</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1564.jpg</image:loc><image:title>A systematic review of radiogenomic applications in prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1565</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1566</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1567</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1567.jpg</image:loc><image:title>Androgen receptor inhibition to overcome taxane resistance in AR-positive metastatic TNBC: Interim results of the 4CAST Phase 1b trial</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1568</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1568.jpg</image:loc><image:title>A phase 1B investigator-initiated trial of niraparib lead-in, followed by niraparib plus dostarlimab for metastatic BRCA1/2 -mutated breast, tubo-ovarian, and pancreatic cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1569</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1569.jpg</image:loc><image:title>Initial clinical and translational results and selection of recommended phase 2 dose (RP2D) from START-002: A Phase 1b/2 study of invikafusp alfa, a first-in-class dual T-cell agonist, in combination with sacituzumab govitecan in metastatic triple-negative or HR+/HER2- breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1570</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1570.jpg</image:loc><image:title>A first-in-class HER2-targeted radiopharmaceutical therapy: Initial findings from the Phase 0/1 HEAT trial of 177Lu-RAD202 in HER2+ advanced solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1571</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1571.jpg</image:loc><image:title>Effects of Maackia amurensis seed lectin (MASL) on OSCC cell morphology, PDPN expression, viability, and motility in a phase 1 clinical trial</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1572</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1572.jpg</image:loc><image:title>A first in human, dose escalation (DE) and biomarker cohort expansion (BCE) of IMT-009 (IMT) in advanced cancer and Phase 1b (Ph1b) combination with fruquintinib (F) in microsatellite stable colorectal cancer (MSS CRC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1573</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1573.jpg</image:loc><image:title>Preliminary clinical results of TAVO412, an anti-EGFR/cMET/VEGF multispecific antibody, in patients with advanced or metastatic solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1574</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1574.jpg</image:loc><image:title>From preclinical models to first-in-human evaluation of STC-1010 immunotherapy in unresectable advanced colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1575</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1575.jpg</image:loc><image:title>Proof of mechanism from a phase 1, single ascending dose (SAD) study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of LRK-4189 in healthy subjects</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1576</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1576.jpg</image:loc><image:title>A phase 1 clinical trial of CT-01, a dual degrader of GSPT1 and NEK7, alone or in combination with everolimus for the treatment of hepatocellular carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1577</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1577.jpg</image:loc><image:title>Results from the phase 1b/2 Morpheus liver study in patients with unresectable locally advanced or metastatic hepatocellular carcinoma (HCC): Muzastotug (ADG126: masked anti-CTLA-4 Ab) combination arm</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1578</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1578.jpg</image:loc><image:title>Early clinical activity and tumor transcriptional modulation of AU409, a first-in-class transcription regulator, in advanced solid tumors and hepatocellular carcinoma: Results from two phase I studies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1579</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1579.jpg</image:loc><image:title>Phase I study of intratumoral microdevices reveals heterogenous immune and apoptotic responses across distinct drug-treated regions in adenoid cystic carcinoma of the head and neck</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1580</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1580.jpg</image:loc><image:title>Preliminary results from the first-in-human study of MK-2010, a PD-1&amp;#215;VEGF bispecific antibody</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1581</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1581.jpg</image:loc><image:title>First in human phase 1 study of D3S-002, a purposely designed ERK1/2 inhibitor, in advanced solid tumors with MAPK pathway mutations</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1582</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1582.jpg</image:loc><image:title>A phase I study of the type II ROS1 TRK inhibitor ANS03 in ROS1 fusion-positive lung cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1583</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1583.jpg</image:loc><image:title>Single institution experience of the phase 1 expansion study of IK-595, a novel MEK-RAF molecular glue, in patients with NRAS/KRAS mutated advanced tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1584</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1584.jpg</image:loc><image:title>An EphA2-targeting Bicycle Drug Conjugate (BDC), BT5528, in combination with nivolumab in patients (pts) with advanced solid tumors: Results from a Phase 1/2 study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1585</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1585.jpg</image:loc><image:title>Updated results from a first-in-human phase 1,2 study of ACE-106, a highly selective and potentially best-in-class PARP1 inhibitor in advanced solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1586</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1586.jpg</image:loc><image:title>Preliminary safety, pharmacokinetics and pharmacodynamics of SGR-3515, a Wee1/Myt1 dual inhibitor from an ongoing Phase 1 study in participants with advanced solid tumors (SGR-3515-101)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1587</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1587.jpg</image:loc><image:title>Targeted hyperthermia induces immunogenic tumor remodeling and demonstrates early clinical response in immunotherapy-refractory metastatic melanoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1588</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1588.jpg</image:loc><image:title>Initial clinical and laboratory results of an ongoing dose escalation study of autologous GD2-CAR-T cells in patients with recurrent GD2-positive glioblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1589</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1589.jpg</image:loc><image:title>Phase I/II study of the anti-P-selectin antibody crizanlizumab for newly-diagnosed unmethylated glioblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1590</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1590.jpg</image:loc><image:title>Novel targeting of the microenvironment to decrease metastatic recurrence of high-risk TNBC: A randomized phase II study of tetrathiomolybdate (TM) plus capecitabine in patients with breast cancer at high risk of recurrence</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1591</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1591.jpg</image:loc><image:title>FiREBOLT: A phase 1 study evaluating radioligand therapy with LY4337713 in adults with select FAP+ solid tumors (Trial in progress)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1592</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1592.jpg</image:loc><image:title>A phase 1 study of CAN2109, a novel,long-acting, tumor-retained, immunogenic cell death inducer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1593</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1594</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1594.jpg</image:loc><image:title>STRO-004 ST1: Phase 1 open-label study to evaluate safety, pharmacokinetics, and preliminary anti-tumor activity of STRO-004 in adults with refractory/recurrent metastatic solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1595</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1595.jpg</image:loc><image:title>First-in-human phase I study of UCL70802, a LACO-Stim armored Anti-CD70 CART cell therapy, in patients with metastatic clear cell renal cell carcinoma (mccRCC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1596</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1596.jpg</image:loc><image:title>EIU-104101: A first-in-human phase 1a/1b study of EVOLVE104, a trispecific CD3&amp;#215;CD2&amp;#215;ULBP2/5/6 T cell engager, in advanced urothelial and squamous cell carcinomas</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1597</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1597.jpg</image:loc><image:title>Open-label, Phase Ib dose-expansion study assessing the efficacy of the CD137/FAP agonist BI 765179 plus pembrolizumab as first-line therapy in metastatic or incurable, recurrent PD-L1-positive head and neck squamous cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1598</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1598.jpg</image:loc><image:title>First-in-human study of neoadjuvant regional delivery of the TLR9 agonist Nelitolimod via pressure enabled drug delivery (PEDD) in resectable microsatellite stable colorectal liver metastases</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1599</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1599.jpg</image:loc><image:title>A phase 1b/2 study of toripalimab and nadunolimab for the treatment of chemotherapy-refractory metastatic microsatellite stable (MSS) colorectal cancer (CRC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1600</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1600.jpg</image:loc><image:title>Ph1b evaluation of ADG126 (muzastotug, an anti-CTLA-4 masking antibody) pembrolizumab (Pembro) IO doublet in combination with fruquintinib (Fruq) in advanced and metastatic microsatellite stable colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1601</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1601.jpg</image:loc><image:title>A Phase 1b/2a study to evaluate the efficacy and safety of BXQ-350 in combination with mFOLFOX7 and bevacizumab in newly diagnosed metastatic colorectal carcinoma patients (mCRC): Evidence of lower incidence and severity of CIPN events</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1602</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1602.jpg</image:loc><image:title>A phase 1b/2 trial of gemcitabine, cisplatin, nab-paclitaxel, and tislelizumab (GENTIS) in patients with advanced biliary tract cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1603</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1603.jpg</image:loc><image:title>A phase 1/2, first-in-human study of an ADC targeting CDH17 (DB-1324) in participants with advanced/metastatic gastrointestinal tumor</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1604</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1604.jpg</image:loc><image:title>Phase I/II FIH study of IPN60300, a first-in-class ADC targeting ITGA2, to assess the safety, tolerability, PK, biomarkers, immunogenicity and antitumor activity in adults with locally advanced solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1605</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1605.jpg</image:loc><image:title>[ 212 Pb]VMT-a-NET in advanced SSTR2+ neuroendocrine tumors: safety and preliminary efficacy results from dose-finding cohorts 1,2 and 3</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1606</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1606.jpg</image:loc><image:title>Irreversible electroporation (IRE) with intratumoral CD40 antibody increases T-cell reactivity to personalized neoantigens in locally advanced pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1607</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1607.jpg</image:loc><image:title>Pilot study of an implantable microdevice for in situ evaluation of drug response in patients with pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1608</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1608.jpg</image:loc><image:title>Trial in progress: A phase I study of personalized neoantigen vaccination combined with PD-1 blockade and CD40 agonism in resected pancreatic ductal adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1609</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1609.jpg</image:loc><image:title>A Phase 1a/1b, first-in-human study of an ADC targeting ADAM9 (DB-1317) in participants with selected advanced or metastatic solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1610</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1610.jpg</image:loc><image:title>Clinical and immunologic assessment of DOC1021 dendritic cell therapy in resectable or borderline resectable pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1611</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1611.jpg</image:loc><image:title>A Phase 1/2 study of BDC-4182, a claudin18.2-targeting next generation immune-stimulating antibody conjugate (ISAC), in patients with advanced gastric and gastroesophageal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1612</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1612.jpg</image:loc><image:title>Phase I/II clinical trial of CVL006 combination therapy in advanced solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1613</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1613.jpg</image:loc><image:title>A first-in-human, intra-tumoral AAV2- RUNX3 gene therapy (RX001) for advanced KRAS-mutant NSCLC (NCT06934590): Phase 1 trial in progress</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1614</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1614.jpg</image:loc><image:title>A Phase 1, first-in-human study of the SMARCA2 degrader, PLX-61639, in patients with SMARCA4-mutated, locally advanced or metastatic solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1615</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1615.jpg</image:loc><image:title>Phase 1/2a open-label clinical trial evaluating VBC101, an EGFR and cMET targeted bi-specific antibody drug conjugate (ADC), in participants with advanced solid tumormalignancies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1616</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1616.jpg</image:loc><image:title>DNA methylation-based classifier predicts SERD benefit in ESR1 wild-type HR+/HER2- breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1617</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1617.jpg</image:loc><image:title>Ligand-activated AR promotes the survival of endocrine therapy-responsive ER+ breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1618</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1619</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1619.jpg</image:loc><image:title>Targeting estrogen receptor mutations and aberrant myelopoiesis in hormone resistant breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1620</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1620.jpg</image:loc><image:title>Obesity predicts greater changes in Ki67 after neoadjuvant aromatase inhibitor therapy in early-stage ER+ breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1621</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1622</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1622.jpg</image:loc><image:title>TGFbeta Induction: An essential tumor suppressive arm of next generation SERDs in ER+ breast cancer models in vitro</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1623</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1624</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1624.jpg</image:loc><image:title>Minimal-length CAG repeats in AR define a hyperactive AR-LSD1 axis driving metabolic reprogramming in prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1625</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1625.jpg</image:loc><image:title>Neoadjuvant treatment of ER-positive/HER2-negative breast cancer with aromatase inhibitors in sequence: Ki67 dynamics and biology shifts</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1626</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1627</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1628</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1628.jpg</image:loc><image:title>Exposure to plastic additives suggests potential androgen receptor agonism in prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1629</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1629.jpg</image:loc><image:title>Interleukin-6 increases glucocorticoid inactivation in a castration resistant prostate cancer cell line model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1630</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1630.jpg</image:loc><image:title>The LncRNA XIST mediates resistance to estrogen receptor beta targeted therapies in triple negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1631</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1631.jpg</image:loc><image:title>Examining the effect of second-generation antiandrogens in androgen receptor-overexpressing prostate cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1632</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1632.jpg</image:loc><image:title>KMT2D loss rewires estrogen-PI3K crosstalk in endometrioid adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1633</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1634</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1635</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1635.jpg</image:loc><image:title>Spatial immune profiling reveals varying tumor microenvironments in papillary thyroid microcarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1636</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1637</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1637.jpg</image:loc><image:title>Novel HER2 antibody drug conjugates with stable hydrophilic linkers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1638</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1638.jpg</image:loc><image:title>Synergy of BCL-2 and MEK/HDAC inhibition in IBC and non-IBC models: Potential for a first IBC specific therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1639</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1639.jpg</image:loc><image:title>Targeted DNA damage through SSTR2: Preclinical development of a novel peptide-drug conjugate for neuroendocrine tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1640</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1640.jpg</image:loc><image:title>Targeting LRRC15 with an aptamer-drug conjugate achieves complete tumor growth inhibition</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1641</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1641.jpg</image:loc><image:title>Preclinical characterization of XB404, a masked anti-ROR1/2 antibody-drug conjugate</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1642</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1643</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1643.jpg</image:loc><image:title>An avidity-driven, dual-targeting ADC with superior tumor selectivity for the treatment of solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1644</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1645</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1646</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1646.jpg</image:loc><image:title>YL413: A novel dual-payload anti-HER2 antibody-drug conjugate demonstrating potent preclinical activity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1647</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1647.jpg</image:loc><image:title>Dual EGFR and Bcl-2 inhibition overcomes resistance in sinonasal squamous cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1648</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1648.jpg</image:loc><image:title>Preclinical efficacy of a first-in-class anti-SLC3A2 ADC in hard-to-treat solid and hematologic malignancies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1649</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1650</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1651</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1651.jpg</image:loc><image:title>Differential in vitro activity of amivantamab, cetuximab, and panitumumab against EGFR ECD resistance mutations</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1652</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1653</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1654</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1655</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1655.jpg</image:loc><image:title>ACR317, a novel CDH17-ADC, shows potent efficacy in preclinical gastrointestinal cancer models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1656</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1657</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1658</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1659</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1659.jpg</image:loc><image:title>Enhanced delivery and activity of a novel antibody-drug conjugate, PF-08052667, for treatment of non-muscle invasive bladder cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1660</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1660.jpg</image:loc><image:title>PF-08046033 (GPS): A novel first in class auristatin S antibody-drug conjugate for treatment of GPNMB-expressing solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1661</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1661.jpg</image:loc><image:title>Diversity-oriented dpADC discovery with high throughput dual-conjugation platform and predictive resistant disease models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1662</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1662.jpg</image:loc><image:title>Payload-recycling ADCs (PR-ADCs): A novel ADC platform for reducing free-payload toxicity and enhancing therapeutic index</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1663</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1664</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1664.jpg</image:loc><image:title>NL019: A next-generation TROP2/NECTIN4 dual-target nanobody-based ADC developed from the NanoOne&amp;#8482; Platform</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1665</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1665.jpg</image:loc><image:title>Integrated ADC platform: From discovery to functional evaluation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1666</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1666.jpg</image:loc><image:title>Plate-based conjugation for antibody and payload optimization in ADC development</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1667</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1668</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1669</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1669.jpg</image:loc><image:title>Enhancing therapeutic efficacy and overcoming resistance with a novel dual-payload antibody-drug conjugate technology</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1670</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1670.jpg</image:loc><image:title>ALM-502: A highly effective ADC for solid tumor therapy - enhancing payload delivery through molecular design</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1671</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1672</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1673</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1673.jpg</image:loc><image:title>Engineering multi-specific and multi-payload ADCs to address tumor heterogeneity and drug resistance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1674</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1674.jpg</image:loc><image:title>Empowering development of next generation ADCs &amp;#38; XDCs through advanced WuXiDARx conjugation technologies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1675</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1676</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1676.jpg</image:loc><image:title>Preclinical development of XNW27011, an antibody drug conjugate targeting claudin18.2 for treatment of CLDN 18.2-positive solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1677</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1677.jpg</image:loc><image:title>Site-specific dual-payload antibody conjugation enhances antitumor efficacy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1678</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1678.jpg</image:loc><image:title>STX-1, a first-in-class ADC targeting DPP4 protein, acts as an anticancer and senolytic treatment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1679</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1680</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1681</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1681.jpg</image:loc><image:title>Preclinical characterization of STRO-227: A PTK7-targeting dual-payload ADC with topoisomerase 1 and tubulin inhibitors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1682</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1682.jpg</image:loc><image:title>IN30758, an integrin-targeted antibody drug conjugate (ADC) demonstrating strong therapeutic effects in multiple solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1683</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1684</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1685</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1685.jpg</image:loc><image:title>GlycoConnect&amp;#174; ADC toolbox expansion with dual payload ADC (dpADC) technology</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1686</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1686.jpg</image:loc><image:title>Method development of purity and assay HPLC method for unstable antibody-drug conjugate linker regulated starting material BCN-OH</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1687</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1687.jpg</image:loc><image:title>Compatibility study of routine chromatographic analytical testing of antibody-drug conjugate payload-linkers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1688</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1688.jpg</image:loc><image:title>An integrate comprehensive in vitro and in vivo strategies for antibody drug conjugate development</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1689</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1689.jpg</image:loc><image:title>ZW191 - a differentiated FRalpha-targeted topoisomerase I antibody drug conjugate active in combination with standard of care drugs</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1690</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1690.jpg</image:loc><image:title>Novel DLL3 x B7H3 bispecific ADC demonstrated superior efficacy in preclinical studies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1691</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1691.jpg</image:loc><image:title>BCG042: A promising anti-LILRB4 antibody with ADCC enhancement demonstrates superior efficacy in preclinical models of monocytic AML</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1692</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1693</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1693.jpg</image:loc><image:title>GS002, a novel anti-PD-L1 ADC with targeted cytotoxic delivery and immune checkpoint inhibition</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1694</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1694.jpg</image:loc><image:title>PA289: A first-in-class prodrug payload with a novel mechanism of action and favorable efficacy/safety profile</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1695</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1695.jpg</image:loc><image:title>STRO-006: An Integrin beta-6-targeting ADC demonstrates favorable safety profile and potent antitumor activity in preclinical solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1696</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1697</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1697.jpg</image:loc><image:title>JS212, a novel bispecific ADC targeting EGFR and HER3, demonstrates superior and broad antitumor activity in preclinical evaluation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1698</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1698.jpg</image:loc><image:title>AT06 is a bispecific antibody drug conjugate targeting DLL3 and SEZ6 with potent activity in small cell lung cancer (SCLC) models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1699</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1699.jpg</image:loc><image:title>SCR-A014, a novel bispecific ADC targeting B7H3 and DLL3 for SCLC therapy, exhibits potent anti-tumor efficacy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1700</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1700.jpg</image:loc><image:title>RT023, a first-in-class CEACAM5/EGFR targeted bispecific antibody drug conjugate (ADC) in colorectal cancer (CRC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1701</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1701.jpg</image:loc><image:title>Preclinical study of BCG039, a Nectin-4&amp;#215;TROP2 bispecific ADC, in urothelial carcinoma and other solid tumor models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1702</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1702.jpg</image:loc><image:title>BCG041: A first-in-class bispecific ADC targeting B7-H3 and the proximal membrane region of MUC1 with superior antitumor activity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1703</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1704</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1705</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1705.jpg</image:loc><image:title>NEOK001 (ABL206): A first in class B7-H3xROR1 bispecific ADC demonstrated enhanced efficacy and promising tolerability</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1706</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1707</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1707.jpg</image:loc><image:title>NEOK002 (ABL209): Redesigning an EGFRxMUC1 bispecific TOP1i ADC with promising anti-tumor activity and enhanced therapeutic window</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1708</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1708.jpg</image:loc><image:title>Dual targeting of HER2 and AXL by an eKiH-engineered bispecific ADC to overcome resistance in solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1709</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1709.jpg</image:loc><image:title>Overcoming target heterogeneity in gastric cancer with an eKiH-engineered CLDN18.2&amp;#215;HER2 bispecific ADC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1710</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1710.jpg</image:loc><image:title>OBI-904, a next-generation nectin-4-targeting exatecan ADC, demonstrates enhanced cytotoxicity and overcomes enfortumab vedotin resistance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1711</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1711.jpg</image:loc><image:title>Guide-effector bsADCs: Driving co-endocytosis for enhanced payload delivery</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1712</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1712.jpg</image:loc><image:title>Hydrophilicity-enhanced linker technology enables site-specific degrader-antibody conjugates with improved stability and enhanced activity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1713</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1713.jpg</image:loc><image:title>A pan-RASi antibody-drug conjugate platform with high activity in RAS-mutant cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1714</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1714.jpg</image:loc><image:title>Targeting LANCL1 with a humanized monoclonal antibody suppresses tumorigenesis in hepatocellular carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1715</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1715.jpg</image:loc><image:title>Maximizing therapeutic index using fully Fc-silent antibody platform</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1716</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1717</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1717.jpg</image:loc><image:title>Real-time imaging for quantitative assessment of antibody-drug conjugate internalization</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1718</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1718.jpg</image:loc><image:title>FcRn humanized mice with an immunodeficient background can be used to evaluate the pharmacokinetics of antibody drugs while avoiding anti-drug antibodies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1719</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1719.jpg</image:loc><image:title>MPSA-AB5000: A high-throughput cell-based membrane protein screening array for accurate early-stage off-target assessment to accelerate safer antibody therapeutic development</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1720</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1720.jpg</image:loc><image:title>Automated imaging-based verification of monoclonality in single-cell cloning confirms higher efficiency of the Pala single cell sorter and dispenser compared to limiting-dilution assays</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1721</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1721.jpg</image:loc><image:title>Binding to bridging: Complete suite of FcgammaR assay tools accelerates antibody therapeutic development</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1722</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1722.jpg</image:loc><image:title>FcRn humanized rats for pharmacokinetics assessment of antibody drugs</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1723</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1723.jpg</image:loc><image:title>Bioluminescent and cell-based assays for comprehensive characterization of antibody-drug conjugate mechanisms of action</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1724</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1725</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1725.jpg</image:loc><image:title>Luminescent assay platforms accelerate therapeutic antibody development in veterinary immuno-oncology</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1726</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1726.jpg</image:loc><image:title>BCG015:A first-in-class antibody-drug conjugate targeting TM4SF5 for the treatment of hepatocellular carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1727</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1727.jpg</image:loc><image:title>Preclinical study of NW008, a novel dual-functional anti-MICA/B antibody-drug conjugate</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1728</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1728.jpg</image:loc><image:title>Development of a novel PSCA-targeting antibody-drug conjugate with high potency and stability for prostate cancer therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1729</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1729.jpg</image:loc><image:title>Design of a synthetic non-natural antibody (NoNabody) against GRP as a new therapy for small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1730</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1730.jpg</image:loc><image:title>Preclinical characterization of XB773, a novel anti-DLL3 antibody-drug conjugate</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1731</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1731.jpg</image:loc><image:title>GSPT1 degrader antibody conjugate, BLB-201, for the treatment of high-risk acute myeloid leukemia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1732</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1732.jpg</image:loc><image:title>Monoclonal antibodies targeting the B-cell receptor complex directly induce widespread kinase inhibition and B-cell killing for the treatment of leukemia and lymphoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1733</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1733.jpg</image:loc><image:title>Novel GPC3-targeting antibody-drug conjugate using novel payload or dual payloads to treat hepatocellular carcinoma and non-small-cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1734</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1734.jpg</image:loc><image:title>Preclinical characterization of IPN60300, a first-in-class ITGA2 antibody-drug conjugate for cancer therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1735</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1735.jpg</image:loc><image:title>Targeting the extra-cellular matrix in the tumor microenvironment with a novel antibody-drug conjugate</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1736</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1737</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1737.jpg</image:loc><image:title>MAC-8001: A KRAS-targeting molecular glue-antibody conjugate with robust antitumor activity in KRAS-mutant cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1738</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1738.jpg</image:loc><image:title>S DUAL&amp;#8482;: An Advanced Bispecific Antibody Platform Delivering Practical Manufacturability and Enhanced Therapeutic Efficacy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1739</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1739.jpg</image:loc><image:title>Improving response of pancreatic cancer to losartan: Mechanistic insights and implications for personalized therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1740</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1740.jpg</image:loc><image:title>Exome-scale CRISPR screening reveals master controllers of cell state maintenance in high-risk neuroblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1741</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1741.jpg</image:loc><image:title>ELF3-driven epigenetic reprogramming creates ERK pathway dependency in SERD-resistant ER+ breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1742</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1742.jpg</image:loc><image:title>Mechanistic characterization of (Z)-endoxifen in ESR1-mutant and endocrine-resistant breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1743</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1743.jpg</image:loc><image:title>Aspects of the YBX1-dependent mechanism of drug resistance in hepatocellular carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1744</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1744.jpg</image:loc><image:title>Convergent FGFR-JAK signaling reprograms luminal identity and drives endocrine resistance in HR&amp;#8314; breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1745</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1745.jpg</image:loc><image:title>Inhibition of MAOA suppresses intracrine androgen biosynthesis and enhances abiraterone treatment in castration-resistant prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1746</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1746.jpg</image:loc><image:title>Cysteine accumulation as a driver of resistance to bortezomib</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1747</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1747.jpg</image:loc><image:title>RNA isoform discovery and quantification with SMART-Seq&amp;#174; mRNA Long Read (v1 and v2) kits</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1748</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1748.jpg</image:loc><image:title>Targeting succinate dehydrogenase impairs the proliferation of ER+ breast cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1749</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1750</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1750.jpg</image:loc><image:title>RAC2 as a mediator of drug resistance in triple-negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1751</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1751.jpg</image:loc><image:title>m 6 A-mediated control of kinase reprogramming in endocrine therapy-resistant breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1752</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1752.jpg</image:loc><image:title>Cooperative role of ESR1 mutations and midasin in endocrine resistance and the therapeutic potential of dual targeting</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1753</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1753.jpg</image:loc><image:title>Lineage-specific survival vs proliferative enzalutamide resistance states as potential drivers of prostate cancer disparities</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1754</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1754.jpg</image:loc><image:title>Nicotinamide phosphoribosyltransferase (NAMPT) inhibitor-resistant rhabdomyosarcoma (RMS) models exhibit alterations in metabolic and genomic profiles</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1755</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1755.jpg</image:loc><image:title>Ferroportin mediates bevacizumab resistance and ferroptosis evasion in ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1756</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1756.jpg</image:loc><image:title>Mitochondrial dysfunction induces asparaginase resistance in R-spondin fusion colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1757</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1757.jpg</image:loc><image:title>H. pylori infection induces WEE1 to promote drug resistance in gastric adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1758</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1758.jpg</image:loc><image:title>Fibroblast-driven tamoxifen resistance in ER+ breast cancer: Experimental validation and development of a high-throughput co-culture screening assay</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1759</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1759.jpg</image:loc><image:title>Dynamic copy number changes and de novo generation of extrachromosomal DNA modulate therapy resistance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1760</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1760.jpg</image:loc><image:title>Midasin inhibition disrupts the sumoylation axis to impair mammosphere stability through alteration of transcriptional network</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1761</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1761.jpg</image:loc><image:title>Ancestry-dependent differences of PASK (Per-Arnt-Sim Kinase) inhibitor efficacy in triple-negative breast cancer under variable glucose conditions</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1762</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1762.jpg</image:loc><image:title>WRN under the scalpel: Helicase-domain hotspot &amp;#38; splice-site knock-ins in HCT116 and RKO</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1763</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1763.jpg</image:loc><image:title>RLIP depletion suppresses ovarian cancer growth and metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1764</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1765</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1765.jpg</image:loc><image:title>EZH2-AR non-canonical axis activation in TKI-resistant RCC: Differential effects of lenvatinib and cabozantinib</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1766</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1766.jpg</image:loc><image:title>Venetoclax rewires Notch signaling to drive resistance in North American adult T-cell leukemia/lymphoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1767</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1767.jpg</image:loc><image:title>Venetoclax-resistant AML cell models as a platform for exploring new generation drug for BCL2 inhibitor resistance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1768</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1768.jpg</image:loc><image:title>Epigenetic rewiring of BCL6 drives responses and unveils synthetic dependencies in large B cell lymphoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1769</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1770</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1770.jpg</image:loc><image:title>Improve proteasome inhibitor response by targeting NHE6-mediated endosomal-autophagic machaniery in multiple myeloma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1771</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1771.jpg</image:loc><image:title>IL-1-driven signaling promotes resistance to PI3K and BCL2 inhibitors in B-cell lymphoma preclinical models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1772</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1772.jpg</image:loc><image:title>Dual inhibition of AURKA and ERBB overcomes resistance to PI3K/BTK/BCL2 inhibitors in marginal zone lymphoma models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1773</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1773.jpg</image:loc><image:title>Co-targeting EZH2 and TEAD elicits apoptosis through tumor-intrinsic innate immune signaling in Hippo pathway-mutated cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1774</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1774.jpg</image:loc><image:title>Overcoming drug resistance in ccRCC through inhibition of protein phosphatase 5 (PP5)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1775</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1775.jpg</image:loc><image:title>CRISPR screening identifies BMF loss as a drug-tolerant persister cell survival factor in ALK-rearranged lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1776</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1776.jpg</image:loc><image:title>NAT10-mediated ac 4 C RNA modification promotes colorectal cancer stemness and 5-FU resistance via ATG5-dependent autophagy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1777</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1777.jpg</image:loc><image:title>Selective Mcl-1 inhibition with KS18 overcomes apoptotic resistance and enhances FLT3-targeted therapy in acute myeloid leukemia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1778</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1778.jpg</image:loc><image:title>PI3K/mTOR dual inhibitor overcomes ceritinib resistance in ALK-rearranged NSCLC via both apoptosis and autophagy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1779</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1779.jpg</image:loc><image:title>Downregulation of ETV4 mediates trametinib resistance via AMPK-ULK1-dependent protective autophagy in breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1780</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1780.jpg</image:loc><image:title>Mechanisms of acquired resistance to BTK and BCL2 inhibitors reveal clinically actionable vulnerabilities in B-cell lymphoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1781</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1781.jpg</image:loc><image:title>FAK inhibition by APG-2449 enhances the antitumor activity of MAPK pathway blockade in BRAF V600E-mutant tumor models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1782</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1783</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1783.jpg</image:loc><image:title>Determining mechanisms of ONC212-resistance in uveal melanoma to develop combination therapy strategies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1784</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1784.jpg</image:loc><image:title>Acquired drug resistance with autophagy is suppressed by fatty acid oxidation inhibition in pancreatic ductal adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1785</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1785.jpg</image:loc><image:title>Targeting nucleolin overcomes MCL-1-mediated venetoclax resistance in acute myeloid leukemia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1786</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1786.jpg</image:loc><image:title>Development and characterization of the venetoclax-resistant AML model to enable preclinical drug discovery</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1787</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1787.jpg</image:loc><image:title>G3BP1 knockdown sensitizes the acute myeloid leukemia cell line HL60 to venetoclax by inducing apoptosis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1788</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1788.jpg</image:loc><image:title>Resistant cell panel-based discovery of multi-target combinations and mechanisms to overcome KRAS inhibitor resistance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1789</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1789.jpg</image:loc><image:title>Combining FGTI-2734 and MRTX1133 to suppress ERK-driven resistance in KRAS G12D pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1790</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1791</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1791.jpg</image:loc><image:title>Combined RAS and ICB inhibition targets NF-KB-driven immune evasion in chemoresistant pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1792</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1792.jpg</image:loc><image:title>A high-throughput combination screen identifies NT-1 as a superior compound to overcome KRAS G12D inhibitor resistance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1793</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1793.jpg</image:loc><image:title>Atebimetinib&#039;s deep cyclic inhibition of MEK constrains MAPK-axis adaptive and acquired alterations in patients with RAS-mutant tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1794</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1794.jpg</image:loc><image:title>Prolonged KRAS-MAPK inhibition activates interferon signaling to promote cellular plasticity and uncover novel targets for combination therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1795</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1795.jpg</image:loc><image:title>Synergistic co-targeting of KRAS G12V and pan-TEAD by an EGFR-directed, inverted chimeric RNAi molecule</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1796</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1796.jpg</image:loc><image:title>Pre-treatment with azacytidine sensitizes RAS mutated secondary AML to the pan-RAS inhibitor RMC-7977</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1797</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1797.jpg</image:loc><image:title>Acquired resistance to Tri-complex inhibitors in colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1798</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1798.jpg</image:loc><image:title>Cotargeting B-Raf and ACLY in Ras mutant cells leads to synergistic loss of cell viability and apoptosis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1799</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1799.jpg</image:loc><image:title>Characterization of intrinsic and acquired resistance to KRAS G12C inhibitors across a broad collection of cancer cell line models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1800</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1800.jpg</image:loc><image:title>Deconstructing the paradigm of oncogene cooperation: Targeting MYC to enhance response and overcome resistance to KRAS inhibitors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1801</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1801.jpg</image:loc><image:title>Understanding evolutionary and ecological mechanisms of sotorasib resistance in KRAS G12C-mutant non-small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1802</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1802.jpg</image:loc><image:title>Generation of daraxonrasib-resistant patient-derived xenograft models of pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1803</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1803.jpg</image:loc><image:title>Predicting resistance mechanisms in pancreatic cancer organoids under KRAS G12D inhibition via pooled CRISPR-Cas9 druggable library screen</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1804</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1804.jpg</image:loc><image:title>Molecular determinants of sensitivity and resistance to the pan-RAS(ON) inhibitor daraxonrasib(RMC-6236) across KRAS-mutant patient-derived models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1805</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1805.jpg</image:loc><image:title>USP7 inhibitor synergistically enhanced the anticancer effect of the KRAS G12C inhibitor by effectively countering feedback signaling pathways&amp;#8203;</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1806</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1806.jpg</image:loc><image:title>Ligand links EGFR reactivation to resistance against KRAS G12C inhibitors in NSCLC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1807</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1807.jpg</image:loc><image:title>Real-time dissection of SCLC emergence in a KRAS G12C LUAD tumour: A case study of targeted therapy resistance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1808</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1808.jpg</image:loc><image:title>Unveiling mechanisms of MRTX1133 resistance in PDAC models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1809</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1809.jpg</image:loc><image:title>Elucidation and therapeutic strategies to overcome intrinsic resistance mechanisms in KRAS G12D-mutant tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1810</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1810.jpg</image:loc><image:title>Targeting ribonucleotide reductase to overcome FLT3 inhibitor resistance in acute myeloid leukemia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1811</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1811.jpg</image:loc><image:title>Minnelide enhances the antitumor activity of pan-KRAS inhibitor RMC-6236 in preclinical models for pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1812</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1812.jpg</image:loc><image:title>Expanding the therapeutic potential of TXNRD inhibitors for triple-negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1813</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1813.jpg</image:loc><image:title>Synergistic anticancer activity of ciclopirox and prexasertib in non-small cell lung cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1814</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1815</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1815.jpg</image:loc><image:title>Alnodesertib (ART0380) in combination with irinotecan is highly efficacious in preclinical models of ATM null pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1816</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1816.jpg</image:loc><image:title>Deciphering the molecular links between DNA damage response and autophagy in cancer: Implications for chemotherapy resistance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1817</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1817.jpg</image:loc><image:title>Quantitative helicase and polymerase assays to accelerate DNA damage repair targeted drug development</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1818</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1818.jpg</image:loc><image:title>Nanoparticle co-delivery of microtubule inhibitors and cisplatin overcomes DNA repair-mediated resistance in head and neck cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1819</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1819.jpg</image:loc><image:title>A novel brain-penetrant dual ATR-mTOR inhibitor for PTEN-deficient cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1820</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1821</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1821.jpg</image:loc><image:title>Dual inhibition of TREX1 and polymerase theta uncovers a synergistic DNA repair vulnerability in BRCA-deficient tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1822</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1823</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1823.jpg</image:loc><image:title>FORX-428: Exploiting PARG inhibition to target replication stress in cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1824</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1824.jpg</image:loc><image:title>Modeling response to alkylating chemotherapy in a syngeneic model of MGMT overexpression and MMR-deficient glioma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1825</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1825.jpg</image:loc><image:title>Building an integrated platform for drug discovery in DNA damage response</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1826</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1826.jpg</image:loc><image:title>Deletion of the DACH1 gene tumor suppressor increases replication fork stress, epithelial mesenchymal transition and sensitivity to WEE1 kinase inhibitors in prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1827</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1827.jpg</image:loc><image:title>APOBEC3B enhances PARP inhibitor response by suppressing ovarian cancer stem cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1828</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1828.jpg</image:loc><image:title>A sensitive MSD-ECL platform for in vivo pharmacokinetic profiling of ADCs</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1829</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1829.jpg</image:loc><image:title>An integrated DMPK and bioanalytical platform for comprehensive characterization of antibody-drug conjugates (ADCs)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1830</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1831</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1831.jpg</image:loc><image:title>ACSL4 mediated ferroptosis and its potential role in enhancing the efficacy of antibody-drug conjugates</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1832</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1832.jpg</image:loc><image:title>Overcoming resistance with OBI-902: Preclinical evaluation of a next-generation TROP2 ADC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1833</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1834</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1835</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1836</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1837</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1838</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1838.jpg</image:loc><image:title>ORM-1153: A Next-Generation CD123-Targeting Degrader Antibody Conjugate (DAC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1839</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1839.jpg</image:loc><image:title>QSP modeling to inform dose and regimen selection for TAK-280: A bi-specific antibody</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1840</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1841</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1841.jpg</image:loc><image:title>Combining PRC2 inhibitors with metronomic chemotherapy: A promising therapeutic strategy for diffuse large B-cell lymphoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1842</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1843</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1843.jpg</image:loc><image:title>Treating breast cancer brain metastases in the leptomeninges through p-selectin targeted delivery of EZH2 PROTACs</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1844</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1845</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1845.jpg</image:loc><image:title>First-in-human clinical pharmacokinetic prediction of D3S-003, an orally bioavailable dual-state KRAS G12D inhibitor</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1846</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1847</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1848</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1848.jpg</image:loc><image:title>A mathematical model for fitting adjusting azacytidine in AML or SMD patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1849</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1850</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1850.jpg</image:loc><image:title>Nivolumab exposure and efficacy in metastatic melanoma patients: A real-world study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1851</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1852</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1852.jpg</image:loc><image:title>Optimal epigenetic therapies in triple-negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1853</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1853.jpg</image:loc><image:title>AI-designed immune sensor-enhanced CAR-T cells for potent solid tumor immunotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1854</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1854.jpg</image:loc><image:title>Improving BCMA-targeted CAR-T cell therapy of myeloma using TGF-beta resistance and inducible production of IL-18</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1855</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1855.jpg</image:loc><image:title>Concurrent targeting of tumors and their microenvironment using CAR-T cells specific for fibroblast activation protein alpha</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1856</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1856.jpg</image:loc><image:title>FMNL1 overexpression enhances tumor-specific TIL and CAR-T cell accumulation and therapeutic efficacy in solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1857</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1857.jpg</image:loc><image:title>Galectin-3 blockade reprograms the tumor microenvironment and improves CAR T-cell therapy in pediatric cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1858</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1858.jpg</image:loc><image:title>Collagen-binding IL-12-armored STEAP1 CAR-T cells for advanced prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1859</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1859.jpg</image:loc><image:title>Optimized CART cell therapy to remodel the tumor microenvironment and eliminate GI malignancies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1860</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1860.jpg</image:loc><image:title>Nanobody-based, DLL3-directed FAST-CAR T-cell therapy for small cell lung cancer (SCLC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1861</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1861.jpg</image:loc><image:title>Conformal external beam radiation increases B7-H3 expression in a murine model of pancreatic cancer liver metastases and promotes CAR T cell function</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1862</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1862.jpg</image:loc><image:title>AZD5851, a TGF-beta-resistant GPC3 CAR-T cell product, prolongs animal survival times in patient derived orthotopic xenograft models of medulloblastoma and atypical teratoid rhabdoid tumor</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1863</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1863.jpg</image:loc><image:title>ST6GAL1 enhanced CAR-T cells improve persistence and antitumor efficacy in DLBCL</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1864</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1864.jpg</image:loc><image:title>Comprehensive preclinical evaluation of CAR-T cell therapeutics in organoid-fibroblast co-cultures</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1865</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1865.jpg</image:loc><image:title>Obesity exacerbates cytokine release syndrome (CRS) toxicity associated with chimeric antigen receptor (CAR) T cell therapy in preclinical models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1866</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1866.jpg</image:loc><image:title>In vivo genome-wide CRISPR screens in human T cells to enhance T cell therapy for solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1867</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1867.jpg</image:loc><image:title>A universal and switchable CAR T cell therapy platform (zCART) targeting tumor antigens and the immunosuppressive microenvironment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1868</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1868.jpg</image:loc><image:title>OriC613: A novel therapeutic strategy for gastric and pancreatic cancers utilizing dual-targeting CAR-T cells against MSLN and CLDN18.2 with a favorable safety profile and potent efficacy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1869</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1869.jpg</image:loc><image:title>Preclinical evaluation of allogeneic BCMA/CD70 Dual CAR T cells for high-risk multiple myeloma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1870</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1870.jpg</image:loc><image:title>CADM1-CAR T cells targeting neuroendocrine subtypes of small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1871</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1871.jpg</image:loc><image:title>Anti GPC3 CAR T lymphocytes effectively target NSCLC, including chemoresistant stem like cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1872</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1872.jpg</image:loc><image:title>Oncostatin-M ligand-based CAR T-cell therapy targets and eliminates lung adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1873</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1874</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1874.jpg</image:loc><image:title>Development of EPHA2 car t cell therapy for solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1875</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1875.jpg</image:loc><image:title>Development of MUC4-directed CAR-T cells against chemoresistant colorectal carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1876</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1876.jpg</image:loc><image:title>ALK expression identifies a therapeutically targetable subset of Merkel cell carcinomas responsive to ALK.CAR-T cell therapy alone or in combination with ALK inhibitors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1877</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1877.jpg</image:loc><image:title>B-cell activating factor plays a critical role in CAR-T cell-associated cytokine release syndrome</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1878</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1879</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1880</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1880.jpg</image:loc><image:title>Non-clinical characteristics of BH3120, a clinical stage bispecific antibody targeting PD-L1 and 4-1BB, in combination with CD3 T cell engagers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1881</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1881.jpg</image:loc><image:title>Intratumoral biodegradable nanofluidic platform for localized multimodal immunotherapy enhances tumor eradication and immune memory</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1882</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1882.jpg</image:loc><image:title>Epigenetic induced increased chromatin accessibility of immune activation loci is associated with response to anti-PD-1 therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1883</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1883.jpg</image:loc><image:title>Combining PD-1 blockade with DLL3-targeted T cell engager potentiates antitumor efficacy in small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1884</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1884.jpg</image:loc><image:title>Combining an optimized irinotecan formulation with self-amplyfing RNA to treat an immunosuppressive lung metastasis melanoma model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1885</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1885.jpg</image:loc><image:title>Differential tumor and immune responses to anti PD-1 and DGK inhibition in patient-derived tumor spheroids reveal additive killing effect</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1886</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1886.jpg</image:loc><image:title>NK cells activated by monoclonal antibody-coated target cells enhance bispecific antibody-induced T cell proliferation, activation and cytotoxicity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1887</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1887.jpg</image:loc><image:title>PHST001 combination with standard-of-care chemotherapy enhances macrophage-mediated elimination of tumor cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1888</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1888.jpg</image:loc><image:title>Preclinical activity of ziftomenib and CAR T cell immunotherapy in KMT2A -rearranged (R) acute leukemias</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1889</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1889.jpg</image:loc><image:title>First-in-class Zalpha-domain-targeted ADAR1 p150 inhibitor demonstrates potent antitumor efficacy in high IFN syngeneic melanoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1890</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1890.jpg</image:loc><image:title>Targeting the non-canonical immune checkpoint MUC1-C enhances anti-PD-1 therapy in solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1891</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1891.jpg</image:loc><image:title>Overcoming immunosuppression in pancreatic cancer: Efficacy of polyamine blockade and anti-PD-1 combinational therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1892</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1892.jpg</image:loc><image:title>Rewiring the immune-excluded tumor microenvironment: Vactosertib/anti-PD-1/VEGF inhibitor triplet therapy reinstates antitumor immunity in CRC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1893</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1893.jpg</image:loc><image:title>Intratumoral IL-12 in combination with HDAC inhibition overcomes checkpoint-refractory tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1894</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1894.jpg</image:loc><image:title>Bortezomib enhances anti-tumor efficacy of PD-1 blockade in lung squamous cell carcinoma via innate immune activation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1895</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1896</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1896.jpg</image:loc><image:title>Genetic and pharmacologic targeting of host ATF4 sensitizes pancreatic ductal adenocarcinoma to CAR T and immune checkpoint blockade</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1897</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1897.jpg</image:loc><image:title>Reprogramming of exhausted T cells in pancreatic cancer with SBRT/IL-12 therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1898</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1898.jpg</image:loc><image:title>Synergistic antitumor effects of immune checkpoint inhibitors and targeted therapy in an orthotopic RCC mouse model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1899</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1899.jpg</image:loc><image:title>Treatment of PAX3-FOXO1 alveolar rhabdomyosarcoma with ICP34.5-armed G47&amp;#8710; oncolytic herpes simplex virus confers survival benefit when co-administered with anti-Pd1 antibody</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1900</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1900.jpg</image:loc><image:title>Preclinical assessment of EGFR and checkpoint inhibitor combination therapy in spontaneous colon cancer model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1901</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1901.jpg</image:loc><image:title>CAF-mediated cancer immunotherapy resistance can be overcome via selective inhibition of NOX1, 2 and 4</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1902</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1902.jpg</image:loc><image:title>Cocktail immunotherapy: Plant virus immunomodulator, HER2 antibody, and co-delivered IL-12 cytokine for the treatment of HER2+ cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1903</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1903.jpg</image:loc><image:title>Immune implications of dual PIKfyve and KRAS inhibition in pancreatic ductal adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1904</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1904.jpg</image:loc><image:title>Combination treatment of mertki and immunomodulatory chemotherapy results in cxcl9 positive macrophage reprogramming and anti tumor adaptive memory in triple negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1905</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1905.jpg</image:loc><image:title>Unlocking pMHC target space for next generation T cell engagers in oncology and autoimmunity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1906</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1906.jpg</image:loc><image:title>A novel and versatile Prodrug T cell engager platform with a novel candidate demonstrating potent and tumor-restricted activity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1907</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1907.jpg</image:loc><image:title>Development of a T cell engager against IGFBPL1: A novel target for small cell lung cancer and other neuroendocrine cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1908</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1908.jpg</image:loc><image:title>Novel CD3 binders enable T cell engagers with potent tumor control, limited cytokine release, and safe pairing with co-stimulation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1909</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1909.jpg</image:loc><image:title>Expanded therapeutic window of potent bispecific PD-L1:CD3 T cell engager using a novel best-in-class CD3 binder</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1910</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1910.jpg</image:loc><image:title>Novel anti-CD3 single domain antibodies for the development of T cell engager</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1911</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1911.jpg</image:loc><image:title>Discovery of CD28 targeting single domain antibodies to facilitate the development of costimulatory T cell engager</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1912</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1912.jpg</image:loc><image:title>CLSP-5282, a first-in-class T cell engager targeting KRas G12V mutant peptide presented on HLA-A*03:01</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1913</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1913.jpg</image:loc><image:title>AI-assisted development of a TCR-like T cell engager targeting MAGE-A4 against melanoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1914</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1914.jpg</image:loc><image:title>A novel pan-gamma-delta T cell engager platform for next-generation cancer therapeutics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1915</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1915.jpg</image:loc><image:title>Discovery and optimization of XTX601, a masked claudin 18.2-targeting T cell engager</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1916</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1916.jpg</image:loc><image:title>ATG-112, a novel ALPP/G x CD3 bispecific T cell engager, for the treatment of ALPP/G + solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1917</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1917.jpg</image:loc><image:title>ATG-106, a novel &amp;#8220;2+1&amp;#8221;format CDH6-targeted T-cell Engager (TCE), shows potent T cell dependent cytotoxicity and in vivo anti-tumor efficacy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1918</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1918.jpg</image:loc><image:title>The affinity-optimized bispecific T cell engager W308051 selectively kills PSMA-expressing tumor cells with limited cytokine secretion</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1919</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1919.jpg</image:loc><image:title>A novel pH dependent T cell engager platform for next generation cancer therapeutics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1920</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1920.jpg</image:loc><image:title>Logic-gated switch-DARPin T cell engager with CD2 co-stimulation for improved safety and efficacy in MSLN and EpCAM co-expressing ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1921</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1921.jpg</image:loc><image:title>VHH nanobody-masked conditionally active CDH17 T cell engager for colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1922</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1922.jpg</image:loc><image:title>A novel machine-learning derived nectin-4 x CD3 bispecific T-cell engager, LGTX-101, demonstrates high degrees of tumor selectivity and potently induces tumor regression in vivo</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1923</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1923.jpg</image:loc><image:title>DS-2243a, an HLA-A*02/NY-ESO-directed bispecific T&amp;#8209;cell engager, shows potent anti-tumor activity in preclinical models of solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1924</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1924.jpg</image:loc><image:title>A bispecific PDL1:CD3 T-cell engager potently kills intractable primary and metastatic intracranial tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1925</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1925.jpg</image:loc><image:title>An innovative approach to improve bispecific T-cell engagers for solid tumor therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1926</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1926.jpg</image:loc><image:title>Preclinical investigation of a novel tumor associated antigen, cb02, as a bispecific t-cell engager in cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1927</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1927.jpg</image:loc><image:title>Leveraging off-the-shelf T cells to enhance bispecific T cell engager therapy efficacy in patients with suboptimal T cell responses</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1928</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1928.jpg</image:loc><image:title>Preclinical characterization of DBXO-1, a multi-pMHC targeted bispecific T cell engager for major solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1929</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1929.jpg</image:loc><image:title>MAIT engagers: Avoiding Treg suppression to deliver stronger activity in solid tumors.</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1930</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1930.jpg</image:loc><image:title>A conditionally-active, dual-targeting TCE with superior tumor selectivity for the treatment of solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1931</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1931.jpg</image:loc><image:title>CBX-663, a first-in-class TCR-mimetic T-Cell Engager targeting the TERT peptide-HLA complex, mediates potent cytotoxicity in vitro and tumor inhibition in vivo in preclinical models of solid malignancies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1932</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1932.jpg</image:loc><image:title>TNF-driven paracrine killing determines the cytotoxic efficacy of Teclistamab in Myeloma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1933</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1933.jpg</image:loc><image:title>Human-cynomolgus cross-reactive CD3 nanobody-centric TCE platform enhances clinical translation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1934</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1934.jpg</image:loc><image:title>A high-throughput luciferase cancer cell panel driving DLL3-targeted TCE discovery</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1935</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1935.jpg</image:loc><image:title>Virus like particles enable targeted gene engineering and pooled CRISPR screening in primary human myeloid cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1936</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1936.jpg</image:loc><image:title>Driver and mechanism of t-cell dysfunction and immune cold microenvironment in deadly developmental tumor in infants</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1937</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1937.jpg</image:loc><image:title>Integrative functional and multi-omics profiling reveals divergent natural killer cell responses and tumor cell plasticity in breast and ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1938</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1938.jpg</image:loc><image:title>Galectin9 targeted therapy for aiming cure in oncogenic driver alterations-positive non-small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1939</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1940</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1940.jpg</image:loc><image:title>Kinetic profiling of ILC and ILTC responses during early hepatocellular carcinoma development reveals IL-15-ILC1 axis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1941</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1941.jpg</image:loc><image:title>Surgery-induced long term innate immune changes facilitate tumor progression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1942</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1943</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1944</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1944.jpg</image:loc><image:title>Spatial and molecular profiling of multinucleated giant macrophages in pancreatic ductal adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1945</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1945.jpg</image:loc><image:title>The oncometabolite D2HG reprograms macrophages to drive immunosuppression in IDH1-mutant cholangiocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1946</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1946.jpg</image:loc><image:title>microRNA-25 drives initial resistance to immune checkpoint therapy by repressing innate and humoral immunity via Syndecan3</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1947</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1947.jpg</image:loc><image:title>Age-driven changes in tumor-associated macrophages contribute to slower tumor growth in murine melanoma and breast cancer models.</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1948</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1948.jpg</image:loc><image:title>Mitochondrial enzyme A promotes macrophage-dependent antitumor responses in colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1949</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1949.jpg</image:loc><image:title>Cyproheptadine and its derivatives inhibit tumor growth by eliciting NK cell-mediated anti-tumor responses in bladder cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1950</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1950.jpg</image:loc><image:title>Combining DNA methylation inhibition and STING agonist in the treatment of metastatic triple-negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1951</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1951.jpg</image:loc><image:title>A spontaneous arthritis mouse model driven by TNF-alpha overexpression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1952</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1952.jpg</image:loc><image:title>Preclinical efficacy of a bispecific NK cell engager studied using a humanized multiple myeloma mouse model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1953</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1953.jpg</image:loc><image:title>Improved humanization of peripheral blood mononuclear cells in NSG-SGM3xIl15xDKO (SDKO) over that of NSG-MHC I/II DKO mice for immuno-oncology modeling</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1954</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1954.jpg</image:loc><image:title>A novel preclinical tool to unlock the potential of IL-18 in cancer immunotherapy: genO-hIL-18-hIL-18R mice</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1955</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1955.jpg</image:loc><image:title>Quaking regulates macrophage MHC II-mediated antigen presentation and immune function in glioblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1956</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1956.jpg</image:loc><image:title>Opposing control of MHC-II antigen presentation by FAK and PYK2: Implications for therapeutic intervention</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1957</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1957.jpg</image:loc><image:title>PTEN-L/CD68 axis regulates diet-induced obesity, monocyte-to-macrophage polarization, and signaling via IL-4 and AKT pathways</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1958</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1958.jpg</image:loc><image:title>Motif neoepitopes demonstrate immunogenic signal in CCL21-gene modified dendritic cell vaccination trial (NCT03546361)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1959</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1959.jpg</image:loc><image:title>Transcriptional regulation of human NK cells: TAL1 as a modulator</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1960</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1960.jpg</image:loc><image:title>Inhibiting CDK9/13 decreases progression of multiple myeloma and myeloma-induced bone disease in preclinical studies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1961</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1961.jpg</image:loc><image:title>Proteome-wide target engagement and selectivity profiling of CDK2 inhibitors using CETSA&amp;#174;</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1962</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1962.jpg</image:loc><image:title>Distinct metabolic adaptations to resistance to CDK4/6 inhibitors in ER+ breast cancer identified using microfluidic mass spectrometry platform</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1963</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1963.jpg</image:loc><image:title>&amp;#8216;Translating&#039; CDK9 inhibitor effects to target prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1964</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1964.jpg</image:loc><image:title>Targeting RB-deficient small cell lung cancer with selective CDK2 inhibition by AZD8421</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1965</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1965.jpg</image:loc><image:title>Thymidine kinase activity as a translational biomarker to support dose optimization in oncology drug development and a tool for monitoring patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1966</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1966.jpg</image:loc><image:title>PTEN loss of function encodes sensitivity to multitargeted small molecule CDK4/6-CDK9-AURKA/B inhibitor, LCI133, and other CDK9 inhibitors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1967</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1967.jpg</image:loc><image:title>Mechanisms of sensitivity and resistance to CDK2 inhibitors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1968</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1968.jpg</image:loc><image:title>Comparative biochemical evaluation of small-molecule inhibitor efficacy on CDK/Cyclin complexes across diverse mammalian species</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1969</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1969.jpg</image:loc><image:title>Targeting autophagy and the cell cycle in mesothelioma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1970</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1971</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1971.jpg</image:loc><image:title>Discovery of ABK-CDK4, a selective and brain-penetrant CDK4 inhibitor</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1972</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1972.jpg</image:loc><image:title>Novel treatment: CDK11 inhibition in rhabdoid tumor of the kidney</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1973</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1973.jpg</image:loc><image:title>CDK2 controls RIPK2 ubiquitination and stability in prostate cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1974</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1974.jpg</image:loc><image:title>Activity of dual BET and CDK9 inhibition in murine models of pancreatic ductal adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1975</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1976</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1976.jpg</image:loc><image:title>GDC-4198, a next-generation CDK4/2 inhibitor, induces durable cell cycle arrest and shows combination benefit with giredestrant</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1977</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1977.jpg</image:loc><image:title>Targeting PLK1 or WEE1 uncovers a therapeutic vulnerability in BRCA1/2 wild-type, homologous recombination-proficient high-grade serous ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1978</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1978.jpg</image:loc><image:title>Extrachromosomal DNA (ecDNA)-mediated replication stress as a potential targetable vulnerability in high-risk medulloblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1979</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1979.jpg</image:loc><image:title>KMT2D deficiency alters CDK-cyclin regulation of Rb in endometrial cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1980</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1980.jpg</image:loc><image:title>Sequential inhibition of CDK4/6 and the mitotic kinase TTK as a potential treatment in triple-negative breast cancer cell lines</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1981</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1981.jpg</image:loc><image:title>Serpine2 promotes melanoma progression through the modulation of the DDX3X/MITF/p21 signaling pathway</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1982</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1982.jpg</image:loc><image:title>Identifying changes in cell cycle regulatory proteins during clobetasol-induced quiescence in UMSCV-4 vulvar cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1983</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1983.jpg</image:loc><image:title>CRISPR screening in human iPSC-derived glioblastoma models reveals RNA-binding protein dependencies associated with TERT promoter mutation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1984</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1984.jpg</image:loc><image:title>Longer leukocyte telomeres and specific alleles of telomere maintenance genes are independently associated with improved survival of colon cancer patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1985</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1985.jpg</image:loc><image:title>Resolving telomere length dynamics in breast cancer evolution through single-cell DNA sequencing</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1986</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1987</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1988</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1988.jpg</image:loc><image:title>De novo enhancer formation at human-viral junctions drives hybrid extrachromosomal DNA amplification in HPV-associated cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1989</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1990</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1990.jpg</image:loc><image:title>Epigenetic CRISPR screen identifies chromatin regulators essential for ovarian cancer spheroid formation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1991</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1991.jpg</image:loc><image:title>SMARCB1-Mediated chromatin remodeling underlies sex differences in gliomagenesis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1992</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1992.jpg</image:loc><image:title>Stag2-cohesin mediates 3d genome dynamics to regulate MYCN driven oncogenic transcriptome in neuroblastoma.</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1993</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1993.jpg</image:loc><image:title>Unveiling ecDNA spatial organization and epigenetic landscapes through long-read multi-omic sequencing and high-content microscopy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1994</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1994.jpg</image:loc><image:title>TIP-ChIP: Tagmented, indexed and pooled ChIP-seq to generate high-throughput, multi-sample results for low input samples</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1995</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1996</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1996.jpg</image:loc><image:title>The relationships between the stability of the +1 nucleosome and DNA superhelicity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1997</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1997.jpg</image:loc><image:title>Druggable dependency on histone demethylase LSD1 in MITF-low therapy resistant melanoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1998</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1998.jpg</image:loc><image:title>FOXK2&amp;#8314; malignant epithelial cells promote platinum resistance via KANSL1-MOF-mediated redox sustaining mechanism in ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/1999</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/1999.jpg</image:loc><image:title>Epigenetic regulation of histone lysine demethylase 4B on cancer therapy in tamoxifen-sensitive and -resistant breast cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2000</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2000.jpg</image:loc><image:title>Oncogenic NSD2 drives Eph-ephrin signaling between myeloma and bone marrow stromal cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2001</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2001.jpg</image:loc><image:title>Dissecting the function of NSD1 in intestinal epithelium and inflammation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2002</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2002.jpg</image:loc><image:title>KMT2D loss drives gastric cancer tumorigenesis through an RCOR3-dependent mechanism</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2003</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2003.jpg</image:loc><image:title>MIRAGE: A ctDNA methylation-driven computational algorithm designed for sensitive detection of minimal residual disease</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2004</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2005</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2005.jpg</image:loc><image:title>Hypermethylation of Sox21 masks its oncogenic role in glioblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2006</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2006.jpg</image:loc><image:title>Epigenetic silencing of ESR1 in primary breast tumors from young women compared to those from older women: An integrative methylation and expression analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2007</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2007.jpg</image:loc><image:title>Clonal expansion of leukocytes harboring mosaic chromosomal alterations accelerates epigenetic aging and reshapes local DNA methylation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2008</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2008.jpg</image:loc><image:title>Integrated transcriptomic and epigenomic analysis to study the mechanism by which smoke-induced hypomethylation of cg05575921 increases lung cancer risk</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2009</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2009.jpg</image:loc><image:title>Non-destructive methylation sequencing enables concurrent detection of genetic and epigenetic variation in FFPE and cfDNA samples</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2010</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2010.jpg</image:loc><image:title>Novel mouse models enabling locus-specific manipulation of DNA methylation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2011</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2012</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2012.jpg</image:loc><image:title>Spatial and single-cell DNA methylation analysis of primary breast cancer reveals lineage independent epigenetic plasticity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2013</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2013.jpg</image:loc><image:title>Early-life gut microbiota programs intestinal stem cell epigenetics to protect against colon cancer later in life</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2014</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2014.jpg</image:loc><image:title>Efficacy of DNA methyltransferase inhibition in combination with immune-checkpoint/PARP-inhibitor in colorectal cancer preclinical model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2015</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2015.jpg</image:loc><image:title>DNA methylation differentiates early-stage lung adenocarcinoma cells-of-origin with distinct smoking history and grade</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2016</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2016.jpg</image:loc><image:title>Targeting UHRF1-SUV39H1/H2 crosstalk enhances DNMT1 inhibitor efficacy in colon cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2017</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2017.jpg</image:loc><image:title>The potential of methylated DNA markers for accurate detection of high-risk, HPV-positive cervical lesions</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2018</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2018.jpg</image:loc><image:title>The stability of epigenetic cell identity in cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2019</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2019.jpg</image:loc><image:title>DNA methylation signatures associated with tumor location in early-onset colorectal cancer identified across two independent cohorts</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2020</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2020.jpg</image:loc><image:title>Epigenetic remodeling of BCOR-PRC1.1 complex dictates response and resistance to IDH inhibitors in AML</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2021</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2021.jpg</image:loc><image:title>The landscape of epigenetic alterations in the prostate cancer patient cohort from India</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2022</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2022.jpg</image:loc><image:title>Age-related p16 epimutation is a targetable driver of Kras -mutant lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2023</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2023.jpg</image:loc><image:title>Conserved endothelial cell-specific DNA methylation alterations in colorectal and breast tumor microenvironments</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2024</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2024.jpg</image:loc><image:title>Vitamin C delays mouse embryonic cells immortalization by maintaining enhancer hypomethylation of senescence-related genes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2025</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2025.jpg</image:loc><image:title>Methylation-based classification of circulating tumor DNA using enzymatic methyl-seq in a pan-cancer clinical cohort</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2026</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2026.jpg</image:loc><image:title>Epigenetic reprogramming via DNMT1 inhibition reduces invasion and migration in docetaxel-resistant prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2027</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2027.jpg</image:loc><image:title>Hypomethylating activity of zebularine suppresses migration in docetaxel-resistant prostate cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2028</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2028.jpg</image:loc><image:title>Epigenetic modulation with 5-Azacytidine reduces aggressive phenotypes in 3D spheroid models of docetaxel-resistant prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2029</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2029.jpg</image:loc><image:title>Distinct genome wide DNA methylation signatures due to pathogenic germline variants in DKC1 , TERC , and TINF2</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2030</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2030.jpg</image:loc><image:title>Genomic drivers of plasticity in transformed small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2031</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2031.jpg</image:loc><image:title>Pathogenic germline KEAP1 variants drive constitutive NRF2 hyperactivation and enhanced oncogenic fitness in non small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2032</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2032.jpg</image:loc><image:title>Whole-genome sequencing of &gt;8,000 TCGA samples reveals diverse and atypical spectra of homologous recombination deficiency in primary human cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2033</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2033.jpg</image:loc><image:title>Copy number analysis of regulatory regions reveal recurrent promoter/enhancer somatic copy number alterations across &gt;8,000 TCGA samples</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2034</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2034.jpg</image:loc><image:title>Genomic profiling of 1,104 consecutive, prospective meningiomas defines the population prevalence of molecular alterations and elucidates potential biomarkers of treatment response</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2035</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2035.jpg</image:loc><image:title>Pan-cancer LINE-1 retrotransposition landscapes in TCGA whole-genome sequences</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2036</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2036.jpg</image:loc><image:title>Absence of somatic copy number alterations in non-neoplastic prostate epithelium</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2037</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2037.jpg</image:loc><image:title>Genomic analyses of patient-derived xenografts reveal novel molecular subsets of PDAC and their association with clinical features</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2038</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2039</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2039.jpg</image:loc><image:title>The pan-cancer landscape of chromosome Y alterations</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2040</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2040.jpg</image:loc><image:title>Human and viral whole genome sequencing identify HPV and APOBEC as oncogenic drivers in sinonasal squamous cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2041</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2041.jpg</image:loc><image:title>Systematic discovery and classification of structural variant drivers across &gt;8,000 TCGA whole genomes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2042</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2042.jpg</image:loc><image:title>Pan-cancer PCR-free whole-genome sequencing refines the somatic driver landscape beyond exome sequencing alone</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2043</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2043.jpg</image:loc><image:title>Germline predisposition in The Cancer Genome Atlas (TCGA) whole-genome sequencing datasets</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2044</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2044.jpg</image:loc><image:title>Delineating genomic instability dynamics in breast cancer by bulk and single-cell whole genome sequencing</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2045</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2045.jpg</image:loc><image:title>Real-world landscape of KMT2A and NPM1 variants and fusions in hematologic malignancies (2020-2025)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2046</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2046.jpg</image:loc><image:title>Integrative multi-omic analysis reveals subtype-specific impact of extrachromosomal DNA in melanoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2047</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2047.jpg</image:loc><image:title>Clinicogenomic landscape of IPMN-derived pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2048</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2048.jpg</image:loc><image:title>Base editing for systematic reclassification of variants of unknown significance in NF1</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2049</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2049.jpg</image:loc><image:title>Integrative single-nuclei spatial transcriptomic profiling of primary and recurrent human glioblastoma reveals cell-specific EGFRvIII expression and ANXA1 signaling axis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2050</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2050.jpg</image:loc><image:title>Minerva: High-Resolution Allele-Specific Copy Number and Complex SV Harmonization with Long Reads</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2051</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2051.jpg</image:loc><image:title>Founder Wnt alterations guide the evolutionary trajectories of colorectal tumorigenesis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2052</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2052.jpg</image:loc><image:title>A spontaneous CTNNB1 driver mutation reversion in a primary ovarian clear cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2053</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2053.jpg</image:loc><image:title>Discovery of coding and non-coding driver mutations across &gt;8,000 TCGA whole genomes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2054</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2054.jpg</image:loc><image:title>The landscape of X chromosome copy number alterations in cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2055</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2055.jpg</image:loc><image:title>Comprehensive genomic profiling of angiosarcoma cells reveals widespread activation of the RAS pathway</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2056</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2056.jpg</image:loc><image:title>Interrogating the genomic co-evolution of the immune system and cancer along the time and treatment continuum</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2057</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2057.jpg</image:loc><image:title>Fasting induces ferroptosis by modulating lipid metabolism in breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2058</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2058.jpg</image:loc><image:title>Targeting metabolic vulnerabilities in basal-like breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2059</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2059.jpg</image:loc><image:title>Ovarian cancer drives mitochondrial dysfunction via WT1 in tumor associated stroma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2060</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2061</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2062</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2062.jpg</image:loc><image:title>Mitochondrial protein translation supports metabolic rewiring of chemo-refractory triple negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2063</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2063.jpg</image:loc><image:title>Metabolic adaptations of obesity-accelerated breast cancer.</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2064</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2064.jpg</image:loc><image:title>Beta-hydroxybutyrate alters one-carbon and branched-chain amino acid metabolism in glucose-restricted ER+ breast cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2065</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2065.jpg</image:loc><image:title>Metabolic and inflammatory crosstalk underlying cancer-related fatigue (CRF) in a mouse model of breast cancer (BC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2066</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2067</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2067.jpg</image:loc><image:title>Investigating the role of Wnt/planar cell polarity signaling in the reprogramming of energy metabolism in breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2068</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2069</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2069.jpg</image:loc><image:title>Fatty acid metabolism supports survival in normoxia and migration upon reoxygenation in lung-metastasizing breast cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2070</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2070.jpg</image:loc><image:title>Tryptophan metabolites drive ferroptosis resistance in triple-negative breast cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2071</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2071.jpg</image:loc><image:title>Tryptophan and serine metabolic axis reveals novel therapeutic vulnerabilities in triple-negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2072</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2073</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2073.jpg</image:loc><image:title>Scd1 overexpression in cancer-associated adipocytes drives breast cancer development and metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2074</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2074.jpg</image:loc><image:title>ATP citrate lyase fuels lipid storage to support triple negative breast cancer chemoresistance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2075</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2075.jpg</image:loc><image:title>Hyperlipidemia drives tumor growth in a mouse model of obesity-accelerated breast cancer growth</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2076</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2076.jpg</image:loc><image:title>Regulation of metabolic and stress adaptation in triple-negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2077</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2078</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2078.jpg</image:loc><image:title>Reproducible serum metabolomics drives biomarker discovery in ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2079</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2080</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2080.jpg</image:loc><image:title>LSR suppresses ferroptosis through alpha-tocopherol uptake and promotes tumor growth in gynecological cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2081</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2081.jpg</image:loc><image:title>H6PD as a metabolic target of DAP5 regulating NADPH homeostasis in TNBC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2082</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2082.jpg</image:loc><image:title>Cell density drives glutamine synthesis in fibroblast-like cells in the tumor microenvironment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2083</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2083.jpg</image:loc><image:title>Post-transcriptional regulation of cancer by a metabolic pathway: modulation of HuR by the mevalonate pathway</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2084</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2084.jpg</image:loc><image:title>Engineering multiplexed NRF2 reporters to decipher single cell oscillations in real time</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2085</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2086</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2086.jpg</image:loc><image:title>A mechanosensitive RNAi machinery regulates pro-tumorigenic transformation in the colon</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2087</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2088</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2089</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2089.jpg</image:loc><image:title>Overcoming drug resistance by novel gemcitabine-modified miR-15a in colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2090</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2091</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2091.jpg</image:loc><image:title>miR-1260a promotes proliferation and migration in breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2092</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2093</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2093.jpg</image:loc><image:title>Simultaneous quantification of microRNA155 and let-7a using digital PCR</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2094</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2094.jpg</image:loc><image:title>miR-342-5p: A promising tumor suppressor in diffuse pleural mesothelioma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2095</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2095.jpg</image:loc><image:title>Developing the miR-888 cluster members as an antimiRNA therapy for aggressive prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2096</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2096.jpg</image:loc><image:title>Melatonin and estradiol action on let-7 family members in triple-negative breast cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2097</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2097.jpg</image:loc><image:title>Isoform-aware miRNA network mapping in NSCLC via computational consensus targeting and functional clustering</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2098</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2098.jpg</image:loc><image:title>Cross-species microRNA expression patterns identify potential therapeutic targets in osteosarcoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2099</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2099.jpg</image:loc><image:title>Subtype-dependent modulation of mir-655-3p by melatonin in breast cancer cell lines</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2100</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2101</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2101.jpg</image:loc><image:title>Auro-Liposome miR-195 delivery system impedes ovarian cancer progression and enhances cisplatin-sensitivity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2102</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2103</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2104</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2105</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2106</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2106.jpg</image:loc><image:title>Prognostic potential of microRNA-encoding gene signatures in gynecologic cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2107</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2107.jpg</image:loc><image:title>Non-invasive screening of gynecologic tumors using miRNAs in urinary extracellular vesicles</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2108</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2108.jpg</image:loc><image:title>PiR-60643 is a novel inhibitor of fatty acid binding protein 5 (FABP5) in lung cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2109</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2109.jpg</image:loc><image:title>Demographic and socioeconomic disparities in access to curative-intent surgery for thymic carcinoma: A population based study.</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2110</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2111</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2111.jpg</image:loc><image:title>KRAS mutations worsen overall survival (OS) in Black but not White colon cancer patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2112</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2112.jpg</image:loc><image:title>Social determinants and lifestyle factors driving colorectal cancer mortality disparities in younger Black and White patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2113</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2113.jpg</image:loc><image:title>Determinants of clinical outcomes: A pooled analysis of 71 phase I clinical trials evaluating metastatic colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2114</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2114.jpg</image:loc><image:title>American Indian and Alaska Native community perspectives on HPV vaccination: Insights from providers and parents in a shared tribal clinic setting</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2115</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2115.jpg</image:loc><image:title>Outcomes after introduction of cervical cancer screening in an opioid treatment program (OTP) by offering HPV self-collect testing to an under-screened population</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2116</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2116.jpg</image:loc><image:title>Uncovering cervical cancer screening disparities among Asian American subgroups in California</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2117</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2117.jpg</image:loc><image:title>Barriers to mammography screening among US women aged 40 and older: Disparities by race, region, and age</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2118</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2118.jpg</image:loc><image:title>Neighborhood and language influences on mammography receipt among latinas in community health centers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2119</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2119.jpg</image:loc><image:title>Stress-responsive immune microenvironment in triple-negative breast cancer among African American women</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2120</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2120.jpg</image:loc><image:title>Heavy-metal exposure and cancer incidence in Puerto Rico</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2121</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2121.jpg</image:loc><image:title>Cancer of unknown primary (CUP) mortality as a surrogate for imaging inequity in the United States (1999-2023)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2122</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2122.jpg</image:loc><image:title>Increased stromal ERV methylation in African American compared to European American prostate cancer patients: Enrichment on chromosome 19</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2123</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2123.jpg</image:loc><image:title>Apolipoprotein E gene &amp;#38; PSA levels in Black men</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2124</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2125</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2125.jpg</image:loc><image:title>Achieving prostate cancer equity globally: Multinational advances from the iCCaRE consortium</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2126</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2126.jpg</image:loc><image:title>The stress survival gene CCNB1 drives colorectal cancer progression and represents a novel target to address ethnic disparities</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2127</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2127.jpg</image:loc><image:title>Demographic representation in randomized controlled trials of colorectal polyp prevention: A systematic review and meta-analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2128</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2128.jpg</image:loc><image:title>Examining structural and social drivers of hepatitis B vaccination across diverse clinical settings</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2129</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2129.jpg</image:loc><image:title>Evaluating ABCC1 as a potential prognostic biomarker in laryngeal cancer health outcomes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2130</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2130.jpg</image:loc><image:title>Colorectal cancer equity and impact (CLEAR-CRC): The colorectal cancer alliance&#039;s community-based model for advancing biomarker testing</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2131</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2131.jpg</image:loc><image:title>Racial and ethnic differences in interest in cancer screening</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2132</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2132.jpg</image:loc><image:title>Geospatial mapping of health-linked risk factors and cancer outcomes in Puerto Rico: Data from the Puerto Rico BioBank</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2133</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2133.jpg</image:loc><image:title>Understanding the reasons for declining to participate in cancer genetics and genomic studies in the United States: A scoping review</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2134</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2135</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2136</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2136.jpg</image:loc><image:title>Contribution of RalA and RalB in colorectal cancer progression and survival</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2137</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2137.jpg</image:loc><image:title>Gene polymorphisms in LEPR and PTGS2 contribute for prognostic evaluation in breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2138</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2139</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2139.jpg</image:loc><image:title>A pan-system approach for mutational signature identification and etiology assignment in cancer genomics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2140</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2141</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2142</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2142.jpg</image:loc><image:title>Natural history and biomarker discovery in gastric preneoplasia: Insights from the TUMMIE longitudinal study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2143</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2144</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2144.jpg</image:loc><image:title>Association of NMR-based metabolomics and lung cancer risk in the UK biobank</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2145</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2145.jpg</image:loc><image:title>Plasma metabolomics profiles in the progression of adverse liver conditions to liver cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2146</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2146.jpg</image:loc><image:title>Metabolomics and liver cancer risk: A systematic review of prospective studies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2147</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2148</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2149</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2150</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2150.jpg</image:loc><image:title>Variation in urinary estrogen levels according to breast parenchymal texture in postmenopausal women</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2151</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2151.jpg</image:loc><image:title>Assessing endometrial cancer etiology by histologic subgroups</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2152</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2153</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2154</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2154.jpg</image:loc><image:title>Associations of stromal markers with breast terminal duct lobular involution</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2155</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2156</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2156.jpg</image:loc><image:title>Association between widowhood and ovarian tumor gene expression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2157</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2158</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2158.jpg</image:loc><image:title>Thymic radiation and oncologic outcomes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2159</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2160</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2161</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2162</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2163</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2163.jpg</image:loc><image:title>A population-based study on thyroidectomies in Mexico from 2010 to 2023</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2164</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2164.jpg</image:loc><image:title>Rectal and sigmoid colon cancers drive rising early-onset colorectal cancer incidence in the United States</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2165</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2165.jpg</image:loc><image:title>Mapping the associations of 144 incidence risk factors with 39 cancers: An AI-driven systematic review and meta-analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2166</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2166.jpg</image:loc><image:title>Oral bacteriome and its association with cancer-specific mortality</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2167</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2167.jpg</image:loc><image:title>Cardio-kidney metabolic health among adult cancer survivors in the Hispanic Community Health Study/Study of Latinos</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2168</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2168.jpg</image:loc><image:title>African ancestry, Duffy-null genotype, and epithelial ovarian cancer in a cohort of Black women</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2169</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2170</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2171</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2172</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2172.jpg</image:loc><image:title>Cardiometabolic health and risk of breast cancer subtypes among US Black women</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2173</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2174</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2175</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2176</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2177</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2177.jpg</image:loc><image:title>Subtype-specific patterns of peripheral T-cell lymphoma in diverse Asian populations</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2178</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2178.jpg</image:loc><image:title>Population awareness of HBV, HCV, and their association with cancer in the US</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2179</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2179.jpg</image:loc><image:title>Disability patterns and subjective cognitive decline among adults with and without cancer history</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2180</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2181</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2181.jpg</image:loc><image:title>Predictors of mortality in patients with hepatobiliary and pancreatic cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2182</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2182.jpg</image:loc><image:title>The association between metabolic syndrome and cancer: A systematic review</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2183</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2184</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2185</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2186</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2187</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2188</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2188.jpg</image:loc><image:title>MELD 3.0 policy and evolving socioeconomic disparities in liver transplantation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2189</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2189.jpg</image:loc><image:title>A mixed-methods evaluation of multilevel barriers and facilitators to inform implementation strategies for advancing equitable clinical trial accrual in a large comprehensive cancer center</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2190</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2190.jpg</image:loc><image:title>Design of a prospective implementation study to evaluate the efficacy of an AI-assisted workflow intervention to increase breast cancer clinical trial participation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2191</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2191.jpg</image:loc><image:title>Effect of biopsy requirement on patient enrollment to phase I trials in cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2192</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2192.jpg</image:loc><image:title>The distribution of non-small cell lung cancer early phase clinical trial sites within and outside the United States</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2193</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2193.jpg</image:loc><image:title>Streamlining combined clinical trial and diagnostic device development: The EMA COMBINE Project Pilot</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2194</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2194.jpg</image:loc><image:title>Genomic Relational Privacy in AI Era: a scoping review</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2195</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2195.jpg</image:loc><image:title>Thematic trends in cancer research from sub-Saharan Africa: Insights from a five-year institutional dataset</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2196</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2197</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2197.jpg</image:loc><image:title>Addressing the EU IVDR challenge in targeted oncology trials</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2198</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2198.jpg</image:loc><image:title>A novel statistical framework for surrogate endpoint prediction of survival in neoadjuvant breast cancer trials</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2199</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2199.jpg</image:loc><image:title>Real world clinical outcomes with trastuzumab deruxtecan in HER2 expressing ovarian and endometrial cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2200</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2200.jpg</image:loc><image:title>Margaret Foti Foundation Prizes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2201</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2202</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2202.jpg</image:loc><image:title>High-throughput imaging approaches to characterize CAR T therapies for solid tumor microenvironments</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2203</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2203.jpg</image:loc><image:title>Hyperpolarized carbon-13 MRI for early treatment response assessment in pancreatic ductal adenocarcinoma patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2204</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2205</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2205.jpg</image:loc><image:title>Fibronectin extra-domain B-recognizing gold nanoparticles as an innovative tool for neuroblastoma targeting</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2206</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2206.jpg</image:loc><image:title>Targeting primary gastric tumors and peritoneal metastases in cell-derived xenograft mouse models using an anti-mucin-4-antibody conjugated near infrared fluorophore</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2207</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2207.jpg</image:loc><image:title>Optimized iron-carbon nanoparticles demonstrate superior; in vivo antitumor efficacy in magnetic hyperthermia treatment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2208</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2209</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2209.jpg</image:loc><image:title>In vivo short-wave infrared imaging for liquid tumor and immuno-oncology models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2210</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2210.jpg</image:loc><image:title>Development of a bioluminescence imaging-guided CTC liquid biopsy procedure to identify the optimal time window for achieving superior photothermal therapy efficacy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2211</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2211.jpg</image:loc><image:title>[ 18 F]-FMISO-PET imaging to characterize the impact of obesity on the hypoxic tumor microenvironment during immunotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2212</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2212.jpg</image:loc><image:title>Diet composition - A critical variable in fluorescence imaging for preclinical cancer research</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2213</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2213.jpg</image:loc><image:title>Progression of blood brain barrier leakage in orthotopic glioma SRG rat model using contrast enhanced MRI</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2214</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2214.jpg</image:loc><image:title>MRI radiomic features to differentiate aggressive and indolent renal tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2215</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2215.jpg</image:loc><image:title>From local growth to distant metastasis: A versatile in vivo imaging platform for modeling cancer progression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2216</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2216.jpg</image:loc><image:title>Sodium nitrite alters perfusion and hypoxia in preclinical models of breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2217</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2217.jpg</image:loc><image:title>Biophysical enhancement of radiation-activated photodynamic therapy (radioPDT) and translational brain tumor models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2218</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2218.jpg</image:loc><image:title>Innovative preclinical platform to highlight the impact of macro and microenvironment on pancreatic cancer development and therapy response</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2219</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2219.jpg</image:loc><image:title>Novel targeted therapies for malignant ascites in pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2220</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2221</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2221.jpg</image:loc><image:title>Biofield therapy inhibits pancreatic cancer invasion and metastasis by modulating multiple steps of metastatic cascade</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2222</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2222.jpg</image:loc><image:title>RIPK2 and CDK2 form a targetable positive feedback loop in prostate cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2223</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2223.jpg</image:loc><image:title>Combined treatment with agonists for CXCR4 and CB2 receptors reduces prostate cancer growth and metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2224</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2224.jpg</image:loc><image:title>Resensitizing therapy-resistant anoxic metastatic melanoma cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2225</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2225.jpg</image:loc><image:title>Investigating the combined inhibition of RAF, MEK, and FAK in melanoma molecular subtypes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2226</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2226.jpg</image:loc><image:title>Novel anticancer mechanisms of melanin: Effects on cancer cell adhesion, survival, and migration</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2227</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2227.jpg</image:loc><image:title>Antibodies that bind to primitive human growth factor NME7-AB block interaction with MUC1* growth factor receptor to inhibit cancer growth and metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2228</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2228.jpg</image:loc><image:title>Intercepting metastasis: 8-step CRISPR design via multi-modal foundation models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2229</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2229.jpg</image:loc><image:title>Evaluation of novel medicinal compounds for therapeutic efficacy against liver cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2230</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2230.jpg</image:loc><image:title>Novel MACC1 transcriptional inhibitor act via reduced NF&amp;#954;B signaling pathway to reduce metastasis formation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2231</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2231.jpg</image:loc><image:title>Anti-metastatic properties of the triterpene diosgenin on lung carcinoma cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2232</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2232.jpg</image:loc><image:title>The transcobalamin receptor, CD320, is a therapeutic target for metastatic triple negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2233</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2233.jpg</image:loc><image:title>Inhibition of STAT3 and PARP1 reduces TNBC invasion through cytoskeletal remodeling</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2234</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2234.jpg</image:loc><image:title>Galectin 1 as a regulator of hormone driven mammary remodeling and early dissemination with therapeutic potential in breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2235</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2235.jpg</image:loc><image:title>Dual TTK/PLK1 inhibition combined with G-CSF treatment synergistically suppresses metastatic progression in triple-negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2236</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2236.jpg</image:loc><image:title>Lasofoxifene is a bone protective treatment option for estrogen receptor positive breast cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2237</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2237.jpg</image:loc><image:title>Pro-metastatic kinase network inhibition to treat drug-resistant triple-negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2238</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2238.jpg</image:loc><image:title>DNMTi in combination with PARPi inhibits aberrant Wnt/beta-catenin signaling and tenasin-C pathways, cancer stemness and metastasis in triple negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2239</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2240</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2240.jpg</image:loc><image:title>Intracellular complement signaling plays a critical role in s1p/s1pr1 mediated inflammasome activation and tumor metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2241</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2241.jpg</image:loc><image:title>Inhibition of the mitochondrial antioxidant response blocks ex vivo lung colonization in pediatric osteosarcoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2242</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2243</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2243.jpg</image:loc><image:title>RNA editing based risk model to predict extrahepatic metastasis in colorectal cancer liver metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2244</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2244.jpg</image:loc><image:title>Transcriptomic insights into MAO B inhibition and bevacizumab synergy in colorectal cancer model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2245</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2245.jpg</image:loc><image:title>High-throughput and accurate intrasplenic injection in mice for metastatic cancer modeling using a robotic injection device</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2246</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2246.jpg</image:loc><image:title>Genomic landscape of melanoma brain metastases: Real-world analysis and comparison with public melanoma cohorts</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2247</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2248</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2249</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2249.jpg</image:loc><image:title>Characterizing drivers of invasiveness in basal-like triple negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2250</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2251</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2251.jpg</image:loc><image:title>Image activated cell sorting reveals distinct morpholomic manifolds in breast cancer cell lines</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2252</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2253</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2253.jpg</image:loc><image:title>Murinemodels of bone and brain metastasis for preclinical cancer research</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2254</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2254.jpg</image:loc><image:title>Development of the cf-MMSP assay for enhanced detection of methylated cfDNA in breast cancer by liquid biopsy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2255</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2255.jpg</image:loc><image:title>Genomic landscape of 1007 pan-cancer brain metastases</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2256</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2256.jpg</image:loc><image:title>Single cell chromatin accessibility profiling of human metastatic tumor cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2257</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2257.jpg</image:loc><image:title>Cell surface anchored ratiometric probes for heparan sulfate enable live cell bioimaging and suppression of cancer cell migraion</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2258</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2259</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2260</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2261</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2261.jpg</image:loc><image:title>A high resolution spatial transcriptomic atlas of the bone marrow microenvironment pre and post prostate cancer seeding</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2262</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2262.jpg</image:loc><image:title>Patient-derived CSF and ascites organoids reveal divergent metastatic mechanisms in advanced gastric cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2263</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2264</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2264.jpg</image:loc><image:title>Drosophila -based screening identifies ferroptosis induction via NAD-GPx4 axis inhibition as a therapeutic strategy for PDAC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2265</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2265.jpg</image:loc><image:title>Understanding the mechanisms by which environmental arsenic elevates the risk of urothelial bladder cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2266</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2266.jpg</image:loc><image:title>The Miniature Oncopig &amp;#174; cancer model as an innovative large animal platform for preclinical pharmaceutical evaluation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2267</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2267.jpg</image:loc><image:title>Modeling olaparib resistance in prostate cancer PDXs to elucidate PARP inhibitor escape mechanisms</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2268</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2268.jpg</image:loc><image:title>Syngeneic mouse models of prostate cancer driver mutations</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2269</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2269.jpg</image:loc><image:title>Feasibility and challenges of developing PDX models of neuroendocrine cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2270</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2270.jpg</image:loc><image:title>Establishment of new preclinical tumor models for pancreatic neuroendocrine carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2271</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2271.jpg</image:loc><image:title>Paired PDX-PDXO models serve an integrated preclinical platform for high-throughput payload screening and ADC drug development</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2272</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2272.jpg</image:loc><image:title>GliomaPDOX - A direct brain-to-brain glioma xenograft library for drug discovery and development</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2273</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2274</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2275</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2275.jpg</image:loc><image:title>An integrated preclinical platform for comprehensive evaluation of T-Cell engagers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2276</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2276.jpg</image:loc><image:title>Robust in vivo CAR-T efficacy evaluation in a PBMC-reconstituted NCG-MHC-dKO model with delayed GVHD</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2277</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2277.jpg</image:loc><image:title>A novel humanized mouse model for preclinical assessment of anti-CD47 and anti-SIRP&amp;#913;therapeutics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2278</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2278.jpg</image:loc><image:title>Human IgG1-expressing mouse models for tolerance induction and reliable assessment of IgG1-based therapeutic antibodies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2279</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2280</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2280.jpg</image:loc><image:title>Maintaining blood-brain barrier integrity in translational brain tumor models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2281</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2281.jpg</image:loc><image:title>Differential expression of the Kv3.4 channel in in vitro and in vivo models of cervical cancer: Potential clinical implications</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2282</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2283</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2284</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2284.jpg</image:loc><image:title>Towards ethical and robust drug development: comprehensive validation of an animal-free matrix for in vivo tumor models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2285</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2286</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2286.jpg</image:loc><image:title>Integrating patient-derived tumor models into translational oncology and drug discovery</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2287</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2287.jpg</image:loc><image:title>Influence of transgenic MUC13 expression on gut microbiota and chemokine profile</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2288</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2289</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2289.jpg</image:loc><image:title>FABP4 functions as a novel cancer stem cell marker in triple-negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2290</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2290.jpg</image:loc><image:title>Defining cancer initiating cells and their vulnerabilities in renal cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2291</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2291.jpg</image:loc><image:title>Trem1 sustains liver cancer stemness in hepatocellular carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2292</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2293</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2293.jpg</image:loc><image:title>Direct regulation of the cancer stemness by eIF4A1 in triple-negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2294</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2295</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2295.jpg</image:loc><image:title>Metabolic control of pancreatic cancer stemness through PDK3 dependent SOX2 lactylation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2296</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2296.jpg</image:loc><image:title>Trib3 identified as a key therapeutic target for pancreatic cancer stem cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2297</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2297.jpg</image:loc><image:title>NQO1 inhibits FBXL14-dependent SNAIL degradation to promote EMT-mediated stemness in colorectal cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2298</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2299</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2299.jpg</image:loc><image:title>UPP1 promotes cisplatin-induced cancer stem cell enrichment in ovarian cancer via metabolic reprogramming</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2300</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2300.jpg</image:loc><image:title>A PLK1-OCT4 regulatory axis controls lineage plasticity and neuroendocrine differentiation in prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2301</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2302</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2303</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2304</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2304.jpg</image:loc><image:title>Targeting Bmi-1 suppresses cancer stemness and tumor growth in mucoepidermoid carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2305</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2305.jpg</image:loc><image:title>Dissecting ROBO4 function in regulating breast cancer cell plasticity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2306</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2306.jpg</image:loc><image:title>The mesenchymal state drives stemness and limits differentiation in glioblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2307</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2308</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2308.jpg</image:loc><image:title>APOBEC3C rewires RNA splicing and self-renewal in hematopoietic stem and progenitor cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2309</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2309.jpg</image:loc><image:title>PSMD2 Suppression Disrupts Autophagy Turnover and Creates an Autophagy-Dependent Vulnerability in ER+ Breast Cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2310</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2310.jpg</image:loc><image:title>ID proteins regulate IL-6 expression and cancer stem-like cell features following chemotherapy in ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2311</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2311.jpg</image:loc><image:title>Isoform-level transcriptome analysis for enriched cancer stem cells from patient-derived ovarian cancer cell lines</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2312</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2312.jpg</image:loc><image:title>Uncovering a pancreatic ductal adenocarcinoma sub-population with stemness and unique therapeutic response</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2313</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2314</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2315</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2315.jpg</image:loc><image:title>RelB drives integrin-mediated stress tolerance and relapse in high-grade serous ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2316</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2317</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2317.jpg</image:loc><image:title>STAT1 and STAT3 cooperatively control cancer stem cell (CSC) fate and IFNgamma-dependent CSC maintenance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2318</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2319</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2319.jpg</image:loc><image:title>Multimodal and multikingdom spatial transcriptomics identify bacterial niches implicated in oral cancer development</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2320</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2320.jpg</image:loc><image:title>3D multimodal spatial profiling of pre-gastric cancer progression using same-slide RNA-protein and fluorescent H&amp;#38;E</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2321</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2321.jpg</image:loc><image:title>Spatial transcriptomics reveals evolving tumor microenvironmental archetype along the lung premalignancy-adenocarcinoma continuum</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2322</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2322.jpg</image:loc><image:title>Age-related transcriptional and alternative splicing changes in lung progenitor cells predisposing to immune dysfunction</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2323</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2323.jpg</image:loc><image:title>Single-cell transcriptomic analysis of fallopian tube and ovary to define cell type and BRCA-specific markers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2324</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2324.jpg</image:loc><image:title>SLC12A2 drives a tumor-promoting microenvironment and poor prognosis in hepatocellular carcinoma by suppressing lipolysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2325</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2325.jpg</image:loc><image:title>Reprogramming of the stromal and immune microenvironment in preinvasive breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2326</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2326.jpg</image:loc><image:title>Macrophage immunometabolism as a targetable driver of early lung cancer progression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2327</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2327.jpg</image:loc><image:title>Deciphering the role of macrophages in the development of pancreatic ductal adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2328</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2328.jpg</image:loc><image:title>Cell division regulates macrophage invasion in mammary epithelia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2329</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2330</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2330.jpg</image:loc><image:title>Spatial trajectories and niche rewiring from ground&amp;#8209;glass to solid transition in lung adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2331</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2331.jpg</image:loc><image:title>Stromal cyclin D1 promotes prostate cancer stemness via the transcriptional regulatory E domain</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2332</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2332.jpg</image:loc><image:title>Unexpected role of nuclear receptor CAR in cholangiocarcinoma development</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2333</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2333.jpg</image:loc><image:title>Microenvironmental CTHRC1 has a pro-tumorigenic role in colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2334</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2334.jpg</image:loc><image:title>Elucidating the role of p21 + senescent cells in early-stage lung tumorigenesis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2335</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2335.jpg</image:loc><image:title>Two-step mechanism of plexiform neurofibroma formation: Role of the NF-&amp;#954;B pathway in neurofibroma formation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2336</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2336.jpg</image:loc><image:title>A MUC1-overexpressing epithelial population is associated with CDH1 loss-of-function gastric adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2337</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2337.jpg</image:loc><image:title>p53-null cells act as supercompetitors in gastroesophageal tumor initiation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2338</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2338.jpg</image:loc><image:title>Dichotomous immunogenetic landscape of lung adenocarcinoma associated with usual interstitial pneumonia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2339</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2339.jpg</image:loc><image:title>Obesogen co-exposure promotes triple-negative breast cancer growth via adipocyte-mediated mechanisms</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2340</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2340.jpg</image:loc><image:title>Cigarette smoke-induced sphingosine-1-phosphate drives cancer-associated fibroblasts activation and esophageal cancer carcinogenesis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2341</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2341.jpg</image:loc><image:title>Biological impact of nanoplastics on the tumor microenvironment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2342</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2343</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2344</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2344.jpg</image:loc><image:title>In vivo single-cell CRISPR screens identify targets to restore T cell function in aged tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2345</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2346</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2347</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2347.jpg</image:loc><image:title>FGFR1 drives progression of ER+ breast cancer brain metastases in young and aged hosts</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2348</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2348.jpg</image:loc><image:title>Remodeling the aged bone marrow niche: LRG1-mediated immunosuppression promotes prostate cancer metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2349</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2350</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2350.jpg</image:loc><image:title>Aging attenuates brain metastasis in lung cancer through the MT1G/NF-&amp;#954;B/SPARC signaling</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2351</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2352</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2353</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2354</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2354.jpg</image:loc><image:title>Spatial profiling reveals distinct immune microenvironments in early vs late onset colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2355</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2356</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2356.jpg</image:loc><image:title>Novel obesity-associated adipokine modulates the malignant phenotype of endometrial cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2357</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2357.jpg</image:loc><image:title>Intermittent fasting remodels gut ecosystem to influence initiation and therapy responses in pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2358</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2358.jpg</image:loc><image:title>Prostaglandin E 2 signaling promotes adverse survival outcome in B-cell acute lymphoblastic leukemia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2359</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2359.jpg</image:loc><image:title>Sex-specific IgA secretion in muscle-invasive bladder cancer: A preliminary study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2360</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2360.jpg</image:loc><image:title>Modifiable lifestyle factors and immune gene expression in breast tumor and normal-adjacent tissue</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2361</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2362</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2363</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2364</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2365</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2365.jpg</image:loc><image:title>Smoking is associated with reduced tumor-infiltrating lymphocyte density in breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2366</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2366.jpg</image:loc><image:title>Investigating the effect of SGLT2 inhibitor dapagliflozin on acute lymphoblastic leukemia in obese mice</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2367</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2367.jpg</image:loc><image:title>Fibroblast galectin-3 remodels the obese breast tumor microenvironment to promote cancer progression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2368</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2368.jpg</image:loc><image:title>CNTF governs exercise-induced myofibroblast reversion in prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2369</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2369.jpg</image:loc><image:title>Iron supplementation rescues anemia of chronic disease in pancreatic ductal adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2370</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2370.jpg</image:loc><image:title>Tertiary lymphoid structure score associates with unique immune profile and therapeutic response in triple negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2371</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2372</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2372.jpg</image:loc><image:title>Immune-active and mesenchymal endothelial programs define TLS presence in the tumor microenvironment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2373</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2373.jpg</image:loc><image:title>Tertiary lymphoid structures in colorectal cancer: Clinical significance and their interaction with CAFs and the immune microenvironment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2374</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2374.jpg</image:loc><image:title>CXCL13 secretion and immobilization show distinct geographies within secondary and tertiary lymphoid structures (TLS)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2375</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2375.jpg</image:loc><image:title>A spatially resolved multi-omics atlas of tertiary lymphoid structures in ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2376</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2376.jpg</image:loc><image:title>Tumor-associated CD207 + cDC2 drives TLS formation via TNF family cytokines in non-small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2377</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2377.jpg</image:loc><image:title>Mapping lymphoid responses to tumor growth and lymph node metastasis: multiomic spatial analysis of pancreatic ductal adenocarcinoma reveals tertiary lymph node structures</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2378</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2379</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2380</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2381</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2381.jpg</image:loc><image:title>Mechanisms of acquired resistance following dual EGFR/MET inhibition in MET-amplified EGFR TKI-resistant lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2382</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2383</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2384</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2385</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2386</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2387</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2388</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2388.jpg</image:loc><image:title>Decoding metastasis and therapy resistance in sarcomatoid bladder cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2389</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2389.jpg</image:loc><image:title>SIRT5 induces a metabolic switch to fuel nucleotide pools and chemoresistance in triple-negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2390</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2390.jpg</image:loc><image:title>Fluorinated cuban-1-yl biguanides overcome hormone therapy resistance to standard of care fulvestrant, and palbociclib</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2391</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2392</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2392.jpg</image:loc><image:title>Targeting galectin-1 overcomes paclitaxel resistance in esophageal squamous cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2393</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2394</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2395</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2396</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2397</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2398</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2399</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2400</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2400.jpg</image:loc><image:title>Ecological shifts and microbiome reorganization across oral precancer-cancer spectrum</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2401</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2402</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2402.jpg</image:loc><image:title>Performance of longitudinal cancer screening in Li-Fraumeni syndrome</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2403</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2404</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2405</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2405.jpg</image:loc><image:title>Evaluation of new oral cancer model using novel CT-based soft tissue imaging</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2406</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2407</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2407.jpg</image:loc><image:title>Case-control study of melatonin metabolite excretion and colorectal adenoma formation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2408</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2408.jpg</image:loc><image:title>Proteomic signatures of doxorubicin-induced lymphatic dysfunction in tumor-bearing rats</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2409</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2409.jpg</image:loc><image:title>Can dietary calcium prevent myeloma onset?</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2410</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2410.jpg</image:loc><image:title>Early macrophage reprogramming drives BRCA1 associated breast cancer initiation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2411</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2411.jpg</image:loc><image:title>MRD Express: Rapid, scalable, and high-performance custom target enrichment for minimal residual disease monitoring</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2412</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2412.jpg</image:loc><image:title>Age-dependent matrisome remodeling in young breast adipose tissue identifies a potential mechanism of tumor aggressiveness</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2413</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2414</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2414.jpg</image:loc><image:title>DPYSL2 mediates extracellular vesicle-driven reprogramming of the glioblastoma tumor microenvironment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2415</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2415.jpg</image:loc><image:title>Single-cell and spatially resolved transcriptomics identifies clinically targetable myeloid niches in fibrolamellar carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2416</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2416.jpg</image:loc><image:title>A prospective immunological analysis of head and neck squamous cell carcinoma in humans</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2417</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2417.jpg</image:loc><image:title>Intra-pancreatic adipocytes promote pancreatic cancer progression by inhibiting tumor immunity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2418</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2419</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2419.jpg</image:loc><image:title>Protein engineering of selective MMP-9 inhibitors reveals a therapeutic strategy for triple-negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2420</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2420.jpg</image:loc><image:title>Cabozantinib remodels the pancreatic tumor microenvironment to potentiate immunotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2421</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2421.jpg</image:loc><image:title>Elucidating the impact of the immune microenvironment on the evolutionary dynamics of early-stage ovarian clear cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2422</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2422.jpg</image:loc><image:title>High-resolution spatial transcriptomics identifies unique spatial programs in lung adenocarcinoma from never smokers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2423</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2423.jpg</image:loc><image:title>Spatial transcriptomics identifies distinct molecular and immune pathways in endometrial cancer in African American women</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2424</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2424.jpg</image:loc><image:title>Spatial programs of cancer-associated and normal fibroblasts diverges with mismatch repair status in colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2425</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2425.jpg</image:loc><image:title>Cross-validated spatial architecture of tissue-resident memory T-cells predicts recurrence pattern in nasopharyngeal carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2426</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2426.jpg</image:loc><image:title>Development of breast adipose-cancer co-culture model to decipher the impact of lipid heterogeneity on triple-negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2427</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2427.jpg</image:loc><image:title>Targeting eRNA-producing super-enhancers converts undruggable regulatory hubs into therapeutic targets in cancer-associated fibroblasts</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2428</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2428.jpg</image:loc><image:title>Osteosclerosis is associated to low anaplastic histological patterns in prostate cancer bone metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2429</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2429.jpg</image:loc><image:title>Collagen remodeling promotes a GPCR-mediated mechanosensory immune checkpoint in ADGRG1+ CD8+ T cells and serves as a spatial biomarker of response to immunotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2430</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2430.jpg</image:loc><image:title>Neoadjuvant androgen signaling inhibition promotes the emergence of mixed basal/club-like cancer identity cells in prostate cancer tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2431</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2432</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2432.jpg</image:loc><image:title>Patterns of lung cancer clinical trials in Latin America and their implications for patient treatment access and research equity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2433</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2433.jpg</image:loc><image:title>Transforming cancer care together: A regional collaborative model to strengthen oncology systems</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2434</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2434.jpg</image:loc><image:title>Patient engagement in research: Lessons from the ASH Research Collaborative Patient Collaboration Team</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2435</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2435.jpg</image:loc><image:title>Backfilling in early-phase oncology trials: A patient perspective on dose-finding innovation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2436</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2436.jpg</image:loc><image:title>Analysis of trends in pancreatic cancer clinical trials and barriers to clinical trial enrollment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2437</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2437.jpg</image:loc><image:title>Meeting people where they are: Feasibility and acceptability of an integrated cancer screening program for NYCHA residents</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2438</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2438.jpg</image:loc><image:title>Lung cancer biomarker testing: Driving precision treatment and improved outcomes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2439</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2439.jpg</image:loc><image:title>Patient perceptions of mammographic compression: Empowering women to improve mammography outcomes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2440</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2440.jpg</image:loc><image:title>Early detection is power</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2441</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2441.jpg</image:loc><image:title>Tenacious at such a time as this</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2442</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2442.jpg</image:loc><image:title>Beyond informed consent: A social work framework for authentic shared decision-making across the cancer survivorship continuum</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2443</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2443.jpg</image:loc><image:title>Community-driven innovation to address breast cancer disparities: The AfroPink Pink Pop-Up Model and the launch of TechPink</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2444</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2444.jpg</image:loc><image:title>The positive impact of one-to-one peer support on AYA cancer patients and survivors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2445</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2445.jpg</image:loc><image:title>Concept to impact: Creating a research-driven, patient informed research program</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2446</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2446.jpg</image:loc><image:title>Pelotonia from community to discovery: How grassroots philanthropy amplifies Ohio State&#039;s cancer research capacity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2447</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2447.jpg</image:loc><image:title>Care and treatment of the LGBTQ+ community in the present hostile political environment?</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2448</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2448.jpg</image:loc><image:title>Ethics and access in pediatric CAR T-cell therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2449</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2449.jpg</image:loc><image:title>Survivorship and peer support: Outcomes from youth leadership initiatives</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2450</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2450.jpg</image:loc><image:title>From survivor to partner: integrating patient voice across the cancer research continuum</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2451</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2451.jpg</image:loc><image:title>Man Up to Cancer to men facing cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2452</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2452.jpg</image:loc><image:title>&quot;What&#039;s that?&quot; The question that saved my life and fueled &quot;The Big See,&quot; a multi-media skin cancer awareness campaign (launched in 2019-present)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2453</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2453.jpg</image:loc><image:title>The culture of cancer: Breaking down barriers to research</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2454</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2454.jpg</image:loc><image:title>Embedding cancer advocates as structural partners in oncology conferences: A scalable implementation model based on RISE UP for Breast Cancer and Women&#039;s Health Conference</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2455</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2455.jpg</image:loc><image:title>How digital spacial profiling is changing the fight against lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2456</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2456.jpg</image:loc><image:title>Thriving in the grey: A patient needs model to balance science and reality</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2457</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2457.jpg</image:loc><image:title>Henrietta Lacks House social determinants of health</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2458</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2459</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2459.jpg</image:loc><image:title>HEALing The Bronx: A grassroots model for cancer education, health equity, and community engagement through art and literacy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2460</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2460.jpg</image:loc><image:title>Lo que no se ve: Indigenous-centered cancer prevention and survivorship equity in California</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2461</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2461.jpg</image:loc><image:title>Bridging gaps in KRAS&amp;#8209;mutant lung cancer care: A patient perspective on clinical trial access and community support</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2462</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2462.jpg</image:loc><image:title>Accelerating gastric cancer research: Programs of the Gastric Cancer Foundation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2463</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2463.jpg</image:loc><image:title>Quantifying patient priorities: Identifying and weighing key non-clinical factors for scalp cooling decision-making in chemotherapy-induced alopecia prevention</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2464</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2464.jpg</image:loc><image:title>Bridging the communication gap in pancreatic cancer: A stage IV PDAC survivor&#039;s perspective on improving research and biotech communication of innovation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2465</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2465.jpg</image:loc><image:title>What survivors really need: A patient-centered model for supporting breast cancer patients through education, advocacy, and community connection</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2466</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2466.jpg</image:loc><image:title>Paths to research advocacy: Webinar education</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2467</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2467.jpg</image:loc><image:title>From silence to science: Survivor advocacy and community partnership to advance equity in cancer research</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2468</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2468.jpg</image:loc><image:title>Timely diagnosis and treatment of childhood and adolescent cancer: Challenges and opportunities</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2469</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2469.jpg</image:loc><image:title>ROS1-positive lung cancer treatment access gap across Canada - A call for equitable, patient-centered care</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2470</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2470.jpg</image:loc><image:title>Addressing gaps in colorectal cancer care: Real-world impact of a national clinical navigation program</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2471</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2471.jpg</image:loc><image:title>Disparities in access to precision oncology drugs across Canada and between Canada and the US, 2009-2025</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2472</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2472.jpg</image:loc><image:title>Subtyping cancer cachexia through automated body composition</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2473</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2474</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2474.jpg</image:loc><image:title>A multimodal model to forecast prostate cancer metastasis from primary tumor transcriptomics and histopathology morphology</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2475</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2475.jpg</image:loc><image:title>Integrated Bulk and Single-Cell Transcriptomics Reveal Hepatocyte-Like Reprogramming in Metastatic Small Intestinal Neuroendocrine Tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2476</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2476.jpg</image:loc><image:title>Dosage-dependent adaptations to Complex I mutations in cancer cell lines</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2477</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2477.jpg</image:loc><image:title>Past exposure to genotoxic cancer therapies is associated with elevated local mutagenesis at CTCF binding sites in metastatic tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2478</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2478.jpg</image:loc><image:title>Multiomic dissection of HBV-, HCV-, and non-viral HCC reveals distinct proliferation, interferon, and metabolic signatures</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2479</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2479.jpg</image:loc><image:title>Multi-omic analysis of patient and preclinical data highlights challenges in targeting tumor heterogeneity in glioblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2480</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2481</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2481.jpg</image:loc><image:title>Analysis of long-read sequencing data with vmwhere reveals variation in microsatellite length and chromatin state in Ewing sarcoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2482</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2483</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2483.jpg</image:loc><image:title>First single slide spatially resolved multiomic integration of pancreatic cancer: High-plex proteomic and whole transcriptome analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2484</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2484.jpg</image:loc><image:title>A unified prostate cancer single-cell atlas reveals molecular subtypes and lineage plasticity across disease progression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2485</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2485.jpg</image:loc><image:title>Single-cell multiome sequencing reveals distinct transcriptional programs associated with ecDNA amplifications in medulloblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2486</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2486.jpg</image:loc><image:title>Leveraging linked-reads to predict extrachromosomal DNA in advanced prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2487</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2488</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2488.jpg</image:loc><image:title>EpiGuide: Tracking epigenetic plasticity in circulating tumor DNA to monitor tumor progression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2489</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2489.jpg</image:loc><image:title>Elucidating the role of specific cancer testis antigens in the progression and development of hepatocellular carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2490</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2490.jpg</image:loc><image:title>Dissecting the mechanisms of drug resistance development post neoadjuvant osimertinib treatment in EGFR-mutant non-small lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2491</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2492</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2492.jpg</image:loc><image:title>Unlocking novel gene-based biomarkers using an explainable deep learning framework for precision oncology</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2493</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2494</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2494.jpg</image:loc><image:title>MicroRNA expression can detect canine multicentric lymphoma in golden retrievers in serum samples taken pre-diagnosis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2495</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2495.jpg</image:loc><image:title>Accumulation of somatic mutation and clonal architecture of fallopian tube epithelium</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2496</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2496.jpg</image:loc><image:title>SpaceMarkers 2.0: A framework for spatially aware cell-cell communication in spatial transcriptomic data</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2497</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2497.jpg</image:loc><image:title>A transcriptomic framework to predict response and prioritize indications for p53 restoration therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2498</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2498.jpg</image:loc><image:title>Integrative Computational Pipeline for Tracking Neoantigen Retention Across PDX Passages in Genitourinary Cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2499</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2499.jpg</image:loc><image:title>PTMax: An AI-enabled platform integrating literature mining and multi-omics for functional interpretation of phosphorylation in cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2500</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2500.jpg</image:loc><image:title>NCI&#039;s childhood cancer data initiative: Advancing pediatric cancer research</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2501</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2501.jpg</image:loc><image:title>Revealing fibroblast-mediated impacts to therapy response through spatially resolved drug response prediction in lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2502</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2502.jpg</image:loc><image:title>PRECISE: A prognostic thyroid follicular cell-derived gene signature for papillary thyroid carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2503</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2503.jpg</image:loc><image:title>Single-nuclei multiomic profiling reveals conserved adaptive states in EGFR- and ALK-mutant lung adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2504</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2504.jpg</image:loc><image:title>Large-scale integration of single-nuclei and spatial transcriptomics from the ETOP BEAT-meso trial reveals clinically relevant heterogeneity in malignant pleural mesothelioma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2505</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2505.jpg</image:loc><image:title>MPACT-DPD: An interpretable machine learning classifier for predicting the functional impact of DPYD missense variants</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2506</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2506.jpg</image:loc><image:title>Ensemble machine learning using unmatched pre-treated multi-omic data can classify response to immune checkpoint inhibition in non-small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2507</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2507.jpg</image:loc><image:title>Development of a novel Ikaros/Aiolos transcriptional signature and correlation with patient response in multiple myeloma patients treated with CELMoDs</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2508</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2508.jpg</image:loc><image:title>A comprehensive single-cell atlas of head and neck squamous cell carcinoma defines malignant cell states and enables deconvolution of legacy bulk transcriptomic cohorts</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2509</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2509.jpg</image:loc><image:title>Machine learning-based screening tool for multiple myeloma detection in chronic kidney disease patients with limited laboratory testing</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2510</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2510.jpg</image:loc><image:title>Prostate cancer risk stratification by polygenic score in diabetic and non-diabetic men</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2511</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2511.jpg</image:loc><image:title>Liquid biopsy cfDNA methylation predicts lung tumor size and metastatic potential in a single assay</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2512</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2512.jpg</image:loc><image:title>Molecularly-informed prediction of treatment efficacy in GDSC cell line data using computational reasoning</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2513</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2513.jpg</image:loc><image:title>A comprehensive LLM-enabled pharmacodynamic biomarker resource to accelerate cancer drug development</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2514</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2515</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2515.jpg</image:loc><image:title>Integrated analysis identifies ELF3-CREB1 co-activation as a prognostic driver of high-risk pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2516</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2516.jpg</image:loc><image:title>Genomic drivers and an immune-cold microenvironment are associated with relapse in Chinese pediatric B-ALL</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2517</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2517.jpg</image:loc><image:title>A machine learning approach to classify breast cancer receptor subtype using genomic features</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2518</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2518.jpg</image:loc><image:title>Grade-dependent survival and co-mutation landscapes in TP53-mutant gliomas: Biological insights and therapeutic implications</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2519</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2519.jpg</image:loc><image:title>Clinicopathological and molecular significance of MUC13 in HCC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2520</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2520.jpg</image:loc><image:title>A designed live bacterial therapeutic restores responder-like microbiome profiles and improves immune checkpoint inhibitor (ICI) response in a predictive model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2521</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2521.jpg</image:loc><image:title>The Cancer Complexity Knowledge Portal: A FAIR-aligned tool for resource discovery</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2522</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2522.jpg</image:loc><image:title>The selective landscape of somatic mutations encodes histopathological information in breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2523</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2523.jpg</image:loc><image:title>Sylvester Data Portal: Population-level characterization of a diverse clinicogenomic cohort</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2524</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2524.jpg</image:loc><image:title>Florida Cancer Research (FL CARES) network and the Platform for Accelerating Collaborative Computational Cancer Research (PAC3R)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2525</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2525.jpg</image:loc><image:title>An interactive web platform for integrative analysis of drug responses in polyploid giant cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2526</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2526.jpg</image:loc><image:title>Real-world usability of a clinical trial knowledge platform in a community cancer network</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2527</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2527.jpg</image:loc><image:title>From chaos to columns: High-accuracy clinical data extraction with CIDER</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2528</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2528.jpg</image:loc><image:title>Evaluation of large language models for automated clinical trial matching in oncology</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2529</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2529.jpg</image:loc><image:title>Applications of large language models to CAR-T cell therapy clinical data using Google cloud computing</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2530</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2530.jpg</image:loc><image:title>Large language model-based triage of Hematology/Oncology patient messages: Performance, safety, and clinical implications</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2531</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2532</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2532.jpg</image:loc><image:title>Deploying artificial intelligence driven digital pathology for real world clinical decision-making in pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2533</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2533.jpg</image:loc><image:title>Automating clinical and pathological staging for breast cancer patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2534</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2534.jpg</image:loc><image:title>Patients prefer ChatGPT to physician responses in cancer communication</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2535</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2535.jpg</image:loc><image:title>AI vs human abstraction of pain scores and analgesic trends in low-dose radiation therapy for osteoarthritis: A concordance study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2536</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2536.jpg</image:loc><image:title>Source discipline matters: Guideline anchored large language model outperforms Open Evidence for decision support in acute leukemias</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2537</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2538</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2539</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2539.jpg</image:loc><image:title>Rapid curation of colon cancer cohorts using on-site peta-scale language model for MSI classification from pathology reports</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2540</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2540.jpg</image:loc><image:title>Large language model-derived molecular patient similarity from real-world MTB data</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2541</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2541.jpg</image:loc><image:title>CancerSTFormer enables multi-scale analysis of spot-resolution spatial transcriptomes and dissects the gene and immune regulatory responses of targeted therapies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2542</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2542.jpg</image:loc><image:title>Ontology-guided hierarchical cell typing with large language models for analyzing tumor microenvironment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2543</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2543.jpg</image:loc><image:title>VGL: Vision-Gene-Language multimodal LLM integrating histopathology and gene expression for cell type classification in lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2544</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2544.jpg</image:loc><image:title>Large scale extraction of adverse events by large language models uncovers latent structure of treatment toxicity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2545</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2545.jpg</image:loc><image:title>Development of an LLM framework for analysis of heterogeneous breast cancer patients genomic reports</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2546</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2546.jpg</image:loc><image:title>Scale meets Speed: A transcriptome-wide spatial analysis that runs a rapid and interactive hypothesis-driven workflow with AtoMx &amp;#174; SIP</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2547</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2547.jpg</image:loc><image:title>PAX3/7::FOXO1 fusion detection and transcriptomic prediction from whole-slide images of rhabdomyosarcoma using attention-based deep learning frameworks: A multi-institutional study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2548</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2548.jpg</image:loc><image:title>An innovative AI-based platform for antibody stability improvement and affinity optimization</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2549</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2549.jpg</image:loc><image:title>Large language model-derived re-contextualization reveals functional landscapes across cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2550</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2550.jpg</image:loc><image:title>LLM-based extraction of immunotherapy toxicities reveals severity-dependent effects on overall survival</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2551</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2551.jpg</image:loc><image:title>Leveraging large language models to classify pathology reports into ontological hierarchies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2552</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2552.jpg</image:loc><image:title>Maximizing high-risk incidental pulmonary nodule referrals using artificial intelligence</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2553</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2553.jpg</image:loc><image:title>Microbiome foundation modeling of cancer: MiFM-derived continuous trajectories and risk clocks for pan-cancer immunotherapy response prediction</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2554</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2554.jpg</image:loc><image:title>Self-supervised learning defines a universal biomarker of malignancy in platelet RNA</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2555</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2555.jpg</image:loc><image:title>astril : Automated segmentation toolkit for radiology image libraries</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2556</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2556.jpg</image:loc><image:title>Integrating image and text-based AI improves identification of metastatic sites from whole-slide pathology images</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2557</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2557.jpg</image:loc><image:title>Noninvasive artificial intelligence system for prediction of lenvatinib based therapeutic regimens response and outcome in unresectable hepatocellular carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2558</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2558.jpg</image:loc><image:title>Multi-regional CT-based radiomics fusion predicts pathological pollutant index associated with lung adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2559</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2559.jpg</image:loc><image:title>Pulmonary nodule tracking in metastatic Ewing sarcoma enables personalized predictive models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2560</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2560.jpg</image:loc><image:title>Deep-learning CT biomarker improves early efficacy detection in simulated randomized phase II NSCLC trials</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2561</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2561.jpg</image:loc><image:title>Prognostic value of CT radiomics in patients with gBRCA1/2 and PALB2 and advanced pancreas cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2562</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2562.jpg</image:loc><image:title>Automatic contrast phase classification of polyphasic CT scans</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2563</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2563.jpg</image:loc><image:title>Learning spatial transcriptomic patterns from whole-slide images with a cancer-scale foundation model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2564</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2564.jpg</image:loc><image:title>Development and evaluation of a MIRAI 5-year risk model with a breast cancer polygenic risk score</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2565</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2565.jpg</image:loc><image:title>Automated segmentation of hepatocellular carcinoma lesions on contrast-enhanced MRI using an AI model in patients with cirrhosis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2566</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2566.jpg</image:loc><image:title>Lung cancer intelligent detection (LUCID) using a universally accessible, cross-platform, AI-powered application</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2567</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2567.jpg</image:loc><image:title>Integrating spatial transcriptomics with MRI reveals distinct radio-spatial genomic profile concordant with prostate cancer clonal heterogeneity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2568</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2568.jpg</image:loc><image:title>Assessing the risk of breast cancer recurrence with pre-treatment MRI: A transfer learning study on multicenter data</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2569</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2569.jpg</image:loc><image:title>CorrectionNet: A lightweight residual refinement framework for improving medical image segmentation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2570</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2570.jpg</image:loc><image:title>Evaluation of imaging-based prognostication (IPRO) using artificial intelligence (AI) in stage IV colorectal cancer (CRC) patients treated with first-line (1L) systemic therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2571</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2572</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2572.jpg</image:loc><image:title>Depth prediction in superficial esophageal cancer using a foundation model from endoscopic images</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2573</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2573.jpg</image:loc><image:title>Foundation model-based gastric cancer staging from complete, uncurated EGD image sequences</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2574</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2574.jpg</image:loc><image:title>Deep learning-based survival prediction of post-operative GBM patients via multimodal radiomic phenotypes drawn from Kaniadakis vector embedding in latent space</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2575</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2575.jpg</image:loc><image:title>Leveraging PR-isometric guided deep learning to decode CT-based tumor heterogeneity and enhanced NSCLC prognosis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2576</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2576.jpg</image:loc><image:title>Capsaicin-nanoparticles sensitize human squamous cell lung cancer towards the growth-inhibitory activity of paclitaxel</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2577</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2577.jpg</image:loc><image:title>The combination of actinomycin D and resveratrol induces synergistic anticancer activities against aerodigestive tract cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2578</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2578.jpg</image:loc><image:title>Chromomycin A2 disrupts leukemia cell viability via integrated autophagic and apoptotic programs</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2579</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2579.jpg</image:loc><image:title>Differential mechanisms of MCF-7 cytotoxicity by oleuropein and punicic acid and the role of oxidative stress and peroxiredoxin antioxidants</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2580</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2581</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2581.jpg</image:loc><image:title>Luteolin inhibits DNA methyltransferase 1 and alpha 6-integrin gene expression to suppress proliferation and stemness in breast cancer cells from patients of West African ancestry</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2582</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2582.jpg</image:loc><image:title>High-throughput screening of natural products discovers inhibitors of ribosome biogenesis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2583</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2583.jpg</image:loc><image:title>Evaluating the immunomodulatory role of celastrol in murine acute graft versus host disease after allogeneic hematopoietic stem cell transplantation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2584</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2584.jpg</image:loc><image:title>Carnosic acid induces ROS and activates ASK1 signalling in NSCLC cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2585</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2585.jpg</image:loc><image:title>Thymoquinone blocks pancreatic ductal adenocarcinoma growth by altering novel circRNAs and miRNAs</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2586</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2586.jpg</image:loc><image:title>Screening of natural products library against 5-lipoxygenase (5-LOX) and mPGES1 proinflammatory targets for CRC interception</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2587</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2588</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2588.jpg</image:loc><image:title>Dose-dependent anti-proliferative activity of a bioactive hemp-derived extract REPYR-SC1 against prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2589</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2589.jpg</image:loc><image:title>A-ring analogs of Andrographolide inhibit wnt1 signaling and exhibit potent anticancer activity in breast and colorectal cancer models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2590</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2590.jpg</image:loc><image:title>Preclinical discovery of proscillaridin A glycan analogs for the in vitro and in vivo treatment of solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2591</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2591.jpg</image:loc><image:title>C-4 analogs of podophyllotoxin inhibit tubulin polymerization: A generalizable platform for the discovery of antimitotic therapeutics for cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2592</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2592.jpg</image:loc><image:title>Heterogeneous expression and cancer-selective regulation of endogenous membrane TRAIL by quercetin across various human cancer cell lines</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2593</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2593.jpg</image:loc><image:title>Network pharmacology reveals functional components and molecular mechanisms of andrographis combined with lactoferrin in pancreatic cancer treatment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2594</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2594.jpg</image:loc><image:title>Discovery of Spondias mombin flavonoid rutin as a novel DNA methyltransferase 1 inhibitor and potential agent to treat triple negative breast cancer in patients of West African ancestry</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2595</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2595.jpg</image:loc><image:title>Activity profiling of natural compounds identifies potent chemotypes active in parental and drug-resistant lymphoma models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2596</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2596.jpg</image:loc><image:title>Antiproliferative screening in B cell lymphoma: Ghanaian medicinal plants and their phytochemical correlates</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2597</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2597.jpg</image:loc><image:title>A novel 4-herb traditional Chinese medicine formula inhibits metastasis of triple-negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2598</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2598.jpg</image:loc><image:title>Oleuropein, a phenolic compound from olive leaves, exerts cytotoxicity and peroxiredoxin induction in MDA-MB-231 breast cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2599</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2599.jpg</image:loc><image:title>Antitumor effects of coffee diterpenes, kahweol acetate and cafestol, on taxane-resistant and neuroendocrine prostate cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2600</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2600.jpg</image:loc><image:title>Neohesperidin dihydrochalcone: A novel natural inhibitor of ferroptosis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2601</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2602</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2602.jpg</image:loc><image:title>Oleuropein downregulates MITF via direct PKA inhibition and ERK-mediated turnover in melanoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2603</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2603.jpg</image:loc><image:title>Beta-lactams, structural mimics of natural products, as anti-pancreatic cancer agents: A pilot study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2604</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2604.jpg</image:loc><image:title>A biologically grounded predictor of neoadjuvant breast cancer therapy response from tumor transcriptomics and histopathology</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2605</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2605.jpg</image:loc><image:title>Spatial determinants of TILs in immunotherapy sensitivity of patients with non-small cell lung cancer (NSCLC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2606</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2606.jpg</image:loc><image:title>Development of a gene expression predictor for bevacizumab response</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2607</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2607.jpg</image:loc><image:title>Time-series deep learning radiomics for predicting post-radiotherapy rib fractures in non-small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2608</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2608.jpg</image:loc><image:title>Optimizing NGS-based biomarkers for mismatch repair and proofreading deficiency</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2609</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2609.jpg</image:loc><image:title>Early-onset low-grade adverse events as predictive biomarkers in advanced NSCL: A multi-treatment cohort analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2610</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2610.jpg</image:loc><image:title>Septin9 isoforms as biomarkers of taxane response in breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2611</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2611.jpg</image:loc><image:title>C3C: A biomarker for extracellular cathepsin activity and ADCs</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2612</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2612.jpg</image:loc><image:title>BXQ-350: A novel biologic that targets dysregulated sphingolipid metabolism and normalizes key anti-tumoral and pro-tumoral sphingolipids in newly diagnosed metastatic colorectal carcinoma patients (mCRC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2613</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2613.jpg</image:loc><image:title>Characterization of TAG-72, a glycan-based ADC target and its pan-tumor expression profile</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2614</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2614.jpg</image:loc><image:title>Isolation and characterization of pancreatic cancer-derived small extracellular vesicles as a novel liquid biopsy approach</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2615</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2615.jpg</image:loc><image:title>OncoGraph: A patient-specific blood test using protein markers to monitor cancer recurrence and treatment response</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2616</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2616.jpg</image:loc><image:title>Radiation-dendritic cell combination therapy drives systemic cellular immune shifts in liver cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2617</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2618</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2618.jpg</image:loc><image:title>ddPLEX EGFR/KRAS/BRAF: A highly multiplexed droplet digital PCR (ddPCR) panel for ultra-sensitive NSCLC biomarker detection</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2619</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2619.jpg</image:loc><image:title>Peripheral immune indices predict pathologic complete response and residual cancer burden in inflammatory breast cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2620</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2620.jpg</image:loc><image:title>Unveiling clear cell renal cell carcinoma heterogeneity associated with locally advanced disease using single nucleus multi-omics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2621</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2621.jpg</image:loc><image:title>Single-cell liquid biopsy profiling in mCRPC receiving PSCA-targeted CAR-T cell therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2622</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2622.jpg</image:loc><image:title>Discovery and functional characterization of enhancer hijacking oncogene rearrangements in NSCLC using Hi-C sequencing of FFPE tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2623</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2623.jpg</image:loc><image:title>A proportion of shared mutations in lung squamous cell carcinoma provides insights that may guide therapeutic approaches</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2624</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2624.jpg</image:loc><image:title>Integrative multiomics and functional studies to identify biomarkers of AOH1996 sensitivity across AML subtypes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2625</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2625.jpg</image:loc><image:title>QVT Subscore: An interpretable radiomic panel of tumor vascularity reveals treatment-specific mechanisms-of-action (MoA) in NSCLC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2626</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2626.jpg</image:loc><image:title>RNA editing deaminase activation as a dynamic marker to track hematopoietic stem cell fitness and leukemia evolution</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2627</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2627.jpg</image:loc><image:title>Uncovering tumor microbial and immune biomarkers of immunotherapy response in lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2628</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2628.jpg</image:loc><image:title>Detection of minimal residual disease in colorectal cancer patients after surgery through circulating tumor DNA profiling</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2629</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2629.jpg</image:loc><image:title>Prognostic significance of PI3K-AKT pathway alterations identified by ctDNA sequencing in metastatic castration-resistant prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2630</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2631</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2631.jpg</image:loc><image:title>Sequencing full-length mRNA in whole blood of breast cancer patients for antibody-drug conjugate therapy selection</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2632</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2632.jpg</image:loc><image:title>Longitudinal ctDNA monitoring in melanoma using highly multiplexed USE-PCR incorporating bespoke targets enables real-time detection of treatment response and recurrence</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2633</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2633.jpg</image:loc><image:title>Enhancing MRD detection through an ultrasensitive ctDNA test: Insights from real-world clinical data</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2634</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2634.jpg</image:loc><image:title>Short double-stranded cfDNA: A novel precision biomarker class for cancer diagnostics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2635</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2635.jpg</image:loc><image:title>Urine cell-free DNA methylation-based deconvolution identifies tumor-specific cell types in localized urinary tract cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2636</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2636.jpg</image:loc><image:title>Frequent monitoring of NSCLC immunotherapy using an mDETECT liquid biopsy reveals unexpected complexity and opportunities</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2637</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2637.jpg</image:loc><image:title>Liquid biopsy-based monitoring of disease status in patients with HPV-positive oropharyngeal carcinoma (OPSCC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2638</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2638.jpg</image:loc><image:title>Ultrasensitive ctDNA monitoring predicts early response of immunotherapy in recurrent metastatic non-small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2639</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2639.jpg</image:loc><image:title>Ultrasensitive AI-driven framework for MRD detection based on multidimensional cfDNA features</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2640</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2640.jpg</image:loc><image:title>Genomic profiling of circulating tumor DNA in endometrial cancer in Asia: A-TRAIN study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2641</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2641.jpg</image:loc><image:title>Plasma cell-free RNA transcriptome analysis reveals transcriptional dysregulation and immune remodeling in pancreatic ductal adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2642</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2643</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2643.jpg</image:loc><image:title>Detection of cfDNA shedding from advanced precancerous lesions</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2644</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2644.jpg</image:loc><image:title>Comprehensive profiling of circulating tumor DNA in blood enables sensitive detection and genomic characterization of HPV cancer and precancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2645</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2645.jpg</image:loc><image:title>Methylation profiling of cell free DNA using EMSeq whole genome sequencing and a targeted methylome panel for classification of pediatric ocular and brain tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2646</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2646.jpg</image:loc><image:title>Dynamic systemic immune modulation in metastatic neuroendocrine tumor (NET) patients treated with targeted alpha-emitter 212 Pb-DOTAMTATE AlphaMedix</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2647</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2647.jpg</image:loc><image:title>A low-cost bioassay for multi-cancer detection in cfDNA using quantitative methylation-specific PCR</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2648</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2648.jpg</image:loc><image:title>Low-cost detection of advanced adenomas in cfDNA using quantitative methylation-specific PCR</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2649</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2649.jpg</image:loc><image:title>Convergent chromatin remodeling enables pan-aerodigestive detection of advanced malignancies in plasma cfDNA</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2650</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2650.jpg</image:loc><image:title>Enhanced cfDNA fragmentation-based treatment monitoring on the Ultima Genomics platform</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2651</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2651.jpg</image:loc><image:title>Serial ctDNA monitoring in metastatic breast cancer using an ultrasensitive tumor informed structural variant based assay</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2652</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2653</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2653.jpg</image:loc><image:title>Spatial mapping of B7-H3 mediated cellular plasticity in treatment naive pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2654</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2654.jpg</image:loc><image:title>Spatial multi-omics dissection of follicular lymphoma by GlycoScope-IN-DEPTH reveals a galectin-8L-driven complement-enriched, immune-exhausted microenvironment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2655</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2655.jpg</image:loc><image:title>Assessing the role of immune aggregates as potential biomarkers of immunotherapy response in appendiceal adenocarcinoma (AA) using spatial proteomics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2656</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2656.jpg</image:loc><image:title>Identifying biomarkers of response in BRAF p.V600E mutant colorectal cancers (mCRC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2657</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2657.jpg</image:loc><image:title>Spatial characterization of tumor-immune interactions in MMR-p and MMR-d among African American colorectal cancer patients using attention-based modeling</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2658</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2658.jpg</image:loc><image:title>Spatial transcriptomic mapping of ER-positive breast tumors reveals immune pathway remodeling and resistance mechanisms following anti-PD-1 therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2659</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2659.jpg</image:loc><image:title>Spatially derived transcriptomic predictors of immune checkpoint blockade outcome in advance gastric cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2660</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2660.jpg</image:loc><image:title>Spatial transcriptomic profiling of peritoneal metastases identifies multicellular programs in patient tumors undergoing pressurized intraperitoneal aerosol chemotherapy (PIPAC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2661</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2661.jpg</image:loc><image:title>Novel methodology to explore glioma malignant transformation with spatial multi-omics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2662</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2662.jpg</image:loc><image:title>Spatially resolved transcriptomic signatures of gallbladder carcinogenesis from precursor to undifferentiated stages</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2663</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2663.jpg</image:loc><image:title>Identifying the molecular signature of infiltrating edge cells in glioblastoma as drivers of tumour invasion and recurrence</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2664</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2664.jpg</image:loc><image:title>Same-species multiplex IF with HCR&amp;#8482;Gold IF: Cross-clone benchmarking using Abcam&#039;s oncology-validated primaries</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2665</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2665.jpg</image:loc><image:title>Spatially Resolved Cell-Cell Communication Reveals Intra-tumoral heterogeneity in Small Cell Lung Cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2666</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2666.jpg</image:loc><image:title>Spatial profiling of the neuroblastoma tumor microenvironment using seqFISH</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2667</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2667.jpg</image:loc><image:title>Spatialomics detection of neuroendocrine involvement in cancer tissue</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2668</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2668.jpg</image:loc><image:title>In situ spatial multiomic profiling of breast cancer tissue utilizing the CosMx Spatial Molecular Imager</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2669</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2669.jpg</image:loc><image:title>Spatial whole transcriptomic profiling of breast cancer tissue with CosMx Spatial Molecular Imager</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2670</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2670.jpg</image:loc><image:title>Spatial transcriptomic features associated with response to neoadjuvant therapy in triple-negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2671</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2672</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2672.jpg</image:loc><image:title>Genome wide testing of archived ovarian and uterine carcinosarcoma FFPE tissue using FusionPlus Hi-C to determine HRD status</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2673</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2673.jpg</image:loc><image:title>Rapid antibody drug conjugate markers and RNA biomarkers in solid tumors using a hybrid Ultivue InSituPlex and Protease-Free RNAscope Workflow</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2674</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2674.jpg</image:loc><image:title>Comprehensive immune landscape analysis of solid tumors using a 17-Plex immunofluorescence assay in clinical trials</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2675</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2675.jpg</image:loc><image:title>A framework for antibody validation via spatial proteo-transcriptomics using the CellScape platform</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2676</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2676.jpg</image:loc><image:title>Decoding cancer hallmarks through single-cell whole transcriptome imaging in invasive ductal carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2677</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2677.jpg</image:loc><image:title>Spatially resolved multi-omics reveal metastatic ecosystem remodeling and immunomodulatory niches in HGSOC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2678</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2678.jpg</image:loc><image:title>Serum soluble TREM2 predicts poor survival, mirrors surface TREM2 level on circulating M-MDSCs, and enhances MDSC-mediated suppression of T-cell proliferation in indolent B-cell lymphoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2679</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2679.jpg</image:loc><image:title>Analytical performance of a novel tissue-informed non-bespoke whole genome MRD detection assay</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2680</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2680.jpg</image:loc><image:title>Dynamic inflammatory biomarkers are associated with cancer cachexia in a prospective lung cancer cohort</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2681</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2681.jpg</image:loc><image:title>Prognostic significance of ctDNA in patients with metastatic uveal melanoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2682</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2682.jpg</image:loc><image:title>Developing a prognostic gene expression biomarker for re-irradiation in recurrent glioblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2683</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2683.jpg</image:loc><image:title>Immune cell profile changes in patients treated with tarlatamab for extensive stage small cell lung cancer in real world practice</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2684</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2684.jpg</image:loc><image:title>Spatial immune checkpoint profiling reveals predictive biomarkers of immunotherapy response in oral squamous cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2685</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2685.jpg</image:loc><image:title>sB7-H3 as a prognostic biomarker in osteosarcoma: Insights into clinical outcomes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2686</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2686.jpg</image:loc><image:title>Apoptosis-inducing factor mitochondria-associated 2 (AIFM2) functions as an oncogenic driver and prognostic biomarker in oral squamous cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2687</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2687.jpg</image:loc><image:title>Peripheral T-cell receptor beta repertoire in breast cancer: Implications for prognosis and therapy-associated immune repertoire dynamics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2688</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2688.jpg</image:loc><image:title>IQGAP3 as a gatekeeper of epithelial integrity and prognostic biomarker in extrahepatic cholangiocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2689</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2689.jpg</image:loc><image:title>Investigation of inherited genetic variation for predictors of immune mediated colitis following immune checkpoint inhibitor (ICI) therapy of patients (pts) with melanoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2690</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2690.jpg</image:loc><image:title>Scalable AI-driven tumor-stroma ratio quantification for prognostic stratification in stage II-III colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2691</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2691.jpg</image:loc><image:title>Circulating tumor cell analysis for early detection of minimal residual disease in oral cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2692</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2692.jpg</image:loc><image:title>Persistent immune microenvironment changes associated with progression risk in Barrett&#039;s esophagus</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2693</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2693.jpg</image:loc><image:title>A RHO GTPase pathway signature as a potential prognostic biomarker and therapeutic target in bladder cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2694</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2694.jpg</image:loc><image:title>NRF2 pathway activation predicts poor radiation response in laryngeal cancer: Insights from a large proteogenomic characterization study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2695</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2695.jpg</image:loc><image:title>Morphology-derived spindle-cell gene signature in HPV+ HNSCC is linked to pEMT, molecular subtype, HPV integration, and recurrence-free survival</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2696</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2696.jpg</image:loc><image:title>The impact of diversity on transcriptional heterogeneity of skeletal muscle from pancreatic ductal adenocarcinoma patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2697</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2698</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2698.jpg</image:loc><image:title>Association between MLK4 expression and colon cancer patient survival</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2699</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2699.jpg</image:loc><image:title>Fusions and rearrangement detection in gastrointestinal and lung tumors leveraging low-pass whole-genome sequencing based Hi-C chemistry</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2700</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2700.jpg</image:loc><image:title>A robust RNA-seq solution for severely degraded FFPE samples: The PredicineWTS Tissue NGS platform</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2701</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2701.jpg</image:loc><image:title>Validation of TruSight Oncology Comprehensive for detecting and reporting clinically relevant mutations</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2702</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2702.jpg</image:loc><image:title>Concordance analyses of a rapid, targeted, and comprehensive genomic profiling panel for the detection of guideline-recommended biomarkers in non-small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2703</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2703.jpg</image:loc><image:title>Clinical utility of a urine-based urothelial cancer test in equivocal upper tract lesions: improving malignancy detection and minimizing unnecessary URS</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2704</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2704.jpg</image:loc><image:title>Enabling multiomic analysis in cell-free DNA tubes by addressing the impact of pre-analytical factors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2705</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2705.jpg</image:loc><image:title>Genomic landscape of resectable hepatocellular carcinoma defined by tissue based whole-exome sequencing</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2706</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2706.jpg</image:loc><image:title>Cross-cohort robust detection of colorectal cancer using a minimal junction-based platelet RNA panel</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2707</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2708</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2708.jpg</image:loc><image:title>Systematic assessment of histomorphologic and immunohistochemical features in metastatic castration-resistant prostate cancer biopsies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2709</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2709.jpg</image:loc><image:title>Cyclic immunofluorescence (CyCIF) staining for highly multiplexed circulating tumor cell (CTC) imaging using the Genesis Cell Isolation System with Celselect Slides</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2710</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2710.jpg</image:loc><image:title>Signatera HRD score enables high accuracy classification of homologous recombination deficiency</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2711</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2711.jpg</image:loc><image:title>Diagnostic potential of salivary miR-300 and miR-340-5p in oral cancer among Pakistani patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2712</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2712.jpg</image:loc><image:title>Validation of blood tumor mutation burden in Labcorp Plasma Complete</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2713</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2713.jpg</image:loc><image:title>Utilization, challenges, and outlook of cell of origin classification by immunohistochemistry in DLBCL: A U.S. survey of oncologists and pathologists</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2714</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2714.jpg</image:loc><image:title>Development of a novel extracellular vesicle-based biomarker approach for pediatric high-grade glioma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2715</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2715.jpg</image:loc><image:title>Performance validation of a next generation sequencing myeloid assay on an integrated nucleic acid purification and sequencing system</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2716</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2717</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2717.jpg</image:loc><image:title>IGF system genes as colorectal cancer biomarkers in Puerto Rico</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2718</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2719</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2720</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2720.jpg</image:loc><image:title>Next-generation liquid biopsy for circulating tumor cell detection in metastatic prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2721</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2722</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2722.jpg</image:loc><image:title>Aneuploid primary cancers metastasize as diploid cancer stem cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2723</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2724</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2725</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2725.jpg</image:loc><image:title>Dynamic regulation and physical interaction of IGF1 and CYR61 in prostate cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2726</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2727</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2727.jpg</image:loc><image:title>Depletion of circulating tumor cells using an automated device using non-hemolytic affinity based substrates</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2728</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2729</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2729.jpg</image:loc><image:title>Spatially resolved lineage and microenvironmental remodeling define metastatic progression in oral squamous cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2730</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2730.jpg</image:loc><image:title>Predicting efficacy of curative-intent surgery in advanced gastric cancer: A biologically informed staging approach</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2731</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2732</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2732.jpg</image:loc><image:title>Monitoring tumor dynamics through circulating cancer stem cells in colorectal cancer patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2733</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2734</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2735</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2735.jpg</image:loc><image:title>Genomic landscape of acute myeloid leukemia in an African ancestry cohort: A pilot study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2736</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2737</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2738</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2739</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2739.jpg</image:loc><image:title>Circulating tumor cell based ex vivo platform for characterizing circulating hybrid cell dynamics in multiple cancer types</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2740</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2740.jpg</image:loc><image:title>Plasma exosomes identify metastatic potential in early stage melanoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2741</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2741.jpg</image:loc><image:title>The role of KRT10 in cancer brain metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2742</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2743</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2743.jpg</image:loc><image:title>The &quot;Preservation &amp;#38; Expansion&quot; process: A key milestone for enhancing accessibility of autologous tumor-infiltrating lymphocyte therapy by enabling long-term cryopreservation of seed cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2744</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2744.jpg</image:loc><image:title>Engineering iPSC-derived NK cells with autocrine feeder signaling to enhance cytotoxic function</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2745</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2745.jpg</image:loc><image:title>Safety and efficacy of CAR T-cell therapy in CNS lymphoma: A meta-analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2746</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2746.jpg</image:loc><image:title>No impact of dexamethasone on CAR-T cell expansion in vitro and in patients with RRMM</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2747</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2747.jpg</image:loc><image:title>Sentinel lymph node-derived CD45&amp;#8314; cells combined with low-dose radiotherapy and PD-1 blockade as a next-generation adoptive cell therapy in head and neck cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2748</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2749</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2749.jpg</image:loc><image:title>Integration of affinity-dependent modulation and CD5/TRAC knockout generates fratricide-resistant and highly cytotoxic anti-CD5 CAR-T cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2750</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2750.jpg</image:loc><image:title>Impact of number of IL-2 infusions and product out of specification status on outcomes of tumor infiltrating lymphocyte therapy for melanoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2751</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2751.jpg</image:loc><image:title>Durable remission of high-risk and refractory neuroblastoma by PHOX2B derived peptide-HLA directed CAR T cells: An IND enabling study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2752</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2752.jpg</image:loc><image:title>Improving antitumor T cell therapy with membrane-tethered engineered cytokine agonists</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2753</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2753.jpg</image:loc><image:title>A first-in-class Erythrocyte-anti-PD-1 conjugate overcomes immunotherapy resistance across pan-solid tumors: A phase I trial</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2754</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2754.jpg</image:loc><image:title>Adapting and validating a humanized mouse model for testing of immune-shielded genetic modifications in therapeutic cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2755</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2755.jpg</image:loc><image:title>Enriching CD8+ and CD4+ neoantigen-reactive tumor infiltrating lymphocytes by cell surface marker-based sorting</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2756</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2756.jpg</image:loc><image:title>Pleiotropic oxidized carbon nanozymes reprogram CAR T cell metabolism to enhance persistence through redox modulation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2757</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2757.jpg</image:loc><image:title>Fluorescence potency assays for evaluating HER2 CAR T-cell-mediated killing in cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2758</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2758.jpg</image:loc><image:title>Immunopeptidomic discovery of fetal WNT-associated antigen NKD1 enables HLA-A2+ restricted TCR-T therapy for MSS mCRC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2759</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2759.jpg</image:loc><image:title>Epigenetic and signaling-based engineering enhances CAR-T cell function in oculo-cerebral lymphoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2760</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2760.jpg</image:loc><image:title>Regulatory immunotherapy utilizing activated natural killer cells and antitumor response for hepatocellular carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2761</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2761.jpg</image:loc><image:title>DLL3-targeted in vivo CAR-T therapy of small cell lung cancer with lipid nanoparticles and circular RNA</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2762</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2762.jpg</image:loc><image:title>CAR Detection Reagents - Pioneering advances in CAR T analytics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2763</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2763.jpg</image:loc><image:title>From gene to bedside: Mayo Clinic&#039;s first-in-house BAFF-R CAR-T</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2764</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2764.jpg</image:loc><image:title>Nectin-4-targeted CAR-NK cells exhibit potent antitumor activity against bladder cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2765</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2765.jpg</image:loc><image:title>Anti-tumor function and long-term persistence of KSQ-001EX, a SOCS1-edited eTIL&amp;#174; therapy, independent of IL-2 co-administration</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2766</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2766.jpg</image:loc><image:title>Preclinical development and evaluation of CD87-directed CART for colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2767</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2767.jpg</image:loc><image:title>Evaluation of ex vivo CAR-T cell cytotoxicity and infiltration using multimodal 2-D and 3-D imaging approaches</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2768</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2768.jpg</image:loc><image:title>Exogenous IL-2 administration promotes circulating T-cell levels, persistence and therapeutic efficacy of allogeneic UCART20x22 in a B-cell lymphoma mouse model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2769</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2769.jpg</image:loc><image:title>Stem cell-derived allogeneic anti-CD19 CAR-iNKT cell therapy GT719 for relapsed/refractory B cell malignancies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2770</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2770.jpg</image:loc><image:title>Peripheral immune signature of dostarlimab in addition to standard of care definitive radiation in patients with medically inoperable endometrial cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2771</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2771.jpg</image:loc><image:title>The safety of PARP inhibitors combined with immune checkpoint inhibitors versus immune checkpoint inhibitor monotherapy: A systematic review, meta-analysis, and trial sequential analysis of randomized controlled trials</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2772</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2772.jpg</image:loc><image:title>Integrated single-cell analysis identifies biomarkers associated with clinical benefit in patients with PD-L1 positive, advanced NSCLC treated with SBRT followed by atezolizumab plus tiragolumab</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2773</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2773.jpg</image:loc><image:title>Treatment with ACR-2316, a potential first- and best-in-class WEE1/PKMYT1 inhibitor, combined with anti-PD-L1 induces complete tumor regression with durable immune memory</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2774</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2774.jpg</image:loc><image:title>Combined inhibition of myeloid cell PI3Kgamma and regulatory T cell integrin alphavbeta8 promotes durable tumor suppression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2775</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2775.jpg</image:loc><image:title>Cry1 inhibition reverses resistance to T cell-based immunotherapy by promoting anti-tumor immunity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2776</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2776.jpg</image:loc><image:title>EGFR promotes immune evasion and resistance to immunotherapy in NF1 mutant melanoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2777</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2777.jpg</image:loc><image:title>Preventing nk cell activation in the damaged liver induced by cabozantinib/pd-1 blockade increases survival in hepatocellular carcinoma models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2778</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2778.jpg</image:loc><image:title>ACR246, a first-in-class 5T4 antibody-drug conjugate (ADC), showed promising anticancer efficacy in preclinical models and patient with esophageal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2779</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2779.jpg</image:loc><image:title>Crept-618: First GalNAc-siRNA targeting CREPT reverses HCC immune evasion and synergizes with anti-PD-1</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2780</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2780.jpg</image:loc><image:title>Targeting midkine with HBS-101 enhances chemotherapy and immunotherapy response in TNBC via immune activation and oncogenic pathway suppression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2781</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2781.jpg</image:loc><image:title>A novel tritherapy overcoming the immune suppressive tumor microenvironment elicits robust antitumor activity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2782</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2782.jpg</image:loc><image:title>In vivo results of AGX101, a TM4SF1-directed tubulin inhibitor conjugate, in combination with immune checkpoint inhibitors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2783</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2783.jpg</image:loc><image:title>HER3 inhibition sensitizes metastatic colorectal and pancreatic cancer to immunotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2784</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2784.jpg</image:loc><image:title>Combinational effects of VC2-GMCSF oncolytic virus and paclitaxel in end-stage breast cancer animal model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2785</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2785.jpg</image:loc><image:title>Synergistic therapy by combination of a plant virus immunomodulator and IL-12 against murine ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2786</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2786.jpg</image:loc><image:title>Adaptive cd73 upregulation undermines parp inhibitor efficacy and creates a therapeutic opportunity for combined blockade in advanced prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2787</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2788</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2789</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2790</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2790.jpg</image:loc><image:title>Engineering and preclinical development of a differentiated EGFR/PDL1 bispecific ADC for the targeted therapy of solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2791</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2791.jpg</image:loc><image:title>Regulation of PD-L1 + tumor associated macrophages by collagen expressing myCAFs and luminal progenitors in endocrine-resistant breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2792</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2792.jpg</image:loc><image:title>Bax activation promotes immune activity and synergizes with PD-L1 blockade immunotherapy against mutant KRAS-driven lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2793</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2793.jpg</image:loc><image:title>Intratumoral (IT) ruxotemitide (LTX&amp;#8209;315) in combination with pembrolizumab in patients with unresectable advanced melanoma refractory to PD-1/PD-L1 therapy: Final results from the ATLAS-IT-05 study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2794</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2794.jpg</image:loc><image:title>Exploring immunomodulatory tumor-derived vaccines targeting triple negative breast cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2795</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2795.jpg</image:loc><image:title>A novel &#039;Seed-and-Boost&#039; immunotherapy drives potent TCR-T cell expansion, tumor infiltration, and durable tumor control</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2796</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2796.jpg</image:loc><image:title>Synergistic immunomodulation by Tumor Treating Fields combined with immunotherapy across solid tumors: A systematic review with translational relevance to pancreatic ductal adenocarcinoma.</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2797</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2798</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2798.jpg</image:loc><image:title>MERTK inhibitor MRX-2843 sensitizes AML to venetoclax and azacitidine in preclinical models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2799</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2799.jpg</image:loc><image:title>Profiling tumor selectivity of state- and paralog-selective RAS inhibitors through a signaling inhibition index (SII)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2800</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2800.jpg</image:loc><image:title>Tegavivint, a first-in-class TBL1 inhibitor demonstrates potent activity in WNT-driven colorectal cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2801</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2801.jpg</image:loc><image:title>BGB-58067, a brain-penetrative MTA-cooperative PRMT5 inhibitor, demonstrates promising anti-tumor activity and favorable selectivity in tumors with MTAP-deletion</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2802</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2802.jpg</image:loc><image:title>WEE1 inhibition as a therapeutic strategy in triple-negative breast cancer: Evaluating single agent and combination activity of azenosertib in preclinical models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2803</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2804</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2804.jpg</image:loc><image:title>SPOP drives AR-V7-mediated ARPI resistance in prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2805</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2805.jpg</image:loc><image:title>A pan-TEAD inhibitor, SIGX2649, blocks Hippo-YAP/TAZ signaling pathway and suppresses solid tumor growth in preclinical studies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2806</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2807</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2807.jpg</image:loc><image:title>Molecular determinants of response in laparoscopically triaged advanced ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2808</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2809</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2809.jpg</image:loc><image:title>SMARCA4 ablation mitigates distal-less homeobox 1 ( DLX1 )- driven oncogenicity in prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2810</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2810.jpg</image:loc><image:title>AR copy number amplification and AR/KLK3 expression patterns reveal mechanisms of AR signaling inhibitor (ARSI) resistance and highlight the need for AR-directed therapeutic innovation in metastatic castration resistance prostate cancer (mCRPC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2811</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2811.jpg</image:loc><image:title>Use of ALK inhibitors in patients with non-lung malignancies bearing ALK alteration prolongs treatment duration</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2812</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2812.jpg</image:loc><image:title>NQO1 as a target to overcome therapy resistance in multiple myeloma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2813</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2813.jpg</image:loc><image:title>Inavolisib demonstrates anti-tumorigenic effects in pre-clinical models of serous endometrial cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2814</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2814.jpg</image:loc><image:title>Inavolisib exhibits anti-proliferative effects in pre-clinical model of endometrioid endometrial cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2815</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2815.jpg</image:loc><image:title>From bench to bedside: A CNS penetrant and Omnipotent EGFR inhibitor, WSD0922-FU targeting primary mutations and the C797S acquired resistance mutation shapes the treatment landscape of EGFR mutant NSCLC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2816</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2816.jpg</image:loc><image:title>A potent CDK7 inhibitor TY-2699a has the potential for combination with chemotherapy or immunotherapy in solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2817</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2817.jpg</image:loc><image:title>FGFR2 might be a promising therapeutic target for some types of carcinomas: Analysis of 1312 tumors with FGFR2 abnormalities</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2818</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2818.jpg</image:loc><image:title>The emerging role of claudin 18.2 as a potential driver in gastric cancer progression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2819</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2819.jpg</image:loc><image:title>PIK3CA and ARID1A co-altered tumors are sensitive to AKT inhibitor, capivasertib</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2820</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2820.jpg</image:loc><image:title>Periostin on tumor stromal cells might be associated with the malignant progression of patients with gastric cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2821</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2821.jpg</image:loc><image:title>Polymeric delivery of TRAIL mRNA for inducing apoptosis in non-small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2822</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2823</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2823.jpg</image:loc><image:title>Distinct tumor microenvironmental landscapes define molecular subtypes in non-muscle-invasive bladder cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2824</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2824.jpg</image:loc><image:title>Leveraging CpG methylation signatures for robust multi-class cancer classification across platforms</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2825</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2825.jpg</image:loc><image:title>Deep learning-powered morphological analysis of acute myeloid leukemia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2826</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2827</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2828</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2829</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2829.jpg</image:loc><image:title>Identifying the tumor site of origin using molecular profiling with an AI-based classifier</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2830</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2831</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2831.jpg</image:loc><image:title>Integrative application of Lymphly reveals shared molecular landscape across B-cell lymphomas</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2832</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2833</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2834</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2834.jpg</image:loc><image:title>Functional high risk multiple myeloma is unified by a highly proliferative signature on gene expression profiling</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2835</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2835.jpg</image:loc><image:title>Heterogeneity in tumor microenvironment across MMR subtypes of endometrial cancer: Analysis from the ENGOT-EN6-NSGO/GOG-3031/RUBY trial</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2836</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2837</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2838</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2839</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2840</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2841</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2842</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2843</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2843.jpg</image:loc><image:title>Morphologic spectrum of bladder cancer variants and incidental prostate pathology in cystoprostatectomy specimens</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2844</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2844.jpg</image:loc><image:title>&amp;#173;A phase 0/1 study of PRMT5 inhibitor BMS-986504 in recurrent glioblastoma participants with MTAP deletion</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2845</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2846</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2846.jpg</image:loc><image:title>Clinical validation of a first-in-class pan-cancer antibody Vartumab targeting oncofetal chondroitin sulfate</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2847</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2848</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2849</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2849.jpg</image:loc><image:title>Data-driven characterization of platelet count and alanine aminotransferase dynamics in the first-in-human LP-184 dose escalation trial</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2850</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2850.jpg</image:loc><image:title>Phase 1 study of HRS-6209, a highly selective CDK4 inhibitor, in patients with advanced solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2851</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2852</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2853</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2854</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2855</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2855.jpg</image:loc><image:title>Immune escape via myeloid-derived suppressor cells in solid tumor cancer patients treated with anchored IL-12? (tolododekin alfa)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2856</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2857</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2857.jpg</image:loc><image:title>Results of phase 1 first-in-human clinical trial of HMBD-002, an IgG4 monoclonal antibody targeting VISTA, in advanced solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2858</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2858.jpg</image:loc><image:title>First-in-human study of ES014, a bispecific antibody targeting CD39 and TGF-beta as monotherapy in patients with advanced solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2859</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2860</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2861</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2862</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2863</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2864</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2865</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2865.jpg</image:loc><image:title>QOL outcomes in Bria-ABC late stage metastatic phase 3 trial</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2866</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2866.jpg</image:loc><image:title>Preliminary delayed-type-hypersensitivity immune response results from open-label arm of on-going Phase III study to evaluate the efficacy and safety of GLSI-100 (GP2 + GM-CSF) in breast cancer patients with residual disease or high-risk PCR after both neo-adjuvant and postoperative adjuvant anti-HER2 therapy, Flamingo-01</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2867</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2867.jpg</image:loc><image:title>Germline HFE mutations predict for durable response to arginine depletion with pegargiminase-based chemotherapy in pleural mesothelioma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2868</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2868.jpg</image:loc><image:title>Final Results from S2302-PRAGMATICA-LUNG: A prospective randomized study of ramucirumab plus pembrolizumab (RP) versus standard of care (SOC) for participants (pts) previously treated with immunotherapy for stage IV or recurrent non-small cell lung cancer (NSCLC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2869</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2869.jpg</image:loc><image:title>Reducing nausea and vomiting while maintaining the full potential for efficacy with spevatamig, a CLDN18.2xCD47 bispecific antibody</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2870</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2870.jpg</image:loc><image:title>Resolved hematological toxicities associated with anti-CD47 agents using a bispecific design involving an optimized anti-CD47 arm: A clinical proof of concept study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2871</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2871.jpg</image:loc><image:title>Pharmacokinetics of spevatamig (PT886), a bispecific antibody targeting CLDN18.2 and CD47, in patients with advanced gastrointestinal cancers as monotherapy or combination therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2872</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2872.jpg</image:loc><image:title>A phase II, multicenter, open-label study (COMPASSION-26) of cadonilimab, a PD-1/CTLA-4 bispecific antibody,combined with chemotherapy (chemo) as first-line therapy for advanced pancreatic ductal adenocarcinoma (PDAC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2873</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2873.jpg</image:loc><image:title>Sequential treatment with surufatinib combined with gemcitabine and nab-paclitaxel (AG) or AG alone as first-line therapy for locally advanced or metastatic pancreatic ductal adenocarcinoma (mPDAC) after 6 weeks of AG induction therapy: A two-cohort, exploratory phase II study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2874</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2874.jpg</image:loc><image:title>High dose intravenous ascorbate with chemotherapy as NAC for muscle invasive cisplatin ineligible bladder cancer patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2875</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2875.jpg</image:loc><image:title>Safety, dosimetry, and RP2D determination of Ga&amp;#8209;68&amp;#8209;NGUL and Lu&amp;#8209;177&amp;#8209;DGUL (pocuvotide satetraxetan) in mCRPC: Results from a phase 1/2 study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2876</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2876.jpg</image:loc><image:title>A phase 2 study of cabozantinib and nivolumab in metastatic castration resistant prostate cancer (CANOPY): Interim analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2877</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2878</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2878.jpg</image:loc><image:title>CDK4/6 inhibitor dalpiciclib combined with mFOLFOX6 in pretreated metastatic colorectal cancer: Results from a Simon two-stage phase II study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2879</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2879.jpg</image:loc><image:title>Preliminary results from a phase II trial evaluating the safety and efficacy of JS207, a bispecific antibody targeting PD-1 and VEGF, in combination with chemotherapy in patients with metastatic colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2880</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2880.jpg</image:loc><image:title>Feasibility of pegulicianine fluorescence guided surgery for detection of peritoneal surface malignancies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2881</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2881.jpg</image:loc><image:title>Clinical activity and safety of novel BRAF inhibitor plixorafenib (FORE8394) in BRAF V600-mutated advanced colorectal cancers (CRC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2882</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2882.jpg</image:loc><image:title>Phase 1b trial of NG-350A, a CD40 agonist antibody expressing adenoviral vector, in combination with chemoradiotherapy (CRT), in patients with mismatch repair-proficient (pMMR) locally advanced rectal cancer (LARC): Initial results from the FORTRESS study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2883</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2883.jpg</image:loc><image:title>ST316, a first in class beta-catenin antagonist, demonstrates safety and efficacy in metastatic colorectal cancer (mCRC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2884</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2884.jpg</image:loc><image:title>MEDOCC-CrEATE trial update: Feasibility of measuring circulating tumor DNA post-surgery to guide adjuvant chemotherapy in stage II colon cancer patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2885</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2886</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2886.jpg</image:loc><image:title>JS207, a bispecific antibody targeting PD-1 and VEGF-A, combined with JS007 (anti-CTLA4), for patients with advanced hepatocellular carcinoma in a randomized, multicenter, Phase II study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2887</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2887.jpg</image:loc><image:title>Updated multicenter phase Ib/II analysis of surufatinib plus sintilimab and capecitabine in previously treated metastatic small bowel adenocarcinoma and appendiceal carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2888</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2888.jpg</image:loc><image:title>A phase II clinical trial of lurbinectedin in patients with advanced gastrointestinal malignancies with DNA repair mutations</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2889</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2889.jpg</image:loc><image:title>Analysis of tumor and biomarker responses in the VIRAGE Trial, a randomized Phase IIb, open-label, study of nab-paclitaxel and gemcitabine with/without intravenous VCN-01 in patients with metastatic pancreatic cancer (mPDAC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2890</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2890.jpg</image:loc><image:title>Inhibiting fatty acid oxidation can overcome acquired drug resistance in pancreatic cancer: A Phase 2 trial has begun</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2891</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2891.jpg</image:loc><image:title>Modifying the tumor microenvironment in gastric and gastroesophageal junction adenocarcinoma using a cGMP-phosphodiesterase inhibitor</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2892</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2892.jpg</image:loc><image:title>A phase II study of agenT-797, botensilimab (BOT) and balstilimab (BAL) in PD-1 refractory gastroesophageal cancer (GEC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2893</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2894</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2894.jpg</image:loc><image:title>Preclinical efficacy of a first-in-class anti-ALCAM ADC in hard-to-treat solid and hematologic malignancies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2895</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2896</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2896.jpg</image:loc><image:title>Development of conformation selective ITGB6 ADC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2897</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2898</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2899</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2900</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2901</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2901.jpg</image:loc><image:title>Nuvisertib (TP-3654) and Dordaviprone (ONC201) synergize to reduce renal cell carcinoma cell viability</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2902</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2903</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2904</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2904.jpg</image:loc><image:title>JM</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2905</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2906</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2906.jpg</image:loc><image:title>Rationale for the development of a differentiated Trop2 ADC in solid tumors of the bladder, lung, and breast</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2907</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2908</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2909</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2910</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2910.jpg</image:loc><image:title>NEK7 overexpression contributes to stemness of hepatocellular carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2911</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2911.jpg</image:loc><image:title>HMGB1 mediates chemoresistance and tumor progression in glioblastoma: Implications for targeted therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2912</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2913</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2914</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2915</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2915.jpg</image:loc><image:title>LIN-T (lipid integrated tag): An optimized tag-lipid nanoparticle design for targeted therapeutic mRNA delivery</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2916</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2916.jpg</image:loc><image:title>A STING-boosted lipid nanoparticle mRNA vaccine for therapeutic cancer vaccination</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2917</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2917.jpg</image:loc><image:title>Lipid nanoparticles enable high efficiency CRISPR HDR mediated gene insertions in primary human T cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2918</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2919</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2920</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2920.jpg</image:loc><image:title>Advancing mRNA therapeutics towards immuno-oncology applications: Lipid nanoparticles demonstrate favorable safety and efficacy profile with repeated mRNA administration in normal and tumor-bearing mice</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2921</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2921.jpg</image:loc><image:title>Enhancing CX-5461 therapy in TNBC through liposomal delivery and ATR inhibitor combination</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2922</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2922.jpg</image:loc><image:title>Combination effect of vinorelbine and doxorubicin in free solutions and liposomes in a multicellular spheroids model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2923</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2923.jpg</image:loc><image:title>Lipopolymer-mediated delivery of fusion oncogene-targeting siRNAs attenuates leukemia burden and improves survival in preclinical models of hematologic malignancies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2924</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2924.jpg</image:loc><image:title>The first coacervate based delivery system for efficient and safe genetic engineering in stem cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2925</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2925.jpg</image:loc><image:title>Lymphocyte-mimetic drug carriers enable targeted therapeutic delivery to lymph nodes for enhanced immunomodulation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2926</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2926.jpg</image:loc><image:title>ONM-421, a pH-responsive polymer-drug conjugate nanoparticle, delivers MMAE to solid tumors and shows antigen-independent antitumor efficacy in mice</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2927</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2927.jpg</image:loc><image:title>A peptide-based drug delivery system to target metastatic prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2928</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2928.jpg</image:loc><image:title>Capsaicin nanoparticles display robust growth-inhibitory activity in human NSCLC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2929</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2929.jpg</image:loc><image:title>Enhancing targeted delivery in multiple myeloma via novel NCI-H929 lipid-extracted-modified nanoliposomes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2930</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2930.jpg</image:loc><image:title>Self-synergizing mutual prodrug liposomes co-targeting redox homeostasis and PIN1 for cancer therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2931</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2931.jpg</image:loc><image:title>A polymer-drug conjugate platform for tumor specific drug delivery: Advancement of a clinically validated ultra pH-sensitive micelle technology</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2932</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2932.jpg</image:loc><image:title>Cellular uptake of nanoliposomes with optimized cholesterol concentration and lipid extract derived from a model low grade serous ovarian carcinoma cell line</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2933</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2933.jpg</image:loc><image:title>Investigating phosphatidylcholine and phosphoethanolamine phospholipids in conventional and novel cationic nanoliposomes for interactions with chronic myeloid leukemia cells in vitro</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2934</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2934.jpg</image:loc><image:title>A modular lipid-based oral drug delivery system for precision combination chemotherapy in breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2935</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2935.jpg</image:loc><image:title>SU-CCS-1 lipid extract-modified nanoliposomes and characteristic growth profile of a model clear cell sarcoma target cell line</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2936</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2936.jpg</image:loc><image:title>Enhanced delivery of doxorubicin via milk-derived extracellular vesicles in lung cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2937</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2937.jpg</image:loc><image:title>Electroporation-enhanced targeted bleomycin delivery for the treatment of canine perianal tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2938</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2938.jpg</image:loc><image:title>Electrochemotherapy for rectal adenocarcinoma: Advancing drug delivery through electroporation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2939</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2939.jpg</image:loc><image:title>Feasibility and safety of electroporation-enhanced bleomycin delivery for the treatment of parenchymal tumors in dogs and cats</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2940</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2940.jpg</image:loc><image:title>Electrochemotherapy as an innovative drug delivery modality for local control of canine acanthomatous ameloblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2941</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2941.jpg</image:loc><image:title>Intellipulse platform for efficient and effective delivery of therapeutics to solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2942</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2942.jpg</image:loc><image:title>Investigating the therapeutic potential of a nanocrystal PRMT5 inhibitor in pancreatic ductal adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2943</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2943.jpg</image:loc><image:title>Dickkopf1 as a potential therapeutic target in highly aggressive breast cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2944</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2944.jpg</image:loc><image:title>A first-in-class ER stress modulator selectively induces regulated cell death of STK11/TP53-deficient cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2945</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2945.jpg</image:loc><image:title>FGFR2b is a highly prevalent and actionable cell surface target in intrahepatic cholangiocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2946</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2946.jpg</image:loc><image:title>Development of a SIX1-specific PROTAC for the treatment of esophageal adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2947</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2947.jpg</image:loc><image:title>A novel MMP-targeting peptide suppresses glioblastoma metastasis by reducing MSI1 activity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2948</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2948.jpg</image:loc><image:title>Targeting the non-canonical neddylation of TGRBR2 suppresses the metastatic potentials of oral squamous cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2949</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2949.jpg</image:loc><image:title>Discovery of a novel, covalent and heterobifunctional thioredoxin reductase inhibitor with antitumor activity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2950</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2950.jpg</image:loc><image:title>Site-specific conjugation of CPL976H-MMAE enables stable and selective dual targeting of PD-L1 and AXL</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2951</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2951.jpg</image:loc><image:title>TEAD inhibition by IAG933 as a novel therapeutic strategy for cholangiocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2952</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2953</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2953.jpg</image:loc><image:title>YT-DP: A glyco-conjugation-based dual-payloads ADC platform</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2954</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2954.jpg</image:loc><image:title>Network-based discovery of tumor-checkpoint inverter drugs targeting pancreatic ductal adenocarcinoma cell states and macrophage reprogramming</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2955</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2955.jpg</image:loc><image:title>Molecular characterization of inhibition of the DNA repair protein RAD51 by the small molecule JKYN-1</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2956</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2956.jpg</image:loc><image:title>ART1 as an immune modulating therapeutic target in EGFR-mutated lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2957</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2957.jpg</image:loc><image:title>Targeting AURKA and TRIP13 exploits mitotic vulnerability and enhances antitumor immunity in Rb-deficient immunocompetent lung cancer models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2958</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2958.jpg</image:loc><image:title>Targeting NONO as a therapeutic strategy for metastatic castration-resistant prostate cancer (mCRPC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2959</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2959.jpg</image:loc><image:title>Characterization of a novel inhibitor of asparagine synthetase that activates the integrated stress response</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2960</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2960.jpg</image:loc><image:title>VRK1 inhibition leverages paralog synthetic lethality to selectively target VRK2-deficient cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2961</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2961.jpg</image:loc><image:title>Exploring the anti-tumor potential of HLA-G-targeted therapeutics through diverse preclinical approaches</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2962</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2962.jpg</image:loc><image:title>Epiregulin and amphiregulin as dual targets in colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2963</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2963.jpg</image:loc><image:title>SLC25A28 is a synthetic lethal target in nucleotide excision repair-deficient cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2964</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2964.jpg</image:loc><image:title>Targeting TUBB2B: Exploiting brain metastatic vulnerabilities in triple-negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2965</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2965.jpg</image:loc><image:title>Optimizing targeting molecule density on drug carriers to improve cellular uptake</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2966</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2966.jpg</image:loc><image:title>The anti-cancer effects of silibinin through the modulation of JAK1/STAT3 signaling and inhibition of MMPs levels in triple-negative breast cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2967</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2968</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2968.jpg</image:loc><image:title>Discovery of the RAD51 inhibitor JKYN-1 and characterization of its anticancer activity in preclinical models of non-small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2969</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2969.jpg</image:loc><image:title>Selective CDK2 inhibition with ECI830: preclinical characterization, efficacy, and on-target mechanism supported by biomarker and gene signature analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2970</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2970.jpg</image:loc><image:title>Identification and characterization of novel peptide binders against platinum resistant epithelial ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2971</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2971.jpg</image:loc><image:title>YB-1 small-molecule inhibitor improves chemotherapy success in treating high-grade serous ovarian carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2972</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2972.jpg</image:loc><image:title>Spatial proteomics reveals vasculature and immune modulation for overcoming doxorubicin resistance in breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2973</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2974</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2975</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2975.jpg</image:loc><image:title>OC201 and OC202e, an AI-driven drug combination, enhance the susceptibility of pancreatic cancer to FOLFIRINOX by modulating HIF-1alpha</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2976</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2976.jpg</image:loc><image:title>CWH43 emerges as a novel therapeutic target linked to chemoresistance in colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2977</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2977.jpg</image:loc><image:title>LEDGF/p75 drives chemoresistance in CML via JAK/STAT pathway modulation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2978</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2978.jpg</image:loc><image:title>Extracellular matrix glycan signatures predict chemotherapy response in ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2979</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2979.jpg</image:loc><image:title>Targeting LIF/LIFR signaling with EC359 overcomes chemoresistance and enhances chemotherapy efficacy in ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2980</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2980.jpg</image:loc><image:title>Pancreatic cancer cells elevate NAD+production in response to nutrient limitation and chemotherapeutic stress</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2981</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2981.jpg</image:loc><image:title>Targeting chemoresistance in ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2982</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2982.jpg</image:loc><image:title>Chronic type 1 interferon exposure phenocopies chronic cisplatin exposure in high grade serous ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2983</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2984</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2984.jpg</image:loc><image:title>CDK4/6 inhibition overcomes 5-FU resistance by suppressing TYMS-driven R-loop-associated DNA damage in colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2985</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2985.jpg</image:loc><image:title>Defining the role of nucleolar stress in mediating DDB2 induced oxaliplatin resistance in colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2986</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2986.jpg</image:loc><image:title>Dichloroacetate reprograms metabolism and disrupts ROS adaptation, attenuating stemness to reverse chemoresistance in ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2987</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2988</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2988.jpg</image:loc><image:title>Using genome wide CRISPR screening to identify synthetic lethal targets for overcoming chemoresistance in rhabdomyosarcoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2989</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2989.jpg</image:loc><image:title>METTL7B-driven m6A RNA methylation promotes gemcitabine resistance and tumor progression in pancreatic ductal adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2990</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2990.jpg</image:loc><image:title>Integrative multi-omic investigation of gene regulatory networks associated with chemotherapy response in acute lymphoblastic leukemia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2991</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2991.jpg</image:loc><image:title>Metabolic reprogramming via statin repurposing: A strategy to reverse the Warburg effect and overcome gemcitabine resistance in pancreatic ductal adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2992</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2992.jpg</image:loc><image:title>SRSF1 orchestrates splicing-directed dual-engine glucose metabolism driving chemoresistance in diabetes-associated pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2993</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2993.jpg</image:loc><image:title>Transcriptomic analysis of glycosylation genes in chemotherapeutic-resistant glioma cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2994</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2994.jpg</image:loc><image:title>Overcoming chemoresistance: Restoring doxorubicin sensitivity and natural killer cell immunity in resistant DLBCL cells through reduction of endoplasmic reticulum stress</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2995</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2995.jpg</image:loc><image:title>IDH1 inhibition potentiates gemcitabine efficacy in pancreatic ductal adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2996</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2997</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2997.jpg</image:loc><image:title>Systematic mechanistic profiling of ADC-resistant cancer cell lines</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2998</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2998.jpg</image:loc><image:title>Determinants of sacituzumab govitecan therapeutic response in breast cancer models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/2999</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/2999.jpg</image:loc><image:title>Retinoic acid pathway regulates NECTIN4 expression and enhances NECTIN4-directed chimeric antigen receptor (CAR) T and antibody-drug conjugate therapies in bladder cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3000</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3000.jpg</image:loc><image:title>P-glycoprotein (ABCB1) overexpression confers resistance to the antibody-drug conjugate Enfortumab vedotin in EV-resistant organoid and PDX models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3001</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3001.jpg</image:loc><image:title>Improving the efficacy of B7-H3 targeting antibody-drug conjugates in TP53-deficient prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3002</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3002.jpg</image:loc><image:title>Overcoming acquired and intrinsic resistance with an integrated ADC platform</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3003</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3003.jpg</image:loc><image:title>Developing ADC-resistant tumor models for efficacy evaluation of next-generation anticancer therapies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3004</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3004.jpg</image:loc><image:title>HER2 ADC resistance driven by IL-17 signaling and ROR1 upregulation: Overcoming DS-8201 resistance with BRY812 and BR111</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3005</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3005.jpg</image:loc><image:title>Development and characterization of a novel in vivo JIMT-1 DS8201a resistant model and its efficacy evaluation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3006</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3006.jpg</image:loc><image:title>Identification of synergistic dual payload combinations for antibody-drug conjugates to overcome resistance through resistance modeling</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3007</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3007.jpg</image:loc><image:title>Identification of TROP2 as an adaptive resistance mechanism in KRAS G12C inhibition and its therapeutic targeting</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3008</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3008.jpg</image:loc><image:title>Zongertinib-tolerant cells enhanced sensitivity to Topo1 inhibition in Her2-positive NCSLC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3009</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3009.jpg</image:loc><image:title>Evolution of TOP1 variants under selective pressure from topoisomerase-based therapeutics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3010</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3010.jpg</image:loc><image:title>EGFR S442 mutation confers cetuximab resistance that can be overcome by ERBB2 blockade by trastuzumab-deruxtecan</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3011</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3011.jpg</image:loc><image:title>B836: A novel bispecific antibody-drug conjugate (ADC) as a clinical candidate to overcome trastuzumab deruxtecan resistance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3012</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3012.jpg</image:loc><image:title>Limited efficacy of HER3-DXd in colorectal cancer PDX models reveals molecular resistance mechanisms and informs rational combinatorial strategies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3013</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3013.jpg</image:loc><image:title>In-depth profiling of SCLC models of acquired chemoresistance reveals SLFN11-dependent antibody-drug conjugate payload sensitivity and ATR inhibitor synergy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3014</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3014.jpg</image:loc><image:title>TROP2 upregulation and interaction with HER2 mediate trastuzumab resistance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3015</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3015.jpg</image:loc><image:title>The anticancer effect of TROP2-targeted antibody-drug conjugates (ADC) is potentially attenuated by dysregulated cholesterol metabolism in cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3016</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3016.jpg</image:loc><image:title>Q702 enhances trastuzumab efficacy for HER2 + gastric cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3017</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3017.jpg</image:loc><image:title>&amp;#950;-Stat inhibits glioblastoma multiforme progression by targeting PKC-&amp;#950;/Cx43 signaling and inducing senescence</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3018</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3018.jpg</image:loc><image:title>Monzosertib, a selective CDC7 inhibitor, induces cell death via premature mitosis promoted by the FOXM1-cyclinB1 axis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3019</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3019.jpg</image:loc><image:title>Sonrotoclax (BGB-11417), a selective Bcl-2 inhibitor, demonstrates better efficacy than Venetoclax (Ven) and Lisaftoclax (APG-2575) in hematological cancer cells, xenografts, and human bloods</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3020</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3020.jpg</image:loc><image:title>Synthetic lethality of G6PD deficiency and asparaginase for colorectal cancer therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3021</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3021.jpg</image:loc><image:title>KRAS inhibition-induced GSDME-mediated pyroptosis and its augmentation by LAT1 inhibition in KRAS-mutant lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3022</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3022.jpg</image:loc><image:title>Immune and pharmacodynamic effects of sotorasib plus panitumumab in KRAS G12C-mutant colorectal cancer: Paired biopsy results from CodeBreaK 101</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3023</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3023.jpg</image:loc><image:title>Unraveling determinants of drug response: PRISM viability profiling of hundreds of oncology therapeutics reveals mediators of selectivity and mechanism</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3024</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3024.jpg</image:loc><image:title>RC108, a c-Met-targeting ADC, exhibits differential cytotoxicity between cMet-high and HGF-dependent tumor cells compared with Teliso-V, suggesting a potential safety advantage</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3025</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3025.jpg</image:loc><image:title>Combination of miRNA-379-5p and miRNA-125a-3p for the treatment of platinum resistant ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3026</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3026.jpg</image:loc><image:title>Itareparib: A potent, selective and non-trapper PARP1 inhibitor for combination therapy with DNA damaging agents in solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3027</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3028</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3028.jpg</image:loc><image:title>Establishment of experimental model for measuring antibody-drug conjugate (ADC) bystander effects in breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3029</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3029.jpg</image:loc><image:title>NAMPT inhibition enhances the efficacy of standard chemotherapies and immunomodulation in pancreatic ductal adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3030</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3030.jpg</image:loc><image:title>Imipridones ONC201, ONC206, and ONC212 show potent killing and colony arrest of small-cell lung cancer cell lines</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3031</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3031.jpg</image:loc><image:title>KRAS and ERK5 signaling pathways in cancer: Implications for targeted therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3032</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3033</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3033.jpg</image:loc><image:title>Tumor-selective dimeric and monomeric RAF targeting with a next-generation Type 1 RAF inhibitor</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3034</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3034.jpg</image:loc><image:title>Pharmacologic ascorbate exerts anticancer activity through ROS-dependent metabolic vulnerability in MYCN-amplified neuroblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3035</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3035.jpg</image:loc><image:title>Inhibition of stearoyl-CoA desaturase 1 (SCD1) by SSI-4 as a therapeutic strategy in non-small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3036</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3036.jpg</image:loc><image:title>Antitumor effect of TROP2-targeted antibody drug conjugate, datopotamab deruxtecan (Dato-DXd), in association with DNA damage response in breast cancer cell lines</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3037</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3037.jpg</image:loc><image:title>Uncovering the zinc-dependent pathways of response and resistance to THZ1 in clear cell ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3038</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3038.jpg</image:loc><image:title>Target actin-microtubule network integrity to enhance taxane drug-target engagement and chemosensitivity in prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3039</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3039.jpg</image:loc><image:title>RQ43: A quinoline derivative that inhibits pancreatic cancer cell EMT and migration</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3040</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3041</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3041.jpg</image:loc><image:title>A spatial-trapping mechanism of RAF by RAF/MEK glue enables full-dose combination with a pan-RAF inhibitor and drives potent, RAS-mutant tumor-selective MAPK and growth inhibition</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3042</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3042.jpg</image:loc><image:title>Palazestrant, a CERAN, in combination with OP-3136, a KAT6 inhibitor, synergistically downregulates cell proliferation and metastasis related gene signatures</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3043</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3043.jpg</image:loc><image:title>Palazestrant directly recruits the corepressor protein NCoR1 in vitro leading to complete antagonism of estrogen receptor alpha</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3044</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3044.jpg</image:loc><image:title>Adaptive and acquired mechanisms underlying RAS-mutant tumor response to mutant and state selective RAS inhibitors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3045</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3045.jpg</image:loc><image:title>MAPK driven kinetochore instability as a biomarker and therapeutic vulnerability in glioblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3046</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3046.jpg</image:loc><image:title>SMARCA2 and SMARCA4 expression in cancer: A tissue microarray study on 14,966 tumors from 134 different tumor types</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3047</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3047.jpg</image:loc><image:title>PM54 targets oncogenic transcriptional networks across multiple cancer types</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3048</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3048.jpg</image:loc><image:title>Role of high mobility group nucleosome-binding domain-containing protein 3 (HMGN3) in prostate cancer progression a novel target for therapeutic intervention</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3049</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3049.jpg</image:loc><image:title>Genome-wide CRISPRi screen identifies RPS27 as a novel synthetic lethal target for TP53 mutant cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3050</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3050.jpg</image:loc><image:title>In situ and functional analysis of Integrin-alpha 5 reveals its role in tumor progression in non-small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3051</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3051.jpg</image:loc><image:title>TRIB2 as a therapeutic vulnerability in ALK-rearranged non-small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3052</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3052.jpg</image:loc><image:title>Vertical inhibition of the autophagy pathway promotes growth arrest and apoptotic cell death in pancreatic ductal adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3053</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3053.jpg</image:loc><image:title>Cordycepin inhibits Intrahepatic cholangiocarcinoma progression by targeting NAT10-mediated ac4C RNA modification of VCAN</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3054</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3054.jpg</image:loc><image:title>A druggable genome screen identifies b-catenin transcription targets as desmoid cell vulnerabilities</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3055</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3055.jpg</image:loc><image:title>ONCO Prime platform enables discovery of synthetic lethal targets for genetically stratified cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3056</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3056.jpg</image:loc><image:title>PSMA expression in neoplastic cells and tumor-associated vasculature: A tissue microarray study evaluating 12,409 cancers from 135 different tumor types</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3057</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3058</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3058.jpg</image:loc><image:title>The role of FOXD1 in the anaplastic transformation of thyroid cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3059</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3059.jpg</image:loc><image:title>Deciphering the key role of the glycosyltransferase GALNT14 in osteosarcoma tumorigenesis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3060</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3060.jpg</image:loc><image:title>Integrative pathway analysis of I-SPY2 HER2+ breast cancers reveals drug-repurposing opportunities</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3061</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3061.jpg</image:loc><image:title>ATRX in-frame fusions promote endogenous chemoresistance programs but yield immunotherapeutic vulnerabilities in neuroblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3062</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3062.jpg</image:loc><image:title>Internalization of B7-H3 is enhanced by cholesterol disruption in esophageal cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3063</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3063.jpg</image:loc><image:title>LTA4H promotes intrahepatic cholangiocarcinoma progression via mTOR activation and T-cell exhaustion</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3064</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3064.jpg</image:loc><image:title>Disrupted clock pathway during lineage plasticity and prostate cancer progression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3065</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3065.jpg</image:loc><image:title>Targeting cholesterol pathways in p53 deficient head and neck cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3066</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3066.jpg</image:loc><image:title>Tumor Treating Fields (TTFields) may weaken glioblastoma network connectivity, with implications for malignancy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3067</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3067.jpg</image:loc><image:title>Therapeutic inhibition of oncogenic miR-181a processing for cancer therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3068</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3068.jpg</image:loc><image:title>Aneuploidy as a metabolic liability: Exploiting novel therapeutic targets in squamous cell carcinomas</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3069</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3069.jpg</image:loc><image:title>Impact of sequencing technology on actionable fusion detection in precision oncology for lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3070</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3070.jpg</image:loc><image:title>OXTR targeted local therapy could be a promising strategy for pleural mesothelioma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3071</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3071.jpg</image:loc><image:title>Ex vivo trial of ODM-212, a novel pan-TEAD inhibitor, in patients with primary and metastatic solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3072</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3072.jpg</image:loc><image:title>Genomic determinants of PIK3CA mutation driven breast cancer initiation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3073</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3074</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3074.jpg</image:loc><image:title>Comparative analysis of phenotypic markers of DPD activity as biomarkers of 5-FU toxicity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3075</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3075.jpg</image:loc><image:title>Pharmacogenetic assays for personalized cancer treatment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3076</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3077</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3077.jpg</image:loc><image:title>CellMiner Cross-Database (CellMinerCDB) for Exploration of Patient-Derived Cancer Cell Line Pharmacogenomics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3078</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3078.jpg</image:loc><image:title>drGT: Attention-guided gene assessment of drug response utilizing a drug-cell-gene heterogeneous network</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3079</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3079.jpg</image:loc><image:title>Characterizing the critical role of enhancer-gene regulation in 5-fluorouracil toxicity and resistance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3080</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3080.jpg</image:loc><image:title>Integrative genomic analysis reveals pharmacogenomic determinants of chemotherapy response</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3081</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3082</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3083</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3083.jpg</image:loc><image:title>Targeting AR-SREBP crosstalk in prostate adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3084</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3084.jpg</image:loc><image:title>Pharmacologic inhibition of SREBP-driven lipogenesis suppresses metastatic progression in prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3085</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3085.jpg</image:loc><image:title>Targeting KMT2D enhances sensitivity to AKT inhibition in treatment resistant prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3086</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3086.jpg</image:loc><image:title>Pinostilbene exhibits anticancer activity in advanced prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3087</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3088</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3089</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3090</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3091</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3091.jpg</image:loc><image:title>Development of iPSC-derived human liver organoids for preclinical drug testing and toxicology studies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3092</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3093</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3093.jpg</image:loc><image:title>Novel inhibitors of BCRP and P-gp found among drugs used in the treatment of cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3094</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3095</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3095.jpg</image:loc><image:title>Pharmacokinetics of a series of anticancer agents in immunodeficient female NOD scid gamma mice</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3096</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3097</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3098</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3098.jpg</image:loc><image:title>Synergistic preclinical activity of dual CDK4/6 and mTORC1 inhibition in translocation renal cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3099</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3099.jpg</image:loc><image:title>Assessing statin sensitivity and hypoxia regulation in aggressive metastatic cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3100</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3100.jpg</image:loc><image:title>FOXM1 as a drug target in NF1-associated malignant peripheral nerve sheath tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3101</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3101.jpg</image:loc><image:title>Selective PARP2 inhibitor disrupting PARP2-FOXA1 interaction to inhibit androgen receptor signaling in prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3102</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3102.jpg</image:loc><image:title>Inhibition of d e novo purine biosynthesis via PPAT targeting by cucurbitacin B restrains esophageal squamous cell carcinoma growth</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3103</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3103.jpg</image:loc><image:title>CKAP2 modulation with a novel small molecule results in excellent in-vitro and in-vivo anti tumor activity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3104</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3104.jpg</image:loc><image:title>PKMYT1 inhibition is synthetically lethal with CCNE1 overexpression and synergizes with standard of care chemotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3105</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3105.jpg</image:loc><image:title>TM4SF20 scaffolds DDR1-IRS4 signaling to drive PDAC metastasis and represents a druggable therapeutic target</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3106</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3106.jpg</image:loc><image:title>Robust and durable antitumor activity of a novel PDE10 inhibitor, ADT-030, that enhances the efficacy of chemotherapy and immunotherapy by blocking RAS and beta-catenin signaling and overcoming resistance to RAS-selective inhibitors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3107</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3107.jpg</image:loc><image:title>A small molecule inhibitor of NVL suppresses tumor growth by blocking ribosome biogenesis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3108</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3108.jpg</image:loc><image:title>Nesuparib enhances anti-tumor efficacy with gemcitabine and nab-paclitaxel in BRCA wild type pancreatic cancer xenograft model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3109</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3109.jpg</image:loc><image:title>Atamparib: First-in-class PARP7 inhibitor for treatment of NSCLC adenocarcinoma in monotherapy and in combination with standards of care</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3110</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3110.jpg</image:loc><image:title>RPT1G, a novel hyperbolic NAMPT inhibitor, effectively synergizes with PARP inhibitors in solid tumors in vitro and in a xenograft breast cancer model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3111</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3111.jpg</image:loc><image:title>Enhancing matchmaking in targeted therapy (TT) for cancer (ca): Beyond the &amp;#8216;arranged&#039; criteria</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3112</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3112.jpg</image:loc><image:title>RK-582, a tankyrase inhibitor, attacks Wnt-driven colorectal cancer cells with short-type APC mutations and high beta-catenin expression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3113</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3113.jpg</image:loc><image:title>Combination of the MDM2 antagonist ASTX295 and Olaparib as a novel treatment option for BRCA2 mutant, TP53 wild-type solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3114</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3114.jpg</image:loc><image:title>Inhibition of ARNT suppresses growth of primary human kidney cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3115</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3115.jpg</image:loc><image:title>Targeting the MKK3/MYC protein-protein interaction to overcome drug resistance in MYC-driven cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3116</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3116.jpg</image:loc><image:title>Inhibition of oncogenic phenotypes by hexanoate in triple-negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3117</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3117.jpg</image:loc><image:title>A first-in-class orally bioavailable small molecule tumor suppressor activator for the treatment of a wide range of cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3118</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3118.jpg</image:loc><image:title>Targeting metabolic dependencies in MYC-driven osteosarcoma through Lp-PLA2 inhibition</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3119</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3119.jpg</image:loc><image:title>Periplocin restores HTR1E signaling by CTCF to inhibit proliferation and dissemination of ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3120</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3120.jpg</image:loc><image:title>CS231295, a novel AURKB-biased multi-kinase inhibitor, demonstrates synthetic lethality in RB1-deficient tumors and potent intracranial efficacy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3121</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3121.jpg</image:loc><image:title>TRIM7 inhibition blocks RTK/RAS pathway driven tumor proliferation independent of mutation and in the setting of KRASi resistance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3122</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3122.jpg</image:loc><image:title>Selective cytotoxicity of butyrate highlights its potential as a targeted anti-cancer agent</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3123</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3123.jpg</image:loc><image:title>Synergistic combinations of novel small molecule CtBP inhibitors with DR5 agonists or BH3-mimetic PROTACs targeting chemoresistant high grade serous ovarian carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3124</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3124.jpg</image:loc><image:title>Therapeutic efficacy of CK2 inhibitor in patient-derived lung metastatic model of Ewing sarcoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3125</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3125.jpg</image:loc><image:title>A novel class of allosteric CDK8/19 inhibitors induces synthetic lethality through concurrent mTOR and c-MYC suppression and activation of p53-mediated G2/M arrest</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3126</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3126.jpg</image:loc><image:title>Short-chain fatty acids suppress invasion and clonogenic survival in triple-negative breast cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3127</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3127.jpg</image:loc><image:title>Targeting ornithine aminotransferase as a promising therapeutic strategy for hepatocellular carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3128</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3128.jpg</image:loc><image:title>Involvement of ROS species in amiloride derivative-induced lysosome-dependent cell death in triple-negative breast cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3129</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3129.jpg</image:loc><image:title>Specificity and timing of TREM-1 blockade initiation impact its therapeutic efficacy in cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3130</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3130.jpg</image:loc><image:title>Safety and activity of cLRRC15-IFNa, a conditionally active biologic targeting IFNa specifically to LRRC15+ CAFs</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3131</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3131.jpg</image:loc><image:title>Selective inhibition of eIF4A targets tumor-associated macrophages to restore lymphoma-specific immunity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3132</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3132.jpg</image:loc><image:title>Alphavirus replicon expressing IL-12 reprograms tumor-associated macrophages and neutrophils and induces anti-tumor immunity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3133</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3133.jpg</image:loc><image:title>JAK inhibition enhances virotherapy in gliomas by modulating interferon-driven resistance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3134</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3134.jpg</image:loc><image:title>Therapeutic targeting of TGR5 abrogates bile acid driven myeloid cell immunosuppression in cholangiocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3135</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3136</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3136.jpg</image:loc><image:title>Aging-related morphological change in regional lymph nodes promotes an immunosuppressive microenvironment in colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3137</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3137.jpg</image:loc><image:title>Oncolytic virus-chemotherapy combination improves control of PDAC growth and spread</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3138</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3138.jpg</image:loc><image:title>Activation of the cGAS-STING signaling pathway as an immunotherapeutic approach to glioblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3139</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3139.jpg</image:loc><image:title>Integrated spatial, single-cell, and in vivo dissection of matrix CAF-driven immune exclusion in colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3140</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3140.jpg</image:loc><image:title>Deciphering the function of lipid-associated macrophages in immunotherapy resistance of hepatocellular carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3141</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3141.jpg</image:loc><image:title>Modulating the tumor microenvironment (TME) to enhance anti tumor immunity using metabolic inhibitors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3142</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3143</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3143.jpg</image:loc><image:title>Pancreatic adenocarcinoma immune tumor microenvironment is shaped by differential miRNA expression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3144</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3144.jpg</image:loc><image:title>The iRGD peptide reprograms the tumor microenvironment and potentiates immunotherapy in an advanced humanized PDAC mouse model.</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3145</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3145.jpg</image:loc><image:title>Characterization of tumor microenvironment phenotypes as potential biomarkers for immune infiltration</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3146</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3147</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3147.jpg</image:loc><image:title>Targeting USP22 reprograms the tumor microenvironment and sensitizes KRAS-mutant, TP53-Null Lung cancer to immunotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3148</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3148.jpg</image:loc><image:title>GRN deficiency loosens stromal barriers and enhances MHC-II signaling yet reduces MHC-I driven cytotoxic immunity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3149</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3149.jpg</image:loc><image:title>Versican expression and proteolysis as a biomarker for CD8+ T cell infiltration across cancer types and molecular profiles</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3150</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3151</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3152</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3152.jpg</image:loc><image:title>Modulating the tumor microenvironmentwith an engineered oncolytic herpesvirus facilitates potent antitumor response</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3153</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3153.jpg</image:loc><image:title>Tumor-intrinsic METTL5 restricts T cell-induced ferroptosis by impairing ATF4 translation in ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3154</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3155</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3155.jpg</image:loc><image:title>Novel strategies for targeting B7-H3 to empower precision oncology</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3156</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3157</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3158</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3159</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3160</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3160.jpg</image:loc><image:title>Afatinib exerts an inhibitory effect on T cell-mediated cytotoxicity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3161</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3161.jpg</image:loc><image:title>Immunomodulatory response in Dato-DXd-treated non-small cell lung cancer patient-derived organotypic tumor spheroids (pDOTS)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3162</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3162.jpg</image:loc><image:title>RAS(ON) inhibition in both cancer and immune cells by daraxonrasib drives anti-tumor immunity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3163</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3164</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3164.jpg</image:loc><image:title>Amivantamab restores antitumor immunity in non-small cell lung cancer through EGFR/MET expression-dependent mechanisms</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3165</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3165.jpg</image:loc><image:title>Identification of CXCL10-CXCR3 axes as mediators of radioresistance in diffuse midline glioma (DMG)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3166</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3166.jpg</image:loc><image:title>Leveraging radiation inducible surface protein targets for tumor microenvironment reprogramming</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3167</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3168</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3168.jpg</image:loc><image:title>Enhanced tumor immune cell infiltration and antigen presentation after carbon ion radiotherapy correlates with curative outcomes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3169</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3169.jpg</image:loc><image:title>Inhibiting both Class IIb HDACs is superior to isoform-specific inhibition for improved antitumor immune response.</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3170</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3170.jpg</image:loc><image:title>Modulation of the tumor microenvironment using 5-fluorouracil to increase T cell infiltration in breast cancer bone metastases</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3171</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3171.jpg</image:loc><image:title>PM54 reshapes the tumor microenvironment to potentiate checkpoint blockade</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3172</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3172.jpg</image:loc><image:title>Investigating the capability of metformin to increase the efficacy of oncolytic herpesvirus in ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3173</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3174</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3174.jpg</image:loc><image:title>Cannabis smoking increases systemic inflammation and reduces immunity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3175</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3176</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3176.jpg</image:loc><image:title>Inflammasome dependent and independent dysregulation associated with periodontal disease and oral cancer risk in people with HIV</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3177</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3177.jpg</image:loc><image:title>Sweet boost: Sucralose enhances regulatory T cell (Treg) functions in vitro</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3178</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3178.jpg</image:loc><image:title>Harnessing SHP2-targeted signaling to reinforce anti-tumor immune responses</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3179</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3179.jpg</image:loc><image:title>Endostatin and prolactin combination trigger PRLR induction and channelize CD1d signaling in TNBC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3180</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3180.jpg</image:loc><image:title>PHI-501, a novel pan-RAF inhibitor, enhances immunotherapy efficacy by converting cold tumors into hot tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3181</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3181.jpg</image:loc><image:title>EGFR-TKI drives the reprogramming of CD8&amp;#8314; T cell immunity in non-small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3182</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3183</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3183.jpg</image:loc><image:title>VPAC antagonism as potential therapeutic for prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3184</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3184.jpg</image:loc><image:title>Antibiotics blunt the innate immune mechanisms underlying HER2+ breast cancer therapy efficacy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3185</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3185.jpg</image:loc><image:title>Evaluation of &amp;#178;&amp;#185;&amp;#178;Pb-PSMA radioligand therapy in an immunocompetent prostate cancer model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3186</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3186.jpg</image:loc><image:title>Induction of immunogenic cell stress through the inhibition of topoisomerase I</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3187</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3188</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3188.jpg</image:loc><image:title>Translating combined PD1 and LAG3 inhibition from preclinical models to patients with refractory, DNA replication repair deficient (RRD) glioblastoma: An IRRDC study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3189</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3189.jpg</image:loc><image:title>A macrophage endocytic checkpoint for PD-1 governs durable vs hyperprogressive response</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3190</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3190.jpg</image:loc><image:title>CD112 drives tumor immune evasion in HER2-positive breast cancer through sphingolipid metabolism-dependent remodeling of CD8+T cell receptor landscapeand consequent dysfunction</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3191</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3191.jpg</image:loc><image:title>Tumoral IL-33/ST2 signaling drives immune escape through reduced antigen presentation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3192</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3192.jpg</image:loc><image:title>Understanding the mechanism by which CD4 + T cells sensitize mesenchymal CD73-deficient tumors to anti-CTLA4 immune checkpoint blockade therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3193</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3193.jpg</image:loc><image:title>SRY-mediated upregulation of PD-L1 promotes immune evasion in hepatocellular carcinoma and contributes to sex-specific disparities in immunotherapy response</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3194</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3194.jpg</image:loc><image:title>In vitro antigen-specific T cell exhaustion model for immunomodulators evaluation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3195</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3195.jpg</image:loc><image:title>Ex vivo micro-tumor testing platform to characterize and predict patient-specific immunotherapy drug responses</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3196</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3196.jpg</image:loc><image:title>Sialic acid inhibits engager-mediated T cell activation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3197</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3197.jpg</image:loc><image:title>Myoglobin expression boosts T-cell metabolism and antitumor effector function</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3198</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3199</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3199.jpg</image:loc><image:title>A first in class VIP receptor antagonist as an immunotherapeutic for acute myeloid leukemia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3200</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3200.jpg</image:loc><image:title>VIP/VPAC signaling as a phagocytosis checkpoint in TP53-mutated acute myeloid leukemia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3201</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3201.jpg</image:loc><image:title>Anti-PD-1 efficacy is associated with a clonal trajectory composed of chronic effectors with lymph node homing capacity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3202</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3202.jpg</image:loc><image:title>Bhlhe40 shapes distinct T cell reponses to anti PD1 and anti CTLA4 immune checkpoint therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3203</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3203.jpg</image:loc><image:title>Targeting AHR overcomes PD-L1-driven resistance to immune checkpoint blockade in triple-negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3204</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3204.jpg</image:loc><image:title>Comprehensive single-cell atlas of immune ecosystem in response to immune checkpoint blockade therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3205</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3205.jpg</image:loc><image:title>Cytoplasmic PD-L1 levels are associated with tumor progression in small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3206</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3206.jpg</image:loc><image:title>Discovery and preclinical evaluation of novel peptide inhibitors targeting the TIGIT immune checkpoint</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3207</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3207.jpg</image:loc><image:title>Immune checkpoint therapy induces tertiary lymphoid structures in a murine model of triple-negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3208</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3208.jpg</image:loc><image:title>Preclinical Characterization of ALG-094295, a highly potent and orally bioavailable small molecule PD-1/PD-L1 inhibitor targeting dimerization, internalization and degradation of PD-L1</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3209</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3209.jpg</image:loc><image:title>Preclinical characterization of ALG-093940, a potent and orally bioavailable small molecule PD-1/PD-L1 inhibitor targeting PD-L1 dimerization, internalization and degradation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3210</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3210.jpg</image:loc><image:title>Spatial mapping of PD1-PD-L2 interactions suggests an additional checkpoint axis in non-small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3211</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3211.jpg</image:loc><image:title>TRIB2 regulates immune evasion in antiandrogen-resistant and neuroendocrine prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3212</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3212.jpg</image:loc><image:title>Serial transcriptomic analyses capture the effects of neoadjuvant immune checkpoint inhibition in resectable gastroesophageal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3213</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3213.jpg</image:loc><image:title>Single-cell RNA-seq reveals insights into the effects of immune checkpoint inhibitors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3214</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3215</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3216</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3217</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3217.jpg</image:loc><image:title>Investigating the impact of metabolic endotoxemia on breast cancer risk and progression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3218</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3219</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3220</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3221</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3222</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3223</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3223.jpg</image:loc><image:title>Maternal obesity promotes gut dysbiosis, CD4&amp;#8314; T-cell reprogramming and increased prostate cancer in offspring</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3224</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3225</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3225.jpg</image:loc><image:title>Neurotensin suppresses anti-tumor immunity and is associated with poor prognosis in colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3226</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3227</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3228</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3228.jpg</image:loc><image:title>The role of oral microbiota in pre-metastatic niche preparation in the brain</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3229</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3230</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3230.jpg</image:loc><image:title>Antibiotic driven microbiota disruption impairs HER2 targeted therapy efficacy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3231</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3232</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3232.jpg</image:loc><image:title>The impact of high fat diet on tumor growth is dependent on fatty acid composition and tumor type</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3233</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3234</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3234.jpg</image:loc><image:title>Defined bacterial consortium highlights the impact of carcinogenic bacteria on DNA methylation and tumorigenesis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3235</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3236</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3236.jpg</image:loc><image:title>Microbiota-driven modulation of tumor growth in Li-Fraumeni Syndrome: Evidence for bile acids as a key mediator</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3237</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3237.jpg</image:loc><image:title>Cell-Autonomous EPHB2 signaling sustains neuroendocrine prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3238</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3238.jpg</image:loc><image:title>Pi3k autoinhibition dictates rras2 dependency across HER2-amplified and PI3K-mutant cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3239</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3240</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3240.jpg</image:loc><image:title>HER2 overexpression confers osimertinib resistance in EGFR-mutant lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3241</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3242</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3242.jpg</image:loc><image:title>Autocrine lymphotoxin signalling promotes ovarian tumor growth through CD74</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3243</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3243.jpg</image:loc><image:title>Targeting OSMR signaling networks for precision oncology</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3244</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3245</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3245.jpg</image:loc><image:title>Phosphorylation of StarD10 regulates ErbB2-mediated alcohol-induced breast cancer progression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3246</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3246.jpg</image:loc><image:title>Investigating the impact of HER4 mutations on HER2 signaling</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3247</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3247.jpg</image:loc><image:title>beta , beta -dimethylacrylalkannin inhibits colorectal cancer growth in vitro and in vivo by targeted FGFR1</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3248</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3249</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3249.jpg</image:loc><image:title>The role of DDR1 ectodomain shedding in glioblastoma radiation resistance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3250</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3250.jpg</image:loc><image:title>CD99 homophilic signaling between tumor-associated macrophages and glioblastoma cells regulates response to immunotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3251</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3251.jpg</image:loc><image:title>NRG1/HER3 axis drives therapy resistance in head and neck squamous cell carcinoma: Evidence from patient-derived xenografts</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3252</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3252.jpg</image:loc><image:title>Daple-FLT3 gene fusion activates and localizes through a distinct mechanism from FLT3-ITD</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3253</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3253.jpg</image:loc><image:title>UCHL1 deubiquitinates CIP2A to promote tumor progression in gastric cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3254</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3254.jpg</image:loc><image:title>Autologous colorectal cancer-mesothelial co-culture model identifies stromal FGFR3 dependency driving peritoneal dissemination</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3255</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3255.jpg</image:loc><image:title>FLT4-mediated ferroptosis resistance in renal cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3256</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3256.jpg</image:loc><image:title>BAP1 stabilizes BIRC5 to promote chemoresistance in gastric cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3257</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3257.jpg</image:loc><image:title>RIPK2 promotes metastatic behavior in inflammatory breast cancer and is an attractive therapeutic target</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3258</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3258.jpg</image:loc><image:title>CYLD regulates thrombin-induced p38-p65 signaling to inhibit breast cancer progression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3259</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3259.jpg</image:loc><image:title>The mystery behind mSin1 phosphorylation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3260</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3260.jpg</image:loc><image:title>ICA-1S and Selinexor decreases atypical teratoid rhabdoid tumor (ATRT) survival and proliferation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3261</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3261.jpg</image:loc><image:title>The regulation of IL-6/gp130 signaling by PTPRF in colon cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3262</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3262.jpg</image:loc><image:title>IL-1 beta/ IL-6 co-stimulation synergistically mediates DUOX2/DUOXA2 complex up-regulation via JAK/STAT and p38 signaling events</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3263</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3263.jpg</image:loc><image:title>Validating upstream kinase predictions by linking activity to drug target proximity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3264</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3265</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3265.jpg</image:loc><image:title>Loss of SMYD5 downregulates proliferative signaling pathways in B cell acute lymphoblasticleukemia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3266</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3267</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3267.jpg</image:loc><image:title>Secreted BRAF V600E drives ADAR1-dependent RNA editing and defines a therapeutic vulnerability in colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3268</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3268.jpg</image:loc><image:title>SETD4 regulates cell proliferation and methotrexate response in pediatric acute lymphoblastic leukemia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3269</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3269.jpg</image:loc><image:title>MPP8 inhibits PRKN signaling through interactions with SIRT1 and ZEB1 to promote bladder cancer proliferation and metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3270</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3270.jpg</image:loc><image:title>PROMISE, a clonal promoter methylation signature capturing early epigenetic evolution and prognostic programs across epithelial cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3271</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3271.jpg</image:loc><image:title>BAP1 loss rewires chromatin and lineage identity in uveal melanoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3272</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3272.jpg</image:loc><image:title>Investigating gene regulatory mechanisms associated with B-cell acute lymphoblastic leukemia incidence in Hispanic/Latino populations</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3273</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3274</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3274.jpg</image:loc><image:title>Chromatin accessibility differentiates cancer associated fibroblast subtypes in pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3275</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3275.jpg</image:loc><image:title>RNA editing is the potential biomarker for carcinogenesis of Crohn&#039;s disease</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3276</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3276.jpg</image:loc><image:title>Deciphering gene regulatory network and spatial heterogeneity underlying cutaneous T cell lymphoma large cell transformation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3277</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3278</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3279</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3279.jpg</image:loc><image:title>Unraveling novel epigenetic therapies for the treatment of TP53 WT glioblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3280</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3280.jpg</image:loc><image:title>SNP rs4381241 promotes renal cell carcinoma progression via the FAF1-HDAC3-PDGFB axis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3281</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3282</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3282.jpg</image:loc><image:title>Epigenomic liquid biopsy molecular lung subtyping and real-world (RW) patient outcomes in advanced NSCLC (aNSCLC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3283</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3283.jpg</image:loc><image:title>A novel workflow for ultra short cfDNA fragmentomics and multiomic profiling in liquid biopsies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3284</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3285</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3285.jpg</image:loc><image:title>Utility of TAPS+: a positive-readout methylation sequencing approach for high-fidelity epigenetic profiling</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3286</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3286.jpg</image:loc><image:title>Dysregulation of the RNA modification m6A promotes cancer progression and provides therapeutic opportunities</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3287</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3287.jpg</image:loc><image:title>Arid1a directs lineage specification in mammary epithelial cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3288</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3288.jpg</image:loc><image:title>Integrated epigenomic profiling reveals distinct transcription factor networks driving therapy resistance in estrogen receptor positive metastatic breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3289</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3289.jpg</image:loc><image:title>Profiling histone modifications in single cells to gain insight into the effects of epigenetic drug treatment on tumor cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3290</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3291</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3291.jpg</image:loc><image:title>Chromatin profiling from formalin-fixed paraffin-embedded samples for biomarker discovery</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3292</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3292.jpg</image:loc><image:title>Loss of PIWIL4-piRNA interaction reveals uncertain somatic epigenomic evolution</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3293</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3293.jpg</image:loc><image:title>Resolving genome regulatory complexity with new multiomic long-read sequencing tools for chromatin state and genetic variation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3294</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3294.jpg</image:loc><image:title>FOXA1 alterations drive endocrine therapy resistance through unique transcriptional and epigenomic programs in breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3295</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3295.jpg</image:loc><image:title>Defining neural molecular features and their functional significance in lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3296</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3296.jpg</image:loc><image:title>Spatial epigenomic landscape of NF-PanNETs defines tumor progression and microenvironmental niches</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3297</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3298</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3298.jpg</image:loc><image:title>Epigenomic rewiring driven by BAP1 loss in uveal melanoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3299</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3299.jpg</image:loc><image:title>Chromatin profiling reveals the impact of fulvestrant on estrogen receptor-driven chromatin dynamics in breast cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3300</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3300.jpg</image:loc><image:title>NOP16 is a histone mimetic that regulates histone H3K27 methylation and gene repression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3301</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3301.jpg</image:loc><image:title>Genomic landscape of bladder cancer in a turkish cohort: Unveiling the unique mutational spectrum with clinical insights</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3302</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3302.jpg</image:loc><image:title>A multimodal sequencing framework to define viral and host genomic heterogeneity in HPV associated head and neck cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3303</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3303.jpg</image:loc><image:title>Integrity of high-molecular-weight DNA is essential for accurate long-read sequencing and comprehensive cancer genomics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3304</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3304.jpg</image:loc><image:title>Single assay, tumor-only, somatic SNVs, SVs, and CNVs profiling using nanopore adaptive sampling</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3305</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3305.jpg</image:loc><image:title>High-fidelity whole genome sequencing from low-input FFPE samples: Enabling accurate tumor-informed MRD assay design through superior variant detection and uniform coverage</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3306</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3306.jpg</image:loc><image:title>Integrated long-read target enrichment and comprehensive genomic profiling for hematologic malignancies using the SureSelect Cancer Pan Heme assay</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3307</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3307.jpg</image:loc><image:title>Investigating the value of testing for actionable alterations and circulating tumor DNA in breast and colorectal cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3308</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3308.jpg</image:loc><image:title>Rapid, one-tube sub 10-minute whole genome library prep for cfDNA</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3309</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3309.jpg</image:loc><image:title>Scaling liquid biopsy biomarker discovery: Multi-center, analytical validation of high resolution ctDNA profiling using TSO500 v2 on NovaSeq X Plus</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3310</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3310.jpg</image:loc><image:title>SeqF&amp;#8482;: evaluation of an affordable nanopore-based assay for decentralized tumor profiling</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3311</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3311.jpg</image:loc><image:title>Origins of structural variant junctional insertions across &gt;8,000 TCGA whole genomes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3312</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3312.jpg</image:loc><image:title>Characterization of multiple myeloma genomes with LinkPrep assay enables detection of somatic variation and SV-driven interactions of the 3D genome</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3313</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3313.jpg</image:loc><image:title>Extending a cfDNA-optimized library preparation workflow to mechanically sheared FFPE DNA for high-quality NGS data</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3314</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3314.jpg</image:loc><image:title>Comparative study of human and canine nerve sheath tumors in terms of morphology, prognosis, treatment, epigenetics, transcriptomics, and genomics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3315</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3315.jpg</image:loc><image:title>Simplified genomic profiling using Aspyre Lung solves real-life challenges with limited and poor-quality tissue</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3316</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3316.jpg</image:loc><image:title>A new workflow for FFPE tumor samples enables a streamlined solution for structural variant detection and phasing of somatic mutations through long read sequencing</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3317</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3317.jpg</image:loc><image:title>Gene profiling using whole genome analysis of bile tract cancer and its association with clinical factors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3318</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3318.jpg</image:loc><image:title>Long-read hybrid-capture based targeting of 95 known cancer genes detects large structural and complex variants with a simple bioinformatics workflow and an AI-based clinical interpretation solution.</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3319</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3319.jpg</image:loc><image:title>Identification of germline variants associated with somatic mutational profiles in triple-negative breast cancer among African American women</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3320</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3320.jpg</image:loc><image:title>Improved Variantplex workflow reduces assay time and enhances sensitivity for acute myeloid leukemia targets</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3321</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3321.jpg</image:loc><image:title>Metatranscriptomic signatures in triple negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3322</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3322.jpg</image:loc><image:title>Detection and functional assessment of extrachromosomal DNA amplifications in FFPE lung tumor specimens using Hi-C sequencing</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3323</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3323.jpg</image:loc><image:title>Development of multimodal comprehensive genomic profiling panel with on-flow cell hybrid capture</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3324</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3324.jpg</image:loc><image:title>Evaluation of FFPE-extracted nucleic acid quality and performance from various commercial extraction kits using contrived multiplexed reference materials</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3325</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3325.jpg</image:loc><image:title>Characterization of NGS reference standards for genetic and epigenetic content</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3326</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3326.jpg</image:loc><image:title>Where sensitivity meets complexity: Electrophoretic assessment of genomic DNA integrity at low concentrations and for FFPE samples using DIN-based analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3327</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3327.jpg</image:loc><image:title>Epidemiology meets novel transcriptomics in poorly differentiated endometrial carcinomas</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3328</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3328.jpg</image:loc><image:title>An optimized WGS workflow for FFPE samples: Enabling high-confidence variant detection for MRD surveillance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3329</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3329.jpg</image:loc><image:title>Rebalancing systemic and cellular energy dysmetabolism in Chronic Lymphocytic Leukemia through exercise training</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3330</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3331</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3331.jpg</image:loc><image:title>Integrated metabolic and cell-health profiling as a framework for defining cellular state</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3332</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3332.jpg</image:loc><image:title>The mitochondrial protease YME1L regulates type 1 interferon signaling via the STING pathway in AML</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3333</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3333.jpg</image:loc><image:title>Low-protein diet limits liver melanoma metastasis by enhancing natural killer cell function</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3334</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3335</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3335.jpg</image:loc><image:title>Tracing and modeling lipid homeostasis to understand keratinocyte biology</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3336</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3336.jpg</image:loc><image:title>Targeting cytosolic mutant IDH1 by hyperactivation to induce cancer cytotoxicity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3337</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3337.jpg</image:loc><image:title>Metabolic pathway signatures defining response to CD19 CAR T-Cell therapy in aggressive B-cell non-hodgkin lymphoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3338</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3339</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3339.jpg</image:loc><image:title>Rewiring glutamine metabolism restores osteoblast differentiation in multiple myeloma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3340</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3340.jpg</image:loc><image:title>Cardiolipin acyl chain remodeling is a therapeutic target in aggressive infantile embryonal brain tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3341</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3341.jpg</image:loc><image:title>Metabolic reprogramming in Li-Fraumeni Syndrome underlies the pre-cancer niche and cancer predisposition</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3342</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3342.jpg</image:loc><image:title>Metabolic crosstalk between fatty acid oxidation and glycolysis underlies glioblastoma viability</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3343</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3344</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3344.jpg</image:loc><image:title>Itaconate acts as an oncometabolite to drive lethal pediatric ependymomas</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3345</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3345.jpg</image:loc><image:title>The Warburg hijack of myeloid immunity via mitochondrial dysregulation in glioblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3346</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3346.jpg</image:loc><image:title>Mitochondrial biogenesis fuels the energetic demands of grade 2 meningiomas</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3347</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3347.jpg</image:loc><image:title>Spermine enhances oxidative phosphorylation independently of translation in glioblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3348</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3348.jpg</image:loc><image:title>Lipid metabolic rewiring in cancer: A proteomic insight into new axis of therapeutic vulnerability</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3349</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3349.jpg</image:loc><image:title>Rewiring of pyruvate metabolism in neonatal CD8 + T cells alters functionality and antitumor immunity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3350</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3350.jpg</image:loc><image:title>C-myc driven by differentiation factors in early-onset colorectal cancer (EOCRC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3351</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3351.jpg</image:loc><image:title>Structure and function of the L-MYC N-terminus impacts strategies to inhibit the MYC family of oncoproteins</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3352</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3352.jpg</image:loc><image:title>Investigating resistance to beta-catenin degradation in a colorectal cancer cell line</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3353</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3353.jpg</image:loc><image:title>Spatial and molecular profiling of tumor initiation in ccRCC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3354</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3354.jpg</image:loc><image:title>NanoGlio recapitulates IDH -mutant glioma biology and therapeutic response to vorasidenib</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3355</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3355.jpg</image:loc><image:title>Functional role of PHLDA1 down regulation leads to morphological changes and increased proliferation in MCF-7 breast cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3356</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3356.jpg</image:loc><image:title>CHAF1A phosphorylation by PLK1 promotes AR-driven enzalutamide resistance in prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3357</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3357.jpg</image:loc><image:title>The human Flower isoform hFWE4 facilitates cornification in cutaneous squamous cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3358</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3358.jpg</image:loc><image:title>Trop-1/EpCAM Thr115 is a novel inducer of cancer cell proliferation and drives hyperproliferative lung damage in COVID-19</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3359</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3359.jpg</image:loc><image:title>cGAS/STING-activated macrophages form lipophagosomes to regulate TME and promote progression in obesity-associated pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3360</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3361</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3361.jpg</image:loc><image:title>Immunogenomic alterations driving premalignant lesions to invasive lesions of the head and neck</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3362</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3362.jpg</image:loc><image:title>Obesity-mediated extracellular vesicle secretion as a targetable driver of endometrial cancer initiation and progression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3363</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3363.jpg</image:loc><image:title>Red cabbage juice reprograms the gut microbiome and enhances butyrate production to prevent colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3364</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3365</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3365.jpg</image:loc><image:title>Fecal microbiome signatures for early detection of colorectal cancer and precursor lesions</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3366</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3367</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3368</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3368.jpg</image:loc><image:title>Long-term running and risk of colorectal adenoma and cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3369</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3369.jpg</image:loc><image:title>Central and peripheral adiposity and breast cancer risk in postmenopausal women: A pooled analysis of 11 cohort studies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3370</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3370.jpg</image:loc><image:title>Early life exposures and cancer in adulthood: World Cancer Research Fund International&#039;s lifecourse research in cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3371</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3372</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3372.jpg</image:loc><image:title>Obesity, metabolic dysfunction, and cancer risk: Uncovering the metabolic landscape</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3373</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3373.jpg</image:loc><image:title>The association between obesity, diabetes and prostate cancer aggressiveness in Louisiana Cohort.</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3374</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3374.jpg</image:loc><image:title>Physical activity, smoking and breast cancer risk: A prospective cohort study in the UK biobank</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3375</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3376</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3376.jpg</image:loc><image:title>Adiposity and cancer: Updated meta-analysis incorporating the largest evidence base to date</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3377</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3377.jpg</image:loc><image:title>Synergistic effects of HIV and HPV coinfection in dysregulation of the oral mycobiome in Puerto Rican people with HIV</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3378</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3378.jpg</image:loc><image:title>Effects of olive oil byproducts polyphenol reach extract on muscle function, sarcopenia-related parameters and skin health</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3379</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3380</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3381</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3382</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3382.jpg</image:loc><image:title>Longitudinal changes in marital status, residence, and income among over 450,000 cancer patients: A SEER-based analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3383</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3384</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3384.jpg</image:loc><image:title>Geospatial clustering of socioeconomic deprivation and its impact on major cancers in Puerto Rico: 2014-2022.</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3385</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3385.jpg</image:loc><image:title>An entire-population analysis of nationwide trends in cancer incidence and mortality in hungary</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3386</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3387</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3387.jpg</image:loc><image:title>Pediatric central nervous system tumors: An analysis of patients treated at Children&#039;s Nebraska over a 10-year period</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3388</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3388.jpg</image:loc><image:title>Oral cancer incidence in British Columbia, Canada since the start of the COVID-19 pandemic</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3389</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3389.jpg</image:loc><image:title>Genetic and clinical profiles of early-onset prostate cancer in Puerto Rican men: A preliminary characterization</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3390</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3391</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3391.jpg</image:loc><image:title>Sex-specific survival patterns in korean breast cancer: Explainable AI insights from K-CURE Cohort</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3392</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3392.jpg</image:loc><image:title>Survival differences after diagnosis of breast cancer as second primary cancer vs as first primary cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3393</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3394</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3395</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3395.jpg</image:loc><image:title>Ovarian cancer survival in the era of targeted treatment: A nationwide study in Germany</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3396</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3397</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3398</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3398.jpg</image:loc><image:title>Long-term mortality trends in hairy cell leukemia: A comprehensive U.S. population analysis (1999-2023)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3399</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3400</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3400.jpg</image:loc><image:title>Narrowing of sex and racial/ethnic ratios for hepatocellular carcinoma incidence in the United States, 1992 - 2022</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3401</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3401.jpg</image:loc><image:title>Epidemiology, survival, and prognostic factors of malignant eyelid tumors: A 17-year population-based study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3402</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3403</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3404</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3405</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3405.jpg</image:loc><image:title>Conditional overall survival analysis of HPV-positive oropharyngeal squamous cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3406</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3407</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3407.jpg</image:loc><image:title>Distinct breast cancer gene signatures by estrogen receptor status associated with psychological distress</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3408</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3409</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3410</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3410.jpg</image:loc><image:title>Validation and population projection of multi-cancer risk incorporating polygenic risk scores and non-genetic factors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3411</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3412</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3413</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3413.jpg</image:loc><image:title>Genetic and immune signaling divergence underlies the inverse associationbetween asthma and cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3414</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3415</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3415.jpg</image:loc><image:title>Mitochondrial DNA breaks and copy number and the risk of lung cancer in never-smoking women</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3416</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3417</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3418</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3419</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3419.jpg</image:loc><image:title>Defining cancer risk germline variants in shelterin complex genes - a genome-first analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3420</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3420.jpg</image:loc><image:title>Investigating divergent ER + and ER - breast cancer subtype risks by using oppositely associated genetic variants</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3421</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3422</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3423</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3424</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3425</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3425.jpg</image:loc><image:title>Implications of multiple myeloma polygenic risk scores (PRS) for MGUS</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3426</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3427</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3427.jpg</image:loc><image:title>Genetic insights into metabolic traits and prostate cancer susceptibility: A two sample Mendelian Randomization study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3428</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3428.jpg</image:loc><image:title>Identification of survival-associated germline variants in hepatocellular carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3429</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3430</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3431</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3431.jpg</image:loc><image:title>Identification of miRNA-related SNPs associated with kidney cancer in the Korean population</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3432</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3432.jpg</image:loc><image:title>Estrogen receptor-mediated pharmacogenomic eQTLs as predictors of endocrine therapy response in breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3433</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3433.jpg</image:loc><image:title>Cell-type aware transcriptome-wide association study of mammographic density phenotypes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3434</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3434.jpg</image:loc><image:title>The impact of race/ethnicity on survival in secondary triple negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3435</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3435.jpg</image:loc><image:title>Identifying determinants of molecular testing for advanced non-small cell lung cancer in the rural United States</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3436</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3436.jpg</image:loc><image:title>Social disparities in the extension of endocrine therapy among premenopausal breast cancer survivors in Denmark</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3437</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3437.jpg</image:loc><image:title>Supporting communities through open dialogue on cancer care and addressing food insecurity: Partnerships with local YMCAs</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3438</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3438.jpg</image:loc><image:title>Capturing Latino health disparities: Lessons from mail and community-based population health surveys in California</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3439</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3439.jpg</image:loc><image:title>Trends and disparities in hepatitis C virus-associated hepatocellular carcinoma mortality in the United States, 1999-2023</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3440</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3440.jpg</image:loc><image:title>Attitudes, beliefs, and perceptions of clinicians on AI-assisted digital health interventions for oncofertility education</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3441</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3441.jpg</image:loc><image:title>Optimizing genetic/genomic health communication in cancer prevention through video development</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3442</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3442.jpg</image:loc><image:title>Nationwide epidemiologic and economic burden analysis of neurologic disorders associated with cancer treatment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3443</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3443.jpg</image:loc><image:title>The breast cancer survivorship experience of Korean American women: A qualitative study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3444</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3444.jpg</image:loc><image:title>Socioeconomic and clinical predictors of survival in patients with squamous cell tonsillar cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3445</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3445.jpg</image:loc><image:title>A case of rapid progression from Stage I to Stage IV in an MSI-H/EMAST African American colorectal patient</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3446</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3446.jpg</image:loc><image:title>Insights into smoking cessation support for lung cancer patients: A multi-site survey of patient perspectives post-diagnosis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3447</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3447.jpg</image:loc><image:title>Establishing a data-driven oncology research ecosystem in sub-Saharan Africa: The Medserve-LUTH Cancer Centre (MLCC) research unit experience</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3448</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3448.jpg</image:loc><image:title>Use of targeted therapies in lung cancer following medicare&#039;s national coverage determination for next-generation sequencing</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3449</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3449.jpg</image:loc><image:title>Lurbinectedin plus atezolizumab vs durvalumab maintenance in ES-SCLC: A comparative clinical and economic analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3450</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3450.jpg</image:loc><image:title>The impacts of prior authorization policy reforms on breast cancer treatment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3451</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3451.jpg</image:loc><image:title>Accelerating global impact in translational cancer research: Lessons from 15 years of the EU TRANSCAN initiative</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3452</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3452.jpg</image:loc><image:title>Barriers and challenges to women leadership in medical research and how to overcome them</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3453</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3453.jpg</image:loc><image:title>Development of a DCE-based classification tree to enhance shared decision-making in patients with advanced prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3454</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3454.jpg</image:loc><image:title>The Artemis Project: A patient-led global research consortium advancing prevention-focused breast cancer innovation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3455</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3455.jpg</image:loc><image:title>Changes in cancer screening rates by housing status, race, and ethnicity following a multi-component implementation strategy at an urban Federally Qualified Health Center, 2023-2025</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3456</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3456.jpg</image:loc><image:title>The scaffold protein CNK3 mediates pro-invasive signalling in glioblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3457</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3457.jpg</image:loc><image:title>Exploiting mechanisms of glioblastoma invasion to induce vulnerabilities that promote synergistic lethality</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3458</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3458.jpg</image:loc><image:title>Defining the role of CRK and CRKL in glioblastoma invasiveness: from cell culture to mouse models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3459</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3459.jpg</image:loc><image:title>An investigation into the role of AVIL, an actin-binding protein, in glioblastoma metabolism</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3460</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3461</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3461.jpg</image:loc><image:title>SUMOylation regulates GATA2 stability to control uterine serous carcinoma invasion</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3462</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3462.jpg</image:loc><image:title>Adrenergic signaling in adipocytes drives ovarian cancer cell invasion</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3463</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3463.jpg</image:loc><image:title>A novel mTORC2 signaling pathway defines the pro-metastatic invadopodia network in urothelial carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3464</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3464.jpg</image:loc><image:title>The role of LAP1 isoform balance in regulating nuclear plasticity during confined cancer cell migration</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3465</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3465.jpg</image:loc><image:title>Double-pillar co-culture (DPC) platform for evaluating cancer invasion and immunotherapy efficacy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3466</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3466.jpg</image:loc><image:title>Targeting a novel secreted protein to modulate MMP activity and restrain lung adenocarcinoma metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3467</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3467.jpg</image:loc><image:title>Hypoxia reveals a polyaneuploid cancer cell phenotype with features implicated in tumor escape and early metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3468</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3468.jpg</image:loc><image:title>Effect of Piezo1 activation and CYRI-B loss in melanoma cell membrane dynamics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3469</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3469.jpg</image:loc><image:title>Pseudopodia coordinate environmental sensing with nuclear signaling through localized gene regulatory machinery</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3470</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3470.jpg</image:loc><image:title>Bioenergetic pathways regulate distinct patterns of invasion and matrix remodeling in breast cancer cells upon YAP/TAZ activation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3471</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3471.jpg</image:loc><image:title>Multi-scale modeling to predict cancer cell mechanics and migration based on transcriptional state and microenvironment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3472</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3472.jpg</image:loc><image:title>The role of Shroom3 downstream of Wnt/planar cell polarity signaling in breast cancer cell migration</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3473</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3473.jpg</image:loc><image:title>Estrogen promotes structural memory in breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3474</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3474.jpg</image:loc><image:title>The HER2&amp;#916;16 splice variant fuels breast cancer metastasis through integrin-driven signaling</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3475</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3475.jpg</image:loc><image:title>Investigating Frizzled7-driven regulation of Vangl1 in Wnt/PCP signaling in breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3476</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3476.jpg</image:loc><image:title>NOVA1 regulates alternative splicing of CD44 to suppress breast cancer invasion and metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3477</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3477.jpg</image:loc><image:title>LRRC15-Integrin beta1 connection in osteosarcoma cells: Linking adhesion to invasion</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3478</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3478.jpg</image:loc><image:title>genO-BRGSF-HIS mice: A humanized mouse model for assessment of Treg-targeting therapies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3479</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3479.jpg</image:loc><image:title>Predictive in vitro assays and PBMC donor banking: reducing variability in humanized mouse studies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3480</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3480.jpg</image:loc><image:title>Metabolism and carcinogenic potential of inorganic arsenic in humanized-liver mice</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3481</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3481.jpg</image:loc><image:title>In vivo evaluation of immune checkpoint inhibitors using PBMC-humanized NOG-&amp;#916;MHC mice engrafted with PDX tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3482</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3482.jpg</image:loc><image:title>Novelapproaches fororthotopic tumor engraftment in humanized immune system mice</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3483</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3483.jpg</image:loc><image:title>Developing the next generation of customized human immune system mice for preclinical oncology</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3484</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3484.jpg</image:loc><image:title>Short telomeres limit braf V600E driven melanomagenesis in humanized telomere (HuT) mice</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3485</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3485.jpg</image:loc><image:title>Small cell lung cancer humanized mouse models identifies unique T cell infiltration immune phenotypes in response to combination immune-radiation therapies.</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3486</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3486.jpg</image:loc><image:title>Enhancing preclinical insights in immuno-oncology with humanized mice</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3487</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3488</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3488.jpg</image:loc><image:title>Characterization and preclinical efficacy of a CD3&amp;#215;CD20 bispecific T cell engager in a humanized PBMC mouse model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3489</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3489.jpg</image:loc><image:title>Robust multiplex cytokine profiling in second-generation humanized NOG mice using a 41-plex humanized mouse immune panel: Cross-donor validation and implications for translational oncology studies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3490</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3490.jpg</image:loc><image:title>Innovative preclinical mouse models support development of CD3/EPCAM-targeting T-cell engagers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3491</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3491.jpg</image:loc><image:title>Humanized mouse models 2.0 - Improved preclinical evaluation of novel immune cell therapies, check point inhibitors, and immune cell engagers by excluding false positive or negative results</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3492</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3493</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3493.jpg</image:loc><image:title>Enhancing the predictability of human pharmacokinetics for antibody-drug conjugates (ADCs) using human FcRn transgenic mice</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3494</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3494.jpg</image:loc><image:title>One-stop solution for preclinical evaluation of bispecific T-cell engagers targeting STEAP1</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3495</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3495.jpg</image:loc><image:title>Preclinical models for evaluating bispecific antibodies targeting PD-1 and VEGF</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3496</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3496.jpg</image:loc><image:title>Enhanced human immune system engraftment in a novel triple-engineered NCG-hIL6-mTSLP-mFlt3-KOmouse model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3497</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3497.jpg</image:loc><image:title>The humanized FcRn mouse model: A superior platform for predicting human PK of therapeutic antibodies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3498</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3498.jpg</image:loc><image:title>Development of novel NCG-hIL15 and hIL-2 mouse models for preclinical assessment of human NK cell function</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3499</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3500</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3500.jpg</image:loc><image:title>Modeling cervical cancer heterogeneity using patient-derived organoids for precision treatment development</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3501</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3501.jpg</image:loc><image:title>Macrophage phagocytosis and efferocytosis: Implications for therapeutic modulation in the tumor microenvironment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3502</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3502.jpg</image:loc><image:title>Highly multiplexed imaging allows for spatial characterization of tumor organoid models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3503</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3503.jpg</image:loc><image:title>A 3D bioprinted hydrogel-based tumor model of non-small cell lung cancer for preclinical drug testing</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3504</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3504.jpg</image:loc><image:title>Modeling the multicellular blood-brain barrier with a PDX-derived glioblastoma microenvironment: comparing human and mouse biochip systems for tumor heterogeneity and drug response</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3505</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3505.jpg</image:loc><image:title>THSD7B loss is associated with oxaliplatin resistance in colorectal cancer patient-derived tumor organoids</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3506</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3506.jpg</image:loc><image:title>High content imaging of patient cells to identify CLL and AML patient cohorts that predict drug responses</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3507</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3508</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3508.jpg</image:loc><image:title>ATCC&#039;s patient-derived 2-D &amp;#38; 3-D cancer models make translational oncology a reality for the scientific community</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3509</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3509.jpg</image:loc><image:title>Establishing an osteosarcoma organoid model reflecting the bone microenvironment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3510</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3510.jpg</image:loc><image:title>Ensuring diverse in vitro lung cancer models: Development of alveolar epithelial cell lines, patient-derived xenografts, and lung adenocarcinoma cell lines from individuals of African ancestry</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3511</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3511.jpg</image:loc><image:title>Patient-derived tumor models of tyrosine kinase inhibitor-induced neuroendocrine-transformed lung carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3512</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3512.jpg</image:loc><image:title>A vascularized 3D microfluidic breast tumor platform for characterizing lymphovascular space invasion among inflammatory breast cancer cell lines</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3513</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3513.jpg</image:loc><image:title>Engineering prostate tumor microenvironments via the granular environment for lattice self-assembly (GELS) system</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3514</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3514.jpg</image:loc><image:title>Mechanochemical effects of growth factor gradients in colorectal cancer organoids</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3515</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3515.jpg</image:loc><image:title>Next-generation cancer organoids 2.0 in precision cancer medicine: Patient-derived pancreatic ductal adenocarcinoma organoids model tells not only drug sensitivity but also complexity of tumor biology</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3516</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3516.jpg</image:loc><image:title>Generation of a distal lung cancer organoid model using oncogenic ret-expressing induced pluripotent stem cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3517</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3517.jpg</image:loc><image:title>PDO as Translational Model for Biomarker Discovery in NSCLC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3518</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3518.jpg</image:loc><image:title>Establishment and characterization of novel patient-derived esophageal tumoroids with long term cultivability</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3519</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3519.jpg</image:loc><image:title>Functional heterogeneity of the human blood-tumor barrier phenotype induced by patient-derived glioblastoma spheroids</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3520</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3520.jpg</image:loc><image:title>Development of a patient-derived pancreatic cancer organoid-CAF coculture model to study tumor microenvironment influence on radiotherapy response</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3521</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3521.jpg</image:loc><image:title>Pre-treatment patient-derived esophageal squamous cell carcinoma organoids as a predictive platform for docetaxel, cisplatin and fluorouracil neoadjuvant chemotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3522</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3522.jpg</image:loc><image:title>Structural heterogeneity of tumor spheroids using quantitative assessment of autofluorescence</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3523</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3523.jpg</image:loc><image:title>DoE-based optimization of transposon-based gene insertion using the Harbor-IN system</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3524</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3525</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3525.jpg</image:loc><image:title>Live, label free 3D virtual HE imaging of small intestinal organoids using holotomography and generative cross-modality artificial intelligence</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3526</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3526.jpg</image:loc><image:title>Integrating PDX and PDX-derived organoid platforms to enhance translational drug discovery in breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3527</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3527.jpg</image:loc><image:title>Comparative analysis of 2D and 3D cell culture methods on DNA methylation patterns in medulloblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3528</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3528.jpg</image:loc><image:title>Leveraging bioconvergence to enhance organ-on-a-chip technology and revolutionize drug discovery and development</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3529</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3529.jpg</image:loc><image:title>Elucidating the role of ecDNA in treatment resistance and immune evasion within pediatric medulloblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3530</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3530.jpg</image:loc><image:title>Advancing pediatric tumor subtype classification on the pediatric cancer (PeCan) knowledge base by integrating molecular and morphology data</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3531</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3531.jpg</image:loc><image:title>EWSR1::WT1 fusion oncoprotein and the androgen receptor shape the biology of desmoplastic small round cell tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3532</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3532.jpg</image:loc><image:title>Preservation and clonal behavior of extrachromosomal DNA in patient-derived xenograft models of childhood cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3533</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3533.jpg</image:loc><image:title>Epigenetic regulation of the RAB5B GTPase expression in B-cell acute lymphoblastic leukemia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3534</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3534.jpg</image:loc><image:title>Targeting ALKBH5 mediated ChREBP signaling impairs cancer stem cell metabolism and tumor growth in medulloblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3535</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3536</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3536.jpg</image:loc><image:title>Epigenetic landscape and gene regulation in embryonal brain tumors with multilayered rosettes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3537</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3537.jpg</image:loc><image:title>Characterizing the MYC-induced immunopeptidome</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3538</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3538.jpg</image:loc><image:title>Epigenetic repurposing by CBFA2T3-GLIS2 reveals a druggable DNA methylation axis in high-risk pediatric AML vulnerability in pediatric AML</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3539</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3539.jpg</image:loc><image:title>Comprehensive analysis of genomic landscape of ultra-rare pediatric malignant rhabdoid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3540</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3540.jpg</image:loc><image:title>Improving the utility of the single-cell pediatric cancer atlas through updated cell type annotations, CNV inference, and visualization tools</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3541</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3541.jpg</image:loc><image:title>BRD9 functions as a negative regulator of GBAF in synovial sarcoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3542</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3542.jpg</image:loc><image:title>Synergistic targeting of EP300/CBP and EYA co-activators collapses the rhabdomyosarcoma core regulatory circuit</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3543</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3543.jpg</image:loc><image:title>A critical dependency in Ewing sarcoma: PAX7 attenuates EWS::FLI1 activity at de novo microsatellite enhancers to maintain oncogenesis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3544</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3544.jpg</image:loc><image:title>Loss of histone 3 lysine 9 trimethylation drives recurrence in high-risk pediatric medulloblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3545</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3545.jpg</image:loc><image:title>Somatic changes in Y chromosome copy number are associated with clinical and molecular features in neuroblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3546</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3546.jpg</image:loc><image:title>Mithramycin analogues trap the EWS-FLI1 transcriptional complex, evict ETV6, and disable oncogenic condensate function in Ewing sarcoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3547</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3547.jpg</image:loc><image:title>DNA methylation signatures of diet quality and treatment-related cardiotoxicity in childhood cancer survivors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3548</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3548.jpg</image:loc><image:title>Structural variation shapes clonal evolution in pediatric cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3549</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3549.jpg</image:loc><image:title>Dynamic evolution of oncogene amplification across 80,000 cancer cell genomes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3550</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3550.jpg</image:loc><image:title>Clonal evolutionary trajectory of HER2-positive breast cancer with ERBB2 or PIK3CA mutations under neoadjuvant treatment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3551</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3551.jpg</image:loc><image:title>EED drives the small cell lung cancer neuroendocrine phenotype in lung cancer histological transformation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3552</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3552.jpg</image:loc><image:title>Identification of the clonal origin of endometriosis-associated ovarian cancer in normal endometrium</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3553</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3554</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3554.jpg</image:loc><image:title>Temporal ordering of genomic events reveals distinct evolutionary trajectories in early-onset breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3555</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3555.jpg</image:loc><image:title>Genetic insights into clonal evolution from normal prostate epithelium to cancer via HighGradePIN</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3556</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3556.jpg</image:loc><image:title>Integrative spatial profiling of protein and chromosomal alterations across normal, precancer, and cancer revealed the presence of aneuploidy in the normal fallopian tube</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3557</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3557.jpg</image:loc><image:title>Forecasting oncogene amplification and tumor suppressor deletion</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3558</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3558.jpg</image:loc><image:title>Multi-omics analysis of longitudinal melanoma samples reveals evolutionary transitions and therapy-associated cell-state switching</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3559</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3559.jpg</image:loc><image:title>Quantifying evolutionary dynamics and tumor heterogeneity in oncogene-addicted advanced non-small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3560</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3560.jpg</image:loc><image:title>Rb1 loss defines distinct migration histories in metastatic prostate cancer subtypes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3561</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3561.jpg</image:loc><image:title>Clonal landscape of human nephrons</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3562</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3562.jpg</image:loc><image:title>Spatial profiling of prostate cancer clonal evolution linked to nodal metastases</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3563</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3563.jpg</image:loc><image:title>KRAS allelic imbalance reshapes tumor evolution through selective clonal outgrowth and chromosomal instability in NSCLC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3564</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3564.jpg</image:loc><image:title>Dynamics of clonal hematopoiesis in ovarian cancer survivors: Correlation with carboplatin and PARP inhibitor exposure</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3565</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3565.jpg</image:loc><image:title>Evolving toward precision oncology: Leveraging collateral drug responses for personalized second-line osteosarcoma treatment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3566</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3566.jpg</image:loc><image:title>Single-cell multi-omics uncovers coordinated epigenetic and transcriptomic evolution in IDH-mutant glioma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3567</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3567.jpg</image:loc><image:title>Integrated genomic and transcriptomic profiling uncovers spatial and evolutionary dynamics in astrocytoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3568</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3568.jpg</image:loc><image:title>Quantifying metabolic and clonal dynamics of evolving cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3569</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3570</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3571</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3572</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3572.jpg</image:loc><image:title>Role of M2 macrophages in chemoresistance about the tumor microenvironment of epithelial ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3573</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3573.jpg</image:loc><image:title>A new classification of tumor-associated macrophages and their roles in resistance to immune checkpoint therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3574</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3575</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3576</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3576.jpg</image:loc><image:title>Emerging evidence of cellular dormancy programs in non-small cell lung cancer (NSCLC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3577</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3577.jpg</image:loc><image:title>Dynamic waves of anti-and pro-tumoral myeloid and Treg cells are generated in response to cyclophosphamide</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3578</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3578.jpg</image:loc><image:title>DNA damaging therapies induce a pro-tumorigenic fibroblast phenotype</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3579</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3580</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3580.jpg</image:loc><image:title>Androgen-driven sexual dimorphism reshapes immune crosstalk and limits immunotherapy response in PDAC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3581</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3581.jpg</image:loc><image:title>TiME evolution in the context of diffuse astrocytoma post-therapy relapse and progression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3582</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3582.jpg</image:loc><image:title>Tumor and microenvironmental co-evolution in metastatic triple-negative breast cancer during immunotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3583</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3584</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3584.jpg</image:loc><image:title>Astrocytes reprogram radiation-resistant glioblastoma to reveal new therapeutic vulnerabilities</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3585</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3585.jpg</image:loc><image:title>Loxl2 drives neutrophil-mediated immune evasion and resistance to anti PD-1 therapy in murine melanoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3586</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3587</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3587.jpg</image:loc><image:title>Sequential senescence-escape cycles drive genomic heterogeneity and osimertinib resistance in EGFR-mutant NSCLC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3588</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3589</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3589.jpg</image:loc><image:title>Tumor mass dormancy - a potential driver of long-term persistent melanoma after immunotherapy?</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3590</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3591</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3592</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3592.jpg</image:loc><image:title>Macrophage polarization in ALK+ non-small cell lung cancer: Implications for treatment targeting</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3593</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3594</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3595</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3596</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3596.jpg</image:loc><image:title>Myeloid-derived suppressor cells mediate ferroptosis resistance in HR+/HER2- breast cancer via the ARID1A/AKR1C2 axis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3597</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3597.jpg</image:loc><image:title>Targeting the CD44-SPP1 axis to overcome therapy resistance in bladder cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3598</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3598.jpg</image:loc><image:title>Toward large-scale clinical implementation of extracellular vesicle profiling for precision oncology</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3599</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3600</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3600.jpg</image:loc><image:title>Mito-EV-driven mitochondrial transfer: A trigger for ferroptosis in glioblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3601</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3602</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3602.jpg</image:loc><image:title>Pyk2 controls rab proteins by vesicle trafficking in glioblastoma cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3603</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3603.jpg</image:loc><image:title>Horizontal transfer of functional extrachromosomal DNA via extracellular vesicles in FGFR2-amplified cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3604</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3605</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3606</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3606.jpg</image:loc><image:title>Liposarcoma-derived extracellular vesicles suppress STING signaling and impair innate immune activation in macrophages</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3607</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3607.jpg</image:loc><image:title>Isolation and characterization of prostate-specific extracellular vesicles from prostate cancer patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3608</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3609</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3610</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3610.jpg</image:loc><image:title>Chemoradiation treatment increases extracellular vesicle release causing treatment resistance in rectal cancer cell lines</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3611</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3611.jpg</image:loc><image:title>Exosomal genetic cargo shift dictated by RD3 deficiency steers progressive neuroblastoma evolution</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3612</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3613</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3613.jpg</image:loc><image:title>The consequences of progenitor neutrophil evacuation into the periphery during breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3614</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3614.jpg</image:loc><image:title>Distinct profile of peritoneal lavage fluid extracellular vesicles in gastrointestinal carcinomatosis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3615</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3615.jpg</image:loc><image:title>Environmental impact on the secretion of tumor-derived exosomes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3616</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3616.jpg</image:loc><image:title>Precise isolation of tumor-relevant EV sub-populations using the Kairos cLDEP particle sorter</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3617</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3617.jpg</image:loc><image:title>Lipid nanoprobe magnetic beads enable high-purity plasma EV isolation for broad-spectrum cancer biomarker detection</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3618</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3618.jpg</image:loc><image:title>Fibroblast exosomes induce stromal matrix assembly and breast tumor growth and metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3619</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3619.jpg</image:loc><image:title>Exosomes derived from tumor cells in acidic extracellular environment inhibit liver metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3620</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3620.jpg</image:loc><image:title>Novel mechanism of tumor fibrosis mediated by interorgan crosstalk</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3621</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3621.jpg</image:loc><image:title>Muscle iron overload contributes to cancer cachexia-induced muscle wasting</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3622</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3623</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3623.jpg</image:loc><image:title>Metabolite-driven post-translational modifications regulate mitochondrial homeostasis in the glioblastoma microenvironment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3624</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3624.jpg</image:loc><image:title>The paradoxical role of SIRT1 in glioblastoma mediated by the tumor microenvironment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3625</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3626</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3626.jpg</image:loc><image:title>Targeting Spns2 induces immunogenic cell death and systemic anti-tumor immunity to suppress metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3627</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3628</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3629</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3630</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3631</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3632</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3633</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3633.jpg</image:loc><image:title>Role of sialic acid-siglec axis in pancreatic cancer immune evasion</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3634</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3634.jpg</image:loc><image:title>PD-L2-RGMb interaction modulates anti-cancer immunity through swinging the shift of Th1/Th2 cell balance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3635</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3635.jpg</image:loc><image:title>New role for CDK6 activation in tumor-induced monocyte and platelet reprogramming in breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3636</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3637</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3638</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3639</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3640</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3640.jpg</image:loc><image:title>ABN202, a TROP2-targeted IFN-beta mutein fusion protein, overcomes ADC resistance and elicits durable CD8&amp;#8314; T cell-dependent antitumor immunity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3641</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3641.jpg</image:loc><image:title>Discovery of A-911, a potent, orally bioavailable 5-HT7 antagonist that promotes DC1-mediated T-cell cross-priming and anti-tumor immunity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3642</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3642.jpg</image:loc><image:title>Redirecting cytomegalovirus immunity against breast tumors for immunotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3643</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3643.jpg</image:loc><image:title>MST-0312: Targeted LTBR agonist designed to induce tertiary lymphoid structures (TLS) and high endothelial venules (HEV) for the treatment of solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3644</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3645</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3645.jpg</image:loc><image:title>A novel tumor-microenvironment-responsive pro-TCE therapy minimizes cytokine release for safer solid tumor treatment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3646</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3646.jpg</image:loc><image:title>A novel anti-PD-1&amp;#215;CTLA-4&amp;#215;VEGF tri-specific antibody enables tumor-selective immune checkpoint blockade with potent anti-tumor activity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3647</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3647.jpg</image:loc><image:title>ProTCE-PSMA, a novel therapeutic PSMA/CD3 prodrug for prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3648</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3648.jpg</image:loc><image:title>BCG047, a novel heavy chain antibody-drug conjugate targeting FOLR1, demonstrates outstanding preclinical antitumor efficacy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3649</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3649.jpg</image:loc><image:title>Turning cold tumors hot: Targeted TNF potentiates the activity of bispecific T cell engagers in solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3650</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3650.jpg</image:loc><image:title>AGB101, a first-in-class Vbeta17 x DLL3 bispecific antibody, selectively redirects Vbeta17 T memory cells to drive robust DLL3 dependent anti-tumor activity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3651</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3651.jpg</image:loc><image:title>VBC229: A novel DLL3-targeting biparatopic T-cell engager-topoisomerase I inhibitor fusion molecule for depth and duration of response in small-cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3652</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3652.jpg</image:loc><image:title>CYT X300, a novel EGFR x pan-gamma delta T cell engager for the treatment of solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3653</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3653.jpg</image:loc><image:title>Preclinical development of 3H-10000, a novel vedotin antibody-drug conjugate for treatment of FGFR2b-expressing cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3654</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3654.jpg</image:loc><image:title>Mechanistic insights into the pharmacology of CDR609 support high potential as a targeted immunotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3655</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3655.jpg</image:loc><image:title>TCE-A: An &amp;#8220;OR-gate&amp;#8221; CD19&amp;#215;CD20&amp;#215;CD3 trispecific T-cell engager for B-cell malignancies and autoimmune diseases</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3656</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3656.jpg</image:loc><image:title>A neoantigen mRNA vaccine generates antitumor immunity in a murine model of intrahepatic cholangiocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3657</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3657.jpg</image:loc><image:title>Exposing a vulnerability to mTOR inhibition in triple negative breast cancer by targeting NIMA related kinase 2 (NEK2)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3658</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3658.jpg</image:loc><image:title>The p53-Reprimo-Hippo-YAP-p73 pathway: An extrinsic apoptosis mechanism for tumor suppression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3659</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3659.jpg</image:loc><image:title>Pancreatic cancer affects entosis by regulating the cytoskeleton through mechanical stress</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3660</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3660.jpg</image:loc><image:title>Tumor-targeted bispecific antibodies effectively inhibit oncogenic pathways while minimizing toxicity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3661</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3661.jpg</image:loc><image:title>PDIA4-NF-&amp;#954;B signaling mediates soluble E-cadherin-driven inflammatory breast cancer progression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3662</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3662.jpg</image:loc><image:title>Loss of ERK pulsatility drives transformation of colonic organoids through collapse of Akt-mediated signaling insulation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3663</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3663.jpg</image:loc><image:title>STIP1 drives metabolic reprogramming in esophageal squamous cell carcinoma via AHCY-LDHA Axis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3664</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3665</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3666</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3666.jpg</image:loc><image:title>RASH3D19 mediates RAS pathway activation and adaptive resistance to KRAS targeting drugs in cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3667</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3667.jpg</image:loc><image:title>Keap1 loss promotes cancer stemness and anti-PD-1 resistance in head and neck cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3668</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3668.jpg</image:loc><image:title>Comparative analysis of senolytic drugs reveals mitochondrial determinants of efficacy and resistance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3669</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3669.jpg</image:loc><image:title>KDM4A mediated chromatin remodeling promotes tumor progression and immune modulation in malignant pleural mesothelioma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3670</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3670.jpg</image:loc><image:title>RNA-binding protein NF90 mediates Polycomb-independent transactivation by EZH2 to promote cancer growth</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3671</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3671.jpg</image:loc><image:title>AR-V7 utilizes a noncanonical nuclear localization signal to sustain androgen-independent nuclear import and signaling</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3672</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3672.jpg</image:loc><image:title>Investigating translation inhibition for the treatment of transcription inhibitor resistant Group 3 medulloblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3673</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3673.jpg</image:loc><image:title>Cystine restriction enhances CD8+ CAR-T potency by promoting OXPHOS via GCN2-eIF2alpha-SLC1A5 axis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3674</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3675</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3676</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3676.jpg</image:loc><image:title>RNA structure-targeted inhibition suppresses glioblastoma growth in human cerebral organoids</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3677</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3677.jpg</image:loc><image:title>Targeting p300/CBP abolishes HOXB13 loss-induced lipogenesis and tumor metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3678</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3678.jpg</image:loc><image:title>Investigation of the immune microenvironment of breast cancer brain metastasis using single-cell spatial genomics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3679</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3679.jpg</image:loc><image:title>C3a-C3aR1 signaling promotes invasion of cutaneous squamous cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3680</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3680.jpg</image:loc><image:title>Ligand-dependent Wnt signaling drives metastatic niche formation in gastric cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3681</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3681.jpg</image:loc><image:title>CARP-1/CCAR1 is a novel regulator of triple-negative breast cancer metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3682</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3682.jpg</image:loc><image:title>Spatial transcriptomics reveals primary-site endothelial EMT reprogramming that drives immunosuppression in metastatic uveal melanoma and predicts poor survival</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3683</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3683.jpg</image:loc><image:title>FUS ablation induces neuroendocrine-differentiation-like phenotypes and promotes leptomeningeal metastases in lung cancer through upregulating CD36 expression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3684</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3684.jpg</image:loc><image:title>Pancreatic cancer metastasis is transcriptionally regulated by an eleven amino-acid sequence</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3685</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3685.jpg</image:loc><image:title>Y chromosome loss drives cellular plasticity through single-cell epigenetic and transcriptional heterogeneity in lung adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3686</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3686.jpg</image:loc><image:title>Adipose-targeted electrical stimulation suppresses metastasis in obesity-associated TNBC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3687</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3688</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3688.jpg</image:loc><image:title>SOX2-driven stemness as a key determinant for long-term maintenance of pre-treatment patient-derived organoids in esophageal squamous cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3689</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3689.jpg</image:loc><image:title>Advancing iPSC derived CAR NK cell therapy for enhanced solid tumor treatment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3690</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3690.jpg</image:loc><image:title>Whole genome methylation sequencingstrongly suggests a novel, non-stem cell origin for some lung adenocarcinomas</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3691</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3691.jpg</image:loc><image:title>Targeting endolysosomal trafficking to overcome paclitaxel resistance in triple-negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3692</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3692.jpg</image:loc><image:title>FOXA2-associated chemoresistance in gastroesophageal adenocarcinoma: A single-cell transcriptomic exploratory analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3693</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3694</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3694.jpg</image:loc><image:title>Identification of molecular signatures in pancreatic ductal adenocarcinoma through multiomics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3695</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3696</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3696.jpg</image:loc><image:title>Cancer stem cells and where to find them: Their trajectories and implications in cancer evolution</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3697</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3698</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3698.jpg</image:loc><image:title>Quantification of step-specific selection reveals ordered acquisition of driver mutations in colon cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3699</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3699.jpg</image:loc><image:title>Inferring transcriptomic programs from circulating tumor DNA methylation signatures in small cell lung cancer using RRBS and EM-seq</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3700</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3700.jpg</image:loc><image:title>Proteomic signatures of tumorigenicity, immune evasion, and multidrug resistance in a murine T-cell lymphoma with CNS/ocular tropism</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3701</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3701.jpg</image:loc><image:title>Spatial single-cell transcriptomic profiling reveals distinct immune and stromal landscapes across TIL/PD-L1-defined TNBC subtypes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3702</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3703</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3703.jpg</image:loc><image:title>Multi-omics characterization of PRMT5 inhibition identifies vulnerabilities for combination therapy in MTAP-deleted cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3704</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3705</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3705.jpg</image:loc><image:title>Single cell multi-omics enables molecular dissection of gastric cancer subtypes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3706</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3707</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3707.jpg</image:loc><image:title>Site-specific oral microbiome patterns in Puerto Rican head and neck cancer patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3708</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3708.jpg</image:loc><image:title>Pan-cancer transcriptomic signatures of immune checkpoint blockade response and machine learning-based prediction across TIGER cohorts</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3709</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3710</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3711</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3711.jpg</image:loc><image:title>Resource allocation deconvolution for pathway analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3712</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3712.jpg</image:loc><image:title>In silico analysis of Lacunae cornuta phytochemical against high-risk HPV targets</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3713</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3714</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3714.jpg</image:loc><image:title>Metabolic transition analysis from dormancy to awakening in breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3715</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3715.jpg</image:loc><image:title>Integrative analysis of XPC and VEGFA as risk biomarkers in T-cell lymphoma: A case-control study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3716</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3716.jpg</image:loc><image:title>Immunotherapy response predictors in colorectal cancer: A multi-omics approach</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3717</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3717.jpg</image:loc><image:title>Genome-wide metabolic modeling identifies key modifiers of precancerous LUSC evolution</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3718</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3718.jpg</image:loc><image:title>Melanocytic transcriptional state is an independent marker of survival in metastatic melanoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3719</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3719.jpg</image:loc><image:title>CEDAR: A comprehensive database of curated cancer epitopes and receptors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3720</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3720.jpg</image:loc><image:title>Phone-based portable slide digitization system for AI-enabled histopathology</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3721</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3721.jpg</image:loc><image:title>Identification and phenotypical evaluation of androgen receptor indifferent phenotype in treatment-na&amp;#239;ve primary prostate cancer cases</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3722</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3722.jpg</image:loc><image:title>Advancing precision oncology through tumor digital twins: A versatile ViT-determined margin-consistent model for lung adenocarcinoma histopathologic subtyping in hematoxylin-eosin images</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3723</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3723.jpg</image:loc><image:title>Graph theoretic spatial heterogeneity analysis of multiplexed immunofluorescence images enables quantitative differentiation of HGSC precursor lesions in the fallopian tube</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3724</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3724.jpg</image:loc><image:title>Development of a virtual Cyclin E1 biomarker using Deep Learning from H&amp;#38;E slides for predicting Cyclin E1 overexpression in gynecological malignancy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3725</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3725.jpg</image:loc><image:title>Comprehensive 40-marker cyclic IF panel for spatial profiling of head and neck squamous cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3726</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3726.jpg</image:loc><image:title>Spatial immune profiling of solid tumors by complementing H&amp;#38;E with a novel 17-plex immunofluorescence approach</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3727</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3727.jpg</image:loc><image:title>Cell lines as quality controls for Quantitative Continuous Scoring (QCS) of IHC stained samples</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3728</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3729</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3729.jpg</image:loc><image:title>Ensuring pathologist alignment to safeguard data integrity in multi-centre oncology IVD/CDx clinical trials</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3730</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3730.jpg</image:loc><image:title>Validation of the ViewsML vIHC platform for biomarker classification and intensity binning: A pilot collaboration with Histowiz&#039;s PathologyMap platform</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3731</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3731.jpg</image:loc><image:title>AI-based detection and scoring of TROP2 expression in IHC-stained NSCLC specimens</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3732</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3732.jpg</image:loc><image:title>A general-purpose AI foundation model for spatial proteomics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3733</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3733.jpg</image:loc><image:title>Implementation of a diffusion-based color checker for histological image batch correction</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3734</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3734.jpg</image:loc><image:title>Advancing high-plex spatial proteomics using cleavable fluorophores and automated multiplex cycling</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3735</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3735.jpg</image:loc><image:title>Molecular diagnosis of lung tumors with a history of pancreatic cancer: Spatial profiling-based differential markers and functional insights into invasive mucinous adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3736</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3736.jpg</image:loc><image:title>Virtual inference of collagen architecture from H&amp;#38;E to characterize stromal fiber morphology and organization in colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3737</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3737.jpg</image:loc><image:title>All-in-one digital pathology compares and contrasts the tumor microenvironment of renal cell carcinoma tissue with paired, patient derived tumoroids</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3738</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3738.jpg</image:loc><image:title>Reading the map: An invitation to the resources of the Human Tumor Atlas Network</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3739</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3739.jpg</image:loc><image:title>An AI-driven multimodal workflow for enhancing late-phase clinical trial outcome prediction</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3740</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3740.jpg</image:loc><image:title>hla2vec: Developing a HLA embedding space using probabilistic cross-reactive groups</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3741</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3742</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3742.jpg</image:loc><image:title>DAG-guided kernel learning framework to mitigate racial disparities in breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3743</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3743.jpg</image:loc><image:title>Integrated meta-clustering reveals subtype-specific transcriptomic heterogeneity of pediatric low-grade glioma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3744</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3744.jpg</image:loc><image:title>Mapping the imputation-augmented somatic mutation landscape of 2,551 NSCLC patients highlights contrasting patterns across histologic subtype, smoking status, and ancestry</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3745</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3745.jpg</image:loc><image:title>Three-dimensional spatial multi-omics of gastric tumor sections reveal hidden features beyond 2D analyses</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3746</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3746.jpg</image:loc><image:title>Protocol-specific and coverage-based RNA-seq metrics characterize RNA integrity signatures across cohorts</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3747</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3747.jpg</image:loc><image:title>De-risk targets through mechanism-enabled simulations in the Virtual Lab</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3748</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3749</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3749.jpg</image:loc><image:title>Finding Goldilocks: How AI-powered covalent drug discovery removes the &amp;#8220;un&amp;#8221; from &amp;#8220;undruggable&amp;#8221;</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3750</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3750.jpg</image:loc><image:title>Multimodal deep learning framework for predicting clinically significant phenotypes in prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3751</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3751.jpg</image:loc><image:title>A modular in silico triage pipeline for multi omic evaluation of surface protein targets across indications</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3752</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3752.jpg</image:loc><image:title>A novel integrated AI ML and COSMIC signature profiling approach resolving blast crisis CML heterogeneity into single patient level pan cancer actionable programs enabling repurposable therapies for relapsed refractory and metastasized cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3753</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3754</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3754.jpg</image:loc><image:title>Breaks in the cancer immunity cycle correlate with response-predictive HNSCC immune microenvironment phenotypes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3755</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3755.jpg</image:loc><image:title>Quantifying uncertainty in virtual spatial transcriptomics using Bayesian neural networks</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3756</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3756.jpg</image:loc><image:title>A scalable, proteome-wide protein profiling platform with absolute quantification of 1000 proteins to power oncologic drug discovery pipelines</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3757</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3757.jpg</image:loc><image:title>TP53 dysfunction drives immunometabolic rewiring via mTORC1 activation and autophagy suppression in colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3758</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3758.jpg</image:loc><image:title>Coordinated miRNA regulation of AR-PI3K/MAPK crosstalk and EMT in prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3759</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3759.jpg</image:loc><image:title>Heterogeneous graph neural network meta-analysis of lung cancer and tuberculosis transcriptomic datasets reveals convergent host response networks</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3760</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3760.jpg</image:loc><image:title>OncoGraphDB: Rapid projections of patient-level multimodal graph database facilitates efficient exploration of tumor subtypes and identifies new combinatorial biomarkers of patient outcomes and gene essentiality</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3761</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3761.jpg</image:loc><image:title>Predicting self-antigen recognition of TCRs derived from tumor infiltrating CD8+ T cells via contrastive learning and T cell phenotyping</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3762</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3762.jpg</image:loc><image:title>Multiomic dissection of KRAS signaling reveals targetable metabolic and DNA repair vulnerabilities in colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3763</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3763.jpg</image:loc><image:title>Integrative single-cell transcriptomics and computational docking identify CCL18 as an immunomodulatory target in prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3764</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3764.jpg</image:loc><image:title>Exploring unrestricted antibiotic use gut microbiome imbalance and chemical carcinogens in liver and kidneys toxicity through computer modeling and in vivo study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3765</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3765.jpg</image:loc><image:title>Simulating trans-endothelial nanoparticle transport via macropinocytosis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3766</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3766.jpg</image:loc><image:title>The ancestry-transcriptome link: Machine learning predicts chemotherapy response in breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3767</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3768</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3768.jpg</image:loc><image:title>Machine learning models for predicting prostate cancer risk in Hispanic men</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3769</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3770</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3770.jpg</image:loc><image:title>Transformer and pretraining on external ehr cohort boosts infection risk prediction in hematologic malignancies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3771</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3771.jpg</image:loc><image:title>AI-driven epigenomic profiling reveals early predictors of cutaneous squamous cell carcinoma risk in hidradenitis suppurativa</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3772</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3773</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3773.jpg</image:loc><image:title>Generative genomics accurately predicts cancer gene expression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3774</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3774.jpg</image:loc><image:title>A comparative assessment of machine learning models for predicting prostate cancer using PVT1 biomarkers and PSA</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3775</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3775.jpg</image:loc><image:title>Interpreting PLMs for cancer discovery: High attention hotspots predict pathogenic mutation positions and novel drug binding sites</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3776</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3776.jpg</image:loc><image:title>Multi-modal modeling of genomic, histopathologic, and lab data predicts survival after hepatectomy in oligometastatic colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3777</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3777.jpg</image:loc><image:title>ProteoBridge: Bridging skipped sections via histology-based protein prediction</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3778</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3778.jpg</image:loc><image:title>Predicting immunotherapy response in patients with hepatocellular carcinoma from clinical and textual features using AI techniques</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3779</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3779.jpg</image:loc><image:title>Predicting high-risk colorectal polyps using pre-colonoscopy features: Machine learning model development and validation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3780</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3781</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3781.jpg</image:loc><image:title>Early prediction of engraftment outcomes in hematopoietic cell transplantation using neural ordinary differential equations</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3782</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3782.jpg</image:loc><image:title>AI-based prescreening of clonal hematopoiesis in patients with liver disease using Sysmex XN hematology analyzer data</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3783</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3784</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3784.jpg</image:loc><image:title>AI-driven de novo design of humanized nanobodies targeting KLK2 for prostate cancer immunotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3785</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3785.jpg</image:loc><image:title>Machine learning based classification of breast cancer using lifestyle and clinical risk factors in Puerto Rican women</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3786</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3786.jpg</image:loc><image:title>Independent validation of the immunotherapy response model using real-world Moffitt Cancer Center cohort</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3787</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3787.jpg</image:loc><image:title>Validation of the CLL treatment infection model (CLL-TIM) in patients with newly diagnosed chronic lymphocytic leukemia (CLL)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3788</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3788.jpg</image:loc><image:title>AI based explainable survival modeling for advanced non small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3789</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3789.jpg</image:loc><image:title>Targeting Beta-catenin in colorectal cancer: Novel molecular glue drug candidates by Coltac&#039;s BOND+ platform</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3790</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3790.jpg</image:loc><image:title>Design and synthesis of highly efficacious CRBN-based pan-KRAS degraders targeting cancers with KRAS G12D, G12V and G12C mutations</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3791</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3791.jpg</image:loc><image:title>Targeted degradation of KRAS using the AUTOTAC platform</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3792</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3792.jpg</image:loc><image:title>Characterization of second-generation AUTOTACs targeting the androgen receptor for castrate-resistant prostate cancer treatment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3793</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3794</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3794.jpg</image:loc><image:title>Development of FBXW7 binders for targeted protein degradation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3795</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3795.jpg</image:loc><image:title>Discovery and characterization of XNW34017, a first-in-class, orally bioavailable, and brain-penetrant AURKA-MYC degrader</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3796</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3797</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3797.jpg</image:loc><image:title>Rational development of novel FBXO22-mediated TEAD Targeted Glues&amp;#8482; for mesothelioma and NSCLC treatment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3798</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3799</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3799.jpg</image:loc><image:title>Leveraging selective degradation of CBP and EP300 for potent anti-cancer activity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3800</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3800.jpg</image:loc><image:title>Exploration of novel E3 ligase to support targeted protein degradation drug discovery</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3801</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3802</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3802.jpg</image:loc><image:title>Design and applications of novel hydrophobic CRBN binders</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3803</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3803.jpg</image:loc><image:title>Expanding the landscape of targeted protein degradation: E3-agnostic discovery and proprietary ligand identification</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3804</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3804.jpg</image:loc><image:title>Identification and optimization of pyridylbenzylamine analog 1 as potent and selective Helios degrader</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3805</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3805.jpg</image:loc><image:title>Design and optimization of small-molecule PROTACs targeting KRAS</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3806</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3807</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3807.jpg</image:loc><image:title>Mechanistic insights into PLK1 target inhibition in ovarian cancer: Functional suppression and PROTAC-based therapeutic agents</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3808</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3809</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3809.jpg</image:loc><image:title>High-throughput capillary immunoassays enable precise quantitation of protein degrader potency and kinetics in oncology discovery</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3810</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3811</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3811.jpg</image:loc><image:title>Selective degradation of SMARCA4 as a therapeutic strategy in SMARCA4 driven cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3812</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3812.jpg</image:loc><image:title>Exceptionally selective and orally bioavailable p300 degraders for the treatment of CBP-mutant and p300-dependent cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3813</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3813.jpg</image:loc><image:title>Discovery and characterization of a selective p300 degrader reveals deep anti&amp;#8209;tumor activity in CBP mutant cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3814</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3814.jpg</image:loc><image:title>Discovery and characterization of a selective p300 degrader reveals broad anti&amp;#8209;tumor activity in p300&amp;#8209;dependent cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3815</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3815.jpg</image:loc><image:title>Engaged but not degraded: Proteome-wide CETSA in degrader research</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3816</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3816.jpg</image:loc><image:title>In silico discovery of potent small molecule inhibitors targeting the AR N-terminal domain for treating castration-resistant prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3817</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3817.jpg</image:loc><image:title>P015, a highly selective PARP7&amp;#38;12 dual inhibitor</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3818</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3818.jpg</image:loc><image:title>Design and discovery of BH-501242, a novel pan-KRAS on/off inhibitor targeting KRAS switch II pocket</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3819</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3819.jpg</image:loc><image:title>Targeting peripheral alpha 2A -adrenoceptors as a dual-benefit approach for integrated cancer therapy and supportive care</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3820</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3821</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3821.jpg</image:loc><image:title>C018, a potent and selective CDK4&amp;#38;9 dual inhibitor</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3822</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3822.jpg</image:loc><image:title>Identification and structural characterization of a novel PCNA-interacting small molecule scaffold</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3823</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3823.jpg</image:loc><image:title>Discovery of a novel, selective brain penetrant CDK4 inhibitor for targeted cancer therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3824</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3824.jpg</image:loc><image:title>Structure-guided discovery of potent and selective DGKalpha inhibitors for targeted cancer therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3825</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3825.jpg</image:loc><image:title>Accelerated discovery of novel RORgammaT modulators using an AI-driven platform integrating generative chemistry and mechanistic PK simulation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3826</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3826.jpg</image:loc><image:title>Discovery and development of a novel PI3K-CDK4/6 dual inhibitor PC-13 for the treatment of breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3827</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3828</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3828.jpg</image:loc><image:title>HDM2021, a potent and selective CBL-B inhibitor exhibits robust immunomodulatory efficacy for anti-tumor therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3829</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3829.jpg</image:loc><image:title>Discovery and preclinical evaluation of a potent, orally bioavailable, highly selective, small molecule non-covalent KRAS[G12D] inhibitor</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3830</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3830.jpg</image:loc><image:title>Design, synthesis and pharmacological evaluation of ACC1 selective inhibitors for cancer treatment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3831</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3831.jpg</image:loc><image:title>Targeting EGFR cysteine 775 in EGFR mutant lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3832</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3832.jpg</image:loc><image:title>Multi-targeted MNK inhibitors as anticancer agents for AML</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3833</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3833.jpg</image:loc><image:title>KBD880 is a potent and selective GPC3 peptide binder for treatment of HCC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3834</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3834.jpg</image:loc><image:title>Chemical optimization of an orally bioavailable macrocyclic peptide KRAS inhibitors that achieve KRAS selectivity by recognizing a single amino acid difference</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3835</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3835.jpg</image:loc><image:title>Development of hydrophilic and metabolically stable heterocyclic AOH1996 analogues for pediatric AML oral liquid formulations</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3836</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3836.jpg</image:loc><image:title>ZMS-4084, a potent and selective WRN inhibitor induces significant tumor regression and sustained complete responses in MSI-H tumor models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3837</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3837.jpg</image:loc><image:title>PRMT5 inhibitor SCR-6920 downregulates HIF-1alpha and exhibits synergistic antitumor activity with Bevacizumab</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3838</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3838.jpg</image:loc><image:title>A novel highly potent multiple-RAS inhibitor ZMS-2195 efficiently blocks MAPK pathway activation and induces robust anti-tumor growth effects in preclinical models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3839</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3839.jpg</image:loc><image:title>Discovery of a novel ALK inhibitor ZM-8195 that targets ALK compound mutations with superior TRK selectivity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3840</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3840.jpg</image:loc><image:title>A novel investigation of the cyclin A/B inhibitor ZMS-7506 demonstrates robust anti-tumor efficacy both in vitro and in vivo</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3841</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3841.jpg</image:loc><image:title>Real world prediction and biological characterization of sotorasib sensitivity using multimodal AI and liquid biopsy genomic inputs</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3842</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3842.jpg</image:loc><image:title>Updated exploratory biomarker analysis of cadonilimab plus regorafenib as second-line or later therapy in advanced hepatocellular carcinoma: Identification of Bola3 as a potential predictive biomarker</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3843</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3843.jpg</image:loc><image:title>The significant co-expression of claudin-3(CLDN3) and B7-H3(CD276) as a potential biomarker for targeted therapy in neuroendocrine carcinomas</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3844</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3844.jpg</image:loc><image:title>Retrospective study for clinical biomarkers to guide post-EGFR-TKI treatment strategies in EGFR-mutant NSCLC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3845</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3845.jpg</image:loc><image:title>Biomarker dynamics in the completed phase I study of DT-9081: An analysis of ex vivo cytokine stimulation, urinary PGEM, and tumoral biomarkers in advanced solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3846</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3846.jpg</image:loc><image:title>A CXCL10/11 and CCL19 duplex chromogenic assay complements PD-L1 immunohistochemistry in non-small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3847</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3847.jpg</image:loc><image:title>Personalized fusion measurable residual disease detection in acute myeloid leukemia using droplet digital PCR</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3848</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3848.jpg</image:loc><image:title>Down regulation of HPV 16 and NF-&amp;#922;B and upregulation of gigaxonin and immune markers in APG-157 treated head and neck cancer: A phase 2A clinical investigation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3849</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3849.jpg</image:loc><image:title>Profiling of peripheral LAG-3+CD8+ T cells: An immune cell population associated with immunotherapy resistance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3850</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3851</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3851.jpg</image:loc><image:title>Immune profiling and targetable biomarkers in NSCLC: Toward rational design of CKI-based combinations</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3852</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3852.jpg</image:loc><image:title>Integrating immunohistochemistry for biomarker detection in NSCLC: A step toward precision therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3853</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3853.jpg</image:loc><image:title>Single-cell multi-omics reveals co-mutation of TP53 and epigenetic gene driving myeloid transformation in B-ALL following CAR-T therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3854</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3854.jpg</image:loc><image:title>Longitudinal liquid biopsy identifies an early predictive biomarker of immune checkpoint blockade response in head and neck squamous cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3855</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3855.jpg</image:loc><image:title>Method development and workflow optimization of a CTC-based biomarker assay to predict response to CDK4/6 inhibitors in HR+/HER2- breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3856</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3856.jpg</image:loc><image:title>Precise description of metabolomic states using NGS uncover new potential biomarkers of response to TKIs in ccRCC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3857</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3857.jpg</image:loc><image:title>Computational modeling of comprehensive genomic profiling to predict chemo-immunotherapy benefit in early stage NSCLC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3858</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3858.jpg</image:loc><image:title>Molecular correlates of progression-free survival in recurrent gliomas treated with pembrolizumab</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3859</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3859.jpg</image:loc><image:title>Copy number amplification of PSG is associated with poor survival in female lung adenocarcinoma patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3860</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3861</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3862</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3862.jpg</image:loc><image:title>Armored TIL GT201 induces potent tumor-specific TCR expansion and durable antitumor responses in advanced solid tumor</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3863</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3863.jpg</image:loc><image:title>Monitoring of molecular response during immunotherapy by circulating tumor DNA in non-small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3864</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3864.jpg</image:loc><image:title>DNMT3A -mutated tumor-infiltrating clonal hematopoiesis predicts immune checkpoint inhibitor response in advanced non-small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3865</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3865.jpg</image:loc><image:title>Serial plasma tumor-informed next generation sequencing as a new efficacy metric to guide immunotherapy treatment discontinuation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3866</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3867</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3867.jpg</image:loc><image:title>Analytical performance of an ultrasensitive whole genome sequencing assay for molecular residual disease detection</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3868</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3868.jpg</image:loc><image:title>Monitoring treatment response in metastatic breast cancer patients using an mDETECT assay</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3869</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3869.jpg</image:loc><image:title>Baseline ctDNA profiling identifies molecular predictors of resistance to second-generation ALK inhibitors in EML4-ALK-positive NSCLC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3870</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3870.jpg</image:loc><image:title>Dynamic changes in ctDNA methylation predict early response to immunotherapy in advanced esophageal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3871</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3871.jpg</image:loc><image:title>Tracking prostate cancer progression by deep whole genome sequencing of primary tumors and longitudinal circulating tumor DNAs</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3872</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3872.jpg</image:loc><image:title>Digital PCR-based plasma DNA methylationassayfor noninvasive molecular subtyping of small cell lung cancer: A prospective feasibility study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3873</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3873.jpg</image:loc><image:title>Fragmentomic analysis of cfDNA WGS at regulatory regions generates gene-level expression-like traits for subtype analysis in breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3874</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3874.jpg</image:loc><image:title>Combining gene expression and mutation profiling in a single cfDNA assay through the addition of a custom hybrid capture panel targeting gene regulatory regions to a commercial CGP panel</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3875</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3875.jpg</image:loc><image:title>Analytical precision and cross-platform replicability of cfDNA-based genome-wide multi-feature classifiers for early cancer detection</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3876</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3876.jpg</image:loc><image:title>Analytical validation of SPIRAL: An integrated genomic and epigenomic liquid biopsy assay</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3877</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3877.jpg</image:loc><image:title>Evaluation of circulating tumor DNA as a biomarker for early relapse detection and molecular profiling in patients with high-risk neuroblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3878</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3878.jpg</image:loc><image:title>A low-cost, ultra-fast, low-input amplicon NGS workflow for rapid cancer profiling</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3879</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3879.jpg</image:loc><image:title>Circulating tumor DNA (ctDNA)-based profiling of acquired resistance to the fibroblast growth factor receptor (FGFR)2/3 inhibitor lavengratinib(ABSK061) in patient(pt)s with advanced solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3880</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3880.jpg</image:loc><image:title>Leveraging enhanced conversion efficiency of the KAPA EvoPrep Boost workflow for urine ctDNA detection</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3881</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3881.jpg</image:loc><image:title>Comprehensive profiling of urine microRNAs in prostate cancer patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3882</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3882.jpg</image:loc><image:title>Non-invasive tracking of clonal evolution and treatment response through liquid biopsies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3883</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3883.jpg</image:loc><image:title>Circulating tumor DNA dynamics predict the response to neoadjuvant chemotherapy but not long-term outcomes in PIK3CA -mutated breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3884</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3884.jpg</image:loc><image:title>Circulating tumor DNA detects minimal residual disease and predicts outcomes in esophageal cancer after esophagectomy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3885</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3885.jpg</image:loc><image:title>Cell-free DNA fragmentomes for treatment response monitoring in patients with metastatic colorectal cancer: The Dolphin study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3886</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3886.jpg</image:loc><image:title>High throughput genomic profiling of tissue and liquid biopsy samples reveals targetable mutations in NSCLC patients from the Indian population</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3887</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3887.jpg</image:loc><image:title>Utilization of urinary cell-free DNA as an informative biomaterial for comprehensive genomic profiling</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3888</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3888.jpg</image:loc><image:title>Analytical performance of magnetic bead-based cfDNA extraction with a low input targeted DNA enrichment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3889</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3889.jpg</image:loc><image:title>Unlocking transrenal DNA: New methods for stabilizing and isolating small cfDNA in urine</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3890</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3890.jpg</image:loc><image:title>Validation of microenvironment gene signatures from FFPE to predict nasopharyngeal cancer prognosis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3891</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3891.jpg</image:loc><image:title>Neutrophilic skin infiltrates in patients with acute myeloid leukemia (AML) are clonal and associate with poor overall survival</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3892</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3892.jpg</image:loc><image:title>Clinicopathological and prognostic analyses of colorectal cancer with neuroendocrine differentiation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3893</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3893.jpg</image:loc><image:title>Prognostic value of tumor-informed circulating tumor DNA in non-small cell lung cancer after curative treatment: real-world cohort with long-term follow-up</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3894</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3894.jpg</image:loc><image:title>Clinical and molecular features of CD276 (B7H3) in liver metastases of pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3895</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3895.jpg</image:loc><image:title>The prognostic role of pretreatment neutrophil-to-lymphocyte ratio in a multiethnic cohort of breast cancer patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3896</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3897</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3897.jpg</image:loc><image:title>Prognostic and metastasis-associated roles of IL-6 and IL-8 in patients with stage IV gastric cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3898</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3898.jpg</image:loc><image:title>Annexin A3 expression is prevalent but highly variable in human cancer: A tissue microarray study involving 5,914 cancers from 105 tumor entities</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3899</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3899.jpg</image:loc><image:title>Fragmentomics analysis of targeted hybrid capture NGS cfDNA gene panel data yields an orthogonal genomic dimension for developing a robust prognostic model for metastatic breast cancer patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3900</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3900.jpg</image:loc><image:title>Prognostic impacts of skeletal muscle gene expression and cachexia in advanced colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3901</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3901.jpg</image:loc><image:title>Immune checkpoint protein expression of PD-1 shows prognostic significance in large B-cell lymphomas of the central nervous system</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3902</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3902.jpg</image:loc><image:title>Development of reference standards for clonal evolution and measurable residual disease in acute myeloid leukemia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3903</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3904</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3904.jpg</image:loc><image:title>Prediction of relapse risk in favorable outcome AML from DNA methylation data</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3905</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3905.jpg</image:loc><image:title>GDF-15 reflects host physiological stress rather than tumor progression in colorectal cancer patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3906</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3906.jpg</image:loc><image:title>Prognostic significance of STING expression in patients with resected lung adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3907</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3907.jpg</image:loc><image:title>Prognostic utility of minimal residual disease detection using circulating tumor DNA in early-stage breast cancer: A systematic review and meta-analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3908</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3908.jpg</image:loc><image:title>Integrated analysis for identification of risk stratification biomarkers for colon cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3909</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3909.jpg</image:loc><image:title>The Yin and Yang of sphingosine kinase 2 (SPHK2): Opposing regulation by nuclear and cytoplasmic localization in lung cancer progression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3910</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3910.jpg</image:loc><image:title>Construction and assessment of the stemness-telomere survival risk framework (STSRF) for precision breast cancer therapy: Insights from multi-omic approaches</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3911</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3911.jpg</image:loc><image:title>High-throughput ex vivo TCR-T cells screening identifies aggrephagy-driven, therapy-resistant clones in KRAS-mutant PDAC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3912</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3912.jpg</image:loc><image:title>From tLNP selection to in vitro/vivo efficiency evaluation: In vivo CAR-T therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3913</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3914</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3914.jpg</image:loc><image:title>Pro-inflammatory cytokine primed Wharton&#039;s jelly mesenchymal stem cells: A potent immunomodulatory strategy to combat pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3915</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3915.jpg</image:loc><image:title>IL-21-Enhanced NK cells: A mitochondrial fitness enhancement for targeting glioblastoma stem cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3916</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3916.jpg</image:loc><image:title>Generating EZH2-inhibitor resistant CAR-T cells to sustain function for combination therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3917</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3917.jpg</image:loc><image:title>Advancing FCRL5 directed immunotherapy for improved treatment of B cell lymphoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3918</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3919</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3919.jpg</image:loc><image:title>Single-cell profiling reveals immune circuit disruption preceding CAR-T relapse in B-ALL</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3920</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3920.jpg</image:loc><image:title>Novel SynKIR-310 outperforms CD3-based second-generation CD28 or 41BB co-stimulated CAR T in B-cell non-Hodgkin lymphoma xenograft mice and shows early clinical signal</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3921</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3921.jpg</image:loc><image:title>Oncolytic virus infected tumors drive AP-1 and IRF signaling in NK cells to sustain anti tumor activity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3922</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3922.jpg</image:loc><image:title>Next-generation CAR-T cells that target only tumor stroma and matrix: Collagen-binding IL-12-expressing FAP-CAR-T show strong anti-tumor efficacy but are safe</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3923</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3923.jpg</image:loc><image:title>Metabolically supercharged NK cells engineered with adenoviral E4ORF-1</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3924</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3924.jpg</image:loc><image:title>A non-viral mRNA engineering platform for rapid, same-day immune-cell therapies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3925</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3925.jpg</image:loc><image:title>uPAR-targeting CAR-NK cells enhance cytotoxicity against acute myeloid leukemia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3926</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3926.jpg</image:loc><image:title>Preclinical evaluation of armored DLL3 biepitope compound nanobody CAR T cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3927</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3927.jpg</image:loc><image:title>Tuning gated CAR-T cells for enhanced activity against acute myeloid leukemia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3928</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3928.jpg</image:loc><image:title>Predictive models for hematologic toxicity after CAR-T therapy: A systematic review of current risk scores and unmet AI needs</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3929</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3929.jpg</image:loc><image:title>Phosphorylated IRF7 enhances antitumor activity of GPC3-targeted CAR T cells in solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3930</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3930.jpg</image:loc><image:title>CD5-directed CAR5/IL-15 NK cells as a therapeutic platform for T-cell malignancies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3931</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3931.jpg</image:loc><image:title>Assessing donor heterogeneity in CAR-T cells with massively parallel mixed lymphocyte reactions</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3932</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3932.jpg</image:loc><image:title>Mitochondrial remodeling sustains CAR-NK stemness for superior tumor control</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3933</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3934</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3935</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3935.jpg</image:loc><image:title>Mechanistic drivers of FAP-targeted ADC performance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3936</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3937</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3937.jpg</image:loc><image:title>Targeting solid tumors with pH-dependent dual-specific TCEs: First-in-human development of CT-202</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3938</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3938.jpg</image:loc><image:title>Preclinical efficacy and safety profile of NPX125, a novel ADC targeting B7-H7</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3939</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3940</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3941</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3942</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3943</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3944</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3944.jpg</image:loc><image:title>Engineering and development of a novel bispecific ADC targeting EGFR and FGFR2b</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3945</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3946</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3947</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3948</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3949</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3949.jpg</image:loc><image:title>An in vivo -validated dual-mechanism model explains and guides FLASH radiotherapy for normal-tissue sparing</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3950</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3951</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3952</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3953</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3953.jpg</image:loc><image:title>Genetic inhibition of FTO does not exacerbate the severity of radiation-induced oral mucositis in C57BL/6 mice</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3954</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3955</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3956</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3956.jpg</image:loc><image:title>Pain signaling in dogs undergoing radiotherapy for head and neck cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3957</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3957.jpg</image:loc><image:title>Signaling pathway insights into spaceflight cancer risks</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3958</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3959</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3959.jpg</image:loc><image:title>Mechanistic insights into the anti-tumor activity of &amp;#178;&amp;#185;&amp;#178;Pb-PSMA radioligand therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3960</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3961</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3962</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3962.jpg</image:loc><image:title>Profiling membrane antigen expression of select antibody-drug conjugate (ADC) targets in EGFR -altered non-small cell lung cancer treated with osimertinib</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3963</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3964</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3964.jpg</image:loc><image:title>Integrated machine learning and large language models reveal molecular determinants of survival and treatment response in KRAS-mutant lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3965</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3965.jpg</image:loc><image:title>Distinct KRAS mutation codons differentially associate with microsatellite instability in colorectal carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3966</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3966.jpg</image:loc><image:title>MSI colon adenocarcinoma transcriptomic subtypes are biomarkers of response to immunotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3967</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3967.jpg</image:loc><image:title>Clinicogenomic predictors of first-line immune checkpoint inhibitor outcomes in non-small cell lung cancer: A nationwide C-CAT cohort from Japan</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3968</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3968.jpg</image:loc><image:title>Prevalence and distinct biological programs of small cell lung cancer molecular subtypes revealed by real-world clinico-genomics database</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3969</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3969.jpg</image:loc><image:title>Landscape of ALK fusion breakpoints and subtypes: A comparative analysis of DNA-NGS versus RNA-NGSs</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3970</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3970.jpg</image:loc><image:title>Real-world landscape of BRAF fusions in chinese patients with lung and colorectal cancers: Insights from 26,248 DNA-NGS and RNA-NGS tests</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3971</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3971.jpg</image:loc><image:title>Analysis of RNA expression of 47 cell surface proteins in real-world small cell lung cancer patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3972</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3972.jpg</image:loc><image:title>Variant allele frequency machine learning model identifies unique TP53-mutant phenotypes with worse post-operative survival in pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3973</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3973.jpg</image:loc><image:title>Large-scale genomic analysis of pancreatic cancer in a real-world patient population</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3974</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3974.jpg</image:loc><image:title>Prognostic impact and clinical characteristics of KRAS mutations and CDKN2A loss in IDH1 -mutant intrahepatic cholangiocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3975</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3976</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3976.jpg</image:loc><image:title>Tumor remodeling pathways are enriched in the tumor microenvironment of obesity-associated colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3977</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3977.jpg</image:loc><image:title>Refining tumor mutational burden as a predictive biomarker for pembrolizumab: A real-world analysis of 1,899 Japanese patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3978</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3978.jpg</image:loc><image:title>Evaluating prognostic biomarkers in advanced epithelial ovarian carcinoma using machine learning on real-world data</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3979</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3979.jpg</image:loc><image:title>Epidemiology of folate receptor alpha expression in ovarian cancer by age, race/ethnicity, and histotype in a real-world, US-based clinicogenomic database</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3980</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3980.jpg</image:loc><image:title>Genomic and ancestry-associated determinants of survival in gynecologic cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3981</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3981.jpg</image:loc><image:title>Extrachromosomal DNA shapes aggressive transcriptional states in multiple myeloma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3982</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3982.jpg</image:loc><image:title>Leveraging a real-world clinicogenomic database for post-sequencing quality assessment in solid tumor comprehensive genomic profiling (CGP)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3983</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3983.jpg</image:loc><image:title>Molecular tumor registries - A learning system for real world data (RWD)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3984</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3984.jpg</image:loc><image:title>Disparities between genomic alterations and clinical trial representation in precision oncology</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3985</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3985.jpg</image:loc><image:title>Precision oncology in practice: Comprehensive genomic profiling identifies actionable alterations and guides therapeutic selection in 756 clinical solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3986</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3986.jpg</image:loc><image:title>Primary osteosarcoma of the short bones: A Surveillance, Epidemiology, and End Results Program (SEER) retrospective study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3987</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3987.jpg</image:loc><image:title>Eyelid malignancies on the rise? A population-based analysis of merkel cell carcinoma, melanoma, and sebaceous carcinoma from the SEER database</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3988</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3988.jpg</image:loc><image:title>Real-world (RW) outcomes by race in patients (pts) receiving first-line (1L) treatment (tx) for advanced/metastatic (a/m) gastric, gastroesophageal junction, or esophageal adenocarcinoma (GC/GEJC/EAC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3989</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3990</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3990.jpg</image:loc><image:title>Association between time-dependent postoperative vitamin D levels and survival&amp;#8239;in&amp;#8239;early-onset colorectal cancer patients undergoing curative surgery: A real-world database analysis&amp;#8239;</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3991</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3991.jpg</image:loc><image:title>Preoperative albumin is associated with unplanned readmission following soft tissue sarcoma resection</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3992</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3992.jpg</image:loc><image:title>Recurrence-free survival in patients with early-stage HPV-associated adenocarcinoma of the cervix stratified by Silva patterns</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3993</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3993.jpg</image:loc><image:title>COVID-19 infection and impact on cancer recurrence: Comprehensive results from over 32,000 patients with breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3994</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3994.jpg</image:loc><image:title>Persistent opioid use during long-term lung cancer survivorship: When did it start?</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3995</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3995.jpg</image:loc><image:title>Identifying dynamic subtypes of cancer cachexia using longitudinal clinical lab values</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3996</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3996.jpg</image:loc><image:title>Determining the benefit of comprehensive molecular testing in advanced cancers: BostonGene and Exigent Genomic INsight (BEGIN) study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3997</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3997.jpg</image:loc><image:title>Turnaround time between NSCLC diagnosis to genomic testing using reflexive next generation sequencing</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3998</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3998.jpg</image:loc><image:title>A Bayesian framework for evaluating somatic copy number variants into comparative genomic analysis of multifocal non-small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/3999</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/3999.jpg</image:loc><image:title>Detection of rare oncogenic fusions through concurrent DNA and RNA next-generation sequencing in a pan-cancer clinical setting</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4000</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4000.jpg</image:loc><image:title>Clinical and genomic characterization of biliary tract tumors (BTT) with ARID1A mutations: A case-control study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4001</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4001.jpg</image:loc><image:title>Anatomic origins of primary skeletal tumors effect metastatic and prognostic behaviors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4002</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4002.jpg</image:loc><image:title>Weekend radiotherapy for oncologic emergencies: A single-institution analysis of indications and practice patterns</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4003</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4003.jpg</image:loc><image:title>Impact of double primary cancer on survival in patients with non-small cell lung cancer: Large-scale cohort</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4004</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4005</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4005.jpg</image:loc><image:title>Lung adenocarcinoma and urothelial carcinoma: Analysis of double cancer in Chang-Gung Medical Foundation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4006</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4006.jpg</image:loc><image:title>Clinical characterization of immune checkpoint inhibitor-induced myocarditis and the triple M overlap syndrome</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4007</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4007.jpg</image:loc><image:title>T-cell transcriptome affected by therapy-related clonal hematopoiesis in long-term survivors of pediatric cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4008</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4008.jpg</image:loc><image:title>The mutational landscape underlying the late effects of anthracyclines on tumor, blood, and heart genomes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4009</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4009.jpg</image:loc><image:title>Metabolic and lipidomic changes in early asparaginase hepatotoxicity in mice</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4010</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4010.jpg</image:loc><image:title>Novel transdermal curcumin attenuates cisplatin induced neuropathy in a mouse model of breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4011</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4011.jpg</image:loc><image:title>Mast cell activation leads to cisplatin-induced peripheral neuropathy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4012</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4012.jpg</image:loc><image:title>Leveraging a PARP inhibitor as neuroprotection against chemotherapy induced cognitive impairments</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4013</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4013.jpg</image:loc><image:title>Systemic therapy and cardiovascular disease in adolescent and young adult breast cancer survivors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4014</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4014.jpg</image:loc><image:title>Association between metabolic syndrome and risk of second primary malignancy among patients with a history of cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4015</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4015.jpg</image:loc><image:title>Racial/ethnic disparities in risk of second primary malignancy among women in the Pathways Study of breast cancer survivors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4016</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4016.jpg</image:loc><image:title>Multifactorial risks for multiple primary cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4017</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4018</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4018.jpg</image:loc><image:title>Shifting the gut microbiome to alleviate anti-cancer treatment-induced cardiovascular toxicity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4019</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4019.jpg</image:loc><image:title>Is endothelial dysfunction induced by aromatase inhibitors reversible after treatment?</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4020</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4020.jpg</image:loc><image:title>The role of pancreatic adenocarcinoma cancer-stromal interactions on cardiac structure and function</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4021</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4021.jpg</image:loc><image:title>Clone wars: Evidence of clonal stability in a longitudinal prospective cohort of cancer survivors with serial NGS analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4022</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4022.jpg</image:loc><image:title>Hair loss in cancer patients receiving small molecule inhibitors: Evidence from clinical trials</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4023</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4023.jpg</image:loc><image:title>Alopecia in cancer immunotherapy: Incidence and patterns with monoclonal antibodies and antibody-drug conjugates</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4024</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4024.jpg</image:loc><image:title>GAS6 signaling links smoke-filled environments to increased invasion and communication in gastric and lung cancer models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4025</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4025.jpg</image:loc><image:title>A novel viral-derived epigenetic gene therapy delivered via mRNA-lipid nanoparticles to inhibit HPV-associated malignancies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4026</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4027</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4028</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4028.jpg</image:loc><image:title>Epigenetic clusters identified in Hispanic/LatinX colorectal cancers reveal novel molecular subtypes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4029</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4029.jpg</image:loc><image:title>Toward a functional characterization of polygenic modifiers of BRCA2 associated prostate cancer risk</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4030</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4030.jpg</image:loc><image:title>Molecular and immune landscape of HER2-amplified colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4031</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4032</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4032.jpg</image:loc><image:title>HMA-induced oncogene reactivation as a driver of disease progression in MDS</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4033</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4033.jpg</image:loc><image:title>Native domain-interaction rewiring collapses the AR neo-enhanceosome in prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4034</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4034.jpg</image:loc><image:title>Investigating the intrinsic epigenetic dependencies of estrogen receptor positive and ESR1 mutant breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4035</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4036</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4036.jpg</image:loc><image:title>Targeting the oncogenic RNA m6A reader YTHDF2 inhibits oral squamous cell carcinoma by preventing p53 degradation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4037</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4037.jpg</image:loc><image:title>Epigenetic modulation by DNMT-1 inhibitor induces cell death in SK-N-AS neuroblastoma cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4038</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4039</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4039.jpg</image:loc><image:title>Epigenetic and transcriptional drivers of mucinous breast carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4040</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4040.jpg</image:loc><image:title>Distinct genomic and pathway-level alterations in early-onset colorectal cancer: A large-scale Korean cohort analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4041</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4042</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4042.jpg</image:loc><image:title>Epigenetic modulation by MDM2 and DNMT inhibitor promotes cell cycle arrest and programmed cell death in neuroblastoma cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4043</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4043.jpg</image:loc><image:title>Clinical utility of whole genome sequencing for upfront risk stratification in AML and MDS patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4044</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4044.jpg</image:loc><image:title>Evaluating the molecular landscape of genetic mutations among Black patients with acute myeloid leukemia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4045</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4045.jpg</image:loc><image:title>Defining the landscape of TP53 mutations in acute myeloid leukemia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4046</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4046.jpg</image:loc><image:title>SON-1010 (IL12-F H AB) synergizes with trabectedin in advanced soft-tissue sarcoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4047</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4047.jpg</image:loc><image:title>Safety and efficacy of pucotenlimab combined with standard chemotherapy regimens in the preoperative treatment of pediatric patients with intermediate or high-risk rhabdomyosarcoma: A phase I/II study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4048</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4048.jpg</image:loc><image:title>Camu camu plus nivolumab/ipilimumab (N/I) as first-line therapy for metastatic renal cell carcinoma (mRCC): A randomized phase I trial</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4049</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4049.jpg</image:loc><image:title>Phase Ib clinical evaluation of a novel CD55- and FcRn-bioselected RNA oncolytic virus, IVX037, combined with sintilimab (anti-PD-1) in advanced microsatellite-stable colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4050</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4050.jpg</image:loc><image:title>Preliminary results of first-line botensilimab (BOT) and balstilimab (BAL) optimization in microsatellite stable colorectal cancer (MSS CRC) without liver, bone, or brain metastasis (BBOpCo)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4051</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4052</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4052.jpg</image:loc><image:title>Pulmonary toxicity associated with increased 6-OH-paclitaxel exposure in pancreatic cancer patients treated with nab-paclitaxel, gemcitabine and cobicistat: Results of the IntenSify trial</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4053</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4053.jpg</image:loc><image:title>Immunogenicity of the therapeutic HPV16-specific cancer vaccine abipapogene suvaplasmid (VB10.16) in combination with pembrolizumab given as 1L treatment for HPV16+ PD-L1+ r/m oropharyngeal cancer: Preliminary results from phase 1 of the VB-C-03 trial</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4054</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4054.jpg</image:loc><image:title>Intralesional PD-1 blockade for oral cancer prevention: First-in-class phase 1 trial</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4055</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4055.jpg</image:loc><image:title>Preliminary results from the phase 1b/2, open-label, multi-center study of ZL-1310, a DLL3-targeted ADC, in patients with neuroendocrine carcinomas and other selected solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4056</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4056.jpg</image:loc><image:title>Brexu-cel + dasatinib: Safety and feasibility of dasatinib pulses after brexucabtagene autoleucel to modulate CAR T cell activity in relapsed/refractory B cell acute lymphoblastic leukemia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4057</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4057.jpg</image:loc><image:title>The combination of ruxolitinib and the CDK4/6 inhibitor abemaciclib demonstrates safety and efficacy in previously treated myelofibrosis patients: Results of a Phase I study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4058</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4058.jpg</image:loc><image:title>The first report of patients with solid tumors treated with LP-118, a novel Bcl-2/Bcl-xL dual inhibitor</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4059</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4059.jpg</image:loc><image:title>Intracranial activity of ZL-1310, a DLL3-targeted ADC, in patients with previously treated extensive-stage small cell lung cancer and baseline brain metastasis: Analysis of a phase 1 trial</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4060</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4060.jpg</image:loc><image:title>Local administration of tumor infiltrating lymphocytes by hepatic artery infusion in patients with uveal melanoma and liver metastases</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4061</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4061.jpg</image:loc><image:title>Fast-manufactured, low IL-2-dependent FAST-TIL for the treatment of advanced melanoma in asian patients: Median 6-month follow-up data from a phase I clinical trial</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4062</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4062.jpg</image:loc><image:title>Phase I study of ERY974 in patients with glypican-3 (GPC-3)-positive advanced solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4063</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4063.jpg</image:loc><image:title>Phase 1 clinical trial of a first-in-class antagomir therapeutic against advanced solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4064</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4064.jpg</image:loc><image:title>SAR445877: A PD-1-targeted IL-15 mutein selectively activates PD-1+ T cells resulting in therapeutic activity across pre-clinical mouse models and in early human clinical trials</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4065</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4065.jpg</image:loc><image:title>Phase I dose-escalation study of ENPP1 inhibitor, vizenpistat, for the treatment of solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4066</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4067</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4068</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4069</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4070</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4071</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4072</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4072.jpg</image:loc><image:title>Neratinib efficacy in second line patients with EGFR exon 18-mutant non-small-cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4073</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4074</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4075</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4075.jpg</image:loc><image:title>RASolve 301: A Phase 3 study of daraxonrasib (RMC-6236) vs. docetaxel in patients with previously treated RAS-mutant NSCLC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4076</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4077</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4078</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4079</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4080</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4081</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4082</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4083</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4083.jpg</image:loc><image:title>AACR Adaptive Biomarker-Driven Organ Preservation Trial in GE Adenocarcinomas (AACR-ADOPT-GEA)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4084</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4085</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4086</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4087</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4088</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4088.jpg</image:loc><image:title>ELAVL3 post-transcriptionally regulation of the NOTCH2 signaling pathway shapes the plasticity of small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4089</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4089.jpg</image:loc><image:title>Combination therapy with AKT and MEK inhibitors is effective in patient-derived models of adrenocortical carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4090</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4090.jpg</image:loc><image:title>A tumor-derived PTHrP-calcium axis drives cardiac dysfunction to connect cancer cachexia with mortality</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4091</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4091.jpg</image:loc><image:title>Loss of SHP phosphorylation reprograms lipid metabolism to promote colorectal tumorigenesis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4092</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4092.jpg</image:loc><image:title>Targeting DUSP1 overcomes resistance to &amp;#185;&amp;#8311;&amp;#8311;Lu-DOTATATE in neuroendocrine tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4093</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4094</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4095</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4095.jpg</image:loc><image:title>CDC73 loss does not augment cyclin D1-driven parathyroid tumorigenesis in transgenic mice</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4096</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4096.jpg</image:loc><image:title>Targeting insulin to improve endometrial cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4097</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4097.jpg</image:loc><image:title>Oncogenic PIK3CA mutation enhances cyclin D1-driven parathyroid tumorigenesis in transgenic mice</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4098</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4098.jpg</image:loc><image:title>Targeting human melanoma growth with non-calcemic vitamin d3 hydroxyderivative: A synergistic approach with vemurafenib</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4099</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4100</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4100.jpg</image:loc><image:title>Oxysterol sulfotransferase in prostate cancer inhibition: Cell-intrinsic and -extrinsic roles</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4101</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4101.jpg</image:loc><image:title>Role of ZFX variants in parathyroid tumorigenesis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4102</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4102.jpg</image:loc><image:title>Hormonal alterations distinguishing high-risk women from breast cancer patients across the menopause transition</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4103</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4103.jpg</image:loc><image:title>USP8, a survival gatekeeper turned oncogenic trigger via hyperactivation of the integrated stress response</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4104</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4105</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4105.jpg</image:loc><image:title>FGF19/ FGFR4 Axis: A key driver in tumorigenesis and treatment resistance in colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4106</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4106.jpg</image:loc><image:title>Targeting LPAR1 as a potential therapeutic strategy for glioblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4107</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4107.jpg</image:loc><image:title>GFS784, a next-generation ADC with a novel panRAS(ON) inhibitor payload</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4108</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4108.jpg</image:loc><image:title>Modified acetate salt form of GHRH-antagonist retains anti-leukemic activity against acute myelogenous leukemia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4109</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4110</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4111</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4111.jpg</image:loc><image:title>DR319-DP: A Nectin-4/Trop-2 bispecific ADC with an avidity-driven VHH design and dual-MOA payloads</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4112</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4112.jpg</image:loc><image:title>Zanidatamab modulates multiple pathways involved in tumor growth and survival and is efficacious post T-DXd</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4113</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4114</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4115</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4115.jpg</image:loc><image:title>Targeting heparan sulfate proteoglycans in pancreatic cancer with Salmonella expressing bacterial heparinase III</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4116</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4117</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4118</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4119</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4120</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4120.jpg</image:loc><image:title>Tumor cell surface targeting of high-grade neuroendocrine carcinomas</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4121</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4121.jpg</image:loc><image:title>Nano-protomers targeted at tumor metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4122</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4123</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4124</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4124.jpg</image:loc><image:title>Correlation of GI cancer antigens expression or association with patient survival outcomes using TCGA data</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4125</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4125.jpg</image:loc><image:title>Advancing ADC therapeutics with next-generation site-specific glycan conjugation and dual-payload flexibility</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4126</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4126.jpg</image:loc><image:title>Preclinical efficacy of a first-in-class anti-Integrin alpha/beta ADC in hard-to-treat solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4127</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4128</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4128.jpg</image:loc><image:title>Development of CLIO-8221: A HER2-targeted multi-payload ADC to address ADC resistance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4129</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4129.jpg</image:loc><image:title>WuXiTecan2: A hydrophilic exatecan linker-payload for dual-payload ADC discovery</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4130</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4130.jpg</image:loc><image:title>ZW427, a Ly6E-targeting antibody drug conjugate bearing a novel pan-RAS inhibitor payload for the treatment of RAS mutated cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4131</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4131.jpg</image:loc><image:title>LNF2105, a next-generation nectin-4-targeted ADC with a specially designed linker and a DXD analogue</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4132</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4132.jpg</image:loc><image:title>Preclinical evaluation of LM-364 TME : A next-generation anti-Nectin4 ADC with promising efficacy and reduced toxicity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4133</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4133.jpg</image:loc><image:title>In vitro and in vivo study of C 2 LP-ADC &amp;#38; CLP 2 -ADC targeting human breast and gastric cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4134</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4134.jpg</image:loc><image:title>Transforming ADC development with novel linker architectures and payload optimization</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4135</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4136</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4136.jpg</image:loc><image:title>Preclinical development of XNW28012, an antibody drug conjugate targeting tissue factor for treatment of solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4137</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4137.jpg</image:loc><image:title>A novel synergistic dual-payload TROP2 ADC (CTPH-03) delivering enhanced safety by increased MTD</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4138</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4138.jpg</image:loc><image:title>Preclinical assessment of HWK-007, a next-generation, PTK7-targeting ADC with novel bioconjugation and linker-payload technology</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4139</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4140</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4140.jpg</image:loc><image:title>Preclinical characterization of novel LIV1 antibody drug conjugates</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4141</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4141.jpg</image:loc><image:title>Targeting ITGB4 with a topoisomerase I ADC: Preclinical antitumor activity in colorectal and head and neck cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4142</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4142.jpg</image:loc><image:title>Preclinical development of GENA-104 ADC, an exatecan-based novel antibody-drug conjugate targeting CNTN4, for solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4143</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4143.jpg</image:loc><image:title>Integrin alpha-2 (ITGA2) is a novel and well-suited antibody-drug conjugate (ADC) target</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4144</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4144.jpg</image:loc><image:title>Diverse ADC novel payloads, comprehensive screening and evaluation platform</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4145</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4146</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4146.jpg</image:loc><image:title>3D-tumor organoid, over 2D-cell, is more predictive of in vivo anti-cancer pharmacology in assessing ADC candidates</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4147</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4147.jpg</image:loc><image:title>Functional organoid screening uncovers target dependency and bystander killing in TROP2 ADCs</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4148</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4148.jpg</image:loc><image:title>Development of an anti-CD171 (L1CAM) antibody-drug conjugate with high avidity and strong activity in resistant tumor models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4149</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4149.jpg</image:loc><image:title>A best-in-class HER2xHER2 novel biparatopic antibody-drug conjugate with an efficacious, low-toxicity design that maximizes antibody functionality</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4150</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4150.jpg</image:loc><image:title>Selective intratumoral distribution and post-T-DXd activity of K-679, an ultra-high-DAR EGFR-targeted antibody drug-loaded unimicelle conjugate (ADUC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4151</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4151.jpg</image:loc><image:title>Leveraging patient-derived organoids to investigate bystander effects of antibody-drug conjugates in solid tumor backgrounds</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4152</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4152.jpg</image:loc><image:title>Developing 3D cell models for high-throughput antibody-drug conjugate screening in cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4153</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4153.jpg</image:loc><image:title>ANT045: A novel format, antibody fragment drug-conjugate (FDC) product for challenging cMET-expressing solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4154</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4154.jpg</image:loc><image:title>Degrader antibody conjugates (DACs) as a next-generation therapeutic approach for selective and potent targeted protein degradation in EGFR-positive cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4155</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4155.jpg</image:loc><image:title>A novel antibody-drug conjugate targeting alkaline phosphatases ALPP and ALPPL2 in solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4156</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4156.jpg</image:loc><image:title>EGFR and LGR5 dual-targeting antibody-drug conjugate-based therapeutic strategies for the improved treatment of colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4157</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4157.jpg</image:loc><image:title>A fast and robust development process providing new highly internalized anti-hHER2 antibody-drug conjugates</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4158</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4159</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4159.jpg</image:loc><image:title>Real-time, label-free assessment of HER2-targeted antibody-drug conjugate therapies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4160</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4160.jpg</image:loc><image:title>Mouse analog of micvotabart pelidotin, an antibody-drug conjugate targeting extradomain-B of fibronectin, demonstrates anti-tumor efficacy in an immunotherapy-refractory syngeneic head and neck squamous cell carcinoma model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4161</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4161.jpg</image:loc><image:title>Integrative design of PSM101 Lock-antibody for EGFR-positive tumors through clinical protease profiling and structure-based computer simulation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4162</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4162.jpg</image:loc><image:title>Comparing potential bispecific formats comprising of trastuzumab and a humanized OKT3</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4163</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4163.jpg</image:loc><image:title>The discovery and development of a bispecific T cell engager prodrug targeting ENPP3</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4164</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4164.jpg</image:loc><image:title>Discovery of mutation-independent cKit degrading bispecific antibodies that suppress tumor growth in preclinical models of GIST</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4165</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4165.jpg</image:loc><image:title>Discovery and characterization of GI-128: A PD-L1 x LILRB1/2/4 bispecific antibody as a macrophage engager</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4166</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4166.jpg</image:loc><image:title>KRAS amplification creates a targetable pMHC antigen for T cell engager therapy to overcome KRAS inhibitor resistance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4167</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4167.jpg</image:loc><image:title>A bispecific antibody-drug conjugate targeting protein tyrosine kinase 7 and fibroblast activation protein alpha simultaneously acts on tumor cells and the tumor microenvironment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4168</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4168.jpg</image:loc><image:title>AI-powered analysis of millions of IHC images identifies 19 spatially highly co-expressed protein pairs to enable bispecific antibody development</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4169</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4169.jpg</image:loc><image:title>Overcoming the limited monospecific target landscape in cancer via discovery of tumor selective AND and OR gate bispecifics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4170</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4170.jpg</image:loc><image:title>GS24-B025, a novel CDH17- and CEA-directed bispecific antibody-drug conjugate, for the treatment of colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4171</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4171.jpg</image:loc><image:title>Preclinical characterization of a potential best-in-class camptothecin-based antibody-drug conjugate targeting ADAM metallopeptidase domain 9</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4172</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4172.jpg</image:loc><image:title>Development of a first-in-class camptothecin-based antibody-drug conjugate targeting ALPP/ALPPL2 with potent antitumor activity and excellent tolerability</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4173</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4173.jpg</image:loc><image:title>Ataxia telangiectasia and Rad3 related kinase inhibitors and gemcitabine induce synergistic killing of uterine leiomyosarcoma cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4174</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4174.jpg</image:loc><image:title>AI-driven discovery of an IRP2-EGFR dual-targeting strategy reveals synergistic antitumor efficacy in colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4175</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4176</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4177</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4177.jpg</image:loc><image:title>A novel CerS2 activator, DH20931, synergizes with doxorubicin to overcome therapeutic resistance in breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4178</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4178.jpg</image:loc><image:title>Enhancing the antitumor efficacy using a combination of FGFR4 inhibitor(H3B-6527) and oxaliplatin in gastric cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4179</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4179.jpg</image:loc><image:title>Repurposed FDA-approved agents for hepatic artery infusion in colorectal liver metastases</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4180</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4180.jpg</image:loc><image:title>Drug repurposing in Nectin-4-positive epithelial ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4181</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4181.jpg</image:loc><image:title>Nebivolol exhibits cell growth inhibition in drug-resistant HR+/HER2- breast cancer and anti-tumoral synergism with abemaciclib in vitro</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4182</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4183</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4184</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4184.jpg</image:loc><image:title>Repurposing nebivolol with CPI-613 for triple-negative breast cancer: Linking in-vitro synergy to in-vivo exposure</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4185</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4186</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4187</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4187.jpg</image:loc><image:title>Synergistic antileukemic activity of JAK inhibition combined with cytarabine in acute megakaryoblastic leukemia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4188</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4188.jpg</image:loc><image:title>WNK1 inhibition induces AML differentiation via ERK-CEBPbeta signaling</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4189</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4189.jpg</image:loc><image:title>FACT Complex - A gatekeeper of differentiation in AML</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4190</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4191</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4192</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4193</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4193.jpg</image:loc><image:title>Advancing new rational drug combinations to treat mutant KRAS-driven pancreatic adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4194</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4195</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4195.jpg</image:loc><image:title>Neuroendocrine-like dedifferentiation mediates resistance to EGFR inhibitors via the NRG1/HER3 axis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4196</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4197</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4197.jpg</image:loc><image:title>Synergistic antitumor activity of tumor-treating fields and multiselect-RAS (ON) inhibitor RMC-6236 in pancreatic ductal adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4198</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4198.jpg</image:loc><image:title>Comprehensive surfaceome proteomics uncovers CD70 as a novel immunotherapeutic target in natural killer/T cell lymphoma (NKTL)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4199</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4199.jpg</image:loc><image:title>Dual targeting of IKKbeta and NR4A1 for AML therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4200</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4200.jpg</image:loc><image:title>WASP activation by BM011 triggers mitochondrial collapse and aldolase-dependent glycolytic vulnerability in lymphoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4201</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4201.jpg</image:loc><image:title>Structural surface protein targets for AML</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4202</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4203</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4203.jpg</image:loc><image:title>Clinically relevant AML modeling with in vitro bone marrow niche and in vivo PDX approaches</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4204</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4205</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4206</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4206.jpg</image:loc><image:title>FS-207: A potential best-in-class WRN helicase inhibitor for treating MSI-H cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4207</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4207.jpg</image:loc><image:title>Development of terfenadine-derived small-molecule inhibitors of TFE3-O dimerization for translocation renal cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4208</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4209</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4210</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4210.jpg</image:loc><image:title>LDHA-positive neutrophils drive Treg-mediated immune tolerance to promote resistance to pan-RAS inhibitors in pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4211</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4211.jpg</image:loc><image:title>Potential of Rac and Cdc42 inhibitors as pancreatic cancer therapeutics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4212</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4212.jpg</image:loc><image:title>Activation of the RXR nuclear receptor improves survival and the therapeutic window of immunotherapy in murine breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4213</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4214</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4214.jpg</image:loc><image:title>Antibody-drug conjugates for the treatment of hematologic malignancies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4215</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4215.jpg</image:loc><image:title>Synergistic targeting of Mediator complex and BCL-2 reveals a novel therapeutic strategy for acute myeloid leukemia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4216</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4216.jpg</image:loc><image:title>Targeting DNA Damage Response Dependencies for Radiosensitization in Li-Fraumeni Syndrome</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4217</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4218</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4218.jpg</image:loc><image:title>Mechanistic insights into the radioprotective action of GM-0111 via CCL5 inhibition and endothelial-immune modulation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4219</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4219.jpg</image:loc><image:title>Radioprotective fullerene derivative as a potential systemic therapeutic to alleviate radiation-induced cardiovascular disease</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4220</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4220.jpg</image:loc><image:title>Receptor-targeted gold nanospheres strengthen radiation efficacy and reprogram tumor immunity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4221</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4222</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4222.jpg</image:loc><image:title>Modeling pharmacokinetics and efficacy of the ATM inhibitor WSD0628 in GBM and melanoma metastasis PDX models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4223</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4224</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4224.jpg</image:loc><image:title>Utilizing a dual action agent for targeted neuroendocrine tumor therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4225</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4225.jpg</image:loc><image:title>LSD1 inhibition enhances radiotherapy efficacy in OSCC by attenuating SUMOylation and activating NK cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4226</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4227</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4227.jpg</image:loc><image:title>Pretreatment with pan-integrin inhibitor GLPG-0187 sensitizes GBM cells to radiation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4228</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4228.jpg</image:loc><image:title>Mapping PSMA-617 sensitivity in prostate cancer PDX models to enable combination therapy and resistance studies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4229</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4230</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4231</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4232</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4232.jpg</image:loc><image:title>Redox modulation by gold nanorods enhances radiosensitivity in MOLT 4 cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4233</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4233.jpg</image:loc><image:title>Benefit of combining DLL3 targeted alpha therapy with standard of care in preclinical small cell lung cancer models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4234</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4235</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4235.jpg</image:loc><image:title>Defining radiosensitivity indicators to predict prognosis using patient-derived organoids in oral cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4236</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4237</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4237.jpg</image:loc><image:title>Protein kinase D1 modulates LET- and dose-dependent radiosensitivity in prostate cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4238</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4238.jpg</image:loc><image:title>Integrative transcriptomic and CRISPRi screening identifies determinants of intrinsic radiosensitivity in breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4239</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4240</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4241</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4241.jpg</image:loc><image:title>Targeting alternative end-joining overcomes miR-21-5p -mediated radioresistance in oral squamous cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4242</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4243</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4243.jpg</image:loc><image:title>The KAT6/7 inhibitor IDE574 disrupts tumor lineage identity and drug tolerance to deliver robust antitumor activity in biomarker selected indications</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4244</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4244.jpg</image:loc><image:title>Characterization and pre-clinical development of LG-CBP/p300 inhibitor, a potent and selective bromodomain inhibitor of CBP/p300</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4245</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4245.jpg</image:loc><image:title>ASTU-045, a novel METTL3 inhibitor with anti-tumor activity in the MC38 syngeneic mouse model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4246</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4246.jpg</image:loc><image:title>The MTA-cooperative PRMT5 inhibitor CTS3497 alone and in synergy with mechanism-based combination targeted therapies for the treatment of MTAP -deleted cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4247</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4247.jpg</image:loc><image:title>CTS2190, a first-in-class PRMT1 inhibitor in phase I/II clinical development, demonstrates robust and broad monotherapy efficacy and provides a rationale for novel combinations based on translational findings&amp;#8203;</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4248</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4248.jpg</image:loc><image:title>Targeting non-canonical PRC2 functions via small-molecule degradation: A novel therapeutic strategy for prostate cancer and other solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4249</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4249.jpg</image:loc><image:title>CAAP1 loss uncovers vulnerability of MTAP-deficient NSCLC to PRMT5 inhibition with AZD3470</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4250</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4250.jpg</image:loc><image:title>PRMT5 inhibition alters cellular chromatin landscape and drives vulnerability to BH3 mimetics in mantle cell lymphoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4251</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4251.jpg</image:loc><image:title>HDAC inhibitors induce NOX5 expression in human uveal melanoma cells in a Brd4-Sp1/Sp3-dependent manner</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4252</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4252.jpg</image:loc><image:title>Linking VHL and SETD2 in a common oncogenic pathway that converges on the mitotic spindle</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4253</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4253.jpg</image:loc><image:title>Comprehensive assay approaches for PRMT5 targeted drug discovery</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4254</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4254.jpg</image:loc><image:title>A highly selective KAT6/7 dual inhibitor with best-in-class potential and favorable pharmacokinetic profile</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4255</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4255.jpg</image:loc><image:title>TACC3 inhibition with KC1101 drives mitotic catastrophe and broad antitumor activity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4256</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4256.jpg</image:loc><image:title>Imofinostat, a histone deacetylase inhibitor, enhances anti-tumoral activity on colorectal cancer with an immune checkpoint inhibitor</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4257</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4257.jpg</image:loc><image:title>Imofinostat enhances chemotherapy response by targeting HDAC3-NRF2 pathway in KRAS-mutant pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4258</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4258.jpg</image:loc><image:title>Discovery of novel SMARCA2 small molecule inhibitors with best-in-class potency and selectivity for the treatment of SMARCA4-mutant cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4259</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4259.jpg</image:loc><image:title>KAT6i prifetrastat combines with PI3K pathway inhibitors to drive superior efficacy in preclinical models of PIK3CA mutated ER+ BC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4260</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4260.jpg</image:loc><image:title>Embryonic ectoderm development (EED) inhibitor APG-5918 synergizes with topoisomerase I inhibitors in preclinical small-cell lung cancer (SCLC) models through epigenetic priming of chemosensitivity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4261</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4262</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4262.jpg</image:loc><image:title>Expanding the PRISM platform: Addition of new hematologic models and a 10-day assay improve drug sensitivity mapping for epigenetic targets</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4263</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4263.jpg</image:loc><image:title>RCZY-843: A potential best-in-class, second-generation menin-MLL inhibitor engineered to overcome clinically observed menin-mutation-mediated resistance, with superior preclinical efficacy and safety in acute leukemia models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4264</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4264.jpg</image:loc><image:title>Synergistic antitumor activity of the MTA-cooperative PRMT5 inhibitor ABSK131 in combination with multiple therapeutic agents in diverse cancer models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4265</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4265.jpg</image:loc><image:title>IDE892 is a highly potent and selective PRMT5 inhibitor, with MTA-positive and SAM-negative cooperativity, optimized for development in MTAPdel cancers in combination with the allosteric MAT2A inhibitor IDE397</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4266</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4266.jpg</image:loc><image:title>H11 is a first-in-class bifunctional HDAC and autophagy inhibitor with potent antileukemic activity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4267</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4267.jpg</image:loc><image:title>SC3613 (IN-207387), a mutant-selective EGFR degrader, exhibits potent anti-tumor activity and improved safety profile in EGFR TKI-resistant NSCLC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4268</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4268.jpg</image:loc><image:title>The highly selective and potent reversible-covalent FGFR4 inhibitor, BB102, induces targeted-protein degradation through lysosomal autophagy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4269</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4269.jpg</image:loc><image:title>PBI-381, a development candidate PROTAC for KRasG12D solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4270</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4270.jpg</image:loc><image:title>LY4584180, a novel BCL6 molecular glue, demonstrates antitumor efficacy in preclinical models of B Cell NHL</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4271</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4271.jpg</image:loc><image:title>A first-in-class potent EZH2 degrader, AXT-1003, exhibits robust anti-tumor activity across multiple lymphomas and solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4272</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4272.jpg</image:loc><image:title>The combination of the AR PROTAC AZD9750 and AKT inhibitor capivasertib delivers improved efficacy over monotherapy in prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4273</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4273.jpg</image:loc><image:title>An orally bioavailable, specific PLK1 bifunctional degrader for the treatment of small cell lung cancer and other cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4274</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4274.jpg</image:loc><image:title>Rationally designed allosteric EGFR degrader SC3499 (IN-207375) selectively eliminates mutant EGFR and overcomes osimertinib resistance in non-small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4275</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4276</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4276.jpg</image:loc><image:title>Rational design of potent androgen receptor degraders via AI-assisted molecular modeling and validation of anti-tumor efficacy in prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4277</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4277.jpg</image:loc><image:title>Dual HDAC3/8 PROTAC degraders exert anti-tumor and immunomodulating effects in diffuse large B-cell lymphoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4278</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4278.jpg</image:loc><image:title>Favorable DMPK properties enable development of a novel arylsulfonamide RBM39 molecular glue degrader, PPI-101, for the treatment of neuroblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4279</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4279.jpg</image:loc><image:title>Preclinical efficacy of a PROTAC pan-KRAS degrader in a KRAS G12D syngeneic mouse model and concurrent immune tumor microenvironment changes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4280</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4280.jpg</image:loc><image:title>Brigatinib based degraders as a therapeutic strategy for triple negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4281</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4281.jpg</image:loc><image:title>Rational development of novel DCAF16-mediated SMARCA2 selective Targeted Glues &amp;#8482; for the treatment of SMARCA4 deficient tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4282</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4282.jpg</image:loc><image:title>Preclinical evaluation of a cardiosafe first-in-class MCL-1 degrader for the treatment of hematological malignancies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4283</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4283.jpg</image:loc><image:title>GSK5471713: A novel, selective oral androgen receptor degrader with best-in-class potential for the treatment of prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4284</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4284.jpg</image:loc><image:title>Discovery and development of PRMT5/MEP50 degraders for the selective targeting of MTAP-null cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4285</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4285.jpg</image:loc><image:title>The B-hCRBN mice model facilitates PROTACs studies based on CRBN ligands</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4286</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4286.jpg</image:loc><image:title>Small-molecule stabilization of non-native c-Myc multimer drives degradation using an IDP-targeting discovery platform</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4287</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4287.jpg</image:loc><image:title>Application of mechanistic preclinical PK/PD/efficacy modeling to support combination strategy for AZD9750, a novel oral androgen receptor degrader (PROTAC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4288</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4288.jpg</image:loc><image:title>ZMS-4426, an oral degrader of SMARCA2 shows potent anti-tumor activity, but variant selectivity against SMARCA4 across species</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4289</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4289.jpg</image:loc><image:title>Evaluation of targeted protein degraders using high-throughput ubiquitination assays for mechanistic and SAR analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4290</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4290.jpg</image:loc><image:title>Preclinical characterization and evaluation of JSB462 (Luxdegalutamide), a novel AR degrader, and its combinations in prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4291</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4291.jpg</image:loc><image:title>Integrated organoid screening approaches enable preclinical assessment of protein degrader efficacy and target engagement</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4292</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4292.jpg</image:loc><image:title>NRX-0305, an orally bioavailable, CNS penetrant pan-mutant BRAF degrader demonstrates robust efficacy in intracranial models of melanoma brain metastasis and primary glioma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4293</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4293.jpg</image:loc><image:title>TRI-611, a development stage molecular glue degrader of ALK for the treatment of ALK-positive NSCLC including central nervous system metastases</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4294</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4294.jpg</image:loc><image:title>Disabling oncogenic signaling with Apertor Interceptors - Proximity inducing bisteric molecules</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4295</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4295.jpg</image:loc><image:title>RCZY-698: An orally bioavailable, highly potent, and selective reversible KRAS G12V (ON)-state inhibitor with robust antitumor activity in preclinical models of KRAS G12V -driven solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4296</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4297</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4297.jpg</image:loc><image:title>PLM-103: A dual-mechanism YES1/YAP pathway inhibitor exhibiting broad antitumor efficacy and immuno-oncology synergy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4298</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4298.jpg</image:loc><image:title>CTPS1 as a metabolic vulnerability and novel therapeutic target in breast and ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4299</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4299.jpg</image:loc><image:title>Cbl-b inhibition with ISM3830 restores innate and adaptive immunity and demonstrates antitumor activity against solid tumors in vitro and in vivo</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4300</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4300.jpg</image:loc><image:title>ISM6210, a potent and selective CDK4 inhibitor for the treatment of HR+/HER2- breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4301</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4301.jpg</image:loc><image:title>Small molecules inhibited dysregulated STAT3-proinflammatory axis and induced antitumor responses in pancreatic and breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4302</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4302.jpg</image:loc><image:title>Dual mechanisms of PARP7 inhibition driving potent antitumor activity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4303</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4303.jpg</image:loc><image:title>Preclinical evaluation of GFH276 monotherapy and combination therapy for RAS-mutant tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4304</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4304.jpg</image:loc><image:title>Discovery and characterization of CKD-9001, a novel PARP1-selective inhibitor and DNA trapper with enhanced efficacy and an improved toxicity profile in HRD cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4305</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4305.jpg</image:loc><image:title>A novel PARP7 inhibitor exhibits dual antitumor activity through immune activation and tumor-intrinsic growth inhibition</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4306</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4306.jpg</image:loc><image:title>Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) impairs cellular viability, affects energy metabolism, induces DNA damage, and drives tumor regression in preclinical models of neuroblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4307</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4307.jpg</image:loc><image:title>D3S-003, an orally bioavailable potent and selective dual-state inhibitor targeting both GDP- and GTP-bound KRAS G12D</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4308</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4308.jpg</image:loc><image:title>HEC228032, an orally bioavailable molecular glue pan-RAS (ON) inhibitor with highly potent anti-tumor efficacy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4309</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4309.jpg</image:loc><image:title>Discovery and characterization of RGT-490, a mutant selective PI3Kalpha inhibitor</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4310</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4310.jpg</image:loc><image:title>Discovery of SY-14556, a highly potent and selective small molecule reactivator of p53 Y220C mutant with differentiated preclinical profile</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4311</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4311.jpg</image:loc><image:title>JMKX007129 is a next generation of androgen receptor inhibitor targeting N-terminal domain for the treatment of metastatic castration-resistant prostate cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4312</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4313</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4313.jpg</image:loc><image:title>Non-clinical characterization of Mocertatug Rezetecan (GSK5733584), a novel B7-H4-directed antibody-drug conjugate</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4314</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4314.jpg</image:loc><image:title>2X-121/ stenoparib - a novel, dual inhibitor of PARP and tankyrase in phase 2 clinical trials in advanced ovarian cancer- blocks the WNT signaling pathway and inhibits growth of human colorectal cancer cell lines at clinically relevant drug concentrations</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4315</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4315.jpg</image:loc><image:title>Targeting midkine-driven oncogenic signaling with HBS-101: A novel therapeutic strategy for lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4316</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4316.jpg</image:loc><image:title>Discovery of a Best-in-Class small molecule p53 Y220C reactivator: Breaking through the potency ceiling</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4317</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4317.jpg</image:loc><image:title>Preclinical evaluation of a novel hyperbolic NAMPT inhibitor in combination with pan-RAS targeted therapies in pancreatic ductal adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4318</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4318.jpg</image:loc><image:title>Novel PCNA inhibitor AOH1996 synergizes with KRAS-targeted therapies in pancreatic ductal adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4319</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4319.jpg</image:loc><image:title>Small molecule restoring mutant p53R273H DNA binding and activity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4320</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4320.jpg</image:loc><image:title>Targeting MEIS2 in platinum resistant ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4321</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4321.jpg</image:loc><image:title>Multitarget kinase inhibitor olverembatinib (HQP1351) is efficacious and synergizes with chemotherapy in preclinical models of endometrial carcinoma (EC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4322</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4322.jpg</image:loc><image:title>Effects of ergosterol peroxide on proteostasis disruption in triple negative breast cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4323</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4323.jpg</image:loc><image:title>A novel thioxanthenone activates p47phox to exploit redox vulnerabilities in acute myeloid leukemia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4324</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4324.jpg</image:loc><image:title>p97/VCP inhibition with CB-5339 induces REDD1-dependent antitumor activity in renal cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4325</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4325.jpg</image:loc><image:title>USP10 inhibition with GL-320 enhances chemo-immunotherapy efficacy and overcomes resistance in NSCLC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4326</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4326.jpg</image:loc><image:title>Single amino acid residue substitution to improve immunogenicity of HLA peptides targeting p53 neoantigen</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4327</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4327.jpg</image:loc><image:title>Mesenchymal stem cells delivering IL-33 oncolytic vaccinia virus enhance antitumor effects and overcome PD-1 inhibitor resistance in bladder cancerResistance in bladder cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4328</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4328.jpg</image:loc><image:title>Viral vector vaccination induces brain resident memory T cells to drive anti-glioblastoma immunity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4329</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4329.jpg</image:loc><image:title>Next-generation RNA vaccine modalities enable high-fidelity antigen discovery and T-cell immunogenicity screening</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4330</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4330.jpg</image:loc><image:title>Pre-existing immunity boosts therapeutic efficacy of oncolytic influenza a virus in the presence and absence of neutralizing antibodies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4331</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4331.jpg</image:loc><image:title>Strong therapeutic efficacy of oncolytic virus KLS-3021 in orthotopic head and neck cancer models regardless of PD-L1 expression via tumor microenvironment remodeling</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4332</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4332.jpg</image:loc><image:title>Vaccine targeting IGF1R induces neutralizing antibody and robust anti-tumor activity in a syngeneic mouse colon cancer model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4333</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4333.jpg</image:loc><image:title>B7-H3 vaccine induces robust humoral and cellular immunity and inhibits tumor growth in mice</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4334</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4334.jpg</image:loc><image:title>TROP2-circular RNA vaccine and IL7 synergistically inhibit TROP2+ tumor growth in mouse models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4335</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4335.jpg</image:loc><image:title>Preclinical potential of gammadelta T cells in novel virus-like particle vaccines for triple-negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4336</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4336.jpg</image:loc><image:title>Proteolysis-targeting vaccines, or PROTAX, for robust tumor combination immunotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4337</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4337.jpg</image:loc><image:title>Rational design of immune-cell-homing macroporous hydrogels for enhanced dendritic cell recruitment and cancer vaccination</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4338</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4338.jpg</image:loc><image:title>A novel RNA-LNP immunotherapy platform to drive anti-tumor efficacy in solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4339</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4339.jpg</image:loc><image:title>Claudin 6 vaccines effectively inhibit tumor growth in a syngeneic mouse colon cancer model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4340</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4340.jpg</image:loc><image:title>Harnessing artificial intelligence to optimize neoantigen prediction and mRNA design for personalized cancer vaccine</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4341</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4341.jpg</image:loc><image:title>High affinity receptor bio-selected novel oncolytic RNA virus, IVX055, demonstrates potent anti-tumor activity in human NSCLC, hepatocellular carcinoma and bladder cancer with potential for immunotherapeutic combinations</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4342</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4342.jpg</image:loc><image:title>Live attenuated MMR vaccines modulate tumor immune cell infiltration and synergize with standard of care to prolong survival in preclinical HCC models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4343</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4343.jpg</image:loc><image:title>Enhanced cancer immunotherapy via sPD1-based DNA vaccination targeting epitope-focused TWIST1 antigen</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4344</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4344.jpg</image:loc><image:title>IRZ-01: A self-adjuvanted outer membrane vesicle vaccine targeting CEA and MUC1 for colorectal cancer immunotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4345</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4345.jpg</image:loc><image:title>Combination therapy with a HIF-1alpha/c-MET peptide vaccine and carboplatin reprograms the tumor microenvironment to overcome platinum resistance in an intraperitoneal metastasis model of high-grade serous ovarian carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4346</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4346.jpg</image:loc><image:title>Bridging in vitro screening to in vivo efficacy for cancer vaccines</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4347</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4347.jpg</image:loc><image:title>Utilization of HBV-vaccinated immunity to suppress tumor progression via targeted delivery of HBsAg to CEA-positive colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4348</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4348.jpg</image:loc><image:title>Advancing novel vaccines: Preclinical evaluation in HLA-A2.1/HLA-DRB1*1.1 humanized mice</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4349</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4349.jpg</image:loc><image:title>Engineering durable tumor immunity with a virus-tumor hybrid antigen dendritic cell vaccine</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4350</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4350.jpg</image:loc><image:title>Expanding the therapeutic potential of Bvax: A B-cell-based vaccine for solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4351</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4351.jpg</image:loc><image:title>A clinical-adopted vaccine platform and new immunogenic epitopes combined against prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4352</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4352.jpg</image:loc><image:title>Inducing memory humoral responses using multiple vaccines in PBMC humanized mice</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4353</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4353.jpg</image:loc><image:title>Establishing a CTC-driven workflow for mRNA-transfected moDC production in personalized cancer immunotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4354</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4354.jpg</image:loc><image:title>CAR-T-cell monitoring using specific multimers: a fast and specific method allowing uniform evaluation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4355</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4355.jpg</image:loc><image:title>In vivo evaluation of autologous anti-BCMA CAR-T therapy in PBMC-humanized SDKO mice reveals donor-specific immune responses</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4356</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4356.jpg</image:loc><image:title>Armored allogeneic Epstein-Barr virus specific T cells expressing a multi-functional B7-H3 chimeric antigen receptor exhibit improved persistence, expansion and performance in solid tumor models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4357</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4357.jpg</image:loc><image:title>Structure-guided protein engineering and humanization of GPC1-targeted nanobody CAR T cells for treating pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4358</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4358.jpg</image:loc><image:title>Enhanced solid tumor rejection using IF-BETTER gated CAR T cells for the treatment of hepatocellular carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4359</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4360</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4361</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4361.jpg</image:loc><image:title>CAR-T cells with GPC3-inducible gene circuits for targeting hepatocellular carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4362</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4362.jpg</image:loc><image:title>Combining circular RNA and a silicon membrane-based cell engineering approach to create CAR-Ts with membrane bound IL-2 and IL-12</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4363</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4363.jpg</image:loc><image:title>Synecta&amp;#8482; T1 cell-derived nanoparticles and Flowfect&amp;#174; continuous flow transfection enhance non-viral engineering efficiency and manufacturing scalability of CD19-directed CAR-T cells for hematologic malignancies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4364</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4364.jpg</image:loc><image:title>AQP3 NOT gating mitigates lethal on-target off-tumor pulmonary toxicity of MSLN-directed CAR-T cells in ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4365</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4365.jpg</image:loc><image:title>Regulatory T cell inspired engineering of CAR-T cells enhances anti-tumor efficacy in solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4366</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4367</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4367.jpg</image:loc><image:title>Restoration of LAT signaling via the ALA-CART platform promotes metabolic resiliency and persistence of AML CAR T cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4368</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4368.jpg</image:loc><image:title>Armoring ROR1 CAR T cells with IL18 improves CAR T cell function and cytotoxicity against pancreatic cancer cell-lines in vitro and in vivo</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4369</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4369.jpg</image:loc><image:title>CD3-positive allogeneic CAR T-cells: A novel platform with persistence, BiTE-capture, and no alloreactivity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4370</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4370.jpg</image:loc><image:title>FT839: A next-generation, off-the-shelf CAR T cell uniquely engineered with a dual CAR system targeting CD19 and CD38 for the treatment of hematological malignancies and autoimmune diseases without conditioning chemotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4371</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4371.jpg</image:loc><image:title>B7-H3 hypoimmune chimeric antigen receptor T cells overcome immune rejection and retain antitumor activity against cholangiocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4372</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4372.jpg</image:loc><image:title>Cell killing dynamics and heterogeneity in engineered T-cells measured in live CellCage enclosures</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4373</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4373.jpg</image:loc><image:title>Use of a 50-marker mass cytometry intracellular cytokine staining panel reveals unforeseen functional diversity within cell therapy products and unmasks potential efficacy &#039;saboteurs&#039;</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4374</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4374.jpg</image:loc><image:title>Harnessing an optimized cellular therapy platform for ALK-expressing pediatric and adult solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4375</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4375.jpg</image:loc><image:title>Synecta&amp;#8482; T1 cell-derived nanoparticles enable accelerated, potent T cell expansion for scalable adoptive immunotherapy manufacturing</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4376</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4376.jpg</image:loc><image:title>COX-2/PGE2 driven, photoimmunotherapy-induced edema is reduced by prophylactic NSAIDs in mouse tumor models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4377</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4377.jpg</image:loc><image:title>High-dose vitamin C induces ROS-dependent calreticulin exposure to drive immunogenic cell death and cancer immune surveillance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4378</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4378.jpg</image:loc><image:title>STING pathway activation reveals feedback inhibition potentially limiting immunostimulatory response in adenoid cystic carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4379</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4379.jpg</image:loc><image:title>IND-enabling development of a novel STING agonist, IMGS-203, for the treatment of glioblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4380</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4381</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4381.jpg</image:loc><image:title>Next-generation STING mRNA therapy with reduced toxicity and dual action against cancer by boosting immunity and inducing tumor cell death</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4382</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4382.jpg</image:loc><image:title>Reprogramming tumor immunogenicity by targeting EGFL6 in ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4383</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4383.jpg</image:loc><image:title>Effects of antisense oligonucleotides targeting PD-1 pre-mRNA identified by DIRAC-dCas13-based screening on PD-1-positive lymphocytes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4384</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4384.jpg</image:loc><image:title>Pregnancy-inspired DNA nanocarriers reproduce a cGAS-driven pro-inflammatory monocyte phenotype</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4385</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4385.jpg</image:loc><image:title>Systemic nanoplasmid gene therapy with engineered cancer-activated promoters selectively programs tumor cells to express inflammatory interleukins and drive antitumor immunity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4386</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4386.jpg</image:loc><image:title>Preclinical antitumor and immunomodulatory activity of ARV-6723, a PROTAC hematopoietic progenitor kinase 1 (HPK1) degrader, versus immune checkpoint inhibitors (ICIs)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4387</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4387.jpg</image:loc><image:title>CLD-401, an IL-15 superagonist gene medicine via redtail virotherapy, achieves sustained tumor eradication</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4388</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4388.jpg</image:loc><image:title>Arenavirus based Non-lytic Viral Immune Drivers with tumor-tropic mutations as new class of amplificators of anti-tumoral T cell responses</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4389</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4389.jpg</image:loc><image:title>FAP-targeting Small molecule-immunostimulator conjugate bearing a novel TLR7 agonist payload induces tumor eradication and long-lasting antitumor immunity in vivo</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4390</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4390.jpg</image:loc><image:title>Light-free photochemical internalization-inducing polymer conjugate elicits cancer pyroptosis to coordinate host immune responses</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4391</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4391.jpg</image:loc><image:title>Bipolar pulsed field ablation triggers local and abscopal tumor control with robust immune activation in a syngeneic PDAC model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4392</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4392.jpg</image:loc><image:title>Co-activation of Wnt/beta-catenin and c-MET induced inflamed hepatocellular carcinoma responsive to immune checkpoint therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4393</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4394</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4394.jpg</image:loc><image:title>A porphyrin-HDL nanoparticle for low-dose photodynamic therapy-induced antitumor immune activation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4395</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4396</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4397</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4397.jpg</image:loc><image:title>Rational design of a repeated-dosing schedule for KNP-101 guided by IFN-gamma regulation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4398</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4398.jpg</image:loc><image:title>Oncolytic virus exhibits potent antitumor and immunomodulatory effects in triple-negative breast cancer using syngeneic and PDX models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4399</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4399.jpg</image:loc><image:title>Tumor treating fields (TTFields) overcome anti-PD-1 resistance in a murine lung adenocarcinoma model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4400</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4400.jpg</image:loc><image:title>The SPHK2 inhibitor opaganib potentiates tumor-intrinsic STING activation in triple-negative breast cancer in vitro</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4401</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4401.jpg</image:loc><image:title>Dipeptidyl peptidase 4 restoration facilitates anti-tumor immunity in KRAS-LKB1-mutant lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4402</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4402.jpg</image:loc><image:title>Dissecting oncolytic virus anti-virus vs anti-tumor immunity in glioma: Insights from a patient derived organoid model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4403</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4403.jpg</image:loc><image:title>Serotonin receptor 5-HT 2A as a potential target for HCC immunotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4404</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4404.jpg</image:loc><image:title>AWT038: Dual GDF15-IL-6 neutralization for cancer cachexia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4405</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4406</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4407</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4407.jpg</image:loc><image:title>A universal pro-immunocytokine platform using a spatial hindrance strategy to overcome MHC resistance and enhance efficacy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4408</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4408.jpg</image:loc><image:title>AR170, a novel PD-1xVEGFxIL-2v tri-specific immunocytokine to redefine next generation cancer immunotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4409</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4410</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4410.jpg</image:loc><image:title>TGI-17a: A potential best-in-class PD-1/IL-2 alpha-bias cytokine fusion protein</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4411</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4412</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4412.jpg</image:loc><image:title>Systematic discovery of attenuated IL-2 variants optimized for bispecific antibodies enabling targeted IL-2 delivery to PD-1 + T cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4413</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4413.jpg</image:loc><image:title>AI-designed PD-1/IL-18v bispecific antibody overcomes PD-1 resistance and drives potent antitumor responses in refractory models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4414</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4415</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4416</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4416.jpg</image:loc><image:title>MDNA113 is a masked conditionally activated tumor-targeted anti-PD1-IL-2 SK with superior safety and therapeutic properties</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4417</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4418</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4418.jpg</image:loc><image:title>Interferon-alpha and PD-1 blockade mutually mask each other in a tumor-activated manner</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4419</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4419.jpg</image:loc><image:title>A multi-modal IL-2, SLC-3010, reprograms the tumor immune environment toward antitumor responses</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4420</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4420.jpg</image:loc><image:title>Tumor-localized monoclonal antibody targeting 4-1BB for superior safety and efficacy in cancer treatment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4421</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4421.jpg</image:loc><image:title>A first-in-class bifunctional anti-TRPV6 antibody turns &quot;cold&quot; tumors &quot;hot&quot;</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4422</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4423</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4423.jpg</image:loc><image:title>Development of galectin-1 and galectin-7-specific inhibitors: Immunotherapy and molecular imaging in triple-negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4424</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4424.jpg</image:loc><image:title>pH-responsive PEGylated antibodies enables tumor-specific activation and attenuates immune-related adverse events</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4425</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4425.jpg</image:loc><image:title>A sex-specific role of CD36 targeting therapy in colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4426</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4426.jpg</image:loc><image:title>Therapeutic antibody inhibits target-mediated immune migration in advanced in-vitromodelofanimmune suppressive tumormicroenvironment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4427</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4428</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4428.jpg</image:loc><image:title>Harnessing VLPs and nanodiscs to unlock antibody discovery for challenging membrane proteins</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4429</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4430</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4430.jpg</image:loc><image:title>Comprehensive characterization of DT-7012, a highly differentiated anti-CCR8 depleting antibody</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4431</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4431.jpg</image:loc><image:title>Novel monoclonal antibody kills lymphoma cells via LFA-1/ICAM-1 dependent, antibody-mediated cellular cytotoxicity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4432</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4432.jpg</image:loc><image:title>Transcription factor c-Maf drives Th17-dependent activation of CD8&amp;#8314; T cells to sustain anti-tumor immunity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4433</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4433.jpg</image:loc><image:title>Glycan-based site specific ADC achieves sustained tumor control through Improved payload delivery and immune activation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4434</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4434.jpg</image:loc><image:title>Cell-level spatial transcriptomics detection of microenvironmental STAT1-expressing plasma cells in colorectal cancer recurrence by G4X</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4435</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4435.jpg</image:loc><image:title>The metabotropic Glutamate receptor-1 is a glutamatergic checkpoint that integrates with TCR to augment anti-tumor CD8&amp;#8314; T cell activation, metabolism and effector function</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4436</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4436.jpg</image:loc><image:title>Immunofluorescence-based adaptive immune subtypes in an association with long-term disease-free interval in the Carolina Breast Cancer Study Phase III</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4437</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4438</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4438.jpg</image:loc><image:title>Aging turns B cells into drivers of CD8&amp;#8314; cells that weaken tumor defenses</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4439</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4439.jpg</image:loc><image:title>Differential impact of short and long-term hypoxia on effector T cell dysfunction</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4440</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4440.jpg</image:loc><image:title>Anti-tumor antigen CD8 T cells infiltrating M3 uveal melanoma metastases are detectable in the blood</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4441</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4441.jpg</image:loc><image:title>IRF8 regulates T cell differentiation and anti-tumor effector function</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4442</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4442.jpg</image:loc><image:title>Mutational-signature adjusted models reveal HLA-mediated depletion of antigenic mutations in non-small cell lung cancer (NSCLC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4443</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4443.jpg</image:loc><image:title>Investigating the spatial immune tumor microenvironment of dermatofibrosarcoma protuberans</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4444</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4445</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4445.jpg</image:loc><image:title>Characterization of T-cells in ER + breast tumors and their matching adjacent tissue reveals that classical exhaustion markers are not indicative of T-cell function</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4446</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4446.jpg</image:loc><image:title>High-throughput discovery of MART1-specific TCR-peptide interactions using a Jurkat NFAT Reporter-K562 antigen-presenting cell system and single-cell adaptive immune receptor profiling</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4447</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4448</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4448.jpg</image:loc><image:title>Th7R cells: CD4&amp;#8314; T-cell partners that drive Tpex-mediated antitumor immunity in the tumor microenvironment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4449</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4449.jpg</image:loc><image:title>Tumor extracellular vesicles prime B cells which promote tumor control and epitope spreading to T cell neoantigens</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4450</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4450.jpg</image:loc><image:title>Integrating neoantigen immunogenicity and tumor clonality for predicting immunotherapy response</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4451</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4451.jpg</image:loc><image:title>Tapasin inhibits MHC I-presentation of a low affinity peptidome which elicits a unique population of highly effective CD8 T cells, in multiple mouse cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4452</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4452.jpg</image:loc><image:title>Long-read RNA sequencing and immunopeptidomics reveal transcriptomic aberrationneoantigens as targets for T cell immunotherapy in diffuse glioma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4453</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4453.jpg</image:loc><image:title>F5446 epigenetically reprograms T cells to boost CEA CAR T cell immunotherapy efficacy in human colorectal cancer metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4454</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4454.jpg</image:loc><image:title>In vivo genome-scale enhancer screen decodes T cell fate decisions in the tumor</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4455</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4455.jpg</image:loc><image:title>Peripheral T cell methylome reveals accelerated systemic immune aging in early lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4456</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4456.jpg</image:loc><image:title>Deciphering the dysfunctional immunological synapse in acute myeloid leukemia through microfluidic</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4457</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4457.jpg</image:loc><image:title>High-sensitivity HLA-I immunopeptidome profiling from limited clinical PBMC samples</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4458</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4459</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4460</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4461</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4461.jpg</image:loc><image:title>Carnosic acid inhibits proliferation and induces apoptosis of breast cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4462</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4463</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4463.jpg</image:loc><image:title>Antigenic cancer persister cells survive direct T cell attack</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4464</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4465</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4465.jpg</image:loc><image:title>Mcl-1 inhibitors and antidepressants as enhancers of chemotherapy response in pleural mesothelioma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4466</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4467</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4467.jpg</image:loc><image:title>The mitochondrial antioxidant mitoquinone alters cancer cell death outcomes in response to therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4468</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4469</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4469.jpg</image:loc><image:title>&amp;#8203;Impacts of endothelial cell autophagy inhibition on tumorigenesis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4470</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4470.jpg</image:loc><image:title>Programmable multivalent siRNA nanostructure rewires apoptosis by co-silencing MCL-1 and BCL-XL in glioblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4471</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4472</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4472.jpg</image:loc><image:title>Targeting ULK1 overcomes autophagy-mediated chemoresistance in cancer cell</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4473</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4473.jpg</image:loc><image:title>Targeting the histone acetyltransferase GCN5 sensitizes cancer cells to ferroptosis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4474</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4475</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4475.jpg</image:loc><image:title>Multimodal mechanistic control of autophagy by the CtBP1/KAISO/TRIM28 Complex in breast cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4476</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4476.jpg</image:loc><image:title>Autophagy alterations in KRAS-mutant colorectal cancer following PRMT5 inhibition</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4477</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4477.jpg</image:loc><image:title>Neuropeptide Y Y1 receptor inhibition induces autophagy to limit colorectal cancer progression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4478</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4478.jpg</image:loc><image:title>Targeting BCL2 pathway to enhance immunogenicity in ALK + NSCLC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4479</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4479.jpg</image:loc><image:title>Activation of a STAT3/LATS1 signaling axis by folate receptor alpha enables breast cancer cells to resist ferroptosis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4480</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4480.jpg</image:loc><image:title>Integrated real-time impedance and fluorescence imaging to characterize NETosis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4481</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4481.jpg</image:loc><image:title>Therapeutic exploitation of AUTAC in hematologic malignancies with cardiac protection</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4482</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4482.jpg</image:loc><image:title>Estrogen induces cell death in non- reproductive cancer cells through disrupting mitotic spindle assembly</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4483</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4483.jpg</image:loc><image:title>Probing the RecQL4 homolog Hrq1: A genetic suppressor screen identifies critical functional features</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4484</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4484.jpg</image:loc><image:title>Metabolic enzymes as protective modulator of BRCA2 haploinsufficiency and genome instability</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4485</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4485.jpg</image:loc><image:title>Loss of nuclear integrity at persistent DNA bridges ties PARP inhibitors to cGAS/STING signaling</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4486</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4486.jpg</image:loc><image:title>A RHNO1-ATR/Chk1 positive feedback loop sustains the cellular DNA replication stress response</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4487</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4488</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4489</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4489.jpg</image:loc><image:title>The BRCT domain is a modular platform for signal transduction in the DNA damage response</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4490</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4490.jpg</image:loc><image:title>The nuclease EXO1 promotes genomic instability by degrading nascent DNA in BRCA-proficient cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4491</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4491.jpg</image:loc><image:title>Dynamic and defective repair of extrachromosomal DNA drives genome instability in cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4492</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4492.jpg</image:loc><image:title>Assessing prognostic and therapeutic associations across EMAST, MSI, and MSS among African Americans colorectal cancer subtypes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4493</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4493.jpg</image:loc><image:title>Environmental toxin-induced m6A RNA modification promotes R-loop accumulation and chromosomal instability</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4494</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4494.jpg</image:loc><image:title>The cancer testis antigen, HORMAD1, promotes genomic stability in lung adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4495</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4495.jpg</image:loc><image:title>Oxidative base damage to telomeres sensitizes cancer cells to ATR inhibition</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4496</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4496.jpg</image:loc><image:title>Distinct genomic remodeling in Li Fraumeni Syndrome breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4497</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4497.jpg</image:loc><image:title>Oncogenic transcriptional rewiring in micronuclei</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4498</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4498.jpg</image:loc><image:title>Quantifying ongoing chromosomal instability using single-cell whole-genome sequencing</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4499</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4499.jpg</image:loc><image:title>CK2alpha is a novel phosphoinositide effector of PIPKIIalpha and PIPKIIbeta in DNA damage repair</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4500</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4500.jpg</image:loc><image:title>SOX4 upregulation contributes to ovarian cancer initiation through a stress-adaptation program</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4501</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4501.jpg</image:loc><image:title>HMGA1: An epigenetic driver of colon carcinogenesis by inducing FGF19 signals which can be targeted with FGFR4 receptor blockade</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4502</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4502.jpg</image:loc><image:title>The SOX2-RUNX2/TEAD4 signaling axis drives ESCC progression and exposes therapeutic vulnerabilities via Hippo/MAPK pathways</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4503</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4503.jpg</image:loc><image:title>ADT-induced stress elevates CDKN2AIP to promote neuroendocrine prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4504</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4504.jpg</image:loc><image:title>Novel SOX2-targeting bioPROTACs as multi-faceted anti-tumor agents overcoming resistance to standard therapies in lung cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4505</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4505.jpg</image:loc><image:title>Evaluation of strategies to target the Myc oncogene</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4506</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4507</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4507.jpg</image:loc><image:title>NELFE and SMARCB1 cooperate to regulate chromatin accessibility and allow MYC-driven gene activation in hepatocellular carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4508</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4508.jpg</image:loc><image:title>Uncovering a highly transforming, Myc-stabilizing isoform of dipeptidase-1 in colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4509</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4509.jpg</image:loc><image:title>Investigation of the role of N-MYC in lung neuroendocrine carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4510</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4510.jpg</image:loc><image:title>KIF11 regulates EWS-FLI1 and EWS-ATF1 target gene expression in Ewing and clear cell sarcomas</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4511</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4511.jpg</image:loc><image:title>Alternative splicing of ABI1 by enzalutamide treatment drives tumor plasticity in prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4512</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4512.jpg</image:loc><image:title>Exploring the anti-proliferative impact of PBX1 perturbation in enzalutamide-resistant CRPC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4513</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4513.jpg</image:loc><image:title>Induction of epidermal like differentiation irreversibly limits the invasive and metastatic potential of basal like breast cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4514</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4514.jpg</image:loc><image:title>Targeted antagonism of the activator protein 1 transcription factor complex results in potent anti-tumor activity in HNSCC models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4515</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4515.jpg</image:loc><image:title>From peptide screens to biological insights, FOXO4 and the PBAF complex</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4516</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4517</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4518</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4518.jpg</image:loc><image:title>DEL data-driven discovery of Brachyury (TBXT) ligands toward chordoma therapeutics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4519</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4519.jpg</image:loc><image:title>snoRNA-guided ribosome heterogeneity in a model of NSCLC collective invasion</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4520</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4520.jpg</image:loc><image:title>MYC associated transcriptional heterogeneity at the single cell level</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4521</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4521.jpg</image:loc><image:title>Reflux-induced NEK2 activates cap-dependent mRNA translation program in esophageal adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4522</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4522.jpg</image:loc><image:title>Lurbinectedin alters EWS::FLI1 binding to chromatin to poison transcription</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4523</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4523.jpg</image:loc><image:title>Core tension and control: Fxr1 mediates mechanoregulation via ahnak in head and neck cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4524</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4524.jpg</image:loc><image:title>FOXR2 reverses MDM2-mediated but not MDM4-mediated p53 repression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4525</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4526</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4527</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4528</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4528.jpg</image:loc><image:title>Construction of a prognostic model for small-cell lung cancer based on lipid metabolism related proteins</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4529</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4529.jpg</image:loc><image:title>Cysteine oxidation is required for brain metastasis in lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4530</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4531</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4531.jpg</image:loc><image:title>Metabolomic profiling among non-small cell lung cancer and non-cancer populations: A case-control study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4532</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4533</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4533.jpg</image:loc><image:title>Trace metal signatures in non-small cell lung cancer: A pilot study of patients attended at Mount Sinai Hospital in New York City</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4534</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4534.jpg</image:loc><image:title>Utilizing patient-derived organoid tumor models to combat chemo-immunotherapy resistance in NSCLC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4535</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4535.jpg</image:loc><image:title>Pharmacological activation of PI3Kalpha triggers cancer cell death under metabolic stress</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4536</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4536.jpg</image:loc><image:title>Targeting PGK1 enhances enzalutamide efficacy in resistant prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4537</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4537.jpg</image:loc><image:title>Exploiting ketone body metabolism as a therapeutic vulnerability in prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4538</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4538.jpg</image:loc><image:title>Loss of SIRT3 promotes metabolic and epigenetic dysregulation in aggressive prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4539</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4539.jpg</image:loc><image:title>Investigating the crosstalk between metabolic reprogramming and epigenetic modifications in bone metastatic prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4540</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4540.jpg</image:loc><image:title>Dual inhibition of PIKfyve and FASN reveals therapeutic potential in neuroendocrine prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4541</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4541.jpg</image:loc><image:title>Metabolomic profiling of fresh and formalin-fixed paraffin-embedded samples reveals metabolome alterations in penile cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4542</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4542.jpg</image:loc><image:title>Tumor-intrinsic Warburg effect as the driver and therapeutic target for cancer-associated cachexia in mouse models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4543</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4544</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4545</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4545.jpg</image:loc><image:title>Sex-specific metabolic features in pre-cancerous polyps identified in Puerto Rican stool samples: A pilot study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4546</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4547</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4547.jpg</image:loc><image:title>A clearer picture of cachexia: Leveraging body composition imaging in C26 tumored mice</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4548</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4549</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4549.jpg</image:loc><image:title>Repurposing statins activates compensatory glutathione metabolism as synergistic vulnerability in colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4550</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4550.jpg</image:loc><image:title>Metabolomics signatures with multidrug-resistant colorectal cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4551</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4551.jpg</image:loc><image:title>Metabolic reprogramming through SREBP2-driven cholesterol synthesis in CAFs of CMS4 colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4552</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4553</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4553.jpg</image:loc><image:title>Investigating synergistic impact of diet-induced hyperinsulinemia and mutant Kras on colorectal cancer metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4554</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4555</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4556</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4557</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4557.jpg</image:loc><image:title>Detection of mitochondria-targeting anticancer agents in tumor organoids</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4558</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4558.jpg</image:loc><image:title>Disruption of mitochondrial dynamics alters DNA repair capacity in colon cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4559</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4560</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4561</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4561.jpg</image:loc><image:title>Dissecting metabolism-driven transcriptional reprogramming in human colon and liver cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4562</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4562.jpg</image:loc><image:title>Glutamine transporter ASCT2 as a therapeutic target in HPV positive organoid models of HNSCC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4563</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4563.jpg</image:loc><image:title>Cross&amp;#8209;species multi&amp;#8209;omics mapping of APC/KRAS&amp;#8209;driven metabolic networks</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4564</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4564.jpg</image:loc><image:title>Genetic background shapes mitochondrial metabolic adaptations underlying thyroid cancer progression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4565</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4565.jpg</image:loc><image:title>Dysregulated lipid metabolism accompanies chromosomal instability in obesity-associated oesophageal adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4566</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4567</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4567.jpg</image:loc><image:title>A pan-pediatric gene-regulatory network analysis reveals druggable dependencies across pediatric solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4568</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4568.jpg</image:loc><image:title>cBioPortal for cancer genomics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4569</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4569.jpg</image:loc><image:title>Genomic and clinical landscape of 10,000 Korean pan-cancer patients reveals molecular determinants of prognosis and therapeutic response: K-MASTER program</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4570</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4570.jpg</image:loc><image:title>Large language models for tumor genomic interpretation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4571</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4571.jpg</image:loc><image:title>EGFR mutation subtype modifies the clinical impact of TP53 functional loss on brain metastasis and survival in lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4572</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4572.jpg</image:loc><image:title>Dynamic co-mutation patterns and therapeutic implications in BRAF-altered malignancies: Evidence from AACR Project GENIE</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4573</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4573.jpg</image:loc><image:title>The genomic landscape of skin adnexal carcinomas in the AACR GENIE database: Implications for precision cancer medicine</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4574</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4574.jpg</image:loc><image:title>Distinct age associated genomic landscapes in colorectal, pancreatic, small bowel, and anal cancers: A pan gastrointestinal analysis of 34,000 tumors from AACR Project GENIE v18.0</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4575</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4575.jpg</image:loc><image:title>Pan cancer enrichment of homologous recombination repair (HRR) gene alterations in 101,240 tumor samples from AACR Project GENIE: Implications for tumor-agnostic PARP inhibitor expansion</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4576</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4576.jpg</image:loc><image:title>Factors associated with early treatment discontinuation in the AACR Project GENIE Biopharma Collaborative (BPC) non-small cell lung cancer (NSCLC) cohort</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4577</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4577.jpg</image:loc><image:title>Pan-cancer landscape of IDH1/2 mutations with a focus on non-small cell lung cancer: Insights from the AACR GENIE Registry</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4578</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4578.jpg</image:loc><image:title>Genomic vulnerabilities and clinical behavior of metaplastic breast cancer through integrated registry and GENIE analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4579</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4579.jpg</image:loc><image:title>Comprehensive multi-omics characterization of colorectal cancer in a community catchment population</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4580</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4580.jpg</image:loc><image:title>Identification of NTRK missense mutations in glioblastoma multiforme: Insights from AACR Project GENIE and structural-functional analyses</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4581</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4581.jpg</image:loc><image:title>Distinct clinical, molecular and multi-omics biomarkers in early-onset head and neck squamous cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4582</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4582.jpg</image:loc><image:title>Population-based patterns of human papillomavirus infections and cervical cancer incidence, driver mutations and overall survival</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4583</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4583.jpg</image:loc><image:title>Clonal trajectories of chronic lymphocytic leukemia and Richter transformation over the patients&#039; lifespan</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4584</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4584.jpg</image:loc><image:title>Projecting individualized probabilities of lifetime total cancer risk across a population</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4585</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4585.jpg</image:loc><image:title>Feasibility and challenges of oral cancer screening in a large healthcare system</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4586</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4586.jpg</image:loc><image:title>Screening biases: The case of mammography for breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4587</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4587.jpg</image:loc><image:title>Candidate eQTL detection for risk refinement using paired DNA-RNA panel data</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4588</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4588.jpg</image:loc><image:title>Identification and validation of an explainable predictive model for early diagnosis of non-small cell lung cancer metastasis: A peripheral immune score based on integrative machine learning</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4589</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4589.jpg</image:loc><image:title>Improved detection of head and neck cancer using spatial raman spectroscopy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4590</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4590.jpg</image:loc><image:title>Assessing the value of CBV in identifying early recurrence risk in glioblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4591</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4591.jpg</image:loc><image:title>Cold atmospheric plasma prevents and treats oral squamous cell carcinoma via disruption of oncogenic pathways</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4592</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4592.jpg</image:loc><image:title>Immunohistochemical expression of programmed death-ligand 1 associated with human papillomavirus-driven high-grade cervical intraepithelial neoplasia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4593</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4593.jpg</image:loc><image:title>Genome-wide promoter DNA methylation signatures and risk of hereditary breast cancer in Korea: A pilot study for phase II validation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4594</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4594.jpg</image:loc><image:title>Salivary transcriptomic signatures reveal early molecular reprogramming in oral potentially malignant disorders: A non-invasive precision oncology approach in indian patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4595</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4595.jpg</image:loc><image:title>Biospecimen collections for cancer etiology and prevention research in the Connect for Cancer Prevention Study: Guiding principles, approach, and key metrics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4596</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4596.jpg</image:loc><image:title>HPV serology for rapid detection of HPV positive oropharyngeal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4597</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4597.jpg</image:loc><image:title>A next-generation extracellular vesicle and particle-based liquid biopsy for early lung cancer detection</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4598</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4598.jpg</image:loc><image:title>Advancing access and equity in colorectal cancer screening: Key insights from Cycles of Impact Philadelphia Initiative</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4599</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4599.jpg</image:loc><image:title>AI-empowered cancer risk assessment model based on routine laboratory tests for enriching individuals at high risk of cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4600</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4600.jpg</image:loc><image:title>Cost-effectiveness analysis of integrating multi-cancer early detection into current cancer screenings in the United States</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4601</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4601.jpg</image:loc><image:title>CervicalMethDx : Precision risk stratification of high-risk HPV samples to reduce unnecessary colposcopy referrals and improve the quality of value-based care</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4602</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4602.jpg</image:loc><image:title>Feasibility and interim results from the prospective international LS-URO study: Urine tumor DNA-based screening for urothelial cancer in Lynch syndrome carriers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4603</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4604</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4604.jpg</image:loc><image:title>Stage at diagnosis and tumor characteristics among screen-detected breast cancer cases in Cartagena, Colombia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4605</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4605.jpg</image:loc><image:title>Early life exposure to antibiotics and early onset colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4606</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4607</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4607.jpg</image:loc><image:title>Assessing hematologic pattern variation in AI-based blood cell analysis for ovarian cancer risk detection</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4608</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4609</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4610</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4610.jpg</image:loc><image:title>A multi-omic liquid biopsy for the earlier detection of colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4611</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4611.jpg</image:loc><image:title>Assessing blood- and stool-based tests for colorectal cancer detection</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4612</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4613</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4613.jpg</image:loc><image:title>Genetic ancestry-associated features of the colorectal cancer T-cell landscape</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4614</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4615</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4615.jpg</image:loc><image:title>Ancestry-associated epigenetic differences in chronic lymphocytic leukemia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4616</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4617</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4617.jpg</image:loc><image:title>Association between genetic ancestry and somatic mutational profiles in colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4618</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4618.jpg</image:loc><image:title>Prospective epigenome-wide association study of pancreatic cancer risk in a multiethnic population</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4619</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4620</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4620.jpg</image:loc><image:title>How stress gets under the skin: Everyday discrimination, inflammation and cancer risk in older adults</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4621</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4621.jpg</image:loc><image:title>Stress and breast cancer risk among Asian American females: The CRANE Study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4622</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4622.jpg</image:loc><image:title>Discriminatory capacity of allostatic load score in colorectal cancer: A pilot case-control study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4623</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4623.jpg</image:loc><image:title>Disparities in timeliness of cancer diagnosis across a multi-site academic health system</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4624</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4624.jpg</image:loc><image:title>Transcriptomic and SNP profiling reveals early-onset and ethnicity-associated signatures in colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4625</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4626</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4627</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4628</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4629</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4630</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4630.jpg</image:loc><image:title>Tumor long-noncoding RNA expression patterns and breast cancer prognosis among Black and White women</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4631</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4632</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4633</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4633.jpg</image:loc><image:title>Joint association of body mass index and waist circumference with head and neck cancer mortality risk in Asian population</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4634</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4635</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4635.jpg</image:loc><image:title>An evaluation of c-reactive protein and sleep in women with breast cancer using the All of Us dataset</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4636</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4636.jpg</image:loc><image:title>Integrating real-world wearable data into breast cancer risk assessment: Evidence from the All of Us Research Program</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4637</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4638</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4639</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4639.jpg</image:loc><image:title>Ultra-processed food intake and inflammatory markers in breast cancer survivors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4640</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4640.jpg</image:loc><image:title>The impact of genetic and lifestyle factors on the risk of invasive postmenopausal breast cancer in the multiethnic cohort study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4641</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4641.jpg</image:loc><image:title>Ultra-processed foods and disease-free survival after colorectal cancer diagnosis: Findings from the Colocare Study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4642</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4642.jpg</image:loc><image:title>Liquid and solid fructose intake and colorectal cancer mortality by physical activity in U.S. prospective cohorts</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4643</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4643.jpg</image:loc><image:title>Associations of WCRF/AICR recommendations with survival and chemotherapy outcomes in colon cancer: CALGB/SWOG 80702 (Alliance)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4644</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4644.jpg</image:loc><image:title>Dietary patterns in young lung cancer: mutation-specific environmental associations</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4645</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4645.jpg</image:loc><image:title>Dietary advanced glycation end-products and risks of lung cancer and chronic respiratory diseases</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4646</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4647</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4647.jpg</image:loc><image:title>Attributable cancer in Asia: A heterogeneous picture</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4648</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4649</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4650</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4651</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4651.jpg</image:loc><image:title>Integrating omics data unravels potential mechanisms linking diet-related inflammation and colorectal cancer risk</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4652</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4652.jpg</image:loc><image:title>Associations of self-reported sleep duration and sleep quality with cancer risk: A pooled analysis of 6 prospective cohorts</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4653</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4654</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4654.jpg</image:loc><image:title>Prospective evaluation of dietary intake of essential metals and pancreatic cancer risk: The Multiethnic Cohort Study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4655</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4656</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4657</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4657.jpg</image:loc><image:title>A network approach using Gaussian graphical models to evaluate dietary patterns and colorectal cancer risk in the UK Biobank</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4658</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4659</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4659.jpg</image:loc><image:title>E-cigarette use among cancer survivors who are ineligible for lung cancer screening</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4660</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4661</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4661.jpg</image:loc><image:title>Metabolic disease and risk for thyroid cancer in a predominantly Black and low-income cohort</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4662</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4663</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4663.jpg</image:loc><image:title>An mRNA vaccine targeting angiogenesis elicits a robust immune response and inhibits tumor growth and angiogenesis in two mouse melanoma models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4664</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4664.jpg</image:loc><image:title>Galectin-1 as a central regulator of angiogenesis and metabolic reprogramming in glioblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4665</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4665.jpg</image:loc><image:title>Thermal regulation of dysbiotic tumor vasculature</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4666</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4666.jpg</image:loc><image:title>AI-powered deep phenotyping: Vision transformers quantify vessel normalization and immune efficacy in a 3D vascularized tumor-on-a-chip</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4667</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4667.jpg</image:loc><image:title>Glutaminolysis promotes cancer-associated angiogenesis via the GLS1-TNC signaling pathway</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4668</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4668.jpg</image:loc><image:title>PSMA-expressing tumor vasculature in renal cell carcinoma: spatial, functional, and therapeutic implications</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4669</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4669.jpg</image:loc><image:title>Apelin is a candidate driver for neuromuscular junction recovery from cancer cachexia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4670</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4670.jpg</image:loc><image:title>Cancer reprograms the remote vascular microenvironment to promote atherosclerosis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4671</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4671.jpg</image:loc><image:title>The role of endothelial cell remodeling in driving immunotherapy resistance of hepatocellular carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4672</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4672.jpg</image:loc><image:title>Kr&amp;#252;ppel-like factor 8 promotes triple negative breast cancer angiogenesis and metastasis through matrix metalloproteinases</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4673</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4673.jpg</image:loc><image:title>Tumor-intrinsic CD80 mediates cancer stemness and vascular mimicry in aggressive oral squamous cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4674</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4674.jpg</image:loc><image:title>Prognostic relevance of angiogenesis-associated genes in gliomas: Influence of idh/1p19q status and opportunities for antiangiogenic immunotherapy strategies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4675</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4675.jpg</image:loc><image:title>CXCL17 Drives angiogenesis to promote progression in cutaneous squamous cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4676</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4677</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4678</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4678.jpg</image:loc><image:title>Lymphangiogenesis in the uterine horns: Implication of the Netrin-1 and UNC5B signaling pathway in physiology and cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4679</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4679.jpg</image:loc><image:title>Targeting CD160 as an immunotherapy approach to modulate tumor angiogenesis and improve outcomes in triple-negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4680</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4680.jpg</image:loc><image:title>DDR2 positive endothelial cells promote angiogenesis and metastasis in breast tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4681</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4681.jpg</image:loc><image:title>Evaluation of the circulating angiome in cancer: Translational assessment of a 44-plex angiogenesis biomarker panel</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4682</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4682.jpg</image:loc><image:title>Ascites protects against ferroptosis and enables the peritoneal spread of ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4683</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4683.jpg</image:loc><image:title>Synchronously implanted cold tumor abrogates anti-PD-1 response of hot tumor in a syngeneic mouse model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4684</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4685</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4686</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4687</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4687.jpg</image:loc><image:title>The defining features of hybrid epithelial-mesenchymal state in head and neck cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4688</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4688.jpg</image:loc><image:title>Mic60&amp;#8209;low breast cancer cells activate epithelial-mesenchymal transition and support aggressive tumor growth</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4689</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4690</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4691</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4691.jpg</image:loc><image:title>Identification of protein kinase signaling networks activating partial EMT as therapeutic targets in non-small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4692</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4692.jpg</image:loc><image:title>Keratin 17 correlates with epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4693</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4693.jpg</image:loc><image:title>Morphological effects of cytokeratin 8/18 and vimentin coexpression in vulvar cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4694</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4694.jpg</image:loc><image:title>High dietary cholesterol promotes epithelial-to-mesenchymal transition and invasion in colorectal cancer via the Wnt/Snai2 axis of transcriptional regulation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4695</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4695.jpg</image:loc><image:title>Mechanistic studies on the role of GABA type A (GABA A ) ion channel receptor in tumor invasion and metastasis in triple negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4696</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4696.jpg</image:loc><image:title>An EMT-driven Exoc7 splicing switch controls the PRPF19-GATA3 axis to destabilize the hybrid E/M state</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4697</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4697.jpg</image:loc><image:title>PTPRE receptor tyrosine phosphatase in matrix-stiffness-driven EMT and breast cancer metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4698</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4698.jpg</image:loc><image:title>KPNA2 drives cancer stemness, which enhances drug resistance and facilitates cancer progression in lung adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4699</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4699.jpg</image:loc><image:title>ZEB1 drives pro-metastatic membrane trafficking through upregulation of REEP2 in lung adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4700</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4701</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4701.jpg</image:loc><image:title>Smarca1 maintains PAX3-FOXO1 fusion oncogene and coordinates EMT networks through chromatin remodeling</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4702</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4702.jpg</image:loc><image:title>Gli2 regulation of EMT in TNBC invasion</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4703</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4703.jpg</image:loc><image:title>Stromal MTA1 silencing reprograms mesenchymal stem cells to suppress EMT and distant metastasis in triple-negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4704</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4704.jpg</image:loc><image:title>Characterisation of C6ORF15 as a marker for epithelial-mesenchymal transition and lymph node metastasis in colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4705</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4705.jpg</image:loc><image:title>Multi-transcriptomics reveal the potential involvement of RAB27A in promoting epithelial-mesenchymal transition in pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4706</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4706.jpg</image:loc><image:title>A human pcVMT platform for personalizing chemotherapy route and regimen selection in peritoneal carcinomatosis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4707</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4707.jpg</image:loc><image:title>Unraveling the molecular events driving BRCA1 -associated transformation in novel models of early m&amp;#252;llerian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4708</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4708.jpg</image:loc><image:title>A comprehensive endometrial cancer organoid biobank reveals subtype-specific transcriptional programs and therapeutic targets</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4709</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4710</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4710.jpg</image:loc><image:title>Cystathionine beta-synthase drives transcoelomic metastasis in ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4711</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4711.jpg</image:loc><image:title>Quantifying the dual effect of anti-tumor and pro-tumor human neutrophils on natural killer cell behaviors in a microphysiological system</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4712</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4712.jpg</image:loc><image:title>Combined pan and precision targeting in extrachromosomal DNA-positive gastric cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4713</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4713.jpg</image:loc><image:title>A novel sarcoma tumoroid platform preserving the tumor microenvironment to guide personalized immunotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4714</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4714.jpg</image:loc><image:title>Predicting therapy efficacy and revealing tumor heterogeneity using patient-derived 3D bioprinted ovarian cancer models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4715</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4715.jpg</image:loc><image:title>Modeling IDH-mutant low-grade astrocytoma using human embryonic stem cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4716</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4717</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4718</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4718.jpg</image:loc><image:title>A leiomyosarcoma cell model based on smooth muscle-committed TP53 -knockout iPSCs identifies novel actionable pathways.</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4719</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4719.jpg</image:loc><image:title>Functional assessment of patient drug sensitivity using AI-powered image analysis on patient-derived organoids and micoorganoid spheres</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4720</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4720.jpg</image:loc><image:title>Interactions between colorectal cancer cells and cancer-associated fibroblasts across desmoplastic reaction subtypes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4721</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4721.jpg</image:loc><image:title>The radiosensitivity index (RSI): A patient-derived organoid platform for predicting radioresistance in cervical cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4722</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4723</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4723.jpg</image:loc><image:title>Isolation, characterization and establishment of male breast cancer cells from male breast cancer patient-derived tumor (PDT)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4724</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4724.jpg</image:loc><image:title>3D bioprinting of fresh NSCLC: The Lung3Dprint proof of concept study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4725</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4726</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4726.jpg</image:loc><image:title>Preclinical assessment of HER2 CAR-T cells using tumor and GI organoid models to define therapeutic window</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4727</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4727.jpg</image:loc><image:title>Cytokine supplementation for improved tumoroid-immune cell co-culture</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4728</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4728.jpg</image:loc><image:title>A high-throughput 3D tumor-immune co-culture platform for evaluating immune checkpoint inhibitors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4729</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4729.jpg</image:loc><image:title>Modeling tumor microenvironment-mediated resistance in NSCLC using a high-throughput spheroid microarray platform</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4730</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4730.jpg</image:loc><image:title>Bladder cancer organoids as a translational models to model disease biology and assess new therapies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4731</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4731.jpg</image:loc><image:title>An in-vitro vascularized micro-tumor model of cervical cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4732</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4733</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4733.jpg</image:loc><image:title>The role of estradiol and estrogen receptors in lung cancer: A focus on sex differences</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4734</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4735</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4736</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4736.jpg</image:loc><image:title>Ontario Tumour Bank: Accelerating commercial oncology research and development with quality samples and data</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4737</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4737.jpg</image:loc><image:title>Diabetes mellitus related fibroblast activation as a premetastatic niche enhances lung metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4738</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4738.jpg</image:loc><image:title>Temporal control of EMT via the miR-200c/Zeb1 regulatory circuit to uncover the drivers of stemness in pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4739</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4739.jpg</image:loc><image:title>Single-cell transcriptomic analysis reveals KRT17 as a prognostic tumor-initiating cell marker in ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4740</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4740.jpg</image:loc><image:title>The role of cancer cell-derived TWEAK in promoting a cancer stem-like phenotype in ovarian cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4741</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4741.jpg</image:loc><image:title>Establishing novel, representative prostate cancer cell lines from fresh prostatectomy tissues via an optimized protocol</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4742</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4743</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4744</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4744.jpg</image:loc><image:title>Investigating FOXC2-dependent mechanisms regulating stem cell Identity in breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4745</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4745.jpg</image:loc><image:title>Investigating the role of miR-27a-3p in the WNT signaling pathway in colorectal cancer stem cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4746</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4747</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4748</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4748.jpg</image:loc><image:title>Distinct colorectal cancer tumor cell subtypes revealed by single-cell and spatial transcriptomics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4749</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4749.jpg</image:loc><image:title>Osteopontin spatially rewires tumor-immune niches to promote colon cancer liver metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4750</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4751</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4751.jpg</image:loc><image:title>Spatial architectures of colorectal cancer microenvironment underlying immune checkpoint inhibitor response</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4752</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4753</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4754</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4755</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4756</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4756.jpg</image:loc><image:title>Spatial tissue architecture as a unifying principle of tumor and microenvironmental states in adult gliomas</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4757</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4758</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4758.jpg</image:loc><image:title>Basescope&amp;#8482; duplex assay enables same-slide detection of short RNA targets including isoforms</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4759</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4760</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4761</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4761.jpg</image:loc><image:title>Spatial transcriptomic profiling reveals heterogeneity in desmoplastic small round cell tumor</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4762</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4763</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4764</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4765</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4766</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4767</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4768</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4769</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4769.jpg</image:loc><image:title>A single-cell spatial proteomic analysis of the TNBC microenvironment defines genotype-specific features</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4770</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4770.jpg</image:loc><image:title>Spatial divergence across glioblastoma multi-regional biopsies and corresponding neurosphere cultures</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4771</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4772</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4773</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4773.jpg</image:loc><image:title>Transcriptomic analysis reveals myoepithelial cell reprogramming in invasive breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4774</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4775</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4775.jpg</image:loc><image:title>Association of an ectopic upper gastrointestinal microbiome with multiple primary lung cancers: A multi-site cross-sectional study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4776</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4776.jpg</image:loc><image:title>Integrative analysis reveals bacterial load as a determinant of molecular and immune phenotypes in colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4777</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4777.jpg</image:loc><image:title>Mapping the cellular landscape of intratumoral bacteria in colorectal cancer using single-cell transcriptomics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4778</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4778.jpg</image:loc><image:title>Association of intratumoral Fusobacterium nucleatum with stromal remodeling and immune exclusion in esophageal squamous cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4779</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4779.jpg</image:loc><image:title>Distinct tumor microbiome profiles in triple negative breast cancer compared to other breast cancer subtypes: A pilot study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4780</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4780.jpg</image:loc><image:title>Patients with high body mass index share tumor microbial profiles with CpG island methylator phenotype-high or early-onset colorectal cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4781</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4781.jpg</image:loc><image:title>Paired metagenomic profiling reveals site-specific microbial composition and conserved diversity in the oral cavity of head and neck cancer patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4782</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4783</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4783.jpg</image:loc><image:title>Profiling the ovarian cancer-specific intratumoral microbiome</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4784</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4784.jpg</image:loc><image:title>Pseudomona s-derived LPS promotes metastatic behavior in papillary thyroid cancer metastasis is attenuated by Hashimoto&#039;s thyroiditis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4785</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4785.jpg</image:loc><image:title>Helicobacter pylori -driven T cell stress in tumors as a mediator of resistance to immune checkpoint blockade in gastric cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4786</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4787</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4787.jpg</image:loc><image:title>Characterization of the intratumoral microbiota in non endemic EBV associated nasopharyngeal carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4788</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4789</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4790</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4791</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4791.jpg</image:loc><image:title>Biodiversity and biogeography of the multi-kingdom cancer microbiome</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4792</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4792.jpg</image:loc><image:title>Gut bacteria as hidden architects of stemness maintenance in the progression of pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4793</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4793.jpg</image:loc><image:title>Explore the effects of Fusobacterium nucleatum on chemotherapy response in colorectal cancer at spatial and single-cell resolution</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4794</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4794.jpg</image:loc><image:title>Reprogramming of the non-pathogenic E. coli surface architecture to create next-generation immune engagers for potent cancer therapies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4795</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4795.jpg</image:loc><image:title>Microbiome-wide association study identifies crosstalk between tumor-associated microbes and the human tumor microenvironment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4796</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4796.jpg</image:loc><image:title>Obligate anaerobes in the gut drive pancreatic cancer metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4797</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4798</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4798.jpg</image:loc><image:title>Microbial stimuli differentially regulate astrocyte and glioblastoma cell phenotypes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4799</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4799.jpg</image:loc><image:title>Single-cell intercellular CRISPR screen reveals stromal regulators of colorectal cancer plasticity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4800</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4800.jpg</image:loc><image:title>Defining the immunoregulatory molecular drivers of dendritic cells using CRISPR screens in ex-vivo modelsvivo models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4801</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4802</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4802.jpg</image:loc><image:title>StromaBlast&amp;#8482;: A novel CRISPR-based functional genomics platform to identify therapeutic targets within the tumor microenvironment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4803</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4803.jpg</image:loc><image:title>Establishment of patient-derived lung epithelial progenitor lines as a foundation for autologous immune and tumor modeling</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4804</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4804.jpg</image:loc><image:title>Bioprinted multicellular microenvironments to accelerate immunotherapy discovery in pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4805</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4806</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4806.jpg</image:loc><image:title>Decoding phenotypic and functional states of in vivo -mimetic 3D human pancreatic CAF/ECM units through sequential high-plex IF</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4807</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4807.jpg</image:loc><image:title>An advanced 3D vascularized tumor immune microenvironment on a chip for predictive efficacy and toxicity testing of IO therapeutics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4808</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4808.jpg</image:loc><image:title>Development of vascularized 3D tumoroid models using microphysiological systems</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4809</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4809.jpg</image:loc><image:title>A micro-vascularized pancreatic ductal adenocarcinoma-on-chip model recapitulates immune exclusion and altered T cell polarization</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4810</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4810.jpg</image:loc><image:title>Decellularized lung biomatrix models to investigate microenvironmental regulation of organ-selective tropism in metastatic breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4811</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4811.jpg</image:loc><image:title>Unlocking the extracellular matrix as a source of novel targets: A matrisome-based platform to characterize the tumor microenvironment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4812</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4812.jpg</image:loc><image:title>Modeling the metaplastic triple negative breast cancer matrix</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4813</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4813.jpg</image:loc><image:title>Expression profiles of TCF-4 variants across digestive system cancers quantified by a novel PNA-directed qPCR assay</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4814</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4815</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4815.jpg</image:loc><image:title>CAR-Tmigration andcytotoxicity in atumor-vasculature-on-chipmodel</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4816</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4817</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4817.jpg</image:loc><image:title>Development of a CyTOF panel for macrophage polarization and functional assessment under treatment conditions</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4818</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4818.jpg</image:loc><image:title>Establishment and characterisation of PDTOs and CAFs for the development of a co-culture system in pancreatic periampullary adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4819</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4820</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4820.jpg</image:loc><image:title>Cell cycle regulation by PAX3-FOXO1 via WEE1 kinase in fusion-positive rhabdomyosarcoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4821</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4821.jpg</image:loc><image:title>Dissecting tumor microenvironment and cellular adaptation in ovarian cancer models using Bio-Rad ddSEQ Single-Cell 3&#039; RNA-Seq technology</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4822</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4822.jpg</image:loc><image:title>Enabling transcriptome-wide single cell RNA sequencing from FFPE tissues with Evercode WT combinatorial barcoding</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4823</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4824</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4825</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4825.jpg</image:loc><image:title>A hybrid mathematical model: Emergent CAF structures and their impact on cancer progression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4826</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4826.jpg</image:loc><image:title>Upregulation of a B7 family protein drives immune escape in therapy-induced senescent cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4827</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4827.jpg</image:loc><image:title>Programmed cell death ligand 1 (PD-L1) expression across molecular subtypes of human high-grade ductal carcinoma in situ (DCIS) of the breast</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4828</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4828.jpg</image:loc><image:title>MHC class 1 expression and distribution of multiple immune cells in chemotherapy-na&amp;#239;ve triple-negative breast cancers: lack of antigen-presentation can bring high TILs and good prognosis, possibly via decreased regulatory T-cell composition</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4829</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4829.jpg</image:loc><image:title>CD155- binding peptide enhances antitumor activity of T cells and cytotoxic activity of a lytic peptide in colon tumor</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4830</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4830.jpg</image:loc><image:title>Clinical and prognostic significance of spatial distribution of CD163-positive tumor-associated macrophages in pleural mesothelioma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4831</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4832</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4832.jpg</image:loc><image:title>Targeting collagen receptor CD49b enhances PD-L1 blockade by promoting CD8&amp;#8314; T-cell immunity in breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4833</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4833.jpg</image:loc><image:title>Dissociative, spatial, and functional single-cell profiling reveals antigen-driven exhaustion and chemotactic failure of tumor-reactive T cells in HPV-negative HNSCC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4834</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4834.jpg</image:loc><image:title>The role of CD5L in regulating liver immune cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4835</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4835.jpg</image:loc><image:title>Identification of tumor microenvironment for high infiltration of lymphocytes in triple negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4836</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4836.jpg</image:loc><image:title>Dual roles of JNK1 and JNK2 in TNBC progression and tumor microenvironment immune modulation reveal a novel therapeutic vulnerability</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4837</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4837.jpg</image:loc><image:title>Comprehensive tumor microenvironment analysis identifies a suppressive immune landscape in stemness-high hepatocellular carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4838</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4838.jpg</image:loc><image:title>Single-cell mass cytometry reveals T-cell exhaustion in sentinel nodes of ER+ breast cancer without histological detectable metastases</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4839</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4839.jpg</image:loc><image:title>Stromal MAOB promotes prostate cancer growth by suppressing antitumor immunity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4840</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4840.jpg</image:loc><image:title>Activin A promotes PDAC progression via immunosuppression and non-canonical signaling</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4841</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4841.jpg</image:loc><image:title>Tumor-associated macrophages promote oral squamous cell carcinoma development</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4842</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4842.jpg</image:loc><image:title>Exosome-targeted xmot-shRNA as a modular platform to dissect signaling pathways driving tolerogenic dendritic cells in the tumor microenvironment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4843</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4843.jpg</image:loc><image:title>LAMP3+ migratory dendritic cells establish immune-accessible tumor microenvironment in non-Hodgkin lymphoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4844</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4844.jpg</image:loc><image:title>Biomarker discovery and the targeting of tumor immune suppression in Renal Cell Carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4845</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4845.jpg</image:loc><image:title>TME profiling in Colombian men with suspected prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4846</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4846.jpg</image:loc><image:title>ImmunoPET imaging of human tumor associated macrophages</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4847</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4847.jpg</image:loc><image:title>GFRAL is not required for PDAC tumor development and TME immune cell suppression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4848</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4848.jpg</image:loc><image:title>Activin receptor subtype-2A regulates innate immune cell activation and non-canonical signaling in pancreatic cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4849</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4849.jpg</image:loc><image:title>Dynamics of HER2-driven MHC I immune evasion utilizing PWK x NeuT mice</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4850</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4850.jpg</image:loc><image:title>Notch4 blockade reprograms tumor-associated macrophages and enhances anti-tumor inflammatory signature in breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4851</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4851.jpg</image:loc><image:title>Treg-specific inhibition of hedgehog signaling alters their function and impedes the growth of murine triple-negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4852</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4852.jpg</image:loc><image:title>Inverse relationship between cancer and Alzheimer&#039;s disease: Important interplay between autophagy and apoptosis signaling mechanisms</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4853</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4853.jpg</image:loc><image:title>Targeting senescence to reverse chemotherapy-induced muscle aging in breast cancer survivors: An ancillary study of the TROFFi Trial</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4854</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4854.jpg</image:loc><image:title>The impact of the Community Living Lab learning health system on the prostate cancer knowledge, attitudes, beliefs, and cues to action of Black men</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4855</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4856</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4856.jpg</image:loc><image:title>Point-of-care-manufactured PRAME-specific TCR T cell therapy induces deep remission in a heavily pre-treated pediatric patient with extensive, multifocal nephroblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4857</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4857.jpg</image:loc><image:title>Optimizing fludarabine exposure in pediatric CAR T-cell patients through an adaptive dosing approach</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4858</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4858.jpg</image:loc><image:title>Optimising the treatment of childhood cancer patients through adaptive dosing and the generation of evidence-based dosing guidelines</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4859</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4859.jpg</image:loc><image:title>Overcoming the blood-brain barrier to potentiate GD2-CAR T therapy using P-selectin-targeted nanomedicine</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4860</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4861</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4861.jpg</image:loc><image:title>First-line (1L) trastuzumab deruxtecan (T-DXd) + rilvegostomig (rilve) + fluoropyrimidine (FP) in HER2-positive (HER2+) gastric cancer (GC), gastroesophageal junction adenocarcinoma (GEJA), or esophageal adenocarcinoma (EA): DESTINY-Gastric03 (DG-03) Part 4 arm A results</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4862</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4863</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4863.jpg</image:loc><image:title>Patient-derived 3D tumor models integrated with AI-driven treatment matching for target discovery and personalized therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4864</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4864.jpg</image:loc><image:title>Silent KRAS mutations confer altered sensitivity to targeted KRAS inhibition</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4865</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4865.jpg</image:loc><image:title>VRN110755: A next-generation non-covalent EGFR tyrosine kinase inhibitor for EGFR-mutated NSCLC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4866</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4866.jpg</image:loc><image:title>Daraxonrasib monotherapy as first-line (1L) treatment for patients with metastatic pancreatic adenocarcinoma (mPDAC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4867</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4867.jpg</image:loc><image:title>Mechanism-based trial matching reveals a 54% target alignment gap in ovarian cancer: Quantifying the precision-eligible ovarian cancer patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4868</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4869</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4869.jpg</image:loc><image:title>HZ-V055, an oral, highly potent pan-Ras molecular glue inhibitor demonstrated robust potency in Ras Mut cancer models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4870</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4871</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4871.jpg</image:loc><image:title>Discovery and identification of SHR-RAS001: A structurally novel, highly potent tri-complex RAS multi (ON) inhibitor</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4872</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4872.jpg</image:loc><image:title>Small-molecule targeting of p27 enables coordinated CDK2/4/6 inhibition in CDK4/6i-resistant breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4873</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4874</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4875</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4876</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4877</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4877.jpg</image:loc><image:title>NPP-2-21: A rationally designed prodrug of a UBA1 inhibitor with improved pharmacologic properties and antitumor activity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4878</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4879</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4880</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4880.jpg</image:loc><image:title>Preclinical evaluation of ARTS-876, an AKR1C3-activated prodrug targeting KEAP1/NFE2L2-mutant NSCLC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4881</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4881.jpg</image:loc><image:title>BPI-585771: A novel, potent pan-KRAS degrader with potent in vitro and in vivo efficacy in KRAS-driven tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4882</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4883</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4883.jpg</image:loc><image:title>Targeted degradation of p300 and CBP via antibody-drug conjugate in prostate cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4884</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4885</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4885.jpg</image:loc><image:title>P65-047, a novel TEAD degrader, overcomes KRAS inhibitor resistance through Hippo pathway disruption in NSCLC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4886</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4887</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4888</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4888.jpg</image:loc><image:title>Mechanistic and early clinical characterization of VRN101099, a selective HER2 inhibitor with receptor degradation activity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4889</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4889.jpg</image:loc><image:title>Zidesamtinib has differentiated preclinical brain penetrance and intracranial activity compared to other ROS1 inhibitors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4890</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4891</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4891.jpg</image:loc><image:title>Understanding the origins of the mutational landscape</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4892</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4892.jpg</image:loc><image:title>Individual and county-level social vulnerability and lifestyle factors among cancer survivors in Maryland</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4893</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4893.jpg</image:loc><image:title>Losing weight, not risk: Persistent cancer risk despite weight loss in adults with obesity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4894</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4895</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4895.jpg</image:loc><image:title>Historical redlining and DNA methylation in prostate tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4896</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4896.jpg</image:loc><image:title>Satellite embedding-derived built environment features predict cancer risk factors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4897</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4897.jpg</image:loc><image:title>Fear of recurrence and cancer screening adherence among cancer survivors: A HINTS-SEER 2021 study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4898</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4898.jpg</image:loc><image:title>Endogenous progesterone metabolism in premenopausal women and subsequent breast cancer risk</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4899</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4899.jpg</image:loc><image:title>Hysterectomy-corrected incidence of cervical cancer among women with HIV in the United States, 2001-2019</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4900</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4900.jpg</image:loc><image:title>Incidence patterns and temporal trends of chordoma: A population-based analysis of over 6000 cases in the United States</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4901</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4902</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4902.jpg</image:loc><image:title>H3K27ac-HiChIP variant-to-gene mapping confirms the importance of cancer drivers and oncogenic signaling pathways in melanoma risk</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4903</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4903.jpg</image:loc><image:title>Polygenic risk score of genetic variants in genes encoding drug-metabolizing enzymes and drug transporters, in association with febrile neutropenia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4904</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4904.jpg</image:loc><image:title>Multi-population GWAS meta-analysis identifies 86 susceptibility regions for renal cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4905</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4905.jpg</image:loc><image:title>Genome-wide association study identifies germline susceptibility loci for acute myeloid leukemia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4906</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4906.jpg</image:loc><image:title>Early postoperative liver outcomes differ by bariatric surgery procedure in multi-site cohort study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4907</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4907.jpg</image:loc><image:title>Genetic risk of prostate cancer: Insights from the Prostate Cancer Sequencing Consortium</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4908</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4908.jpg</image:loc><image:title>Pre-diagnostic exposures, mutational signatures, and immune profiles in triple-negative breast cancer: An overview of the PREMISE-TN project</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4909</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4909.jpg</image:loc><image:title>Associations between perceived costs and rewards of sun protection and sun safety practices among high school students</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4910</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4910.jpg</image:loc><image:title>Association between treatment delay and prognosis among breast cancer patients: A population-based cohort study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4911</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4912</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4912.jpg</image:loc><image:title>Potential survival benefits from early detection: Development and results of a multi-cancer simulation model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4913</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4913.jpg</image:loc><image:title>Samsung Organoids: A GxP-based drug screening leveraging patient-derived tumor organoids platform accompanied with clinical records and multi-omics data</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4914</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4915</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4915.jpg</image:loc><image:title>Spatial identification of hypoxic and normoxic dormancy hotspots predicting in her2-positive and metastatic breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4916</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4917</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4917.jpg</image:loc><image:title>Transcript isoform diversity in esophageal squamous cell carcinoma: Insights into tumor heterogeneity and therapeutic targets in Africa</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4918</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4918.jpg</image:loc><image:title>Shared and divergent transcriptional signatures of ductal cells in distal human cholangiocarcinoma at a single cell resolution</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4919</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4919.jpg</image:loc><image:title>Structural and kinetic effects of R361H SMAD4 mutation on TGF-&amp;#223; signaling in colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4920</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4920.jpg</image:loc><image:title>Identifying cell-cell interactions across spatial scales in spatial transcriptomics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4921</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4921.jpg</image:loc><image:title>Copy number loss and somatic loss of heterozygosity calling in liquid- and tissue-based genomic profiling</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4922</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4922.jpg</image:loc><image:title>Analytical validation of HLA class I allele typing in a liquid biopsy platform</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4923</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4924</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4924.jpg</image:loc><image:title>BRCA1, RNA-binding proteins, and miR-18a, a molecular tri(umph) in breast carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4925</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4925.jpg</image:loc><image:title>In silico analysis of GSK3alpha to identify novel potential ligands for cancer therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4926</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4926.jpg</image:loc><image:title>A serotonin transcriptional axis shapes immune phenotypes and clinical outcomes in lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4927</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4927.jpg</image:loc><image:title>The effects of survivorship patterns and survival parameters on cancer risk across vertebrates</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4928</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4928.jpg</image:loc><image:title>Decoding ADC payload dynamics with a spatial transcriptomics-integrated tumor microenvironment PK model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4929</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4929.jpg</image:loc><image:title>Omicology: A comprehensive AI/LLM/NLP-based web resource for the ontology, phylogeny, and practical navigation of omics literature</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4930</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4930.jpg</image:loc><image:title>Deep learning enables matched-normal free estimation of tumor mutational burden from whole exome reads in colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4931</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4932</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4933</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4933.jpg</image:loc><image:title>RNA-seq profiling identifies FOX genes as potential CRC biomarkers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4934</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4934.jpg</image:loc><image:title>Multiplatform bioinformatic profiling identifies TTK and NEK2 as survival-associated drivers in triple-negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4935</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4935.jpg</image:loc><image:title>From tumor to model: Transcriptomic and therapeutic insights from patient-derived colorectal cancer organoids</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4936</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4936.jpg</image:loc><image:title>Single-cell metabolic flux analysis defines distinct metabolic programs across tumor-infiltrating immune cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4937</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4937.jpg</image:loc><image:title>Elucidation of breakage-fusion-bridge (BFB)-mediated EGFR amplification in lenvatinib-resistant hepatocellular carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4938</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4939</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4939.jpg</image:loc><image:title>A segmentation-free method for modeling high-resolution spatial transcriptomics at the molecule level</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4940</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4940.jpg</image:loc><image:title>From transcripts to cells: Dissecting sensitivity, signal contamination, and specificity in Xenium spatial transcriptomics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4941</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4941.jpg</image:loc><image:title>AI-augmented immersive 3D and 4D spatial analysis interface for cancer research</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4942</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4942.jpg</image:loc><image:title>Resolving phenotyping discordance with SPACEMAP, an integrated machine learning framework</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4943</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4943.jpg</image:loc><image:title>SpatialTopic exploring tumor ecosystem in 3D multiplexed imaging of melanoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4944</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4944.jpg</image:loc><image:title>Morphology-aware profiling of highly multiplexed tissue images using variational autoencoders</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4945</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4945.jpg</image:loc><image:title>A quantum-enabled atlas-scale resource to study metabolic landscapes and heterogeneity in cancer TME</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4946</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4946.jpg</image:loc><image:title>gOS: A total molecular oncology interpretation framework applied to repaired FFPE and heme whole genome and clinical targeted assays</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4947</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4947.jpg</image:loc><image:title>Cancer epitope prediction tools &amp;#38; analysis pipelines in CEDAR</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4948</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4948.jpg</image:loc><image:title>CoMMpass Explorer: An interactive platform to explore clinical and genomic data from newly diagnosed multiple myeloma patients from the landmark CoMMpass observational study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4949</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4949.jpg</image:loc><image:title>A unified framework for cross-platform spatial omics analysis and deep spatial profiling</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4950</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4950.jpg</image:loc><image:title>An ensemble machine learning approach to ALT detection revals therapeutic vulnerabilities in pediatric cancers lacking actionable drug targets</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4951</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4951.jpg</image:loc><image:title>A user-friendly, no-code, application for HIPAA-compliant automated analysis of tabular data at scale</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4952</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4952.jpg</image:loc><image:title>Bioinformatic method for the detection of micro copy number variations with exome sequencing data</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4953</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4953.jpg</image:loc><image:title>A computational framework for reproducible analysis of cancer drug screening data</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4954</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4954.jpg</image:loc><image:title>Hunting for microsatellite instability in long-read data with Owl</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4955</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4955.jpg</image:loc><image:title>Exacto: Accurate identification of mutant proteoforms and neoantigens using integrative long-read sequencing</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4956</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4956.jpg</image:loc><image:title>ProteoRon: High-fidelity proteome inference from transcriptomes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4957</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4957.jpg</image:loc><image:title>BART-spatial: Predicting biologically significant transcriptional regulators from spatial omics data</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4958</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4958.jpg</image:loc><image:title>Accelerating minimal residual disease (MRD) detection through GPU-accelerated genomic analysis using NVIDIA Parabricks</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4959</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4959.jpg</image:loc><image:title>Learning-based invariant feature engineering reveals symmetry-encoded fingerprints of cancers that facilitate drug discovery</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4960</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4960.jpg</image:loc><image:title>Standardizing global patient safety and site compliance in oncology trials using a configurable, technology-driven oversight model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4961</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4961.jpg</image:loc><image:title>Towards an accurate quantum support vector module for predicting cancer cell dynamics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4962</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4962.jpg</image:loc><image:title>SOMaC: An interpretable and generalizable framework for integrating and clustering multimodal spatial omics to resolve cell states and immune niches in cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4963</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4963.jpg</image:loc><image:title>Multi-modal integration in the NetFlow framework for comprehensive exploratory data analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4964</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4964.jpg</image:loc><image:title>MeDOC-KB: Knowledge base for unraveling the metabolic links between obesity-related cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4965</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4965.jpg</image:loc><image:title>scSurvival: Single-cell survival analysis of clinical cancer cohort data at cellular resolution</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4966</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4966.jpg</image:loc><image:title>TNMplot 2.0: Stage-resolved and pan-cancer transcriptomic analytics for target discovery in oncology</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4967</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4967.jpg</image:loc><image:title>Visualization and analysis of cancer genomics data using UCSC Xena</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4968</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4968.jpg</image:loc><image:title>Aneuploidy prediction in the spatial domain</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4969</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4969.jpg</image:loc><image:title>Inferring tissue element identities from sample-level compositional data in cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4970</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4970.jpg</image:loc><image:title>Multi-scale foundational AI descriptors enable accurate tumor localization in digitized renal cell carcinoma pathology</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4971</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4971.jpg</image:loc><image:title>Scalable and interpretable multimodal AI: Integrating imaging and genomics via image-based encodingfor cancer and disease classification</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4972</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4972.jpg</image:loc><image:title>AI foundation model for single cell annotation from conventional histopathology images of cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4973</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4973.jpg</image:loc><image:title>Differential protein pattern analysis in highly multiplexed imaging</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4974</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4974.jpg</image:loc><image:title>Patterns of acid-suppressive therapy prescriptions in cancer: Are we treating symptoms or fueling the disease?</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4975</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4975.jpg</image:loc><image:title>Multiplex immunohistochemistry for immuno-oncology: A flexible approach to characterize the tumor microenvironment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4976</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4976.jpg</image:loc><image:title>AI-assisted Ki67 evaluation in solid tumors: Consistency and reliability compared to expert pathologists</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4977</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4977.jpg</image:loc><image:title>Improving early cancer detection by training scalable deep neural networks to extract tumor signal from cell-free DNA</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4978</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4978.jpg</image:loc><image:title>Integrating intra- and inter-cell gene-gene interactions into deep omics data analysis for enhanced single-cell cancer biology</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4979</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4979.jpg</image:loc><image:title>Deep learning-based analysis reveals patient-level proton radiation therapy trajectories using single-cell PBMC chromatin images</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4980</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4980.jpg</image:loc><image:title>Data-efficient morphological deep learning for fine-grained Gleason grading based on AI-triaged 3D pathology</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4981</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4981.jpg</image:loc><image:title>Low-magnification deep learning model for rapid HER2 status prediction from H&amp;#38;E whole-slide images</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4982</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4982.jpg</image:loc><image:title>Genie-ADLA: A deep learning algorithm for methylation-based multiple cancer early detection (MCED)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4983</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4983.jpg</image:loc><image:title>Deep learning reveals hidden pan-cancer drug signatures across the brain-gut axis through latent space modeling of 6.6 million single-cell perturbations</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4984</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4984.jpg</image:loc><image:title>A deep learning framework for extracting comprehensive single-cell biophysical profiles from brightfield images</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4985</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4985.jpg</image:loc><image:title>Dyna-Q Reinforcement Learning for breast tumor malignancy classification using phantom-trained models applied to human data</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4986</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4986.jpg</image:loc><image:title>GLEAM: Democratizing high-quality machine learning for cancer research</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4987</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4987.jpg</image:loc><image:title>AI-driven de novo design of miniproteins targeting mutant p53 peptide-MHC-I complex for cancer immunotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4988</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4988.jpg</image:loc><image:title>Benchmarking gene expression foundation models on bulk RNA-Seq data</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4989</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4989.jpg</image:loc><image:title>Optical spectral fingerprinting for anthracycline detection in synthetic clinical biofluids</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4990</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4990.jpg</image:loc><image:title>Artificial intelligence-designed peptide PROTACs suppress TNBC by regulating PD-L1 palmitoylation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4991</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4991.jpg</image:loc><image:title>Learning the mechanisms of chemotherapy response using a pathway-informed transformer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4992</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4992.jpg</image:loc><image:title>MethylFM: A DNA methylation foundation model for modeling epigenomic regulatory dynamics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4993</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4993.jpg</image:loc><image:title>Revealing dynamic temporal trajectories and underlying regulatory networks with Cflows</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4994</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4994.jpg</image:loc><image:title>Designing ATP-gated proteins for tumor selective drug delivery</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4995</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4996</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4996.jpg</image:loc><image:title>Identification of novel CRBN molecular glue ternary binders from a highly diverse CRBN MG library</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4997</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/4997.jpg</image:loc><image:title>High-content morphology profiling identifies autophagy-modulating compounds and their off-target activities</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4998</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/4999</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5000</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5000.jpg</image:loc><image:title>Accelerating selective cancer ligand discovery through an accessible phage display analysis suite</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5001</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5002</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5002.jpg</image:loc><image:title>Unlocking the unlockable: AS-MS for swift hit identification against challenging targets</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5003</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5003.jpg</image:loc><image:title>AI-accelerated discovery of B7-H3 and DLL3-targeted cyclic peptide radioligands: From library design to preclinical validation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5004</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5005</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5005.jpg</image:loc><image:title>A high content live cell cancer toolbox uniquely enabled by high throughput imaging</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5006</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5006.jpg</image:loc><image:title>Development of a high-throughput assay platform for the screening of selective integrin inhibitors in cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5007</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5008</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5009</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5010</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5010.jpg</image:loc><image:title>DEL-chemomics approach for the discovery of targeted protein degraders for cancer therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5011</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5011.jpg</image:loc><image:title>High-throughput peptide screening for radioligands by DNA encoded libraries</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5012</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5012.jpg</image:loc><image:title>Adapting the SAR-MAP chemical biology platform to target tumor immune checkpoints</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5013</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5013.jpg</image:loc><image:title>Automated culture and AI-enabled image analysis of compound responses in patient-derived colorectal cancer organoids</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5014</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5014.jpg</image:loc><image:title>Monitoring S-adenosylmethionine (SAM) and S-Adenosyl homocysteine (SAH) using a homogeneous luminescent assay</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5015</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5015.jpg</image:loc><image:title>Enabling phenotypic high-throughput drug screening with patient-derived organoids</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5016</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5016.jpg</image:loc><image:title>A 3D bioprinted vascularized tumor tissue model of non-small cell lung cancer: A model for drug screening</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5017</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5017.jpg</image:loc><image:title>DNA-encoded chemical library screening for glue discovery for oncology targets</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5018</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5018.jpg</image:loc><image:title>MICRO-TAG&amp;#174; cell target engagement redefines GPCR drug discovery with functional relevance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5019</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5019.jpg</image:loc><image:title>High throughput screening identifies novel drugs for calreticulin surface translocation in pancreatic ductal adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5020</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5020.jpg</image:loc><image:title>Development and validation of HTS assays for discovery of SMARCAL1 ATPase inhibitors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5021</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5021.jpg</image:loc><image:title>BRETTSA: A BRET-based assay for ultra-sensitive measurement of target engagement through protein denaturation in live cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5022</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5022.jpg</image:loc><image:title>DiscoveryDirect: Extending direct-to-biology paradigms to accelerate oncology drug discovery</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5023</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5023.jpg</image:loc><image:title>NMR assessment of ternary complex formation by targeted protein degraders</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5024</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5024.jpg</image:loc><image:title>Targeted polymeric nanoconjugates for BBB penetration and time specific delivery of PDL1 blocking small peptides via LRP1 targeting in melanoma brain metastases</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5025</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5025.jpg</image:loc><image:title>Enhanced therapy for triple-negative breast cancer (TNBC) using combinatorial drug delivery</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5026</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5026.jpg</image:loc><image:title>Development of a lipid nanoparticle formulation of the bifunctional PARP and HDAC inhibitor kt-3283</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5027</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5027.jpg</image:loc><image:title>Sodium chloride nanoparticles as urinary bladder cancer therapeutics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5028</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5028.jpg</image:loc><image:title>Tardigrade Dsup mRNA nanoparticles reduce chemotherapy-induced normal tissue toxicity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5029</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5029.jpg</image:loc><image:title>Magnetoelectric MOFs for ferroptosis-driven and immune-enhanced glioblastoma therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5030</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5030.jpg</image:loc><image:title>Intranasal delivery of lipid-based nanoparticle encapsulating CXCR7 agonist improves PD-L1 blockade efficacy in glioblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5031</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5031.jpg</image:loc><image:title>Gadolinium-based nanocomposite as a theranostic agent for triple-negative breast cancer: Synergistic radiosensitization, immune modulation, and image-guided therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5032</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5032.jpg</image:loc><image:title>Targeted delivery of RNA using synthetic bacterial spores</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5033</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5034</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5034.jpg</image:loc><image:title>Temozolomide co-encapsulated radioPDT nanoparticles possess effective cytotoxicity for the treatment of glioblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5035</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5035.jpg</image:loc><image:title>Targeted co-delivery of paclitaxel and honokiol using MUC1-aptamer PBM-NP encapsulation for enhanced breast cancer treatment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5036</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5036.jpg</image:loc><image:title>Nanoparticle mediated disruption of tumor-nerve crosstalk enhances pancreatic cancer treatment and pain mitigation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5037</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5037.jpg</image:loc><image:title>Targeted delivery of suicide gene to tumor cells using PD-L1-targeted extracellular vesicles for cancer therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5038</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5038.jpg</image:loc><image:title>Small bowel obstruction and short bowel syndrome may impair the efficacy of Avutometinib and Defactinib in recurrent low grade serous ovarian cancer: A case report</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5039</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5039.jpg</image:loc><image:title>Optimizing GPC3 gene editing in liver cancer: A comparison of Cas9 RNP and mRNA nanoliposome delivery systems</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5040</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5040.jpg</image:loc><image:title>Subcutaneous ANtibody-conjugated microGel platform enabling combination immunotherapy for refractory solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5041</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5041.jpg</image:loc><image:title>Maximizing systemic LNP-DNA delivery for cancer-activated expression of immunotherapy agents using nanoprimer technology</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5042</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5042.jpg</image:loc><image:title>Nanoprimer technology for enhanced efficacy of intravenously administered vaccines</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5043</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5043.jpg</image:loc><image:title>Development of a stabilized Z-endoxifen topical formulation for breast cancer prevention</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5044</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5044.jpg</image:loc><image:title>Harnessing facial neuronal pathways via iontophoresis for targeted intradermal delivery of bimodal spherical nucleic acids to the brain for anti-glioma&amp;#8239; effect</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5045</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5046</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5046.jpg</image:loc><image:title>Ferroptosis amplified by a tumor-targeted artesunate nano-derivative for effective colon cancer treatment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5047</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5048</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5048.jpg</image:loc><image:title>Next-generation sabizabulin nanoformulation for cervical cancer treatment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5049</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5049.jpg</image:loc><image:title>Immunogenic eradication of melanoma via ultrasmall lactoferrin-ICD inducer nanoconjugates integrated with BRAF-inhibitory liposomes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5050</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5050.jpg</image:loc><image:title>Spatial proteo-transcriptomic profiling of pancreatic adenocarcinoma unveils distinct malignant subtype-associated immune and stromal functional states</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5051</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5051.jpg</image:loc><image:title>CellScape Quality Control (CSQC): A tissue- and protein-agnostic platform for spatial proteomics quality assessment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5052</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5052.jpg</image:loc><image:title>High quality whole transcriptome RNA-sequencing from challenging clinical samples</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5053</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5053.jpg</image:loc><image:title>Spatial genomics reveals microenvironmental programs associated with organ-specific metastatic propensity in prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5054</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5054.jpg</image:loc><image:title>Integrated spatial transcriptomic and proteomic profiling reveals tumor-immune niches driving heterogeneity and resistance in clear cell renal cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5055</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5055.jpg</image:loc><image:title>Single-cell spatial proteomics of 1200+ protein targets in tumor microenvironments from diverse cancers using GeoMx Discovery Proteome Atlas</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5056</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5056.jpg</image:loc><image:title>Validation of two melanoma biomarkers and two novel ready-to-use multiplex immunofluorescence panels for spatial profiling of the stromal and vascular compartments in the tumor microenviroment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5057</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5058</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5058.jpg</image:loc><image:title>Integrated spatial transcriptomics and proteomics workflows for high-resolution multiomics analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5059</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5059.jpg</image:loc><image:title>Spatial and transcriptomic remodeling of the tumor microenvironment following neoadjuvant atezolizumab in urothelial carcinoma: Insights from the ABACUS Study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5060</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5060.jpg</image:loc><image:title>Spatially resolved multiplex immunofluorescence profiling of antibody-drug conjugate targets in bladder cancer using an AI-powered end-to-end workflow</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5061</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5061.jpg</image:loc><image:title>Automated co-detection of small RNAs, RNAs and proteins in tumor tissues with Roche DISCOVERY&amp;#8482;ULTRA</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5062</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5062.jpg</image:loc><image:title>Actionable resistance mechanisms in osteosarcoma uncovered by the elucidate spatial biomarker platform</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5063</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5063.jpg</image:loc><image:title>Expanding the boundaries of spatial proteomics with a universal antibody labeling strategy and EpicIF&amp;#8482; multiplexing chemistry</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5064</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5064.jpg</image:loc><image:title>MERFISH 2.0 enables high-sensitivity, customizable spatial transcriptomics for resolving immune and tumor programs in human cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5065</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5065.jpg</image:loc><image:title>Metabolic reprogramming in advanced renal tumors contributes to a dysfunctional immune response and immune exhaustion within the tumor microenvironment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5066</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5066.jpg</image:loc><image:title>An end-to-end quality control pipeline for spatially resolved molecular imaging data in the multi-omic SpaceIQ&amp;#8482; platform</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5067</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5067.jpg</image:loc><image:title>Spatial proteomics and AI-driven analysis uncover therapeutic landscapes within the glioblastoma microenvironment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5068</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5068.jpg</image:loc><image:title>Multiplexed imaging and AI-guided analysis reveal immune landscape diversity across multiple cancer types</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5069</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5069.jpg</image:loc><image:title>Ultra-high-plex immunofluorescence analysis of the tumor-immune microenvironment with EpicIF technology on the CellScape platform</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5070</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5070.jpg</image:loc><image:title>Decoding immune and tumor niches through high-plex spatial multi-omics in human cancer tissues</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5071</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5071.jpg</image:loc><image:title>Decoding the tumor microenvironment with triple-omics: Automated spatial analysis of protein-protein interactions, RNA, and protein markers on the same section</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5072</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5072.jpg</image:loc><image:title>Innovative 10x Genomics technologies enable clinical-scale cancer research and AI-driven biomarker discovery</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5073</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5073.jpg</image:loc><image:title>Chimeric antibodies in oncology research: Properties and application in low-multiplexing assays</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5074</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5074.jpg</image:loc><image:title>Streamlined high-plex imaging with InSituPlex&amp;#174;and ZEISS Axioscan 7 for spatial phenotyping</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5075</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5075.jpg</image:loc><image:title>Spatial multi-omics profiling of clear cell renal cell carcinoma (ccRCC) pre-and post-immunotherapy identifies new druggable targets</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5076</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5076.jpg</image:loc><image:title>Integrated high-throughput multimodal spatial profiling of RNA, protein, and morphology in FFPE sections with the G4X&amp;#8482; Spatial Sequencer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5077</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5077.jpg</image:loc><image:title>Direct-Seq&amp;#8482; enables spatially resolved in situ sequencing of IgH and TCRbeta transcripts in FFPE tissue at subcellular resolution</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5078</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5078.jpg</image:loc><image:title>Exploring clinical actionability of expanded liquid biopsy in advanced breast and colorectal cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5079</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5079.jpg</image:loc><image:title>Detection of bladder cancer in patients with gross hematuria using Oncuria-Detect, a urine-based multiplex immunoassay</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5080</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5080.jpg</image:loc><image:title>Detection of bladder cancer in patients with microscopic hematuria using Oncuria-Detect, interim analysis of an international prospective study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5081</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5081.jpg</image:loc><image:title>High-throughput, 96-well plate-based single-cell TCR sequencing for scalable chain-pairing and immunophenotyping of cancer-associated T cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5082</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5082.jpg</image:loc><image:title>Novel liquid biopsy epigenomic molecular tumor typing in carcinoma of unknown primary (CUP)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5083</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5083.jpg</image:loc><image:title>A decade-ahead signal of lung cancer from circulating exosomal sncRNAs</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5084</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5084.jpg</image:loc><image:title>Integrating machine learning to optimize FFPE variant calling in a comprehensive genomic profiling assay for hematologic malignancies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5085</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5085.jpg</image:loc><image:title>In silico discovery of fusion-specific RNA biomarkers in pediatric leukemias</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5086</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5086.jpg</image:loc><image:title>Development and first clinical experiences of a phage display derived bicyclic peptide for EphA2-specific PET imaging</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5087</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5087.jpg</image:loc><image:title>Actionable fusions and rearrangements can be efficiently identified by Hi-C whole genome sequencing in lung tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5088</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5088.jpg</image:loc><image:title>Novel serum biomarkers that detect ovarian cancer recurrence earlier than CA125</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5089</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5089.jpg</image:loc><image:title>High-purity isolation of tumor-derived extracellular vesicles via SEC-immunoaffinity integration improves diagnostic sensitivity in breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5090</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5090.jpg</image:loc><image:title>Identification of diagnostic and prognostic extracellular vesicle biomarker signatures in inflammatory breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5091</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5091.jpg</image:loc><image:title>Real-time clinical validation of the Geneverify blood mRNA test for breast cancer screening and diagnosis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5092</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5092.jpg</image:loc><image:title>Integrated disc-fluidic platform for high-throughput extracellular vesicle processing in liquid biopsy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5093</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5094</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5094.jpg</image:loc><image:title>Evaluating molecular tumor type predictions for identifying new primary malignancies - A real-world clinical genomics analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5095</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5095.jpg</image:loc><image:title>Vaginal microbiome dynamics and clinical outcomes in cervical cancer patients undergoing radiotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5096</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5096.jpg</image:loc><image:title>Molecular biological differences between breast and cutaneous apocrine carcinomas</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5097</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5097.jpg</image:loc><image:title>Immunoaffinity-enriched extracellular vesicles reveal tumor-derived DNA mutations for breast cancer detection</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5098</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5098.jpg</image:loc><image:title>Affective trajectories during adaptive pharmacotherapy for smoking cessation: Insights from EMA data</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5099</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5099.jpg</image:loc><image:title>Dose optimization in multi-indication oncology basket trials: Leveraging Bayesian borrowing to identify OBD</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5100</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5100.jpg</image:loc><image:title>Adjuvant immunotherapy in resected pancreatic ductal denocarcinoma: A 25-year landscape analysis of ClinicalTrials.gov (2000-2025)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5101</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5102</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5103</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5104</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5104.jpg</image:loc><image:title>Effects of cumulative tobacco exposure on lung cancer genomic profiles in Latin Americans</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5105</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5105.jpg</image:loc><image:title>Safety profile of post-CDK4/6 treatments in HR+/HER2&amp;#8722; metastatic breast cancer (mBC): A network meta-analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5106</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5107</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5108</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5109</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5110</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5111</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5111.jpg</image:loc><image:title>The obesity paradox in pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5112</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5113</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5114</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5114.jpg</image:loc><image:title>A novel multi-modal PD-L1xVEGF-ADC, HX116, could be a new potent candidate treatment for pan-solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5115</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5115.jpg</image:loc><image:title>Tumor IDO1 drives resistance to adoptive cell transfer by suppressing T cell recruitment and effector function</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5116</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5116.jpg</image:loc><image:title>A phase-separation mechanism underlying PD-1-mediated T-cell inhibition via Shp2 condensation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5117</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5117.jpg</image:loc><image:title>Characteristics and predictors of multi-system immune-related adverse events in a large pan-cancer cohort: A retrospective analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5118</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5118.jpg</image:loc><image:title>Dissecting mechanisms of tumor immune checkpoint blockade resistance due to host genetic variation within Adam17</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5119</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5119.jpg</image:loc><image:title>Time-of-day of first checkpoint inhibitor dose influences clinical outcomes and immune responses in hepatocellular carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5120</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5120.jpg</image:loc><image:title>Targeting ITGB3 reverses terminal T cell exhaustion to enhance therapeutic efficacy in esophageal squamous cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5121</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5121.jpg</image:loc><image:title>NTX1088 demonstrates the first-ever clinical restoration of DNAM1, defining a novel immune-oncology axis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5122</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5122.jpg</image:loc><image:title>Immune checkpoint inhibitor therapy in kidney transplant recipients: Real-world outcomes of antitumor activity and graft rejection risk</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5123</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5123.jpg</image:loc><image:title>Characterizing ATF6 activation-driven mechanisms improving ICB efficacy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5124</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5124.jpg</image:loc><image:title>Beyond density: Topography-aware spatial metrics predict immunotherapy outcomes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5125</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5125.jpg</image:loc><image:title>Phase II single arm study of tremelimumab and durvalumab (MEDI4736) (T300+D) in advanced hepatocellular carcinomas with Child-Pugh-B cirrhosis (STRIDE in CP-B)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5126</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5126.jpg</image:loc><image:title>A human multiorgan microphysiological system for modeling immunotherapies tumor clearance and normal tissue immune injury</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5127</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5127.jpg</image:loc><image:title>Integrating functional biosignatures and same-cell spatial multiomics to predict synergistic benefit of combination checkpoint therapy in head and neck cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5128</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5128.jpg</image:loc><image:title>In vitro characterization of fully human antagonistic anti-BTLA monoclonal antibodies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5129</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5129.jpg</image:loc><image:title>Mifepristone-mediated induction of PD-L1 expression in hormone receptor positive breast tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5130</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5130.jpg</image:loc><image:title>Nonresponders to PD-1 therapy share a combined OXPHOS and neuronal-like resistance program in melanoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5131</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5132</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5132.jpg</image:loc><image:title>A bispecific TROP2/PDL1 antibody-drug conjugate demonstrates enhanced antitumor activity and favorable safety profile</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5133</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5133.jpg</image:loc><image:title>BTN1A1 blockade with Nelmastobart potentiates cisplatin-induced tumor suppression in NSCLC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5134</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5134.jpg</image:loc><image:title>The role of VISTA in the lung tumor microenvironment of metastatic melanoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5135</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5135.jpg</image:loc><image:title>Combined PARP inhibition and immune checkpoint blockade elicit differentially improved survival in BRCA1, BRCA2 vs CHEK2, ATM deficient breast cancer by promoting an anti-tumor immune response through tertiary lymphoid structure formation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5136</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5136.jpg</image:loc><image:title>Selenium dependent regulation of immune checkpoint control in acute myeloid leukemia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5137</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5137.jpg</image:loc><image:title>Investigating the transcriptomic signature of B7-H7-mediated activation of NK cell activity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5138</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5139</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5139.jpg</image:loc><image:title>Rational design of a B7-H3/PD-L1 bsADC combining checkpoint blockade with targeted cytotoxicity for improved antitumor efficacy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5140</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5140.jpg</image:loc><image:title>Identifying vulnerabilities to immune checkpoint inhibitors of oncogene-addicted non-small cell lung cancer subgroups.</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5141</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5141.jpg</image:loc><image:title>Immune and clinical determinants of response to immune checkpoint blockade (ICB) rechallenge after perioperative chemoImmunotherapy in gastroesophageal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5142</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5142.jpg</image:loc><image:title>Spatially resolved immunologic hallmarks of response to neoadjuvant immune checkpoint blockade in metastatic melanoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5143</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5143.jpg</image:loc><image:title>Serum pharmacodynamic biomarkers of IPI/NIVO/RELA plus sarilumab in Stage III-IV melanoma: Stage 1 results of a Simon Phase II trial (NCT05428007)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5144</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5144.jpg</image:loc><image:title>Enhanced monocyte activation and T cell cytotoxicity underlie the benefit of neoadjuvant durvalumab plus gemcitabine-cisplatin (D+GP) in localized biliary tract cancer (BTC): Phase 2 DEBATE study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5145</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5145.jpg</image:loc><image:title>Cytotoxic T-cell signatures underlie therapeutic response to 177Lu-DOTATATE plus pembrolizumab in well-differentiated gastroenteric neuroendocrine tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5146</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5146.jpg</image:loc><image:title>Pan-tumor investigation of peripheral biomarkers of excellent response to anti-PD(L)1-based therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5147</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5147.jpg</image:loc><image:title>Phase I study of STA551 (STA) a tumor-selective CD137 agonist, as monotherapy and in combination with atezolizumab (atezo) using CD8 PET imaging to assess pharmacodynamic effects</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5148</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5148.jpg</image:loc><image:title>Harnessing tumor-informed B cell receptors for discovery and antibody-based immunotherapy in sarcoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5149</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5149.jpg</image:loc><image:title>Development of FL115, a novel IL-15 superagonist, as subcutaneous injection for cancer immunotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5150</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5150.jpg</image:loc><image:title>Immunologic and transcriptional features associated with long-term response and resistance to immune checkpoint inhibitors in non-small cell lung cancer checkpoint inhibitors in non-small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5151</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5151.jpg</image:loc><image:title>Comprehensive cytokine, chemokine and immune marker evaluation in plasma samples of primary, non-metastatic high grade serous ovarian cancer patients to estimate outcome and platinum resistance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5152</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5152.jpg</image:loc><image:title>Baseline peripheral immune signatures associate with toxicity to immunotherapy in melanoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5153</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5154</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5154.jpg</image:loc><image:title>Surgery-induced expansion of myeloid-derived suppressor cells and loss of cytotoxic lymphocyte function predict poor survival in pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5155</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5155.jpg</image:loc><image:title>Validating tumor-infiltrating lymphocyte classification in primary cutaneous melanoma using cytokine immune scores: Addressing biomarker disparities in underserved populations</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5156</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5156.jpg</image:loc><image:title>Preliminary results of a phase 2 study of leronlimab in combination with TAS-102 and bevacizumab in previously treated metastatic colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5157</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5157.jpg</image:loc><image:title>Myeloma cells with therapy-induced senescence-like phenotype are associated with resistance to CAR-T therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5158</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5158.jpg</image:loc><image:title>Biopsy site-specific variation in immune signatures identified by RNA profiling in breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5159</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5159.jpg</image:loc><image:title>Longitudinal loss of microbiome stability is associated with poor response to immune checkpoint inhibitors in lung cancer and melanoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5160</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5160.jpg</image:loc><image:title>Spatial remodeling of the tumor microenvironment by IL-18-armored CD19 CAR T cells is associated with durable remission in relapsed or refractory lymphoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5161</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5161.jpg</image:loc><image:title>Immune correlates post MMF omission lead to accelerated immune reconstitution without increased graft versus host disease risk signatures for allogenic stem cell transplant (OmitMMF trial)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5162</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5163</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5163.jpg</image:loc><image:title>Clonal consolidation and transcriptional re-programming define non-small cell lung cancers resistant to immune checkpoint inhibitors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5164</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5164.jpg</image:loc><image:title>Robust and precise rare event analysis for immunotherapy clinical trials</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5165</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5165.jpg</image:loc><image:title>Myeloma cells with therapy-induced senescence-like phenotype have increased resistance to killing by T cell directed therapies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5166</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5166.jpg</image:loc><image:title>Microbiome modulation via CBM588 dampens T cell exhaustion in patients with metastatic renal cell carcinoma on dual immune checkpoint blockade</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5167</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5167.jpg</image:loc><image:title>Peptide-based tumor-associated antigen vaccine in glioblastoma: Correlative results of the ETAPA Phase I clinical trial</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5168</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5168.jpg</image:loc><image:title>Temporal dynamics of T cell reprogramming associate with clinical response to ICI-based combination therapy in metastatic renal cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5169</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5170</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5170.jpg</image:loc><image:title>Single-cell transcriptomics reveal functional interaction between CD4+ T cells and B cells driving the activated peripheral immune phenotype in healthy women living with germline pathogenic BRCA1 variants</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5171</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5171.jpg</image:loc><image:title>Assessment of multiplexed human and mouse cytokines in humanized mouse samples</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5172</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5172.jpg</image:loc><image:title>Proliferative T cell infiltration is associated with colorectal cancer molecular subtypes and cancer specific survival</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5173</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5173.jpg</image:loc><image:title>Obesity shapes a reversible immune microenvironment that fosters breast cancer growth</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5174</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5174.jpg</image:loc><image:title>Assessment of the T cell receptor repertoire in racially diverse prostate cancer patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5175</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5175.jpg</image:loc><image:title>NK cell therapy enhances the efficacy of CDK4/6i in breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5176</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5176.jpg</image:loc><image:title>Investigating the role of glucocorticoid-induced leucine zipper (GILZ) in triple-negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5177</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5177.jpg</image:loc><image:title>Integrative spatial transcriptomics reveals EMT-driven immune regulatory programs underlying metastasis in HNSCC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5178</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5178.jpg</image:loc><image:title>Heat shock protein inhibitors suppress cytokine-induced DUOX2 mRNA and protein expression in human pancreatic cancer cells in a JAK, STAT dependent manner</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5179</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5179.jpg</image:loc><image:title>Investigating the role of signal peptide peptidase in tumor immune evasion via Qa-1-mediated peptide presentation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5180</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5180.jpg</image:loc><image:title>A novel regulator of T-cell motility: Fhl2 controls CD8 + T-cell migration and infiltration</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5181</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5181.jpg</image:loc><image:title>Reprogramming microglial and GAMs phenotype and function, with HDAC inhibitors to overcome immune suppression in glioblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5182</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5182.jpg</image:loc><image:title>Cell surface plectin as a master regulator of tumor-immune interactions in pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5183</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5183.jpg</image:loc><image:title>Genetic characterization of KLRC2 deletion in racially diverse prostate cancer patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5184</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5184.jpg</image:loc><image:title>Spatial mapping and significance of IL12 signaling in non-small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5185</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5185.jpg</image:loc><image:title>DUOX2 is finely tuned by synergism between cytokines IL-6, IL-22, IL-17A, and TNFalpha in colon cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5186</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5186.jpg</image:loc><image:title>CCL3+ tumor cells orchestrate immune equilibrium and stemness maintenance in ESCC via IDE+ M2 macrophages and CCR3+ CAFs</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5187</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5187.jpg</image:loc><image:title>Characterizing the autoreactome in thymoma-associated myasthenia gravis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5188</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5189</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5189.jpg</image:loc><image:title>Nrf2 as a therapeutic target to improve T cell function in muscle invasive bladder cancer (MIBC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5190</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5191</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5191.jpg</image:loc><image:title>Cross platform same slide multi-omics reveals Treg heterogeneity and links to spatial niche variability in pre-cancerous colonic inflammation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5192</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5192.jpg</image:loc><image:title>In vitro neutrophil assays to support immuno-oncology drug development</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5193</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5193.jpg</image:loc><image:title>B-cell guided inflammatory cascade perpetuates ICI-mediated colitis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5194</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5194.jpg</image:loc><image:title>Establishing ex vivo models for targeting leukemic stem cells to investigate relapse and refractory pediatric leukemias</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5195</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5195.jpg</image:loc><image:title>Memory B cell Responses Ignite Anti-Tumor Immunity by Activating CD8+ T cell Cytotoxicity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5196</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5196.jpg</image:loc><image:title>Understanding DAP12-independent antitumor activation in KIR-based CAR T cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5197</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5197.jpg</image:loc><image:title>Unfavorable early progression-free survival of immunotherapy compared to chemotherapy in bladder cancer: A meta-analysis of randomized trials</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5198</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5198.jpg</image:loc><image:title>Pattern of inferior early progression-free survival with immunotherapy versus chemotherapy in head and neck cancer: A meta-analysis of randomized trials</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5199</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5199.jpg</image:loc><image:title>Self-adjuvanting alpha-helical polypeptide simultaneously delivers neoantigen mRNAs and activates dendritic cells to eradicate tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5200</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5200.jpg</image:loc><image:title>KLRG1 + PD-1 + CD8 + T cells drive potent antitumor immunity induced by a systemic STING nanovaccine</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5201</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5201.jpg</image:loc><image:title>Monocyte-derived dendritic cells for antigen-specific T cell activation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5202</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5202.jpg</image:loc><image:title>Early progression disadvantage of immunotherapy-only treatment versus chemotherapy in NSCLC: A meta-analysis of randomized controlled trials</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5203</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5203.jpg</image:loc><image:title>A senescent whole-cell vaccine platform derived from conditionally reprogrammed primary tumor cells primes potent T-cell immunity and overcomes ICI resistance in murine breast cancer models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5204</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5204.jpg</image:loc><image:title>Pelareorep combined with atezolizumab and chemotherapy shows immune conversion activity in advanced pancreatic cancer: Biomarker results of cohort 1 of the GOBLET trial</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5205</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5205.jpg</image:loc><image:title>EpitopeMiner: Scalable knowledge mining for evidence-driven personalized cancer vaccine design</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5206</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5206.jpg</image:loc><image:title>Novel preclinical immunocompetent mouse model for assessment of immunotherapies targeting cGAS-STING axis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5207</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5207.jpg</image:loc><image:title>A fully integrated set of in vitro and in vivo tools for utilization of micro-organisms as new therapeutic weapons against cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5208</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5208.jpg</image:loc><image:title>Re-engineering cancer vaccines: Bria-OTS+ integrates innate and adaptive immunity for broad and persistent anti-tumor responses</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5209</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5209.jpg</image:loc><image:title>A Cxcl10 mRNA-LNP adjuvant enhances immune checkpoint inhibitor responses in melanoma models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5210</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5210.jpg</image:loc><image:title>Rg002: An mRNA-LNP-based immunotherapy targeting HPV-16/18-related malignancies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5211</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5211.jpg</image:loc><image:title>Exercise attenuates anti-PD-1-induced adventitial macrophage inflammation in the aorta of aged melanoma-bearing mice</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5212</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5212.jpg</image:loc><image:title>A versatile coacervate based delivery system to overcome engineering barriers in immune cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5213</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5214</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5214.jpg</image:loc><image:title>Neoadjuvant pembrolizumab with therapeutic DNA vaccine reshape intratumoral immunity in a phase 2 trial of HPV-positive HNSCC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5215</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5215.jpg</image:loc><image:title>Temporal trends in biomarker utilization across 24,000+ immuno-oncology trials</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5216</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5217</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5217.jpg</image:loc><image:title>Investigating MyD88 and NLRP3 pathway modulation in a TLR4 and TLR9 driven immunotherapy in a murine model of ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5218</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5219</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5219.jpg</image:loc><image:title>Engineering a hydrogel-based vaccine to prevent recurrence in pancreatic ductal adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5220</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5220.jpg</image:loc><image:title>Humanized SLE mouse model for evaluating B-cell CAR-T therapy efficacy and safety</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5221</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5222</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5222.jpg</image:loc><image:title>ALK-mRNA vaccine as a new Immunotherapy for ALK+ cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5223</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5223.jpg</image:loc><image:title>Preclinical study of armored claudin 18.2 nanobody CAR NK cells targeting gastric cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5224</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5224.jpg</image:loc><image:title>Identifying new cell surface markers of T-cell reactivity through single cell transcriptomic analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5225</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5225.jpg</image:loc><image:title>Convergent CDK4/6 and PI3K/mTOR pathway hyperactivation defines a targetable axis in osteosarcoma across RB1-proficient and RB1-deficient contexts</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5226</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5226.jpg</image:loc><image:title>Divergent roles of SPOP and CHD1 in ACSL4 regulation reveal context-dependent vulnerabilities for targeting ferroptosis in prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5227</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5227.jpg</image:loc><image:title>Combination of the GCN2 activator HC-7366 with VEGFR-TKI results in greater efficacy than VEGFR-TKI alone or VEGFR-TKI/HIF-2i combinations in ccRCC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5228</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5228.jpg</image:loc><image:title>Exploratory study of camrelizumab combined with chemotherapy as second-line treatment for advanced esophageal squamous cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5229</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5229.jpg</image:loc><image:title>Dual targeting of PARP and RAS enhances antitumor activity in pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5230</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5230.jpg</image:loc><image:title>Metabolic molecular subtyping of ovarian cancer reveals the role of oleic acid-CD36 in facilitating cisplatin resistance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5231</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5231.jpg</image:loc><image:title>MEK inhibition overcomes stromal-mediated resistance to a MERTK targeted therapy in AML co-cultures and vascularized mesenchymal organoids</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5232</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5232.jpg</image:loc><image:title>Co-treatment with FAK and PARP inhibitors for the treatment of homologous recombination-proficient high grade serious ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5233</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5233.jpg</image:loc><image:title>Targeting phospholipase D1 overcomes platinum resistance and enhances cisplatin efficacy in ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5234</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5234.jpg</image:loc><image:title>Azvudine combined with Doxitinib, a potential therapy for EGFRm + NSCLC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5235</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5235.jpg</image:loc><image:title>The selective YAP/TEAD inhibitor TY-1054 enhances the efficacy of KRAS inhibitors or Trop2-ADC in multiple solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5236</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5236.jpg</image:loc><image:title>NXP900, a Phase 1b, first-in-class YES1/SRC inhibitor demonstrates potent synergy with KRAS inhibitors in KRASi sensitive and resistant NSCLC models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5237</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5237.jpg</image:loc><image:title>Methylseleninic acid enhances anti-FN14 CAR-T cell effector function and redirects cytotoxicity against TGF-beta-rich kidney, prostate, and brain tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5238</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5238.jpg</image:loc><image:title>Synergistic disruption of KRAS and FAK pathways: A preclinical pipeline for PDAC therapy optimization</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5239</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5239.jpg</image:loc><image:title>Combination of MDM2 inhibitor and lipophilic gemcitabine: Strong synergism in lung cancer, while antagonism in brain cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5240</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5240.jpg</image:loc><image:title>Targeting BCR-ABL1-independent mechanisms of resistance in chronic myeloid leukemia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5241</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5241.jpg</image:loc><image:title>Preclinical evidence for synergistic activity of alectinib and everolimus in ALK-positive non-small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5242</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5242.jpg</image:loc><image:title>Investigating synergistic effects with CK2 and C-KIT inhibition in B-ALL</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5243</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5243.jpg</image:loc><image:title>Combination therapy with selective SMARCA2 (BRM) inhibitor HD-11273 for treatment of SMARCA4 (BRG1)-deficient cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5244</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5244.jpg</image:loc><image:title>Antitumor synergy of AOH1996 and next-generation caPCNA Inhibitors in combination with targeted and chemotherapeutic agents</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5245</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5246</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5246.jpg</image:loc><image:title>Triad-SL: A new synthetic lethality paradigm combining two distinct DNA damage response pathway inhibitors and particle radiotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5247</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5248</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5249</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5249.jpg</image:loc><image:title>Aurora kinase B inhibition enhances radiation response and activates type 1 interferon signaling in triple-negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5250</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5251</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5251.jpg</image:loc><image:title>Overcoming reduced efficacy of fractionated radiotherapy in obese mice</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5252</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5252.jpg</image:loc><image:title>HDAC6 inhibition modulates macrophage function in the post-radiation therapy tumor microenvironment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5253</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5253.jpg</image:loc><image:title>WNC0901 is a novel DNA-PK inhibitor and potent radiosensitizer of otherwise radioresistant solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5254</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5254.jpg</image:loc><image:title>Targeting pancreatic cancer with combination RAS inhibition and radiation therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5255</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5255.jpg</image:loc><image:title>Ferroptotic vulnerability in M1 and M2 macrophages is associated with adaptive radiation resistance in esophageal adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5256</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5256.jpg</image:loc><image:title>Targeting CPT&amp;#8209;1&amp;#8209;mediated fatty acid oxidation causes radiation sensitization in glioblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5257</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5257.jpg</image:loc><image:title>Targeting the G2/M checkpoint as a radiosensitizing strategy in BRAF wild-type anaplastic thyroid cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5258</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5258.jpg</image:loc><image:title>Limiting O-GlcNAcylation support prostate cancer radiation sensitivity through metabolic and epigenetic reprogramming</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5259</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5259.jpg</image:loc><image:title>Targeting the PLK1-PRMT5 axis enhances radiosensitivity in prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5260</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5260.jpg</image:loc><image:title>Investigation of 8-O-acetylharpagide induced G2/M arrest and radiosensitization effects on hypopharyngeal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5261</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5261.jpg</image:loc><image:title>Inhibition of PLK4 overcomes radioresistance in locally advanced rectal cancer through genomic instability and apoptotic cell death</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5262</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5262.jpg</image:loc><image:title>CYLD induces ferroptosis through ALOX12B to enhance radiosensitivity in non-small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5263</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5264</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5264.jpg</image:loc><image:title>Novel selective binders for gastrointestinal DCLK1 isoforms</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5265</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5265.jpg</image:loc><image:title>Stem cell transdetermination is a targetable driver of therapeutic response to neoadjuvant chemoradiotherapy in rectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5266</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5266.jpg</image:loc><image:title>Exploiting radiation-induced tumor vulnerabilities via targeted antibody-drug conjugates</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5267</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5267.jpg</image:loc><image:title>Photodynamic activation of CX-5461 enhances its anti-tumor efficacy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5268</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5268.jpg</image:loc><image:title>Atomically precise NHC-stabilized gold nanoclusters for enhanced photodynamic and X ray activated cancer therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5269</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5270</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5270.jpg</image:loc><image:title>Cancer photodynamic therapy: Silicon quantum dots as therapeutic nanomaterials</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5271</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5271.jpg</image:loc><image:title>Trends in treatment and survival among patients with glioblastoma in the United States, 2000 to 2020: A population-based SEER analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5272</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5272.jpg</image:loc><image:title>PD-L1 expression-dependent efficacy of first-line immune checkpoint inhibitor plus chemotherapy in advanced gastric and gastroesophageal junction adenocarcinoma: A systematic review and meta-analysis of phase III trials</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5273</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5273.jpg</image:loc><image:title>Real-world comparative outcomes of nivolumab + ipilimumab vs. atezolizumab + bevacizumab in advanced hepatocellular carcinoma: A TRINETX study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5274</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5274.jpg</image:loc><image:title>Evaluation of stage IV PTCL, NOS of the liver and gastrointestinal tract using a large national cancer database</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5275</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5276</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5276.jpg</image:loc><image:title>Real world outcomes for patients with KRAS G12D -mutated non-small cell lung cancer: A University of California Health Data Warehouse retrospective analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5277</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5277.jpg</image:loc><image:title>Real-World evidence of eflapegrastim (efla) usage in patients with gastrointestinal (GI) malignancies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5278</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5278.jpg</image:loc><image:title>Impact of preexisting heart disease on survival and postoperative outcomes in pancreatic cancer: A TriNetX analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5279</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5279.jpg</image:loc><image:title>Geriatric nutritional risk index at diagnosis predicts survival in pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5280</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5280.jpg</image:loc><image:title>Metabolic predictors of chemotherapy response in pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5281</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5281.jpg</image:loc><image:title>Incidence and outcomes of brain metastasis in ER-low breast cancer: Insights from a National Cancer Database (NCDB)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5282</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5282.jpg</image:loc><image:title>Adjuvant dose-dense chemotherapy is not associated with improved recurrence-free survival in early-stage, node-negative, HER2-negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5283</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5283.jpg</image:loc><image:title>Practice patterns impacting relative dose intensity of adjuvant capecitabine among triple negative breast cancer patients with residual disease following neoadjuvant chemotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5284</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5284.jpg</image:loc><image:title>Impact of histology subtypes (ductal, lobular, and mixed ductal/lobular) on pathological complete response (pCR) following neoadjuvant chemotherapy (NAC) and chemoimmunotherapy (NACI) for estrogen receptor low (ER-low) HER2-negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5285</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5286</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5286.jpg</image:loc><image:title>Association between area deprivation index (ADI) and treatment persistence (TP) with CDK4/6 inhibitors (CDK4/6i)in HR+/HER2- breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5287</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5288</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5288.jpg</image:loc><image:title>Safety and efficacy of belzutifan for Von Hippel-Lindau disease-associated tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5289</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5289.jpg</image:loc><image:title>Characterizing the risk of infections with T-cell engagers in multiple myeloma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5290</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5290.jpg</image:loc><image:title>Viral hepatitis paradox: Better outcomes in geriatric HCC transplant patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5291</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5291.jpg</image:loc><image:title>Hepatosplenic T-cell lymphoma gamma-delta versus alpha-beta: A comparative study of clinicopathologic features and outcomes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5292</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5292.jpg</image:loc><image:title>Assessing skin cancer risk in systemic sclerosis patients with organ transplantation: A cohort study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5293</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5293.jpg</image:loc><image:title>Characterization of adverse cutaneous effects in the setting of ponatinib, bosutinib, andasciminib for chronic myeloid leukemia patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5294</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5294.jpg</image:loc><image:title>Epigenetic immune reprogramming overcomes PD-1 resistance in metastatic melanoma patients: The phase II NIBIT-ML1 study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5295</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5295.jpg</image:loc><image:title>SCOPE, A phase 2 clinical trial with off-the-shelf DNA plasmid vaccine in first line advanced melanoma combined with check point blockade, shows good T cell responses which correlate with long progression free survival</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5296</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5296.jpg</image:loc><image:title>Intratumoral sotigalimab with pembrolizumab induces rapid activation of antigen presenting cells and drives anti-tumor responses in non-injected tumors in metastatic melanoma: A phase I/II study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5297</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5297.jpg</image:loc><image:title>IOB-032/PN-E40: A phase 2 study of neoadjuvant/adjuvant IO102-IO103 cancer vaccine plus pembrolizumab in resectable HNSCC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5298</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5298.jpg</image:loc><image:title>Phase 2 window of opportunity trial of pyrimethamine in locoregionally advanced head and neck squamous cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5299</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5299.jpg</image:loc><image:title>Covalent FAPI imaging-guided precision surgery in medullary thyroid carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5300</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5300.jpg</image:loc><image:title>Dirozalkib in patients with advanced ALK-positive non-small cell lung cancer (NSCLC): Results from a phase 2 study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5301</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5301.jpg</image:loc><image:title>Taletrectinib in tyrosine kinase inhibitor (TKI)-pretreated patients with ROS1+ non-small cell lung cancer (NSCLC): Updated data from TRUST-I and TRUST-II</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5302</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5302.jpg</image:loc><image:title>PDR001 in patients with unresectable non-small cell lung cancer (NSCLC) harboring KRAS/NRAS mutation or without actionable genetic abnormalities: Phase II, multicenter, single arm study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5303</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5303.jpg</image:loc><image:title>An ensemble multi-omics framework for chemo de-escaltion NSCLC patients with PD-L1-low/negative disease in the PEOPLE phase II trial (NCT03447678)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5304</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5304.jpg</image:loc><image:title>Savolitinib combined with Durvalumab in EGFR wild-type advanced NSCLC patients with MET alterations (SOUND): A multicenter, open-label, Phase II trial</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5305</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5305.jpg</image:loc><image:title>Zidesamtinib in patients with ROS1 + NSCLC previously treated with repotrectinib or taletrectinib</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5306</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5306.jpg</image:loc><image:title>Detection of EGFR T790M mutation in bronchial washing fluid and therapeutic efficacy of lazertinib in T790M-positive NSCLC patients after first-line EGFR-TKI failure: An open-label, multicenter, single-arm exploratory study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5307</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5307.jpg</image:loc><image:title>A phase 1b / 2 study of JK06, a 5T4-targeted antibody drug conjugate, in patients with unresectable locally advanced or metastatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5308</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5308.jpg</image:loc><image:title>Double lung transplantation in patients with metastatic lung-limited non-small cell lung carcinoma (NSCLC): A case series</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5309</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5310</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5310.jpg</image:loc><image:title>Results of a randomized placebo-controlled phase 2 study of metformin for the prevention of progression of precursor multiple myeloma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5311</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5311.jpg</image:loc><image:title>AdAPT-001 in the BETA-PRIME trial: Spatially and temporally coordinated TGF-beta inhibition and oncolytic infection</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5312</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5312.jpg</image:loc><image:title>A Phase II chemo/immunotherapy study using metronomic gemcitabine, doxorubicin, docetaxel and nivolumab for advanced angiosarcoma (NCT04535713): An interim analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5313</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5313.jpg</image:loc><image:title>Double lung transplantation in patients with recent history of malignancy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5314</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5314.jpg</image:loc><image:title>Digital survivorship care planning through the eyes of cancer survivors: A qualitative analysis of a phase I/II randomized controlled trial</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5315</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5315.jpg</image:loc><image:title>Rapid analysis and response evaluation of combination anti-neoplastic agents in rare tumors (RARE CANCER) trial (RARE 3): Tiragolumab + Atezolizumab</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5316</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5316.jpg</image:loc><image:title>Pembrolizumab and epigenetic modification with azacitidine reprogram the tumor microenvironment of platinum-resistant epithelial ovarian cancer: clinical and translational findings from a phase II study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5317</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5317.jpg</image:loc><image:title>Molecular iodine impairs chemotherapy resistance and adverse effects in breast cancer treatments</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5318</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5318.jpg</image:loc><image:title>Elacestrant (Ela) in combination with everolimus (Eve) or abemaciclib (Abema) in patients with ER+/HER2- locally advanced or metastatic breast cancer mBC: phase 2 results from ELEVATE, an open-label, umbrella study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5319</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5319.jpg</image:loc><image:title>Window of opportunity trial of preoperative low dose azacitidine in high-risk early-stage breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5320</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5321</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5322</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5323</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5324</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5325</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5325.jpg</image:loc><image:title>Clinical trial in progress: BCC022 a phase II trial of tipifarnib and naxitamab for relapsed/refractory neuroblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5326</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5326.jpg</image:loc><image:title>FORTE: A phase 2 master protocol assessing plixorafenib for BRAF-altered cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5327</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5328</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5329</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5329.jpg</image:loc><image:title>PROFFi: A phase II randomized controlled study of fisetin and exercise in postmenopausal breast cancer survivors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5330</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5331</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5331.jpg</image:loc><image:title>A phase 2 multicohort study to evaluate lorigerlimab (PD-1 x CTLA-4) in participants with advanced solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5332</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5333</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5333.jpg</image:loc><image:title>A phase II trial of ivonescimab for previously treated thymic carcinoma UCLA L-11</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5334</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5334.jpg</image:loc><image:title>Immune checkpoint inhibitors plus personal dendritic cell vaccines in patients with metastatic melanoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5335</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5336</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5337</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5337.jpg</image:loc><image:title>Design and rationale of DOMISOL, a first-in-human Phase I/II study of DT-7012 (NCT06819735) in advanced solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5338</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5338.jpg</image:loc><image:title>Toward personalized atezolizumab dosing by therapeutic drug monitoring</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5339</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5340</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5340.jpg</image:loc><image:title>First-in-human study of oral PARG inhibitor SYN608 in advanced solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5341</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5341.jpg</image:loc><image:title>Phase Ib study of POLQ inhibitor SYN818 combined with olaparib in advanced solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5342</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5343</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5344</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5344.jpg</image:loc><image:title>CAN016, a HER2-targeted dual-payload ADC, phase 1 clinical development</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5345</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5345.jpg</image:loc><image:title>Pilot study of pidnarulex pharmacodynamics in patients with advanced solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5346</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5346.jpg</image:loc><image:title>Phase I study of TROP2 CAR engineered IL-15-transduced cord blood-derived NK cells in advanced solid tumors (TROPIKANA)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5347</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5348</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5349</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5349.jpg</image:loc><image:title>Enhancing dual-payload ADC discovery projects by overcoming heterogeneity and resistance through dual-payload innovation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5350</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5351</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5352</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5352.jpg</image:loc><image:title>Rational design of a bispecific ADC targeting ITGB4 and TROP2 for co-expressing solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5353</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5353.jpg</image:loc><image:title>Preclinical evaluation of LM-338: An innovative anti-STn antibody drug conjugate for solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5354</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5355</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5355.jpg</image:loc><image:title>A first-in-class photo-responsive EGFR-ADC drives ROS-mediated, energy-dependent tumor eradication in preclinical models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5356</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5357</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5357.jpg</image:loc><image:title>ZW439, a novel CLDN18.2-targeting pan-RAS inhibitor antibody drug conjugate for the treatment of RAS mutated pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5358</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5359</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5359.jpg</image:loc><image:title>BCG040, a novel B7-H4-targeting biparatopic ADC, demonstrates superior preclinical efficacy in heterogeneous tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5360</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5361</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5362</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5362.jpg</image:loc><image:title>NW006-296, a novel ROR1 targeting ADC, demonstrates compelling anti-tumor efficacy in preclinical studies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5363</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5364</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5364.jpg</image:loc><image:title>Preclinical efficacy and safety of KIVU-305, a novel CEACAM5-targeting antibody-drug conjugate (ADC) for colorectal cancer (CRC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5365</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5365.jpg</image:loc><image:title>KIVU-107: A clinical-stage, best-in-class PTK7 antibody-drug conjugate (ADC) with favorable PK and an improved tolerability profile</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5366</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5366.jpg</image:loc><image:title>Preclinical development of LUA006: A bispecific EGFR/B7-H3 ADC with dual payloads to address tumor heterogeneity and resistance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5367</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5368</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5369</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5369.jpg</image:loc><image:title>Preclinical characterization of LUA004, a novel 5T4-targeting ADC with improved therapeutic window</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5370</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5370.jpg</image:loc><image:title>Novel ALDC and ADC with TMEAlinker and eribulin payload demonstrate excellent safety and efficacy in preclinical evaluation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5371</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5371.jpg</image:loc><image:title>YL252: A dual-functional PD-L1/VEGF-targeting ADC integrating immunotherapy, anti-angiogenesis, and cytotoxicity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5372</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5373</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5374</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5374.jpg</image:loc><image:title>Unveiling the PanCancer potential of dual-targeting uPAR-directed ADCs across cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5375</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5375.jpg</image:loc><image:title>Development and utility of precision FISH/IF multiomic panel to elucidate T cell functionality in the tumor microenvironment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5376</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5376.jpg</image:loc><image:title>Therapeutic targeting of adhesion receptor GPR56 for the treatment of triple-negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5377</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5377.jpg</image:loc><image:title>Dual targeting GLI1 and EZH2 for treatment of invasive breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5378</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5378.jpg</image:loc><image:title>Treatment of pancreatic cancer cells with Tumor Treating Fields (TTFields) and KRAS inhibitors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5379</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5380</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5380.jpg</image:loc><image:title>Tolvaptan as a potential anticancer and immunomodulatory treatment for triple-negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5381</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5381.jpg</image:loc><image:title>QLS2401: A novel PSMA/STEAP1/CD3 tri-specific T-cell engager for the treatment of mCRPC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5382</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5382.jpg</image:loc><image:title>Tumor-selective treatment of metastatic pancreatic cancer with an engineered, probiotic living drug</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5383</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5384</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5384.jpg</image:loc><image:title>Targeting type XI collagen to facilitate elimination of cancer-associated fibroblasts?</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5385</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5386</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5387</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5388</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5388.jpg</image:loc><image:title>BCG010, a potentially best-in-class NKG2A blocker for cancer treatment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5389</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5390</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5391</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5391.jpg</image:loc><image:title>Leveraging expression of tumor microenvironment GAGs to enhance platinum-based therapy in pancreatic adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5392</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5392.jpg</image:loc><image:title>Novel platinum nanotherapeutics reprogram the tumor microenvironment to potentiate cancer immunotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5393</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5394</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5395</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5396</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5397</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5398</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5399</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5399.jpg</image:loc><image:title>SCR-M030, an innovative and potential first-in-class trispecific T cell engager targeting PSMA and STEAP1 for mCRPC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5400</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5400.jpg</image:loc><image:title>Novel T cell engager targeting CD3 and CDH17 for the treatment of solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5401</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5401.jpg</image:loc><image:title>Mitotic error-tolerant survival following WRN inhibition is overcome by sustained spindle checkpoint activation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5402</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5402.jpg</image:loc><image:title>SF3B1 inhibition suppresses prostate cancer by disrupting ATRX splicing and inducing cell cycle arrest</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5403</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5403.jpg</image:loc><image:title>Targeting KIFC1 induces anaphase catastrophe in small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5404</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5404.jpg</image:loc><image:title>Synthetic lethal targeting of TRIP13 and Aurora A induces mitotic DNA damage and concurrent pyroptotic-apoptotic cell death in Rb-deficient cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5405</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5405.jpg</image:loc><image:title>Flow-cytometric analysis of cell-cycle arrest and apoptosis induced by a novel benzopyran derivative (SK6) in MCF-7 breast cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5406</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5406.jpg</image:loc><image:title>Mechanisms of efficacy of endonuclease FEN1 inhibition in neuroblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5407</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5407.jpg</image:loc><image:title>Per and polyfluoroalkyl substances (PFAS) promote proliferation and migration in genetically distinct kidney cancer cell lines</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5408</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5408.jpg</image:loc><image:title>Mechanism of antiproliferative activity of tolfenamic acid</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5409</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5409.jpg</image:loc><image:title>Synergy of a CDK4/6 inhibitor and an HDAC inhibitor in pancreatic cancer overcomes autophagy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5410</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5410.jpg</image:loc><image:title>SQLE inhibitor triggers ovarian cancer apoptosis by causing ER stress</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5411</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5411.jpg</image:loc><image:title>CyTOF analysis of targeted therapy in addition to standard of care against Ewing sarcoma tumor subpopulations</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5412</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5412.jpg</image:loc><image:title>RAS(ON) multi-selective inhibitors stimulate the hydrolysis of RAS-GTP to RAS-GDP and drive synergistic combination benefit with KRAS(OFF) inhibitors in G12 mutant tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5413</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5413.jpg</image:loc><image:title>EZH2 inhibition upregulates GD2 to enhance anti-GD2 immunotherapy in Ewing sarcoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5414</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5414.jpg</image:loc><image:title>Exploiting MYC Oncogenic Stress for Therapeutic Benefit in Lymphoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5415</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5415.jpg</image:loc><image:title>Tegavivint directly targets TBL1 to inhibit b-catenin nuclear oncogenic activity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5416</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5417</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5418</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5418.jpg</image:loc><image:title>Preclinical studies reveal that protease-mediated payload release and immuno-oncology/immunomodulatory effects contribute to the antitumor activity of HLX43</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5419</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5419.jpg</image:loc><image:title>Identifying androgen deprivation-induced responses in prostate cancer with single cell multiomic analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5420</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5420.jpg</image:loc><image:title>Modeling the influence of Tumor Treating Fields (TTFields) treatment usage time and break patterns on therapeutic outcomes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5421</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5421.jpg</image:loc><image:title>Mechanism of action of GEM144, a POLA1-HDAC11 dual inhibitor, in colorectal cancer models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5422</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5422.jpg</image:loc><image:title>Dual targeting of PDPK1 and mutated BRAFV600E is synthetically lethal</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5423</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5424</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5424.jpg</image:loc><image:title>Targeting cholangiocarcinoma with ferroptosis-inducing siRNA-based nanotherapeutics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5425</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5425.jpg</image:loc><image:title>Levistolide A inhibits bladder cancer progression by suppressing GPX4 expression and activating ferroptosis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5426</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5426.jpg</image:loc><image:title>Tambiciclib (SLS009), a CDK9 inhibitor, promotes apoptosis and suppresses MCL-1 levels in AML cell lines</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5427</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5427.jpg</image:loc><image:title>Ferroptosis necessitates caspase 5 dependent GSDME cleavage in ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5428</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5428.jpg</image:loc><image:title>USP7 and ITCH/UBE4B ubiquitin ligase regulate the switch between apoptosis and necroptosis via Ku70 and c-FLIPL polyubiquitination in neuroblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5429</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5429.jpg</image:loc><image:title>Investigating the role of TRPM4 in the cancer cell death induced by ErSO and derivatives</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5430</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5430.jpg</image:loc><image:title>Oxidative stress-mediated non-apoptotic, non-autophagic cell death: A mechanistically distinct strategy to overcome resistance in colorectal cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5431</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5431.jpg</image:loc><image:title>Mitotic entry with DSB induces pyroptosis through 53BP1-mediated NLRP3 inflammasome activation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5432</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5432.jpg</image:loc><image:title>PRMT5 inhibition enhances therapeutic vulnerability to Bcl-xL/Bcl-2 inhibitors in glioblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5433</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5433.jpg</image:loc><image:title>Ferroptosis induction synergizes with KRAS inhibitors in KRAS -mutant lung adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5434</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5434.jpg</image:loc><image:title>CD47 blockade induces necroptosis and complements the effects of BCL-2 inhibition in hematologic malignancies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5435</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5435.jpg</image:loc><image:title>MUC1-C-directed exatecan ADC induces genotoxic stress and transcriptional suppression of UPR-inflammatory pathways in metastatic colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5436</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5436.jpg</image:loc><image:title>Bites that kill: Understanding cancer cell fate after macrophage mediated trogocytosis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5437</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5437.jpg</image:loc><image:title>GPX4-FTH1-ARNT signaling regulates iron efflux to suppress ferroptotic cell death and promote immune remodeling in osteosarcoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5438</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5438.jpg</image:loc><image:title>Cuproptosis induction in TP53-mutated acute myeloid leukemia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5439</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5439.jpg</image:loc><image:title>LIFR inhibition with EC359 triggers ferroptosis to overcome chemoresistance in endometrial cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5440</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5441</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5441.jpg</image:loc><image:title>Mechanism of mitochondria-independent cuproptosis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5442</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5442.jpg</image:loc><image:title>Elucidating and overcoming therapeutic resistance in esophageal adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5443</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5443.jpg</image:loc><image:title>Virtual screening identification of FDA approved drugs blocking the therapeutic action of tumor-specific amplitude-modulated radiofrequency electromagnetic fields</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5444</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5445</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5446</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5446.jpg</image:loc><image:title>Histone-modifying enzymes in androgen-deprived prostate cancer: EZH1 as a synergistic therapeutic target</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5447</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5448</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5448.jpg</image:loc><image:title>Identifying the regions responsible for isoaspartylation and aggregation of SCLC antigen ELAVL4</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5449</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5449.jpg</image:loc><image:title>Cbx5 as a potential target to enhance immunotherapy in small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5450</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5450.jpg</image:loc><image:title>Contrasting roles of MSH2 and MLH1 in basal-like breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5451</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5451.jpg</image:loc><image:title>High TROP2 expression is frequent and linked to nodal metastasis in head and neck cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5452</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5452.jpg</image:loc><image:title>Aldehyde dehydrogenase inhibition as a strategy to overcome drug-refractory multiple myeloma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5453</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5453.jpg</image:loc><image:title>Protein regulator of cytokinesis 1 (PRC1) promotes Wilms tumor progression by orchestrating tumor-stromal crosstalk</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5454</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5454.jpg</image:loc><image:title>TMEM165-CLOCK fusion protein drives metastasis through enhanced lysosomal exocytosis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5455</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5455.jpg</image:loc><image:title>HMGB1 overexpression is a strong and independent prognostic feature in ERG negative prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5456</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5456.jpg</image:loc><image:title>Targeting Rac1 as a therapeutic vulnerability in T-cell lymphomas</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5457</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5457.jpg</image:loc><image:title>Targeting canine bladder cancer with Nimbolide, a Neem ( Azadirachta indica ) limonoid</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5458</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5458.jpg</image:loc><image:title>MTAP deficiency is common in head and neck tumors but dependent on the site of tumor origin</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5459</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5460</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5460.jpg</image:loc><image:title>Discovery of tumor-specific antigens in melanoma tissue biopsies via integrated proteogenomic analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5461</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5461.jpg</image:loc><image:title>CDX1 binding to the PVT1 exon 9-associated promoter drives oncogenic PVT1 exon 9 overexpression in aggressive prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5462</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5462.jpg</image:loc><image:title>ID4 maintains undifferentiated and immune-evasive states in aggressive triple-negative breast cancer and represents a novel druggable vulnerability</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5463</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5463.jpg</image:loc><image:title>Identification and functional analysis of chloride intracellular channel protein 1-binding peptide and its uses for ProTac-based cancer therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5464</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5464.jpg</image:loc><image:title>Decoding ELAVL4 isoaspartylation in SCLC using engineered PCMT1: A strategy for uncovering immune triggers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5465</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5465.jpg</image:loc><image:title>Targeting exportin 1 reduces cutaneous squamous cell carcinoma growth alone and in combination with 5-fluorouracil</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5466</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5467</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5467.jpg</image:loc><image:title>BMAL2 maintains DNA integrity via regulating homologous recombination to promote ovarian clear cell carcinoma tumorigenesis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5468</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5468.jpg</image:loc><image:title>Developing agents to target IL-8 signaling and intercept progression to esophageal adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5469</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5469.jpg</image:loc><image:title>Beyond bulk: Resolving RNASeq/mass spectrometry/IHC discrepancies with multiplexed spatial profiling and 3D cluster analysis to refine HER3 (bs)Ab and (bs)ADC therapeutic strategies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5470</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5470.jpg</image:loc><image:title>Defining sodium channel isoforms in oral squamous cell carcinoma in vitro</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5471</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5472</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5473</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5473.jpg</image:loc><image:title>Preclinical evaluation of [ 212 Pb]Pb-AG1002, a next generation SSTR2-targeting, non-agonist radiopharmaceutical</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5474</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5475</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5475.jpg</image:loc><image:title>Mass dose effects of the immunotheranostic [ 89 Zr]Zr-LNTH-2403 by PET/CT and dosimetry in non-human primates</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5476</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5476.jpg</image:loc><image:title>Towards treating prostate cancer with 188 ReO 4 - using an engineered human sodium/iodide symporter (NIS) protein</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5477</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5477.jpg</image:loc><image:title>pH-targeted gadolinium-based nanoparticles for enhanced radiotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5478</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5478.jpg</image:loc><image:title>A novel NTSR1-targeting diagnostic radioligand SKL35502 for noninvasive solid tumor imaging</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5479</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5480</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5480.jpg</image:loc><image:title>De novo protein design of calreticulin binders for theranostic applications</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5481</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5482</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5483</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5484</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5485</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5486</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5486.jpg</image:loc><image:title>Discovery of FL-261 as a theranostic RDC vector for the treatment of c-MET overexpression cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5487</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5487.jpg</image:loc><image:title>RT01: A novel anti-TF, radionuclide drug conjugate (RDC) for theranostic precision oncology</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5488</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5489</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5489.jpg</image:loc><image:title>Discovery of potent CDK8/CDK19 PROTAC degraders with superior anti-leukemia efficacy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5490</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5490.jpg</image:loc><image:title>When CDK meets CIP: Linking target engagement to functional outcomes in CDK2 molecular glue and CDK&amp;#8209;TCIP</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5491</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5491.jpg</image:loc><image:title>Discovery of an orally bioavailable AKT degrader with sustained in vivo efficacy and translational potential</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5492</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5492.jpg</image:loc><image:title>Functional role of PLK1 in colorectal cancer progression and its potential to chemoresistance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5493</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5493.jpg</image:loc><image:title>RCZY-690: A tri-complex molecular glue pan-RAS (ON) inhibitor exhibiting best-in-class potential for RAS-addicted solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5494</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5494.jpg</image:loc><image:title>RCZY-869: A highly potent, selective, and orally bioavailable covalent KRAS G12D (ON-state) inhibitor with robust antitumor activity in preclinical models of KRAS G12D -driven solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5495</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5495.jpg</image:loc><image:title>Discovery of ATH-007, a novel, potent and highly selective CCNE1 molecule glue shows robust anti-tumor activities and better safety profile</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5496</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5496.jpg</image:loc><image:title>CXB-7138, A novel GSPT1/ZFP91 dual molecular glue degrader, for targeted treatment of pancreatic ductal adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5497</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5497.jpg</image:loc><image:title>Machine learning and structure-guided discovery of EP300-selective, orally bioavailable degraders for cancer therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5498</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5498.jpg</image:loc><image:title>HY809382, a PRC2 degrader with best-in-class properties, demonstrates efficacy across multiple tumors and overcomes EZH2 inhibitor clinical resistance caused by EZH2 genetic mutations</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5499</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5499.jpg</image:loc><image:title>Discovery of FX-111, a first-in-class heterobifunctional degrader of transcriptionally active androgen receptor (AR ON ), to treat patients with AR-driven prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5500</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5500.jpg</image:loc><image:title>RBM39 degrader anticancer activity against neuroblastoma: CDKN2A/B deletion as a biomarker</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5501</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5501.jpg</image:loc><image:title>Novel non-CRBN based molecular glue identification and corresponding E3 ligase target deconvolution through multi-omics analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5502</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5502.jpg</image:loc><image:title>TRI-611, a development stage molecular glue degrader of ALK, promotes the degradation of TKI-resistant ALK fusion proteins and leads to regression of ALK TKI-refractory tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5503</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5503.jpg</image:loc><image:title>Rational discovery of novel molecular glues</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5504</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5504.jpg</image:loc><image:title>Discovery of a selective molecular glue degrader of CCNE1 for the treatment of CCNE1-amplified solid tumors and CDK4/6i-resistant HR+/HER2- breast cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5505</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5505.jpg</image:loc><image:title>Next-generation PRMT5 activity modulation through directed degradation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5506</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5506.jpg</image:loc><image:title>Preclinical characterization of NEO-811, a novel molecular glue degrader of ARNT for the treatment of clear cell renal cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5507</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5507.jpg</image:loc><image:title>Identification of first in class selective ARID1B degraders</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5508</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5508.jpg</image:loc><image:title>First-in-class potent and selective oral KAT6A degrader development candidate, PRT13722, drives complete tumor regressions as a monotherapy with an improved pre-clinical hematological safety profile</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5509</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5509.jpg</image:loc><image:title>Leveraging E2 ligases for induced proximity and modulation of novel cancer-relevant targets and neosubstrates</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5510</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5510.jpg</image:loc><image:title>The discovery of BLU-020: A potent and selective degrader of CDK2 for the treatment of CCNE1 aberrant cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5511</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5511.jpg</image:loc><image:title>Rpn13Pru targeting small molecules induce mitotic arrest in breast cancer.</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5512</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5512.jpg</image:loc><image:title>PK/PD and preclinical ADME characterization of TB-008, a first-in-class CDK9 degrader in xenograft models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5513</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5513.jpg</image:loc><image:title>Targeted protein degradation of cell surface proteins through peptide-induced clearance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5514</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5514.jpg</image:loc><image:title>Lumit-based profiling of degrader dynamics reveals signaling-dependent, cell context-specific sensitivity to degraders</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5515</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5515.jpg</image:loc><image:title>Discovery of pan-KRAS molecular glue degraders via protein-first coevolution-guided E3 ligase recruitment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5516</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5516.jpg</image:loc><image:title>NRX-0305 is an orally bioavailable, pan-mutant BRAF degrader that exhibits single-agent and combination efficacy with MEKi or anti-EGFR across Class 1/2/3 BRAF-mutant cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5517</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5517.jpg</image:loc><image:title>Long acting injectable of pan-RAF-MEK molecular-glue: Metronomic exposure for the treatment of pancreatic ductal adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5518</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5518.jpg</image:loc><image:title>Discovery of a paralog selective p300 protein degrader with potent anti-cancer activity in hematological malignancies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5519</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5519.jpg</image:loc><image:title>Discovery of a novel orally available microtubule-destabilization agent that targets the colchicine binding site and exhibits antitumor activity in KRAS -mutant models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5520</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5520.jpg</image:loc><image:title>Robust anti-tumor activity of the novel KIF18A inhibitor, ATX-295, in preclinical models of chromosomally instable tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5521</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5521.jpg</image:loc><image:title>Discovery of AZD4956, a potent and selective inhibitor of DNA polymerase theta, a clinical candidate for treatment of HRR-deficient tumors in combination with saruparib</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5522</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5523</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5523.jpg</image:loc><image:title>GenSci145: A mutant selective PI3Kalpha inhibitor overcoming brain metastasis treatment barriers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5524</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5524.jpg</image:loc><image:title>PM534, a novel tubulin inhibitor, has antitumor activity in patient-derived xenograft models of soft tissue sarcoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5525</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5525.jpg</image:loc><image:title>DNA damage, apoptosis and cell cycle disruption: Antitumor effects of a novel tin(IV) complexes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5526</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5526.jpg</image:loc><image:title>Solid tumor cell-intrinsic function of PI3Kdelta</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5527</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5527.jpg</image:loc><image:title>(E,E)-bisantrene silences c-MYC expression by stabilizing its promotor region G-quadruplex</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5528</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5528.jpg</image:loc><image:title>Bi-functional thiopurine-based oligonucleotides for AML cell-targeted telomere damage and immunostimulation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5529</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5529.jpg</image:loc><image:title>Clinical-stage anticancer agent BOLD-100 demonstrates protective effects against chemotherapy-induced peripheral neuropathy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5530</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5530.jpg</image:loc><image:title>PM54 suppresses WNT/beta-catenin signaling and synergizes with chemotherapy in gastric cancer models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5531</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5531.jpg</image:loc><image:title>MTORC1/2 inhibition enhances STX-478, a PIK3CA H1047R mutant inhibitor, in PIK3CA H1047R mutant colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5532</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5532.jpg</image:loc><image:title>Preclinical evaluation of BH4601, a novel tetravalent PD-L1 and B7H3 bispecific antibody-drug conjugate (ADC) with Topo1 inhibitor for the treatment of solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5533</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5533.jpg</image:loc><image:title>Exatecan payload-based antibody-drug conjugates with a short hydrophilic beta-glucuronidase cleavable linker</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5534</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5535</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5535.jpg</image:loc><image:title>Genome-wide CRISPR screen identifies GPX4 as a potential vulnerability in cells treated with PI3Kalpha-mutant selective inhibitor RLY-2608</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5536</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5536.jpg</image:loc><image:title>Metabolic rewiring renders KEAP1 -mutant lung cancers sensitive to AKR1C3-activated prodrugs</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5537</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5537.jpg</image:loc><image:title>FMC-242, a highly potent and selective covalent inhibitor of the PI3Kalpha -RAS interaction, demonstrates robust anti-tumor activity as monotherapy and in combination with targeted therapies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5538</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5538.jpg</image:loc><image:title>Roginolisib stabilizes inactive PI3Kdelta to deliver specific target blockade with reduced immune toxicity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5539</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5539.jpg</image:loc><image:title>Evaluating the molecular mechanism of axitinib response in head and neck squamous cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5540</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5540.jpg</image:loc><image:title>Discovery of QLS1522, a mutant-selective allosteric PI3Kalpha inhibitor for the treatment of PIK3CA-mutant solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5541</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5541.jpg</image:loc><image:title>Network&amp;#8209;level kinase activity associate with differential drug sensitivity in B-Cell lymphoma cell lines</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5542</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5542.jpg</image:loc><image:title>Combining SUMO inhibition and irinotecan increases pancreatic cancer cytotoxicity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5543</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5543.jpg</image:loc><image:title>Repurposing veratridine, a previously used antihypertensive supplement, for effective treatment of metastatic colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5544</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5544.jpg</image:loc><image:title>A potent TOP2 poison with robust preclinical efficacy and a favorable therapeutic window supporting clinical evaluation in pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5545</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5546</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5547</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5547.jpg</image:loc><image:title>Enhanced antitumor activity of zipalertinib and amivantamab combination in EGFR mutant NSCLC models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5548</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5548.jpg</image:loc><image:title>Taletrectinib, a next generation selective ROS1 inhibitor, demonstrates a differentiated profile in ROS1 fusion models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5549</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5549.jpg</image:loc><image:title>Developing COUPLrs, dual-warhead cysteine-reactive compounds, to target oncoproteins through interaction modulation and degradation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5550</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5550.jpg</image:loc><image:title>Preclinical combination approaches with the pan-KRAS inhibitor AMG 410 in KRAS- mutant cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5551</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5551.jpg</image:loc><image:title>IN10028, a next-generation FAK inhibitor discovered for the treatment of solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5552</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5553</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5554</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5554.jpg</image:loc><image:title>Momelotinib: Unique polypharmacology and novel combination strategies for myelofibrosis and beyond</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5555</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5556</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5556.jpg</image:loc><image:title>CLK inhibitor BH-30236 synergizes with venetoclax in anti-leukemia activity via splicing modulation in preclinical AML and CLL models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5557</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5557.jpg</image:loc><image:title>OB-001 boost the brain penetration of multiple TKIs</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5558</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5559</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5560</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5561</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5561.jpg</image:loc><image:title>Tumor Treating Fields remain effective in therapy-resistant glioblastoma with kinome shifts revealing novel therapeutic opportunities</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5562</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5562.jpg</image:loc><image:title>Spleen tyrosine kinase as a novel target in medulloblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5563</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5563.jpg</image:loc><image:title>A comprehensive approach to targeting PI3K and Hippo pathways in sarcomas</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5564</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5564.jpg</image:loc><image:title>Fragment-recombination design of a dual VEGFR2/TIE2 inhibitor with sarcoma-selective cytotoxicity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5565</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5566</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5566.jpg</image:loc><image:title>FAK inhibitor APG-2449 triggers immunogenic ferroptosis in gastric cancer via the AKT-FOXO1-ACSL4 axis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5567</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5567.jpg</image:loc><image:title>Targeting multivalent receptor tyrosine kinases to enhance the efficacy of anti-PD-1 immunotherapy in gastric cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5568</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5569</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5569.jpg</image:loc><image:title>In vitro profiling of IDRX-42 and NB003 against secondary and tertiary (AP/AL) mutations found in TKI-resistant GIST</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5570</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5571</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5571.jpg</image:loc><image:title>Quantitative phospho-proteomics uncovers CX-4945 effects on translational control and differentiation in neuroblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5572</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5572.jpg</image:loc><image:title>Preclinical evaluation of EO1001 in EGFR-ECD mutant solid tumor models: Toward biomarker-directed therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5573</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5573.jpg</image:loc><image:title>Mechano-dynamic-principle-driven rational design of next-generation TCRs with high specificity and sensitivity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5574</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5574.jpg</image:loc><image:title>Characterization of cancer-reactive T cells and neoantigen-specific T cell receptors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5575</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5575.jpg</image:loc><image:title>Adoptive T cell transfer suppresses endogenous tumor-specific CD8&amp;#8314; T cell recovery following lymphodepletion</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5576</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5576.jpg</image:loc><image:title>Antigen-specific T cells engineered with nanoparticle photothermal therapy demonstrate antitumor efficacy in an immunocompetent murine model of ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5577</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5577.jpg</image:loc><image:title>RenTCR-derived MAGEA1-specific TCRs demonstrated superior peptide sensitivity and potent antitumor activity in vitro and in vivo</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5578</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5578.jpg</image:loc><image:title>RenTCR-derived natural MAGE-A4-specific TCRs outperformed affinity-enhanced TCRs in antitumor efficacy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5579</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5579.jpg</image:loc><image:title>ALK-specific TCR-T cells showed potent and specific activity in ALK-positive anaplastic large cell lymphoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5580</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5580.jpg</image:loc><image:title>Tumor necrosis factor-alpha armed TCR-T and CAR-T cells for solid tumors provide superior anticancer activity in the absence of toxicity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5581</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5581.jpg</image:loc><image:title>Humanized antibody Fab-TCR T cells targeting GPC2 effectively regress neuroblastoma via enhanced TCR signaling and sustained cytotoxicity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5582</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5582.jpg</image:loc><image:title>KRASG12V- and CTAG1B-targeted TCR-T cells from phage TCR library suppress colorectal and esophageal tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5583</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5583.jpg</image:loc><image:title>First-in-class anaplastic lymphoma kinase (ALK)-specific TCR-T cells induce potent and selective antitumor immunity across ALK-driven human cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5584</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5584.jpg</image:loc><image:title>Development of T cell receptor (TCR) based cellular therapy for fibrolamellar HCC uncovers role of TCR in CD4 T cell differentiation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5585</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5586</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5586.jpg</image:loc><image:title>Development of allogeneic TCR-mimic activating gdT (TAG-T) cells targeting KRAS G12D /HLA-A*11 pMHC for undruggable KRAS-mutated cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5587</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5587.jpg</image:loc><image:title>Novel mechanism for eliminating tumor collagens to boost efficacy by attIL12-TIL therapy in PDX sarcoma models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5588</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5589</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5589.jpg</image:loc><image:title>Epigenetic reprogramming of T cell exhaustion</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5590</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5590.jpg</image:loc><image:title>Combination epigenetic therapy unmasks non-canonical neoantigens to improve adoptive T cell therapy in ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5591</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5591.jpg</image:loc><image:title>Intermittent cyclophosphamide and vinorelbine combined with anti-PD-1 induce transferable T-cell-mediated antitumor immunity and long-term memory in TNBC mouse models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5592</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5592.jpg</image:loc><image:title>Trispecific TCE with second signal boosts solid tumor response efficacy, durability and safety</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5593</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5593.jpg</image:loc><image:title>TCX-101, a trispecific T-cell engager (TcE) co-targeting a tumor-associated carbohydrate (TACA) antigen and a tumor-associated protein antigen (TAA) for the treatment of solid tumors with enhanced preclinical activity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5594</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5594.jpg</image:loc><image:title>ARK102, a novel tri-specific T cell engager targeting TROP2, HER2, and CD3 for treatment of solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5595</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5595.jpg</image:loc><image:title>A next-generation CD8-selective tri-specific T cell engager targeting CDH17 with enhanced efficacy and reduced toxicity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5596</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5596.jpg</image:loc><image:title>VTS208: A first-in-class CD3/CLDN18.2/CDH17 Tri-specific T cell engager (TCE) for the treatment of gastrointestinal (GI) cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5597</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5597.jpg</image:loc><image:title>A next-generation tri-specific T cell engager targeting CDH17 with 4-1BB co-stimulation for the treatment of gastrointestinal cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5598</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5598.jpg</image:loc><image:title>A biparatopic DLL3-targeting trispecific T-cell engager delivered by mRNA-LNP drives potent anti-tumor activity in vitro and in vivo</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5599</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5599.jpg</image:loc><image:title>BCG024: A novel DLL3&amp;#215;CD3&amp;#215;4-1BB trispecific T cell engager enhances T cell persistence and functionality in preclinical models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5600</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5600.jpg</image:loc><image:title>Development of a novel anti-CD19 x BCMA dual targeted T cell engager for the treatment of autoimmune diseases and B cell malignancies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5601</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5601.jpg</image:loc><image:title>QL535: A novel CD2-costimulating PSMA-targeted T-cell engager with dose-responsive efficacy in PDX models and a favorable GLP toxicology profile in NHP</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5602</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5602.jpg</image:loc><image:title>A CD19/BCMA dual-targeting VHH format T-cell engager with novel CD3 binder for enhanced potency and safety profile</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5603</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5603.jpg</image:loc><image:title>Pharmacological integration of CD3 and CD2 signaling triggers formation of a CD2 corolla that boosts T cell activation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5604</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5604.jpg</image:loc><image:title>Development of EDP001, a tetravalent T Cell engager targeting CD19 and BCMA for B Cell lymphoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5605</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5605.jpg</image:loc><image:title>Plinabulin boosts antitumor efficacy of topoisomerase inhibitor-based antibody-drug conjugates without or with immune checkpoint inhibitor</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5606</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5606.jpg</image:loc><image:title>Exploiting electron transport chain dynamics to sensitize OXPHOS-dependent cancers to immunotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5607</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5607.jpg</image:loc><image:title>ATG-125, a novel B7H3 &amp;#215; PD-L1 bispecific antibody-drug conjugate, demonstrates potent antitumor efficacy by dual targeting of immune evasion and direct tumor killing</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5608</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5608.jpg</image:loc><image:title>LBL-061: A novel EGFR&amp;#215;PD-L1 targeted drug conjugate for the treatment of multiple solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5609</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5609.jpg</image:loc><image:title>Novel ATR inhibitor payloads for antibody-drug conjugates targeting PD-L1</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5610</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5610.jpg</image:loc><image:title>Targeting B7-H3 in the small cell lung carcinoma (SCLC) tumor-immune microenvironment (TIME)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5611</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5611.jpg</image:loc><image:title>TAK-188, an antibody-drug conjugate with a novel amanitin payload, disrupts immune suppression and leads to potent anti-tumor immunity through selective depletion of CCR8 + intratumoral regulatory T-cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5612</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5612.jpg</image:loc><image:title>Advanced dual payload antibody-drug conjugates for targeted chemoimmunotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5613</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5613.jpg</image:loc><image:title>Preclinical characterization of LY4336619, a novel ALPPL2xCD3 bispecific antibody, for the treatment of ovarian and endometrial cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5614</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5614.jpg</image:loc><image:title>Preclinical validation of the antitumor activity and safety of M0324, a novel MUC-1 conditional CD40 agonist, and its combination with immune checkpoint inhibitors (ICIs), for selective immune activation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5615</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5615.jpg</image:loc><image:title>Bispecific antibodies targeting EGFR and HER2 for effective killing of solid tumor cells via a safe CD47-SIRPA modulation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5616</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5616.jpg</image:loc><image:title>VISTA&amp;#215;MSLN bispecific antibody-directed therapies as a biomarker-guided strategy for epithelioid malignant pleural mesothelioma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5617</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5617.jpg</image:loc><image:title>INCA036873, a first-in-class CD70&amp;#215;CD3 T cell-redirecting bispecific antibody, for the treatment of CD70-positive malignancies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5618</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5618.jpg</image:loc><image:title>GPRC5D multispecific antibodies: Engineering for affinity, cross-species reactivity, and bi/trispecific engagement in multiple myeloma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5619</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5619.jpg</image:loc><image:title>Preclinical immunotoxicity assessment of bispecific antibodies using an ex vivo circulating human whole blood assay</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5620</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5620.jpg</image:loc><image:title>A half-life extended PD-1&amp;#215;VEGFA bispecific antibody demonstrates potent anti-tumor activity in preclinical models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5621</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5621.jpg</image:loc><image:title>Pan-alphabeta-T-cell reactive anti-TCR VHH bispecifics demonstrate potent cytotoxicity through novel constant region targeting</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5622</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5622.jpg</image:loc><image:title>The anti-tumor activity of BB-202, a novel anti-PD-1/anti-VEGF bispecific antibody</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5623</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5623.jpg</image:loc><image:title>SCR-M015, a PD-1/VEGF bispecific antibody exhibits potent anti-tumor efficacy in preclinical studies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5624</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5624.jpg</image:loc><image:title>Characterization and functional evaluation of PF-08634404 (SSGJ-707) a tetravalent PD-1 x VEGF bispecific for the treatment of cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5625</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5625.jpg</image:loc><image:title>Novel PD-1xVEGFxIL-2 trispecific immune modulator with superior safety and greater efficacy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5626</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5626.jpg</image:loc><image:title>Mechanism-driven cell-based assays to screen &amp;#38; characterize bi-specific antibodies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5627</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5628</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5628.jpg</image:loc><image:title>Collagen-binding anti-GITR antibody reshapes immunosuppressive microenvironment and prolongs survival in recurrent glioblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5629</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5629.jpg</image:loc><image:title>Rilvegostomig elicits greater immune activation and tumor inhibition than clinically approved anti-PD-1 monotherapy in models of HNSCC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5630</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5630.jpg</image:loc><image:title>Enhancing antibody-dependent cellular cytotoxicityin mesothelioma through concurrent EGFR and MET targeting withamivantamab</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5631</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5631.jpg</image:loc><image:title>Unbiased discovery of novel macrophage-activating immunotherapies for ALK+ non-small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5632</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5632.jpg</image:loc><image:title>Non-clinical modeling the therapeutic window of HX044, a novel CTLA4xCD47 BsAb</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5633</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5633.jpg</image:loc><image:title>T cell transcriptome is altered by Talquetamab in presence of GPRC5D on MM cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5634</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5634.jpg</image:loc><image:title>MHC class II targeted immunotherapy in the treatment of pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5635</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5635.jpg</image:loc><image:title>MHC class II engager immunotherapy for the treatment of acute myeloid leukemia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5636</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5636.jpg</image:loc><image:title>Tumor-selective activation of 4-1BB receptor via bispecific antibody combinations</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5637</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5637.jpg</image:loc><image:title>Anti-human CTLA-4&amp;#215;TIGIT bispecific antibody: A novel immunotherapy specifically targeting tumor-infiltrating FOXP3+ regulatory T cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5638</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5638.jpg</image:loc><image:title>KRT6A mediates immune exclusion and anti-PD-1 resistance in head and neck squamous cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5639</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5639.jpg</image:loc><image:title>Spatial neuroimmune crosstalk driving perineural invasion in head and neck squamous cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5640</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5640.jpg</image:loc><image:title>KRAS G12D inhibition stimulates antigen presentation and potentiates mRNA-based immunotherapy in pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5641</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5641.jpg</image:loc><image:title>LILRB1 antibody targeting the LILRB1/HLA-G axis: Preclinical efficacy, pharmacokinetics, and safety supporting first-in-human trials</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5642</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5642.jpg</image:loc><image:title>Antagonism of beta-Catenin/BCL9 interaction suppresses polymorphonuclear myeloid-derived suppressor cell generation and maintenance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5643</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5643.jpg</image:loc><image:title>Long noncoding RNAs networks as novel master regulators of cytotoxic immune cell exhaustion in triple-negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5644</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5644.jpg</image:loc><image:title>Crosstalk between ceramide and prostaglandin signaling mediates resistance to immune checkpoint blockade</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5645</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5646</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5646.jpg</image:loc><image:title>Molecular evolution reveals low-prevalence driver mutations, mutational synergies, and associated immune dynamics in ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5647</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5647.jpg</image:loc><image:title>Combination therapies promote immune-mediated bystander killing of KRAS-G12C inhibitor resistant cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5648</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5648.jpg</image:loc><image:title>PRTN3 suppresses cytotoxic immune-cell activation and antitumoral immunity through proteolytic cleavage of CXCL9 in KRAS mutant lung adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5649</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5649.jpg</image:loc><image:title>Multi-omics dissection of tumor-related leukocytosis in urothelial carcinoma identifies IL13RA2 as a key driver</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5650</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5650.jpg</image:loc><image:title>Dynamic transcriptional remodeling and functional adaptation drive malignant progression in lymphoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5651</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5651.jpg</image:loc><image:title>Conservation of driver mutations and oncogenic pathway alterations revealed through a comparative genomic analysis of human angiosarcoma and canine hemangiosarcoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5652</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5652.jpg</image:loc><image:title>Novel ASPORIN/CRABP2 axis drives cell-state plasticity from adenocarcinoma to neuroendocrine-like prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5653</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5653.jpg</image:loc><image:title>Role of KMT2C and KMT2D in modulating tumor immune microenvironment of endometrial cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5654</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5654.jpg</image:loc><image:title>Inhibition of immune evasion via targeting the dysregulated EZH2-RKIP axis in cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5655</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5655.jpg</image:loc><image:title>BRD- and EHMT-dependent immunosuppressive transcriptome in triple-mutant Astrocytoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5656</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5656.jpg</image:loc><image:title>LSD1 inhibition remodels the tumor microenvironment to enhance anti-PD1 immunotherapy in HNSCC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5657</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5657.jpg</image:loc><image:title>Regulation and expression of transposable elements in ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5658</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5659</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5660</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5661</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5661.jpg</image:loc><image:title>RASurgence: ARF6 boosts RAS oncoprotein synthesis and accelerates tumor progression.</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5662</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5663</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5663.jpg</image:loc><image:title>Metabolic stress conditions dictate MAPKAPK2-dependent efficiency of MEK1/2 inhibition in colorectal carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5664</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5664.jpg</image:loc><image:title>Eradicating metastatic cancers by targeting a major tumor vulnerability of the K-RAS pathway: Seven in absentia homolog (SIAH)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5665</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5665.jpg</image:loc><image:title>Functional characterization of the RAS processing enzyme Rce1</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5666</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5666.jpg</image:loc><image:title>Small molecule induced KRAS activation triggers ferroptosis in mutant KRAS expressing PDAC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5667</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5667.jpg</image:loc><image:title>GNAS R201C enhances peritoneal carcinomatosis in K RAS G12D -driven gastrointestinal cancer models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5668</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5669</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5669.jpg</image:loc><image:title>Dual targeting of Pyk2/FAK and MEK/ERK pathways enhances growth suppression in glioblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5670</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5670.jpg</image:loc><image:title>MEK1/2 degraders uncover kinase-independent role of MEK1/2 in CRAF stabilization and maturation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5671</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5671.jpg</image:loc><image:title>Targeting SHOC2 and GAB2 in acral melanomas driven by RAS-GTP</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5672</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5672.jpg</image:loc><image:title>UBE3A and SV2A modulate GBM progression through MAPK pathway regulation.</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5673</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5673.jpg</image:loc><image:title>p53-induced FBXL20 suppresses the PP2A regulatory subunit PR55alpha</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5674</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5674.jpg</image:loc><image:title>A hotspot phosphorylation site on SHP2 drives oncoprotein activation and drug resistance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5675</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5675.jpg</image:loc><image:title>The Rho-GEF ECT2 links Rho GTPases to MEK/ERK pathway activation in pancreatic ductal adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5676</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5676.jpg</image:loc><image:title>Mechanism of oncogenicity induced by overexpression of the PRL phosphatases</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5677</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5677.jpg</image:loc><image:title>Pterostilbene enhances dabrafenib activity in BRAF mutant melanoma through synergistic MAPK suppression and apoptotic induction</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5678</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5678.jpg</image:loc><image:title>Evaluating the effects of the Pan-KRas inhibitor RMC-6236 in KRas-mutant colorectal cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5679</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5680</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5680.jpg</image:loc><image:title>Transglutaminase 2 mediates the p53-dependent senescence-associated secretory phenotype</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5681</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5681.jpg</image:loc><image:title>Senescence-inhibitory &amp;#916;133p53alpha mitigates accelerated ageing in mice</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5682</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5682.jpg</image:loc><image:title>The lncRNA TUG1 enhances helicase-mediated R-loop resolution through RNA-protein interaction</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5683</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5683.jpg</image:loc><image:title>Modulation of cytokine-induced senescence in melanoma cells by JAK inhibitor: A possible way to improve therapeutic efficacy of immune checkpoint inhibitor</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5684</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5684.jpg</image:loc><image:title>A link between the nuclear envelope protein LEM2 and an endoplasmic reticulum stress signaling pathway provides new insight into features of tumor development</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5685</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5685.jpg</image:loc><image:title>Human DEAH-box RNA helicase 8 regulates HSF1-mediated stress response and cancer-associated pre-mRNA splicing</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5686</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5686.jpg</image:loc><image:title>Discovery of nuclear p62-PI4,5P 2 colocalization suggests a new regulatory layer in cancer proteostasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5687</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5687.jpg</image:loc><image:title>Fibroblast-driven IGF1 signaling suppresses CD44 and promotes tumor cell senescence at the invasive front of colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5688</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5688.jpg</image:loc><image:title>Defining PON2 as a metabolic immune checkpoint of iron redox balance and ferroptotic defense in lung adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5689</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5689.jpg</image:loc><image:title>Mitochondrial glutathione reductase as a redox vulnerability in KEAP1/NRF2-mutant non-small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5690</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5690.jpg</image:loc><image:title>Cellular senescence in the cancer microenvironment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5691</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5691.jpg</image:loc><image:title>Treatment-induced senescence in metastatic colorectal adenocarcinomas: implications for single-cell biology and therapeutic intervention</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5692</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5692.jpg</image:loc><image:title>TUSC2 drives NK cell maturation and aging-associated functional decline</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5693</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5693.jpg</image:loc><image:title>From metal to malignancy: How ROS and inflammatory cytokines accelerate cadmium-induced prostate carcinogenesis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5694</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5694.jpg</image:loc><image:title>Senescence-associated secretory phenotype &amp;#8203;drives PGCC&amp;#8216;s lifecycles and blastomere-like reprogramming to promote therapeutic resistance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5695</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5695.jpg</image:loc><image:title>Identification of a novel non-flavonoid senolytic agent from natural resources targeting oncogene- and DNA damage-induced senescence</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5696</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5696.jpg</image:loc><image:title>BET inhibition potentiates salvage chemotherapy response through TXNIP upregulation in osteosarcoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5697</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5697.jpg</image:loc><image:title>Reactive oxygen species (ROS)-sensitive SOX4 signaling mediates ferroptosis in esophageal adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5698</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5698.jpg</image:loc><image:title>Fatty acid exposure promotes age-related mammary tissue alterations with pro-tumorigenic potential</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5699</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5699.jpg</image:loc><image:title>Cargo profiling of extracellular vesicles from senescent glioblastoma identifies small nucleolar RNAs as candidate liquid biomarkers for therapy-induced senescence</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5700</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5700.jpg</image:loc><image:title>Proteomics at the guanylin gene locus reveals Wnt/beta-catenin regulatory factors underlying GUCY2C hormone silencing in colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5701</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5701.jpg</image:loc><image:title>LSD1 performs demethylase-independent and context-specific functions in Ewing sarcoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5702</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5702.jpg</image:loc><image:title>EGR1 Expression and Perineural Invasion in Salivary Duct Carcinoma: A comparison of SDCDN and SDCXPA</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5703</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5703.jpg</image:loc><image:title>Targeting SLC25A13 sensitizes melanoma to treatment and reduces tumor aggressiveness via metabolic rewiring</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5704</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5704.jpg</image:loc><image:title>Dynamic low-complexity domain interactions of PAX3::FOXO1 mediate endogenous pathological transcriptional hub formation in alveolar rhabdomyosarcoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5705</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5705.jpg</image:loc><image:title>Hypertrophic chromatin condensates govern oncogene control in cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5706</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5706.jpg</image:loc><image:title>A unifying mechanism for shared splicing aberrations in splicing factor mutant cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5707</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5707.jpg</image:loc><image:title>Unlocking new frontiers in mouse research by exploring the whole-transcriptome in space and time with mouse embryo stages E11 - E14</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5708</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5708.jpg</image:loc><image:title>Enabling single-cell transcriptomics from samples with degraded and low-input RNA using TempO-LINC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5709</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5710</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5710.jpg</image:loc><image:title>Effect of the evolutionary selected Andean Aymara NFKB1 polymorphisms on inflammatory and HIF-dependent gene expression in endometrial and ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5711</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5711.jpg</image:loc><image:title>Transcriptional alterations in neoplastic transformation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5712</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5712.jpg</image:loc><image:title>APOBEC4, a novel regulator of p53-dependent tumor suppression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5713</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5714</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5714.jpg</image:loc><image:title>CRISPR-Cas engineering of allogeneic regulatory T cells reveals an essential role for steroid receptor coactivator 3 (SRC-3) in maintaining FOXP3 expression and suppressive function</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5715</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5715.jpg</image:loc><image:title>The roles of METTL3 in colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5716</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5716.jpg</image:loc><image:title>METTL1-mediated m7G modification of valine tRNAs drives pancreatic ductal adenocarcinoma progression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5717</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5717.jpg</image:loc><image:title>mTORC1-eIF4A1 dependent translational regulation of oncogenic fatty acid desaturases</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5718</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5718.jpg</image:loc><image:title>Single-cell multi-omics profiling unveils the regulatory mechanisms of small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5719</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5719.jpg</image:loc><image:title>Plk1-BRN2 signaling axis drives lineage plasticity in castration-resistant prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5720</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5721</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5722</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5722.jpg</image:loc><image:title>FOXM1 as a key regulator of metastatic outgrowth in brain metastasis of breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5723</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5723.jpg</image:loc><image:title>Splicing variability and oncogenic isoforms: Transforming our understanding of HNSCC biology</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5724</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5724.jpg</image:loc><image:title>Rescuing VHLD missense mutations to prevent or treat renal cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5725</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5725.jpg</image:loc><image:title>MYC cooperatives with KDM7A to repress SIDT2 and dampens dsRNA-mediated anti-tumor immunity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5726</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5726.jpg</image:loc><image:title>Transcriptional dysregulation of pediatric B-ALL derived from Hispanic/Latino patients with and without high-risk genetic structural variants</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5727</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5727.jpg</image:loc><image:title>Integrative transcriptomic profiling reveals stromal activation patterns in gastric cancer beyond HER2 status</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5728</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5728.jpg</image:loc><image:title>Utility of long-read RNA-sequencing for isoform and fusion discovery in lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5729</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5730</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5730.jpg</image:loc><image:title>Single cell functional characterization of cancer mutations and their cellular phenotype</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5731</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5731.jpg</image:loc><image:title>Dissecting gene regulation of cellular states in glioblastoma using single-cell multi-omics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5732</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5732.jpg</image:loc><image:title>Cell type-specific mapping of endometrial cancer risk genes using single-nucleus multi-omics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5733</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5733.jpg</image:loc><image:title>Single-cell mapping of the colon epithelium reveals a pre-malignant stem cell that defines early transformation risk</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5734</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5734.jpg</image:loc><image:title>Optical pooled CRISPR screening coupling multiplexed guide RNA detection and single-cell spatial multi-omics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5735</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5735.jpg</image:loc><image:title>Single-cell full-length transcriptome of lung cells reveals genetic effects on isoform regulation beyond eQTL</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5736</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5737</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5737.jpg</image:loc><image:title>Overcoming low SEPTIN14 expression to detect EGFR-SEPTIN14 fusion in RNA sequencing</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5738</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5738.jpg</image:loc><image:title>Integrative analysis of EMT and hippo pathway activity in gastric cancer peritoneal metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5739</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5739.jpg</image:loc><image:title>Global mRNA 3&#039;UTR lengthening in small-cell neuroendocrine carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5740</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5740.jpg</image:loc><image:title>Spatial transcriptomics of colonic neoplasia presenting mucinous adenocarcinoma with genetically-engineered mouse model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5741</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5741.jpg</image:loc><image:title>Modeling of bladder cancer evolution from field effects by multi-platform spatial mapping on the whole-organ scale</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5742</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5743</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5743.jpg</image:loc><image:title>Whole-genome sequencing of lung neuroendocrine neoplasms reveals a TP53 WT / RB1 WT subtype with CCND amplification</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5744</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5745</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5745.jpg</image:loc><image:title>Accurate detection of DNA variants and ecDNA from prostate FFPE biopsies using LinkPrep</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5746</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5746.jpg</image:loc><image:title>Massively parallel installation and evaluation of cancer coding mutations</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5747</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5747.jpg</image:loc><image:title>Panorama of chromosomal instability in 1209 lung cancer genomes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5748</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5748.jpg</image:loc><image:title>High-resolution multi-omic dissection of bone marrow in TP53-mutant acute myeloid leukemia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5749</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5750</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5751</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5751.jpg</image:loc><image:title>Large-scale analysis reveals distinct molecular subtypes in real-world gastric cancer data</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5752</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5752.jpg</image:loc><image:title>Longitudinal liquid biopsy profiling in breast cancer patient: Clinical utility and guidelines</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5753</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5754</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5755</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5755.jpg</image:loc><image:title>Identification of lncRNAs associated with breast cancer prognosis from Latina America patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5756</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5756.jpg</image:loc><image:title>piRNA-5939 drives lung cancer progression via PIWIL3-mediated post-transcriptional regulation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5757</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5757.jpg</image:loc><image:title>Characterization of prostate-derived glycoRNA in the context of cancer progression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5758</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5759</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5759.jpg</image:loc><image:title>Using chimeric eCLIP to uncover ancestry-related noncoding RNAs in head and neck cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5760</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5761</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5761.jpg</image:loc><image:title>TUG1-mediated replication stress regulation as a potential vulnerability in bladder cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5762</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5762.jpg</image:loc><image:title>Long noncoding RNA, RAMS11, promotes DNA damage response in colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5763</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5763.jpg</image:loc><image:title>Comparative analysis of lncRNA detection using qPCR and ddPCR technologies in breast cancer research</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5764</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5764.jpg</image:loc><image:title>Analysis of metabolic dysfunction-associated transcripts in hepatocellular carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5765</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5765.jpg</image:loc><image:title>Splicing of 3&#039;UTR contributes to colon cancer progression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5766</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5766.jpg</image:loc><image:title>PCGEM1 overload: Triggering lethal stress responses in castration-resistant prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5767</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5768</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5768.jpg</image:loc><image:title>High prevalence of clonal hematopoiesis in biopsy-proven MASH and implications for cancer care</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5769</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5769.jpg</image:loc><image:title>Accumulation of p21+ cells and enrichment of growth arrest signature in persistent high-grade premalignant lesions</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5770</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5771</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5771.jpg</image:loc><image:title>Distinct molecular signatures in dense breast tissue as potential drivers of breast cancer development</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5772</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5772.jpg</image:loc><image:title>Using paired germline genome to predict the age of onset in pediatric cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5773</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5773.jpg</image:loc><image:title>Plasma proteomics of cancer risk in patients with chronic kidney disease</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5774</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5774.jpg</image:loc><image:title>Characterizing plasma protein LEG1 homolog, a novel potential risk factor for post-menopausal breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5775</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5776</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5777</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5777.jpg</image:loc><image:title>A proteomics-based model improves the accuracy of upper gastrointestinal cancer prediction</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5778</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5778.jpg</image:loc><image:title>Smoking and sex specific proteomic markers of lung cancer: A prospective cohort study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5779</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5779.jpg</image:loc><image:title>Pregnancy, lactation, and involution-induced remodeling and cell state changes in breast tissues of healthy women</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5780</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5780.jpg</image:loc><image:title>Translation of lung cancer biomarkers from nanoparticle-based LCMS to enzyme-linked immunosorbent assay</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5781</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5782</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5782.jpg</image:loc><image:title>Improved sensitivity in high-risk HPV genotype detection via processor-mediated PCR</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5783</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5783.jpg</image:loc><image:title>Evaluating targeted versus universal BRCA testing in Asian women with ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5784</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5785</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5786</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5787</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5788</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5789</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5789.jpg</image:loc><image:title>AmbientcfRNApreservation: standardized extraction reveals superior stability in a multi-analyte tube</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5790</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5790.jpg</image:loc><image:title>Single-reaction KRAS variant profiling via processor-mediated PCR: Enhanced SNV discrimination using the iProbe</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5791</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5791.jpg</image:loc><image:title>Clinical validation of a multi-gene blood test for kidney cancer screening and stratification</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5792</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5793</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5793.jpg</image:loc><image:title>Detection of ectopic phosphorylated PDGFRA antibodies in the serum samples of HCC patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5794</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5794.jpg</image:loc><image:title>High-fidelity detection and classification of ovarian cancer from histopathological images using Artificial Intelligence</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5795</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5795.jpg</image:loc><image:title>Performance of longitudinal cancer screening in Li-Fraumeni syndrome</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5796</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5797</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5797.jpg</image:loc><image:title>How do healthcare providers approach breast cancer diagnoses in young women? Findings from the BRAVE Study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5798</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5798.jpg</image:loc><image:title>Coronary atherosclerosis as an incidental finding within the lung cancer screening program</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5799</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5799.jpg</image:loc><image:title>Impact of biological aging due to chemotherapy on breast cancer survivorship</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5800</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5800.jpg</image:loc><image:title>Designing an integrative theoretical framework for predicting endocrine toxicity in a large prospective cohort of cancer patients treated with immune checkpoint inhibitor therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5801</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5801.jpg</image:loc><image:title>Predictors of engagement and healthcare resource utilization in chemotherapy patients using a text message response system</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5802</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5803</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5803.jpg</image:loc><image:title>Novel application of the iCCaRE consortium virtual reality assistant (ViRA) to support Black men at the point of prostate cancer diagnosis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5804</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5804.jpg</image:loc><image:title>Feasibility of a survivorship app for black prostate cancer survivors: Results from a 12-week mHealth pilot study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5805</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5805.jpg</image:loc><image:title>Perturbations in gut liver axis functions are associated with chemotherapy induced nausea and fatigue in patients with breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5806</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5806.jpg</image:loc><image:title>Reduction of infections with intravenous immunoglobulin in chronic lymphocytic leukemia: A single-center retrospective analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5807</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5808</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5809</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5810</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5811</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5811.jpg</image:loc><image:title>Determinants of Cancer Risk in Hereditary Cancer-Prone Individuals: The eGene Study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5812</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5812.jpg</image:loc><image:title>Unraveling the missing heritability of unexplained familial cancers with germline genome sequencing</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5813</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5813.jpg</image:loc><image:title>Socioeconomic and geographic disparities in germline genetic testing for Korean male breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5814</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5815</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5815.jpg</image:loc><image:title>Germinal pathogenic variants in Chilean early-onset gastric cancer patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5816</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5816.jpg</image:loc><image:title>Evidence for pathogenicity of inherited biallelic MSH3 variants causing early-onset colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5817</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5818</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5818.jpg</image:loc><image:title>A novel functional cell line model for high throughput assessment of SDHA VUS for pathogenicity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5819</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5820</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5820.jpg</image:loc><image:title>Ancestry-enriched ACKR1 germline variant and its functional impact on normal and breast cancer biology</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5821</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5822</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5823</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5823.jpg</image:loc><image:title>Next-generation sequencing utilization among U.S. Veterans with metastatic cancer in the VA Healthcare System</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5824</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5824.jpg</image:loc><image:title>Clonal hematopoiesis and incident hematologic and myeloid malignancy in ARIC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5825</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5826</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5827</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5827.jpg</image:loc><image:title>Rare germline variants in key pathways contribute to hepatocellular carcinoma risk in Hispanics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5828</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5828.jpg</image:loc><image:title>Mutational processes in esophageal and gastroesophageal junction adenocarcinomas across geographical regions</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5829</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5829.jpg</image:loc><image:title>Deciphering the promotional determinants of esophageal cancer in countries with varying incidence</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5830</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5831</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5832</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5832.jpg</image:loc><image:title>High-throughput screening for cancer-relevant chemicals in hair relaxer products sold in Kenya</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5833</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5833.jpg</image:loc><image:title>Hair products usage and breast cancer among Latinas living in Puerto Rico: The HERSAFE Study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5834</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5834.jpg</image:loc><image:title>Mapping risk: spatial analysis of 2,4-D herbicide emissions and colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5835</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5835.jpg</image:loc><image:title>Agricultural glyphosate use and early-onset colorectal cancer mortality in the United States</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5836</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5837</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5838</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5838.jpg</image:loc><image:title>Long-term air pollution and lung cancer incidence by histological subtypes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5839</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5839.jpg</image:loc><image:title>PM2.5 and black carbon levels associated with increased mortality in lung cancer patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5840</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5840.jpg</image:loc><image:title>Chemical composition of fine particulate matter and mortality of older lung cancer patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5841</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5841.jpg</image:loc><image:title>Long-term exposure to wildfire smoke PM 2.5 and survival of older lung cancer patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5842</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5842.jpg</image:loc><image:title>Wildfire smoke and cancer risk in the United States: Evidence from the PLCO Trial</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5843</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5843.jpg</image:loc><image:title>Spatial association between thyroid cancer incidence and environmental carcinogen emissions in Korea</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5844</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5844.jpg</image:loc><image:title>Pre-diagnosis green space exposure and survival in women diagnosed with ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5845</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5845.jpg</image:loc><image:title>Occupation and breast cancer risk in the Long Island Breast Cancer Study Project cohort</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5846</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5847</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5848</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5849</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5849.jpg</image:loc><image:title>Circadian disruption from time zone position and risk of colorectal cancer precursors in women</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5850</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5851</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5852</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5853</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5854</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5854.jpg</image:loc><image:title>Familial gastric conditions indicating helicobacter pylori infection and risk of childhood leukemia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5855</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5856</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5857</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5858</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5858.jpg</image:loc><image:title>How case based education elevated clinical performance in metastatic breast cancer management: A study for TROP2 directed antibody drug conjugates</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5859</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5859.jpg</image:loc><image:title>Cancer Voices: A community-engaged approach to transform cancer disparities through verbatim theater</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5860</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5860.jpg</image:loc><image:title>Cover stories: How journal front pages amplify cancer research reach</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5861</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5861.jpg</image:loc><image:title>Engaging communities in cancer research: Outcomes from the CaRE 2 health center&#039;s 2025 community scientist ambassador program</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5862</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5862.jpg</image:loc><image:title>Social media and technology preferences among colorectal cancer patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5863</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5863.jpg</image:loc><image:title>Leveraging artificial intelligence and short educational videos to expand accessible cancer education for diverse communities</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5864</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5864.jpg</image:loc><image:title>Strengthening guideline compliant care delivery in a safety net hospital through artificial intelligence (AI) enabled technology solutions</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5865</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5865.jpg</image:loc><image:title>Age-related differences in lung cancer patients&#039; and caregivers&#039; perceptions and challenges: 2025</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5866</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5866.jpg</image:loc><image:title>Unpacking clinical trial referral processes: A qualitative study of community and academic oncologists</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5867</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5867.jpg</image:loc><image:title>Building the first comprehensive research ecosystem and preclinical model platform for myoepithelial carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5868</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5869</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5869.jpg</image:loc><image:title>Surprising myself of how much more confident I got in being able to share my voice : A qualitative study exploring patient and public engagement in cancer research</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5870</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5870.jpg</image:loc><image:title>Project CoMMunity: A local learning network deployed to address multiple myeloma care gaps in two communities</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5871</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5871.jpg</image:loc><image:title>Lineberger Excellence in Advocacy Program (LEAP): Implementation and evaluation of a comprehensive patient and community engagement program at the University of North Carolina to improve patient centered research</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5872</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5873</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5873.jpg</image:loc><image:title>Patient and patient group engagement in cancer clinical trials in low- and middle-income countries</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5874</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5874.jpg</image:loc><image:title>Optimization of outreach and engagement of patients/survivors and community supporters to reduce the cancer burden</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5875</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5875.jpg</image:loc><image:title>Supportive community and patient-centered spaces for discussing health concerns throughout the cancer journey</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5876</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5876.jpg</image:loc><image:title>A qualitative evaluation of storytelling narratives designed as strategy to increase uptake of lung cancer screening for veterans</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5877</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5877.jpg</image:loc><image:title>Prostate cancer awareness and car show: An initiative to increase prostate cancer screening</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5878</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5878.jpg</image:loc><image:title>SOX2-LGR5 signaling mediates ovarian cancer cell survival in response to loss of anchorage.</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5879</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5879.jpg</image:loc><image:title>USP15 promotes ovarian cancer progression by modulating cell cycle checkpoints and DNA damage signaling</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5880</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5880.jpg</image:loc><image:title>Comprehensive analysis of NR2F2 functions during tumor initiation and progression in a genetically engineered mouse model of high-grade serous ovarian carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5881</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5881.jpg</image:loc><image:title>Characterization of eIF3h as a driver of triple negative breast cancer progression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5882</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5882.jpg</image:loc><image:title>Neuronal architect Pax6 orchestrates stemness and brain metastatic progression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5883</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5883.jpg</image:loc><image:title>STAT5 modulates STAT3 and the aggressive behaviors of triple negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5884</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5884.jpg</image:loc><image:title>Investigating the role of stress induced nuclear relocalization of SIPA1 in breast cancer metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5885</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5885.jpg</image:loc><image:title>Caveolin-1 modulates stemness and chemosensitivity in triple negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5886</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5886.jpg</image:loc><image:title>Breast cancer metastasis to the liver; a new mouse model system</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5887</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5887.jpg</image:loc><image:title>Characterization of a novel doxycycline inducible model of EZH2 overexpression in mammary glands</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5888</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5888.jpg</image:loc><image:title>In vivo CRISPR knockout screen reveals ribosome biogenesis as a driver and a potential therapeutic target for melanoma metastasis.</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5889</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5889.jpg</image:loc><image:title>Signature surface glycan architecture promotes galectin-8-mediated vascular adhesion and metastatic dissemination of human melanomas</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5890</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5890.jpg</image:loc><image:title>Identification of key pathways regulating colorectal cancer stemness and metastasis through compound screening</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5891</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5891.jpg</image:loc><image:title>MYADM drives RhoA-dependent amoeboid plasticity and chromatin remodeling to promote metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5892</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5892.jpg</image:loc><image:title>Spectrin SPTAN1 loss triggers genome instability and tumor growth in bladder cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5893</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5893.jpg</image:loc><image:title>In vivo CRISPR screening of chromatin regulators reveals p53-dependent drivers of lung metastasis in esophageal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5894</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5894.jpg</image:loc><image:title>Extrachromosomal circular DNA-mediated NOSIP amplification drives OXPHOS-dependent metastasis in hepatocellular carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5895</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5895.jpg</image:loc><image:title>STK11 loss enhances stress-adaptive programs supporting shear resilience in circulating tumor cells from KRAS-driven lung adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5896</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5896.jpg</image:loc><image:title>Cholecystokinin-B receptor epigenetic regulation and targeted therapy in hepatocellular carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5897</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5897.jpg</image:loc><image:title>Targeting intracellular Galectin-3 disrupts BRAF V600E mutated dormant cell dissemination and restores chemosensitivity in thyroid cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5898</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5898.jpg</image:loc><image:title>Activation of NF-&amp;#954;B signaling drives pro-metastatic programs in STK11-deficient lung adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5899</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5899.jpg</image:loc><image:title>Tumor exosome-initiated neutrophil IRG1/itaconate axis awakens dormant tumor cells and promotes lung metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5900</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5900.jpg</image:loc><image:title>A site-specific microenvironmental program&amp;#8239;in plantar skin confers heightened metastatic capacity to acral melanomas</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5901</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5901.jpg</image:loc><image:title>Regulation of small extracellular vesicle production by sirtuin 1 as a determinant of breast cancer metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5902</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5903</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5903.jpg</image:loc><image:title>GPR35 as a therapeutic target to halt breast cancer progression and osteolytic bone metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5904</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5904.jpg</image:loc><image:title>Oncogenic ASPP2 kappa exerts a regulatory role within the tumor microenvironment and promotes metastasis in TNBC models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5905</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5905.jpg</image:loc><image:title>Cathepsin G as a central regulator of tumor plasticity and osteolytic metastasis in breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5906</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5906.jpg</image:loc><image:title>A single-cell atlas reveals a tumor microenvironment-dominated ecosystem in breast cancer brain metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5907</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5907.jpg</image:loc><image:title>S-Nitrosylated COX-2 is a microenvironment-regulated breast cancer biomarker of mesenchymal phenotypes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5908</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5908.jpg</image:loc><image:title>Omega-6 lipid-gene module linked to colorectal cancer pre-metastatic niche</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5909</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5909.jpg</image:loc><image:title>Single-cell characterization of tumor niches driving liver metastasis in colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5910</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5910.jpg</image:loc><image:title>Senescent tumor-associated macrophages promote peritoneal metastatic niche formation in gastric cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5911</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5911.jpg</image:loc><image:title>Co-evolution of cancer cells and their microenvironment of primary and lymph node metastatic prostate cancer under androgen deprivation therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5912</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5912.jpg</image:loc><image:title>TRPV6/CXCR4 signaling complexes as therapeutic targets to prevent osteoblastic bone metastasis in castration-resistant prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5913</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5914</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5915</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5916</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5917</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5918</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5918.jpg</image:loc><image:title>Patient-derived models of primary breast cancer for preclinical evaluation of neoadjuvant therapies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5919</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5920</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5920.jpg</image:loc><image:title>The role of sex hormones and sex chromosomes in urethane-induced lung carcinogenesis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5921</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5921.jpg</image:loc><image:title>MICAL2 promotes oncogenic Kras -induced pancreatic cancer initiation by regulating acinar to ductal metaplasia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5922</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5922.jpg</image:loc><image:title>The in vivo impact of UBTF tandem duplications on hematopoiesis and leukemia development</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5923</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5924</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5924.jpg</image:loc><image:title>A model of spontaneous brain metastasis in small cell lung cancer undergoes epithelial-to-neuronal transition</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5925</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5925.jpg</image:loc><image:title>HPV+ and HPV- head and neck cancer patient-derived models in the NCI Patient-Derived Models Repository</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5926</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5926.jpg</image:loc><image:title>Mutant BRAF and AKT cooperate to induce melanoma formation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5927</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5927.jpg</image:loc><image:title>Clinical and genomic determinants of PDX engraftment across solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5928</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5928.jpg</image:loc><image:title>Characterization of the immunological responses in a mouse model expressing humanized FcgammaR/FcRn</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5929</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5930</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5930.jpg</image:loc><image:title>Lentiviral vector induced modeling of low grade glioma in the minipig spinal cord</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5931</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5931.jpg</image:loc><image:title>Preclinical models of cancer cachexia: Bridging the gap to clinical applications</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5932</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5933</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5933.jpg</image:loc><image:title>Integrating patient-derived systems to model metastatic prostate cancer and decode therapy resistance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5934</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5934.jpg</image:loc><image:title>Multi-omics analysis revealed clonal evolution of sarcoma patient-derived xenografts</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5935</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5936</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5937</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5938</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5938.jpg</image:loc><image:title>Matrix density shapes early invasion and EWSR1::FLI1 protein dynamics in Ewing sarcoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5939</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5939.jpg</image:loc><image:title>Next-generation models to advance pediatric solid cancer treatments</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5940</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5940.jpg</image:loc><image:title>Modeling the impact of chemotherapy and small molecule inhibitors on the 3D microenvironment of pediatric bone sarcomas</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5941</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5941.jpg</image:loc><image:title>Investigating the mechanism of oncogenesis of BCOR-CCNB3 fusion positive sarcomas</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5942</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5942.jpg</image:loc><image:title>Evaluating TCR mimetic CAR T cell preclinical therapeutics in an immunocompetent MYCN-driven murine neuroblastoma allograft model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5943</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5944</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5944.jpg</image:loc><image:title>Patient-derived pediatric glioblastoma models provide key insights into IDH1-driven drug resistance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5945</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5945.jpg</image:loc><image:title>The transcription factor DMRTA2 regulates radial glial maintenance and tumorigenicity of pediatric high-grade glioma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5946</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5946.jpg</image:loc><image:title>Developing zebrafish avatars for pediatric sarcomas to support functional precision oncology</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5947</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5947.jpg</image:loc><image:title>Development of a human neuroblastoma organoid model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5948</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5948.jpg</image:loc><image:title>Embryonic reprogramming of neural crest cells drives the development of Ewing sarcoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5949</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5949.jpg</image:loc><image:title>Targeted posterior fossa A ependymoma therapy using a tumor-selective nanoparticle drug delivery approach</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5950</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5950.jpg</image:loc><image:title>Establishment and analysis of spontaneous metastatic PDX models of Ewing sarcoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5951</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5951.jpg</image:loc><image:title>Differential sensitivity of paired FUS-TFCP2+ RMS PDX models developed from tumor specimens obtained prior to and after ALK inhibitor therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5952</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5952.jpg</image:loc><image:title>Gene editing in the mouse reveals functional mechanisms of ASPS-TFE3 induced translocation renal cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5953</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5953.jpg</image:loc><image:title>Development of a clinically relevant in vitro model of ETMR and implications for drug efficacy studies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5954</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5954.jpg</image:loc><image:title>Post-transcriptional silencing of p14ARF drives retinoblastoma malignant conversion in CRISPR-engineered retinal organoids</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5955</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5955.jpg</image:loc><image:title>MIAC51 cells induce rapid-onset leukemia across multiple rat strains: A novel and reproducible model of Chloroleukemia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5956</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5956.jpg</image:loc><image:title>Site-specific tumor modeling: DIPG and meningioma in mice</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5957</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5958</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5959</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5959.jpg</image:loc><image:title>Inflammatory niche remodeling by metastatic breast cancer stem cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5960</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5961</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5962</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5963</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5963.jpg</image:loc><image:title>Spatial multi-omics dissection of colorectal cancer micrometastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5964</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5965</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5966</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5966.jpg</image:loc><image:title>Immune-vascular profiles in primary tumors and paired liver metastases of colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5967</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5967.jpg</image:loc><image:title>Histologic growth pattern dictates immune cell spatial topography in liver metastases</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5968</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5968.jpg</image:loc><image:title>Hippo/YAP1 mediated interplay of tumor-stromal-immune suppressive TME through IL6/gp130/STAT3 axis in advanced gastric cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5969</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5969.jpg</image:loc><image:title>Organ-specific immune and metabolic programs shape spatial microenvironments in MSS colorectal cancer metastases</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5970</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5971</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5972</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5972.jpg</image:loc><image:title>Osteosarcoma exploits macrophage VCAM1-VLA4 signaling axis to facilitate pulmonary metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5973</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5974</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5974.jpg</image:loc><image:title>Hepatic niche driven metabolic-epigenetic reprogramming mediates metastatic colonization through liver progenitor like plasticity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5975</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5976</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5976.jpg</image:loc><image:title>Linking metabolic reprogramming to JAK-STAT signaling in triple-negative breast cancer brain metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5977</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5977.jpg</image:loc><image:title>Horizontal mitochondria transfer stimulates pro-tumorigenic astrocyte reprogramming in glioblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5978</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5978.jpg</image:loc><image:title>Immunomodulatory PIGR + RORC + dendritic cells (PRDCs) are enriched in malignant ascites</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5979</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5979.jpg</image:loc><image:title>Amyloid-beta accumulation in glioblastoma is driven by vascular remodeling and APP-processing pathways</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5980</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5980.jpg</image:loc><image:title>Macrophages support the growth of pediatric posterior fossa ependymoma type A</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5981</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5981.jpg</image:loc><image:title>Multi-omicsinpostoperative lymphatic exudate in HPV-negative head and neck cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5982</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5983</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5983.jpg</image:loc><image:title>Development of a flow cytometry panel for microglia and immune cell populations in a brain tumor model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5984</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5985</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5985.jpg</image:loc><image:title>Decoding the archetypes and ecotypes of triple-negative breast cancer in responses to chemotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5986</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5987</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5988</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5989</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5989.jpg</image:loc><image:title>Multi-omics reveals the diversity of CAF in ESCC lymph node metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5990</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5990.jpg</image:loc><image:title>Spatial remodeling of immune and stromal microenvironments in sentinel lymph nodes during melanoma progression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5991</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5991.jpg</image:loc><image:title>Spatial architecture of immunochemotherapy response in pleural mesothelioma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5992</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5993</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5993.jpg</image:loc><image:title>Neutrophil extracellular traps is involved in ovarian cancer-associated venous thrombosis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5994</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5995</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5996</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5996.jpg</image:loc><image:title>Spatially revealed malignant and microenvironment ecosystems in PanIN- and IPMN-derived PDAC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5997</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/5997.jpg</image:loc><image:title>Single-cell spatial CRISPR screen for tumor microenvironment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5998</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/5999</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6000</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6001</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6002</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6003</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6004</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6005</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6006</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6007</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6008</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6009</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6009.jpg</image:loc><image:title>Spatial immune and vascular remodeling defines recurrence in oligodendroglioma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6010</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6011</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6012</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6013</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6014</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6014.jpg</image:loc><image:title>Decoding new mechanisms of stromal-driven inflammation in breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6015</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6015.jpg</image:loc><image:title>Transgelin-positive cancer-associated fibroblasts promote pancreatic cancer progression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6016</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6016.jpg</image:loc><image:title>Iron metabolism underlies the activation of cancer associated fibroblasts</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6017</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6018</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6018.jpg</image:loc><image:title>The impact of CAF-derived ANKRD1 on the lung cancer tumor microenvironment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6019</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6020</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6020.jpg</image:loc><image:title>Gli2 increases Osteopontin expression to alter cancer associated fibroblast behavior</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6021</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6021.jpg</image:loc><image:title>The Treg-fibroblast axis shapes the immunosuppressive tumor microenvironment in colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6022</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6023</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6024</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6024.jpg</image:loc><image:title>Non-immune stromal reprogramming shapes breast cancer immunotherapy resistance: insights from mouse models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6025</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6026</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6026.jpg</image:loc><image:title>An immune-activating and tumor-suppressive subtype of cancer-associated fibroblasts identified in gastric cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6027</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6027.jpg</image:loc><image:title>Cancer associated fibroblast subtype heterogeneity in colorectal cancer influences primary tumor invasion</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6028</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6028.jpg</image:loc><image:title>Cancer cell-driven HIF-1alpha activation enhances the motility of cancer-associated fibroblasts in the lung tumor microenvironment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6029</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6030</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6030.jpg</image:loc><image:title>Fidaxomicin targets PDGFR&amp;#8314; cancer-associated fibroblast to restrain colorectal cancer progression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6031</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6031.jpg</image:loc><image:title>Targeting GABA signaling in cancer associated fibroblasts to reduce immunosuppression in pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6032</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6032.jpg</image:loc><image:title>Deactivating liver metastatic colorectal cancer-associated fibroblasts with all-trans retinoic acid</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6033</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6033.jpg</image:loc><image:title>Immunosuppressive role of DKK1 and cancer-associated fibroblasts across molecular subtypes of endometrial cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6034</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6035</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6035.jpg</image:loc><image:title>Spatial transcriptomic profiling of cancer-associated fibroblast niches in extrahepatic cholangiocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6036</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6036.jpg</image:loc><image:title>CTHRC1-TGFb crosstalk between myofibroblasts and tumors drives invasion in early-stage lung adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6037</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6037.jpg</image:loc><image:title>CAF-secreted periostin promotes tumor aggressiveness in BRAF - mutant papillary thyroid carcinoma by upregulating MMP1</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6038</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6039</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6040</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6040.jpg</image:loc><image:title>Stromal SPARC drives tumor-nerve-stroma crosstalk and perineural invasion in pancreatic ductal adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6041</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6041.jpg</image:loc><image:title>Senescent cancer-associated fibroblasts drive perineural invasion and pain in pancreatic ductal adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6042</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6042.jpg</image:loc><image:title>Microbiotas activate a tuft cell-sensory neuron feedback loop to promote esophagogastric junction (EGJ) tumorigenesis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6043</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6043.jpg</image:loc><image:title>Characterize the role of cholinergic signalling in pancreatic cancer liver metastasis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6044</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6045</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6045.jpg</image:loc><image:title>Spatial biomarker related to PNI and LVI in stage II colon cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6046</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6047</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6048</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6049</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6049.jpg</image:loc><image:title>Neighborhood analyses in nerve fiber-associated tumor regions in hereditary diffuse gastric cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6050</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6050.jpg</image:loc><image:title>Tumor nuclear uPA: A transcriptional modulator of perineural invasion in PDAC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6051</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6051.jpg</image:loc><image:title>Schwann like reprogramming of cancer associated fibroblasts remodels the tumor neural niche in pancreatic ductal adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6052</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6053</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6053.jpg</image:loc><image:title>Characterizing the competitive interactions between glioblastoma and oligodendrocyte progenitor cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6054</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6054.jpg</image:loc><image:title>Smoking behavior is associated with increased tumor-associated neurogenesis in prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6055</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6056</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6056.jpg</image:loc><image:title>RNA1-DA: A domain-adaptive RNA foundation model for forward and reverse translation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6057</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6057.jpg</image:loc><image:title>Large-scale foundation model-based PDX model selection and cancer subtype assignment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6058</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6059</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6059.jpg</image:loc><image:title>Extreme gene expression is widespread and functional in cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6060</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6061</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6061.jpg</image:loc><image:title>ISWI double-knockout signatures stratify PAX3/7-FOXO1 fusion-positive vs fusion-negative rhabdomyosarcoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6062</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6063</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6064</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6065</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6065.jpg</image:loc><image:title>A foundation model of cancer genotype enables precise predictions of therapeutic response</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6066</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6066.jpg</image:loc><image:title>Improved sensitivity for low-burden mutational signature detection in human cancers with SigProfilerCleaner</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6067</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6067.jpg</image:loc><image:title>Improved mutation detection in duplex sequencing data with sample-specific error profiles</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6068</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6069</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6069.jpg</image:loc><image:title>Clustered somatic mutations in normal tissues reveals shared and divergent mechanisms with cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6070</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6071</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6071.jpg</image:loc><image:title>AI-assisted pathology report abstraction for breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6072</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6072.jpg</image:loc><image:title>Reprogramming immunity: Personalized T cell approaches in gastric cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6073</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6073.jpg</image:loc><image:title>Peripheral blood as the sole source for cancer neoantigen and reactive T cell discovery</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6074</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6074.jpg</image:loc><image:title>Updated clinical efficacy and translational biomarker analysis of tumor infiltrating lymphocyte therapy (LM103) in metastatic melanoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6075</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6075.jpg</image:loc><image:title>Nanobody:STING agonists reprogram the tumor microenvironment and improve adoptive cell therapy for solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6076</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6076.jpg</image:loc><image:title>Targeting XPO1 reprograms immune microenvironment and confers sensitivity to immune checkpoint blockade in pancreatic ductal adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6077</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6077.jpg</image:loc><image:title>Reprogramming anti-tumor immunity through therapeutic antagonism of the mSWI SNF chromatin remodeling complex</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6078</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6078.jpg</image:loc><image:title>RELATIVITY-104 Part 2: translational analyses in the programmed death ligand 1 (PD-L1) &amp;#8805; 1% and non-squamous (NSQ) non-small cell lung cancer (NSCLC) subgroup</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6079</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6079.jpg</image:loc><image:title>Dose escalation and expansion of nivolumab plus relatlimab (NIVO + RELA) in solid tumors in RELATIVITY 020 Parts A-C</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6080</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6080.jpg</image:loc><image:title>SAAL1: A novel biomarker for predicting and therapeutic target for overcoming immunotherapy resistance in esophageal squamous cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6081</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6081.jpg</image:loc><image:title>Extracorporeal photopheresis vs. systemic immunosuppression for treatment of immune-related adverse events: Final analysis of the prospective two-arm PRIA study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6082</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6082.jpg</image:loc><image:title>Clinical value of immune checkpoints in pancreatic ductal adenocarcinomaco-overexpressing with CEACAM6</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6083</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6083.jpg</image:loc><image:title>Invigorating pre-existing tumor-infiltrating expandable (TIE) T cell clonotypes in exceptional responders with dual PARP-PD-1 blockade in homologous recombination deficient (HRD) pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6084</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6084.jpg</image:loc><image:title>GZMA+ CD8+ T cells underlie the pathological complete response of BRCA-mutated breast cancers to neoadjuvant PARPi plus anti-PD-1 therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6085</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6086</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6086.jpg</image:loc><image:title>Blockade of tumor-intrinsic TGF-beta signaling drives hyperprogression in small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6087</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6087.jpg</image:loc><image:title>Humanized PDX models uncover drug-reversible epigenetic immune exclusion governing T-cell therapy response in DLBCL, captured in patients by EPICORE stratifier</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6088</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6088.jpg</image:loc><image:title>Targeting EZH2 to overcome immunotherapy resistance in mCRPC unlocks NSD2-dependent tumor vulnerabilities</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6089</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6089.jpg</image:loc><image:title>Impact of severe liver metastases on clinical response to immunotherapy in solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6090</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6090.jpg</image:loc><image:title>Complete restoration of p53 in p53 mutant cancers through co-delivery of p53 siRNA and mRNA using a targeted LNP platform</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6091</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6092</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6092.jpg</image:loc><image:title>Her2-targeted p53 mRNA-LNP platform: A novel strategy for overcoming radioresistance in p53-deficient ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6093</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6094</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6094.jpg</image:loc><image:title>Restoring a telomere dependent Hayflick limit to treat hematological malignancies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6095</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6096</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6097</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6098</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6098.jpg</image:loc><image:title>Exploring the molecular landscape of ovarian cancer through immunohistochemistry multi-marker prevalence screening</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6099</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6100</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6100.jpg</image:loc><image:title>Establishing quantitative image analysis driven multiplex immunofluorescence panels for retrospective clinical research</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6101</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6101.jpg</image:loc><image:title>Scalable, digitally enabled FISH workflows for high-confidence HER2 and genomic biomarker assessment in precision oncology</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6102</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6103</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6104</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6105</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6105.jpg</image:loc><image:title>Rational engineering of nanobody pharmacokinetics and linker chemistry to maximize targeted radiotherapy efficacy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6106</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6106.jpg</image:loc><image:title>Engineering biologic radiopharmaceuticals with lower unspecific organs uptake</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6107</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6107.jpg</image:loc><image:title>Theranostic 89 Zr/ 225 Ac anti-CEACAM5 radioimmunotherapy for metastatic castration-resistant prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6108</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6109</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6109.jpg</image:loc><image:title>Impact of first-line (1L) amivantamab-lazertinib vs osimertinib on second-line (2L) progression-free survival (PFS)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6110</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6111</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6111.jpg</image:loc><image:title>Neoadjuvant chemotherapy induces clinically distinct spatial remodeling of the tumor microenvironment in PDAC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6112</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6112.jpg</image:loc><image:title>Epigenetic inactivation of CTHRC1 promotes immune suppressive microenvironment and cancer metastatic relapse</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6113</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6113.jpg</image:loc><image:title>Benchmarking human tumor slices from gastrointestinal malignancies for precision cancer therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6114</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6114.jpg</image:loc><image:title>Evaluation of immune-checkpoint inhibitor-induced pneumotoxicity using a patient-derived alveolar organoid and PBMC co-culture model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6115</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6115.jpg</image:loc><image:title>Integrative analyses of cervical cancer and patient-derived organoids uncover signaling and metabolic circuits associated with therapy-resistant</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6116</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6116.jpg</image:loc><image:title>Origination and refinement of blood brain barrier spheroid model for glioblastoma therapy discovery</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6117</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6117.jpg</image:loc><image:title>Patient-specific esophageal adenocarcinoma-on-a-chip: Modeling tumor-stromal-immune interactions and therapeutic response</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6118</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6118.jpg</image:loc><image:title>Organ-on-Chip: An in vitro model to study the efficacy and prediction of adjuvant therapy in lung cancer patient-derived cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6119</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6119.jpg</image:loc><image:title>A comparative analysis of paired normal, primary, and metastatic breast cancer organoids derived from core-needle biopsies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6120</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6120.jpg</image:loc><image:title>Preclinical evaluation of the nectin-4 antibody-drug conjugate MK-3120 (SKB410) in a panel of solid-tumor patient-derived xenograft models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6121</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6121.jpg</image:loc><image:title>PET imaging and response to amivantamab treatment of non-small cell lung cancer xenografts</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6122</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6122.jpg</image:loc><image:title>Chromosome 17q genes BIRC5 , CDC6 , IGF2BP1 , and TK1 are oncogenic dependencies in MYCN -amplified neuroblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6123</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6123.jpg</image:loc><image:title>A conserved enhancer locus in ecDNA and HSRs activates MYC transcription in group 3 medulloblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6124</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6124.jpg</image:loc><image:title>Neuroblastoma phenotypic switching is blocked by FHD-286, a small molecule inhibitor of the SWI/SNF ATPases SMARCA2/4</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6125</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6125.jpg</image:loc><image:title>Amplified MYCN, GLI2 and mutant TP53 medulloblastoma are vulnerable to the translation inhibitor homoharringtonine</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6126</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6126.jpg</image:loc><image:title>Subtype-specific evolutionary constraints shape the genomic architecture of adult diffuse gliomas</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6127</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6127.jpg</image:loc><image:title>Portraits of clonal landscape and mutational signature in primary tumors and matched lung metastatic model of osteosarcoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6128</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6128.jpg</image:loc><image:title>Transcriptional heterogeneity in hematopoietic stem cells prospectively predicts clonal fitness in aged microenvironments</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6129</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6129.jpg</image:loc><image:title>scDeBussy: Cohort-level pseudotime alignment reveals recurrent dynamic gene programs in histological transformation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6130</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6130.jpg</image:loc><image:title>AI-empowered virtual immunopeptidomics uncovers novel regulators of neoantigen immunogenicity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6131</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6131.jpg</image:loc><image:title>Subcellular 3D multi-omic models of CDH1-mutant diffuse gastric cancer improve recapitulation of tumor microenvironment structure and reveal precancer signature niches</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6132</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6132.jpg</image:loc><image:title>Context dependent functional aneuploidy in cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6133</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6133.jpg</image:loc><image:title>A pan-cancer atlas of telomere length in tissues and plasma cell-free DNA</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6134</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6134.jpg</image:loc><image:title>MambaSV: Accurate germline and somatic structural variant calling from long-reads with deep sequence model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6135</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6135.jpg</image:loc><image:title>Predict, perturb, and process: A systems biology pipeline for identifying synthetic lethality</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6136</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6136.jpg</image:loc><image:title>DISSECT integrates cytological images and spatial transcriptomics for cell segmentation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6137</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6137.jpg</image:loc><image:title>ELEVATE: Axis-coupled mapping of co-varying gene programs in single-cell transcriptomic data</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6138</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6138.jpg</image:loc><image:title>A bi-partition function algorithm to evaluate inferred subclonal structures in single-cell sequencing data</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6139</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6139.jpg</image:loc><image:title>Identifying robust subclonal structures through tumor progression tree alignment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6140</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6140.jpg</image:loc><image:title>Wakhan: Reconstruction of chromosome-scale copy number profiles of tumor genomes with long-read sequencing</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6141</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6142</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6142.jpg</image:loc><image:title>Remodeling of cancer cell architecture by chemotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6143</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6143.jpg</image:loc><image:title>A transcript-only framework for pseudocell boundary inference in high-resolution spatial transcriptomics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6144</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6144.jpg</image:loc><image:title>OTTER: Optimal transport-based transcriptomics and genomics representation fusion for T-ALL subtyping</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6145</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6145.jpg</image:loc><image:title>Reconstruction of Tumor Clonal Trees with Multi-Sample Bulk Sequencing Data by Integrative Combinatorial Optimization</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6146</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6146.jpg</image:loc><image:title>Test-time compute for subtype classification in pediatric T-cell acute lymphoblastic leukemia using transcriptomics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6147</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6147.jpg</image:loc><image:title>ecSegCls: Deep learning-based method for detecting extrachromosomal DNAs in both interphase and metaphase cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6148</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6148.jpg</image:loc><image:title>Large-scale patient cohorts integration via a novel Bayesian transfer learning framework identifies robust drug response signatures in AML</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6149</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6149.jpg</image:loc><image:title>Dimensionless, null-calibrated spatial indices from Xenium RNA and protein in breast IDC and lung adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6150</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6150.jpg</image:loc><image:title>Consistency-guided diffusion reconstruction enhances peri-hepatic tumor visibility in magnetic particle imaging</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6151</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6151.jpg</image:loc><image:title>Frequency-domain signal separation network improves dual-tracer detection of aneurysm regions in magnetic particle imaging</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6152</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6152.jpg</image:loc><image:title>Phasing tumor clones by timing point mutations using bulk long-read sequencing</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6153</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6154</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6154.jpg</image:loc><image:title>STCS: Spatial transcriptomics cell segmentation outperforms existing methods on multiple slides</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6155</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6155.jpg</image:loc><image:title>Investigating the role of the conserved notch pathway in glioblastoma cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6156</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6156.jpg</image:loc><image:title>Single-cell elucidation of molecularly distinct states and therapeutic vulnerabilities in IDH-mutant glioma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6157</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6157.jpg</image:loc><image:title>Targeting master regulators to reprogram neutrophils and enhance PD-1 blockade efficacy in castration-resistant prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6158</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6158.jpg</image:loc><image:title>Ensemble somatic variant calling and transcript reconstruction for high-fidelity neoantigen discovery in mRNA cancer vaccine design</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6159</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6159.jpg</image:loc><image:title>NeonDisco: A Nextflow orchestration framework for in silico discovery and prioritization of recurrent neoantigen candidates</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6160</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6160.jpg</image:loc><image:title>A scalable workflow for in silico TMA construction and groupwise comparison of spatial transcriptomic data for analyzing tumor microenvironment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6161</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6161.jpg</image:loc><image:title>Integrating computational and experimental approaches to optimize RNA fusion identification in BRCA associated breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6162</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6162.jpg</image:loc><image:title>A knowledge graph screen of innovative versus incremental lung cancer trials for need-aligned designs</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6163</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6163.jpg</image:loc><image:title>Mapping cancer-relevant genetic interactions with functional module prediction and in4mer enCas12a platform</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6164</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6164.jpg</image:loc><image:title>Uncovering the systems-level mutational landscape of intrinsically disordered regions in cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6165</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6165.jpg</image:loc><image:title>Understanding molecular mechanisms of prostate cancer via transcriptome-wide causal gene regulatory networks</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6166</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6166.jpg</image:loc><image:title>Multi-omic profiling identified three molecular clusters in urothelial carcinoma: A path towards clinical precision</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6167</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6167.jpg</image:loc><image:title>Quartet: A database of robust somatic mutations in tumor cell lines</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6168</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6168.jpg</image:loc><image:title>Real-world analytical concordance of four next-generation sequencing assays: Impact of assay methodology and bioinformatics on clinical decision-making</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6169</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6169.jpg</image:loc><image:title>Assessing the Impact of Variant Calling Pipelines on De Novo SBS Mutational Signature Extraction</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6170</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6170.jpg</image:loc><image:title>Knowledge graph driven insights and drug repurposing opportunities for neuroendocrine prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6171</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6171.jpg</image:loc><image:title>A transcriptome-based AI meta-model for immunotherapy response classification in hepatocellular carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6172</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6172.jpg</image:loc><image:title>Mapping convergent neurodegenerative and oncogenic pathways in ALS using a multi-scale knowledge-graph framework</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6173</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6173.jpg</image:loc><image:title>Chromatin networks inform the development of prognostic gene expression signatures in human cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6174</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6174.jpg</image:loc><image:title>AI-driven structural variant annotation expands therapeutic stratification in breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6175</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6175.jpg</image:loc><image:title>Integrating omics-driven digital avatars with patient-derived experimental models to accelerate precision oncology</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6176</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6176.jpg</image:loc><image:title>Optimization of a urine based NGS assay for detecting minimal residual disease in bladder cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6177</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6177.jpg</image:loc><image:title>Fast and cost-effective cloud-based pipelines to analyze cancer sequencing data</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6178</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6178.jpg</image:loc><image:title>Mechanism-concordant cell-line selection: Bridging real-world tumor drivers and in vitro models for target validation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6179</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6179.jpg</image:loc><image:title>An RNA-based survival model predicting real-world response to trastuzumab deruxtecan</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6180</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6180.jpg</image:loc><image:title>Quantum mechanics-based multi-tensor AI/ML correctly predicts - glioblastoma patients&#039; overall survival, gene targets to sensitize the tumors, and the tumors&#039; response to their targeting - from their whole genomes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6181</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6181.jpg</image:loc><image:title>State-transition model of time-series single-cell RNA-seq identifies gene-level origins of disease microstate stability in chronic myeloid leukemia (CML)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6182</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6182.jpg</image:loc><image:title>Virtual clinical trials of BMP4 differentiation therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6183</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6183.jpg</image:loc><image:title>Toward personalized rotational multi-agent therapies to overcome treatment resistance in pancreatic cancer: A virtual trial framework in mice</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6184</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6184.jpg</image:loc><image:title>Modeling the role of homeostatic T-cell reconstitution in durable response to CAR T-cell therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6185</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6185.jpg</image:loc><image:title>Multiomic state-transition framework reveals chemotherapy-induced metabolic reprogramming in acute myeloid leukemia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6186</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6187</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6187.jpg</image:loc><image:title>Scalable cell type and spatial domain modeling using spatially informed topic inference of cancer niches</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6188</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6188.jpg</image:loc><image:title>Most severe adverse events in approved combination therapies occur at rates consistent with independent action</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6189</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6189.jpg</image:loc><image:title>Structural vulnerabilities of the breast tumor-draining lymph node to radiotherapy-induced fibrosis and lymphedema risk</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6190</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6190.jpg</image:loc><image:title>Developing a data assimilation framework to forecast patient-specific tumor burden in low-grade glioma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6191</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6191.jpg</image:loc><image:title>ctDNA precedes imaging: A predictive model for real-time treatment adaptation in HPV-associated anal squamous cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6192</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6192.jpg</image:loc><image:title>A joint model for integrating serial methylation-based tumor fraction and ESR1 assessment to forecast overall survival in patients with ER+/HER2- metastatic breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6193</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6193.jpg</image:loc><image:title>Functional data analysis of spatial protein imaging data using spatial trajectories with application to ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6194</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6194.jpg</image:loc><image:title>Using cell-type-specific nucleosome patterns to improve cell-free DNA fragmentation models in lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6195</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6195.jpg</image:loc><image:title>Using physiologically-based pharmacokinetics-quantitative systems pharmacology model to optimize peptide-drug conjugates design</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6196</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6196.jpg</image:loc><image:title>HPlot: A novel quantitative framework for spatial profiling of Immune heterogeneity in tumor microenvironments</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6197</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6197.jpg</image:loc><image:title>Tumor microenvironment gene expression dynamics: Keystone cell types and non-cancer cell driver genes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6198</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6199</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6199.jpg</image:loc><image:title>Multi-cell type model for analyzing spatial single-cell protein imaging data with application to ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6200</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6200.jpg</image:loc><image:title>Measure of three cell population co-localization for spatial protein imaging data analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6201</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6202</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6202.jpg</image:loc><image:title>Ultra-low-abundance cancer biomarker discovery: Multiplexed protein profiling with attomolar sensitivity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6203</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6203.jpg</image:loc><image:title>Advanced proteomic profiling of patient-derived tumor models reveals high cross-model concordance and improved translational fidelity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6204</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6204.jpg</image:loc><image:title>Pre-diagnostic plasma proteomic signatures associated with early-onset colorectal cancer in two large prospective cohorts</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6205</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6206</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6206.jpg</image:loc><image:title>Integrative Blood Proteomics Reveals the HuBP Atlas of over 10,000 Proteins Informing Human Physiology and Disease.</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6207</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6208</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6209</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6209.jpg</image:loc><image:title>Absolute quantification of aqueous humor proteins for prognostic stratification in uveal melanoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6210</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6210.jpg</image:loc><image:title>Identification of a first-in-class therapeutic target using machine learning enabled translational-optimized proteomics system (TPS)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6211</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6212</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6213</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6213.jpg</image:loc><image:title>Extracellular kinome network reveals secretory kinase FAM20C as a key driver of recurrence in oral squamous cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6214</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6214.jpg</image:loc><image:title>A magnetic bead-based workflow for streamlined and quantitative mass spectrometry sample preparation in cancer proteomics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6215</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6216</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6217</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6218</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6218.jpg</image:loc><image:title>Blood-based proteomics analysis for uveal melanoma prognosis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6219</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6219.jpg</image:loc><image:title>Quantitative plasma proteomics on stellar MS enables discovery of clinically relevant cancer biomarkers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6220</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6220.jpg</image:loc><image:title>Machine learning-based plasma proteomic signatures for diagnosis and prognosis of cholangiocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6221</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6222</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6222.jpg</image:loc><image:title>Quantitative TMT-based proteomic profiling reveals stage-specific protein dysregulation in colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6223</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6223.jpg</image:loc><image:title>Secretomic profiling of triple-negative breast cancer media using Mag-Net&amp;#8482; HP</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6224</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6224.jpg</image:loc><image:title>Potential clinical utility of small extracellular vesicles derived from head and neck tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6225</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6225.jpg</image:loc><image:title>Integrin alphavbeta3-driven secretome remodeling uncovers THBS1 as a potential prognostic mediator in cutaneous T-cell lymphoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6226</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6226.jpg</image:loc><image:title>Proteomic profiling of Neem (Azadirachta indica) leaves</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6227</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6228</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6229</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6229.jpg</image:loc><image:title>Phase-separated RTK fusion condensates orchestrate oncogenic signaling through extensive protein recruitment and RTK crosstalk</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6230</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6230.jpg</image:loc><image:title>Ecotype-guided multi-omics profiling identifies potential cell-surface therapeutic targets in gastric cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6231</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6231.jpg</image:loc><image:title>Plasma proteo-transcriptomic integration identifies molecular signatures and circulating biomarkers in ependymomas</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6232</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6232.jpg</image:loc><image:title>Urinary arsenic speciation and metabolic indices associate with exposure chemistry and prostate cancer aggressiveness</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6233</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6233.jpg</image:loc><image:title>High-resolution detection of post-translational modifications using single-molecule protein sequencing</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6234</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6235</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6235.jpg</image:loc><image:title>Novel therapeutic opportunities in POU2F3 transcription factor-driven small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6236</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6236.jpg</image:loc><image:title>Unique oncogenic mechanisms of ultrahigh-frequency mutant PTEN R 130G in endometrial cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6237</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6237.jpg</image:loc><image:title>Defining molecular interfaces of glyco-immune checkpoint ligands using tandem mass spectrometry and ion-ion reactions</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6238</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6238.jpg</image:loc><image:title>Comprehensive investigation of stool metaproteomes among patients with precancerous lesions and colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6239</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6239.jpg</image:loc><image:title>An AFA assisted workflow for mass-spectrometry based proteomics of FFPE samples</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6240</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6241</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6242</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6242.jpg</image:loc><image:title>Integrated multiomics profiling of lysates using nCounter&amp;#174; protein and RNA panels for comprehensive oncology insights</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6243</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6244</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6244.jpg</image:loc><image:title>Discovery of tumor-specific and neoantigenic peptides in cancer tissue samples using mass spectrometry-based immunopeptidomic</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6245</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6245.jpg</image:loc><image:title>An automated sequential protein/DNA/RNA extraction workflow for comprehensive multiomics analysis from cells and tissue</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6246</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6246.jpg</image:loc><image:title>Multi-step antibody validation for nCounter high-plex multiomics panels</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6247</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6247.jpg</image:loc><image:title>Comprehensive surfaceome profiling reveals tumor specific targets in osteosarcoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6248</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6248.jpg</image:loc><image:title>Integrating multi-omics and AI-driven approaches into STEMM education to advance cancer research training</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6249</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6249.jpg</image:loc><image:title>Characterization of outer membrane vesicles (OMVs) from pks+ NC101 and pks- DH10B E. coli strands</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6250</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6250.jpg</image:loc><image:title>Automated multiplex profiling of human cytokines and autoantibodies using an Automated Assay Workstation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6251</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6251.jpg</image:loc><image:title>Integrated mass spectrometric workflows enabling next-generation conjugate therapeutics in cancer research</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6252</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6252.jpg</image:loc><image:title>Integrated proteogenomics of primary tumoroid models for precision oncology</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6253</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6254</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6255</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6256</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6256.jpg</image:loc><image:title>Extracellular vesicle immunopeptidomics recovers immunogenic neoantigen peptides from cancer patient plasma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6257</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6257.jpg</image:loc><image:title>Wnt-driven chromosomal instability as a biomarker for PORCN inhibition</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6258</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6259</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6259.jpg</image:loc><image:title>Extracellular vesicle glycosylation profilepredictsand affectstherapeutic outcomes ofCLDN18.2-targeted CAR-T cell therapyagainst gastrointestinal cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6260</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6260.jpg</image:loc><image:title>Elevated baseline DKK1 plasma is a biomarker for sirexatamab treated colorectal cancer patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6261</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6261.jpg</image:loc><image:title>Tumor-intrinsic MHC-II activation in pancreatic ductal adenocarcinoma enhances immune response and treatment efficacy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6262</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6262.jpg</image:loc><image:title>TRPM4 expression predicts Acetalax sensitivity in prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6263</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6263.jpg</image:loc><image:title>Stearic acid-macrophage crosstalk identifies MIF-CD44 signaling as a therapeutic target in lung cancer initiation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6264</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6264.jpg</image:loc><image:title>Exploring biomarker predictors of response to nintedanib and bevacizumab combination therapy in advanced cancer patients: Correlative studies from Phase 1b study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6265</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6266</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6266.jpg</image:loc><image:title>Correlation between PD-L1, desmocollin 3, and stromal lymphocytes in recurrent head and neck squamous cell carcinomas</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6267</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6267.jpg</image:loc><image:title>Biomarkers of nelmastobart efficacy: BTN1A1 expression and tumor microenvironment dynamics in colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6268</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6268.jpg</image:loc><image:title>Implementation of a novel immune monitoring strategy for multicenter clinical trials to enable equity in cancer prognosis for individuals from remote settings of Australia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6269</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6269.jpg</image:loc><image:title>A circulating GPNMB-based multimodal model integrates tumor-immune crosstalk to predict immunotherapy response in esophageal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6270</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6270.jpg</image:loc><image:title>Integrative molecular profiling identifies predictors of response to sacituzumab govitecan in advanced prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6271</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6271.jpg</image:loc><image:title>Expression profile of therapeutic target CDH17 in gastric cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6272</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6272.jpg</image:loc><image:title>Integrated FHIT and IDH2 biomarkers predict synthetic lethal response to DCPS inhibition in acute myeloid leukemia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6273</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6273.jpg</image:loc><image:title>Glycogen branching enzyme 1 as a metabolic determinant and prognostic driver of the CMS4 subtype in colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6274</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6274.jpg</image:loc><image:title>Phosphorylated FRS2 (pFRS2) as a biomarker for FGFR mutation or fusion activity assessment in formalin-fixed paraffin-embedded tumor sections</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6275</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6276</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6276.jpg</image:loc><image:title>Tumor immune microenvironment features associated with response to neoadjuvant durvalumab plus gemcitabine, cisplatin, and nab-paclitaxel (DURGAP) in resectable biliary tract cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6277</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6277.jpg</image:loc><image:title>A stromal-immune spatial transcriptomic signature associated with MUC4 identifies potential biomarkers of trastuzumab resistance in HER2-positive breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6278</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6278.jpg</image:loc><image:title>Reliable antibodies for cancer research: TROP2 as a case study of Abcam&#039;s enhanced validation framework</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6279</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6279.jpg</image:loc><image:title>The gap score: A functional biomarker of drug sensitivity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6280</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6280.jpg</image:loc><image:title>HER2 expression and tumor-infiltrating lymphocytes predict response to tucatinib plus trastuzumab in HER2 -positive metastatic colorectal cancer (MOUNTAINEER): Exploratory analysis of a multicenter, Phase II trial</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6281</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6281.jpg</image:loc><image:title>Rare EGFR cis compound L833V/H835L mutation in non-small cell lung cancer is oncogenic and a therapeutic target of EGFR tyrosine kinase inhibitors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6282</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6282.jpg</image:loc><image:title>Baseline CD16 + NK cells are associated with clinical outcome of nivolumab plus ipilimumab immunotherapy in advanced hepatocellular carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6283</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6283.jpg</image:loc><image:title>CHIP detection in solid tumors differs between liquid biopsy testing approaches</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6284</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6284.jpg</image:loc><image:title>Plasma-based comprehensive epigenomic profiling enables multiplexed prediction of target gene expression and detection of resistance mechanisms</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6285</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6285.jpg</image:loc><image:title>High-sensitivity cfDNA detection of KRAS amplification subtypes to inform targeted therapy response and resistance mechanisms</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6286</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6286.jpg</image:loc><image:title>Ultrasensitive abnormal DNA methylation detection in plasma samples from patients with three different childhood sarcomas</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6287</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6288</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6289</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6289.jpg</image:loc><image:title>Monitoring molecular residual disease in colorectal cancer using tumor-informed ctDNA analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6290</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6290.jpg</image:loc><image:title>Analytical evaluation of tumor-naive ctDNA molecular response detection through baseline informed comprehensive genomic profiling with matched white blood cell analyses</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6291</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6291.jpg</image:loc><image:title>Development of a comprehensive tumor-informed ctDNA workflow for ultrasensitive molecular residual disease detection using diverse tumor profiling inputs</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6292</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6292.jpg</image:loc><image:title>Fragmented plasma cfDNA as a prognostic and surveillance biomarker for locoregional recurrence in oral squamous cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6293</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6293.jpg</image:loc><image:title>Transport under various conditions: Evaluating blood sample stability across seasons</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6294</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6294.jpg</image:loc><image:title>Diagnostic genomics in retinoblastoma: Aqueous humor outperforms blood for tumor-specific insights</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6295</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6295.jpg</image:loc><image:title>Plasma epigenomic profiling captures B-cell lymphoma biology</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6296</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6296.jpg</image:loc><image:title>A novel extraction method for enrichment of circulating cell-free DNA</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6297</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6298</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6298.jpg</image:loc><image:title>Integrated DNA/RNA recovery from 1-20 mL inputs enables sensitive KRAS G12V detection in a liquid biopsy model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6299</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6299.jpg</image:loc><image:title>Automated high-volume cfDNA extraction on a liquid-handling platform achieves analytical equivalence to a manual high-input magnetic-bead workflow with 96-sample throughput</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6300</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6300.jpg</image:loc><image:title>Enhanced sensitivity and scalability in liquid biopsy through integrated high-volume cfDNA extraction and droplet digital PCR mutation detection</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6301</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6301.jpg</image:loc><image:title>Innovative biomarker discovery: A non-invasive, comprehensive tumor characterization approach with plasma and urine from breast cancer patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6302</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6302.jpg</image:loc><image:title>EU Instand-NGS4P: Pre-analytical multimodal workflows for NGS research and future precision cancer care</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6303</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6303.jpg</image:loc><image:title>Evaluation of somatic mutations in cell-free DNA as noninvasive biomarkers of cancer in asymptomatic pregnant women</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6304</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6304.jpg</image:loc><image:title>Evaluation of uProcess for detection of oncogene sequences in buffer and urine by qPCR following 3-minute capture and 5- minute purification procedure</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6305</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6305.jpg</image:loc><image:title>A new high fidelity PCR master mix with broad NGS workflow compatibility and superior performance in high sensitivity applications</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6306</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6306.jpg</image:loc><image:title>Integrated multiomics for deep molecular exploration of prostate cancer from urine</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6307</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6307.jpg</image:loc><image:title>Simultaneous identification of methylation and somatic variants can improve sensitivity for cancer detection and monitoring</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6308</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6308.jpg</image:loc><image:title>Dynamic plasma KRAS and EGFR ctDNA profiling identifies treatment response and nascent resistance in metastatic lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6309</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6309.jpg</image:loc><image:title>AI-designed personalized neoantigen vaccine, EVX-01, induces durable de novo T-cell responses in advanced melanoma patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6310</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6310.jpg</image:loc><image:title>Intratumoral effector T-cells and macrophages underlie prolonged survival after PD-1 axis blockade in metastatic non-small cell lung cancer (mNSCLC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6311</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6311.jpg</image:loc><image:title>Pre-existing T cells drive durable anti-tumor immunity after oncolytic virus therapy in glioblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6312</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6312.jpg</image:loc><image:title>Single-cell and spatial profiling reveal tumor-immune features underlying pathologic complete response to neoadjuvant anti-PD-L1 and chemoradiotherapy in NSCLC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6313</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6313.jpg</image:loc><image:title>EGFR-TKI enhances anti-CD47 antibody-mediated macrophage phagocytosis in EGFR-mutant non-small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6314</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6314.jpg</image:loc><image:title>CEACAM5/6+ cancer cell and IL1B+ macrophage-mediated resistance in anti-PD-1 treated gastric cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6315</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6315.jpg</image:loc><image:title>Comparison of T-cell activation status in patients treated with retifanlimab in combination with anti-LAG3/Anti-TIM3 vs retifanlimab alone</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6316</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6316.jpg</image:loc><image:title>Immune-related RNA-seq biomarker-based clustering reveals heterogeneous immunotherapy responses and guides subtype-specific strategies in metastatic NSCLC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6317</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6317.jpg</image:loc><image:title>Increased immune activity in patients with high-grade serious ovarian cancer after combination PARPi + ATRi therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6318</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6318.jpg</image:loc><image:title>Integration of spatial single cell proteomics and spatial metabolomics reveals tumor microenvironment predictive of immunotherapy response in mucosal melanoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6319</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6319.jpg</image:loc><image:title>Integrative multi-omics and spatial transcriptomics reveal novel immunotherapy targets in hepatocellular carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6320</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6320.jpg</image:loc><image:title>Targeting SOAT1 to Boost NK Cell Mediated Cytotoxicity in High Grade Serous Ovarian Cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6321</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6321.jpg</image:loc><image:title>Circulating thymidine kinase activity (TKa) as a predictive and dynamic biomarker in the metastatic non-small cell lung cancer (NSCLC): Immunoblood study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6322</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6322.jpg</image:loc><image:title>Peripheral immune signatures associated with peptide receptor radionuclide therapy in neuroendocrine tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6323</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6323.jpg</image:loc><image:title>Precision immune therapies for cancer developed through understanding the role of myeloid checkpoints as key mediators of adaptive resistance in T-cell checkpoint inhibitor resistant patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6324</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6324.jpg</image:loc><image:title>A tumor-targeting IL-12 immunocytokine therapy increases peripheral natural killer (NK) cells with phenotypes associated with increased tumor cell lysis in patients with advanced solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6325</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6325.jpg</image:loc><image:title>Investigating the mechanisms underlying regulatory T cell dysfunction in ICI-induced colitis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6326</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6326.jpg</image:loc><image:title>Prediction of pharmacokinetics and pharmacodynamics profile for a fixed dosing and body weight-based dosing of GI-102 based on cell-level pharmacodynamics-mediated drug disposition model in patients with advanced or metastatic solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6327</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6327.jpg</image:loc><image:title>Construction of a novel immune gene signature to distinguish immunotherapy responders and non-responders</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6328</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6328.jpg</image:loc><image:title>Tertiary lymphoid structure (TLS) representative cells elicit response to anti-PD-1 + therapy in a cold tumor</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6329</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6329.jpg</image:loc><image:title>PD-L1-dependent 4-1BB costimulation enhances anti-tumor efficacy and T cell persistence as monotherapy or in combination with tarlatamab</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6330</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6330.jpg</image:loc><image:title>FOXA1 in ovarian cancer: Therapeutic target and immunotherapy enhancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6331</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6331.jpg</image:loc><image:title>Modeling CRS in humanized immune system mice</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6332</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6332.jpg</image:loc><image:title>Single-dose neoadjuvant atezolizumab in resectable stage IA-IIIA non-N2 NSCLC: Tumor infiltrate analysis from the PRINCEPS trial</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6333</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6333.jpg</image:loc><image:title>Spatial profiling of the tumor immune microenvironment following oncolytic herpes simplex virus treatment in glioblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6334</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6334.jpg</image:loc><image:title>Biological pathways of response to neoadjuvant chemo-immunotherapy in triple-negative breast cancer (TNBC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6335</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6335.jpg</image:loc><image:title>IL-12/anti-PD-1 armored oncolytic HSV-1 reprograms CNS immunity: Integrated longitudinal immune, genomic, and metabolic CSF profiling in the MVR-C5252 PuMP Trial</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6336</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6336.jpg</image:loc><image:title>Continuation of immune checkpoint inhibitor therapy after progression in head and neck squamous cell carcinoma: A multicenter study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6337</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6337.jpg</image:loc><image:title>Blockade of cell-ECM interaction with an oncolytic virus suppresses tumoral STING activation while inducing antitumor immunity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6338</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6338.jpg</image:loc><image:title>Pharmacodynamic biomarkers of TGFbetaR2xPD-1 bispecific antibody INCA33890 in patients with MSS metastatic colorectal cancer (mCRC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6339</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6339.jpg</image:loc><image:title>An exopolysaccharide-containing yogurt preserves CCR6 + CD4 + T Cells: Th7R, and may enhance immunotherapy responses in lung cancer patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6340</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6340.jpg</image:loc><image:title>Direct in vivo activation and functional reprogramming of human TILs using a multifunctional nanoengager in humanized renal carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6341</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6341.jpg</image:loc><image:title>GS24-B047, a potential best-in-class DLL3-targeting T-cell engager with integrated costimulatory signal, for the treatment of small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6342</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6342.jpg</image:loc><image:title>A tunable interleukin-18 (IL-18) platform engineered for complete escape from the decoy receptor IL-18 binding protein (IL-18BP)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6343</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6343.jpg</image:loc><image:title>Patient derived tumor-immune organoids capture the functional and mechanistic interface in predicting response to standard therapeutics and immunotherapeutics in colorectal cancer patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6344</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6344.jpg</image:loc><image:title>Cbl-b-Notch1 axis blockers rewire immunosuppressive tumors to drive cytotoxic and anti-angiogenic immune responses</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6345</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6345.jpg</image:loc><image:title>Collagen-binding IL-12 remodels immunosuppresive microenvironment and improves survival in recurrent glioblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6346</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6346.jpg</image:loc><image:title>Targeting PRMT7 elicits anti-AML immunity by promoting MHC-I expression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6347</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6347.jpg</image:loc><image:title>Spatial profiling reveals epigenetic and immunotherapy-driven remodeling of the tumor and lymph node microenvironment in HPV-associated HNSCC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6348</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6349</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6349.jpg</image:loc><image:title>Phenotype-tailored prophylactic immunomodulation enables safe immune checkpoint inhibitor rechallenge after severe irAEs in high-risk patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6350</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6350.jpg</image:loc><image:title>Daiad-2/15: A conditionally active, targeted, hyperpotent IL-2/IL-15 immune agonist is safe and effective in vivo</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6351</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6351.jpg</image:loc><image:title>Peptide-delivered low dose IL-2 reprograms pancreatic cancer immunity to improve survival</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6352</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6352.jpg</image:loc><image:title>PAI-1 inhibition attenuates the inflammatory response in a murine model of sclerodermatous chronic graft-versus-host disease</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6353</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6354</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6354.jpg</image:loc><image:title>Bioelectromagnetic reprogramming of tumor-immune metabolism to selectively destroy NSCLC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6355</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6356</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6356.jpg</image:loc><image:title>Efficacy, in vivo safety, and PK/PD studies for novel, oral, highly selective PTPN2/1 inhibitor (ZE00-0388)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6357</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6357.jpg</image:loc><image:title>Exosomes, regulated by SPRED2, reshape tumor microenvironment via activating IL6/ STAT3 signaling</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6358</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6358.jpg</image:loc><image:title>Immune microenvironmental patterns in rapidly progressive young-onset tongue cancer: A case series analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6359</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6359.jpg</image:loc><image:title>DDR2-CAR macrophages reprogram the tumor microenvironment and normalize vasculature to potentiate antitumor immunity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6360</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6360.jpg</image:loc><image:title>Interaction of visceral adiposity and age in shaping the human breast tumor microenvironment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6361</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6361.jpg</image:loc><image:title>Distinct microbiota composition in anorectal mucosal melanoma is associated with resistance to immune checkpoint inhibition</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6362</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6362.jpg</image:loc><image:title>FL115, a novel IL-15 superagonist rationally designed to minimize safety risks for cancer immunotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6363</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6363.jpg</image:loc><image:title>Extracellular vesicle-mediated transfer of cortisol-induced miR-143-3p from macrophages promotes angiogenesis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6364</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6364.jpg</image:loc><image:title>IL-24 engineered mesenchymal stem cells as a novel therapeutic strategy to remodel the tumor microenvironment in non-small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6365</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6365.jpg</image:loc><image:title>Multimodal immunotherapy remodels the tumor microenvironment in hepatocellular carcinoma: Integrative spatial and transcriptomic profiling from a Phase II trial</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6366</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6366.jpg</image:loc><image:title>Epigenetic reprogramming of stromal-epithelial crosstalk to improve immunotherapy response in pancreatic ductal adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6367</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6367.jpg</image:loc><image:title>Advancing the best-in-class cross-specific LILRB1/LILRB2 antibody IOMX-0675 into clinical development for solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6368</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6368.jpg</image:loc><image:title>Identification of a novel lncRNA in pancreatic cancer: Contribution to malignancy through Wnt pathway regulation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6369</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6369.jpg</image:loc><image:title>Stress-induced anoikis-resistance triggers malignant-like phenotypes in uterine leiomyoma cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6370</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6370.jpg</image:loc><image:title>Pharmacokinetics of TNX-1700 in non-human primates and human FcRn/serum albumin transgenic mice</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6371</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6371.jpg</image:loc><image:title>The Sphk1-B cell axis as a targetable immunoregulatory pathway in cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6372</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6372.jpg</image:loc><image:title>TAE226 reprograms immune-cold head and neck tumors to immune-hot, augmenting immunotherapy efficacy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6373</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6373.jpg</image:loc><image:title>TP53 mutation reshapes the immune microenvironment in endometrial cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6374</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6374.jpg</image:loc><image:title>Tumor immune micro-environment (TME) dynamics in longitudinal diffuse large B-cell lymphoma (DLBCL) cases from diagnosis to RCHOP relapse</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6375</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6375.jpg</image:loc><image:title>Whole-genome doubling induces chromosomal instability to shape the tumor-immune microenvironment and impair the response to immune checkpoint inhibitors in non-small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6376</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6376.jpg</image:loc><image:title>Identification of a highly selective ITK inhibitor which promotes Th1 differentiation and alleviates T cell exhaustion in vitro and in vivo</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6377</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6377.jpg</image:loc><image:title>miR-150 orchestrates immune activation and lymphocyte trafficking in breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6378</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6378.jpg</image:loc><image:title>Targeting the UFMylation pathway to promote immunotherapy response of breast cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6379</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6379.jpg</image:loc><image:title>Pharmacologic wtIDH1 inhibition remodels the PDAC immune landscape and improves checkpoint blockade efficacy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6380</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6380.jpg</image:loc><image:title>Targeting the OSM-OSMR signaling axis to reprogram the tumor microenvironment and overcome immune suppression in pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6381</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6381.jpg</image:loc><image:title>Ovarian tumor FAK inhibition releases omega-3 fatty acids stimulating GATA6 peritoneal macrophage CXCL13 production augmenting TIGIT immunotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6382</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6382.jpg</image:loc><image:title>Integrated tissue and secretome profiling identifies an IL-6/IL-8-dominant immune phenotype in peritoneal carcinomatosis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6383</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6383.jpg</image:loc><image:title>Engineered IL7/IL15 secreting iPSC-derived mesenchymal stromal cells convert the immunosuppressive into immune-activated tumor microenvironments (TME) and potentiate antitumor immunity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6384</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6384.jpg</image:loc><image:title>Embryonal and alveolar rhabdomyosarcoma immunotherapy treatment benefit prediction by CURE AI</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6385</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6385.jpg</image:loc><image:title>Preclinical efficacy of DLL3 targeted CAR T cells in neuroblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6386</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6386.jpg</image:loc><image:title>cGAS-STING pathway agonist plus immune checkpoint inhibitor augments chemotherapy effectiveness in murine osteosarcoma models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6387</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6387.jpg</image:loc><image:title>Development of a GFRA2-targeting antibody drug conjugate for neuroblastoma (NB), and Ewing sarcoma (EWS)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6388</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6388.jpg</image:loc><image:title>CAR priming lowers TCR activation threshold to enhance recognition of low affinity tumor antigens</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6389</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6389.jpg</image:loc><image:title>Efficacy of AZD0754, a dominant-negative TGFbetaRII-armored STEAP2 CAR T-cell therapy, in Ewing sarcoma xenograft models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6390</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6390.jpg</image:loc><image:title>Epitope-encoded mRNA-LNP vaccine to enhance anti-tumor potency and persistence of PHOX2B peptide-centric CAR T cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6391</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6391.jpg</image:loc><image:title>Engineering macrophages as a novel therapeutic approach for high-risk neuroblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6392</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6392.jpg</image:loc><image:title>Using gammadelta T cells as a potent adoptive cell therapy platform in models of pediatric sarcoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6393</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6393.jpg</image:loc><image:title>Preclinical evaluation of a dnTGFbetaR-armored GPC3 CAR-T (AZD5851) in pediatric solid tumor PDX models - A report from the Pediatric Preclinical In Vivo Testing (PIVOT) Consortium</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6394</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6394.jpg</image:loc><image:title>Antitumor activity of a B7-H3 antibody-drug conjugate in osteosarcoma patient-derived and metastatic models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6395</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6395.jpg</image:loc><image:title>Ganglioside targeting: Exerting sweet revenge on neuroblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6396</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6396.jpg</image:loc><image:title>Efficacy of ABBV-706, a SEZ6-targeted topoisomerase 1 inhibitor ADC: A report from the Pediatric Preclinical In Vivo Testing (PIVOT) Program</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6397</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6397.jpg</image:loc><image:title>Spatial profiling identifies tumor-associated stroma enrichment and MIF as potential immunotherapy targets in primary Ewing sarcomas</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6398</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6399</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6399.jpg</image:loc><image:title>Onvansertib-mediated PLK1 inhibition reduces cell viability in neuroblastoma cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6400</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6400.jpg</image:loc><image:title>CDK7 inhibition mitigates AZD1775 resistance via chromatin reprogramming in MYC-MB</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6401</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6402</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6403</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6403.jpg</image:loc><image:title>Eflornithine and venetoclax combination therapy: Targeting senescence to induce apoptosis in neuroblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6404</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6405</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6406</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6407</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6408</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6408.jpg</image:loc><image:title>Hijacking the BRD4-NUT fusion oncoprotein to activate programmed cell death</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6409</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6410</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6410.jpg</image:loc><image:title>Germline genetic testing trends in pediatric cancer patients: A SEER registry analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6411</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6412</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6412.jpg</image:loc><image:title>Therapy-related clonal hematopoiesis in pediatric cancer survivors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6413</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6414</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6414.jpg</image:loc><image:title>Financial hardships and chronic medical conditions in adolescent and young adult cancer survivors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6415</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6415.jpg</image:loc><image:title>Integrating genetic predictors into breast cancer risk stratification among female survivors of childhood cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6416</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6416.jpg</image:loc><image:title>Insights into chemotherapy-related cognitive impairment in childhood acute myeloid leukemia survivors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6417</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6418</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6419</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6419.jpg</image:loc><image:title>Real-world landscape analysis of circulating tumor DNA minimal residual disease as a clinical trial endpoint in breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6420</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6421</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6422</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6423</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6423.jpg</image:loc><image:title>A seven-gene mutation signature predicts immunotherapy benefit in bladder cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6424</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6424.jpg</image:loc><image:title>Prognostic impact of gain-of-function TP53 mutations on outcomes in HER2-negative advanced gastric cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6425</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6425.jpg</image:loc><image:title>Transcriptomic profiling of Ki67 expression in melanoma patient specimens reveals distinct immune signatures</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6426</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6427</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6427.jpg</image:loc><image:title>Multi-modal real-world data uncovers predictors of clinical response to TOP1i and optimizes ADC strategies in colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6428</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6428.jpg</image:loc><image:title>Machine learning predicts retinoblastoma (Rb) function in real-world small cell lung cancer patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6429</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6430</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6430.jpg</image:loc><image:title>Fusion gene machine learning models improve clinical outcome prediction of hepatocellular carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6431</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6431.jpg</image:loc><image:title>Translating temporal multi-disease pathways in multiple cancer types using real-world clinical data</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6432</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6433</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6434</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6435</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6435.jpg</image:loc><image:title>Survival profile of patients presented at technology-enhanced multidisciplinary cancer conferences</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6436</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6436.jpg</image:loc><image:title>BMI- and subtype-specific molecular clusters reveal distinct obesity mechanisms in breast cancer across Nigerian and U.S. cohorts</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6437</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6438</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6438.jpg</image:loc><image:title>Skin and systemic interplay in immune checkpoint inhibitor therapy: Evidence of global immune activation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6439</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6439.jpg</image:loc><image:title>Induction of targeted-cytoxicity and immunogenic cell death using an anti-CEA antibody linked to IRDye700Dx</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6440</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6441</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6442</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6443</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6443.jpg</image:loc><image:title>Clinical significance of elevated UBQLN4 expression with resistance to cisplatin in intrahepatic cholangiocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6444</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6444.jpg</image:loc><image:title>Renal cancer early diagnosis using a novel B7-H3 targeted ultrasound contrast imaging</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6445</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6446</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6446.jpg</image:loc><image:title>MiR-362-3p enhances platinum response in breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6447</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6447.jpg</image:loc><image:title>Galectin-9 as a glycan-modulating adjuvant to enhance Elotuzumab-mediated immunotherapy in multiple myeloma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6448</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6449</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6449.jpg</image:loc><image:title>Integrated multi-omics profiling identifies an immunotherapy vulnerable and prognostic associated subtype in cholangiocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6450</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6451</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6452</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6452.jpg</image:loc><image:title>Exploring a LINC00092-associated multiomics signature as a clinically tractable biomarker in colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6453</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6454</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6454.jpg</image:loc><image:title>Multi-cohort transcriptomic profiling identifies pathways driving high-risk biochemical recurrence in prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6455</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6455.jpg</image:loc><image:title>Performance analysis of a novel PD-L1 CAL10 assay in esophageal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6456</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6456.jpg</image:loc><image:title>OXC-101 (karonudib) in canine lymphoma and hemangiosarcoma: Safety, early efficacy, and translational potential</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6457</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6457.jpg</image:loc><image:title>Preclinical modeling of plasmacytoid urothelial carcinoma to study cancer mechanisms and therapeutic response</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6458</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6458.jpg</image:loc><image:title>Molecular landscape of colorectal cancer (CRC) with KRAS 13D mutations</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6459</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6459.jpg</image:loc><image:title>Galectin-2 expression in the tumor microenvironment: A silent pathway of pancreatic ductal adenocarcinoma progression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6460</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6460.jpg</image:loc><image:title>RUVBL1 and SPARC as prognostic biomarkers in breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6461</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6461.jpg</image:loc><image:title>Suppression of MAGED1 increases sensitivity to PARP inhibitor in BRCA-mutated breast cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6462</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6463</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6463.jpg</image:loc><image:title>Integrated proteogenomics reveals molecular predictors of recurrence beyond HER2 IHC in HER2-positive breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6464</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6464.jpg</image:loc><image:title>The development of a novel PDGFRA resistance mutation in a recurrent KIT -mutant gastrointestinal stromal tumor (GIST)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6465</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6465.jpg</image:loc><image:title>Effect of plasma activated media, with and without chemotherapeutics, on viability of normal and malignant human breast cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6466</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6466.jpg</image:loc><image:title>ML-016: A silicon &amp;#8220;plateloid&amp;#8221;-based phenotype targeting platform for lung and liver malignancies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6467</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6468</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6469</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6469.jpg</image:loc><image:title>Targeting tumor macrophage TGF-beta signaling overcomes immunotherapy resistance in hepatocellular carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6470</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6470.jpg</image:loc><image:title>CAR T-Cell therapy efficacy evaluation inTumorGraft3D tri-culture platform with reconstructed tumor microenvironment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6471</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6472</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6472.jpg</image:loc><image:title>ICA-1S targets protein kinase C-iota to inhibit the WNT/beta-catenin signaling in hepatocellular carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6473</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6474</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6474.jpg</image:loc><image:title>ICA-1S targets PKC-&amp;#953; and Cx43 to inhibit glioblastoma multiforme progression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6475</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6476</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6476.jpg</image:loc><image:title>The role of TNIK and MINK1 in TNBC tumorigenesis and invasion</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6477</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6478</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6478.jpg</image:loc><image:title>Inhibition in the proliferation of pediatric glioblastoma facilitated with atypical protein kinase c inhibitors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6479</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6479.jpg</image:loc><image:title>Programmable RNA-triggered cancer cell elimination using CRISPR-Cas12a2</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6480</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6480.jpg</image:loc><image:title>Human sialidase-armed anti-B7-H3 antibody that enhances innate and adaptive antitumor immune responses</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6481</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6481.jpg</image:loc><image:title>Antitumor activity of Avaren-Fc, a novel high-mannose-glycan-targeting immunotherapy, in ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6482</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6482.jpg</image:loc><image:title>NEK2 drives pathogenesis, drug resistance, and LMP1 expression in EBV-positive non-Hodgkin lymphoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6483</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6483.jpg</image:loc><image:title>A novel StarLinker TM -based, CLDN18.2/PD-L1 bispecific dual-payload ADC (CAN017) overcomes tumor heterogeneity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6484</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6484.jpg</image:loc><image:title>CD180-targeting ADCs with a topoisomerase I inhibitor payload achieve strong efficacy in AML tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6485</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6486</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6486.jpg</image:loc><image:title>The role of NEK2 and AURKB on triple-negative breast cancer progression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6487</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6487.jpg</image:loc><image:title>Understanding and overcoming resistance of triple-negative breast cancer brain metastases to RET monotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6488</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6488.jpg</image:loc><image:title>Targeting breast cancer brain metastasis through novel combination of FDA-approved orally active BBB-permeable RET and tGLI1 inhibitors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6489</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6489.jpg</image:loc><image:title>Therapeutic potential of BTK targeted degrader in B-cell malignancies harboring ibrutinib-resistant mutation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6490</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6490.jpg</image:loc><image:title>Pharmacological disruption of YAP1/TEAD and NF-kappa B crosstalk suppresses prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6491</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6491.jpg</image:loc><image:title>TNKS inhibition rewires AMOT-YAP signaling to overcome YAP-driven therapy resistance in solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6492</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6492.jpg</image:loc><image:title>Large-scale drug screening identifies clinically actionable combinations to overcome BTK/PI3K inhibitor resistance in marginal zone lymphoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6493</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6493.jpg</image:loc><image:title>Rinzimetostat, an allosteric EED inhibitor with best-in-class properties for the treatment of prostate cancer, is effective in PRC2 methyltransferase-resistant settings in preclinical studies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6494</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6494.jpg</image:loc><image:title>CRISPR druggable-genome screen identifies BRD4 as a synergistic vulnerability with the natural product cerberin in pancreatic cancer organoids</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6495</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6495.jpg</image:loc><image:title>Nanoparticle-mediated restoration of pomalidomide sensitivity in multiple myeloma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6496</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6496.jpg</image:loc><image:title>QW-5-70 targets the colchicine site to overcome multidrug resistance and shows potent antitumor activities</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6497</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6497.jpg</image:loc><image:title>Resistance to the SFK inhibitor NXP900 in cholangiocarcinoma is characterized by IL13RA2-AKT signaling and can be overcome by combination therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6498</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6498.jpg</image:loc><image:title>Mechanistic basis of resistance to HDAC6 inhibitors reveals proteasome inhibition as a rational combination strategy in breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6499</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6499.jpg</image:loc><image:title>Targeting Aurora A kinase together with alternative survival signaling overcomes resistance to endocrine and CDK4/6 therapies in ER+ breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6500</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6500.jpg</image:loc><image:title>RalBP1 inhibition: A novel therapy for prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6501</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6501.jpg</image:loc><image:title>The rise of YAP: A new hope in glioblastoma treatment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6502</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6503</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6503.jpg</image:loc><image:title>GRN-300 restores PARP inhibitor sensitivity through inhibition of the HDAC-MEF2A-RAD51 pathway in BRCA2-revertant ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6504</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6504.jpg</image:loc><image:title>Targeting oxidative phosphorylation with lixumistat overcomes PARP inhibitor resistance in ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6505</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6505.jpg</image:loc><image:title>Rinzimetostat blockade of PRC2 activity, a key mechanism of treatment resistance, improves response of androgen receptor pathway inhibition across a spectrum of prostate cancer models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6506</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6506.jpg</image:loc><image:title>Combined anti-CSF-1R and anti-TIM-3 overcome macrophage-mediated mechanisms of PARP inhibitor (PARPi) resistance in BRCA1-associated triple negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6507</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6507.jpg</image:loc><image:title>Developing drug combinations with AMG 193, a novel MTA-cooperative PRMT5 inhibitor, using patient-derived xenograft models of MTAP -deleted non-small cell lung cancer and mesothelioma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6508</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6508.jpg</image:loc><image:title>A first-in-class orally bioavailable small molecule to overcome treatment resistance in hormone receptor-positive breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6509</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6509.jpg</image:loc><image:title>Targeting RRM2 to enhance PARP inhibitor sensitivity in TNBC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6510</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6510.jpg</image:loc><image:title>Acquired saruparib (AZD5305) resistance in BRCA1-deficient triple negative breast cancer is vulnerable to DNA damage response-targeted therapeutics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6511</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6511.jpg</image:loc><image:title>Uncovering PGRMC1-PARP interaction: A novel combination therapeutic strategy in triple-negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6512</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6512.jpg</image:loc><image:title>Synthetic lethality of Hsp90beta-selective inhibition with PARPi in homologous recombination repair proficient ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6513</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6514</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6514.jpg</image:loc><image:title>Simultaneous targeting of CHI3L1 and PD-1/PD-L1 axis to overcome drug resistance and immune tolerance of EGFR non-small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6515</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6515.jpg</image:loc><image:title>Mechanisms of zongertinib resistance in HER2-mutant non-small cell lung cancer and potential strategies to overcome resistance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6516</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6516.jpg</image:loc><image:title>IL-1 alpha expression induces drug resistance to all generations of EGFR inhibitors in HNSCC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6517</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6517.jpg</image:loc><image:title>Multi-lineage evolution of drug resistance via a novel keratin 17+ drug tolerant persister population in EGFR -mutant NSCLC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6518</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6518.jpg</image:loc><image:title>Investigating the role of PLK4 and GDF15 in NSCLC tumorigenicity and EGFR-TKI resistance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6519</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6519.jpg</image:loc><image:title>Engineering isogenic models harboring resistance mechanisms to the latest-generation EGFR inhibitor in non-small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6520</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6520.jpg</image:loc><image:title>Tumor-macrophage crosstalk promotes resistance to EGFR targeted therapy in lung adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6521</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6521.jpg</image:loc><image:title>Intra-tumoral Porphyromonas gingivalis mediates osimertinib resistance in EGFR-mutant lung adenocarcinoma through gingipain-mediated IGF1R activation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6522</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6522.jpg</image:loc><image:title>GLAST (SLC1A3), a novel therapeutic target for overcoming osimertinib resistance in lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6523</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6523.jpg</image:loc><image:title>Inhibition of PGC1b/mitochondrial biogenesis as a critical event in mediating therapeutic response of EGFR mutant NSCLC to third generation EGFR inhibitors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6524</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6524.jpg</image:loc><image:title>The potential of dequalinium chloride and osimertinib combination in overcoming osimertinib acquired resistance in EGFR-mutant non-small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6525</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6525.jpg</image:loc><image:title>CD24 as a therapeutic vulnerability in osimertinib-induced drug-tolerant persister cells of EGFR-mutant NSCLC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6526</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6526.jpg</image:loc><image:title>EcDNA-mediated oncogene amplification underlies EGFR TKI resistance in NSCLC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6527</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6527.jpg</image:loc><image:title>Phospho-reprogramming mitochondrial respiration underlies sunitinib resistance in renal cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6528</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6528.jpg</image:loc><image:title>SIPA1L3 loss induces TKI resistance via Rap1-MAPK activation in ALK-/RET-fusion positive NSCLC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6529</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6529.jpg</image:loc><image:title>FER drives drug-tolerant persister cell survival in EGFR-mutant lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6530</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6530.jpg</image:loc><image:title>Cancer persister cells are sensitized to copper-mediated death</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6531</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6531.jpg</image:loc><image:title>Integrated multi-omics and spatial transcriptomics reveal tumor stroma co-evolution driving dabrafenib resistance in BRAF-V600E cholangiocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6532</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6532.jpg</image:loc><image:title>Missense mutant p53 regulates DNA replication and damage response to promote resistance to targeted therapies in ALK fusion lung adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6533</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6533.jpg</image:loc><image:title>Resistance to sorafenib leads to epithelial-to-mesenchymal transition and alterations in cell phenotype in HCC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6534</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6534.jpg</image:loc><image:title>Multi-omics identifies EMT and PI3K/AKT pathways as mechanisms for Astragalus membranaceus polysaccharide-mediated reversal of osimertinib resistance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6535</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6535.jpg</image:loc><image:title>BRAF/EGFR inhibition induces ERBB2 as a targetable tolerance mechanism in BRAF -mutant colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6536</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6536.jpg</image:loc><image:title>Characterization of TKI-induced drug-tolerant persister cells from patient-derived cell lines</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6537</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6537.jpg</image:loc><image:title>Neuregulin-1(NRG1 ) -directed therapies induce alkaline phosphatase placental (ALPP) expression in NRG1 -fusion positive cancers: Preclinical data and therapeutic perspective</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6538</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6538.jpg</image:loc><image:title>Genome-wide CRISPR-Cas9 screen identifies genes conferring lenvatinib resistance in hepatocellular carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6539</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6540</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6541</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6542</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6542.jpg</image:loc><image:title>Antitumor and antiangiogenic activities of E7386 in combination with lenvatinib in human endometrial carcinoma xenograft models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6543</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6544</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6544.jpg</image:loc><image:title>Mechanistic studies of fibroblast activation protein activated prodrug AVA6000 in pancreatic and liposarcoma models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6545</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6545.jpg</image:loc><image:title>Restoring antitumor immunity and improving immunotherapy outcomes in KRAS-mutant NSCLC through MYC inhibition by OMO-103</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6546</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6546.jpg</image:loc><image:title>Targeting spatial patterns of CAFs and tumor cells for precision stroma-targeted radionuclide therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6547</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6547.jpg</image:loc><image:title>Next-generation human vascularized tumor models reveal HER2-independent efficacy and reduced vascular toxicity of T-DXd</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6548</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6548.jpg</image:loc><image:title>Targeted modulation of the blood-tumor barrier enhances drug delivery and survival in glioblastoma models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6549</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6549.jpg</image:loc><image:title>Chromosome 3p mutations drive unique and non-redundant transcriptional programs in primary ccRCC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6550</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6550.jpg</image:loc><image:title>Frequent intra-regional PLAP expression heterogeneity in gastric adenocarcinomas</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6551</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6552</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6552.jpg</image:loc><image:title>MRE11 deficiency occurs in a small group of cancers from various different tumor entities</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6553</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6553.jpg</image:loc><image:title>Evaluation of folate receptor-alpha antibody-drug conjugate mirvetuximab soravtansine-gynx in ovarian cancer PDXs</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6554</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6554.jpg</image:loc><image:title>LymphGen-based stratification of DLBCL PDX models mirrors clinical tumor complexity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6555</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6555.jpg</image:loc><image:title>The OTP, CD44, Ki67 biomarker panel predicts prognosis in preoperative lung NET biopsy specimens</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6556</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6556.jpg</image:loc><image:title>HMGB1 expression is linked to unfavorable tumor features and poor prognosis in colorectal cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6557</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6557.jpg</image:loc><image:title>Homogeneity of mesothelin expression is tightly linked to its levels of expression in non-small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6558</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6559</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6559.jpg</image:loc><image:title>Nectin-4 expression is abundant in many different cancer entities</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6560</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6560.jpg</image:loc><image:title>Claudin-6 (CLDN6) expression is abundant in many different cancer entities</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6561</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6562</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6563</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6563.jpg</image:loc><image:title>TROP2 expression is abundant in primary and recurrent prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6564</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6564.jpg</image:loc><image:title>Tumor cell ICAM-1 expression is frequent in many tumor entities and linked to unfavorable tumor phenotype in renal cell carcinomas</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6565</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6566</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6566.jpg</image:loc><image:title>A novel digital PCR assay can detect MLH1 variants in patients with hereditary colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6567</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6567.jpg</image:loc><image:title>TM-PAP, everywhere you need it: Cross-species, multi-host panel for fast readouts</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6568</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6568.jpg</image:loc><image:title>A paclitaxel-induced rat model of chemotherapy-induced alopecia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6569</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6570</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6571</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6572</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6573</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6573.jpg</image:loc><image:title>Characterization of LY4257496, a novel GRPR antagonist radiolabeled with lutetium-177</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6574</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6575</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6576</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6576.jpg</image:loc><image:title>Innovative theranostic Trop2 antibody-radionuclide conjugates (ARCs) for precision medicine</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6577</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6577.jpg</image:loc><image:title>Novel peptide radioligands targeting CAIX for theranostic applications in clear cell renal cell carcinoma (ccRCC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6578</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6579</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6579.jpg</image:loc><image:title>FLASH reduces radiation-induced oral mucositis in a mouse model of Fanconi anemia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6580</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6581</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6582</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6582.jpg</image:loc><image:title>Blocking hERG1 enhances radiation sensitization in glioblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6583</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6584</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6585</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6586</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6586.jpg</image:loc><image:title>From simulation to reality: Evidence supporting safe high-dose TTFields delivery with the LB10000</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6587</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6587.jpg</image:loc><image:title>High-dose adaptive tumor treating fields (TTFields): Expanding the boundaries of electric field therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6588</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6589</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6590</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6591</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6591.jpg</image:loc><image:title>A universal duplex sequencing approach for accurate detection of somatic mutations</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6592</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6592.jpg</image:loc><image:title>BET domain functions in IDH1 R132H /p53 mut /ATRX loss astrocytoma malignancy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6593</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6593.jpg</image:loc><image:title>Synergistic effects of HM97662 as an EZH1/2 dual inhibitor combined with DNA-damaging agents on malignant lung cancers harboring SMARCA4-deficiency</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6594</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6594.jpg</image:loc><image:title>Telomir-1: A novel metal ion modulator targeting aging-related disorders and cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6595</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6595.jpg</image:loc><image:title>Therapeutic potential of PCNA and HDAC inhibitor combinations in cutaneous T-cell lymphoma and other cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6596</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6596.jpg</image:loc><image:title>Highly selective HDAC6 inhibitors: Are they the answer for immunomodulation?</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6597</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6597.jpg</image:loc><image:title>Targeting KMT2C induces paralog synthetic lethality in KMT2D null DLBCL through DREAM targets regulation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6598</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6599</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6599.jpg</image:loc><image:title>EP102: Pharmacological inhibition of METTL3 is effective as a monotherapy and potentiates radiation therapy in pancreatic adenocarcinoma via DNA damage and stemness modulation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6600</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6600.jpg</image:loc><image:title>p300 bromodomain inhibitors impair cell proliferation by inducing senescence in HPV positive head and neck squamous cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6601</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6601.jpg</image:loc><image:title>Development of a new class of KAT6A/B inhibitors with in vivo efficacy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6602</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6602.jpg</image:loc><image:title>Targeting MTAP-deleted/KRAS mutant cancers using RAS inhibitors in combination with AMG 193, an MTA-cooperative PRMT5 inhibitor</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6603</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6603.jpg</image:loc><image:title>Comparative in vivo evaluation of RG-7388, CM-272, and SGI-1027 to determine epigenetic targeting as an effective strategy for treating high-risk neuroblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6604</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6604.jpg</image:loc><image:title>Synergistic cytotoxicity through combination of DNA methyltransferase (DNMT) inhibitors in cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6605</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6605.jpg</image:loc><image:title>Co-targeting menin and LSD1 dismantles oncogenic programs and restores differentiation in MLL-rearranged acute myeloid leukemia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6606</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6606.jpg</image:loc><image:title>Butyrate modulates key oncogenic pathways in oral squamous cell carcinoma: Insights from transcriptomic profiling</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6607</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6607.jpg</image:loc><image:title>CRISPRi screening identifies epigenetic vulnerabilities and an ARID1A-PRC2 synthetic-lethal axis sensitizing cutaneous T-cell lymphoma to combined JAK/STAT and EZH2 inhibition</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6608</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6608.jpg</image:loc><image:title>Targeted inhibition of PRC1 in acute leukemia models induces prominent cell growth and differentiation effects</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6609</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6609.jpg</image:loc><image:title>PLX-61639, a potent and orally bioavailable SMARCA2-selective monovalent direct degrader, enhances efficacy of standard of care agents in SMARCA4 mutant tumor models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6610</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6610.jpg</image:loc><image:title>Preclinical characterization of FHT-171, a first-in-class degrader targeting CREB-binding protein (CBP) in CBP-dependent solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6611</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6611.jpg</image:loc><image:title>Discovery of a highly potent and selective KAT6A degrader ATH-002 that demonstrates robust anti-tumor activity with a low risk of hematotoxicity in preclinical studies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6612</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6612.jpg</image:loc><image:title>ISM1745, an MTA-cooperative PRMT5 inhibitor for the treatment of MTAP-deleted cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6613</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6614</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6614.jpg</image:loc><image:title>Pseudoginsenoside F11 enhances YBX1-mediated transcriptional repression of PRPS2 to inhibit the stemness and pulmonary metastasis of triple negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6615</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6615.jpg</image:loc><image:title>ABSK211, a highly potent and orally available pan-KRAS inhibitor, demonstrates robust antitumor efficacy in combination with multiple agents</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6616</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6617</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6617.jpg</image:loc><image:title>Obscurin-PH as a chemo-sensitizer in triple-negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6618</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6618.jpg</image:loc><image:title>Preclinical characterization of a potent and selective Werner helicase (WRN) inhibitor with activity in low-TA repeat microsatellite instability-high (MSI-H) cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6619</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6619.jpg</image:loc><image:title>Optimizing the linker of venetoclax-artemisinin conjugates to improve water solubility and antileukemia effects</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6620</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6620.jpg</image:loc><image:title>NAD(P)H: Quinone oxidoreductase 1 (NQO1): Is it a potential molecular target in colorectal cancer?</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6621</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6621.jpg</image:loc><image:title>Diphyllin induces autophagy-mediated ferroptosis in liver cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6622</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6622.jpg</image:loc><image:title>Preclinical characterization of ABSK211: A highly potent, orally bioavailable and selective pan-KRAS inhibitor with broad and robust activity in KRAS-driven tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6623</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6623.jpg</image:loc><image:title>DWP216, a TEAD1/2 inhibitor, enhances efficacy of diverse KRAS inhibitors by reversing resistance mechanisms in RAS-dependent cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6624</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6624.jpg</image:loc><image:title>Highly potent and mutant-selective p53 Y220C reactivators with best-in-class potential</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6625</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6625.jpg</image:loc><image:title>Potential use of MYCN and AURKA dual inhibitors for the treatment of pediatric cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6626</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6626.jpg</image:loc><image:title>Discovery of QLS1303, a potent and selective KIF18A inhibitor with robust anti-tumor activity in CIN+ preclinical cancer models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6627</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6627.jpg</image:loc><image:title>QLS1403, a novel and potent PARG inhibitor with robust anti-tumor efficacy in homologous recombination deficient cancer models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6628</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6628.jpg</image:loc><image:title>Design and development of a biparatopic antibody-drug conjugate against CDH17</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6629</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6629.jpg</image:loc><image:title>Non-clinical characterization of GSK5764227, a novel B7-H3-directed antibody-drug conjugate (ADC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6630</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6630.jpg</image:loc><image:title>Novel Ect2-Rac inhibitor CPV-337 in breast and pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6631</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6631.jpg</image:loc><image:title>VS-7375: An oral, selective KRAS G12D dual ON/OFF inhibitor with potent anti-tumor activity as a single agent and in combination with other agents</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6632</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6632.jpg</image:loc><image:title>Discovery of first-in-class YTHDC1 small molecule inhibitors for the treatment of MYC-driven cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6633</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6633.jpg</image:loc><image:title>Overcoming cytidine deaminase (CDA) mediated resistance via EO-4426 dual DNA-replication targeting: Implications for CDA-high solid tumors and mesenchymal GBM</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6634</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6634.jpg</image:loc><image:title>Evaluation of anti-parasitic agents as potential therapeutics in ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6635</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6635.jpg</image:loc><image:title>BBO-11818: An orally bioavailable, highly potent and selective non-covalent pan-KRAS(ON) and (OFF) inhibitor with robust anti-tumor activity in KRAS-mutant preclinical models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6636</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6636.jpg</image:loc><image:title>Therapeutic targeting of ADAR1 p150 splicing activity impairs CD44 + TNBC cell populations in preclinical studies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6637</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6637.jpg</image:loc><image:title>Q-2361, a treatment for skin cancer prevention in organ transplant recipients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6638</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6638.jpg</image:loc><image:title>Dual FLT3/BRAF inhibitor PHI3 overcomes RAS-driven resistance in FLT3-mutant AML</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6639</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6639.jpg</image:loc><image:title>Polyamine depletion via ivospemin and doxorubicin combination treatment leads to alterations in the ovarian tumor immune microenvironment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6640</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6640.jpg</image:loc><image:title>Preclinical development of a first-in-class CD64-ADC to target leukemic monocytes and tumor-associated macrophages</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6641</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6641.jpg</image:loc><image:title>Phosphonate-antibody-drug conjugates, a novel immunostimulatory class of ADCs driving inside-out activation of Vgamma9Vdelta2 T cells leading to selective tumor cell killing</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6642</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6642.jpg</image:loc><image:title>BHB810: A novel site-specific CDH17-directed VHH-Fc ADC for gastric cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6643</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6643.jpg</image:loc><image:title>Targeting tumor-specific Tn-glycoforms of MUC1 and MUC4 with first-in-class antibody-drug conjugates: Preclinical efficacy and translational potential of GO-M100B and GO-M400</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6644</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6644.jpg</image:loc><image:title>Leveraging AI-enhanced multi-omics discovery of novel tumor-selective targets for ADC development</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6645</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6645.jpg</image:loc><image:title>An AI-guided biparatopic DLL3-targeting ADC demonstrates enhanced preclinical efficacy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6646</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6646.jpg</image:loc><image:title>ADCE-T02 - A clinical stage antibody drug conjugate targeting tissue factor demonstrates strong efficacy in preclinical models of head and neck squamous cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6647</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6647.jpg</image:loc><image:title>Dual-payload antibody drug conjugate targeting TROP2: Multi-Payload Conjugates&amp;#8482; targeting orthogonal mechanisms of cell killing</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6648</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6648.jpg</image:loc><image:title>Targeting intracellular KRAS G12D /HLA-A11 pMHC with a novel TCR-mimic antibody-drug conjugate (TCRm-ADC) demonstrates potent antitumor activity in preclinical models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6649</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6649.jpg</image:loc><image:title>Preclinical efficacy of BCG018, an ADC targeting ITGB6 and incorporating a topoisomerase I inhibitor payload, was demonstrated to be effective in PDX models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6650</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6650.jpg</image:loc><image:title>Preclinical study of BCG044, a novel bispecific ADC targeting EpCAM and HER3 for the treatment of colorectal and other tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6651</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6651.jpg</image:loc><image:title>BCG045: A first-in-class bispecific ADC targeting TROP2 and MUC1 demonstrates promising tumor efficacy and potentially reduced toxicity in preclinical studies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6652</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6652.jpg</image:loc><image:title>GQ1035: First-in-class ADC against novel targets for gastric cancer and ovarian cancer discovered via high-throughput screening&amp;#8203;</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6653</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6653.jpg</image:loc><image:title>Integrated evaluation of payload-, Fc-, and target-mediated mechanisms of ADCs using streamlined complementary platforms</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6654</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6654.jpg</image:loc><image:title>BCG029: An ADAM9-Targeting ADC Featuring a Novel Topoisomerase I Inhibitor Payload Demonstrated Potent Efficacy in PDX Models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6655</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6655.jpg</image:loc><image:title>A novel MSLN&amp;#215;CDH3 bispecific antibody-drug conjugate (BsADC) demonstrates promising anti-tumor efficacy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6656</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6656.jpg</image:loc><image:title>BCG046, a CDCP1 ADC that targets CTF, has demonstrated potent in vitro and in vivo efficacy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6657</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6657.jpg</image:loc><image:title>BCG026: FAP &amp;#215; GPC1 bispecific ADC - A novel targeting approach for stromal and tumor cells in pancreatic cancer and other solid tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6658</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6658.jpg</image:loc><image:title>Tri-specific ADC platform offers potential therapeutic advantage over bi-specific ADC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6659</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6659.jpg</image:loc><image:title>A first-in-class PD-L1/B7-H3/VEGF tri-specific ADC achieves enhanced preclinical antitumor efficacy through direct cytotoxicity, immune checkpoint blockade and VEGF inhibition</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6660</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6660.jpg</image:loc><image:title>Bi- and tri-specific ADCs that target two distinct growth factor receptor forms of MUC1* and HER2 or alpha-v-beta-6 inhibit tumor recurrence and overcome acquired resistance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6661</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6661.jpg</image:loc><image:title>Validation of HER2, TROP2, and NECTIN4 IHC prediction algorithms for the ADC MATCH trial</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6662</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6662.jpg</image:loc><image:title>Bispecific antibody with dual-payload ADC for metastatic castration-resistant prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6663</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6663.jpg</image:loc><image:title>Preclinical evaluation of a novel and highly differentiated FGFR2b-targeting ADC with low risk of ocular toxicity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6664</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6664.jpg</image:loc><image:title>HDM2024: A novel EGFR and HER3 bispecific antibody-drug conjugate exhibits superior antitumor activity and favorable toxicological profile</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6665</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6665.jpg</image:loc><image:title>Preclinical evaluation of BCG017, a novel bispecific ADC targeting PTK7 and EGFR</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6666</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6666.jpg</image:loc><image:title>A novel bispecific antibody-drug conjugate, BCG016, that targets 5T4 and MUC1, demonstrates robust preclinical antitumor activity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6667</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6667.jpg</image:loc><image:title>A novel bispecific antibody-drug conjugate targeting CEACAM5 and CDH17 exhibits potent anti-tumor activity and enhanced tumor-selectivity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6668</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6668.jpg</image:loc><image:title>A novel multi-modal PD-L1-ADC could be a potential BIC candidate treatment for pan-solid tumors with enhanced tumor-specificity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6669</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6670</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6671</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6672</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6673</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6674</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6675</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6675.jpg</image:loc><image:title>Improving immune checkpoint blockade efficacy using combination therapy with bioactive molecules</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6676</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6677</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6677.jpg</image:loc><image:title>Expanding multiplexing capabilities with TrailBlazer StarBright Dye antibody conjugation kits</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6678</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6678.jpg</image:loc><image:title>Empowering IL-2 therapy development: A novel humanized mouse model with functional IL-2 and IL-15 receptors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6679</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6680</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6680.jpg</image:loc><image:title>Utilizing a humanized CD8 mouse model for non-clinical studies of cancer immunotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6681</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6681.jpg</image:loc><image:title>A novel humanized mouse model for evaluating anti-human IL23R drugs</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6682</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6682.jpg</image:loc><image:title>Humanized HLA-A11.1 mice: A preclinical platform for novel vaccine evaluation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6683</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6683.jpg</image:loc><image:title>Preclinical assessment of cell, gene, and antibody therapies using humanized mice</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6684</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6685</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6685.jpg</image:loc><image:title>RBM10 loss promotes KRAS -mutant non-small cell lung cancer immune tolerance and PD-1 inhibitor resistance via a non-canonical STING/ NF-&amp;#954;B axis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6686</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6687</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6687.jpg</image:loc><image:title>Direct adhesion of activated platelets suppresses anti-tumor activity of CTL through CD62p-PSGL1 binding</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6688</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6689</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6689.jpg</image:loc><image:title>Targeting PDE4A ablates an immune checkpoint and unleashes STING-Driven anti-tumor immunity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6690</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6690.jpg</image:loc><image:title>Proline metabolic competition drives CD8&amp;#8314; T cell ferroptosis in BRAF-mutated thyroid cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6691</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6691.jpg</image:loc><image:title>Spatial immune landscape in metastatic colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6692</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6692.jpg</image:loc><image:title>Immune regulatory functions and therapeutic opportunities of MIF signaling in pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6693</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6693.jpg</image:loc><image:title>Defining mechanisms limiting NK cell function in the multiple myeloma tumor microenvironment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6694</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6694.jpg</image:loc><image:title>Use of non-steroidal anti-inflammatory drugs, acetaminophen and somatic immune profiles in breast tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6695</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6695.jpg</image:loc><image:title>GDF-15 inhibition overcomes treatment resistance to platinum- and taxane-based cytotoxic chemoimmunotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6696</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6696.jpg</image:loc><image:title>Genome-wide CRISPR screening reveals tumor-intrinsic immune evasion mechanism in ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6697</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6697.jpg</image:loc><image:title>Tumor-intrinsic suppression of phagocytosis by RRP1 (ribosomal RNA processing 1) in glioblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6698</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6698.jpg</image:loc><image:title>Immune evasive characteristics of the KRAS mutant colorectal cancer tumor microenvironment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6699</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6699.jpg</image:loc><image:title>The RKIP-HER2 axis regulates breast cancer immune evasion</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6700</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6700.jpg</image:loc><image:title>Tumor cell CEBPB expression contributes to T cell-mediated immune evasion of microsatellite stable colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6701</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6701.jpg</image:loc><image:title>Inhibiting intracellular cPLA2alpha in cervical cancer cells enhances antitumor immunity and facilitates the efficacy of anti-PD1 checkpoint immunotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6702</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6702.jpg</image:loc><image:title>Hypoxia-mediated suppression and memory of IFI44L and its interaction with STING in breast cancer metastasis and immune evasion</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6703</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6704</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6704.jpg</image:loc><image:title>From correlation to causation: SOX11 drives a coordinated immune-suppressive network that represses antigen presentation in triple-negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6705</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6705.jpg</image:loc><image:title>Trogocytosis-orchestrated CLDN18.2-dressed CD8 + T cells drive pancreatic cancer progression via glucose metabolic reprogramming-induced cytotoxicity debilitation and systematic immune senescence-cascade</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6706</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6706.jpg</image:loc><image:title>ROCK2-regulated LIF-STAT3 drives immunosuppression in pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6707</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6707.jpg</image:loc><image:title>Single-cell multi-omics identifies MRD-associated Tr1-like CD4 cells in B-ALL</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6708</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6708.jpg</image:loc><image:title>SPIN1 drives PD-1 immunotherapy resistance in gastric cancer by inducing M2 macrophage polarization and suppressing CD8&amp;#8314; T-cell immunity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6709</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6709.jpg</image:loc><image:title>USP5 suppresses MRE11 endonuclease function to facilitate tumor immune escape</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6710</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6710.jpg</image:loc><image:title>Targeting sialylation promotes anti-tumor immunity in small cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6711</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6711.jpg</image:loc><image:title>EMP2 is a potential immunotherapeutic target to modulate macrophage-induced phagocytosis in glioblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6712</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6712.jpg</image:loc><image:title>The CBS-CXCL10 signaling axis supports tumor progression by driving immune suppression within the tumor microenvironment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6713</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6713.jpg</image:loc><image:title>B-NDG hIL15, FcgammaR KO mice: An optimized humanized model for evaluating T cell-modulating antibodies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6714</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6714.jpg</image:loc><image:title>A CD3/CD19 double-humanized mouse model for preclinical evaluation of CD19-targeted T-cell engagers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6715</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6715.jpg</image:loc><image:title>Endogenous retrovirus-derived neoantigens enable a personalized cancer vaccine strategy for glioblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6716</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6716.jpg</image:loc><image:title>B-CDG mice: A novel severe immunodeficient model suitable for radiotherapeutic and radiopharmaceutical evaluation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6717</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6717.jpg</image:loc><image:title>B-NDG MHC I/II DKO mice plus: A refined humanized model for evaluating T cell engager efficacy and toxicity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6718</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6718.jpg</image:loc><image:title>HIS models lacking FcgammaR provide increased predictability and facilitate study design for evaluation of immuno-oncology therapeutics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6719</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6719.jpg</image:loc><image:title>An immune-competent, durable MB49-Luc orthotopic bladder cancer model demonstrates bladder-specific tumor immunity for translational immunotherapy research</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6720</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6720.jpg</image:loc><image:title>PDX ovo : Avian embryos as hosts for rapid and quantitative modelling of immunotherapy responses in patient-derived xenografts</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6721</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6721.jpg</image:loc><image:title>Involvement of type I interferon signaling in anti-PD-1-induced tumor rejection in a novel humanized NOG-FcgammaR&amp;#8315;/&amp;#8315; mouse model</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6722</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6722.jpg</image:loc><image:title>Patient-derived uveal melanoma organoids reveal HLA-I-restricted tumor antigens and tumor-reactive T cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6723</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6723.jpg</image:loc><image:title>A novel syngeneic model for evaluating the efficacy of MYC-driven liver cancer targeted and immunotherapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6724</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6724.jpg</image:loc><image:title>Modeling late-stage ovarian cancer and validating oncolytic adenoviral tools for transgene expression and tumor monitoring</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6725</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6725.jpg</image:loc><image:title>Overcoming pancreatic ductal adenocarcinoma immunoresistance: Microfluidic-primed organoid interacting lymphocytes demonstrate superior infiltration, cytotoxicity, and tumor suppression in patient-derived models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6726</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6727</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6727.jpg</image:loc><image:title>Tumor treating fields (TTFields) enhance chemotherapy-induced proteotoxic stress in pancreatic cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6728</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6728.jpg</image:loc><image:title>Hypoxia selects for early PI3K pathway alterations and drives clonal complexity in HPV-positive oropharyngeal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6729</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6729.jpg</image:loc><image:title>Hypoxia-driven HIF-1alpha/YAP-AXL signaling drives adaptive resistance to TKIs in NSCLC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6730</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6730.jpg</image:loc><image:title>The impact of oxygen exposure on clinical biomarkers - an underrecognized source of pre-analytic variability</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6731</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6731.jpg</image:loc><image:title>SDHA isoform expression modulates reverse electron flow during hypoxia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6732</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6733</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6733.jpg</image:loc><image:title>A KRAS G12V-mutant patient-derived organoid model of brain metastasis as a target discovery platform</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6734</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6734.jpg</image:loc><image:title>HIF-1alpha pathway is a therapeutic vulnerability in mucinous colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6735</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6735.jpg</image:loc><image:title>Extracellular acidosis modulates calcium signaling and adaptive resistance mechanisms in acute myeloid leukemia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6736</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6736.jpg</image:loc><image:title>A new approach to lung cancer treatment: Targeting endoplasmic reticulum stress</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6737</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6738</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6738.jpg</image:loc><image:title>Effect of chronic exposure to acidic pH on the MOLM-13 acute myeloid leukemia cell line</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6739</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6739.jpg</image:loc><image:title>Critical involvement of PRELID2 in the regulation of mitochondrial homeostasis in renal carcinogenesis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6740</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6741</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6741.jpg</image:loc><image:title>Lactate mediated suppression of tumor intrinsic type I interferon response in luminal breast cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6742</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6742.jpg</image:loc><image:title>Evaluating the unfolded protein response as a therapeutic target in clear cell renal cell carcinoma patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6743</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6743.jpg</image:loc><image:title>Does ribosomal protein haploinsufficiency induce cell competition in mammalian epithelia?</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6744</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6744.jpg</image:loc><image:title>Cyclin-dependent kinase 5 (CDK5) contributes to Bruton tyrosine kinase inhibitor (BTKI) resistance via IRE1alpha/Xbp1s axis in mantle cell lymphoma (MCL)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6745</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6746</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6746.jpg</image:loc><image:title>Chronic extracellular acidosis drives metabolic plasticity and adaptive survival in multiple myeloma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6747</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6747.jpg</image:loc><image:title>Interplay between HIF-1alpha and HIF-2alpha modulates TNBC phenotypes</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6748</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6748.jpg</image:loc><image:title>Characterization of PERK-positive polyploid-like breast cancer cells and their association with unfolded protein response signatures</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6749</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6749.jpg</image:loc><image:title>A SWI/SNF-specific Ig-like domain, SWIFT, is a transcription factor binding hub</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6750</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6750.jpg</image:loc><image:title>Integrated spatial multiomic profiling of 3D genome architecture and transcriptome-wide gene expression in breast cancer models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6751</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6751.jpg</image:loc><image:title>Defining and targeting drivers of lineage plasticity in stem cell-like prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6752</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6752.jpg</image:loc><image:title>LDB1-dependent enhancer connectivity constrains a metabolic synthetic lethality in T-cell acute lymphoblastic leukemia</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6753</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6753.jpg</image:loc><image:title>Cis-regulatory role of alternative promoters in cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6754</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6755</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6756</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6756.jpg</image:loc><image:title>Decoding 3D enhancer architecture identifies hierarchical oncogenic regulatory programs in prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6757</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6757.jpg</image:loc><image:title>In-situ direct single-cell visualization of 3D genome architecture in ER+ and HER2+ breast cancer cell lines using PaintScape TM system</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6758</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6759</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6759.jpg</image:loc><image:title>Mechanistic dissection of ABI1 as DNA-binding transcriptional regulator in cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6760</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6760.jpg</image:loc><image:title>Transcriptional control of myeloid differentiation trajectories in AML</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6761</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6761.jpg</image:loc><image:title>BPTF regulates androgen receptor activity in prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6762</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6762.jpg</image:loc><image:title>RUNX1T1 as an early driver in treatment-induced neuroendocrine transdifferentiation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6763</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6763.jpg</image:loc><image:title>SYMPK regulates AR alternative polyadenylation and AR variant expression in advanced prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6764</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6764.jpg</image:loc><image:title>Pioneer round of translation factor CTIF regulates tumor immunity in drug-tolerant persister cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6765</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6765.jpg</image:loc><image:title>The landscape of alternative splicing in hepatocellular carcinoma and its association with TP53 mutation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6766</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6766.jpg</image:loc><image:title>Regulation of TbRIII expression and ectodomain shedding via the sheddase, PRSS8, and ERG transcription factor</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6767</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6767.jpg</image:loc><image:title>Post-transcriptional upregulation of GPC3 via CSTF2-driven 3&#039;UTR remodeling promotes hepatocellular carcinoma progression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6768</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6768.jpg</image:loc><image:title>RNA binding proteins mediated oncogenic adaptions in cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6769</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6770</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6770.jpg</image:loc><image:title>Identification of KDR as a novel effector downstream of ETS variant transcription factor 4 in NSCLC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6771</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6771.jpg</image:loc><image:title>NRG1 knock out in cancer cell lines decreases their aggressiveness</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6772</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6773</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6773.jpg</image:loc><image:title>RNA-seq analysis confirms post-thaw transcriptomic stability in ThawReady (TM) THP-1 assay-ready cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6774</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6775</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6776</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6776.jpg</image:loc><image:title>DPF3a-YY1 cooperation drivesimmunosuppression in renal cell carcinoma by activating CSF2 transcription</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6777</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6778</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6778.jpg</image:loc><image:title>ETS1 orchestrates a hybrid EMT program to drive metastasis and immune evasion in UASCC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6779</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6779.jpg</image:loc><image:title>Investigating the interplay of transcription factor, ERG, and TGF-beta signaling in cervical cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6780</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6781</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6781.jpg</image:loc><image:title>The role of USP21 in prostate cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6782</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6782.jpg</image:loc><image:title>Side-by-side evaluation of STAT3 targeted agents in oncology</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6783</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6784</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6785</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6786</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6786.jpg</image:loc><image:title>Molecular differences between ovarian and uterine carcinosarcomas</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6787</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6787.jpg</image:loc><image:title>MBCproject: multi-omic profiling of metastatic breast cancer evolution through patient-partnered research</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6788</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6789</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6789.jpg</image:loc><image:title>Genomic architecture of prostate cancer in BRCA1/2 germline carriers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6790</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6790.jpg</image:loc><image:title>AI-Driven stratification of cancer patients using The Cancer Genome Atlas whole-genome sequencing data</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6791</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6792</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6792.jpg</image:loc><image:title>Comprehensive mutation profiling from The Cancer Genome Atlas (TCGA) whole-genome sequencing datasets</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6793</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6794</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6794.jpg</image:loc><image:title>Genomic Concordance Patterns Distinguish Multiple Primary Tumors from Metastatic Recurrences</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6795</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6795.jpg</image:loc><image:title>Structural variant signature discovery across &gt;8,000 TCGA whole genomes using QuantHDP</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6796</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6797</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6797.jpg</image:loc><image:title>Understanding cutaneous immune-related adverse events at single-cell resolution</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6798</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6799</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6799.jpg</image:loc><image:title>Beyond HLA LOH: Alternative modes of HLA loss are common and vary by cancer type</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6800</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6800.jpg</image:loc><image:title>Pan-cancer single-cell RNA sequencing analysis refines multiorigin monocyte and macrophage lineages</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6801</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6802</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6803</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6804</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6804.jpg</image:loc><image:title>Clinically significant cancer variants detected by comprehensive genomic profiling test PGDx elio tissue complete</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6805</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6806</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6806.jpg</image:loc><image:title>Targeting sulfatide metabolism as a therapeutic vulnerability in pancreatic pre-cancer lesions</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6807</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6808</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6808.jpg</image:loc><image:title>Pancreatic ductal adenocarcinoma causes altered whole-body iron distribution</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6809</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6809.jpg</image:loc><image:title>Targeting HDAC1 activity presents vulnerabilities in pancreatic cancer metabolism</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6810</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6810.jpg</image:loc><image:title>KRAS-PIP5K1A-SDC1 axis regulates nutrient scavenging in pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6811</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6811.jpg</image:loc><image:title>The link between metabolism and inflammation in Black African pancreatic ductal adenocarcinoma patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6812</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6812.jpg</image:loc><image:title>Vav1 promotes pancreatic tumor cell invasion via GLS1-dependent glutamine metabolism</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6813</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6813.jpg</image:loc><image:title>ACADS-dependent fatty acid oxidation drive mitochondrial remodeling in pancreatic cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6814</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6814.jpg</image:loc><image:title>HER3 mediates metabolic reprogramming in metastatic colorectal and pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6815</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6815.jpg</image:loc><image:title>Cytosolic transport of citrate protects nutrient-austere pancreatic cancer from ferroptosis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6816</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6816.jpg</image:loc><image:title>PU-H71 alters metabolism to suppress growth in pancreatic cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6817</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6817.jpg</image:loc><image:title>Dissecting lysosomal metabolic dependencies in pancreatic cancer through functional genomics</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6818</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6818.jpg</image:loc><image:title>EPR imaging of oxygen consumption driven by NQO1-activated compounds in FH-deficient renal tumors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6819</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6819.jpg</image:loc><image:title>Host organ environment shapes clear cell renal cell carcinoma metastatic metabolism</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6820</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6820.jpg</image:loc><image:title>Hypoxia enhances sensitivity to RAS inhibition in PDAC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6821</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6821.jpg</image:loc><image:title>Hepatic proton conductance as a bioenergetic vulnerability and therapeutic target in MASH-associated HCC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6822</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6823</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6823.jpg</image:loc><image:title>Disrupting tumor lipid homeostasis by MUFA depletion drives cell death in HCC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6824</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6824.jpg</image:loc><image:title>Mitochondrial creatine kinase promotes hepatocellular carcinoma progression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6825</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6825.jpg</image:loc><image:title>Spatio-temporal interactome of fructose-1,6-bisphosphate aldolase B in hepatocellular carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6826</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6827</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6827.jpg</image:loc><image:title>Estrogen-related receptor gamma maintains oxidative metabolism via glutamine-derived anaplerosis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6828</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6829</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6830</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6830.jpg</image:loc><image:title>Exploring the role of PNPLA3 I148M in cancer using the selective small molecule degrader NUV-244</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6831</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6831.jpg</image:loc><image:title>Early cancer detection using early-access Illumina protein prep 6K assay and machine learning</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6832</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6833</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6833.jpg</image:loc><image:title>Early detection of pancreatic cancer with a multi-omic liquid biopsy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6834</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6834.jpg</image:loc><image:title>A multi-omic liquid biopsy for the earlier detection of ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6835</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6836</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6837</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6837.jpg</image:loc><image:title>Early-onset colorectal cancer detection through a non-invasive label-free electrochemical immunosensor probe</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6838</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6838.jpg</image:loc><image:title>Breaking barriers to scalable multi-cancer early detection (MCED)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6839</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6840</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6840.jpg</image:loc><image:title>Liquid biopsy MCED enabled by a novel 800K-locus bimodal amplicon sequencing technology</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6841</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6841.jpg</image:loc><image:title>Development of a blood-based tumor hypoxia detection assay</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6842</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6843</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6844</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6845</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6846</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6846.jpg</image:loc><image:title>Predicting and preventing cancer stemness in low Earth orbit</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6847</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6847.jpg</image:loc><image:title>Plasma proteomics for risk prediction of lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6848</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6849</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6850</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6851</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6852</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6853</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6853.jpg</image:loc><image:title>Ciliated cells drive critical STING-mediated tumor suppression in fallopian tube epithelium</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6854</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6855</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6856</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6856.jpg</image:loc><image:title>A novel pH-sensitive probe to quantify autophagy on high throughput/content imaging platforms</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6857</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6858</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6858.jpg</image:loc><image:title>Tumor microRNA expressions associated with prostate cancer aggressiveness across independent cohorts</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6859</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6860</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6861</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6862</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6863</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6864</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6865</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6866</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6867</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6867.jpg</image:loc><image:title>Personalized risk assessment of breast cancer using administrative health data</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6868</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6869</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6869.jpg</image:loc><image:title>Survival outcomes in chemotherapy patients using a multi-institutional risk model. A retrospective analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6870</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6870.jpg</image:loc><image:title>Risk factors and prediction models for colorectal cancer in older US individuals</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6871</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6872</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6873</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6873.jpg</image:loc><image:title>Effectiveness of initiating FIT screening at age 45: Comparative yield with adults aged 50-54 years</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6874</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6875</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6876</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6877</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6877.jpg</image:loc><image:title>Tumor and Host Determinants of the Breast Tumor Immune Microenvironment in Kenyan Breast Cancer Women</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6878</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6878.jpg</image:loc><image:title>CT-assessed body composition and tumor immunologic characteristics in patients with endometrial cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6879</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6879.jpg</image:loc><image:title>Characterizing myoepithelial marker loss in young-onset DCIS through integrated mouse and human studies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6880</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6880.jpg</image:loc><image:title>Emotional functioning and NR3C1 and FKBP5 expression in multiple myeloma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6881</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6882</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6882.jpg</image:loc><image:title>Digital access, health literacy, and cancer beliefs: Findings from a multi-region community survey</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6883</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6883.jpg</image:loc><image:title>Association of political ideology and fatalistic cancer beliefs</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6884</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6885</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6886</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6887</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6887.jpg</image:loc><image:title>Understanding beliefs about hereditary susceptibility for cancer: An analysis of HINTS 2020</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6888</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6889</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6889.jpg</image:loc><image:title>Psychological distress, antidepressants, and sympathetic-immune profiles in cancer survivors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6890</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6890.jpg</image:loc><image:title>Use of supportive care medications is associated with pancreatic cancer tumor location at diagnosis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6891</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6891.jpg</image:loc><image:title>Predictors of antidepressant use in older adults after pancreatic cancer diagnosis: A SEER-Medicare analysis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6892</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6893</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6893.jpg</image:loc><image:title>Health literacy and beliefs about cancer causation and prevention in a Haitian immigrant population</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6894</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6895</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6896</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6897</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6898</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6899</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6899.jpg</image:loc><image:title>Characterizing radiation oncologist work patterns with a time-motion study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6900</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6901</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6901.jpg</image:loc><image:title>Advancing the science, practice and impact of COE</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6902</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6902.jpg</image:loc><image:title>Developing patient-derived organoid and xenograft models for preclinical assessment in ovarian cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6903</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6903.jpg</image:loc><image:title>Optimization of tumor tissue enzymatic dissociation for rapid and viable tumoroid generation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6904</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6904.jpg</image:loc><image:title>Ex vivo drug sensitivity and in silico evaluation of phytochemicals in gynaecological cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6905</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6906</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6906.jpg</image:loc><image:title>Genetically defined organoid systems uncover PIK3CA-mediated suppression of an oral-immune program during early squamous neoplastic evolution</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6907</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6907.jpg</image:loc><image:title>Drug screening using patient-derived tumoroids harboring diverse mutations to identify effective therapeutics for metastatic cancer patients</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6908</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6908.jpg</image:loc><image:title>Breast cancer organoids as a complementary preclinical model to PDX, enabling immunotherapy evaluation</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6909</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6909.jpg</image:loc><image:title>Sequential 3D functional profiling shows preserved drug resistance and sensitivity profiles after neoadjuvant treatment in an ovarian cancer patient</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6910</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6910.jpg</image:loc><image:title>Utilizing confocal live-cell imaging for evaluating therapeutic efficacy and toxicity in complex oncology models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6911</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6912</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6912.jpg</image:loc><image:title>Comparative analysis of therapy responses and stem cell marker expression in glioblastoma neurospheres verus monolayer cultures using imaging, cytotoxicity assays, and flow cytometry</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6913</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6913.jpg</image:loc><image:title>Multi-cancer patient-derived organoid platform for translational cancer research</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6914</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6914.jpg</image:loc><image:title>The protease MALT1 is required for chronic lymphocytic leukemia genesis in E&amp;#956;-TCL1 mice</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6915</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6915.jpg</image:loc><image:title>Novel mouse models for cancer research</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6916</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6916.jpg</image:loc><image:title>Over 800! Establishment of an ADC payload efficacy database across diverse tumor cell lines: Foundation for optimized in vitro ADC evaluation and drug development</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6917</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6917.jpg</image:loc><image:title>In vitro and in vivo screening platform for discovery of JAK2 inhibitors</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6918</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6918.jpg</image:loc><image:title>From BTK in-situ mutation (C481S, A428D, etc.) to in vivo screening: A comprehensive platform to address drug resistance in BTK-targeted therapy</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6919</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6919.jpg</image:loc><image:title>Establishment of a translational research ecosystem: A globally networked PDX model platform to accelerate oncology drug development</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6920</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6920.jpg</image:loc><image:title>In vivo metastatic prostate tumor model development and follow-up progression using in vivo bioluminescence imaging</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6921</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6921.jpg</image:loc><image:title>Integrated multi-omics analysis reveals conserved tumor-associated antigens (TAAs) profiles in PDX and organoid models for advancing ADC development</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6922</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6922.jpg</image:loc><image:title>Comprehensive preclinical in vivo oncology platform for rational drug candidate nomination</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6923</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6923.jpg</image:loc><image:title>In vitro and in vivo evaluation of bortezomib using the 5TGM1 cell line and a syngeneic mouse model of multiple myeloma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6924</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6924.jpg</image:loc><image:title>Validation of a bone metastasis technology platform against clinically used standard-of-care therapies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6925</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6925.jpg</image:loc><image:title>Mechanistic insights into reactive oxygen species (ROS) homeostasis in ovarian cancer chemoresistance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6926</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6926.jpg</image:loc><image:title>Development of personalized medicine strategies for rectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6927</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6928</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6929</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6930</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6930.jpg</image:loc><image:title>Proton versus photon VMAT craniospinal irradiation for hematologic leptomeningeal disease: A comparative study</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6931</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6931.jpg</image:loc><image:title>Dynamic molecular and immune characterization for personalized treatment in locally advanced rectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6932</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6933</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6933.jpg</image:loc><image:title>End-to-end in vitro and in vivo evaluation of radiopharmaceuticals in patient-derived models</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6934</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6935</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6935.jpg</image:loc><image:title>HOXA1 promotes radioresistance via activation of the ERK/HIF1A signaling pathway</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6936</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6937</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6937.jpg</image:loc><image:title>Molecular imaging guided precision radiotherapy and quantitative assessment of metastatic colorectal cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6938</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6939</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6939.jpg</image:loc><image:title>HMGB2-mediated radioresistance of glioblastoma stem cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6940</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6941</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6941.jpg</image:loc><image:title>Prolonged radiation exposure alters cellular proteome network in human hepatocellular carcinoma cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6942</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6943</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6943.jpg</image:loc><image:title>TP53 mutants cooperate with H3K27M to enhance survival after DNA damage and drive radioresistance in DIPG</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6944</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6944.jpg</image:loc><image:title>Adhesion plasticity and bidirectional paracrine signaling cooperatively drive glioblastoma invasion</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6945</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6945.jpg</image:loc><image:title>Self-made matrix: Tumor-derived Laminin-alpha5 supports pancreatic cancer cell survival and metastatic persistence</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6946</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6946.jpg</image:loc><image:title>RNA modification control of platinum sensitivity via ADAM23-dependent pathway</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6947</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6947.jpg</image:loc><image:title>SORL1 promotes mesothelial clearance and migration of ovarian cancer cells through regulating integrin trafficking</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6948</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6948.jpg</image:loc><image:title>C-Met and Integrin-alphaV regulated the response of desmoid cells to sorafenib</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6949</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6949.jpg</image:loc><image:title>Unraveling a new ECM stiffening function of the axon guidance molecule Netrin-1</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6950</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6950.jpg</image:loc><image:title>MYBBP1A is part of a mechanically modulated system that alters breast cancer metastatic potential by regulating focal adhesion</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6951</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6951.jpg</image:loc><image:title>Preclinical osimertinib-resistant mouse models for advancing third-generation EGFR-TKI drug development</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6952</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6952.jpg</image:loc><image:title>Novel preclinical models for evaluating checkpoint inhibitor resistance</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6953</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6953.jpg</image:loc><image:title>Development of enhanced enhertu-resistant HER2-positive breast cancer models for ADC resistance research</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6954</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6954.jpg</image:loc><image:title>Modeling of de novo and experimentally induced acquired resistance to trastuzumab deruxtecan in HER2-positive patient-derived xenografts</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6955</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6956</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6956.jpg</image:loc><image:title>Dependent lineage regulatory programs in TP53-mutated acute myeloid leukemia revealed through deep single-cell multi-omic profiling of patient samples</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6957</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6957.jpg</image:loc><image:title>Spindle assembly checkpoint integrity determines sensitivity to KIF18A inhibition in small-cell lung cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6958</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6958.jpg</image:loc><image:title>Spatio-temporal analysis of EGFR inhibitor resistant tumor epithelial clusters</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6959</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6959.jpg</image:loc><image:title>Do secondary MSH3/MSH6 alterations define an immune-modulatory subtype of MSI gastric cancer?</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6960</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6960.jpg</image:loc><image:title>Single-cell transcriptomics identifies distinct EPCAM-low and EPCAM-negative epithelial populations with aggressive phenotypes in hormone-receptor positive breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6961</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6961.jpg</image:loc><image:title>CEACAM1-dominant molecular program drives immune escape in EGFR-mutant lung adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6962</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6962.jpg</image:loc><image:title>Genomic evolution and heterogeneity of von Hippel-Lindau (VHL)-associated clear cell renal cell carcinoma revealed by multi-region whole-genome sequencing</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6963</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6963.jpg</image:loc><image:title>A spatiotemporal cancer cell trajectory underlies glioblastoma heterogeneity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6964</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6964.jpg</image:loc><image:title>Molecular and clinical correlates of extrachromosomal DNA in oral squamous cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6965</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6965.jpg</image:loc><image:title>Extrachromosomal MDM2 amplifications define an ecDNA-permissive tumor cell state that impacts intercellular tumor heterogeneity and treatment response across cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6966</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6966.jpg</image:loc><image:title>Integrated clonal and single-cell analyses uncover progenitor-driven tumor diversification in early-stage endometrioid endometrial carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6967</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6967.jpg</image:loc><image:title>Spatial multimodal and functional dissection reveal a UCHL1-driven malignant program in clear cell renal cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6968</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6968.jpg</image:loc><image:title>Uncovering transdifferentiation mechanisms underlying heterogeneity in neuroblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6969</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6970</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6970.jpg</image:loc><image:title>Evaluation of chemo-radiation therapy&#039;s effect on the senescence status of tumor microenvironment of HNSCC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6971</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6972</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6972.jpg</image:loc><image:title>Mechanistic study of CX3CL1 promoting T cell exhaustion in ESCC via the JAK/STAT3 axis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6973</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6973.jpg</image:loc><image:title>Palmatine modulates tumor microenvironment and improves gemcitabine efficacy in PDAC via HOXA10-STAT3 axis suppression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6974</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6975</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6975.jpg</image:loc><image:title>Longitudinal tumor microenvironment analysis to predict immunochemotherapy response in salivary duct carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6976</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6976.jpg</image:loc><image:title>Longitudinal and spatial heterogeneity of intra-tumoral TCR repertoires during immunotherapy in metastatic cancers</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6977</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6978</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6979</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6979.jpg</image:loc><image:title>Tumors induce a NR4A1 transcriptional program in dendritic cells leading to immune tolerance and cancer progression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6980</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6981</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6982</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6983</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6984</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6984.jpg</image:loc><image:title>Dual stromal and tumoral origins of TWEAK drive CSC maintenance in ovarian cancer relapse</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6985</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6985.jpg</image:loc><image:title>Metabolic dependence of prostate cancer subtypes and its association with the tumor-immune microenvironment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6986</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6986.jpg</image:loc><image:title>Spatial transcriptomics unveils tumor microenvironment changes in murine glioblastoma upon EGFRvIII suppression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6987</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6987.jpg</image:loc><image:title>Dissecting the spatial architecture of plasmacytoid urothelial carcinoma to inform therapeutic strategies</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6988</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6989</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6989.jpg</image:loc><image:title>Residual disease on a dish: A practical approach to deep intrinsic resistance in melanoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6990</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6990.jpg</image:loc><image:title>SPP1 positive macrophage spatial feature correlation to stage III-IV colon cancer multiple pathology parameters</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6991</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6992</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6992.jpg</image:loc><image:title>Mapping immune clonotypes in prostate cancer using spatial V(D)J to resolve cancer vaccine response</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6993</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6994</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6995</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6995.jpg</image:loc><image:title>Tetraspanin-driven metabolic plasticity and chemoresistance in disseminated breast cancer cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6996</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6997</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6997.jpg</image:loc><image:title>Inflammation and chemotherapy induce immune mimicry in PDAC and promote crosstalk between fibroblasts and tumor cells</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6998</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6998.jpg</image:loc><image:title>Electrical activity powered neural circuit sustains systemic immune evasion in gastric cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/6999</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/6999.jpg</image:loc><image:title>Cholesterol-associated immune cell dysfunction across lung cancer progression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7000</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/7000.jpg</image:loc><image:title>Estradiol-responsive niches drive immune exclusion in the tumor microenvironment</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7001</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7002</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/7002.jpg</image:loc><image:title>Evaluation of tumor-infiltrating gammadelta T cells across solid tumor indications</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7003</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/7003.jpg</image:loc><image:title>A pd-l1 acetylation switch coordinates chromosome cohesion and antitumor immunity</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7004</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7005</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7006</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7007</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7008</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/7008.jpg</image:loc><image:title>Senescent regulatory T cells retain potent suppressive function in clear cell renal cell carcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7009</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/7009.jpg</image:loc><image:title>Eosinophils promote an immunosuppressive bone marrow microenvironment in multiple myeloma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7010</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/7010.jpg</image:loc><image:title>UHRF1 as an epigenetic driver of tumorigenicity and immune evasion in triple negative breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7011</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/7011.jpg</image:loc><image:title>STING proton channel function controls T cell survival and tumor immune evasion</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7012</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/7012.jpg</image:loc><image:title>Tumor-intrinsic miR-21a orchestrates Treg-mediated immunosuppression through Pag-1 repression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7013</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/7013.jpg</image:loc><image:title>Clinical impact of intraepithelial versus stromal immune cells in kidney cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7014</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/7014.jpg</image:loc><image:title>MTAP loss reshapes the immune and proliferative landscape of pancreatic ductal adenocarcinoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7015</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/7015.jpg</image:loc><image:title>Targeting cysteine cathepsins to boost gemcitabine in PDAC</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7016</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/7016.jpg</image:loc><image:title>FcRn and macropinocytosis promote albumin uptake in tumor-associated macrophages</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7017</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7018</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7019</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/7019.jpg</image:loc><image:title>CD4 T cells regulate B and plasma cells to restrict tumor growth in Medulloblastoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7020</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7021</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7022</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/7022.jpg</image:loc><image:title>ANXA1 and MYADM regulate CD4 + T cell differentiation and exhaustion in non-small cell lung cancer (NSCLC)</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7023</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/7023.jpg</image:loc><image:title>TGF-beta heterogeneity in cancer cells might be associated with tumor progression in gastric cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7024</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7025</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/7025.jpg</image:loc><image:title>Claudin 18.2 targeted proapoptotic peptide for early pancreatic diagnosis and tumor-target killing</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7026</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7027</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/7027.jpg</image:loc><image:title>IL-33-mediated control of myeloid immunity in glioblastoma progression</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7028</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7029</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/7029.jpg</image:loc><image:title>Localized co-delivery of hyaluronidase enhances CSPG4 CAR-T cells cytotoxicity against chordoma</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7030</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7031</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7032</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/7032.jpg</image:loc><image:title>DAPK3-DCAF1 pathway regulates ZBP1 protein stability to orchestrate innate immune responses and PANoptosis</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7033</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7034</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7035</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7036</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7037</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7038</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7039</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/7039.jpg</image:loc><image:title>Targeting the tumor immune microenvironment to promote efficacy of chemo agents against breast cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7040</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7041</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7042</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7043</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7044</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/7044.jpg</image:loc><image:title>M4N as a potential anti-inflammatory therapy for KDM6A-deficient bladder cancer</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7045</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7046</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.5</priority></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7047</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/7047.jpg</image:loc><image:title>Angiogenic profile associated with KRAS dependency upon modulation of TIMP1</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7048</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/7048.jpg</image:loc><image:title>Targeting the extracellular matrix in Wilms tumor</image:title></image:image></url>
<url><loc>https://www.posterkeep.com/c/aacr-2026/p/7049</loc><lastmod>2026-07-09</lastmod><changefreq>monthly</changefreq><priority>0.7</priority><image:image><image:loc>https://www.posterkeep.com/web/thumbs/7049.jpg</image:loc><image:title>A CCL20-high chemokine program defines a CCR6&amp;#8314; immune-myeloid niche in gastric cancer</image:title></image:image></url>
</urlset>